Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7529682399742643,-2.9216522235823477,0.0,0.0,0.0,63/87,13.00%,RPLP1;RPS16;RPL41;RPS14;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL10;RPL27A;RPS9;RPS3;RPL37A;RPL38;RPL39;RPL18A;RPL11;RPS8;RPL32;RPS10;RPS28;RPL17;RPL23;RPS15A;RPL14;RPS5;RPL21;RPS27A;RPS24;RPL18;RPS13;RPS19;RPL35;RPL27;RPL23A;RPL34;RPL29;RPL8;RPL35A;RPL31;RPS18;RPS20;RPL13A;RPL12;SEC63;RPL10A;RPL36;RPS7;RPS6;RPL3;RPL15
prerank,cytoplasmic translation (GO:0002181),-0.7449656434331521,-2.9035853008773267,0.0,0.0,0.0,65/91,13.00%,RPLP1;RPS16;RPL41;RPS14;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL10;RPL27A;RPS9;RPS3;RPL37A;RPL38;RPL39;RPL18A;RPL11;RPS8;RPL32;RPS10;RPS28;RPL17;RPL23;RPS15A;RPL14;RPS5;RPL21;RPS27A;RPS24;RPL18;RPS13;RPS19;RPL35;RPL27;RPL23A;RPL34;RPL29;RPL8;RPL35A;RPL31;RPS18;RPL22L1;RPS20;RPL13A;RPL12;ZC3H15;RPL10A;EIF3I;RPL36;RPS7;RPS6;RPL3;RPL15
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.741435867748187,-2.886188767923489,0.0,0.0,0.0,63/91,13.00%,RPLP1;RPS16;RPL41;RPS14;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL10;RPL27A;RPS9;RPS3;RPL37A;RPL38;RPL39;RPL18A;RPL11;RPS8;RPL32;RPS10;RPS28;RPL17;RPL23;RPS15A;RPL14;RPS5;RPL21;RPS27A;RPS24;RPL18;RPS13;RPS19;RPL35;RPL27;RPL23A;RPL34;RPL29;RPL8;RPL35A;RPL31;RPS18;RPS20;RPL13A;RPL12;SEC63;RPL10A;RPL36;RPS7;RPS6;RPL3;RPL15
prerank,protein targeting to ER (GO:0045047),-0.7206870899347444,-2.8401965822440225,0.0,0.0,0.0,64/99,13.00%,RPLP1;RPS16;RPL41;RPS14;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL10;RPL27A;RPS9;RPS3;RPL37A;RPL38;RPL39;RPL18A;RPL11;RPS8;RPL32;RPS10;RPS28;RPL17;RPL23;RPS15A;RPL14;RPS5;RPL21;RPS27A;RPS24;RPL18;RPS13;RPS19;RPL35;RPL27;RPL23A;RPL34;RPL29;RPL8;SPCS1;RPL35A;RPL31;RPS18;RPS20;RPL13A;RPL12;SEC63;RPL10A;RPL36;RPS7;RPS6;RPL3;RPL15
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6891479324003513,-2.7659134831423042,0.0,0.0,0.0,70/110,13.68%,RPLP1;RPS16;RPL41;RPS14;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL10;RPL27A;RPS9;RPS3;RPL37A;RPL38;RPL39;RPL18A;RPL11;RPS8;RPL32;RPS10;RPS28;RPL17;RPL23;RPS15A;RPL14;RPS5;RPL21;RPS27A;RPS24;RPL18;RPS13;RPS19;RPL35;PPP2R1A;RPL27;RPL23A;RPL34;RPL29;RPL8;RPL35A;RPL31;RPS18;PNRC2;RPS20;RPL13A;RPL12;SMG9;RPL10A;RPL36;UPF3A;RPS7;RPS6;RPL3;RNPS1;RPL15;SMG8;PPP2R2A;MAGOH
prerank,peptide biosynthetic process (GO:0043043),-0.6444498967363352,-2.7102457998638183,0.0,0.0,0.0,77/153,13.07%,EEF1A1;DMD;RPLP1;RPS16;RPL41;RPS14;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL10;RPL27A;RPS9;RPS3;RPL37A;RPL38;RPL39;RPL18A;RPL11;RPS8;RPL32;RPS10;RPS28;RPL17;RPL23;RPS15A;RPL14;RPS5;SARS1;RPL21;RPS27A;RPS24;RPL18;RPS13;RPS19;RPL35;RPL27;GGTA1;MRPL52;RPL23A;RPL34;RPL29;RPL8;RPL35A;RPL31;HBS1L;RPS18;MRPL51;WARS1;CARNS1;MRPL28;RPS20;RPL13A;RPL12;GGT5;RPS6KB2;RPL10A;RPL36;RPS7;MRPL43;COPS5;RPS6;RPL3;RPL15;MRPL32
prerank,translation (GO:0006412),-0.5713739364313369,-2.5065221413309247,0.0,0.0,0.0,93/208,15.58%,EEF1A1;RPLP1;RPS16;RPL41;RPS14;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;EEF2;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL10;RPL27A;RPS9;RPS3;RPL37A;RPL38;RPL39;RPL18A;RPL11;RPS8;RPL32;RPS10;RPS28;RPL17;RPL23;RPS15A;RPL14;RPS5;QRSL1;SARS1;RPL21;RPS27A;RPS24;RPL18;RPS13;RPS19;RPL35;RPL27;PTCD3;MRPL52;RPL23A;WARS2;RPL34;RPL29;EEF1D;RPL8;RPL35A;RPL31;HBS1L;RPS18;MRPL51;EEFSEC;RPL22L1;CARS1;LARS2;WARS1;MRPL28;RPS20;RPL13A;RPL12;ZC3H15;RPS6KB2;EEF1B2;RPL10A;RPL36;RPS7;MRPL43;TSFM;COPS5;RPS6;SARS2;RPL3;GATC;RPL15;MRPL32;TARS1;RPL22;MRPS17;MRPL24;FARS2;RPL24
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5689800042013279,-2.4369442140876427,0.0,0.0,0.0,76/168,13.68%,DDX5;RPLP1;RPS16;RPL41;RPS14;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL10;RPL27A;RPS9;RPS3;RPL37A;RPL38;RPL39;RPL18A;RPL11;RPS8;RPL32;RPS10;RPS28;RPL17;RPL23;RPS15A;RPL14;RPS5;RPL21;RPS27A;RPS24;RPL18;RPS13;RPS19;RPL35;CNOT7;PPP2R1A;RPL27;DCPS;RPL23A;RPL34;RPL29;RPL8;ERI1;RC3H1;RPL35A;RPL31;RPS18;PNRC2;RPS20;RPL13A;RPL12;SMG9;DIS3L2;RPL10A;RPL36;UPF3A;RPS7;RPS6;RPL3;RNPS1;RPL15;SMG8;PPP2R2A;MAGOH
prerank,cellular response to copper ion (GO:0071280),-0.8394622741896189,-2.2493114754127643,0.0,0.0,0.0,9/16,3.88%,MT1E;MT1F;MT1M;MT1G;MT1H;MT1A;MT1X;MT1B;MT2A
prerank,regulation of bone mineralization (GO:0030500),0.6265733350080267,2.174601721587264,0.0,0.016735141380474956,0.018,15/55,2.20%,BMP6;ENPP1;ADGRV1;NELL1;WNT4;NOTUM;BMP2;PTN;FBN2;DDR2;SLC8A1;BCOR;CYP27B1;KL;AHSG
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.8493250116847082,2.149516229097656,0.0,0.01506162724242746,0.032,5/13,0.75%,LTBP1;GREM2;FBN1;BMP2;FBN2
prerank,response to copper ion (GO:0046688),-0.7603057014345209,-2.144935178553256,0.0,0.0005732998706542634,0.005,10/20,4.84%,MT1E;MT1F;MT1M;MT1G;MT1H;MT1A;MT1X;MT1B;MT2A;ATP5F1D
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.6451066172415041,-2.117677885889321,0.0,0.0008338907209516558,0.007,20/36,20.78%,CAV1;NOS3;NOSTRIN;SCARB1;GCH1;CALM1;AKT1;S100A1;WASL;APOE;LYPLA1;NPR3;EGFR;HSP90AA1;SPR;NOSIP;CYGB;NUS1;DNM2;DDAH1
prerank,rRNA processing (GO:0006364),-0.49125584541222744,-2.11215143381026,0.0,0.001242149719750904,0.012,87/172,25.59%,RPLP1;RPS16;RPL41;RPS14;RPL6;RPL26;RPL19;RPL13;RPS25;RPS15;RPL28;NOP14;RPL30;RPS27;RPL10;RPL27A;RPS9;RPL37A;RPL38;RPL39;RPL18A;RPL11;RPL32;RPS28;RPL17;RPL23;RPL14;RRP15;RPL21;RPS24;RPL18;RPS19;RPL35;MTREX;RPL27;RPL23A;RPL34;PRKDC;RPL29;RPL8;ERI1;RPL35A;RPL31;THUMPD1;NOP56;NOP2;WDR18;RPL13A;RPL12;UTP14A;NOB1;PES1;DHX37;PELP1;RPL10A;RPL36;RPS7;RPS6;DKC1;RPL3;RPL15;RPL22;MDN1;RPL24;WDR74;EMG1;EXOSC8;RPLP2;RPL7;RPL5;HELQ;WDR12;NSA2;DDX10;UTP4;DDX49;PWP2;PIH1D2;TBL3;MRM2;WDR55;RPL7A;DDX47;RSL1D1;UTP15;DIS3;RIOK2
prerank,rRNA metabolic process (GO:0016072),-0.490063274138084,-2.1062302685976064,0.0,0.0014111996816104943,0.015,77/160,24.09%,RPLP1;RPS16;RPL41;RPS14;RPL6;RPL26;RPL19;RPL13;RPS25;RPS15;RPL28;NOP14;RPL30;RPS27;RPL10;RPL27A;RPS9;RPL37A;RPL38;RPL39;RPL18A;RPL11;RPL32;RPS28;RPL17;RPL23;RPL14;RPL21;RPS24;RPL18;RPS19;RPL35;MTREX;RPL27;RPL23A;RPL34;RPL29;RPL8;RPL35A;RPL31;NOP56;WDR18;RPL13A;RPL12;UTP14A;NOB1;PES1;DHX37;PELP1;RPL10A;RPL36;RPS7;RPS6;DKC1;RPL3;RPL15;RPL22;MDN1;RPL24;WDR74;EMG1;EXOSC8;RPLP2;RPL7;RPL5;HELQ;WDR12;DDX10;UTP4;DDX49;PWP2;PIH1D2;TBL3;MRM2;WDR55;RPL7A;DDX47
prerank,establishment of endothelial barrier (GO:0061028),-0.676294141093198,-2.080769694350418,0.0,0.0022931994826170536,0.026,13/29,9.33%,PECAM1;RAP1A;RAP1B;F11R;PDE4D;RAPGEF1;TJP2;PPP1R16B;PDE2A;MSN;ROBO4;EZR;SOX18
prerank,positive regulation of bone mineralization (GO:0030501),0.6526302453914227,2.067083955209475,0.0,0.06024650896970985,0.169,9/35,2.01%,BMP6;ADGRV1;NELL1;WNT4;BMP2;PTN;FBN2;SLC8A1;KL
prerank,membrane lipid biosynthetic process (GO:0046467),-0.5836807201469956,-2.0599806370175147,0.0,0.0038984391204489907,0.047,20/58,13.30%,SGMS1;ST3GAL4;CERT1;SGMS2;ACER2;SPTLC2;DEGS2;ELOVL7;PLPP1;CSNK1G2;PRKD3;SPTLC1;ST8SIA6;KDSR;SPTSSB;SPNS2;ELOVL5;ACER3;SPHK2;SGPL1
prerank,cellular response to zinc ion (GO:0071294),-0.7875299890540847,-2.040198665235777,0.0,0.005589673738879067,0.07,9/15,3.88%,MT1E;MT1F;MT1M;MT1G;MT1H;MT1A;MT1X;MT1B;MT2A
prerank,positive regulation of biomineral tissue development (GO:0070169),0.6233622428293664,2.039931116450767,0.0,0.07405300060860168,0.264,9/40,2.01%,BMP6;ADGRV1;NELL1;WNT4;BMP2;PTN;FBN2;SLC8A1;KL
prerank,positive regulation of synapse assembly (GO:0051965),0.6897626018427276,2.0342012403604572,0.0,0.06576910562526658,0.291,14/27,11.04%,SRPX2;GRID2;NRXN1;CLSTN2;PTPRD;IL1RAP;SYNDIG1;NLGN2;NLGN3;IL1RAPL1;EPHB1;NLGN1;CUX2;VSTM5
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.6959566372631814,-2.0335354595727417,0.0,0.005935339837361785,0.077,9/22,8.69%,TMSB4X;KANK3;CYRIB;SLIT2;KANK4;SSH2;HIP1R;PFN1;TMSB10
prerank,activation of protein kinase A activity (GO:0034199),0.7661537135014074,2.033113627378137,0.0,0.0560627236245911,0.296,5/16,2.74%,ADCY7;ADCY2;ADCY1;ADCY5;PRKACA
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.4425041533697091,-2.021559627347085,0.0,0.007198098375992418,0.098,134/306,24.31%,ST3GAL4;EEF1A1;RPLP1;RPS16;RPL41;RPS14;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;MEF2A;RPS25;EEF2;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL10;RPL27A;RPS9;RPS3;RPL37A;RPL38;RPL39;RPL18A;RPL11;RPS8;RPL32;RPS10;RPS28;RPL17;RPL23;RPS15A;NR4A2;RPL14;RPS5;SARS1;RPL21;RPS27A;RPS24;ING5;RPL18;RPS13;RPS19;PTMA;RPL35;RPL27;MRPL52;RPL23A;RPL34;RPL29;EEF1D;RPL8;RPL35A;RPL31;RAD1;HBS1L;RPS18;MRPL51;EEFSEC;WARS1;MRPL28;RPS20;FAM111A;RPL13A;RPL12;RPS6KB2;INHBA;XAB2;EEF1B2;RPL10A;RPL36;PPP5C;RPS7;MRPL43;TSFM;COPS5;RPS6;EPC1;RPL3;RNPS1;E2F1;RPL15;MRPL32;PTMS;APOE;RAD9B;HUS1;RPL22;POLR3A;MRPS17;MRPL24;RPA3;RPL24;RAD9A;RAD17;RPS26;MED20;CHEK1;RPLP2;MRPS18C;RPL7;RPL5;TYMS;PWP1;MRPL35;ALAS2;MRPS18A;MRPS6;RHNO1;DHPS;MLF1;MRPL13;RFC3;EIF4G1;TUFM;FARSB;MRPL11;RRAGC;RFC2;MCM5;LARGE1;RPL7A;POLL;GOLPH3;EXO1;HOXD3
prerank,tight junction assembly (GO:0120192),-0.577156838321842,-2.0030136858221006,0.0,0.010138355607359605,0.142,9/49,2.72%,PECAM1;OCLN;CLDN5;ESAM;LSR;ACTG1;PARD3;F11R;RAMP2
prerank,positive regulation of ossification (GO:0045778),0.6202310251216442,1.9976980277183893,0.0,0.08403431707481353,0.452,9/39,2.01%,BMP6;ADGRV1;NELL1;WNT4;BMP2;PTN;FBN2;SLC8A1;KL
prerank,ribosome assembly (GO:0042255),-0.5812080973070828,-1.9952153503156322,0.0,0.011007357516561856,0.162,20/47,15.58%,RPS14;RPL6;RPSA;RPS15;RPS27;RPL10;RPL11;RPS28;RPS5;RPS19;RPL23A;NOP2;RPS27L;DHX37;RPL3;PPAN;MTERF3;ERAL1;MDN1;RPL24
prerank,maintenance of blood-brain barrier (GO:0035633),-0.6365314688551141,-1.9890170172177677,0.0,0.011465997413085268,0.176,15/30,6.59%,PECAM1;ACTB;OCLN;CLDN5;ESAM;SLC12A2;JAM2;DMD;LSR;ACTG1;F11R;TJP2;JAM3;SLC1A1;MFSD2A
prerank,response to cadmium ion (GO:0046686),-0.6607807832619736,-1.98092001106329,0.0,0.012143533623858489,0.193,10/26,3.88%,MT1E;MT1F;MT1M;MT1G;MT1H;MT1A;MT1X;MT1B;MAPK3;MT2A
prerank,cellular response to glucagon stimulus (GO:0071377),0.7324509574277839,1.9808325160373614,0.0,0.09444895416605553,0.538,5/17,2.74%,ADCY7;ADCY2;ADCY1;ADCY5;PRKACA
prerank,cellular zinc ion homeostasis (GO:0006882),-0.6554258335103473,-1.9757977686694044,0.0018315018315018315,0.013011414455718497,0.213,11/26,5.21%,SLC39A10;MT1E;MT1F;MT1M;MT1G;MT1H;MT1A;MT1X;MT1B;MT2A;SLC39A8
prerank,axonal fasciculation (GO:0007413),0.7944812565452111,1.9706739277799843,0.0,0.0960411169223924,0.589,7/12,11.90%,SEMA5A;CNTN4;EPHA3;RTN4;NRCAM;CDK5R1;AMIGO1
prerank,regulation of synapse assembly (GO:0051963),0.5831882287771996,1.9674069214917982,0.0,0.0902860877476624,0.6,17/46,10.98%,GPC6;SRPX2;ROBO2;GRID2;NRXN1;CLSTN2;GPC4;PTPRD;IL1RAP;SYNDIG1;NLGN2;NLGN3;IL1RAPL1;EPHB1;NLGN1;CUX2;MUSK
prerank,presynapse assembly (GO:0099054),0.7583478118082295,1.9539057315030424,0.0,0.10185615594752713,0.671,8/16,10.32%,LRP4;PTPRD;LRRTM3;NLGN2;NLGN3;IL1RAPL1;NLGN1;PTEN
prerank,neurotransmitter uptake (GO:0001504),0.7996064713259173,1.953491858460544,0.0,0.09385625124216372,0.674,7/12,9.05%,SLC1A3;ATP1A2;SLC29A1;SLC22A3;SLC38A1;SNAP25;GLUL
prerank,negative regulation of reproductive process (GO:2000242),0.7442229279444735,1.949823498740936,0.002127659574468085,0.09075595902488341,0.691,4/17,1.64%,IGF1;SULF1;HYAL3;GJA1
prerank,skeletal system development (GO:0001501),0.4818189000236203,1.9455643982517232,0.0,0.08881578604066352,0.705,42/148,12.29%,IGF1;BMP6;COL13A1;FBN1;NOTUM;BMP2;TBX3;COL1A2;FGFR2;SULF1;BMP5;HYAL3;SULF2;TRPS1;GJA1;MATN3;GLI2;AHSG;CHD7;SH3PXD2B;MMP16;ANKRD11;EVC;CDH11;ANKH;SPEF2;COL10A1;TGFBR1;PAPSS1;SOX5;IGF2;HES5;CNMD;FRZB;RAB33B;PAX1;COL9A2;UFD1;EXTL1;FGFR1;VCAN;SUFU
prerank,cellular response to cadmium ion (GO:0071276),-0.661999823199025,-1.9423765226658833,0.0,0.020925445278880614,0.323,10/24,3.88%,MT1E;MT1F;MT1M;MT1G;MT1H;MT1A;MT1X;MT1B;MAPK3;MT2A
prerank,diol biosynthetic process (GO:0034312),-0.7294341715689537,-1.9365249322583304,0.0,0.02284026684686585,0.361,9/15,16.75%,ACER2;SPTLC2;GCH1;SPTLC1;ASAH2;ACER3;SPHK2;ABCA2;SPR
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.6952514543762169,-1.9359953649841852,0.0,0.022094095015214303,0.363,9/19,11.72%,IFIH1;MAP2K5;LIFR;KLF4;ELF1;IRAK2;CBFB;DHX9;MAVS
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.653022268946364,-1.9331194760686743,0.0018450184501845018,0.02242239494114452,0.378,13/26,16.75%,ACER2;SPTLC2;NOS3;GCH1;SPTLC1;CYP1B1;ASAH2;AKT1;ACER3;SPHK2;ABCA2;NQO1;SPR
prerank,negative regulation of growth (GO:0045926),-0.46503190489335866,-1.9263639146722202,0.0,0.023996694585957025,0.412,53/121,20.19%,APBB2;PTPRJ;NOTCH1;SERTAD2;OSGIN2;RACK1;BMPR2;SH3BP4;FHL1;MT1E;MT1F;MT1M;MT1G;MT1H;MT1A;MT1X;MT1B;CCN3;SOX17;SLIT2;NPR1;ADAM15;MT2A;CDKN1B;TGFB1;TGFB2;ING5;PPP2R1A;NDUFA13;SIPA1;RB1;WFDC1;BCL6;WNT11;CRLF3;CCDC85B;INHBA;SPHK2;NDUFS3;SMARCA4;OSGIN1;SMAD4;CDKN2AIP;SMARCA2;CDKN1A;HSPA1A;CDKN2C;CCAR2;NME6;ESR2;TSPYL2;MSX1;NDRG3
prerank,cAMP biosynthetic process (GO:0006171),0.8351403028479488,1.919991187361314,0.0,0.11469150226085505,0.804,4/10,1.34%,ADCY7;ADCY2;ADCY1;ADCY5
prerank,response to glucagon (GO:0033762),0.693010108081039,1.9190972588890782,0.0,0.10856922970583127,0.805,5/19,2.74%,ADCY7;ADCY2;ADCY1;ADCY5;PRKACA
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.5856488500061348,-1.9177733969340778,0.0,0.026648559504894722,0.468,28/39,33.31%,RPS16;RPS14;RPSA;RPS25;RPS15;NOP14;RPS27;RPS28;RPS5;RPS24;RPS19;NOB1;RPS27L;RPS7;RPS6;ERAL1;EMG1;UTP4;PWP2;NOM1;RIOK2;NPM1;RIOK1;LTV1;RIOK3;LSM6;RRP7A;RRP36
prerank,cellular response to mechanical stimulus (GO:0071260),-0.5594294725110348,-1.9170071752220605,0.0,0.02618069409321136,0.47,21/46,22.07%,PIEZO2;F11R;MAPK3;PIEZO1;MAP3K1;CRADD;PDE2A;CASP8;TLR3;FAS;MAP3K2;TLR4;BAK1;TNFRSF1A;BAD;CHEK1;SOX9;PTGER4;GADD45A;LTBR;CASP1
prerank,zinc ion homeostasis (GO:0055069),-0.6142840115952467,-1.9164625300262499,0.0018018018018018018,0.025447116839363435,0.471,11/28,5.21%,SLC39A10;MT1E;MT1F;MT1M;MT1G;MT1H;MT1A;MT1X;MT1B;MT2A;SLC39A8
prerank,neuron projection fasciculation (GO:0106030),0.8049713963731662,1.9152365315207607,0.0022271714922048997,0.10715412583909995,0.811,6/10,11.90%,SEMA5A;CNTN4;RTN4;NRCAM;CDK5R1;AMIGO1
prerank,regulation of protein processing (GO:0070613),0.6640343227400992,1.9130634105760782,0.0042643923240938165,0.10501301216248035,0.816,2/21,1.56%,CCBE1;SERPINE2
prerank,negative regulation of vascular permeability (GO:0043116),-0.7762156088160725,-1.909773251244857,0.0017921146953405018,0.027518393791404642,0.505,7/12,5.80%,CLDN5;PTPRJ;RAMP2;SLIT2;FERMT2;PDE2A;VEGFA
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.6728584995760005,1.9093936537342726,0.0,0.10362575702173045,0.827,4/24,1.55%,CCBE1;RORA;SULF1;SULF2
prerank,ribosome biogenesis (GO:0042254),-0.44006260989827073,-1.9061614327094936,0.0,0.028352284512356298,0.529,57/187,13.00%,RPLP1;RPS16;RPL41;RPS14;RPL6;RPL26;RPL19;RPL13;RPS25;RPS15;RPL28;NOP14;RPL30;RPS27;RPL10;RPL27A;RPS9;RPL37A;RPL38;RPL39;RPL18A;RPL11;RPL32;RPS28;RPL17;RPL23;RPL14;RPL21;RPS24;RPL18;RPS19;RPL35;MTREX;RPL27;RPL23A;RPL34;RPL29;RPL8;RPL35A;RPL31;CUL4A;NOP56;WDR18;RPL13A;RPL12;UTP14A;NOB1;PES1;DHX37;PELP1;RPL10A;RPL36;RPS7;RPS6;DKC1;RPL3;RPL15
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.5490574197113701,1.9049215343054857,0.0,0.10421809294690779,0.839,13/57,13.03%,ADCY7;ADCY2;ADCY1;LPAR1;ADCY5;GNAI1;CHRM2;OPRK1;CHRM3;ADCY8;HTR4;HTR5A;GRM4
prerank,gene expression (GO:0010467),-0.4109616002920228,-1.903524971375695,0.0,0.028799887619925937,0.546,151/348,24.63%,TSPAN5;EEF1A1;RPLP1;RPS16;RPL41;RPS14;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;MEF2A;RPS25;RPS15;RPL28;RPL30;RPS21;RPS4X;RPS27;RPL10;RPL27A;RPS9;RPS3;RPL37A;RPL38;HNRNPA2B1;RPL39;RPL18A;RPL11;ADAR;RPS8;RPL32;RPS10;RPS28;RPL17;RPL23;DDX17;RPS15A;NR4A2;RPL14;RPS5;SARS1;RPL21;RPS27A;RPS24;RPL18;RPS13;RPS19;PTMA;RPL35;SRSF5;SRSF2;RPL27;MRPL52;RPL23A;RPL34;RPL29;RPL8;NUP93;RPL35A;RPL31;HBS1L;RPS18;MRPL51;SRSF6;WARS1;HHEX;NUP54;NDC1;MRPL28;RPS20;RPL13A;RPL12;U2AF1;HSPD1;TSPAN14;RPS6KB2;XAB2;RPL10A;ZC3H11A;RPL36;PPP5C;LMF2;RPS7;MRPL43;COPS5;RPS6;DKC1;EPC1;RPL3;RNPS1;E2F1;RBMS2;RPL15;MRPL32;RBM6;SRSF4;MAGOH;NUP188;CHTOP;NUP155;RANBP2;RPL22;POLR3A;MRPS17;MRPL24;ALYREF;TSPAN17;HNRNPK;RPL24;DDX39B;AGFG1;DDX20;NUP37;RPS26;MED20;DUSP11;RPLP2;CASC3;MRPS18C;RPL7;RPL5;PWP1;MRPL35;CPSF4;THOC6;SMG7;NUP160;MRPS18A;MRPS6;DDX39A;DHPS;MLF1;MRPL13;EIF4G1;FARSB;MRPL11;SYNCRIP;NCBP2;RRAGC;RPL7A;SMG1;GOLPH3;HOXD3;NUP43;SEH1L;EIF4E
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.5698568242194022,1.901925367900747,0.0,0.10359849426008307,0.854,8/43,3.29%,IGF1;BMP6;NELL1;WNT4;BMP2;FBN2;DDR2;CCN4
prerank,neuron cell-cell adhesion (GO:0007158),0.7456988137876771,1.9014070585925227,0.009302325581395349,0.09957409121382599,0.855,9/14,9.52%,NRXN1;CNTN4;NCAM2;ASTN2;NLGN2;NLGN3;NRXN3;NLGN1;CDK5R1
prerank,cell-substrate junction assembly (GO:0007044),-0.5894134153173148,-1.8942827694097408,0.0,0.03223583272707401,0.594,14/33,11.68%,FN1;ITGA6;THSD1;SORBS1;PEAK1;FERMT2;ITGB4;LAMA3;CD151;ACTN1;BCR;LAMC2;TAOK2;RCC2
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.5115552064313778,-1.8936589972456306,0.0,0.03156334287879861,0.595,21/67,11.34%,UTRN;FN1;CDK6;LIMS2;RREB1;VIT;DOCK1;PTK2B;FERMT2;NEDD9;RAC1;LIMS1;CRK;MYOC;NPNT;JUP;PPM1F;S100A10;EMP2;FBLN2;CIB1
prerank,sphingosine biosynthetic process (GO:0046512),-0.7771958031109909,-1.8898523291395262,0.0,0.031591840240790196,0.614,7/11,13.23%,ACER2;SPTLC2;SPTLC1;ASAH2;ACER3;SPHK2;ABCA2
prerank,sphingoid biosynthetic process (GO:0046520),-0.7771958031109909,-1.8898523291395262,0.0,0.031591840240790196,0.614,7/11,13.23%,ACER2;SPTLC2;SPTLC1;ASAH2;ACER3;SPHK2;ABCA2
prerank,ribosomal small subunit assembly (GO:0000028),-0.7264906539048263,-1.8855163346055233,0.0,0.033045592544379075,0.638,10/16,14.44%,RPS14;RPSA;RPS15;RPS27;RPS28;RPS5;RPS19;PRKDC;RPS27L;ERAL1
prerank,renal water homeostasis (GO:0003091),0.6602670560374823,1.8814328766130652,0.002178649237472767,0.1208204446186029,0.913,5/23,2.74%,ADCY7;ADCY2;ADCY1;ADCY5;PRKACA
prerank,positive regulation of nervous system development (GO:0051962),0.5746338486757685,1.8757445825351542,0.0,0.12401437060489462,0.925,14/42,10.15%,SRPX2;GRID2;NRXN1;CLSTN2;SERPINF1;PTPRD;IL1RAP;SYNDIG1;NLGN2;NLGN3;IL1RAPL1;EPHB1;NLGN1;CUX2
prerank,positive regulation of protein processing (GO:0010954),0.6785097864098677,1.8756924161584063,0.004282655246252677,0.11912073634622074,0.926,2/19,0.77%,CCBE1;CLEC3B
prerank,ncRNA processing (GO:0034470),-0.42919659600525356,-1.873214041937702,0.0,0.03866907627563006,0.706,90/200,25.58%,RPLP1;RPS16;RPL41;RPS14;RPL6;RPL26;RPL19;RPL13;RPS25;RPS15;RPL28;NOP14;RPL30;RPS27;RPL10;RPL27A;RPS9;RPL37A;RPL38;HNRNPA2B1;RPL39;RPL18A;RPL11;ADAR;RPL32;RPS28;RPL17;RPL23;RPL14;SARS1;RPL21;RPS24;RPL18;RPS19;RPL35;MTREX;RPL27;RPL23A;RPL34;RPL29;RPL8;RPL35A;RPL31;NOP56;WDR18;RPL13A;RPL12;UTP14A;NOB1;PES1;DHX37;PELP1;INTS8;RPL10A;RPL36;RPS7;RPS6;DKC1;RPL3;RPL15;INTS1;RPL22;MDN1;FARS2;RPL24;WDR74;EMG1;EXOSC8;TRPT1;RPLP2;RPL7;RPL5;HELQ;RPP21;WDR12;SMAD2;DDX10;UTP4;DDX49;PWP2;PIH1D2;TBL3;MRM2;WDR55;RPL7A;DDX47;UTP15;ADAT1;SMAD1;DIS3
prerank,regulation of glucose import (GO:0046324),0.6055761615908204,1.8695786850272598,0.002257336343115124,0.1239044121439011,0.941,7/30,5.58%,IGF1;ENPP1;PIK3R1;PID1;PRKAG2;OSBPL8;IRS2
prerank,embryonic digestive tract development (GO:0048566),0.6885719598198015,1.8672112356317214,0.00437636761487965,0.12312725315671667,0.943,6/18,3.50%,SALL1;FGFR2;RARB;PDGFRA;GLI2;GLI3
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7687619475637764,-1.861691445568003,0.0,0.045108911773918375,0.77,7/12,14.26%,CAV1;PDE4D;CAMK2D;CALM1;GJD3;CALM3;SRI
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.6719889614729774,1.8594246254879438,0.0021691973969631237,0.12996630332800999,0.955,3/19,1.79%,CCBE1;ROBO1;DCN
prerank,synaptic membrane adhesion (GO:0099560),0.7176078994358325,1.8538489302545678,0.006578947368421052,0.13448705857654097,0.965,4/14,3.72%,GPC6;LRRC4C;GPC4;PTPRD
prerank,cAMP metabolic process (GO:0046058),0.7415534614863273,1.8521174657714,0.0,0.13254231973336167,0.966,4/13,1.34%,ADCY7;ADCY2;ADCY1;ADCY5
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.719054337628366,1.851841681427094,0.002145922746781116,0.12886058862965716,0.967,6/16,5.19%,IGF1;IGFBP2;BMP2;BMP5;PHIP;MYORG
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.663243559520445,-1.8496476922149745,0.00186219739292365,0.052197588223378645,0.821,10/18,16.53%,MSN;CD81;EZR;CTSC;PTTG1IP;ABCA2;APOE;VPS11;ATP5IF1;HSP90AA1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6415674501933288,1.8476001852131718,0.0,0.13142315715354239,0.972,4/26,1.55%,CCBE1;RORA;SULF1;SULF2
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.5731980014066879,-1.8449345708238363,0.005208333333333333,0.05431682960570858,0.834,19/37,21.20%,HSP90AB1;RPL11;RPL23;N4BP1;USP7;GIPC1;CAMLG;DDRGK1;BAG5;UBXN1;RPS7;SGTA;SDCBP;CSNK2A1;CSNK2A2;CCAR2;MAP1A;RPL5;TAF9
prerank,negative regulation of viral life cycle (GO:1903901),-0.7077064795132104,-1.8447375900004535,0.003683241252302026,0.053212651630727546,0.834,8/15,19.81%,LY6E;MID2;PPIA;IFITM1;IFITM3;IFITM2;TRIM5;SNX3
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.6611154021096195,-1.84266829502595,0.0037243947858473,0.053915667835752044,0.842,7/18,4.94%,TEK;RACK1;RAP1B;PTK2B;CYRIB;SHTN1;BCAS3
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.7338531608688592,-1.836084304484544,0.0018484288354898336,0.05740476530942471,0.866,6/12,11.83%,FOXP1;MAP2K5;KLF4;CD74;TIRAP;TLR4
prerank,negative regulation of signaling receptor activity (GO:2000272),0.6209685395880066,1.83569445768884,0.008421052631578947,0.14397292842172243,0.982,7/25,7.86%,ERRFI1;SLC6A9;CBLB;PPARA;VPS25;CALCR;ZFYVE28
prerank,apical junction assembly (GO:0043297),-0.5144771118722976,-1.835293778488768,0.0,0.056915259499421125,0.866,16/53,19.77%,PECAM1;OCLN;CLDN5;ESAM;PARD3;F11R;CTNNA1;RAMP2;WDR1;VCL;CLDN11;STRN;CLDN10;ECT2;ARL2;CDH5
prerank,activation of adenylate cyclase activity (GO:0007190),0.5754210721301577,1.835239926163107,0.006048387096774193,0.14040291408177888,0.983,5/35,1.34%,ADCY7;ADCY2;ADCY1;LGR4;ADCY5
prerank,amide transport (GO:0042886),-0.5987388071748174,-1.8348998677386674,0.001834862385321101,0.05606394985106483,0.866,6/26,5.92%,ABCG2;CERT1;PLTP;SLC5A6;SLC38A5;AQP11
prerank,endothelial cell development (GO:0001885),-0.6139409497759696,-1.8344224522573909,0.0,0.05527078753001511,0.868,12/25,9.33%,PECAM1;RAP1A;RAP1B;PDE4D;RAPGEF1;PPP1R16B;PDE2A;MSN;ROBO4;COL18A1;EZR;SOX18
prerank,negative regulation of protein polymerization (GO:0032272),-0.5895179493958536,-1.8304187760873558,0.0019342359767891683,0.057284123075774,0.878,8/27,8.49%,KANK3;CYRIB;SLIT2;KANK4;SSH2;HIP1R;STMN2;PFN1
prerank,diterpenoid metabolic process (GO:0016101),0.52842133952817,1.82799604162806,0.002012072434607646,0.1482255379413496,0.988,8/55,4.15%,ALDH1A1;GPC6;AKR1B1;LRP1;DHRS3;GPC4;ABCA4;GPC2
prerank,cellular response to ketone (GO:1901655),0.5743901717164772,1.8194267484719076,0.00625,0.15896059986259478,0.988,8/35,3.70%,ADCY2;ADCY1;AR;PTGFR;ADCY5;ROCK2;GNAI1;SFRP1
prerank,anterograde trans-synaptic signaling (GO:0098916),0.4170442839488136,1.8109623148061147,0.0,0.168821392439521,0.992,66/224,15.63%,SLC1A3;NOVA1;GRIA4;CACNA1E;NRXN1;PDE7B;PCDHB10;HTR7;CHRNA1;OMP;PRKACA;DLG2;RIT2;GABRA2;GABRR3;UNC13C;CHRNB4;GLRB;GRIK2;CHRM2;OPRK1;GRM1;CAMK4;GABRB3;PCDHB13;DLGAP1;KCND2;NLGN2;HRH1;NLGN3;CHRM3;SYT1;GABRR2;CACNB1;ASIC2;GRIK1;SNAP25;CACNB4;NLGN1;CACNB2;HRH2;MYCBPAP;ATXN3;GABRA5;SLC6A1;GRIA3;CHRNA4;CHRFAM7A;CHRNA7;HTR4;DLG4;PCDHB16;HTR5A;AMPH;APBA1;GRM4;GRIN2A;CHRNB1;SLC1A2;PNOC;GRIA1;GLRA3;GABRG1;HCRT;HCRTR1;GABRB1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.5745321396201498,-1.8088353928526417,0.005813953488372093,0.07491118309882373,0.936,18/32,13.42%,THBS1;NOTCH1;RHOJ;MAP2K5;KDR;STARD13;KLF4;ANXA1;HDAC7;HDAC9;MAP3K3;VEGFA;GATA2;PIK3C2A;JCAD;FOXC2;CIB1;FGF2
prerank,cellular protein metabolic process (GO:0044267),-0.38573074832623255,-1.8079811789828077,0.0,0.0742423332497271,0.94,128/396,15.25%,FN1;ST3GAL6;ST8SIA4;GPC3;EEF1A1;IGFBP7;IGFBP6;RPLP1;RPS16;RPL41;RPS14;RPL6;RPL26;RPL19;RPS11;RPSA;RPS12;RPS23;RPL13;RPS29;RPS25;RPS15;RPL28;MANBA;RPL30;RPS21;RPS4X;RPS27;RPL10;RPL27A;RPS9;RPS3;RPL37A;RPL38;DAB2IP;RPL39;PLOD2;RPL18A;RPL11;APP;IGFBP5;RPS8;RPL32;RPS10;RPS28;RPL17;RPL23;WWP2;RPS15A;MSLN;RPL14;ADAM10;RPS5;SPARCL1;SARS1;RPL21;IGFBP3;RPS27A;RPS24;RPL18;RPS13;RPS19;RPL35;RPL27;LTA4H;SFTPA2;SFTPA1;MRPL52;RPL23A;CSNK1G3;MSRA;RPL34;NUCB1;PRKDC;GATA6;IDE;RPL29;RPL8;SPCS1;RPL35A;DENND3;RPL31;RIPK1;HBS1L;CST3;QSOX1;RPS18;MRPL51;MFGE8;UBE2L6;CPE;WARS1;PSENEN;PNPLA2;SPP1;MRPL28;RPS20;RPL13A;RPL12;UBE2G2;ATG3;ABL2;RPS6KB2;CHRDL1;RPL10A;STK38;RPL36;SEC11A;RPS7;MRPL43;COPS5;ICMT;RPS6;MMP15;RNF5;RPL3;RPL15;FBXL2;MRPL32;APH1A;FUCA2;APOE;LOX;UBE2G1;RPL22;FSTL1;MRPS17;MRPL24
prerank,regulation of steroid biosynthetic process (GO:0050810),0.7736321059054863,1.8067668846905842,0.006437768240343348,0.1715351991498683,0.995,3/11,1.29%,WNT4;BMP2;BMP5
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.6536016241380023,-1.8057530417300431,0.0019723865877712033,0.07517800190654962,0.942,5/18,7.56%,ESR1;DDX5;NCOR1;TGFB1;RIPK1
prerank,bicellular tight junction assembly (GO:0070830),-0.524508615289037,-1.8047387562792114,0.0,0.07480501645611,0.943,7/46,2.72%,PECAM1;OCLN;CLDN5;ESAM;PARD3;F11R;RAMP2
prerank,response to zinc ion (GO:0010043),-0.6048624339776212,-1.8000866979371277,0.0036900369003690036,0.07769776792467052,0.957,10/25,4.50%,MT1E;MT1F;MT1M;MT1G;MT1H;MT1A;MT1X;MT1B;MT2A;CRIP1
prerank,regulation of phospholipase activity (GO:0010517),0.7754668063804007,1.7981507923018145,0.008849557522123894,0.18179083707277477,0.996,4/10,2.31%,FGFR2;LRP1;PLA2G5;PDPK1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.5807474112671867,-1.7981429058332985,0.005154639175257732,0.07837828231659001,0.957,20/30,29.76%,HSP90AB1;RPL11;N4BP1;USP7;GIPC1;SVIP;CAMLG;DDRGK1;BAG5;UBXN1;STYX;SGTA;SDCBP;CCAR2;MAP1A;TAF9;TRIM39;PARK7;FHIT;USP14
prerank,regulation of response to biotic stimulus (GO:0002831),-0.5856944304836167,-1.7961207900825853,0.0036968576709796672,0.07879352959132455,0.96,11/28,14.45%,FOXP1;CD55;N4BP1;ERAP1;GATA6;CASP8;LRP8;TIRAP;DHX58;SAMHD1;TRIM5
prerank,regulation of cell junction assembly (GO:1901888),-0.5937376064469918,-1.7956061845170848,0.0,0.07785016864263755,0.96,10/27,9.46%,PRKCH;MEF2C;OCLN;CLDN5;RAP1A;RAP1B;F11R;RAPGEF1;CBFB;FLOT1
prerank,positive regulation of protein maturation (GO:1903319),0.7324983800106096,1.7923838532909004,0.008733624454148471,0.18730806990096596,0.996,1/11,0.01%,CCBE1
prerank,retinoid metabolic process (GO:0001523),0.4962990142817872,1.7902964090553402,0.0019880715705765406,0.18700500057230734,0.996,9/71,4.15%,ALDH1A1;GPC6;ALDH1A2;AKR1B1;LRP1;DHRS3;GPC4;ABCA4;GPC2
prerank,negative regulation of type I interferon production (GO:0032480),-0.5278215206641265,-1.78576407557868,0.0,0.08632535679478771,0.977,13/40,13.14%,TAX1BP1;IFIH1;TRIM25;REL;NLRC5;RNF125;OTUD5;UBE2L6;YY1;RELB;DHX58;MAVS;ITCH
prerank,sodium-independent organic anion transport (GO:0043252),-0.7593130409064073,-1.7848683211129523,0.0035778175313059034,0.08586121062832017,0.978,4/10,1.30%,SLCO3A1;SLCO2A1;SLCO1C1;SLCO2B1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.6331299325079662,1.7836999066927088,0.008714596949891068,0.19054709813675672,0.997,3/20,3.71%,IGF1;ZBTB20;PFKFB4
prerank,positive regulation of glycolytic process (GO:0045821),0.6331299325079662,1.7836999066927088,0.008714596949891068,0.19054709813675672,0.997,3/20,3.71%,IGF1;ZBTB20;PFKFB4
prerank,endoderm formation (GO:0001706),-0.5581343314270364,-1.7831334018871496,0.001869158878504673,0.08622054120298708,0.98,12/35,14.85%,FN1;COL12A1;SOX17;COL4A2;LAMA3;COL6A1;SOX7;MMP14;INHBA;MMP15;ITGA7;ITGA4
prerank,chemical synaptic transmission (GO:0007268),0.3989592148028005,1.7827350464149148,0.0,0.18792803082028808,0.997,82/284,15.63%,SLC1A3;NOVA1;GRIA4;GRID2;CACNA1E;NRXN1;PDE7B;CDH8;PCDHB10;HTR7;CHRNA1;OMP;RIMS1;PRKACA;DLG2;RIT2;GABRA2;GABRR3;UNC13C;CHRNB4;GLRB;GRIK5;GRIK2;CHRM2;OPRK1;GRM1;CAMK4;GABRB3;PCDHB13;DLGAP1;RIMBP2;KCND2;NLGN2;HRH1;NLGN3;TBC1D24;CHRM3;SYT1;GABRR2;GRID1;CACNB1;ASIC2;GRIK1;SNAP25;CACNB4;NLGN1;CACNB2;HRH2;PDZD11;MYCBPAP;ATXN3;GABRA5;SLC6A1;GRIA3;CHRNA4;PTEN;STAC3;BRSK1;CBLN2;CHRFAM7A;CHRNA7;HTR4;PTPRN2;STXBP3;DLG4;PCDHB16;HTR5A;AMPH;APBA1;GRM4;GRIN2A;CHRNB1;SNAPIN;SLC1A2;PNOC;DRD2;GRIA1;GLRA3;GABRG1;HCRT;HCRTR1;GABRB1
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.4567201265220936,-1.7821716539391146,0.0,0.08601347414235415,0.982,29/92,13.47%,TEK;FOXP1;RREB1;THBS1;NRP2;PLCG2;DOCK1;FGF1;PTK2B;SCARB1;RAB11A;BMPR2;KDR;GPI;ETS1;TGFB2;BCAS3;RAC1;VEGFA;EDN1;PPM1F;FLT4;PFN1;AKT1;RHOB;FOXC2;PRKCE;FGF2;EMC10
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.69105761852461,-1.7806267897692338,0.0037243947858473,0.08657738046674064,0.983,5/14,7.01%,DMD;ACTN4;WNK1;CHP1;ATP1B1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.6871754482402767,-1.7717239562096867,0.0055762081784386614,0.09473780362561701,0.988,5/14,2.56%,THBS1;NOTCH1;MAP2K5;STARD13;KLF4
prerank,diol metabolic process (GO:0034311),-0.657851100885404,-1.7716948186173271,0.00186219739292365,0.09333321894251408,0.988,11/19,20.07%,NOS3;DEGS2;GCH1;CALM1;PLPP1;ASAH2;AKT1;SPHK2;HSP90AA1;SPR;PLPP2
prerank,angiogenesis involved in wound healing (GO:0060055),-0.7335080032633117,-1.7716446810997641,0.0018975332068311196,0.09198857015497952,0.989,8/11,14.53%,ADIPOR2;CD34;KDR;VEGFA;GATA2;PRCP;MCAM;SRF
prerank,response to progesterone (GO:0032570),-0.6446428264594308,-1.7701539622787357,0.0,0.09208736131315197,0.992,7/18,11.65%,CAV1;ABHD2;THBS1;TGFB1;TGFB2;TGFB3;WBP2
prerank,ceramide metabolic process (GO:0006672),-0.5104984543380212,-1.7643206793319155,0.0,0.09744411625032318,0.995,14/49,13.30%,SGMS1;ST6GALNAC3;SGMS2;ACER2;SPTLC2;DEGS2;PLPP1;SPTLC1;PPP2R1A;SPTSSB;ASAH2;ACER3;ABCA2;SGPL1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.6795130976781568,1.7628679611387068,0.018223234624145785,0.22196375850969952,1.0,5/14,10.22%,AUTS2;KMT2A;PRDM9;DNMT1;PAXIP1
prerank,aerobic electron transport chain (GO:0019646),-0.47897517604143164,-1.759601584321234,0.001937984496124031,0.10183135093824133,0.997,38/68,27.14%,COX4I1;NDUFV2;COX7C;COX6B1;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;CYC1;UQCRQ;COX15;NDUFB7;SDHD;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFS3;NDUFB9;NDUFS6;COX6C;NDUFC1;UQCRB;UQCR11;NDUFA4;COX10;NDUFA3;UQCRH;NDUFA10;NDUFB10;COX8A;NDUFB3;NDUFA1;COX4I2;NDUFA7;UQCC3;NDUFA8
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.49395741219992517,-1.7577918207137673,0.0038095238095238095,0.10235859690624262,0.997,23/54,21.17%,CAV1;NXN;RPS3;SMAD7;RPL11;IVNS1ABP;CHP1;SH3RF2;N4BP1;CAMLG;AKT1;DNAJA1;BAG5;UBXN1;SOX4;PRMT3;UFL1;HSPA1A;TNFAIP3;COPS9;USP4;RPL5;HSPA1B
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.606314682263,1.7575418190045902,0.006741573033707865,0.22843467984348317,1.0,3/23,3.71%,IGF1;ZBTB20;PFKFB4
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.4868655051482004,-1.7554590062839088,0.0,0.10363000760530726,0.997,20/64,14.20%,UTRN;CDK6;ACER2;THBS1;ACTG1;LIMCH1;PTK2B;PEAK1;PTK2;ADAM15;MINK1;MYOC;JUP;VCL;EMP2;CIB1;DUSP3;NF1;NEXMIF;LDB1
prerank,retina homeostasis (GO:0001895),-0.607406042050104,-1.752579119026137,0.005494505494505495,0.10561457617164097,0.997,7/23,13.00%,ACTB;POTEF;B2M;ACTG1;HSPB1;WHRN;POC1B
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.6674266520226058,1.7519343126546096,0.0125,0.23683785721750888,1.0,3/16,6.02%,ADCY7;PPARA;ABCD2
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.7621912470785864,-1.7512821690627207,0.0,0.10594267472775361,0.997,7/10,13.75%,NOTCH1;DPP4;FAP;TGFB1;TNFRSF1B;CST3;TNFRSF1A
prerank,cellular response to fatty acid (GO:0071398),0.7064658305624534,1.748122340205482,0.012658227848101266,0.24009698149300165,1.0,3/12,6.08%,PID1;PDK4;PDK3
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.708387981896213,-1.7464610613838825,0.0018214936247723133,0.11027500484990249,0.997,7/12,19.81%,LY6E;MID2;IFITM1;IFITM3;IFITM2;TRIM5;SNX3
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.627728646846182,1.744528366355438,0.006342494714587738,0.2429669301646915,1.0,4/21,1.34%,ADCY7;ADCY2;ADCY1;ADCY5
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.5402591113844836,-1.744299904083064,0.002004008016032064,0.11134247887933334,0.997,14/33,13.57%,BMPER;SEMA6A;THBS1;FGF1;RHOJ;KLF2;KLF4;PPP1R16B;EPN1;VEGFA;PKM;FGF2;S100A1;EPN2
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.7342884999988246,-1.7441490454559023,0.0055762081784386614,0.11005848832691714,0.997,6/11,16.75%,NOS3;GCH1;CALM1;AKT1;HSP90AA1;SPR
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.7353324935117551,1.7432143370171485,0.013392857142857142,0.24100277102021986,1.0,2/10,0.66%,ENPP1;PID1
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.64343356432573,1.741789159562255,0.01284796573875803,0.23960784776515318,1.0,5/16,10.22%,AUTS2;BCOR;KMT2A;DNMT1;PAXIP1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.4712073147219831,-1.7407620363771341,0.0019305019305019305,0.11279861091444271,0.998,38/69,27.14%,COX4I1;NDUFV2;COX7C;COX6B1;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;CYC1;UQCRQ;COX15;NDUFB7;SDHD;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFS3;NDUFB9;NDUFS6;COX6C;NDUFC1;UQCRB;UQCR11;NDUFA4;COX10;NDUFA3;UQCRH;NDUFA10;NDUFB10;COX8A;NDUFB3;NDUFA1;COX4I2;NDUFA7;UQCC3;NDUFA8
prerank,melanocyte differentiation (GO:0030318),0.7276502807973932,1.7404056831381343,0.018223234624145785,0.23820220947612575,1.0,6/11,4.47%,ENPP1;LRMDA;SLC24A5;MITF;KIT;HPS6
prerank,regulation of interferon-beta production (GO:0032648),-0.5031695117950112,-1.7376365954751034,0.0,0.11504217404462215,0.998,15/46,16.53%,IFIH1;REL;TLR3;DHX9;YY1;FLOT1;RELB;TIRAP;DHX58;MAVS;TLR4;TRIM56;POLR3A;OAS2;HSP90AA1
prerank,regulation of cellular component biogenesis (GO:0044087),-0.5271309407063413,-1.7361006086710689,0.0,0.1154292119319837,0.998,18/39,20.08%,RAP1A;TIE1;NOTCH1;RAP1B;RAPGEF1;DAB2IP;MSN;HSPA8;EZR;HCFC1;BAG5;NCLN;APOE;VPS11;HSP90AA1;GFAP;RAPGEF2;TJP1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.4768345637384371,-1.7355007369099196,0.001937984496124031,0.1146456416340863,0.998,35/66,27.03%,CDK6;CCND3;FHL1;KLF4;ANXA1;PKD1;RGCC;KANK2;AKT1;RB1;FAM107A;LSM11;CDK4;E2F1;PTPN6;EGFR;CDKN1A;ANKRD17;CDKN2C;CCND1;CDK2AP2;RBL1;FGF10;E2F7;LSM10;EIF4G1;HYAL1;PKD2;RDX;DCUN1D3;CCL2;AIF1;PLK5;CDKN2B;RPTOR
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.7474000359283373,-1.7346620140014768,0.003683241252302026,0.11432024087416866,0.998,4/10,3.26%,PODXL;DPP4;WNK1;PIEZO1
prerank,negative regulation of interleukin-1 production (GO:0032692),0.6114978886660185,1.7335173129930015,0.016227180527383367,0.2494325459152112,1.0,4/23,8.37%,IGF1;NLRP12;GSTP1;NLRP2B
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.46925813102842445,-1.7313357766542161,0.0,0.1169951223844932,0.998,31/68,30.71%,LBP;PLCG2;IFIH1;APP;IL33;TLR3;DHX9;TWIST1;HSPD1;CD74;TIRAP;MAVS;TLR4;SYK;SPHK2;NOD2;POU2F2;IL17RA;XBP1;ARHGEF2;LGALS9;BCL10;AIF1;TMEM106A;C1QTNF4;TLR6;HYAL2;TLR1;MBP;NOS2;TYROBP
prerank,positive regulation of integrin activation (GO:0033625),-0.7178119666326352,-1.7307005053232258,0.007936507936507936,0.11649729660788923,0.998,4/11,3.55%,RASIP1;RAP1B;PIEZO1;FERMT2
prerank,regulation of osteoblast proliferation (GO:0033688),0.6270965833190271,1.72696617868076,0.006578947368421052,0.25984406093443013,1.0,4/17,3.70%,NELL1;BMP2;FGFR2;SFRP1
prerank,positive regulation of cellular component movement (GO:0051272),-0.5891124901415501,-1.7266861468866188,0.0038910505836575876,0.12039297283739529,0.999,9/24,12.87%,SPOCK2;ACTN4;ETS1;CAVIN1;RPS19;VEGFA;TWIST1;NTN1;CSF1R
prerank,negative regulation of GTPase activity (GO:0034260),-0.6036585154086982,-1.7264356787174018,0.00946969696969697,0.1191789260524804,0.999,9/22,13.37%,SH3BP4;F11R;LRCH1;WNK1;DAB2IP;BCAS3;GMIP;RCC2;HRAS
prerank,sphingolipid metabolic process (GO:0006665),-0.43713661976759355,-1.726171916805212,0.0,0.1179931129137263,0.999,28/108,13.50%,SGMS1;CERT1;ST6GALNAC3;SGMS2;ACER2;SPTLC2;ESYT2;DEGS2;ELOVL7;SUMF2;HEXA;PLPP1;CSNK1G2;PRKD3;SPTLC1;PPP2R1A;PSAP;KDSR;SPTSSB;SPNS2;ASAH2;ELOVL5;ACER3;SUMF1;SPHK2;ABCA2;SGPL1;CERKL
prerank,proteoglycan metabolic process (GO:0006029),0.5911724732612023,1.7254118333922488,0.010683760683760684,0.2585883618581208,1.0,6/26,1.55%,IGF1;ADAMTS12;SULF1;CHST8;GAL3ST3;SULF2
prerank,regulation of epithelial cell migration (GO:0010632),-0.4957016946289853,-1.7244840245750717,0.0019342359767891683,0.1189300697191741,1.0,16/51,11.76%,PTPRG;BMPER;RREB1;PLCG2;DOCK1;RHOJ;RAB11A;BMPR2;PTK2;DAB2IP;TGFB2;ADIPOR1;PPM1F;PFN1;EMP2;PRKCE
prerank,endodermal cell differentiation (GO:0035987),-0.5638382302953027,-1.7233092786348574,0.005905511811023622,0.11903790041584887,1.0,10/31,14.85%,FN1;COL12A1;COL4A2;LAMA3;COL6A1;MMP14;INHBA;MMP15;ITGA7;ITGA4
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.7381916850794702,1.7229642677346877,0.014705882352941176,0.2592751546732156,1.0,7/11,22.88%,BLM;FBXO5;FBH1;DONSON;SMARCAL1;ZRANB3;TIMELESS
prerank,positive regulation of cell projection organization (GO:0031346),0.43272836916185226,1.7228657010662511,0.0,0.25485858728633837,1.0,33/115,12.52%,PLXNA2;ROBO1;CAMK1D;ROBO2;PTN;NTRK3;TENM3;MAGI2;PTK7;GRIP1;EPHA3;RIT2;PTPRD;GPC2;LYN;NPTN;DPYSL3;CAMK2B;IL1RAPL1;CUX1;CDKL3;ROR1;LRRC7;DVL3;PRKCI;CUX2;PLXNB2;FUT9;AMIGO1;OBSL1;NGFR;CBFA2T2;DLG4
prerank,platelet aggregation (GO:0070527),-0.5411198932013024,-1.7214999607392063,0.007874015748031496,0.11998071225625066,1.0,10/33,9.11%,FN1;ACTB;ACTG1;CLIC1;PPIA;ACTN1;HSPB1;MYL9;MYL12A;VCL
prerank,positive regulation of angiogenesis (GO:0045766),-0.4306665688609809,-1.7196454176682792,0.0,0.1209535327109239,1.0,40/108,20.08%,TEK;FLT1;BMPER;NOS3;THBS1;CD34;GAB1;TIE1;FGF1;KDR;HIPK1;KLF4;F3;RAMP2;VEGFC;ETS1;PIK3R6;VEGFA;CYP1B1;PKM;GATA2;HSPB1;GATA6;JUP;TWIST1;RHOB;FOXC2;VEGFD;FGF2;EMC10;S100A1;RAPGEF3;JMJD8;SP1;NINJ1;PGF;XBP1;CDH5;ANGPTL4;TJP1
prerank,regulation of interleukin-8 production (GO:0032677),-0.4639092621012145,-1.718768646656333,0.0019646365422396855,0.12095997270947093,1.0,34/69,30.84%,TMSB4X;AFAP1L2;LBP;NOD1;MAP2K5;KLF4;F3;ANXA1;TLR3;ANXA4;RIPK1;MAPKBP1;CD74;TIRAP;MAVS;TLR4;SYK;RAB1A;NOD2;HSPA1A;RELA;HSPA1B;LGALS9;PTPN22;PRKD2;BCL10;PARK7;LAMTOR5;TLR6;HYAL2;TLR1;C5AR2;NOS2;TLR5
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.653507516936771,1.7177635443977575,0.013513513513513514,0.2625397438292097,1.0,5/17,7.72%,IGF1;NRP1;CCN4;PDGFRB;DOCK7
prerank,amyloid fibril formation (GO:1990000),-0.4854647952109023,-1.7171921235142973,0.0,0.12176390731069896,1.0,18/51,10.69%,B2M;TSPAN5;APP;FKBP1A;UBB;ADAM10;UBC;RPS27A;TGFBI;BACE1;RIPK1;CST3;MFGE8;UBE2L6;PSENEN;H3-3A;TSPAN14;USP9X
prerank,organic anion transport (GO:0015711),-0.45163794380328914,-1.7126238992428988,0.0,0.12670543592933042,1.0,13/76,5.21%,ABCG2;SLC4A10;ABCC4;SLC26A7;SLCO3A1;SLCO2A1;SLCO1C1;SLCO2B1;LRRC8C;LRRC8D;SLC35A3;CA4;SLC39A8
prerank,intraciliary retrograde transport (GO:0035721),0.7026447117701152,1.7125381135639655,0.02702702702702703,0.2695492348112771,1.0,10/12,24.11%,DYNC2H1;DYNC2I2;IFT122;DYNC2LI1;IFT140;DYNLT2B;IFT43;WDR19;TTC21A;WDR35
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.5593012005473695,-1.7125045990421708,0.011029411764705883,0.12557706741246044,1.0,14/28,18.01%,NOTCH3;ZBTB7A;WWP2;GATA2;AKT1;ARRDC1;TCIM;MMP14;LFNG;YTHDF2;HEY1;EGFR;RITA1;DLL4
prerank,nucleotide catabolic process (GO:0009166),-0.6414680336621521,-1.7108578919543584,0.0019342359767891683,0.1261983883697048,1.0,7/16,13.13%,NT5E;GPX1;NT5C;VCP;GDA;NT5C1A;SAMHD1
prerank,positive regulation of locomotion (GO:0040017),-0.572038952305519,-1.7108438516599205,0.011538461538461539,0.12489576557149232,1.0,9/27,12.87%,THBS1;SPOCK2;STX3;TGFB1;CAVIN1;PPM1F;TWIST1;NTN1;CSF1R
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.4949161529390923,-1.7106821807950836,0.001893939393939394,0.12386823390899022,1.0,21/48,11.34%,TMSB4X;NOS3;THBS1;RHOJ;KDR;ETS1;ANXA1;TGFB1;HDAC7;HDAC9;MAP3K3;VEGFA;ATP5F1A;GATA2;HSPB1;ATP5F1B;AKT1;PIK3C2A;JCAD;FOXC2;CIB1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.7259406799035816,-1.708871518879442,0.00929368029739777,0.12521337174983524,1.0,6/10,16.46%,NAMPT;KDR;IL33;TLR4;NOD2;JAK2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.5606186625773715,-1.7077891757360493,0.0056179775280898875,0.1255005535032242,1.0,9/27,10.51%,MAP3K5;MAPK3;MAP3K20;UBB;UBC;RPS27A;IKBKB;MAP3K8;TAOK2
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.5390224383453012,-1.7061741542381785,0.0037735849056603774,0.12629796150513423,1.0,19/34,19.50%,FLT1;SEMA6A;GAB1;NOTCH1;KDR;MT1G;RAMP2;VEGFC;DAB2IP;ANXA1;VEGFA;HSPB1;FLT4;VEGFD;PIK3CA;RELA;PGF;DLL4;NUS1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.5600479047407234,-1.7057164510882685,0.007532956685499058,0.125671872636489,1.0,11/26,18.17%,IFIH1;NOD1;IRAK2;UBB;UBC;RPS27A;CASP8;ITCH;NOD2;TAB2;TNFAIP3
prerank,tryptophan catabolic process (GO:0006569),0.7176988724722291,1.704262090196296,0.016260162601626018,0.2843579439565703,1.0,5/11,10.52%,IL4I1;AFMID;TDO2;KMO;KYNU
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5592824041882268,1.7042392404867184,0.013972055888223553,0.2797100556469384,1.0,18/35,18.55%,CDH8;PCDHB10;DCHS1;CDH18;CDH11;PCDHB13;CDH19;CDH20;CDH7;NLGN1;CDH10;CDHR3;PCDHB16;CDH12;PCDHGB4;PCDHB14;CDH9;CDH24
prerank,granulocyte differentiation (GO:0030851),-0.6297809246005039,-1.7039476720806406,0.0037174721189591076,0.12698030076295214,1.0,8/18,16.06%,LEF1;CBFA2T3;LBR;RARA;TAL1;CDK4;E2F1;CDKN1A
prerank,cellular biogenic amine catabolic process (GO:0042402),0.7326282542285589,1.7028994518669776,0.02,0.2778033469158843,1.0,5/10,10.85%,CHDH;ALDH7A1;SLC44A1;COMT;HNMT
prerank,homotypic cell-cell adhesion (GO:0034109),-0.5207386131889231,-1.7019268663152975,0.004032258064516129,0.1283412467722913,1.0,12/39,9.11%,FN1;ACTB;ACTG1;MEGF11;CLIC1;TJP2;PPIA;ACTN1;HSPB1;MYL9;MYL12A;VCL
prerank,regulation of macrophage migration (GO:1905521),-0.7161250732520376,-1.6971024492319582,0.01195219123505976,0.13387654479528308,1.0,5/10,18.12%,MTUS1;PTK2B;CD81;CX3CR1;CD200
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.7315541077378469,-1.6930748498562036,0.007079646017699115,0.13838912877717102,1.0,3/10,5.31%,CD55;TGFBR2;CD81
prerank,apical protein localization (GO:0045176),-0.713032096620668,-1.6907536773837002,0.011494252873563218,0.1406856248628179,1.0,6/10,15.29%,ACTB;ATP8B1;JAM3;MAL;CELSR1;SHROOM3
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.7348678071349299,-1.6904318210429785,0.008896797153024912,0.1385262354129042,1.0,3/10,2.78%,MAP2K5;KLF4;WNK1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.7348678071349299,-1.6904318210429785,0.008896797153024912,0.1385262354129042,1.0,3/10,2.78%,MAP2K5;KLF4;WNK1
prerank,response to lipid (GO:0033993),-0.424003428123222,-1.6904295851089834,0.0,0.13725535251920784,1.0,39/105,22.11%,FOXP1;ACER2;NOS3;LBP;ESR1;PPARD;FOXO1;FOXO3;RPS6KA3;GCH1;ANXA1;SOCS2;MAPKAPK3;TGFB1;SMAD6;RARA;GATA6;OTUD5;TRIM16;TNFRSF11A;IFNAR1;SPP1;ABCG1;TRIB1;GGT5;TIRAP;TLR4;ABCA2;STRN3;JAK2;TAB2;PELI1;HSD17B2;SOX9;GGT1;RXRB;PAQR7;LGALS9;PTPN22
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.5119144809300419,-1.6874614347851966,0.011235955056179775,0.14035423197017557,1.0,23/38,27.14%,NDUFV2;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;NDUFB7;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFS3;NDUFB9;NDUFS6;NDUFC1;NDUFA4;NDUFA3;NDUFA10;NDUFB10;NDUFB3;NDUFA1;NDUFA7;NDUFA8
prerank,cristae formation (GO:0042407),-0.5523493282832201,-1.6848643703617583,0.009487666034155597,0.14258122729082517,1.0,16/27,29.29%,ATP5PD;ATP5F1D;ATP5MF;ATP5F1A;ATP5F1B;CHCHD3;ATP5ME;ATP5MC3;ATP5MC1;CHCHD6;APOO;ATP5F1E;MICOS13;UQCC3;ATP5PO;LETM1
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.47743685859906015,-1.6834582696811904,0.0,0.14316116770052176,1.0,17/56,16.60%,LBP;PLCG2;NOD1;RPS6KA3;IRAK2;MAPKAPK3;UBB;UBC;RPS27A;SFTPA2;SFTPA1;TLR3;TLR4;CTSB;S100A1;NOD2;TAB2
prerank,peptide cross-linking (GO:0018149),-0.5747514469813764,-1.6828748539031102,0.011342155009451797,0.1429596792504056,1.0,5/25,3.86%,FN1;THBS1;TGM2;ANXA1;COL3A1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.4572708583932341,-1.6813057811562506,0.0042643923240938165,0.14386809385681723,1.0,24/69,21.74%,THBS1;LBP;PTPRJ;PLCG2;IFIH1;APP;IL33;HSPB1;TLR3;RIPK1;DHX9;TWIST1;TIRAP;MAVS;TLR4;SYK;SPHK2;NOD2;OAS2;JAK2;IFNGR1;ARHGEF2;FZD5;LGALS9
prerank,skeletal system morphogenesis (GO:0048705),0.5127185038629669,1.6810876605068583,0.012219959266802444,0.3272649869959547,1.0,13/42,11.68%,FBN2;FGFR2;PDGFRA;HOXC4;HOXB3;ANKRD11;HOXC9;SPEF2;TGFBR1;RAB33B;HOXB9;FUZ;FGFR1
prerank,regulation of adaptive immune response (GO:0002819),0.6286915408103086,1.6809845681044402,0.015151515151515152,0.3224521811458233,1.0,4/18,10.97%,ADCY7;IL4I1;TRIM27;AHR
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.48454984385621225,-1.6761823489025034,0.0019083969465648854,0.1501547139487514,1.0,25/49,30.84%,AFAP1L2;LBP;NOD1;F3;TLR3;RIPK1;CD74;TIRAP;MAVS;TLR4;SYK;RAB1A;NOD2;HSPA1A;RELA;HSPA1B;LGALS9;PRKD2;BCL10;PARK7;LAMTOR5;HYAL2;TLR1;NOS2;TLR5
prerank,regulation of establishment of cell polarity (GO:2000114),-0.620535432747875,-1.6758430409895673,0.007259528130671506,0.14945334559124934,1.0,6/16,4.94%,RACK1;RAP1B;PTK2B;CYRIB;SHTN1;BCAS3
prerank,sphingosine metabolic process (GO:0006670),-0.6331118017576461,-1.675398306338593,0.014519056261343012,0.14889136640769612,1.0,8/17,13.23%,ACER2;SPTLC2;PLPP1;SPTLC1;ASAH2;ACER3;SPHK2;ABCA2
prerank,positive regulation of response to stimulus (GO:0048584),-0.5088617636098899,-1.6752449959042643,0.003861003861003861,0.1477850463183168,1.0,18/40,24.75%,B2M;IL15;IFIH1;TGFB2;ABI3;DHX9;YPEL3;MAVS;HOMER1;FMR1;CDKN2AIP;NSMCE4A;RSAD2;CGAS;IER5;TAF9;PRKCD;NSMCE1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.5594734863499579,1.675172940545776,0.008849557522123894,0.3327203570151967,1.0,7/32,5.22%,IGF1;ZBTB20;PID1;PPARA;PFKFB4;ACTN3;IL4
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.6261262425490426,1.6748142288815013,0.018518518518518517,0.3287441030270573,1.0,4/18,8.86%,IGF1;IGFBP2;IGF2;IL18
prerank,purine nucleotide catabolic process (GO:0006195),-0.6600481840239685,-1.6747727600179456,0.011235955056179775,0.14724653148467987,1.0,6/13,12.93%,NT5E;GPX1;NT5C;GDA;NT5C1A;HINT1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.5193279212804219,-1.6714486555555323,0.011904761904761904,0.15078742097991552,1.0,18/33,25.05%,MEF2C;THBS1;NOTCH1;MAP2K5;STARD13;KLF4;TGFB1;RGCC;JUP;CSNK2B;FGF2;APOE;DLL4;GADD45A;TBXA2R;PDCD10;CARD10;ANGPT4
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.6727434177523189,1.669344186580935,0.02702702702702703,0.33904896880383145,1.0,8/13,17.60%,B3GALT1;GAL3ST3;B3GALNT1;B3GNT7;B3GALT2;B3GALT5;B3GNT6;B4GAT1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.5950197830074337,-1.6679744654289357,0.007312614259597806,0.15510367409700798,1.0,10/18,19.51%,SEL1L;UBB;UBC;RPS27A;MAN1B1;RNF185;RNF5;DERL2;AMFR;EDEM2
prerank,positive regulation of interferon-beta production (GO:0032728),-0.5238273961653627,-1.6661427569162761,0.005825242718446602,0.15657665319836112,1.0,11/33,16.53%,IFIH1;TLR3;DHX9;FLOT1;DHX58;MAVS;TLR4;TRIM56;POLR3A;OAS2;HSP90AA1
prerank,regulation of cell growth (GO:0001558),-0.3799093638268963,-1.6651330759654366,0.0,0.15693501337340687,1.0,81/204,22.61%,PLCE1;APBB2;PTPRJ;SERTAD2;LTBP4;NET1;OSGIN2;RACK1;BMPR2;SH3BP4;FHL1;TFRC;CCN3;RPS6KA3;SOX17;DCUN1D5;SLIT2;NPR1;CAMK2D;ADAM15;SOCS2;CDKN1B;TGFB1;TGFB2;ADAM10;PPP2R1A;MFSD2A;EGLN2;NDUFA13;AKT1;SIPA1;RB1;PABIR1;FAM107A;WFDC1;H3-3A;BCL6;WNT11;AKAP6;MMP14;TAOK2;CRLF3;CCDC85B;INHBA;KIF26A;CIB1;SPHK2;ITCH;FXN;NDUFS3;LAMTOR2;CISH;SMARCA4;ERBB2;OSGIN1;SMAD4;CDKN2AIP;SDCBP;SMARCA2;OGFR;EGFR;CDKN1A;TMEM97;HSPA1A;CSNK2A1;CDKN2C;CCAR2;DERL2;NME6;SLC25A33;ESR2;TSPYL2;MSX1;BRAT1;NDRG3;HSPA1B;DDX49;SESN2;ADNP2;EIF4G1;HYAL1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.6741043658480712,-1.6651174836968432,0.011049723756906077,0.15571564228738377,1.0,4/12,4.92%,MEF2C;PRKG1;IGFBP5;DOCK4
prerank,regulation of dendrite development (GO:0050773),0.5187786634979586,1.664605691347097,0.006593406593406593,0.346958857620494,1.0,12/37,10.87%,CAMK1D;HECW2;PTN;ADGRB3;BMP5;CSMD3;RAP2A;HECW1;TNIK;BCL11A;DCC;ALK
prerank,receptor clustering (GO:0043113),0.5538139537375085,1.6637398215590822,0.01680672268907563,0.3440769321653739,1.0,9/27,12.52%,PTN;MAGI2;NRXN1;LRP4;DLG2;NLGN1;LRRC7;MUSK;DLG4
prerank,regulation of Notch signaling pathway (GO:0008593),-0.44268783585828275,-1.6619809982327238,0.002004008016032064,0.15930398165844145,1.0,27/76,16.01%,TSPAN5;NOS3;NOTCH3;NOTCH1;CCN3;ZBTB7A;TGFB2;WWP2;NEPRO;JAG2;NOTCH4;GATA2;AKT1;ARRDC1;TCIM;TSPAN14;MMP14;LFNG;MFNG;TM2D3;POGLUT1;YTHDF2;EPN2;HEY1;NOD2;EGFR;RITA1
prerank,regulation of integrin activation (GO:0033623),-0.628178881793219,-1.661849812344039,0.005607476635514018,0.15833996427593938,1.0,5/15,4.24%,RASIP1;RAP1B;PIEZO1;FERMT2;JAM3
prerank,positive regulation of wound healing (GO:0090303),-0.5171456135555089,-1.6615218762135964,0.009671179883945842,0.15758975184677426,1.0,12/36,13.37%,ST3GAL4;OCLN;RREB1;THBS1;ACTG1;PTK2;FERMT2;ANXA1;ENPP4;FOXC2;PRKCE;HRAS
prerank,regulation of angiogenesis (GO:0045765),-0.38238911282517235,-1.6609537888054988,0.0,0.15721853171645275,1.0,62/192,18.17%,TEK;FLT1;CLDN5;BMPER;SEMA6A;NOS3;THBS1;CD34;GAB1;TIE1;FGF1;RHOJ;KDR;HIPK1;KLF4;F3;RAMP2;PPP1R16B;VEGFC;ETS1;DAB2IP;NPR1;STAB1;TGFB2;COL4A2;SARS1;PIK3R6;PTPRM;AMOT;VEGFA;CYP1B1;GATA2;HSPB1;GATA6;RGCC;JUP;WARS1;NAXE;TWIST1;HHEX;RHOB;ISM1;EMP2;EGLN1;VEGFD;PLXND1;HTATIP2;NF1;FGF2;EMC10;ERBB2;RAPGEF3;EPHA2;PGK1;SP1;KRIT1;NINJ1;RNH1;PGF;XBP1;STAT1;TNFAIP3
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.6204777019268685,1.658923488660404,0.0211864406779661,0.3522269113693393,1.0,3/19,8.37%,IGF1;GSTP1;NLRP2B
prerank,regulation of GTPase activity (GO:0043087),-0.38516838601212494,-1.6584344564692122,0.0,0.16004399179845993,1.0,50/177,15.32%,DOCK9;PKP4;CHN2;FGD5;ITGA6;RAP1A;NET1;PRKG1;RASIP1;RACK1;SIPA1L1;TGM2;SH3BP4;AGRN;F11R;CAV2;LRCH1;SGSM2;WNK1;RAPGEF1;PTK2;ARHGAP27;DAB2IP;FERMT2;PLXNA4;BCAS3;CHN1;LIMS1;CRK;FGD6;GPR137B;RGS6;CCL15;S100A10;WNT11;PLXNA1;ADAP1;GMIP;ZC3H15;PLXND1;RCC2;NF1;ARHGEF5;HRAS;NDEL1;ERBB2;BCAR3;SNX18;RAP1GDS1;RAPGEF3
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.5302626394704792,-1.6583117817596902,0.003738317757009346,0.15901574412347252,1.0,10/32,16.42%,PPP1R13B;DDX5;HIPK1;DYRK2;RPS27L;HINT1;TMEM109;AEN;DDIT4;PHLDA3
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.5620216603228382,-1.6581220678220245,0.013182674199623353,0.15815199027254784,1.0,7/24,14.85%,PECAM1;F11R;NT5E;MSN;EZR;SYK;ITGA4
prerank,sphingolipid biosynthetic process (GO:0030148),-0.4495840436121714,-1.657321742209044,0.004073319755600814,0.15812652796045773,1.0,20/71,13.30%,SGMS1;CERT1;SGMS2;ACER2;SPTLC2;DEGS2;ELOVL7;PLPP1;CSNK1G2;PRKD3;SPTLC1;KDSR;A4GALT;SPTSSB;SPNS2;ASAH2;ELOVL5;ACER3;SPHK2;SGPL1
prerank,negative regulation of hydrolase activity (GO:0051346),-0.4738238334544059,-1.653000647606718,0.009505703422053232,0.16387755250025401,1.0,16/49,18.52%,SH3BP4;F11R;LRCH1;WNK1;DAB2IP;BCAS3;CHP1;SH3RF2;CST3;EGLN1;GMIP;RCC2;HRAS;ATP5IF1;NEIL1;ARL2
prerank,odontogenesis (GO:0042476),0.5297199950872892,1.6520210992143083,0.017543859649122806,0.36666459058404005,1.0,7/35,5.10%,BMP2;COL1A2;FGFR2;BCOR;GLI2;ANKRD11;AXIN2
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4236640241257249,1.6516526552982476,0.002044989775051125,0.36250175690262143,1.0,16/113,4.24%,IGF1;BMP6;TCF7L2;NRP1;BMP2;PTN;AREG;FGFR2;SEMA5A;BMP5;PRKCA;VEGFB;AKT3;SFRP1;TGFA;STXBP4
prerank,gliogenesis (GO:0042063),-0.6256250622655409,-1.6514067050519725,0.014705882352941176,0.1652814970381754,1.0,5/15,11.95%,CDK6;ANXA1;TGFB2;CD9;NDUFS2
prerank,cellular response to increased oxygen levels (GO:0036295),-0.6916813320244182,-1.6512679214378163,0.008787346221441126,0.16427801626955202,1.0,9/11,25.08%,CAV1;FOXO1;ATP6V0A2;FAS;ATG7;ATP6V1G1;ATP6AP1;ATP6V0D1;CCDC115
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.4047218001984287,-1.6503013709640348,0.002,0.16493331425896107,1.0,45/114,26.57%,TMSB4X;PTK2B;ACTN4;TNFRSF11B;NFKBIA;FOXO3;CARD14;LIMS1;IKBKB;TNFRSF1B;PSMA6;RIPK1;TNFRSF11A;PSMB5;PSMC4;PSMC5;PSMD14;TRAF1;AIM2;COMMD7;TNFRSF1A;EDA2R;PSMD8;TNFSF13;PSMC1;JAK2;PSMB4;PSMD11;PSMD12;RELA;CHUK;STAT1;PSMA1;PSMC3;LTBR;TXNDC17;PSMB1;PSMA2;TNFSF13B;PSMA4;TRAF6;TNFRSF9;TNFRSF12A;TNFRSF25;PSMB8
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.483116929906209,-1.6499400232689942,0.007736943907156673,0.1643487527012813,1.0,20/50,19.28%,CAV1;NXN;RPS3;SMAD7;IVNS1ABP;CHP1;SH3RF2;N4BP1;CAMLG;AKT1;DNAJA1;BAG5;UBXN1;SOX4;PRMT3;LIMK1;UFL1;HSPA1A;TNFAIP3;USP4
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5791791927234117,1.6488874856232707,0.025,0.36535335367209504,1.0,4/22,4.24%,AREG;FGFR2;VDR;STXBP4
prerank,regulation of macrophage cytokine production (GO:0010935),-0.6505772500944182,-1.6482625795020607,0.020484171322160148,0.16589137996352205,1.0,6/13,10.67%,SEMA7A;PLCG2;TGFB1;TGFB2;TGFB3;CD74
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.673784929356543,-1.6474941958720966,0.020793950850661626,0.1659352546486498,1.0,4/11,15.90%,DDX5;TGFB1;RIPK1;EGFR
prerank,positive regulation of immune system process (GO:0002684),-0.6127816030441008,-1.6471055771545688,0.027472527472527472,0.16535606269299397,1.0,4/16,5.80%,IL15;ANXA1;TGFB2;VEGFA
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.5183584680580829,-1.6460799396354395,0.005813953488372093,0.16595608170655612,1.0,22/33,37.61%,MAP3K5;NET1;RPS3;ANXA1;CYP1B1;RIPK1;RHOB;IMPACT;FXN;RELA;TNFAIP3;ECT2;PRKCD;RNF112;PARK7;AQP1;MAPK7;ABL1;ANKZF1;OSER1;SIGMAR1;PLEKHA1
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.4293751264238023,-1.6446406017396102,0.001937984496124031,0.16711287497268498,1.0,22/85,8.30%,PLCE1;ARHGEF28;NOTCH1;EPS8;OPHN1;STARD13;STARD8;ARHGAP17;RAPGEF1;DENND1A;DAB2IP;SHOC2;NGF;EPS8L2;ARHGDIA;TGFB2;ARHGDIB;GABARAP;SHC1;BCR;DENND3;KANK2
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.4609679461420808,-1.644483471914622,0.0056179775280898875,0.16614470796960826,1.0,22/54,15.48%,MEF2C;TMSB4X;NOS3;THBS1;KDR;ETS1;TGFB1;VEGFA;ATP5F1A;GATA2;HSPB1;ATP5F1B;RGCC;JUP;PRCP;AKT1;CSNK2B;NF1;FGF2;APOE;STAT5A;EPHA2
prerank,myoblast differentiation (GO:0045445),0.640332110440352,1.644264670513051,0.03282275711159737,0.37386079693421853,1.0,4/14,1.45%,IGF1;TCF7L2;EPAS1;NRG1
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.61631724436943,-1.643294617131415,0.009208103130755065,0.1668939623460189,1.0,8/17,13.45%,ATP5PD;ATP5F1D;ATP5MF;ATP5F1A;ATP5F1B;ATP5ME;ATP5MC3;ATP5MC1
prerank,negative regulation of viral process (GO:0048525),-0.4594287433551151,-1.6423340889195008,0.006109979633401222,0.167356116724508,1.0,18/57,18.13%,IFIH1;MID2;PPIA;IFITM1;IFITM3;N4BP1;SRPK1;IFITM2;TRIM14;TRIM28;IFIT1;FAM111A;MAVS;TRIM62;TRIM5;OAS2;RSAD2;STAT1
prerank,lamellipodium organization (GO:0097581),-0.5307317660377315,-1.6420582511541535,0.003795066413662239,0.16658680625093472,1.0,18/29,27.98%,ABLIM1;PARVB;S1PR1;ABLIM3;RAC1;SPATA13;VCL;SPEF1;ABLIM2;ARHGEF4;ARHGEF6;CTTN;PTPRO;DMTN;CCDC88A;GOLPH3;CARMIL1;SNX2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.632651857316903,1.6414448837771922,0.021367521367521368,0.3765295242997662,1.0,5/16,6.08%,RORA;PDK1;PDK4;PRKN;PDK3
prerank,regulation of transmembrane transport (GO:0034762),-0.5249199990732556,-1.640717869984256,0.011152416356877323,0.16755956219584878,1.0,11/31,12.14%,ACTB;OCLN;SLC2A1;CTTNBP2NL;KCNJ2;NEDD4L;WWP2;KCNJ10;ACE2;KCNJ8;KCNJ15
prerank,regulation of ossification (GO:0030278),0.5194087331980635,1.64022284071217,0.014344262295081968,0.375351605225758,1.0,11/36,7.89%,ENPP1;NOTUM;BMP2;PTN;DDR2;CYP27B1;AHSG;LRP4;SFRP1;ANKH;RBPJ
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.5948204382928337,-1.639432386339537,0.02185792349726776,0.16841071065246455,1.0,5/19,4.11%,SLCO1C1;MAP2K5;KLF2;KLF4;APP
prerank,regulation of interleukin-6 production (GO:0032675),-0.4124769310914781,-1.639214862726573,0.0,0.16767289774074823,1.0,38/96,30.71%,AFAP1L2;LBP;PLCG2;IFIH1;APP;IL33;TLR3;DHX9;TWIST1;HSPD1;CD74;TIRAP;MAVS;TLR4;SYK;SPHK2;NOD2;POU2F2;PTPN6;IL17RA;XBP1;CD200;TNFAIP3;ARHGEF2;LGALS9;PTPN22;BCL10;AIF1;TREM2;TMEM106A;C1QTNF4;TLR6;HYAL2;TLR1;MBP;C5AR2;NOS2;TYROBP
prerank,striated muscle cell development (GO:0055002),-0.6246204481831289,-1.6384888677140013,0.016885553470919325,0.167502934208625,1.0,5/14,8.53%,PGM5;TMOD3;LMOD1;FLII;TMOD1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6616807396695389,1.6378679822117008,0.013544018058690745,0.37649721316099694,1.0,4/13,7.86%,ERRFI1;CBLB;VPS25;ZFYVE28
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.5862495650933169,-1.6344776170933781,0.016791044776119403,0.17303025367680397,1.0,8/19,18.13%,IFIH1;TLR3;DHX9;HSPD1;MAVS;TLR4;CHUK;STAT1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.6759395952150273,-1.6286684600137904,0.017857142857142856,0.18163799454584223,1.0,3/11,4.28%,MEF2C;TGFB1;TGFB2
prerank,clathrin coat assembly (GO:0048268),-0.6354305160050946,-1.6281010558978364,0.005628517823639775,0.18129765321396,1.0,9/15,26.26%,HIP1R;PIK3C2A;HIP1;SGIP1;FCHO2;CLTA;NSG2;CLTB;EPS15
prerank,lipid transport (GO:0006869),-0.41414610326258294,-1.6275505018336758,0.00411522633744856,0.18117020457961283,1.0,26/97,13.88%,PITPNC1;ABCC4;CERT1;SLCO3A1;SLCO2A1;SLCO1C1;LBP;ATP8A1;PLTP;ATP8B1;SLCO2B1;SCARB1;PPARD;TNFAIP8L3;PITPNA;MFSD2A;SPNS2;CHKA;ABCG1;FABP5;PRELID2;STARD5;MFSD2B;ABCA2;APOE;PITPNM1
prerank,presynapse organization (GO:0099172),0.7036485571149932,1.627396934056813,0.04612159329140461,0.40004497257646904,1.0,4/10,8.00%,LRRTM3;NLGN2;NLGN3;NLGN1
prerank,response to hydrogen peroxide (GO:0042542),-0.477869520210225,-1.6263449344371637,0.0039603960396039604,0.18189510347764748,1.0,27/45,37.91%,MAP3K5;NET1;RPS3;ANXA1;CYP1B1;RIPK1;GPX1;STK25;RHOB;IMPACT;FXN;STK26;RELA;TNFAIP3;ECT2;PDCD10;PRKCD;SOD1;PARK7;AQP1;MAPK7;ABL1;ANKZF1;OSER1;FYN;PLEKHA1;HP
prerank,regulation of dendrite morphogenesis (GO:0048814),0.5250571266672316,1.6261114663886078,0.015086206896551725,0.3988683253834974,1.0,15/32,17.01%,HECW2;ADGRB3;RAP2A;PTPRD;HECW1;IL1RAPL1;CUX1;TNIK;CDKL3;CUX2;OBSL1;SARM1;CAPRIN2;NEDD4;CUL7
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.7018750967352363,-1.6259445589886894,0.012612612612612612,0.18142735906704918,1.0,5/10,13.45%,ATP5PD;ATP5F1D;ATP5F1A;ATP5MC3;ATP5MC1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.6233374342508262,-1.6252104265450114,0.015151515151515152,0.18135994506952002,1.0,8/16,13.45%,ATP5PD;ATP5F1D;ATP5MF;ATP5F1A;ATP5F1B;ATP5ME;ATP5MC3;ATP5MC1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5901159244268428,1.6237684126221803,0.031185031185031187,0.4008903117692776,1.0,7/17,8.28%,ATP1A2;SLC8A1;SCN3B;ANK2;CACNA2D1;CACNA1G;CACNB2
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5792848786043492,1.6235752909595371,0.020366598778004074,0.3966641720539984,1.0,6/20,6.21%,IGF1;NRP1;LRP1;CCN4;SERPINE1;PDGFRB
prerank,positive regulation of vasculature development (GO:1904018),-0.4161027160271381,-1.6218906355938931,0.00390625,0.1860466934678905,1.0,24/94,10.91%,TEK;FLT1;NOS3;THBS1;CD34;GAB1;TIE1;FGF1;KDR;HIPK1;F3;RAMP2;VEGFC;ETS1;PIK3R6;VEGFA;CYP1B1;GATA2;HSPB1;GATA6;JUP;TWIST1;RHOB;VEGFD
prerank,negative regulation of stress fiber assembly (GO:0051497),0.5623372997278627,1.6191216801007133,0.03112033195020747,0.40456183851848176,1.0,6/24,4.57%,ARHGAP6;PIK3R1;ARHGAP28;PHLDB2;CGNL1;DLC1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.5044750676600208,-1.6188947357457848,0.010638297872340425,0.18991008922867955,1.0,19/36,26.70%,OPHN1;HSP90AB1;RPL11;AQP11;N4BP1;USP7;GIPC1;CAMLG;DDRGK1;BAG5;UBXN1;SDCBP;CCAR2;MAP1A;TAF9;ALAD;TRIM39;F8A1;PARK7
prerank,response to ethanol (GO:0045471),0.6266206340458994,1.618871617237925,0.03537735849056604,0.40040337964356854,1.0,2/14,2.84%,ADCY7;GRIN3A
prerank,negative regulation of protein binding (GO:0032091),-0.4295117628186045,-1.6183021875646015,0.0037735849056603774,0.18978375593171068,1.0,26/71,23.48%,CAV1;ACTB;B2M;RACK1;ADAM15;CTSZ;RALB;ATP2A3;NES;AKT1;BAX;IFIT1;DISC1;CAMK1;CTNNBIP1;STYX;MITD1;ITGA4;CDKN1A;GTF2F1;KDM1A;PIN1;TMBIM6;PPP1CA;ZFPM1;PRKCD
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.3877906410233035,-1.6177413179177749,0.0,0.18952367897951872,1.0,42/149,17.24%,PRKCH;CAV1;SLCO3A1;RPS6KA5;NOD1;NFKBIA;TFRC;MID2;RPS3;CARD14;IRAK2;TRIM25;ZBTB7A;APP;UBB;PPIA;PRKCZ;UBC;RPS27A;IKBKB;PSMA6;RIPK1;TNFRSF11A;DHX9;TRIM14;FLOT1;DDRGK1;TIRAP;CIB1;TLR4;TRIM62;TRAF1;AIM2;TRIM68;EDA2R;TRIM5;NOD2;CX3CR1;FLOT2;TAB2;HSPA1A;RELA
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.6228736528985261,-1.6177206387118495,0.016917293233082706,0.18723340683686535,1.0,2/14,1.30%,ABCG2;SLCO2B1
prerank,heme catabolic process (GO:0042167),-0.6228736528985261,-1.6177206387118495,0.016917293233082706,0.18723340683686535,1.0,2/14,1.30%,ABCG2;SLCO2B1
prerank,stress-activated MAPK cascade (GO:0051403),-0.44963949516580126,-1.6171755772722458,0.014373716632443531,0.1870076212226858,1.0,23/61,21.74%,MAP3K5;MAP4K3;NOD1;MAPK3;IRAK2;MAP3K20;UBB;MINK1;UBC;RPS27A;IKBKB;MAP3K8;MAP3K11;TRIB1;TAOK2;NOD2;TAB2;CHUK;CUL1;ARHGEF6;PTGER4;MAPK11;LGALS9
prerank,positive regulation of ruffle assembly (GO:1900029),-0.6478100853418225,-1.6171607344840326,0.03383458646616541,0.1858881398788066,1.0,7/13,14.40%,EPS8;PLEKHM1;EPS8L2;PFN1;FAM98A;HRAS;NDEL1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.5585675614186942,-1.6148675475295282,0.010657193605683837,0.18887122485747201,1.0,12/24,14.26%,DMD;PDE4D;CAMK2D;CALM1;FKBP1A;JPH2;AKAP6;JPH4;GSTM2;CALM3;CASQ2;SRI
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.37086701985775405,1.613707094569051,0.0,0.41122625385045664,1.0,49/248,12.41%,BICC1;TCF7L2;IGFBP2;RNF220;LGR4;NOTUM;BMP2;LRRK1;RBMS3;WLS;DAAM2;LYPD6;CDK14;FGFR2;SEMA5A;TBL1XR1;PRICKLE1;PTK7;LRP4;ZEB2;DKK3;GLI3;SFRP1;ZNRF3;MCC;AXIN2;CTNND2;PRKN;HECW1;FRAT1;SMURF2;TLE1;SOX2;PSMA3;ADGRA2;PSMF1;PSMA7;NPHP3;NKD2;DVL3;FRZB;SIAH2;GPC5;DACT3;FUZ;USP47;BTRC;RNF146;PSME3
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.6296533277691841,-1.6125849659886047,0.029197080291970802,0.19178425493395854,1.0,8/14,23.95%,TMSB4X;NFKBIA;PKD1;CCDC22;MDFI;KEAP1;NFKBIE;PKD2
prerank,cellular response to alcohol (GO:0097306),0.4942187672218687,1.6114976673939363,0.018789144050104383,0.4126590538400763,1.0,7/42,3.70%,ADCY7;ADCY2;ADCY1;PTGFR;ADCY5;GNAI1;SFRP1
prerank,histone H2A monoubiquitination (GO:0035518),0.5891320903913,1.610923509656237,0.03496503496503497,0.4094369095533527,1.0,9/17,22.63%,BCOR;DDB2;RNF2;PCGF5;PCGF6;SKP1;TRIM37;PCGF2;KDM2B
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.5878192804053579,-1.6104819430147874,0.01845018450184502,0.19439643114101646,1.0,6/17,10.41%,TMSB4X;MAP2K5;KLF4;ANXA1;ANXA4;MAPKBP1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.45078274839947186,-1.610439672059433,0.009578544061302681,0.19334792560834554,1.0,23/57,20.02%,RPS16;RPL26;RPS25;RPS15;NOP14;RPL38;RPL11;RPS28;RPL14;RPS24;RPS19;RPL35A;CUL4A;PES1;DHX37;RPS7;RPS6;WDR74;EMG1;RPL7;RPL5;WDR12;TGS1
prerank,regulation of viral release from host cell (GO:1902186),-0.568337853222626,-1.609913799125346,0.013157894736842105,0.19308739643635592,1.0,8/21,17.86%,MID2;TRIM25;CHMP2B;TRIM28;TRIM62;TSG101;TRIM5;CHMP2A
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.4226661907207404,-1.6096835403045842,0.005714285714285714,0.19244100921377028,1.0,26/84,10.57%,TEK;FOXP1;TMSB4X;NOS3;THBS1;NRP2;FGF1;PTK2B;SCARB1;BMPR2;KDR;GPI;ETS1;TGFB1;BCAS3;RAC1;VEGFA;ATP5F1A;GATA2;HSPB1;ATP5F1B;EDN1;FLT4;AKT1;RHOB;FOXC2
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.43291538175709493,-1.6094665287611676,0.0064516129032258064,0.1916554800152334,1.0,24/73,21.74%,THBS1;LBP;PTPRJ;PLCG2;IFIH1;APP;IL33;HSPB1;TLR3;RIPK1;DHX9;TWIST1;TIRAP;MAVS;TLR4;SYK;SPHK2;NOD2;OAS2;JAK2;IFNGR1;ARHGEF2;FZD5;LGALS9
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.5517555956388067,1.6086415540413892,0.02727272727272727,0.4116075347809231,1.0,5/25,8.28%,CEMIP;PDPK1;ANK2;CALCR;CACNB2
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.5884698060253787,1.6079672049710894,0.04251012145748988,0.40894600027924255,1.0,4/18,2.72%,BMP2;DDR2;EFEMP2;SMAD3
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.667251834361394,1.6043573307039927,0.033860045146726865,0.41532296094521415,1.0,3/10,8.75%,KDM1B;PCGF5;IGF2
prerank,extracellular structure organization (GO:0043062),0.3802043963647496,1.6033255528952908,0.0,0.41365550572227316,1.0,38/204,7.55%,COL4A6;LAMA1;COL4A5;ADAMTS6;ITGA9;COL13A1;ADAMTS12;FBN1;LAMA2;FBN2;LAMC3;COL1A2;DDR2;ADAMTS10;NID2;COL22A1;DCN;ITGA11;MATN3;ADAMTS5;NID1;RECK;MIA;TNC;COL4A4;MMP16;DDR1;LUM;COL16A1;ADAM12;MMP11;SERPINE1;COL4A3;ITGAD;COL10A1;COL8A2;MFAP2;TGFBR1
prerank,positive regulation of type I interferon production (GO:0032481),-0.4279392163216709,-1.6022464132907146,0.00211864406779661,0.20327954142007992,1.0,35/73,35.10%,IFIH1;LRRFIP1;PRKDC;TLR3;DDX41;GAPDH;DHX9;FLOT1;HSPD1;DHX58;MAVS;TLR4;TRIM56;POLR3E;POLR3A;OAS2;HSP90AA1;RELA;CHUK;STAT1;CGAS;PTPN22;POLR3B;SETD2;CTNNB1;MRE11;POLR2F;POLR1C;PQBP1;RIOK3;POLR2L;CD14;TLR8;IRF3;CREBBP
prerank,negative regulation of binding (GO:0051100),-0.4131490000684828,-1.602127782003722,0.0,0.2023353164188409,1.0,31/81,23.99%,LEF1;CAV1;ACTB;RACK1;NFKBIA;CTSZ;SMO;RALB;NES;AKT1;BAX;IFIT1;DISC1;CAMK1;CTNNBIP1;E2F1;STYX;MITD1;SUMO3;CDKN1A;JAK2;WAPL;GTF2F1;KDM1A;PIN1;TMBIM6;MDFI;PPP1CA;ZFPM1;PRKCD;BTAF1
prerank,protein localization to cell-cell junction (GO:0150105),-0.6131998689417363,-1.6020510332461206,0.014678899082568808,0.20132981057673377,1.0,9/15,20.08%,ACTB;LSR;ACTG1;F11R;TJP2;ARHGEF18;DSP;CDH5;TJP1
prerank,regulation of viral entry into host cell (GO:0046596),-0.5143185439351016,-1.6019785199628829,0.019193857965451054,0.2002836127673184,1.0,15/30,21.74%,LY6E;MID2;TRIM25;IFITM1;IFITM3;IFITM2;TRIM14;CD74;TRIM62;TRIM68;TRIM5;NECTIN2;LGALS1;SNX3;LGALS9
prerank,regulation of endothelial cell migration (GO:0010594),-0.4132150347429602,-1.6013649700865522,0.0,0.20011080569921866,1.0,31/85,13.85%,TEK;FOXP1;BMPER;THBS1;NRP2;FGF1;RHOJ;PTK2B;SCARB1;BMPR2;KDR;GPI;PTK2;ETS1;SLIT2;DAB2IP;BCAS3;RAC1;PTPRM;VEGFA;PRCP;EDN1;FLT4;AKT1;RHOB;EMP2;FOXC2;NF1;FGF2;EMC10;APOE
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5455552340211022,1.600907761200721,0.030973451327433628,0.4166958252411998,1.0,6/26,7.86%,ERRFI1;AREG;CBLB;TGFA;VPS25;ZFYVE28
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.6536535941394326,-1.600356019193509,0.013539651837524178,0.2008482018764037,1.0,3/12,4.15%,ESR1;NCOR1;TGFB1
prerank,histone deubiquitination (GO:0016578),-0.5830210980922867,-1.6001259627195945,0.02022058823529412,0.20014250791723417,1.0,9/18,18.56%,TRRAP;BRCC3;USP7;UIMC1;ENY2;USP3;USP15;USP22;USP49
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.6759317255136117,1.5997883375879605,0.045951859956236324,0.41557721736775094,1.0,3/10,12.84%,AREG;TGFA;BTC
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5930740966284602,-1.5988980301760967,0.01603206412825651,0.2013046945824003,1.0,7/16,19.50%,SCARB1;GCH1;AKT1;S100A1;APOE;NPR3;NUS1
prerank,hemidesmosome assembly (GO:0031581),-0.6666371482088367,-1.596916491638493,0.020484171322160148,0.20361330875767214,1.0,5/11,8.94%,ITGA6;ITGB4;LAMA3;CD151;LAMC2
prerank,skeletal muscle contraction (GO:0003009),0.5929943503172072,1.5968448529083719,0.04047619047619048,0.41970115052420176,1.0,6/19,14.78%,CHRNA1;TNNC1;TNNI3;TNNI1;STAC3;TNNT3
prerank,camera-type eye development (GO:0043010),0.5420824908951296,1.59678981464943,0.04411764705882353,0.41538757307366136,1.0,4/25,1.42%,LAMA1;FBN1;FBN2;TENM3
prerank,external encapsulating structure organization (GO:0045229),0.3773101470904517,1.5966722087312972,0.0,0.4113321591937792,1.0,36/205,6.94%,COL4A6;LAMA1;COL4A5;ADAMTS6;ITGA9;COL13A1;ADAMTS12;FBN1;LAMA2;FBN2;LAMC3;COL1A2;DDR2;ADAMTS10;NID2;COL22A1;DCN;ITGA11;MATN3;ADAMTS5;NID1;RECK;MIA;TNC;COL4A4;MMP16;DDR1;LUM;COL16A1;ADAM12;MMP11;SERPINE1;COL4A3;ITGAD;COL10A1;COL8A2
prerank,regulation of interleukin-12 production (GO:0032655),-0.4498881706631449,-1.596228963971898,0.01383399209486166,0.2036978540424648,1.0,13/47,21.74%,FOXP1;THBS1;PLCG2;CMKLR1;TLR3;HSPD1;TIRAP;TLR4;SYK;JAK3;LAPTM5;MAPK11;LGALS9
prerank,negative regulation of potassium ion transport (GO:0043267),-0.6258128754014638,-1.5961358017881848,0.01601423487544484,0.20278524933033037,1.0,5/13,15.21%,CAV1;NEDD4L;PTK2B;CASQ2;CAB39
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.48081588555323057,-1.595845307316865,0.011049723756906077,0.2021941402512922,1.0,13/42,12.21%,VIT;NOTCH1;PTK2;FZD4;RAC1;MINK1;LIMS1;NPNT;PPM1F;FZD7;EMP2;FBLN2;NF1
prerank,membrane depolarization during action potential (GO:0086010),0.5348946634131376,1.5957057508611965,0.020179372197309416,0.41006326113845043,1.0,8/26,7.60%,ATP1A2;SCN7A;SLC8A1;SCN3B;SCN3A;CACNA1I;CACNA1G;SCN2A
prerank,regulation of amyloid-beta formation (GO:1902003),0.5061210920165544,1.5953665203770933,0.027722772277227723,0.4069744845608492,1.0,8/34,11.25%,IGF1;SLC2A13;ROCK2;LRRTM3;RTN4;CASP3;TMED10;CHRNA7
prerank,ceramide biosynthetic process (GO:0046513),-0.48113272712249605,-1.5951435984398765,0.01855287569573284,0.20245232729644877,1.0,10/40,8.60%,SGMS1;ST6GALNAC3;SGMS2;ST8SIA4;SPTLC2;DEGS2;SPTLC1;ST8SIA6;SPTSSB;ASAH2
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.5619600926293625,-1.5942575441758013,0.021937842778793418,0.2029173316379181,1.0,5/22,9.46%,MAP2K5;KLF4;WNK1;CD44;FLOT1
prerank,macrophage activation (GO:0042116),-0.49345566568111343,-1.5933184201374944,0.003913894324853229,0.2035306514063916,1.0,11/34,18.02%,FOXP1;LBP;PLCG2;CD93;APP;DYSF;TLR4;SYK;JAK2;C1QA;IFNGR1
prerank,ribosomal large subunit assembly (GO:0000027),-0.5477902980066424,-1.5925547299998979,0.018796992481203006,0.20387519230032675,1.0,10/24,19.51%,RPL6;RPL10;RPL11;RPL23A;NOP2;RPL3;PPAN;MDN1;RPL24;RPL5
prerank,keratan sulfate catabolic process (GO:0042340),0.6588963873582864,1.591991609600235,0.05627705627705628,0.4131018419745609,1.0,7/11,13.07%,FMOD;LUM;GNS;OMD;GALNS;OGN;GLB1
prerank,neuronal action potential (GO:0019228),0.5630689340080763,1.591869524824572,0.034482758620689655,0.4091573025694001,1.0,6/22,7.60%,SCN7A;CHRNA1;SCN3A;CACNA1I;CACNA1G;SCN2A
prerank,regulation of activated T cell proliferation (GO:0046006),0.5223706795580132,1.5906070357996438,0.025490196078431372,0.40838765510773034,1.0,5/30,8.86%,IGF1;IGFBP2;CD274;IGF2;IL18
prerank,tryptophan metabolic process (GO:0006568),0.669338752925364,1.590595031973173,0.02834008097165992,0.40439392131868496,1.0,4/11,10.52%,IL4I1;TDO2;KMO;KYNU
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.48947790442249794,-1.5903783354862284,0.007366482504604052,0.20665488670864365,1.0,11/36,13.14%,MECOM;NCOR1;FOXO1;PPIA;EZR;TAOK3;SH3RF2;AIDA;ZMYND11;DUSP3;ITCH
prerank,primary alcohol metabolic process (GO:0034308),0.538501315196877,1.58932447971351,0.023454157782515993,0.40408803633305657,1.0,2/25,2.08%,IGF1;DHRS3
prerank,toll-like receptor signaling pathway (GO:0002224),-0.41108258925604435,-1.588575363353778,0.00823045267489712,0.20885616024708845,1.0,22/84,13.54%,SCARA3;LBP;PLCG2;RPS6KA3;IRAK2;MAP3K1;MAPKAPK3;UBB;UBC;RPS27A;SFTPA2;SFTPA1;IKBKB;CASP8;TLR3;RIPK1;HSPD1;TIRAP;TLR4;CTSB;PIK3AP1;S100A1
prerank,ketone body metabolic process (GO:1902224),0.6830422417335312,1.5882478986473305,0.044642857142857144,0.40332503112448553,1.0,2/10,0.57%,HMGCLL1;ACSS3
prerank,indolalkylamine catabolic process (GO:0046218),0.6842176908606907,1.5880791049742347,0.036072144288577156,0.4000020619575446,1.0,4/10,10.52%,IL4I1;TDO2;KMO;KYNU
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.6389225070859863,1.5877518610047219,0.05200945626477541,0.39726834902764624,1.0,7/12,17.60%,B3GALT1;B3GALNT1;B3GNT7;B3GALT2;B3GALT5;B3GNT6;B4GAT1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.5054665509164723,1.587346920551504,0.023605150214592276,0.3946256852600583,1.0,5/35,1.77%,IRAG1;ADCY2;ADCY1;KSR1;PDE7B
prerank,regulation of vasculature development (GO:1901342),-0.5225109035717305,-1.5872210136572902,0.031007751937984496,0.21017593477985771,1.0,12/26,17.83%,BMPER;ETS1;WARS1;EMP2;EGLN1;PLXND1;HTATIP2;NF1;FGF2;ERBB2;EPHA2;RNH1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.6671254860964625,1.5863673348322354,0.05870020964360587,0.39374503201257666,1.0,3/11,5.34%,GRK3;ADM;GTF2H2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.5825673980584997,-1.5858551331335125,0.029411764705882353,0.21167903349178147,1.0,7/17,17.39%,PODXL;PIEZO1;TGFB2;FOXC2;CIB1;SYK;RET
prerank,purine-containing compound catabolic process (GO:0072523),-0.6258343290634025,-1.5845656884654538,0.039399624765478425,0.2129289187991653,1.0,5/13,11.58%,NT5E;GPX1;NT5C;GDA;NT5C1A
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.4911125107955876,-1.5822514389745657,0.02480916030534351,0.21598629353803506,1.0,11/34,11.34%,LIMS2;RREB1;DOCK1;FERMT2;NEDD9;RAC1;LIMS1;CRK;MYOC;S100A10;CIB1
prerank,response to prostaglandin E (GO:0034695),0.6814249782809896,1.5812297539703526,0.03879310344827586,0.4039599705724925,1.0,2/10,3.70%,TGFBR3;SFRP1
prerank,neurotransmitter transport (GO:0006836),0.4395488538854385,1.5810280243437203,0.008247422680412371,0.40089875610667136,1.0,22/73,15.47%,SLC1A3;ATP1A2;NRXN1;RIMS1;GABRA2;SLC29A1;SLC22A3;SLC38A1;SYT1;SNAP25;PDZD11;GLS2;GLUL;BRSK1;PTPRN2;STXBP3;APBA1;GRM4;SNAPIN;SLC1A2;PPFIA2;SLC1A7
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.6114658080554726,-1.5791462712816788,0.03125,0.2207704301906151,1.0,3/14,4.67%,PTK2B;WNK1;ADAM10
prerank,positive regulation of behavior (GO:0048520),-0.6648840402307625,-1.5782120508629522,0.023985239852398525,0.2213522500593471,1.0,4/10,10.12%,MEF2C;STRA6;AGRP;SGIP1
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.6046398267812462,1.5774871431715198,0.02981651376146789,0.4071507760220644,1.0,3/15,2.75%,IGF1;ROCK2;PRKCA
prerank,neuromuscular junction development (GO:0007528),0.5350151673296094,1.5747835672993473,0.045064377682403435,0.4109984879301239,1.0,10/24,12.92%,PDZRN3;PPFIBP2;CHRNA1;LRP4;UNC13C;CACNB1;CACNB4;CACNB2;MUSK;DOK7
prerank,chordate embryonic development (GO:0043009),0.45655209915993444,1.5742049454301932,0.012422360248447204,0.4089500753948385,1.0,14/55,9.40%,ARNT2;ALDH1A2;BMP2;FGFR2;SULF1;BMP5;SULF2;CHD7;TGFBR1;SIX4;IGF2;FOXD3;HES5;GATA3
prerank,regulation of membrane repolarization (GO:0060306),-0.6284272378666304,-1.5730616378787714,0.0338680926916221,0.23036760284767255,1.0,7/13,14.19%,CAV1;KCNJ2;NEDD4L;KCNQ1;AKAP6;CACNB3;CASQ2
prerank,regulation of biomineral tissue development (GO:0070167),0.5353037523609208,1.5705316755600454,0.04319654427645788,0.41557947104204235,1.0,8/26,6.20%,ENPP1;NOTUM;DDR2;CYP27B1;AHSG;ROCK2;CEBPB;ANKH
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.5691530629908553,-1.5701961889210658,0.023255813953488372,0.2345665107143595,1.0,6/19,7.14%,PRKCH;OCLN;CLDN5;F11R;IKBKB;CBFB
prerank,cardiac muscle tissue development (GO:0048738),0.4614612958343308,1.569971670446609,0.02335456475583864,0.4134754316863663,1.0,9/50,3.86%,BMP2;SGCZ;BMP5;GJB6;NRG1;GJA1;TBX18;SGCD;CSRP3
prerank,positive regulation of lyase activity (GO:0051349),-0.6121875539619656,-1.569692975932168,0.025408348457350273,0.23432119738459883,1.0,10/14,33.20%,NOS3;ORAI1;NF1;FXN;CACNA1D;CACNA1C;PARK7;NOS2;AKAP5;NOS1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.5092917715711447,-1.5692293462143323,0.021484375,0.23404393919589647,1.0,20/27,36.65%,IRAK2;MAP3K1;UBB;UBC;RPS27A;HSPD1;TIRAP;TLR4;TAB2;IRAK4;BTK;TRAF6;TLR6;CD36;TLR1;TLR5;CD14;LY96;UBA52;TLR2
prerank,positive regulation of blood coagulation (GO:0030194),-0.5856986824167261,-1.5689348145441322,0.02033271719038817,0.23352414731316995,1.0,5/17,2.90%,ANO6;ST3GAL4;THBS1;F3;THBD
prerank,positive regulation of cell migration (GO:0030335),-0.3456166272599038,-1.5685191365867108,0.0,0.23303220683010023,1.0,59/253,12.89%,FN1;LEF1;PECAM1;PODXL;CAV1;FLT1;IGF1R;ITGA6;SEMA6A;RREB1;SEMA3C;THBS1;GAB1;NOTCH1;SEMA7A;ACTG1;PLCG2;DOCK1;FGF1;RACK1;PTK2B;RAB11A;BMPR2;ACTN4;KDR;F3;PTK2;DAB2IP;FERMT2;TGFB1;TGFB2;SHTN1;SMO;ADAM10;NEDD9;CD151;VEGFA;SH3RF2;MYOC;EDN1;PPM1F;INSR;PDGFC;ELP6;PFN1;PLAA;PDGFA;LAMC2;FAM107A;SEMA3G;DDRGK1;WNT11;MMP14;CIB1;HSPA5;PRKCE;PIK3R3;CSF1R;ACVR1
prerank,regulation of interferon-alpha production (GO:0032647),-0.5330617168767326,-1.5673011039916276,0.026365348399246705,0.23441469193983483,1.0,13/23,34.93%,IFIH1;TLR3;DHX9;HSPD1;MAVS;TLR4;CHUK;STAT1;SETD2;PTPRS;NLRC3;TLR8;IRF3
prerank,membrane depolarization (GO:0051899),0.49441456824020835,1.5659879942468107,0.037444933920704845,0.4202921615479891,1.0,11/32,10.03%,SCN7A;CACNA1E;SCN3B;P2RX4;SCN3A;CACNA1I;CACNG4;CACNA1G;SCN2A;CACNB4;CHRNA4
prerank,regulation of T cell cytokine production (GO:0002724),-0.6021424314269415,-1.565687481592571,0.03389830508474576,0.23640750842734282,1.0,4/15,7.30%,B2M;CD55;SMAD7;TNFRSF1B
prerank,circulatory system development (GO:0072359),-0.3878776472147272,-1.5649289946469882,0.00411522633744856,0.23669174562289869,1.0,41/118,16.84%,FN1;TEK;PLCE1;MEF2C;HEG1;CXADR;NXN;NOTCH1;TGFBR2;MEF2A;RAMP2;TBX1;SOX17;COL3A1;PDLIM1;CDKN1B;RBM20;TGFB1;TGFB2;HDAC9;CRIP1;PKD1;STRA6;MICAL2;NOTCH4;CASP8;FLT4;SOX18;SMG9;FOXC2;TCF25;NF1;SOX4;ACVR1;HEY1;PIK3CA;SRF;PDLIM3;CDKN1A;TAB2;KDM6A
prerank,embryonic eye morphogenesis (GO:0048048),0.6510480208050919,1.5644076728985024,0.05701754385964912,0.421061927871157,1.0,4/11,7.85%,FBN1;FBN2;MFAP2;RARG
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.5185181693398607,-1.563147563329853,0.0273972602739726,0.23911614022628302,1.0,18/26,28.90%,CCND3;ANXA1;RGCC;AKT1;LSM11;CDK10;MTBP;EGFR;ANKRD17;CCND1;FGF10;LSM10;EIF4G1;HYAL1;RDX;AIF1;RPTOR;PLCB1
prerank,phospholipid transport (GO:0015914),-0.450099434428364,-1.562734313614323,0.009671179883945842,0.23879739829735214,1.0,16/52,13.88%,PITPNC1;ATP10A;ATP8A1;PLTP;ATP8B1;SCARB1;ATP11C;TNFAIP8L3;ATP11A;PITPNA;MFSD2A;ATP9B;ABCG1;PRELID2;APOE;PITPNM1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.5061976684423191,-1.560521250053708,0.023722627737226276,0.24203728289246865,1.0,12/29,19.85%,ESR1;UFM1;CBFB;KANK2;DDRGK1;KMT2D;WBP2;VPS11;STRN3;UFL1;UBA5;SRARP
prerank,regulation of metal ion transport (GO:0010959),0.5984208002101427,1.56042066912943,0.06140350877192982,0.42835525341177244,1.0,5/16,6.93%,ANK2;SLC30A10;CACNA2D1;BCL2;CAMK2B
prerank,positive regulation of glial cell differentiation (GO:0045687),0.593094630387201,1.5593010089995314,0.04112554112554113,0.4277601413111825,1.0,4/17,1.56%,IL34;BMP2;PTN;SERPINE2
prerank,ureteric bud development (GO:0001657),0.5871229035079456,1.5591114157822703,0.04670912951167728,0.4246928861755993,1.0,4/17,1.12%,ROBO2;BMP2;SALL1;FGFR2
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.5782617409898799,-1.5587397468188848,0.024208566108007448,0.24433546736199926,1.0,8/18,16.73%,HEG1;RASIP1;CCDC125;MYOC;TNFAIP1;ABL2;MET;KCTD10
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.40516706542292136,-1.5580964794019247,0.0039603960396039604,0.24452604483096366,1.0,31/87,15.07%,CLDN5;PARD3;ID1;PXN;TGFBR2;F11R;NLK;PTK2;SMAD9;FERMT2;SMAD7;COL3A1;TGFB1;FKBP1A;TGFB2;UBB;PRKCZ;UBC;RPS27A;SMAD6;TGFB3;USP9X;ZMIZ2;ENG;NRROS;ACVR1;USP15;ARHGEF18;SMURF1;EID2;SMAD4
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.4528849389189305,-1.5568794859229438,0.011673151750972763,0.24586141561972974,1.0,14/47,11.68%,LIMS2;RREB1;DOCK1;ACTN4;PTK2;FERMT2;NEDD9;RAC1;LIMS1;CRK;MYOC;S100A10;CIB1;RCC2
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.5716431589161106,-1.5568268395783922,0.029850746268656716,0.24477741081198726,1.0,13/18,13.42%,RHOJ;KDR;ANXA1;HDAC7;HDAC9;MAP3K3;VEGFA;GATA2;PIK3C2A;JCAD;FOXC2;CIB1;FGF2
prerank,pyruvate metabolic process (GO:0006090),-0.4396682195047642,-1.555421095981213,0.018218623481781375,0.24650279508920214,1.0,24/52,34.09%,BSG;ME1;GPI;DLD;HK1;PGM1;PKM;GAPDH;GLO1;LDHA;SLC16A1;ME2;PGK1;PFKL;PGAM1;PGAM4;ENO1;PFKFB1;PFKFB2;ALDOA;SRR;PDHA1;SLC16A3;TPI1
prerank,female gamete generation (GO:0007292),0.5189520137600311,1.5553645033976353,0.03958333333333333,0.4313970799107684,1.0,10/29,13.25%,PTN;DMC1;PRDM9;NANOS3;DIAPH2;MCM9;FMN2;MCM8;PIWIL2;PARN
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.5585727244404978,-1.5535790159721254,0.020560747663551402,0.24916041014051596,1.0,7/19,16.42%,HIPK1;DYRK2;RPS27L;TMEM109;AEN;DDIT4;PHLDA3
prerank,response to cAMP (GO:0051591),-0.47223073300617174,-1.5535247631383924,0.021568627450980392,0.2481241840191652,1.0,15/37,23.95%,RAP1A;RAP1B;RAPGEF1;IGFBP5;PDE2A;KCNQ1;EZR;NDUFS4;AKAP6;HCN2;RAPGEF3;STAT1;RAPGEF2;DMTN;PKD2
prerank,innate immune response (GO:0045087),-0.3475731854950768,-1.553498737445887,0.0020242914979757085,0.2470444692627663,1.0,56/217,18.20%,B2M;LBP;PLCG2;PTK2B;IFIH1;MID2;PTK2;GCH1;RPL39;TRIM25;ADAM15;ADAR;APP;MFHAS1;REL;NLRC5;NCF2;S100B;STYK1;IKBKB;IFITM1;IFITM3;SRPK1;TLR3;IFITM2;TRIM14;TRIM28;IFIT1;CLPB;FCER1G;PGLYRP1;RELB;CD74;DHX58;MAVS;TLR4;TTC4;FRK;ZDHHC1;SYK;TRIM62;TRIM56;NRROS;TRIM68;PHB2;TRIM5;CFP;POLR3A;NOD2;CX3CR1;YES1;ANKRD17;HCK;RELA;CHUK;SLA
prerank,ethanol metabolic process (GO:0006067),0.6465672300333728,1.5532492587029894,0.07268722466960352,0.4338619979626521,1.0,1/12,0.10%,ALDH1A1
prerank,lamellipodium assembly (GO:0030032),-0.5212711746291256,-1.5527341450966365,0.025341130604288498,0.24729038936857306,1.0,16/26,26.10%,ABLIM1;PARVB;S1PR1;ABLIM3;RAC1;SPATA13;VCL;SPEF1;ABLIM2;ARHGEF4;ARHGEF6;PTPRO;DMTN;CCDC88A;GOLPH3;CARMIL1
prerank,positive regulation of cell motility (GO:2000147),-0.35533743022707037,-1.5519960384237188,0.0,0.24753405332662015,1.0,51/205,13.37%,LEF1;PECAM1;PODXL;CAV1;FLT1;IGF1R;ITGA6;SEMA6A;SEMA3C;THBS1;SPOCK2;NOTCH1;SEMA7A;ACTG1;FGF1;RACK1;PTK2B;ACTN4;KDR;F3;PTK2;FERMT2;TGFB1;SMO;ADAM10;NEDD9;CAVIN1;CD151;VEGFA;SH3RF2;MYOC;EDN1;PPM1F;INSR;PDGFC;ELP6;PDGFA;LAMC2;TWIST1;FAM107A;SEMA3G;DDRGK1;WNT11;MMP14;CIB1;HSPA5;PIK3R3;NTN1;CSF1R;ACVR1;HRAS
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.6218801475908422,-1.5519085691652272,0.025547445255474453,0.24655035807287592,1.0,7/13,16.46%,NAMPT;KDR;IL33;EDN1;TLR4;NOD2;JAK2
prerank,aorta development (GO:0035904),0.6089217201636266,1.551572974555139,0.05274725274725275,0.43488048129934226,1.0,5/14,6.21%,ROBO1;ROBO2;LRP1;EFEMP2;PDGFRB
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.501486244029499,-1.5514418294729848,0.017341040462427744,0.2464147080412143,1.0,11/28,18.17%,NOD1;IRAK2;UBB;UBC;RPS27A;CASP8;ITCH;NOD2;TAB2;RELA;TNFAIP3
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.4053231874441917,1.5509546619831014,0.006382978723404255,0.43315443982829327,1.0,19/102,11.17%,ADCY7;ENPP1;ADCY2;PIK3R1;ADCY1;TBC1D4;ADCY5;PDPK1;PRKACA;SLC30A10;MYO5A;IRS2;INSIG2;RAB10;PDE3B;C2CD5;PRKCI;LPIN3;ADCY8
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.46344721520199966,1.5508398994980643,0.022494887525562373,0.4299581726606219,1.0,13/49,12.39%,IGF1;IL31RA;KIT;LYN;GHR;IL4;IL18;HES5;ERBB4;CNTF;IL6R;TSLP;PIBF1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.4636751588385269,-1.550432146927281,0.00946969696969697,0.24732312067048629,1.0,16/42,11.34%,UTRN;TEK;CDK6;PTPRJ;PTK2B;KDR;FERMT2;RAC1;LIMS1;VEGFA;MYOC;JUP;PPM1F;S100A10;EMP2;CIB1
prerank,modulation by symbiont of host process (GO:0044003),-0.6580548411899538,-1.550186010123,0.036608863198458574,0.2466274065190246,1.0,6/10,17.45%,B2M;UBB;UBC;RPS27A;PGK1;MRC1
prerank,muscle tissue morphogenesis (GO:0060415),0.5872800188318017,1.5497106170401462,0.05543237250554324,0.4295643030105834,1.0,4/16,6.15%,TGFBR3;BMP2;EFEMP2;MYLK
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.519764939424127,-1.5475144001844232,0.030303030303030304,0.25081226628264547,1.0,5/25,3.66%,SPTBN1;PLCG2;PDE4D;RPS3;ANXA1
prerank,activation of protein kinase B activity (GO:0032148),0.5103430640106619,1.5473380830773484,0.03512396694214876,0.43231784473315044,1.0,5/29,3.16%,IGF1;NTRK3;NRG1;PDPK1;OSBPL8
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.5194263821928925,-1.5466815019880513,0.027829313543599257,0.2513919932818945,1.0,10/24,18.17%,NOD1;IRAK2;UBB;UBC;RPS27A;CASP8;ITCH;NOD2;TAB2;TNFAIP3
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.4053550015508375,-1.5464397888952006,0.016,0.25081996741095275,1.0,38/76,33.16%,TMSB4X;NR3C2;NOD1;ACTN4;NFKBIA;CCN3;RPS3;APP;HDAC7;ADIPOR1;LIMS1;EZR;TLR3;RASSF2;TCIM;TLR4;PHB2;NOD2;EGFR;RELA;LAPTM5;TRIP6;ADGRG3;TSPAN6;LGALS9;PTPN22;TRAF6;PTP4A3;PDCD4;CD86;C1QTNF4;SPI1;TERF2IP;NLRP3;RHOA;NLRC3;CD14;TRIM44
prerank,regulation of axonogenesis (GO:0050770),0.4542433125019825,1.5463975878219092,0.0205761316872428,0.4317864135312702,1.0,13/51,12.38%,PLXNA2;ROBO1;ROBO2;LRRC4C;KIF13B;LRP4;MCF2;RTN4;PTEN;BRSK1;PLXNB2;AMIGO1;NGFR
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.6135131373055832,-1.54558491442612,0.034545454545454546,0.2513539424055236,1.0,8/13,29.93%,SLC35A3;UAP1L1;GFPT1;AMDHD2;RENBP;PGM3;GNPDA1;UAP1
prerank,regulation of smoothened signaling pathway (GO:0008589),0.45639768043851603,1.545323890916873,0.018789144050104383,0.4312763602711227,1.0,15/50,12.29%,RORA;FGFR2;IFT81;ZIC1;GLI3;SFRP1;EVC;IFT122;TULP3;KCTD21;KIF7;MGRN1;FUZ;BTRC;SUFU
prerank,phosphate ion homeostasis (GO:0055062),0.6679989078025802,1.5448325243698584,0.05947136563876652,0.4293082683204399,1.0,2/10,9.37%,ENPP1;FGFR4
prerank,cellular response to cAMP (GO:0071320),-0.4953121088775132,-1.544320956480696,0.03592814371257485,0.25295909711335246,1.0,13/30,23.95%,RAP1A;RAP1B;RAPGEF1;IGFBP5;PDE2A;KCNQ1;EZR;AKAP6;HCN2;RAPGEF3;RAPGEF2;DMTN;PKD2
prerank,regulation of JNK cascade (GO:0046328),-0.39238773309064257,-1.543265050492167,0.00196078431372549,0.2539265821837344,1.0,32/101,15.90%,MECOM;IGF1R;MAP3K5;PTK2B;NCOR1;TPD52L1;DAB2IP;APP;MFHAS1;MINK1;TAOK3;SH3RF2;RASSF2;RIPK1;FLT4;AIDA;ZMYND11;FZD7;MAP3K11;TAOK2;TIRAP;ULK4;GADD45G;DUSP3;COPS5;TRAF1;ITCH;HRAS;EDA2R;SDCBP;NOD2;EGFR
prerank,activation of protein kinase activity (GO:0032147),0.39967301843338515,1.5426163444720604,0.011560693641618497,0.43217215296508843,1.0,13/106,5.22%,IGF1;ADCY7;ADCY2;ADCY1;NRK;NTRK3;ADCY5;NRG1;PDPK1;PRKACA;OSBPL8;GHR;IL4
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.41350622211131544,-1.5423242816454974,0.012320328542094456,0.2546853381720503,1.0,24/72,18.17%,TAX1BP1;RACK1;LIFR;HIPK1;ELF1;IRAK2;HSP90AB1;IKBKB;CBFB;CASP8;RIPK1;CD74;SYK;TRAF1;AGPAT1;TNFRSF1A;SIGIRR;MADD;PTPN6;JAK2;CHUK;IFNGR1;STAT1;TNFAIP3
prerank,embryonic organ morphogenesis (GO:0048562),0.47665841890440225,1.5404532223441505,0.024439918533604887,0.43508173859963806,1.0,11/42,11.27%,FBN1;FBN2;FGFR2;PDGFRA;HOXC4;HOXB3;HOXC9;MFAP2;RARG;HOXB9;FUZ
prerank,axon guidance (GO:0007411),0.3629771447578373,1.5399735152404892,0.0,0.4333640929298447,1.0,39/201,10.66%,LAMA1;PLXNA2;EPHA7;ROBO1;PIK3R1;NRP1;ROBO2;LAMA2;LRTM1;SEMA5A;NRXN1;GDNF;GLI2;CNTN4;EPHA3;PRKCA;SEMA3A;EPHA6;DOK2;ARTN;RHOH;KIF5C;DAB1;EFNA3;SEMA3D;IRS2;NPTN;NRXN3;EPHB1;UNC5C;ALCAM;RYK;UNC5D;EPHA8;CDK5R1;EPHA5;DCC;NCAM1;PLXNB2
prerank,positive regulation of protein metabolic process (GO:0051247),-0.38833950907172415,-1.5397523811648437,0.0019723865877712033,0.2584784782048078,1.0,37/110,18.17%,WWP1;GPC3;NEDD4L;MAP2K5;NFKBIA;KLF2;KLF4;FOXO1;DAB2IP;CDKN1B;APP;RNF41;TGFB1;WWP2;IDE;EGLN2;NDUFA13;PLK2;AKT1;ATG7;VCP;INHBA;PAEP;OAZ2;RAB7A;ITCH;ABCA2;APOE;LDB1;SMURF1;RAB1A;SNF8;NR1H2;CSNK2A1;NSF;FZR1;TNFAIP3
prerank,regulation of actin filament polymerization (GO:0030833),-0.4234325171564531,-1.5397233566328845,0.010526315789473684,0.25743397828236114,1.0,29/69,28.10%,ESAM;KANK3;BAIAP2L1;PTK2B;CYRIB;SLIT2;KANK4;SSH2;HIP1R;LMOD1;PFN1;PRKCE;DBNL;DBN1;WASHC5;NCKAP1;HCK;CDC42EP3;RASA1;CTTN;HCLS1;ARHGAP18;NCK1;PLEKHG2;PRKCD;NCK2;CARMIL1;CDC42EP2;FCHSD1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.48133765313527566,-1.5390291242440377,0.023032629558541268,0.2577131185798841,1.0,18/33,26.51%,CDK6;FHL1;KLF4;KANK2;RB1;FAM107A;CDK4;CDKN1A;CDKN2C;CDK2AP2;RBL1;E2F7;PLK3;PKD2;DCUN1D3;CCL2;PLK5;CDKN2B
prerank,positive regulation of JNK cascade (GO:0046330),-0.41761675268644954,-1.5387102016538459,0.009560229445506692,0.25717789304946315,1.0,22/70,15.24%,MAP3K5;PTK2B;TPD52L1;DAB2IP;APP;MFHAS1;MINK1;TAOK3;SH3RF2;RASSF2;RIPK1;FLT4;FZD7;MAP3K11;TAOK2;TIRAP;GADD45G;TRAF1;HRAS;EDA2R;SDCBP;NOD2
prerank,neutrophil activation involved in immune response (GO:0002283),-0.3240976849215726,-1.5379434697442431,0.0,0.2577595418452724,1.0,110/428,17.27%,PTPRB;ANO6;PECAM1;B2M;RAP1A;ATP8A1;EEF1A1;PTPRJ;CD55;OSTF1;ADGRE5;RAP1B;CD93;GPI;EEF2;IQGAP1;MANBA;STK10;CD44;HSP90AB1;VAMP7;RAB27A;CTSZ;IGF2R;HSPA8;ADAM10;PPIA;PGM1;ANXA2;RAC1;ATP11A;RAB18;DIAPH1;VAT1;LTA4H;PSAP;ACLY;PKM;CAP1;CTSC;FTL;TNFRSF1B;STOM;JUP;PRCP;SVIP;ARPC5;CST3;QSOX1;SPTAN1;NHLRC3;IMPDH1;TMC6;ENPP4;VCL;CTSD;LAMP1;COMMD9;ATP6V0C;CSNK2B;FCER1G;PGLYRP1;CEP290;ATG7;TSPAN14;TOLLIP;RAB4B;VCP;FABP5;LRG1;ILF2;MOSPD2;SURF4;FTH1;TUBB4B;RAB24;CTSB;FRK;PDAP1;COMMD3;DBNL;SYK;RAB7A;FAF2;PSMD14;ERP44;FUCA2;HRNR;LAMTOR2;CCT2;GDI2;CFP;DYNC1LI1;GUSB;SDCBP;CAB39;PTPN6;DSP;TIMP2;SLC15A4;HMOX2;HSP90AA1;HSPA1A;PSMD11;CDK13;PSMD12;SLC2A3;IST1;TMEM30A;ATP11B
prerank,neutrophil mediated immunity (GO:0002446),-0.32281083862664856,-1.5376181735960335,0.0,0.2573506525758223,1.0,148/432,25.62%,PTPRB;ANO6;PECAM1;B2M;RAP1A;ATP8A1;EEF1A1;PTPRJ;CD55;OSTF1;ADGRE5;RAP1B;CD93;GPI;EEF2;IQGAP1;MANBA;STK10;CD44;HSP90AB1;VAMP7;RAB27A;CTSZ;IGF2R;HSPA8;ADAM10;PPIA;PGM1;ANXA2;RAC1;ATP11A;RAB18;DIAPH1;VAT1;LTA4H;PSAP;ACLY;PKM;CAP1;CTSC;FTL;TNFRSF1B;STOM;JUP;PRCP;SVIP;ARPC5;CST3;QSOX1;SPTAN1;NHLRC3;IMPDH1;TMC6;ENPP4;VCL;CTSD;LAMP1;COMMD9;ATP6V0C;CSNK2B;FCER1G;PGLYRP1;CEP290;ATG7;TSPAN14;TOLLIP;RAB4B;VCP;FABP5;LRG1;ILF2;MOSPD2;SURF4;FTH1;TUBB4B;RAB24;CTSB;FRK;PDAP1;COMMD3;DBNL;RAB7A;FAF2;PSMD14;ERP44;ACE;FUCA2;HRNR;LAMTOR2;CCT2;GDI2;CFP;DYNC1LI1;GUSB;SDCBP;CAB39;PTPN6;DSP;TIMP2;SLC15A4;HMOX2;HSP90AA1;HSPA1A;PSMD11;CDK13;PSMD12;SLC2A3;IST1;TMEM30A;ATP11B;PLAU;IRAK4;ADGRG3;CYBB;PSMC3;TMEM179B;CPNE3;CANT1;HSPA1B;PGM2;PYGL;PFKL;ANXA3;CCT8;PSMB1;NRAS;PSMA2;ARHGAP45;PGAM1;ABCA13;CD68;LCN2;RAB3D;PRKCD;DOK3;STXBP2;TOM1;ALAD;MLEC;DPP7;PLAUR;NFAM1;SLC27A2;ACTR1B;CYB5R3;NAPRT;RAB5C;CTSS
prerank,negative regulation of cell growth (GO:0030308),-0.37248369956396016,-1.536218168098444,0.006060606060606061,0.25910724916832645,1.0,44/121,20.19%,APBB2;PTPRJ;SERTAD2;OSGIN2;RACK1;BMPR2;SH3BP4;FHL1;CCN3;SOX17;SLIT2;NPR1;ADAM15;CDKN1B;TGFB1;TGFB2;PPP2R1A;NDUFA13;SIPA1;RB1;DIP2B;WFDC1;SEMA3G;BCL6;WNT11;CRLF3;CCDC85B;INHBA;SPHK2;NDUFS3;SMARCA4;OSGIN1;SMAD4;CDKN2AIP;SMARCA2;CDKN1A;HSPA1A;CDKN2C;CCAR2;NME6;ESR2;TSPYL2;MSX1;NDRG3
prerank,axonogenesis (GO:0007409),0.3533561233920888,1.5360304319472258,0.0,0.44127296288914775,1.0,45/237,10.64%,LAMA1;AUTS2;EPHA7;ROBO1;PIK3R1;NRP1;ROBO2;LAMA2;LRTM1;FGFR2;SEMA5A;NRXN1;GDNF;GLI2;CNTN4;EPHA3;PRKCA;SEMA3A;EPHA6;DOK2;ARTN;KIF5C;CTNNA2;DAB1;SLITRK4;EFNA3;SEMA3D;IRS2;NPTN;NLGN3;NRXN3;EPHB1;DOCK7;UNC5C;NRCAM;RAB10;RYK;UNC5D;EPHA8;CDK5R1;EPHA5;PTEN;DCC;NCAM1;BRSK1
prerank,neutrophil degranulation (GO:0043312),-0.3227122018943802,-1.5347349561244819,0.0,0.2610618929989426,1.0,109/425,17.27%,PTPRB;ANO6;PECAM1;B2M;RAP1A;ATP8A1;EEF1A1;PTPRJ;CD55;OSTF1;ADGRE5;RAP1B;CD93;GPI;EEF2;IQGAP1;MANBA;STK10;CD44;HSP90AB1;VAMP7;RAB27A;CTSZ;IGF2R;HSPA8;ADAM10;PPIA;PGM1;ANXA2;RAC1;ATP11A;RAB18;DIAPH1;VAT1;LTA4H;PSAP;ACLY;PKM;CAP1;CTSC;FTL;TNFRSF1B;STOM;JUP;PRCP;SVIP;ARPC5;CST3;QSOX1;SPTAN1;NHLRC3;IMPDH1;TMC6;ENPP4;VCL;CTSD;LAMP1;COMMD9;ATP6V0C;CSNK2B;FCER1G;PGLYRP1;CEP290;ATG7;TSPAN14;TOLLIP;RAB4B;VCP;FABP5;LRG1;ILF2;MOSPD2;SURF4;FTH1;TUBB4B;RAB24;CTSB;FRK;PDAP1;COMMD3;DBNL;RAB7A;FAF2;PSMD14;ERP44;FUCA2;HRNR;LAMTOR2;CCT2;GDI2;CFP;DYNC1LI1;GUSB;SDCBP;CAB39;PTPN6;DSP;TIMP2;SLC15A4;HMOX2;HSP90AA1;HSPA1A;PSMD11;CDK13;PSMD12;SLC2A3;IST1;TMEM30A;ATP11B
prerank,renal system development (GO:0072001),0.4438659323656428,1.5342327003413747,0.018072289156626505,0.4429379789332948,1.0,12/52,9.40%,WNT4;SALL1;GREB1L;SULF1;SULF2;GLI2;TBX18;LRP4;TGFBR1;ITGA8;NPHP3;GATA3
prerank,negative regulation of JNK cascade (GO:0046329),-0.4882390405690944,-1.5328036838761276,0.017142857142857144,0.2639299169237241,1.0,9/31,13.14%,MECOM;NCOR1;TAOK3;SH3RF2;AIDA;ZMYND11;DNAJA1;DUSP3;ITCH
prerank,regulation of Wnt signaling pathway (GO:0030111),0.39652805436320215,1.5324289400148363,0.003738317757009346,0.44506178771296456,1.0,20/108,6.49%,NOTUM;BMP2;SALL1;WLS;DAAM2;CDK14;FGFR2;SULF1;TRABD2B;LRP1;SULF2;PTK7;SFRP1;RNF43;TAX1BP3;WIF1;CTNND2;PRKN;SENP2;TLE1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.5320719637333168,-1.5312889610773521,0.0379746835443038,0.26611668472964006,1.0,7/21,7.61%,CAV1;DMD;RACK1;PDE4D;SMAD7;RASSF2;PPM1F
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5454554481911267,-1.5311621330013647,0.03018867924528302,0.26525629515388344,1.0,6/21,7.14%,PRKCH;FOXP1;SLC39A10;ELF1;CD81;CBFB
prerank,adenine nucleotide transport (GO:0051503),-0.5647356225467168,-1.5308149929021324,0.03153988868274583,0.2647789020873172,1.0,3/17,2.19%,ABCC4;LRRC8C;LRRC8D
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.47501776495395226,-1.5307069998488108,0.025547445255474453,0.26384586691837986,1.0,14/35,11.70%,NR3C2;ESR1;DDX5;DDX17;PPARGC1B;PLPP1;RBFOX2;KDM3A;NR3C1;SAFB;EGLN2;ARID1A;WBP2;NCOA4
prerank,neuron projection extension (GO:1990138),0.48974799339659575,1.530548422899957,0.05263157894736842,0.4470005483728921,1.0,8/32,8.39%,AUTS2;NRP1;SEMA5A;SEMA3A;FLRT1;NLGN3;ALCAM;CDKL3
prerank,negative regulation of viral genome replication (GO:0045071),-0.45804906822200675,-1.5303783879316193,0.0199203187250996,0.2635008886980797,1.0,13/40,18.10%,IFIH1;MPHOSPH8;IFITM1;IFITM3;N4BP1;SRPK1;IFITM2;IFIT1;FAM111A;MAVS;TASOR;OAS2;RSAD2
prerank,negative regulation of cytokine production (GO:0001818),-0.35717452738843,-1.5301342847844117,0.0021321961620469083,0.2628861857705857,1.0,47/163,19.45%,FN1;LEF1;TMSB4X;THBS1;RPS6KA5;CD34;TAX1BP1;SRGN;IFIH1;MAP2K5;KLF4;TRIM25;ANXA1;HDAC7;HDAC9;SARS1;RAC1;NLRC5;CMKLR1;EZR;RNF125;RARA;N4BP1;RGCC;ANXA4;OTUD5;TRIB2;TNFRSF21;UBE2L6;MAPKBP1;DHX58;INHBA;MAVS;TLR4;ITCH;SIGIRR;INHBB;PTPN6;CD84;VSIR;JAK3;ATP2B1;CD200;TNFAIP3;PIN1;PTGER4;LAPTM5
prerank,extracellular matrix organization (GO:0030198),0.3498303462070449,1.5295101160487357,0.0018867924528301887,0.4467366591211969,1.0,47/276,7.55%,COL4A6;LAMA1;COL4A5;ADAMTS6;ITGA9;COL13A1;FLRT2;ADAMTS12;FBN1;LAMA2;FBN2;LAMC3;COL1A2;DDR2;ADAMTS10;NID2;SCUBE1;COL22A1;DPT;DCN;ITGA11;MATN3;ADAMTS5;NID1;RECK;MIA;CREB3L1;SH3PXD2B;TNC;COL4A4;MMP16;DDR1;LUM;COL16A1;ADAM12;MMP11;SERPINE1;COL4A3;PLG;ITGAD;P4HA2;COL10A1;LOXL2;COL8A2;LOXL3;MFAP2;TGFBR1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.4504798742647113,1.529277130603425,0.009727626459143969,0.4440754653707336,1.0,12/55,5.87%,CEMIP;GPC6;HYAL3;SPAM1;FMOD;DCN;GPC4;LUM;GPC2;GNS;OMD;GALNS
prerank,regulation of wound healing (GO:0061041),-0.45428947600535285,-1.5284810274376865,0.022944550669216062,0.26528106014829606,1.0,17/42,25.01%,CAV1;OCLN;ACTG1;PTK2;ANXA1;CD109;CRK;SRSF6;PRKCE;HRAS;FGF2;TNFAIP3;PLAU;CADM4;CLDN1;DMTN;TNFRSF12A
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.4236879110980807,1.528290332616867,0.0102880658436214,0.4438063176741496,1.0,16/74,7.78%,IGF1;TCF7L2;AR;BMP5;EYA2;GDNF;BCL2;SH3RF1;CFLAR;PHIP;IL4;SERPINE1;GSTP1;EYA1;TGFBR1;SCG2
prerank,glycerolipid catabolic process (GO:0046503),-0.5354783382327941,-1.5278145125024116,0.04291044776119403,0.2655730083751107,1.0,3/19,3.37%,GPCPD1;ABHD2;MGLL
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.5424058674708652,-1.527418162556811,0.021400778210116732,0.2653008980385571,1.0,6/20,6.41%,B2M;CD55;PRKCZ;CD81;IL1R1;DENND1B
prerank,cranial nerve development (GO:0021545),0.6272993290117009,1.5270054768783476,0.06164383561643835,0.44397732398779327,1.0,3/11,8.73%,SALL1;CHD7;ERBB3
prerank,cell junction organization (GO:0034330),-0.40864417160564304,-1.5238564409268978,0.009560229445506692,0.2716100604945646,1.0,16/71,5.33%,ACTB;OCLN;LIMS2;APBB2;CXADR;ACTG1;AGRN;OPHN1;TJP2;FERMT2;RAB8B;APP;TGFB1;TGFB2;SDK1;LIMS1
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.6108781999396362,-1.523016380925653,0.044642857142857144,0.27231974096989414,1.0,6/13,16.75%,NOS3;GCH1;CALM1;AKT1;HSP90AA1;SPR
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5191512279071455,1.5222966611899815,0.04904051172707889,0.4540148905366087,1.0,4/26,5.02%,IGF1;FHL2;CAMTA1;ACTN3
prerank,regulation of epithelial cell proliferation (GO:0050678),0.40809423002959827,1.5209243674800343,0.021912350597609563,0.4545535461086118,1.0,11/85,4.60%,IGF1;BMP6;TCF7L2;TGFBR3;FGFR2;BMP5;MTSS1;RUNX3;SFRP1;TGFA;MCC
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.4016035283470797,-1.5206123517704566,0.02976190476190476,0.2761883592874326,1.0,22/76,19.62%,TMSB4X;TAX1BP1;MAP2K5;NFKBIA;KLF4;DAB2IP;IRAK2;NLRC5;CMKLR1;CHP1;CYP1B1;USP7;ANXA4;AIM2;COMMD7;ITCH;UFL1;CHUK;CD200;TNFAIP3;CDK5RAP3;CCDC22
prerank,negative regulation of cell junction assembly (GO:1901889),0.5061425767587788,1.5201069954426718,0.0508130081300813,0.45368032050781987,1.0,5/25,4.57%,ARHGAP6;ROBO2;PHLDB2;ROCK2;DLC1
prerank,heart contraction (GO:0060047),0.4712303850290887,1.5199402236385067,0.02586206896551724,0.4509365196350688,1.0,8/41,3.86%,ATP1A2;SGCZ;SLC8A1;SCN3B;SGCD;TNNC1;TNNI3;CSRP3
prerank,purine ribonucleotide transport (GO:0015868),-0.5683884805454105,-1.5179338870779522,0.027985074626865673,0.28074334781513194,1.0,3/16,2.19%,ABCC4;LRRC8C;LRRC8D
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.5361429739637046,-1.5177868638496825,0.03802281368821293,0.27993413684232454,1.0,6/21,5.26%,MTUS1;THBS1;PTK2B;MAPK3;PTK2;CMKLR1
prerank,response to chemokine (GO:1990868),-0.6001556345780752,-1.516597306604407,0.0518783542039356,0.28126136974446037,1.0,3/13,2.78%,SLC12A2;LRCH1;WNK1
prerank,endothelial cell proliferation (GO:0001935),-0.5544859094556627,-1.516505789759687,0.04066543438077634,0.2803165517166755,1.0,4/17,2.16%,TEK;BMPER;CD34;BMPR2
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.4771252539200868,-1.516321907394453,0.033271719038817,0.2797118827748216,1.0,16/31,26.51%,CDK6;FHL1;KLF4;KANK2;RB1;FAM107A;CDK4;CDKN1A;CDKN2C;CDK2AP2;RBL1;E2F7;PKD2;DCUN1D3;CCL2;CDKN2B
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.5109604091118255,-1.5137833856143905,0.039399624765478425,0.28426267883448536,1.0,12/25,26.30%,OPHN1;HSP90AB1;RPL11;RPL23;RPS7;SGTA;CSNK2A1;CSNK2A2;RPL5;ALAD;TRIM39;F8A1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.6318181943295029,-1.5126600589040684,0.03963963963963964,0.28560148809286123,1.0,4/11,15.21%,CAV1;NEDD4L;CASQ2;CAB39
prerank,T-helper cell differentiation (GO:0042093),-0.6000887015784601,-1.5125982771943407,0.03669724770642202,0.28466782879758284,1.0,2/14,0.18%,LEF1;FOXP1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.5736867369098951,-1.5125297143404746,0.038817005545286505,0.28262801623454176,1.0,10/15,33.84%,SORBS1;PDLIM1;FAM171A1;TNFAIP1;FHDC1;PDCD10;SRC;RHOA;KCTD13;CUL3
prerank,stress fiber assembly (GO:0043149),-0.5736867369098951,-1.5125297143404746,0.038817005545286505,0.28262801623454176,1.0,10/15,33.84%,SORBS1;PDLIM1;FAM171A1;TNFAIP1;FHDC1;PDCD10;SRC;RHOA;KCTD13;CUL3
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3846070713105096,1.5120607120825622,0.007722007722007722,0.47003241399347095,1.0,13/110,5.74%,ADCY7;ADCY2;ADCY1;LGR4;LPAR1;ADGRB3;PTGFR;GPHB5;ADCY5;ABCA1;MC5R;ADM;IAPP
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.5058870599421629,1.5119725586163366,0.05197505197505198,0.46708238089929727,1.0,4/27,2.20%,ENPP1;PID1;PIP4K2A;AHSG
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.6324277937399367,-1.5110545522120233,0.03350970017636684,0.283709038280722,1.0,8/11,27.52%,CALM1;FKBP1A;GSTM2;CALM3;CASQ2;SRI;PKD2;GSTO1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.6324277937399367,-1.5110545522120233,0.03350970017636684,0.283709038280722,1.0,8/11,27.52%,CALM1;FKBP1A;GSTM2;CALM3;CASQ2;SRI;PKD2;GSTO1
prerank,kidney development (GO:0001822),0.4193546912315445,1.5095560121812828,0.02004008016032064,0.4704225473151673,1.0,9/65,2.77%,WNT4;ROBO2;SALL1;GREB1L;SULF1;SULF2;GDNF;GLI2;LRP4
prerank,regulation of small molecule metabolic process (GO:0062012),0.503282747667247,1.5095522097507363,0.048582995951417005,0.4672722854099643,1.0,6/28,6.08%,RORA;PPARA;PDK1;PDK4;PRKN;PDK3
prerank,heme biosynthetic process (GO:0006783),-0.5219054445971381,-1.5093123907162638,0.04460966542750929,0.28641451180610256,1.0,11/22,29.70%,ABCG2;SLC25A38;UROS;COX15;FXN;ATP5IF1;COX10;ALAS2;ALAD;ABCB6;ABCB10
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5484006036446943,1.5089763516659873,0.05088495575221239,0.46573112247166076,1.0,4/21,9.33%,IGF1;GJA1;DNMT1;BMPR1A
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.6612478031634447,-1.507363928980709,0.0351493848857645,0.2897726823498621,1.0,10/10,33.92%,FN1;HSP90AB1;GATA6;TSKU;LAPTM4B;LILRB1;CD24;CDH3;TYROBP;FURIN
prerank,protein localization to lysosome (GO:0061462),-0.482451634933161,-1.5069731512030096,0.03557312252964427,0.28951427128466467,1.0,15/28,31.13%,SH3BP4;AP3M1;CD81;GLMP;NCOA4;RAB7A;MFSD1;GCC2;AP4M1;LAPTM5;ZFYVE16;VPS4A;LAMTOR5;ATP13A2;SNX16
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.40594293689209365,-1.5066581888757795,0.01949317738791423,0.28915004002622546,1.0,25/71,17.17%,ACTB;ACTG1;WASF2;PLCG2;DOCK1;ARPC1B;MAPK3;PTK2;HSP90AB1;RAC1;CRK;ARPC5;FCER1G;PRKCE;ACTR3;SYK;WASL;ABI1;PIK3CA;LIMK1;NCKAP1;PIK3R2;YES1;HSP90AA1;HCK
prerank,membrane repolarization during action potential (GO:0086011),-0.6112490505883854,-1.5066246742190768,0.044036697247706424,0.2881658518390489,1.0,7/13,26.31%,KCNJ2;ATP1A1;KCNQ1;ATP1B1;KCND3;KCNIP2;YWHAE
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.571547824667153,-1.5065798342724799,0.047244094488188976,0.2871718949108617,1.0,5/15,3.00%,IGF1R;PTK2B;KDR;MAPK3;BMX
prerank,sodium ion transmembrane transport (GO:0035725),0.4025161195812038,1.5063108330413826,0.007936507936507936,0.4701737970844439,1.0,17/84,9.95%,ATP1A2;NALCN;SLC24A3;SCN7A;SLC6A12;SLC8A1;SLC6A9;SLC6A13;SCN3B;SCN3A;SLC9A7;ASIC2;SCN2A;SLC6A11;SLC6A1;SLC24A4;SLC24A2
prerank,histone lysine methylation (GO:0034968),0.4787503758440541,1.505685787414729,0.03736263736263736,0.46875574321713814,1.0,14/33,16.33%,PRDM5;WDR5B;KMT2A;PRDM9;SETMAR;MEN1;SMYD1;CXXC1;PAXIP1;SMYD3;EHMT2;EZH2;DYDC2;WDR82
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.4966024044174547,-1.5052202886658892,0.039525691699604744,0.2891392076279651,1.0,16/25,38.45%,HSPA8;DNAJB12;HSPA5;HSPA1A;HSPA9;HSPE1;HSPA1B;ERO1A;BAG1;DNAJB1;SDF2L1;HSPA14;SDF2;ST13;DNAJC7;HSPA1L
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.4987566959641414,1.504924488263983,0.05106382978723404,0.467725181661406,1.0,6/26,10.12%,IGF1;PIK3R1;OSBPL8;IRS2;C2CD5;PRKCI
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6002537846262437,1.5047236888857831,0.07392197125256673,0.46524239937765494,1.0,4/13,3.28%,BMP2;BMP5;CYP27B1;DKK3
prerank,regulation of ion transmembrane transport (GO:0034765),-0.46469414882736193,-1.5043404483653748,0.04621072088724584,0.28992836125413235,1.0,11/33,14.19%,ANO6;KCNJ2;NEDD4L;WNK1;WWP2;KCNQ1;KCNJ10;AKAP6;KCNJ8;KCNJ15;CASQ2
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.5291535066751759,-1.5036477778269128,0.054003724394785846,0.29036474924915706,1.0,6/20,12.37%,RPS6KA5;MAPK3;PPARGC1A;DIP2B;TADA2B;SOX4
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.5448830380314096,-1.5035229392366622,0.03136531365313653,0.2895670199631078,1.0,10/19,9.65%,TEK;PTPRJ;KDR;FERMT2;RAC1;LIMS1;VEGFA;MYOC;PPM1F;S100A10
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.6173446722684311,1.5028130270883475,0.084070796460177,0.4643785795773665,1.0,2/12,4.83%,IGF1;CAMTA1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.6173446722684311,1.5028130270883475,0.084070796460177,0.4643785795773665,1.0,2/12,4.83%,IGF1;CAMTA1
prerank,regulation of type I interferon production (GO:0032479),-0.3956138967537537,-1.5027287373855474,0.006185567010309278,0.2901107345463193,1.0,25/84,19.23%,TAX1BP1;IFIH1;TRIM25;NLRC5;LRRFIP1;RNF125;PRKDC;OTUD5;DDX41;GAPDH;UBE2L6;DHX9;TIRAP;DHX58;MAVS;TRIM56;ITCH;POLR3E;NLRP4;POLR3A;RELA;TNFAIP3;IRF8;CGAS;PIN1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.6114628187266136,-1.5024803921379286,0.059130434782608696,0.2896419747980645,1.0,7/11,29.93%,UAP1L1;GFPT1;AMDHD2;RENBP;PGM3;GNPDA1;UAP1
prerank,regulation of presynapse organization (GO:0099174),0.5424224582706081,1.5019883098108469,0.04946236559139785,0.4606800686318834,1.0,4/18,7.29%,GPC6;GPC4;PTPRD;IL1RAPL1
prerank,regulation of presynapse assembly (GO:1905606),0.5424224582706081,1.5019883098108469,0.04946236559139785,0.4606800686318834,1.0,4/18,7.29%,GPC6;GPC4;PTPRD;IL1RAPL1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.5497645300861013,1.5017497310281318,0.046296296296296294,0.45837340403888244,1.0,7/18,7.77%,GRID2;CDH8;UNC13C;GRIK5;GRIK2;GRID1;GRIK1
prerank,axon extension (GO:0048675),0.521189799013496,1.5011914819251213,0.06828193832599119,0.45705881411768867,1.0,6/23,8.17%,AUTS2;NRP1;SEMA5A;SEMA3A;NLGN3;ALCAM
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.5626544433363471,-1.500867023974344,0.04181818181818182,0.29214110572459834,1.0,9/16,25.00%,THBS1;PPP1R16B;VEGFA;GATA2;JCAD;FGF2;DLL4;PDCD10;APLNR
prerank,positive regulation of programmed cell death (GO:0043068),-0.3350277550631723,-1.500620155650924,0.0022471910112359553,0.2915105211870265,1.0,83/272,19.75%,ANO6;ITGA6;MAP3K5;MCF2L;ARHGEF3;NET1;UNC13B;RACK1;TGM2;RASGRF2;ARL6IP5;FOXO1;FOXO3;SLIT2;DAB2IP;NGF;CRADD;MAP3K20;CTNNBL1;REST;UBB;TRIO;TNFSF10;HTT;IGFBP3;UBC;RPS27A;ING5;SOS2;HIP1R;TNFAIP8;CYP1B1;ATF4;TGFB3;CASP8;RASSF2;RIPK1;MAP3K11;DNAJA1;BAX;PSENEN;CTSD;FAS;ITSN1;RHOB;BCL6;ATG7;HSPD1;GADD45G;PREX1;ABR;HTATIP2;NF1;SOX4;RPS6;SYK;BAK1;RNPS1;E2F1;RPS6KA2;SPHK2;ARHGEF5;APH1A;BNIP3L;ARHGEF18;TOP2A;PHLDA3;PDCD2;BAD;DDX20;FOXL2;CCAR2;ARHGEF17;ECT2;ARHGEF12;ARHGEF4;CALHM2;ARHGEF2;ARHGEF6;LAPTM5;DNM2;GADD45A;FGD2
prerank,positive regulation of immune response (GO:0050778),-0.4091289636108002,-1.4999346476193347,0.02145922746781116,0.291981417156754,1.0,31/64,39.41%,IL15;GBP5;TGFB2;CD81;DHX9;CD74;SPHK2;AKIRIN2;NOD2;SLC15A4;XBP1;RSAD2;IL6ST;LGALS9;POLR3B;STX4;SKAP1;LILRB1;KARS1;RIOK3;NLRP3;TLR8;SASH3;CCL5;GRN;CD226;FCGR2B;MYB;IL12RB1;ITGB2;ADAM8
prerank,regulation of multicellular organism growth (GO:0040014),0.5695460652590842,1.49980193967538,0.06697459584295612,0.45776887353616685,1.0,3/15,4.41%,IGF1;STAT5B;GHR
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.5559750888732278,-1.4990904441342623,0.055248618784530384,0.2928407490382975,1.0,8/17,13.75%,CLDN5;F11R;VEGFA;IKBKB;S1PR3;ADD1;VCL;TNFRSF1A
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.5841492776305849,1.4988596726016203,0.07006369426751592,0.45737869007680687,1.0,2/14,5.22%,IGF1;IL4
prerank,regulation of glucose metabolic process (GO:0010906),0.47984561915559754,1.4982678891435304,0.04201680672268908,0.45612557562561185,1.0,6/34,6.08%,RORA;PDK1;PDK4;IRS2;PRKN;PDK3
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.40297213046906727,-1.4981445021161748,0.023391812865497075,0.29405146268948523,1.0,25/73,17.17%,ACTB;ACTG1;WASF2;PLCG2;DOCK1;ARPC1B;MAPK3;PTK2;HSP90AB1;RAC1;CRK;ARPC5;FCER1G;PRKCE;ACTR3;SYK;WASL;ABI1;PIK3CA;LIMK1;NCKAP1;PIK3R2;YES1;HSP90AA1;HCK
prerank,phosphatidylcholine catabolic process (GO:0034638),0.6472682852435319,1.4969811175542478,0.06575963718820861,0.45661268573941305,1.0,2/10,2.52%,PLA2G5;PLA2G4A
prerank,small GTPase mediated signal transduction (GO:0007264),-0.3793366643837168,-1.4961918037662398,0.016842105263157894,0.29723141293977895,1.0,32/103,14.70%,ARHGAP31;RAPGEF5;PLCE1;RREB1;RASGRP3;RGL1;SHOC2;ARHGAP1;SHTN1;RAC1;RALB;CHP1;RAB18;SHC1;BCR;NUCB1;KRAS;USP8;GRAP;RIT1;PLK2;RB1;RASSF1;TRIM28;ABR;NF1;NTN1;HRAS;FGF2;GNB1;ARHGEF18;RGL2
prerank,negative regulation of signal transduction (GO:0009968),0.34390018307378406,1.4960939060189034,0.005504587155963303,0.45630301801220025,1.0,52/249,10.73%,ENPP1;ADAMTS12;LGR4;NOTUM;BMP2;PID1;SULF1;TRABD2B;BMP5;LRP1;SULF2;DCN;PIP4K2A;AHSG;LEPROT;CREB3L1;DKK3;BCL2;GLI3;SFRP1;LYN;PTPRT;RNF43;TAX1BP3;WIF1;TMEM25;TSPAN15;SMPDL3B;NLRP12;TLE1;IFT122;TULP3;CXXC4;CRY1;MAPK8IP2;KCTD21;KIF7;LRRC14;NLRP2B;GPR108;ERBB3;CNMD;NKD2;GATA3;PRKCB;FRZB;MGRN1;PTEN;DCC;PIP4K2B;SIAH2;DACT3
prerank,positive regulation of nuclear division (GO:0051785),0.5080040897676316,1.4959998648827992,0.06359649122807018,0.4538468917285533,1.0,6/25,8.75%,IGF1;TGFA;PHIP;PDGFRB;SIRT2;IGF2
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.4258578844646058,-1.494418437974925,0.024667931688804556,0.2999929287580174,1.0,25/54,27.44%,RPL6;RPL26;RPL10;RPL11;RPL14;RRP15;RPL23A;RPL35A;NOP2;PES1;RPL10A;RPL3;PPAN;MDN1;RPL24;WDR74;RPL7;RPL5;WDR12;NSA2;RPL7A;RSL1D1;RPF2;NPM1;TRAF7
prerank,monocarboxylic acid transport (GO:0015718),-0.41721509269521084,-1.4925435233297744,0.02012072434607646,0.3033122251848705,1.0,10/51,3.12%,ABCG2;ABCC4;SLCO3A1;SLCO2A1;SLCO1C1;ATP8B1;SLCO2B1;SLC16A6;SLC16A9;SLC5A6
prerank,inositol phosphate metabolic process (GO:0043647),-0.44034066560284474,-1.4923928085021159,0.03824091778202677,0.30258888720807775,1.0,15/46,16.22%,PLCE1;ITPKB;PLCG2;PLCB3;CALM1;INPP5D;IPMK;INPP5A;ISYNA1;NUDT4;FGF2;IP6K1;SYNJ1;IMPA2;MINPP1
prerank,positive regulation of cell aging (GO:0090343),-0.6193017943981814,-1.4918149332605866,0.061567164179104475,0.3029728323486471,1.0,4/11,18.81%,B2M;ABI3;YPEL3;CGAS
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.5531190178991724,-1.4915007394398387,0.03409090909090909,0.30254542858295613,1.0,7/18,13.85%,ADAM10;BACE1;ADAM19;PSENEN;ABCG1;APH1A;APOE
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.5038585105268377,1.4910524909708354,0.0670611439842209,0.46456147587570273,1.0,7/27,5.78%,ARHGAP6;PIK3R1;ARHGAP28;PHLDB2;CGNL1;DLC1;PRKN
prerank,protein targeting to lysosome (GO:0006622),-0.5276200574540115,-1.4909055808648048,0.03415559772296015,0.3026141317253504,1.0,10/20,26.56%,AP3M1;HSPA8;NCOA4;RAB7A;GCC2;AP4M1;LAPTM5;GNPTAB;ZFYVE16;VPS4A
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.5298299525451188,-1.4905098581915848,0.045454545454545456,0.30242267323196115,1.0,10/20,25.32%,CCND3;CCNY;HSP90AB1;PKD1;RGCC;AKT1;EGFR;CCND1;PKD2;SPDYA
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.548186459238106,-1.4903813964938797,0.04460966542750929,0.30166720693899196,1.0,10/17,23.72%,PARD3;SMAD7;CALM1;CALM3;DDIT4;CADM4;EIF4G1;SPRED3;DMTN;PPEF2
prerank,carboxylic acid transmembrane transport (GO:1905039),0.4616668594113951,1.4903680711047624,0.035864978902953586,0.4634131005980143,1.0,6/40,7.18%,SLC7A11;SLC13A3;SLC36A2;SLC38A1;SLC7A9;SLC25A10
prerank,regulation of stress fiber assembly (GO:0051492),0.40725547214962954,1.4895008158069487,0.03225806451612903,0.4628860414689942,1.0,12/74,4.57%,ARHGAP6;PIK3R1;PPM1E;NRP1;ARHGAP28;LPAR1;PHLDB2;ROCK2;ASAP3;SFRP1;CGNL1;DLC1
prerank,positive regulation of catabolic process (GO:0009896),-0.4075311214344621,-1.4893659790731617,0.017408123791102514,0.3027420064369842,1.0,24/65,18.17%,WWP1;GPC3;NEDD4L;FOXO1;DAB2IP;CDKN1B;RNF41;WWP2;IDE;EGLN2;NDUFA13;PLK2;ATG7;VCP;OAZ2;RAB7A;ITCH;SMURF1;SNF8;VSIR;CSNK2A1;NSF;FZR1;TNFAIP3
prerank,alpha-amino acid catabolic process (GO:1901606),0.5055091305622605,1.48909566307108,0.04583333333333333,0.46125119404250486,1.0,8/29,10.52%,ALDH4A1;IL4I1;PRODH;ACADSB;TDO2;KMO;DDO;KYNU
prerank,regulation of intracellular pH (GO:0051453),-0.46476664679357366,-1.4890441490538624,0.03917910447761194,0.30243347383507524,1.0,16/34,28.10%,SLC4A10;SLC9A2;TMEM165;CHP1;ATP5F1B;SLC4A8;SLC4A2;GPR89B;GPR89A;VPS33A;SLC9B1;SLC9A5;SLC4A3;SLC9A4;SLC26A6;NOX1
prerank,regulation of actin filament depolymerization (GO:0030834),0.6079506341775578,1.48884644157753,0.08387096774193549,0.45933040988997736,1.0,2/12,1.22%,PLEKHH2;SEMA5A
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.49799246009751486,1.4887819230058394,0.05473684210526316,0.4568840396355457,1.0,4/28,2.20%,ENPP1;PID1;PIP4K2A;AHSG
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.5381126526742102,1.4880259004323808,0.06108597285067873,0.45621746755179665,1.0,6/20,7.89%,TGFBR3;BMP2;TBX3;OLFM1;TGFBR1;RBPJ
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.38116146485517666,-1.4872124071279702,0.015444015444015444,0.30554321972429443,1.0,28/93,15.24%,MAP3K5;PTK2B;ARL6IP5;TPD52L1;DAB2IP;APP;TGFB2;MFHAS1;MID1;MINK1;VEGFA;TAOK3;SH3RF2;RASSF2;RIPK1;FLT4;STK25;FZD7;MAP3K11;TAOK2;TIRAP;GADD45G;TRAF1;HRAS;EMC10;EDA2R;SDCBP;NOD2
prerank,gonad development (GO:0008406),0.45961584673059,1.486929684930364,0.04809619238476954,0.4563228073817658,1.0,9/41,9.40%,WNT4;SALL1;AR;NR2F2;KIT;CSDE1;ADAM21;SIX4;GATA3
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.5357999793082596,-1.4867970874259262,0.040145985401459854,0.3054902968298656,1.0,5/18,12.47%,LBP;PLCG2;DYSF;FCER1G;SYK
prerank,response to nitric oxide (GO:0071731),-0.595403513913894,-1.4866242017369438,0.0735009671179884,0.30483117218078154,1.0,4/13,10.64%,MTR;FOXO1;GUCY1B1;EGLN1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.5654861890551114,-1.4863640203035116,0.049429657794676805,0.3042779313499703,1.0,8/16,29.49%,VAMP7;LYST;PLEKHM2;TUBB4B;ARL8B;VAMP2;CORO1A;KIF5B
prerank,negative regulation of endopeptidase activity (GO:0010951),0.4419179680523264,1.4858245278147975,0.0465587044534413,0.45654716012590546,1.0,9/47,7.52%,TIMP3;SERPINE2;AHSG;SERPINI2;RECK;SERPINF1;SPOCK3;SERPINE1;TIMP4
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.36545699599890963,1.4848213592726565,0.005747126436781609,0.4565729086110836,1.0,40/138,12.10%,EPHA7;IL31RA;PTN;DDR2;NTRK3;FGFR2;PDGFRA;EFS;KIT;MTSS1;EPHA3;TNK2;EPHA6;PTPRD;DDR1;STAP1;LYN;PTPRT;AXL;PDGFRB;SHC4;EPHB1;POLR1G;ROR1;GUCY2F;RYK;ERBB3;FGFR4;EPHA8;SH2D6;AHI1;ERBB4;EPHA5;ALK;MUSK;MST1R;MERTK;FGFR1;EPHA1;GFRA2
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.6060220173016866,-1.48469594250339,0.047872340425531915,0.3070982785102644,1.0,7/12,11.72%,CAV1;IFIH1;RALB;DHX9;IFIT1;FLOT1;MAVS
prerank,acylglycerol catabolic process (GO:0046464),-0.4699601488306281,-1.484298111676862,0.043478260869565216,0.3069633442576111,1.0,5/30,13.52%,ABHD2;MGLL;PNPLA2;FABP5;FAAH
prerank,anterior/posterior axis specification (GO:0009948),0.573863036920498,1.4832957935275888,0.061052631578947365,0.4578392371987893,1.0,2/15,0.85%,WLS;TBX3
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.4956321383032726,-1.482408015792176,0.05454545454545454,0.3103540511912204,1.0,9/26,18.10%,CAV1;LBP;MFHAS1;TLR3;FLOT1;TIRAP;SLC15A4;NINJ1;RSAD2
prerank,regulation of defense response (GO:0031347),-0.38793592946797045,-1.4821994064932784,0.017475728155339806,0.3097512267594015,1.0,26/76,17.88%,FOXP1;TMSB4X;SEMA7A;MGLL;ANXA1;IL1R1;N4BP1;BRD4;ERAP1;CASP8;PSMA6;ACE2;BCL6;LRP8;TIRAP;DHX58;PIK3AP1;SAMHD1;APOE;BCL6B;NOD2;UFL1;JAK2;HCK;RELA;DAGLB
prerank,regulation of intracellular protein transport (GO:0033157),-0.4748040589261537,-1.4815084107655312,0.034545454545454546,0.3102108343592373,1.0,14/32,24.41%,PTPN14;TGFB1;PRR5L;BCAS3;CEP290;OAZ2;PCM1;UHMK1;NDEL1;GCC2;RIPOR1;PLK3;PDCD10;PTPN1
prerank,focal adhesion assembly (GO:0048041),-0.5190429488713353,-1.4813568930497423,0.04990403071017274,0.3096316161420922,1.0,11/21,19.71%,THSD1;SORBS1;PEAK1;FERMT2;ACTN1;BCR;TAOK2;RCC2;PTPRK;TRIP6;CTTN
prerank,pancreas development (GO:0031016),0.6135569536798852,1.4807708837402802,0.0700218818380744,0.4617149867815954,1.0,3/12,8.60%,TCF7L2;NKX6-1;NPHP3
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.49995656354594165,-1.4806861942485834,0.038181818181818185,0.30995905099845017,1.0,11/22,19.51%,SEL1L;UBB;EDEM3;UBC;RPS27A;MAN1B1;RNF185;RNF5;DERL2;AMFR;EDEM2
prerank,positive regulation of glucose import (GO:0046326),0.5150700847089652,1.4800696155017612,0.07912087912087912,0.4610813503265465,1.0,4/21,5.58%,IGF1;PIK3R1;OSBPL8;IRS2
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.5032033861021687,-1.4798136789171479,0.03669724770642202,0.31106263842850196,1.0,11/25,19.80%,CXADR;JAM3;JUP;CTNNA3;ITGA7;DSG2;ITGA4;DSP;NINJ1;CD200;ITGB3
prerank,detection of mechanical stimulus (GO:0050982),-0.530055461152964,-1.4798019707302363,0.04816955684007707,0.31004738153343736,1.0,5/19,7.44%,PIEZO2;PTK2;PIEZO1;PKD1;JUP
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.4320365309979677,-1.479667951942431,0.021442495126705652,0.3093103670566765,1.0,16/45,18.17%,B2M;CAMK2D;TRIM25;CD44;MT2A;MID1;TRIM62;TRIM68;TRIM5;IRF9;OAS2;JAK2;HCK;IFNGR1;STAT1;IRF8
prerank,regulation of cellular response to heat (GO:1900034),-0.38911985203342453,-1.4791473412954954,0.010526315789473684,0.30943155641673714,1.0,35/77,27.37%,CD34;MAPK3;CAMK2D;HSP90AB1;HSPA8;NUP93;NUP54;NDC1;HSBP1;BAG5;HSPB8;NUP188;NUP155;RANBP2;RPA3;HSP90AA1;HSPA1A;NUP37;CRYAB;CCAR2;FKBP4;NUP160;HSPA1B;IER5;BAG1;DNAJB1;NUP43;SEH1L;NUP42;SEC13;NUP107;YWHAE;NUP98;RPTOR;CAMK2G
prerank,protein-containing complex disassembly (GO:0032984),-0.4153785999373706,-1.4790243442765203,0.022944550669216062,0.30866390094865975,1.0,19/54,21.70%,CAV1;MAP1LC3B;VAMP7;RPL23;HSPA8;GABARAP;LIX1L;TECPR1;VCP;MAP1LC3A;TSG101;VPS33A;VPS16;VTI1B;WIPI2;FZD5;PPP1CA;RUBCNL;PYM1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.37502898857785677,-1.4788789152186435,0.008146639511201629,0.30801329207073025,1.0,33/94,20.34%,RPS6KA5;NOD1;NFKBIA;MAPK3;IRAK2;UBB;MAP3K3;UBC;RPS27A;IL1R1;IKBKB;MAP3K8;PSMA6;PSMB5;PSMC4;TOLLIP;PSMC5;PSMD14;RBX1;PSMD8;NOD2;PSMC1;PSMB4;TAB2;PSMD11;PSMD12;RELA;PELI1;CHUK;CUL1;IRAK4;PSMA1;PSMC3
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.5511437535991132,-1.4788026752632961,0.06776556776556776,0.3071919397834318,1.0,9/15,20.08%,BMPER;FGF1;KLF4;VEGFA;PKM;FGF2;S100A1;JMJD8;TJP1
prerank,epithelial tube morphogenesis (GO:0060562),-0.46969554871426433,-1.4787176491892149,0.04038461538461539,0.30637219301339325,1.0,12/32,12.89%,MEF2C;PODXL;RASIP1;SOX17;SLIT2;PKD1;COL4A1;CSNK2B;RHOB;HES1;CSF1R;ACVR1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.4816243759998353,1.4787097018747282,0.04932735426008968,0.4621890778129385,1.0,10/33,8.00%,LRRC4C;NRG3;GRID2;GRIK5;GRIK2;NLGN2;NLGN3;GRID1;GRIK1;NLGN1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.3982095806545158,-1.4775337835004367,0.023121387283236993,0.30807285694538644,1.0,24/70,17.17%,ACTB;ACTG1;WASF2;PLCG2;DOCK1;ARPC1B;MAPK3;PTK2;HSP90AB1;RAC1;CRK;ARPC5;PRKCE;ACTR3;SYK;WASL;ABI1;PIK3CA;LIMK1;NCKAP1;PIK3R2;YES1;HSP90AA1;HCK
prerank,negative regulation of peptidase activity (GO:0010466),0.43573062160908627,1.4773944284836478,0.04032258064516129,0.4631403890542609,1.0,9/47,7.52%,LRP1;TIMP3;SERPINE2;AHSG;SERPINI2;SERPINF1;SPOCK3;SERPINE1;TIMP4
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.553129199502554,-1.4771439169476912,0.043795620437956206,0.3079044289240566,1.0,9/17,25.32%,CCND3;CCNY;PKD1;RGCC;AKT1;EGFR;CCND1;PKD2;SPDYA
prerank,negative regulation of cell death (GO:0060548),-0.37640007384318425,-1.476681278549743,0.011741682974559686,0.3079686055172944,1.0,26/88,18.12%,MECOM;CD34;CCN3;FERMT2;PPARGC1A;DCPS;PDE8A;TNFRSF1B;DUS2;SRSF6;KANK2;AKT1;WNT11;SPEF1;INPP5A;IMPACT;PSMC5;SOX4;CCN5;TMEM109;FGF2;BNIP3L;RAD18;HSPA1A;CHMP2A;CD200
prerank,embryonic hemopoiesis (GO:0035162),-0.5854036431803827,-1.4766166675263328,0.06666666666666667,0.3071312105784287,1.0,5/12,8.32%,KITLG;TGFBR2;KDR;ATF4;TAL1
prerank,JNK cascade (GO:0007254),-0.44881079465622203,-1.4764380001784017,0.03294573643410853,0.3065657155471848,1.0,14/40,19.41%,MAP3K5;MAP4K3;NOD1;IRAK2;UBB;MINK1;UBC;RPS27A;MAP3K11;TRIB1;NOD2;TAB2;ARHGEF6;PTGER4
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.4133563599720145,1.47620898467652,0.03285420944558522,0.46375758086290764,1.0,17/66,9.59%,ROBO1;TGFBR3;NR2F2;FGFR2;SULF1;APOH;VDR;MTSS1;RUNX3;SFRP1;MCC;SCG2;SOX2;ATOH8;CNMD;GATA3;AIMP1
prerank,I-kappaB phosphorylation (GO:0007252),-0.6364264766156688,-1.475818052025763,0.05649717514124294,0.3069538507462395,1.0,6/10,26.44%,DAB2IP;TLR3;TLR4;CHUK;PRDX4;ERC1
prerank,positive regulation of cyclase activity (GO:0031281),-0.5731921945290314,-1.4755486777349653,0.059369202226345084,0.3065231213497481,1.0,9/14,33.20%,NOS3;MAPK3;ORAI1;NF1;CACNA1D;CACNA1C;NOS2;AKAP5;NOS1
prerank,synapse organization (GO:0050808),0.37129207708905787,1.4743012573219847,0.0041753653444676405,0.4663311511597733,1.0,36/125,12.92%,GPC6;PDZRN3;PPFIBP2;LRRC4C;SDK2;NRXN1;PCDHB10;CHRNA1;LRP4;GPC4;GPM6A;PTPRD;UNC13C;CTNND2;PCDHB13;KIRREL3;NLGN2;NLGN3;RAB29;CACNB1;CACNB4;NLGN1;CACNB2;NRCAM;FARP1;RYK;ARHGAP39;SLC6A1;PTEN;MUSK;CBLN2;CHRNA7;RAB39B;OBSL1;PCDHB16;DOK7
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.5169714989091702,1.4736926217494117,0.05220883534136546,0.46544726275520976,1.0,7/23,6.47%,TGFBR3;SMAD3;DKK3;TGFBR3L;NREP;IL4;SMURF2
prerank,negative regulation of DNA binding (GO:0043392),-0.4805422569718329,-1.4731936414799487,0.027881040892193308,0.31075023209791625,1.0,9/28,20.04%,LEF1;NFKBIA;SMO;E2F1;SUMO3;HEY1;JAK2;KDM1A;MDFI
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.5145731808343781,1.4727046863602367,0.05895196506550218,0.4656280233551171,1.0,4/23,3.77%,TGFBR3;FGFR2;TNNC1;TNNI3
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.520718608608609,1.4723519721803167,0.053061224489795916,0.4641468846818809,1.0,7/22,11.25%,SLC2A13;ROCK2;LYN;EFNA3;LRRTM3;CASP3;CHRNA7
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.602413952762271,1.4720271161021155,0.06436781609195402,0.4625602074951117,1.0,6/13,9.66%,GJA1;SCN3B;ANK2;KCNJ3;CACNB2;KCNJ5
prerank,engulfment of apoptotic cell (GO:0043652),0.5586786198200923,1.4719105734217668,0.08045977011494253,0.46039089879563844,1.0,5/15,5.01%,XKR4;MEGF10;RHOH;XKR6;RHOBTB1
prerank,cellular response to organonitrogen compound (GO:0071417),-0.3634917425758856,-1.4711682887015793,0.01606425702811245,0.3142188083524304,1.0,33/99,24.23%,MEF2C;ACTB;RAP1A;CDH1;RAP1B;SH3BP4;CTNNA1;RAPGEF1;SLIT2;CAPN2;IGFBP5;PDE2A;KCNQ1;DIAPH1;EZR;JUP;AKAP6;IMPACT;LAMTOR2;HCN2;RAPGEF3;RRAGD;RELA;XBP1;SOX9;RAPGEF2;RRAGA;SESN2;RRAGC;DMTN;PKD2;NSMF;GOLPH3
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.49698044538924147,-1.470619998531625,0.05046728971962617,0.3144450945733349,1.0,11/24,29.70%,ABCG2;SLC25A38;UROS;COX15;FXN;ATP5IF1;COX10;ALAS2;ALAD;ABCB6;ABCB10
prerank,digestive tract development (GO:0048565),0.4845528478120517,1.470496483685501,0.04276985743380855,0.46166736032743233,1.0,7/32,3.50%,SALL1;FGFR2;CLMP;RARB;GLI2;KIT;GLI3
prerank,energy reserve metabolic process (GO:0006112),0.5450338051850767,1.4701973141431135,0.05714285714285714,0.4600260146616432,1.0,4/19,2.84%,PID1;PRKAG2;PHKA1;LEPR
prerank,negative regulation of bone mineralization (GO:0030502),0.5757247732852555,1.470119373771494,0.10244988864142539,0.45775015660172813,1.0,3/13,2.20%,ENPP1;BCOR;AHSG
prerank,endocrine system development (GO:0035270),0.5280347183879199,1.4692525255402258,0.0784313725490196,0.45738630908039457,1.0,6/21,7.79%,WNT4;SALL1;GLI2;DKK3;TGFBR1;SOX2
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.529939423009536,1.4683397369121818,0.06918238993710692,0.45754050858607914,1.0,5/21,6.88%,PPARA;SLC30A10;PRKN;ABCD2;SIRT2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.6031283388065037,-1.4681692564995084,0.0297951582867784,0.3189195517965835,1.0,4/11,3.90%,SEMA6A;THBS1;KLF2;EPN1
prerank,nervous system development (GO:0007399),0.3171470961065143,1.4677294007369766,0.0,0.4566048924268086,1.0,91/429,13.05%,ROBO1;ADGRV1;NELL1;ARNT2;ROBO2;ALDH1A2;LDB2;RBFOX1;PTN;ATXN1;CNTFR;TBX3;LPAR1;SDK2;SEMA5A;CHST8;NRG1;NRXN1;GDNF;TEAD1;ZIC1;CNTN4;PCDHB10;CHD7;LSAMP;GPM6A;DCHS1;ZEB2;ARTN;GLRB;CHRM2;IGF2BP2;PRKN;AXL;PCDHB13;GSTP1;SCD5;KIRREL3;NLGN2;NLGN3;CHRM3;RAB29;APAF1;ASIC2;EPHB1;TGFBR1;SCN2A;GRIK1;NLGN1;ADGRA2;NRCAM;SCIN;FARP1;RYK;ERBB3;HES5;ATN1;GMFB;ATXN3;ZIC4;TMEM223;AHI1;CYP46A1;APLP1;CXCL1;ERBB4;PTEN;ANKLE2;NAB2;RPS6KA6;NFASC;MST1R;ST8SIA2;PCDHB15;YAP1;SDHA;MERTK;ATXN10;OBSL1;GFRA2;VCAN;COX7B;EDNRB;NAV3;DLG4;KALRN;PCDHB16;GBA2;APBA1;PAX8;CXCR4
prerank,regulation of interleukin-2 production (GO:0032663),-0.4318640740398806,-1.4670542784113927,0.026422764227642278,0.320512133294748,1.0,8/43,6.15%,CD34;SPTBN1;PLCG2;PDE4D;RPS3;ANXA1;HDAC7;EZR
prerank,maturation of SSU-rRNA (GO:0030490),-0.45578909362226855,-1.4665937267293057,0.047058823529411764,0.32051023638335147,1.0,8/34,10.89%,RPS16;RPS14;NOP14;RPS8;RPS28;RPS19;NOB1;DHX37
prerank,macrophage activation involved in immune response (GO:0002281),-0.5741225903462377,-1.4663366604061423,0.056896551724137934,0.3201604664663035,1.0,5/13,15.58%,LBP;PLCG2;DYSF;SYK;CX3CR1
prerank,positive regulation of proteolysis (GO:0045862),0.42797758884870496,1.4655608903034927,0.030303030303030304,0.4598195753323902,1.0,15/55,17.94%,CCBE1;SH3D19;AURKAIP1;SNX33;ASPH;FGFR4;NKD2;SNX9;BTRC;NRDC;TANK;TBC1D10A;CTSH;FADD;FBXW11
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.46591290996300083,-1.4650620329824349,0.038461538461538464,0.32213082732206777,1.0,19/31,29.13%,PPP1R13B;HIP1R;PPP3CC;CASP8;BAX;YWHAZ;BAK1;BBC3;E2F1;CHCHD10;YWHAG;YWHAH;BAD;SFN;YWHAB;YWHAE;YWHAQ;PMAIP1;NMT1
prerank,positive regulation of cellular senescence (GO:2000774),-0.6260654577133248,-1.4640895349758143,0.07366482504604052,0.32333407105059647,1.0,4/10,18.81%,B2M;ABI3;YPEL3;CGAS
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.5794519523233028,-1.4639472394962778,0.048327137546468404,0.32268693210457694,1.0,6/14,13.56%,ADAM10;BACE1;ADAM19;PSENEN;ABCG1;APH1A
prerank,sodium ion transport (GO:0006814),0.38665816627712046,1.4638849011593547,0.03373015873015873,0.46154661714971446,1.0,16/85,9.95%,ATP1A2;NALCN;SLC24A3;SCN7A;SLC6A12;SLC8A1;SLC6A9;SLC6A13;SCN3B;SCN3A;ASIC2;SCN2A;SLC6A11;SLC6A1;SLC24A4;SLC24A2
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.56926647949261,-1.4636581200352066,0.06560283687943262,0.3223628355266037,1.0,11/15,34.27%,SMAD7;RPL11;RPL23;BAG5;RPS7;LIMK1;RPL5;DTX3L;PARK7;MAD2L2;ABL1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.6248563468856204,1.4629176346296997,0.09579439252336448,0.461731942858487,1.0,3/11,4.41%,IGF1;PIK3R1;GHR
prerank,organophosphate ester transport (GO:0015748),-0.49979923468928295,-1.462128564772982,0.0625,0.32508200104647905,1.0,7/24,13.88%,PITPNC1;PLTP;SCARB1;TNFAIP8L3;PITPNA;PRELID2;PITPNM1
prerank,amino sugar biosynthetic process (GO:0046349),-0.5889123674626354,-1.4618575652852028,0.06463195691202872,0.32474910971006427,1.0,7/12,29.93%,UAP1L1;GFPT1;AMDHD2;RENBP;PGM3;GNPDA1;UAP1
prerank,cellular component maintenance (GO:0043954),-0.5966456483323913,-1.4609627054063759,0.06060606060606061,0.3257941555864706,1.0,5/12,27.06%,IGF1R;INSR;CLDN1;MTMR2;TREM2
prerank,negative regulation of biosynthetic process (GO:0009890),0.569220953120585,1.4603603481223182,0.08668076109936575,0.46626057734996884,1.0,5/16,6.85%,PPARA;SLC30A10;ABCD2;GSTP1;ASXL3
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.46547773009946813,-1.460292330699384,0.053231939163498096,0.32626131913940665,1.0,12/31,20.27%,CRIM1;CDK6;NOTCH1;LRP5;HDAC7;SMAD6;TWIST1;LIMD1;GREM1;SKI;SOX9;BAMBI
prerank,positive regulation of protein polymerization (GO:0032273),-0.39992262858500266,-1.460131166217485,0.02053388090349076,0.3257690174650885,1.0,23/65,28.10%,OCLN;BAIAP2L1;PTK2B;RPS3;RAC1;LMOD1;SLAIN2;PFN1;DCTN1;PRKCE;MET;NCKAP1;HSP90AA1;HCK;CDC42EP3;ARL2;CTTN;NCK1;CLIP1;NCK2;CARMIL1;CDC42EP2;FCHSD1
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.4373256150392524,-1.4600091420435235,0.04911591355599214,0.32511095367672993,1.0,14/39,8.61%,PODXL;CDH1;NOTCH1;MAP2K5;FXYD5;KLF4;WNK1;PTK2;TGFB1;VEGFA;NOTCH4;RGCC;PPM1F;AKT1
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.5016784417329895,-1.4597500575325264,0.04690431519699812,0.32471773332524617,1.0,7/20,13.85%,LPCAT3;MBTPS2;ACADL;ACADVL;FMO5;ABCA2;APOE
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.5818215367315582,-1.4595708977269242,0.06727272727272728,0.32409069523809875,1.0,7/13,14.26%,CAV1;PDE4D;CAMK2D;CALM1;CALM3;CASQ2;SRI
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.5670311112016115,-1.4589053264704557,0.06126482213438735,0.324689064244888,1.0,7/14,21.65%,TLR3;DHX58;USP15;ANKRD17;ZDHHC5;PUM2;ZCCHC3
prerank,cell chemotaxis (GO:0060326),0.41736562648046194,1.4585999787544202,0.034261241970021415,0.46838110845474756,1.0,18/60,15.04%,NRP1;LPAR1;SEMA5A;PDGFRA;KIT;CCR6;ACKR2;ACKR4;CCR10;PDGFRB;EPHB1;CCR9;HOXB9;CCL25;BCAR1;CXCR4;ELMO2;CXCL12
prerank,microvillus organization (GO:0032528),-0.5745167396617932,-1.4577391613105288,0.059845559845559844,0.3264747126921652,1.0,5/13,6.15%,RAP1A;RAP1B;FXYD5;MINK1;EZR
prerank,positive regulation of signal transduction (GO:0009967),0.3370686355284132,1.4577024729253165,0.0057692307692307696,0.4686218019378275,1.0,42/238,10.32%,CCBE1;IGF1;BMP6;ROBO1;PIK3R1;NRP1;BMP2;SALL1;WLS;NTRK3;FGFR2;SULF1;SULF2;NRXN1;CYP27B1;RIMS1;PRKCA;PTGIS;SFRP1;PHIP;EVC;AAK1;MYORG;MAML3;AXL;NPTN;NLGN2;NLGN3;LOXL3;TGFBR1;RBPJ;NLGN1;KIF7;STX1B;CITED2;IGF2;MN1;GATA3;PRKCB;PRKCI;CUX2;PTEN
prerank,regulation of osteoclast differentiation (GO:0045670),0.4796978928968613,1.4572303641413147,0.05052631578947368,0.4675087258196033,1.0,6/33,5.34%,FBN1;OCSTAMP;GPR55;CEBPB;IL4;CAMK4
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5451821651770135,-1.4569901758626997,0.06043956043956044,0.327374579985146,1.0,5/17,5.11%,CAV1;ADIPOR2;PPARD;NCOR1;ADIPOR1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3551317851890767,1.4565652811953393,0.009560229445506692,0.466889629662788,1.0,29/161,11.27%,BICC1;TCF7L2;IGFBP2;NOTUM;BMP2;RBMS3;PRICKLE1;TBX18;LRP4;DKK3;GLI3;SFRP1;ZNRF3;MCC;AXIN2;PRKN;HECW1;TLE1;SOX2;PSMA3;PSMF1;PSMA7;NPHP3;NKD2;DVL3;FRZB;SIAH2;DACT3;FUZ
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.5035028935673127,1.4564243648840653,0.08254716981132075,0.46501324284390044,1.0,3/22,1.88%,ALDH1A2;VDR;CYP27B1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.6298467703161039,1.4554497755013458,0.1013215859030837,0.4651998327731584,1.0,2/10,2.39%,ADGRV1;STRC
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3518555169798521,1.455301861425636,0.013157894736842105,0.46324347971276486,1.0,23/152,8.59%,RNF220;LGR4;BMP2;LRRK1;SALL1;WLS;DAAM2;LYPD6;FGFR2;SULF1;SEMA5A;TBL1XR1;SULF2;PTK7;ZEB2;SFRP1;AXIN2;FRAT1;SMURF2;PSMA3;ADGRA2;PSMF1;PSMA7
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.49734261193357365,-1.4552896487642049,0.05058365758754864,0.3303458706013643,1.0,8/23,13.05%,MAP3K5;RPS3;DAB2IP;TAOK3;EDN1;TNFRSF11A;MAP3K11;ARHGEF5
prerank,carbohydrate derivative transport (GO:1901264),-0.5291236738634585,-1.4552420133398223,0.05871886120996441,0.32950915918680834,1.0,8/18,16.33%,LBP;PLTP;SCARB1;MFSD2A;SLC10A7;ABCG1;SLC15A2;SLC15A4
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.5067530919953787,1.4546260191523512,0.06564551422319474,0.46275523136273333,1.0,4/22,3.87%,IGF1;ROCK2;PRKCA;P2RX4
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4078417662735782,1.45459216742499,0.043052837573385516,0.46061039493245604,1.0,8/61,5.58%,AUTS2;IGF1;ROBO1;LPAR1;GPR55;GPR174;LYN;IRS2
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5879721198749314,1.4544620178999876,0.0958904109589041,0.45873286214503367,1.0,3/13,7.26%,ENPP1;TPST1;SULT6B1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.5380904047572364,-1.4533686773788372,0.061420345489443376,0.3326685982583589,1.0,10/18,28.95%,HIP1R;ACAA2;BAX;BAK1;CHCHD10;HSPA1A;SLC35F6;TMEM14A;MUL1;FZD9
prerank,negative regulation of inflammatory response (GO:0050728),0.34263004089955545,1.4531800238997852,0.01717557251908397,0.4598261695222185,1.0,22/182,7.65%,IGF1;ADCY7;RORA;ADCY2;ADCY1;GPHB5;ADCY5;PPARA;HTR7;PRKACA;MC5R;PTGIS;LYN;ADM;IL4;PTGDR;SMPDL3B;IAPP;NLRP12;GSTP1;CALCR;GLP2R
prerank,mitochondrial gene expression (GO:0140053),-0.435966771464667,-1.4530175710518487,0.031598513011152414,0.3325843302267461,1.0,21/42,32.78%,FOXO3;QRSL1;PTCD3;MRPL51;LARS2;GATC;MRPS17;MRPL16;SLC25A33;MRPL47;MRPS18A;MRPS6;GATB;MRPS24;MRPL2;NDUFA7;MRPS14;MRPS2;TWNK;MRPS12;IARS2
prerank,positive regulation of histone methylation (GO:0031062),0.5020328241548643,1.4529884128067319,0.0515695067264574,0.4580744500112541,1.0,6/24,16.04%,AUTS2;KMT2A;DNMT1;PAXIP1;RIF1;MTF2
prerank,maturation of LSU-rRNA (GO:0000470),-0.48365681610226013,-1.4523175071674428,0.07400379506641366,0.33317581054442635,1.0,14/26,26.49%,RRP15;RPL35;NOP2;PES1;RPL10A;URB1;RPL7;WDR12;NSA2;RPL7A;RSL1D1;RPF2;FTSJ3;ZNHIT6
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.5672305359397011,1.4522197515998914,0.1070615034168565,0.45797706666405485,1.0,1/14,0.19%,ENPP1
prerank,cellular response to dsRNA (GO:0071359),-0.5612533241813984,-1.4520019781504898,0.04830053667262969,0.33294723302124635,1.0,13/15,30.74%,CAV1;IFIH1;RALB;DHX9;IFIT1;FLOT1;MAVS;CGAS;ZCCHC3;NPM1;MUL1;PQBP1;RIOK3
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.43804514512783993,1.4519722938029127,0.041666666666666664,0.4564450326424851,1.0,8/48,8.64%,ADCY7;ADCY2;ADCY1;ADCY5;AMPD3;SLC26A1;PAPSS1;GUCY2F
prerank,regulation of protein dephosphorylation (GO:0035304),-0.4425080239882352,-1.4516700012946577,0.0367504835589942,0.3327964205679111,1.0,19/37,23.97%,PPP1R16B;CALM1;TGFB1;MFHAS1;PPIA;HTT;PPP2R5A;PPP1R8;CALM3;PPP6R3;CDCA2;PIN1;PPP1R16A;CDH5;CNEP1R1;ARPP19;YWHAB;PRKCD;NSMF
prerank,regulation of axon guidance (GO:1902667),0.6120917921673286,1.4510277271919554,0.11182795698924732,0.45676673853699173,1.0,3/10,8.25%,NRP1;MYCBP2;ZSWIM5
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.35202301697802735,-1.4509923571818064,0.016913319238900635,0.3333954149540047,1.0,43/136,20.69%,TMSB4X;ESR1;TAX1BP1;ID1;ID3;MAP2K5;FZD6;NFKBIA;KLF4;DAB2IP;IRAK2;SMAD7;ZNF431;WWP2;NLRC5;PKD1;CMKLR1;CHP1;BHLHE40;HEYL;CYP1B1;USP7;ANXA4;HDAC4;RB1;TRIB1;EGLN1;CTNNBIP1;HES1;AIM2;COMMD7;ITCH;PHB2;SIGIRR;UFL1;KDM1A;CHUK;CD200;TNFAIP3;CDK5RAP3;ADGRG3;MDFI;KEAP1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.3522242946039741,-1.4504964810114829,0.0,0.33356800370419154,1.0,36/140,11.69%,ARHGAP31;CHN2;PLCE1;MCF2L;ARHGEF3;NET1;RHOJ;TGM2;OPHN1;RASGRF2;ARAP3;STARD13;ARHGAP23;STARD8;ARHGAP17;ARHGAP26;CYRIB;CD2AP;SLIT2;ARAP2;ARHGDIA;ARHGAP1;TRIO;RAC1;ARHGDIB;CHN1;ARHGAP25;SOS2;BCR;RHOT1;ITSN1;RHOB;GMIP;RHOT2;PREX1;ABR
prerank,purine nucleotide metabolic process (GO:0006163),-0.4931034984284387,-1.4503467135881527,0.04743083003952569,0.3329949696985275,1.0,8/24,11.58%,NT5E;PRPS2;GPX1;NT5C;GDA;PRPS1;PRPS1L1;NT5C1A
prerank,platelet degranulation (GO:0002576),-0.35706041772706715,-1.4501047993584073,0.007889546351084813,0.33254349345417694,1.0,28/118,9.11%,FN1;VWF;ABCC4;PECAM1;TMSB4X;THBS1;SRGN;ACTN4;CYRIB;VEGFC;CALM1;APP;TGFB1;TGFB2;FAM3C;LHFPL2;CD109;VEGFA;PSAP;WDR1;ISLR;ACTN1;CD9;TGFB3;PCDH7;QSOX1;PDGFA;VCL
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.4533580016126185,-1.4498581695031496,0.05108055009823183,0.332176497055602,1.0,9/31,21.74%,PLCG2;TLR3;HSPD1;TIRAP;TLR4;SYK;LAPTM5;MAPK11;LGALS9
prerank,regulation of blood coagulation (GO:0030193),-0.48319084368115894,-1.4495033087177274,0.06111111111111111,0.3320402584196729,1.0,8/27,9.11%,CAV1;ST3GAL4;THBS1;CD34;THBD;FAP;EDN1;ENPP4
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.4450272930425157,-1.4479731565541298,0.05009276437847866,0.33474197674951545,1.0,10/39,13.92%,ACER2;THBS1;NOTCH1;ACTN4;FZD4;ADAM15;MYOC;FZD7;RCC2;NEXMIF
prerank,defense response to virus (GO:0051607),-0.35943630471090615,-1.447750800944364,0.022916666666666665,0.3343621268287774,1.0,29/100,18.81%,IFIH1;ABCC9;NLRC5;LYST;CNOT7;IFITM1;IFITM3;TLR3;IFITM2;ZMYND11;IFIT1;CLPB;ATG7;BCL2L1;MAVS;TTC4;ZDHHC1;TRIM56;SAMHD1;PHB2;BNIP3L;TRIM5;OAS2;DDIT4;RELA;MLKL;RSAD2;STAT1;CGAS
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.578223023475067,1.4456120807625499,0.09643605870020965,0.46856431646857993,1.0,7/14,16.60%,SEC24D;SCAP;SEC31A;SEC24A;SEC23A;TBC1D20;MIA3
prerank,muscle contraction (GO:0006936),-0.35404651893242356,-1.4454767603975174,0.004098360655737705,0.3384963253246616,1.0,22/126,9.11%,UTRN;ITGA1;SORBS3;SORBS1;EDNRA;TMOD3;DMD;VIM;PXN;MYL6;MYOF;CALM1;MYH11;MYOM1;DYSF;ACTA2;LMOD1;MYL9;MYL12A;GJC1;TMOD1;VCL
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.4684835295722264,-1.4453476248813306,0.05660377358490566,0.33779797336477063,1.0,7/29,5.31%,TEK;FLT1;PTK2B;PTK2;TNFAIP8L3;TGFB1;CD81
prerank,microvillus assembly (GO:0030033),-0.5615143609639056,-1.4450921080938806,0.059961315280464215,0.33743850645267703,1.0,5/14,6.15%,RAP1A;RAP1B;FXYD5;MINK1;EZR
prerank,positive regulation of hydrolase activity (GO:0051345),-0.3510210940042963,-1.4445151843098976,0.013100436681222707,0.33787435906418967,1.0,41/137,19.77%,DOCK9;PKP4;ITGA6;RAP1A;NET1;RACK1;TGM2;AGRN;F11R;CAV2;SGSM2;RAPGEF1;ARHGAP27;RPS3;FERMT2;CALM1;BCAS3;LIMS1;PSAP;RGS6;NDUFA13;CCL15;S100A10;WNT11;ZC3H15;NF1;CALM3;HRAS;NDEL1;ERBB2;BCAR3;SNX18;RAP1GDS1;RAPGEF3;TBC1D2;MAPK12;CD200;ECT2;MAPRE2;PIN1;RAPGEF2
prerank,nitric oxide biosynthetic process (GO:0006809),-0.5769425478640565,-1.4444142702413238,0.07142857142857142,0.33713235187044166,1.0,6/13,16.75%,NOS3;GCH1;CYP1B1;AKT1;NQO1;SPR
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.5016269225533831,-1.4441961446882756,0.07196969696969698,0.33671067166493074,1.0,10/20,24.00%,HSP90AB1;HSPD1;HSPA4;CCT2;HSP90AA1;HSPA1A;PTGES3L;PFDN6;PSMG2;MKKS
prerank,eye morphogenesis (GO:0048592),0.5220765896002738,1.4439619860063369,0.08779443254817987,0.4706289303687166,1.0,6/19,7.85%,FBN1;FBN2;TENM3;IFT122;MFAP2;RARG
prerank,sensory perception (GO:0007600),0.43972663421691804,1.4432047971506616,0.06415929203539823,0.47049487828534836,1.0,13/45,19.33%,ADGRV1;TTC8;P2RX4;OPRK1;PCDH15;TRPA1;CHRNA4;CHRNA7;PTGES;PNOC;CLRN1;SCN9A;PDYN
prerank,modulation by symbiont of entry into host (GO:0052372),-0.5493016429829378,-1.442938455039956,0.07001795332136446,0.3387724485674484,1.0,8/16,14.90%,CAV1;TRIM25;TRIM14;TRIM62;TRIM68;FUCA2;TRIM5;NECTIN2
prerank,B cell activation (GO:0042113),-0.39182018763835735,-1.4427915373538163,0.039525691699604744,0.33818340015464093,1.0,32/68,32.27%,MEF2C;PTPRJ;PLCG2;TPD52;CTPS1;ZBTB7A;HDAC9;CASP8;HDAC4;HHEX;HSPD1;PHB2;ITGA4;CLCF1;KLF6;JAK3;TCF3;ADGRG3;BTK;BANK1;LAT2;DCAF1;NFAM1;HDAC5;LAX1;RASGRP1;CD86;PTPN2;CHRNB2;LYL1;CR2;BLNK
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5131253507077469,1.44235916530923,0.09192825112107623,0.4704550404326435,1.0,6/20,3.77%,ATP1A2;SLC8A1;ANK2;PRKACA;ATP2A2;TNNI3
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.48206495951534,-1.4417344216412342,0.060784313725490195,0.33975143992115775,1.0,10/26,18.52%,OCLN;RPS3;RAC1;SLAIN2;STMN2;DCTN1;TRPV4;KATNB1;MET;ARL2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.5607776707001867,-1.440712128304114,0.0718232044198895,0.3411181610547467,1.0,4/14,7.48%,ANXA1;PRKCZ;RARA;NFKBIZ
prerank,inner ear morphogenesis (GO:0042472),0.5084428119151142,1.4398716990912725,0.07792207792207792,0.4745685069073303,1.0,7/22,13.04%,FGFR2;ZIC1;TBX18;CHD7;TMIE;TTC39C;PAX8
prerank,regulation of hydrolase activity (GO:0051336),-0.3897191733427854,-1.4398651175115804,0.028169014084507043,0.3421182728125763,1.0,19/71,13.05%,CHN2;FGD5;CAV1;PRKG1;RASIP1;SIPA1L1;PTK2;ARHGAP27;DAB2IP;PLXNA4;CHN1;CRK;FGD6;GPR137B;PLXNA1;ADAP1;PLXND1;NF1;ARHGEF5
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.4981105254239873,-1.439378793326487,0.06923076923076923,0.3422176142970126,1.0,17/23,44.74%,PIK3R6;PVR;LAMP1;NECTIN2;LGALS9;RASGRP1;LILRB1;AP1G1;CADM1;SLAMF6;CD226;IL12A;CRTAM;NCR1;KLRD1;CD160;KLRK1
prerank,dicarboxylic acid transport (GO:0006835),0.4773578879185398,1.439133790585353,0.057203389830508475,0.4745180248400451,1.0,7/28,7.30%,SLC1A3;SLC13A3;GJA1;ABCC2;SLC26A1;SLC25A10;SLC25A13
prerank,oxoacid metabolic process (GO:0043436),0.4894116569107058,1.4390323645232699,0.0821917808219178,0.4726301948911808,1.0,8/27,14.43%,ENPP1;TPST1;SULT6B1;PPA1;PPA2;DDO;ABHD14B;GRHPR
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.4742819774732519,1.4387714392372402,0.05970149253731343,0.4712159399795008,1.0,5/29,3.77%,TGFBR3;BMP2;FGFR2;TNNC1;TNNI3
prerank,nitric oxide metabolic process (GO:0046209),-0.5651697760928086,-1.438293662084145,0.07760141093474426,0.3437355650706398,1.0,6/14,16.75%,NOS3;GCH1;CYP1B1;AKT1;NQO1;SPR
prerank,triglyceride biosynthetic process (GO:0019432),0.5219707805752686,1.4380996891836717,0.08314606741573034,0.4707572552941116,1.0,6/18,16.56%,AGMO;MOGAT3;LPIN3;MOGAT2;DGAT2;LPIN1
prerank,cellular response to reactive oxygen species (GO:0034614),-0.39907314983481385,-1.4378213926739847,0.028397565922920892,0.34398617089251066,1.0,32/59,34.41%,MAP3K5;NET1;PXN;MAPK3;RPS3;ANXA1;CYP1B1;RIPK1;AKT1;RHOB;IMPACT;FXN;EGFR;RELA;CHUK;TNFAIP3;ECT2;PTPRK;PRKCD;PKD2;CAMKK2;PARK7;ROMO1;AQP1;JUN;NCF1;MAPK7;FOS;TPM1;ABL1;MAPK9;ANKZF1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.5104947848824581,-1.4376441969374623,0.05595667870036101,0.34343154860323655,1.0,5/21,5.31%,PRKCH;FOXP1;SLC39A10;RPS3;CD81
prerank,ion homeostasis (GO:0050801),-0.46241745527321976,-1.437590400870301,0.07307692307692308,0.3426344544034345,1.0,8/30,12.14%,SLC4A10;NEDD4L;FHL1;WNK1;CAMK2D;SLC4A8;KLHL3;SLC4A2
prerank,synapse assembly (GO:0007416),0.4008954909417203,1.4375073661773539,0.05010438413361169,0.470287626199239,1.0,21/67,12.75%,SDK2;GRID2;NRXN1;PCDHB10;GPM6A;GABRA2;LRRTM3;GABRB3;PCDHB13;KIRREL3;NLGN2;NLGN3;RAB29;NLGN1;NRCAM;FARP1;RYK;PTEN;PLXNB2;OBSL1;PCDHB16
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.5425974336205734,-1.4363871340071488,0.05870841487279843,0.34454082659033325,1.0,8/16,25.42%,NCOR1;ERLIN2;ACADL;ACADVL;WDTC1;SOX9;TRIB3;APOC1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.39028780275390973,-1.436198375856727,0.02895752895752896,0.34405718652606937,1.0,36/69,34.41%,SEL1L;TRIM25;FBXO17;DNAJB12;MAN1B1;RNF185;ERLIN2;UBE2G2;VCP;HSPA5;UBXN8;RNF5;FAF2;SEC61B;SGTA;RNF121;TMEM67;DERL2;AMFR;EDEM2;TMEM129;TMUB2;SGTB;TMUB1;FBXO6;UBE4A;UBE2J2;STT3B;UBQLN2;FBXO2;DERL1;PSMC6;SYVN1;EDEM1;OS9;ANKZF1
prerank,oogenesis (GO:0048477),0.557760594655216,1.436048213482765,0.0728476821192053,0.4718709505477598,1.0,6/15,18.98%,PTN;NANOS3;FMN2;PIWIL2;METTL3;MARF1
prerank,regulation of cell killing (GO:0031341),-0.5332668164124558,-1.4359151000193007,0.08030592734225621,0.3438473853256863,1.0,4/16,8.48%,CD55;TGFB2;RAC1;FZD7
prerank,receptor metabolic process (GO:0043112),-0.4034827500469973,-1.4356192679661512,0.04609218436873747,0.34364178305866006,1.0,20/53,19.67%,CAV1;DNM3;ACKR3;RAMP2;TFRC;TGFB1;CD81;CD9;AP2M1;LMTK2;FCER1G;RAB11B;REP15;KIF16B;SYK;SMURF1;RAMP1;DNM1;EHD3;DNM2
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.39796204708792077,1.4333324880372726,0.04483430799220273,0.47679463739309436,1.0,12/63,7.78%,IGF1;TCF7L2;AR;SH3RF1;DEPTOR;CFLAR;PHIP;IL4;GSTP1;BCL2L12;TGFBR1;SCG2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.5794687812848015,1.4330572224608404,0.09411764705882353,0.47546024230052053,1.0,3/12,7.43%,MYCBP2;GLI2;EPHB1
prerank,myelin maintenance (GO:0043217),0.6258109342743187,1.4326071259154882,0.11956521739130435,0.47450049757498003,1.0,4/10,13.05%,EPB41L3;ABCD2;PTEN;CXCR4
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.6212600381522181,-1.4325317807207192,0.052823315118397086,0.3496700002531693,1.0,4/10,21.90%,HK1;PFKP;GFPT1;PFKL
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.4501682302722282,-1.4321317983244146,0.060546875,0.34963036591772645,1.0,19/30,38.45%,HSPA8;DNAJB12;HSPA5;CHCHD4;CCT2;HSPA1A;HSPA9;HSPE1;HSPA1B;ERO1A;BAG1;DNAJB1;SDF2L1;HSPA14;SDF2;ST13;DNAJC7;UGGT1;HSPA1L
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.4551608372282736,-1.431790625825635,0.06934306569343066,0.34958179400102546,1.0,21/33,29.59%,CCND3;PLCG2;ANXA1;RGCC;AKT1;DDRGK1;LSM11;PHB2;EGFR;ANKRD17;GLI1;CCND1;FGF10;LSM10;EIF4G1;HYAL1;RDX;AIF1;RPTOR;PLCB1;FAM83D
prerank,negative regulation of angiogenesis (GO:0016525),-0.3767340731729918,-1.431080893780656,0.032818532818532815,0.35036985888191935,1.0,20/84,9.93%,TEK;CLDN5;SEMA6A;SLC12A2;THBS1;KLF2;KLF4;DAB2IP;NPR1;EPN1;STAB1;TGFB2;COL4A2;SARS1;PTPRM;AMOT;RGCC;NAXE;HHEX;ISM1
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.5311046708909024,-1.4306194679429465,0.07156673114119923,0.3504985542551824,1.0,5/18,6.47%,ESR1;NCOR1;TGFB1;RPS13;PTBP3
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.3728908811290265,-1.4297388968496987,0.020366598778004074,0.3515553465409394,1.0,30/86,22.98%,OCLN;BAIAP2L1;PTK2B;RPS3;APP;RAC1;WDR1;LMOD1;SLAIN2;EDN1;STMN2;GPX1;PFN1;RB1;DCTN1;TRPV4;SYNPO;PRKCE;KATNB1;APOE;LIMK1;MET;NCKAP1;HCK;CDC42EP3;ARL2;CTTN;COLGALT1;NCK1;CLIP1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.5177211800031011,-1.429713786619291,0.07735849056603773,0.3507026177179143,1.0,6/18,14.90%,THBS1;LBP;IL33;HSPD1;TLR4;NECTIN2
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.3695777045051009,-1.429558299563595,0.02681992337164751,0.35022151783474664,1.0,43/87,29.57%,NDUFV2;UQCC2;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;IMMP2L;COA8;NDUFB7;NDUFS2;NDUFA12;TIMM21;COA3;NDUFB5;CHCHD4;NDUFA9;NDUFS3;NDUFB9;SURF1;NDUFS6;NDUFC1;FASTKD3;DMAC2;NDUFA3;ECSIT;LYRM7;SLC25A33;NDUFA10;NDUFB10;SDHAF4;NDUFB3;SCO1;PET100;NDUFA1;NDUFAF3;NDUFA7;BCS1L;UQCC3;NDUFA8;ACAD9;SDHAF1;NDUFAF5
prerank,inner mitochondrial membrane organization (GO:0007007),-0.41452983800322535,-1.42887876198404,0.05523809523809524,0.3509315585204914,1.0,25/47,29.86%,ATP5PD;ATP5F1D;ATP5MF;ATP5F1A;ATP5F1B;NDUFA13;CHCHD3;ATP5ME;ATP5MC3;ATP5MC1;TIMM29;OPA1;HSPA9;TIMM13;CHCHD6;TIMM10;TIMM8B;APOO;ATP5F1E;TIMM10B;MICOS13;UQCC3;ATP5PO;LETM1;ROMO1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.4998835377301214,1.4287098979439332,0.07643312101910828,0.4822374748808933,1.0,8/21,18.02%,EPHA7;NLRP12;SOX2;NGFR;BIRC2;DELE1;PSMB9;GRIN2B
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5047044019583602,1.4276054087566008,0.08280254777070063,0.48308040787542067,1.0,4/21,3.16%,PLA2G5;OSBPL10;PLA2G4A;OSBPL8
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.4204180577134997,-1.427296503184857,0.03954802259887006,0.3536287238709846,1.0,24/44,31.42%,THBS1;MAP2K5;KLF4;RPS6KA3;CD44;NGF;CAST;VEGFA;GPX1;AKT1;BEX3;DHCR24;IGBP1;CSNK2A1;SFN;TRIAP1;CARD16;XIAP;YWHAE;LAMTOR5;RPS6KA1;SRC;AQP1;DNAJB6
prerank,positive regulation of neuron projection development (GO:0010976),0.3760662164967979,1.4269916821046587,0.015779092702169626,0.48254939759569504,1.0,21/85,10.87%,CAMK1D;PTN;NTRK3;BMP5;TENM3;MAGI2;PTK7;EPHA3;RIT2;GPC2;LYN;NPTN;DPYSL3;CAMK2B;ROR1;LRRC7;PRKCI;CUX2;PLXNB2;FUT9;ALK
prerank,regulation of cellular component organization (GO:0051128),-0.3453397368099196,-1.4268382838929363,0.01002004008016032,0.35376782330924905,1.0,44/135,20.69%,PLCE1;RAP1A;MLLT3;LTBP4;NET1;RAP1B;OPHN1;TFRC;RAPGEF1;DCUN1D5;DAB2IP;CAMK2D;SOCS2;HSPA8;HIP1R;HCFC1;EGLN2;FAM107A;WFDC1;HIP1;TAOK2;RAB4B;ABL2;BAG5;NCLN;RUFY1;RAB4A;ITCH;APOE;LAMTOR2;CISH;SETD1A;STK38L;PACSIN1;OGFR;TMEM97;HSP90AA1;GFAP;TSC2;PACSIN2;PACSIN3;RAPGEF2;TJP1;MKI67
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.5406220253347129,-1.4266009420253714,0.06296296296296296,0.3534356475319205,1.0,9/16,11.70%,ESR1;DDX5;DDX17;PPARGC1B;RBFOX2;SAFB;EGLN2;ARID1A;NCOA4
prerank,response to exogenous dsRNA (GO:0043330),-0.5159781222325429,-1.4264205095366735,0.06390977443609022,0.3530190493687286,1.0,9/18,13.80%,CAV1;IFIH1;RALB;TLR3;DHX9;IFIT1;FLOT1;MAVS;SLC3A2
prerank,regulation of apoptotic process (GO:0042981),-0.2897608829414172,-1.4262860910200508,0.0,0.3524446135060424,1.0,194/676,20.13%,LEF1;TEK;ANO6;MEF2C;PPP1R13B;IGF1R;ITGA6;MAP3K5;ACER2;THBS1;MCF2L;TPT1;ARHGEF3;NET1;TAX1BP1;UNC13B;RACK1;PTK2B;TGM2;ACTN4;RASGRF2;KDR;NFKBIA;ARL6IP5;FOXO1;EGLN3;TFRC;PTK2;RNF144B;RPL10;FOXO3;RPS3;RPS6KA3;SLIT2;CARD14;DAB2IP;ZBTB7A;ANXA1;CD44;NGF;CRADD;SOCS2;MAP3K20;TMBIM4;CTNNBL1;REST;ARHGDIA;UBB;ADAM10;PPIA;TRIO;TNFSF10;HTT;CD38;IGFBP3;UBC;RPS27A;ING5;SPTLC1;PTMA;SOS2;HIP1R;SMAD6;VEGFA;TNFAIP8;RHBDD1;UFM1;IKBKB;SH3RF2;CYP1B1;TMEM219;SHC1;ACTN1;ATF4;HSPB1;TOX3;PRKDC;GATA6;TGFB3;ANP32A;EGLN2;CASP8;RASSF2;ANXA4;RIPK1;FLT4;PERP;PLK2;GLO1;AKT1;MAP3K11;DNAJA1;BAX;PSENEN;CTSD;FAS;PIM3;ITSN1;HIP1;RHOB;BCL6;ATG7;DDRGK1;WNT11;HSPD1;TCIM;LRP8;VCP;CD74;CFL1;GRK5;CIB1;HSPA5;BCL2L1;GADD45G;PREX1;ABR;HTATIP2;SERPINB9;RTKN;CTSB;AVEN;NF1;COPS5;SOX4;RPS6;YWHAZ;BAK1;HIGD2A;RNPS1;E2F1;RPS6KA2;SPHK2;ARHGEF5;ITCH;DHCR24;FXN;APH1A;PHB2;BNIP3L;ARHGEF18;NUAK2;MADD;TOP2A;OSGIN1;OPN3;FSTL1;HYPK;STK26;HNRNPK;PTPN6;EGFR;OPA1;PHLDA3;JAK2;LGALS1;HSP90AA1;GREM1;HSPA1A;PDCD2;BAD;DDX20;JAK3;HCK;FOXL2;RELA;CRYAB;HSPA9;CCAR2;XBP1;STAT1;ARHGEF17;ECT2;ARHGEF12;ARHGEF4;CALHM2;BABAM2;ARHGEF2;ARHGEF6;GCLC;RASA1;SRA1;SOX9;ASNS;MCL1;TMBIM6;DNM2;HIGD1A;GADD45A;FGD2;ANGPTL4;LCMT1;TJP1;FAIM2
prerank,dendritic cell differentiation (GO:0097028),0.49451781917770565,1.4262684384511293,0.09417040358744394,0.48232496495635396,1.0,5/22,5.90%,PRTN3;LYN;IL4;CAMK4;AXL
prerank,regulation of osteoblast differentiation (GO:0045667),0.3852391951054525,1.4259776324254299,0.034482758620689655,0.48099042168968986,1.0,11/82,4.04%,IGF1;BMP6;NELL1;WNT4;BMP2;FBN2;DDR2;FGFR2;PRKACA;CCN4;RANBP3L
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.34807346529550076,1.4258890116120246,0.015444015444015444,0.47914440993821916,1.0,16/152,5.74%,ADCY7;ADCY2;ADCY1;LGR4;LPAR1;ADGRB3;PTGFR;GPHB5;ADCY5;ABCA1;GNAI1;MC5R;CHRM2;OPRK1;ADM;IAPP
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.6055803370743497,-1.4258107243934481,0.06785714285714285,0.35264443383976574,1.0,5/10,14.57%,ACAD11;ACADL;ACADVL;ETFB;ETFDH
prerank,sphingoid metabolic process (GO:0046519),-0.5853318211529899,-1.425543848972343,0.0851063829787234,0.3523863554573701,1.0,7/12,24.10%,DEGS2;PLPP1;KDSR;ASAH2;SPHK2;PLPP2;SGPP1
prerank,pre-miRNA processing (GO:0031054),0.5766110269662307,1.425529108947197,0.12910284463894967,0.47798221294357846,1.0,9/14,22.93%,TUT4;AGO4;LIN28B;DROSHA;AGO3;AGO1;AGO2;DICER1;MRPL44
prerank,negative regulation of RNA splicing (GO:0033119),-0.5108816724989856,-1.424710672554217,0.06766917293233082,0.35337910027195124,1.0,9/19,19.60%,RPS13;PTBP3;SRSF6;PCBP4;RNPS1;SRSF4;SFSWAP;RPS26;TMBIM6
prerank,regulation of interleukin-4 production (GO:0032673),-0.5025878207327685,-1.4245427604773002,0.08052434456928839,0.3528037551843671,1.0,6/21,12.47%,LEF1;SLC7A5;PRKCZ;RARA;FCER1G;SYK
prerank,mesonephric tubule development (GO:0072164),0.5430854188083056,1.42440004755221,0.1038135593220339,0.47891826604423315,1.0,3/15,1.12%,ROBO2;SALL1;FGFR2
prerank,response to molecule of bacterial origin (GO:0002237),-0.38385124981068086,-1.424327276545619,0.0248565965583174,0.35240099549262754,1.0,23/69,22.11%,FOXP1;NOS3;LBP;CYRIB;RPS6KA3;GCH1;MAPKAPK3;SMAD6;OTUD5;TNFRSF11A;IFNAR1;TRIB1;GGT5;TIRAP;TLR4;JAK2;TAB2;PELI1;TNFAIP3;GGT1;FZD5;LGALS9;PTPN22
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.5933050283314314,-1.4240103407835178,0.07587548638132295,0.35217533886415,1.0,2/11,1.16%,MECOM;CD34
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.5783129808905019,-1.4235575790936823,0.08534322820037106,0.35233496771564626,1.0,6/12,30.47%,LPCAT3;MFSD2A;APOC1;P4HB;SOAT2;MTTP
prerank,positive regulation of heart contraction (GO:0045823),0.5235887535115169,1.4233117671709576,0.08405172413793104,0.47975377535767105,1.0,4/19,5.00%,ATP1A2;SCN3B;ATP2A2;ADM
prerank,amino sugar metabolic process (GO:0006040),-0.612572304686613,-1.4229862355642797,0.08347826086956522,0.3529001781015228,1.0,4/10,12.39%,CSGALNACT1;SLC35A3;ST6GAL1;GFPT1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.5870851964949594,1.422858676726179,0.10548523206751055,0.47874559322881594,1.0,5/11,14.99%,NRP1;SIRT2;MST1R;BCAR1;PAK1
prerank,positive regulation of filopodium assembly (GO:0051491),0.49723196451882407,1.422647879064429,0.0957683741648107,0.47729046891579907,1.0,7/24,8.00%,PIK3R1;NRP1;DOCK11;GPM6A;TENM2;DPYSL3;NLGN1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3398519230310448,1.4214355745043334,0.013333333333333334,0.478523085687459,1.0,33/186,10.73%,BICC1;TCF7L2;IGFBP2;NOTUM;BMP2;RBMS3;TRABD2B;LRP1;PRICKLE1;LRP4;DKK3;GLI3;SFRP1;ZNRF3;MCC;RNF43;AXIN2;TAX1BP3;WIF1;PRKN;HECW1;TLE1;CXXC4;SOX2;PSMA3;PSMF1;PSMA7;NPHP3;NKD2;DVL3;FRZB;SIAH2;DACT3
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.4041920749207803,-1.4208401416373078,0.05263157894736842,0.35615929546333397,1.0,29/56,29.57%,NDUFV2;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;NDUFB7;NDUFS2;NDUFA12;TIMM21;NDUFB5;NDUFA9;NDUFS3;NDUFB9;NDUFS6;NDUFC1;DMAC2;NDUFA3;ECSIT;NDUFA10;NDUFB10;NDUFB3;NDUFA1;NDUFAF3;NDUFA7;BCS1L;NDUFA8;ACAD9;NDUFAF5
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.4041920749207803,-1.4208401416373078,0.05263157894736842,0.35615929546333397,1.0,29/56,29.57%,NDUFV2;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;NDUFB7;NDUFS2;NDUFA12;TIMM21;NDUFB5;NDUFA9;NDUFS3;NDUFB9;NDUFS6;NDUFC1;DMAC2;NDUFA3;ECSIT;NDUFA10;NDUFB10;NDUFB3;NDUFA1;NDUFAF3;NDUFA7;BCS1L;NDUFA8;ACAD9;NDUFAF5
prerank,lipid oxidation (GO:0034440),-0.5821166763923636,-1.4196396387612487,0.09123434704830054,0.3581395649265566,1.0,3/12,5.11%,ADIPOR2;PPARGC1A;ADIPOR1
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.4965903386757871,-1.4195922192247794,0.08795411089866156,0.3573310562224312,1.0,13/21,35.94%,PPP1R16B;FKBP1A;MFHAS1;PPP1R8;BOD1;ARPP19;YWHAB;YWHAE;STYXL1;PPP1R1B;CRY2;FKBP1B;PTPA
prerank,response to ketone (GO:1901654),-0.4776724897574399,-1.4194966001126772,0.07339449541284404,0.3566441165353107,1.0,7/24,7.08%,CAV1;ABHD2;THBS1;SLIT2;TGFB1;TGFB2;TGFB3
prerank,regulation of focal adhesion assembly (GO:0051893),-0.40483096218186737,-1.4193932313496398,0.04518664047151277,0.3560235087027612,1.0,20/54,11.74%,TEK;THBS1;PTPRJ;ACTG1;LIMCH1;KDR;PEAK1;PTK2;FERMT2;BCAS3;RAC1;LIMS1;VEGFA;MYOC;PPM1F;VCL;FAM107A;S100A10;RCC2;DUSP3
prerank,regulation of glycogen metabolic process (GO:0070873),-0.580541173054672,-1.4191189712495653,0.09549549549549549,0.3557967450996257,1.0,6/12,23.17%,PPP1R3B;AKT1;PPP1R3F;PPP1R3C;RUBCNL;PPP1R3E
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.35561237464886725,-1.4187988234570437,0.022,0.3556678423362191,1.0,35/112,15.34%,MEF2C;CLDN5;PARD3;ID1;PXN;TGFBR2;F11R;NLK;PTK2;SMAD9;FERMT2;SMAD7;COL3A1;TGFB1;FKBP1A;TGFB2;PDE2A;UBB;PRKCZ;UBC;RPS27A;LIMS1;SMAD6;NR3C1;TGFB3;USP9X;ZMIZ2;ENG;NRROS;ACVR1;USP15;ARHGEF18;SMURF1;SMAD4;SOX6
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5074623646808843,1.4187933134115407,0.06971677559912855,0.4832289578990157,1.0,6/22,13.72%,SH3D19;TIMP3;SNX33;TIMP4;SNX9;NRDC
prerank,negative regulation of leukocyte activation (GO:0002695),0.5432120158438882,1.418715659790209,0.10021786492374728,0.48138285532157454,1.0,3/15,8.01%,IL31RA;IL4;CD300LF
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.3839382244848863,-1.4182624772889756,0.03481624758220503,0.35599083849458196,1.0,23/63,22.40%,RPL26;CRADD;CDKN1B;CNOT7;PRKDC;RGCC;PLAGL1;PLK2;PCBP4;BAX;RPS27L;SOX4;E2F1;CDKN1A;E2F4;CCND1;GADD45A;CNOT11;SFN;E2F7;PLK3;TRIAP1;CNOT3
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.3476385030019837,-1.4182319365024556,0.020202020202020204,0.3551939509736026,1.0,41/132,20.02%,RPS14;RPL6;RPSA;RPS15;RPS27;RPL10;RPL38;HSP90AB1;RPL11;RPS28;RPS5;RPS19;SRSF5;SNRPC;RPL23A;PRKDC;ISY1;SRPK1;SRSF6;DHX9;NOP2;SNRPD3;RPS27L;LUC7L2;XAB2;RPL3;PPAN;ZRSR2;DDX23;ERAL1;MDN1;RPL24;DDX39B;HSP90AA1;DDX20;SMN1;SNRPG;SCAF11;EIF5;RPL5;TGS1
prerank,autophagosome maturation (GO:0097352),-0.44749433026656976,-1.4179681653929097,0.07352941176470588,0.354892388896046,1.0,16/32,24.12%,MAP1LC3B;CALM1;VAMP7;GABARAP;LIX1L;TECPR1;VCP;MAP1LC3A;TSG101;VMP1;VPS33A;VPS16;VTI1B;WIPI2;RUBCNL;GABARAPL1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.46947713130434926,-1.4178555448008716,0.06618962432915922,0.35431058885786115,1.0,11/25,28.27%,RIN3;APP;RAC1;ANKRD13A;ABCA2;SDCBP;NEU3;ITGB3;APOC1;MTMR2;UBQLN2
prerank,sulfur compound transport (GO:0072348),-0.4653497743181312,-1.417675508025371,0.064453125,0.353911499563598,1.0,5/27,3.12%,ABCG2;SLC26A7;SLC6A6;LRRC8D;SLC5A6
prerank,positive regulation of cell adhesion (GO:0045785),-0.37878513378523,-1.4172679249358278,0.03992015968063872,0.3539376785811348,1.0,22/74,18.52%,FRMD5;VIT;PTPRJ;TGM2;STX3;SMAD7;TGFB2;RAC1;LIMS1;VEGFA;ADGRG1;NPNT;PPM1F;FBLN2;FOXC2;CIB1;SYK;ERBB2;ZFHX3;JAK2;RET;ARL2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.5056669491975421,1.417224674743134,0.09190371991247265,0.4833643521920295,1.0,10/23,12.29%,ENPP1;GLI3;IFT122;TULP3;KCTD21;KIF7;MGRN1;GPR161;BTRC;SUFU
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.461222402226759,-1.417085197916533,0.07335907335907337,0.3535358524317073,1.0,11/30,18.03%,ACKR3;TPT1;RPS3;CD44;TWIST1;PTTG1IP;CD74;BCL2L1;DDX39B;KDM1A;CCAR2
prerank,vesicle organization (GO:0016050),-0.4148499384288193,-1.416640138261866,0.030947775628626693,0.35364651145249487,1.0,24/46,30.15%,CAV1;CD34;FNBP1L;SRGN;CAV2;SNX11;PI4K2A;CHMP2B;USP8;ALS2CL;WASL;VPS11;WASHC5;LAPTM4B;DNM1;PLEKHF1;ANXA8L1;ANXA8;PHETA2;ZFYVE16;EPS15;VPS33B;CORO1A;LAMTOR1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.5290451871734654,-1.415969077048562,0.07692307692307693,0.35420469775558594,1.0,7/17,13.85%,FGF1;LPCAT3;MBTPS2;ABCG1;ERLIN2;ABCA2;APOE
prerank,substantia nigra development (GO:0021762),-0.4319905462238793,-1.4154256129946128,0.05223880597014925,0.3546185911787427,1.0,20/37,30.56%,ACTB;CALM1;COX6B1;RAD1;CKB;MAPKAP1;HSPA5;GNB4;CALM3;S100A1;NDUFS3;INA;YWHAH;FGF9;SYNGR3;YWHAE;CDC42;YWHAQ;CNP;MBP
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5687777680366474,-1.4142719772896133,0.08070175438596491,0.356478967398658,1.0,5/13,6.89%,ABHD2;NR3C2;ESR1;PLPP1;NR3C1
prerank,metal ion homeostasis (GO:0055065),-0.43027183382724243,-1.4137391649706734,0.053742802303262956,0.35676105589446944,1.0,7/40,8.02%,SLC12A7;CAV1;TMTC2;SLC12A2;FAM20A;LETM2;JPH2
prerank,negative regulation of dephosphorylation (GO:0035305),-0.5159778089623273,-1.4133576051243262,0.0776173285198556,0.35671655076896835,1.0,8/18,22.82%,PPP1R16B;MFHAS1;CHP1;SH3RF2;PPP1R8;PPP1R26;ARPP19;YWHAB
prerank,calcium-mediated signaling (GO:0019722),0.3676297504448698,1.4131223872802767,0.03219315895372234,0.4918437305678556,1.0,18/93,9.87%,RCAN2;PTGFR;SLC8A1;PDPK1;ANK2;PRKACA;DMPK;ATP2A2;TNNI3;P2RX4;CCR6;ACKR2;ACKR4;CCR10;CHRM3;PPP1R9A;CCR9;MCTP2
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.4655649396557899,-1.4130440448490795,0.08226691042047532,0.3565540245916081,1.0,6/27,4.15%,TEK;FLT1;PTK2B;PTK2;TNFAIP8L3;TGFB1
prerank,ureteric bud morphogenesis (GO:0060675),0.5303347066553928,1.412995345365774,0.10538116591928251,0.4901502529878492,1.0,3/16,1.83%,BMP2;SALL1;GDNF
prerank,negative regulation of cell development (GO:0010721),0.4828242565659333,1.4127477988118717,0.08459869848156182,0.48878615493862215,1.0,2/25,0.46%,IGF1;FBN1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.5915143231073766,-1.4126252969913666,0.059845559845559844,0.3558071397718789,1.0,8/11,35.49%,DKC1;CCT2;CCT3;MEPCE;CCT8;CCT7;CCT4;CCT6A
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.5915143231073766,-1.4126252969913666,0.059845559845559844,0.3558071397718789,1.0,8/11,35.49%,DKC1;CCT2;CCT3;MEPCE;CCT8;CCT7;CCT4;CCT6A
prerank,response to acidic pH (GO:0010447),-0.5628649585749694,-1.4124096110368662,0.07719928186714542,0.3553722098222734,1.0,6/13,26.90%,CHP1;GPR4;RAB11B;IMPACT;CTSS;RAB11FIP5
prerank,cellular response to fluid shear stress (GO:0071498),-0.5803170310103244,-1.411138027126862,0.08545454545454545,0.3574340856278648,1.0,4/12,2.56%,MEF2C;MAP2K5;KLF2;KLF4
prerank,regulation of protein localization to nucleus (GO:1900180),-0.41482065071203006,-1.4103980451283784,0.05811623246492986,0.3582607949999457,1.0,19/43,31.54%,LIMK2;CTNNA1;TFRC;FERMT2;TGFB1;MFHAS1;AKT1;SUMO3;PIN1;CDK5RAP3;SESN2;DTX3L;CARD10;PARK7;LAMTOR5;ATP13A2;PARP9;CDK1;PLK1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.4660176598212506,-1.4103751840204506,0.07495069033530571,0.3574599236065706,1.0,10/27,22.57%,DDX5;TGFB1;RIPK1;DHX9;WTIP;LIMD1;FMR1;EGFR;PUM2;EIF4G1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5725923321181275,1.4099103067653582,0.10585585585585586,0.4938301147929867,1.0,3/13,2.87%,PLXNA2;NRP1;SEMA3A
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.5224169229312651,1.4096978401174516,0.09544468546637744,0.49234649883297316,1.0,2/17,2.52%,PLA2G5;PLA2G4A
prerank,cellular response to lipid (GO:0071396),0.3314491956044368,1.4096447481769532,0.020366598778004074,0.4904717619851305,1.0,33/191,11.17%,RORA;ADCY2;ADCY1;ATP1A2;PID1;AR;ADCY5;PTK7;ROCK2;EPHA3;GNAI1;SFRP1;PDK4;STAP1;LYN;ZNF35;TICAM1;BRINP1;SERPINE1;AXL;BRINP3;PDK3;GSTP1;PPBP;NUGGC;CD274;ABCB4;PABPN1;CXCL1;TNIP3;AHR;PDE4B;ADCY8
prerank,in utero embryonic development (GO:0001701),0.4695657285881685,1.4094300144382337,0.0859538784067086,0.48912499508965596,1.0,7/25,8.83%,ARNT2;BMP2;FGFR2;CHD7;TGFBR1;IGF2;FOXD3
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.38143766961953424,-1.4093734798257074,0.033663366336633666,0.3589154657209707,1.0,19/59,18.89%,NFKBIA;DAB2IP;IRAK2;UBB;REL;UBC;RPS27A;IKBKB;TLR3;FAIM;RIPK1;AKT1;RELB;TLR4;TNFRSF1A;TAB2;RELA;CHUK;NKIRAS2
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.3848968869250524,-1.4092166206305792,0.03822937625754527,0.35842438125130116,1.0,24/72,10.92%,HEG1;ARHGEF28;ARHGEF3;NET1;EPS8;RASIP1;OPHN1;F11R;STARD13;STARD8;EPS8L2;COL3A1;ARHGDIA;RAC1;ARHGDIB;CCDC125;GPR4;MYOC;BCR;ADGRG1;KANK2;LPAR6;TNFAIP1;ABL2
prerank,response to metal ion (GO:0010038),-0.3833710275838064,-1.4091494078821298,0.04933586337760911,0.3577256615448177,1.0,17/67,14.48%,CAV1;THBS1;TRPC3;NEDD4L;MT1A;MT1X;CALM1;ITPR3;MT2A;CRIP1;ATP5F1D;SLC25A12;PPP5C;HOMER1;CALM3;FXN;PEF1
prerank,mammary gland development (GO:0030879),0.4977267639401127,1.4090185973335774,0.09341825902335456,0.48824270907012174,1.0,4/21,1.96%,WNT4;TBX3;NRG1;GLI2
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.34004694631337024,-1.4089004225689894,0.012396694214876033,0.3574195750980596,1.0,46/151,20.84%,SGMS1;ST3GAL4;CERT1;SGMS2;ACER2;SPTLC2;DMD;DEGS2;GCH1;ELOVL7;LPCAT3;PLPP1;CSNK1G2;PRKD3;SPTLC1;CDO1;MFSD2A;KDSR;SPTSSB;SPNS2;GSTA4;CHKA;ELOVL5;CSNK2B;INHBA;GSTM2;ACER3;GSTA3;CEPT1;SPHK2;SGPL1;APOE;GSTM1;CSNK2A1;CSNK2A2;GSTO2;TYW1;LCAT;MGST3;ELOVL1;HACD4;PLPP2;PCYT1A;ALAS2;LPCAT2;CHAT
prerank,regulation of monooxygenase activity (GO:0032768),-0.4816301602743621,-1.40880786813643,0.08333333333333333,0.35676933165659286,1.0,14/23,20.78%,CAV1;NOS3;NOSTRIN;CALM1;AKT1;WASL;LYPLA1;EGFR;HSP90AA1;SPR;NOSIP;CYGB;DNM2;DDAH1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.538490811752178,1.4083886808300936,0.10042735042735043,0.4878059420429124,1.0,4/17,2.74%,ATP1A2;SLC8A1;GJA1;PRKACA
prerank,ceramide transport (GO:0035627),-0.5695532309716789,-1.4082849382806562,0.09010600706713781,0.35706024671415226,1.0,7/12,24.10%,CERT1;PLTP;PSAP;ABCA2;GLTP;ABCA13;SGPP1
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5326472176022692,1.4078711483100752,0.09956709956709957,0.48716596623392977,1.0,3/17,11.25%,IGF1;RTN4;CHRNA7
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.5778954394810967,-1.4073954934055917,0.08224299065420561,0.3582510894053097,1.0,4/12,5.09%,ACTB;ACTG1;LAMA5;LAMA3
prerank,response to cholesterol (GO:0070723),-0.5226531850430165,-1.4072588299480118,0.09925093632958802,0.35773113831558295,1.0,9/17,20.62%,TGFBR2;TGFB1;SMO;GRAMD1C;GRAMD1A;ABCA2;MLC1;OSBPL7;SMAD2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.494903721660037,-1.4067860699392203,0.08043875685557587,0.35794879840761995,1.0,7/21,10.22%,CYRIB;CD2AP;SLIT2;DAB2IP;TGFB2;ARHGAP25;MAPKAP1
prerank,regulation of protein autophosphorylation (GO:0031952),0.4332130410521855,1.4065285985357976,0.062360801781737196,0.48868937156178605,1.0,5/36,6.16%,EPHA7;ENPP1;ERRFI1;RAP2A;NLRP12
prerank,positive regulation of phosphorylation (GO:0042327),0.3248796061605824,1.4065094813225416,0.01107011070110701,0.4868040957807763,1.0,51/240,11.68%,IGF1;EPHA7;NRP1;ZBTB20;IL34;BMP2;AR;DDR2;NTRK3;FGFR2;PELI2;PDGFRA;KIT;ROCK2;EPHA3;VEGFB;LEPR;EPHA6;RAP2A;PFKFB4;LMO4;DDR1;FNIP1;LYN;AXIN2;AXL;GLMN;NPTN;PDGFRB;EPHB1;TNIK;THPO;ROR1;RYK;ERBB3;IGF2;FGFR4;EPHA8;DVL3;MYDGF;ERBB4;AKTIP;EPHA5;ALK;MUSK;ANG;MST1R;CHRNA7;FXR2;MERTK;FGFR1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.5478730905777703,1.4061743250797436,0.10845986984815618,0.48573088992994684,1.0,3/15,3.76%,BMP2;GLI2;ANKRD11
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.6125847880158632,-1.4056534864337864,0.0920353982300885,0.359801939608074,1.0,4/10,5.48%,PARD3;DGKH;PLPP1;PRKD3
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.5108601991177689,1.4050322896656042,0.08628318584070796,0.48682526275801646,1.0,3/19,5.22%,CAMK1D;DAPK2;IL4
prerank,positive regulation of protein modification process (GO:0031401),-0.32313410025435785,-1.4047847496639456,0.008602150537634409,0.36098077339560036,1.0,68/203,20.91%,TEK;PECAM1;SLCO3A1;CCND3;FGF1;LIMCH1;RACK1;LIMK2;KDR;MAPK3;TFRC;TBX1;NIBAN1;PTK2;PPP1R16B;VEGFC;CARD14;CALM1;APP;TGFB1;FAM20A;PPIA;RAC1;RALB;CHP1;VEGFA;PDE8A;KRAS;SVIP;RIPK1;FLT4;PPP2R5A;INSR;AKT1;FAS;FLOT1;ATG7;CAMK1;CD74;VEGFD;CIB1;MAVS;PIK3R3;CALM3;ENG;CSF1R;ACE;HRAS;FGF2;FMR1;ERBB2;RAPGEF3;EGFR;HSP90AA1;RAMP1;PGF;CDCA2;CCND1;PIN1;SOX9;CDH5;ITGB3;FGF9;BRAT1;RAB3GAP2;CNEP1R1;WDFY2;FGF10
prerank,mesenchymal to epithelial transition (GO:0060231),0.606573890839251,1.4047223326294755,0.14157303370786517,0.48579631304970133,1.0,3/10,13.04%,SALL1;GATA3;PAX8
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.5958472235418029,-1.4043092986148873,0.09107806691449814,0.3613660646768592,1.0,2/10,4.67%,WNK1;ADAM10
prerank,negative regulation of metabolic process (GO:0009892),0.40800138744655123,1.4036381663761177,0.061752988047808766,0.4867744712783404,1.0,11/54,7.89%,ALDH1A1;LGR4;PLCL1;NOVA1;ADAMTS5;ACTN3;GSTP1;PLCL2;ACOT11;DOCK7;RBPJ
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.39406356089496714,-1.4021049481559504,0.04500978473581213,0.365746908765977,1.0,20/54,22.40%,RPL26;CRADD;CDKN1B;CNOT7;RGCC;PLAGL1;PLK2;PCBP4;BAX;SOX4;E2F1;CDKN1A;E2F4;GADD45A;CNOT11;SFN;E2F7;PLK3;TRIAP1;CNOT3
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.6065833936276848,-1.402001347291026,0.06049149338374291,0.36513822974704757,1.0,8/10,35.49%,DKC1;CCT2;CCT3;CCT8;CCT7;CCT4;WRAP53;CCT6A
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.4325519681896095,-1.4019082259394506,0.06187624750499002,0.36458992185219735,1.0,18/35,29.75%,CDK6;FOXO3;ETS1;PRKDC;TAL1;INHBA;LDB1;HSPA1A;HSPA9;FAM210B;STAT1;HSPA1B;MAPK11;ZFPM1;SPI1;HMGB2;ABCB10;ANKRD54
prerank,regulation of neuroinflammatory response (GO:0150077),0.5109440047056165,1.4008748189557336,0.102,0.4921785620530963,1.0,3/19,8.86%,IGF1;IL4;IL18
prerank,negative regulation of macrophage activation (GO:0043031),0.527678081879903,1.4008000665302582,0.12359550561797752,0.4904624098943367,1.0,2/16,5.22%,IL31RA;IL4
prerank,carbohydrate catabolic process (GO:0016052),-0.4270920916040268,-1.4005706486610208,0.06275303643724696,0.36688841061810945,1.0,19/38,31.09%,GPI;MANBA;HK1;PGM1;PKM;GAPDH;LDHA;PGK1;NEU3;PFKL;PGAM1;PGAM4;ENO1;NEU2;NAGA;NEU1;PFKFB1;PFKFB2;ALDOA
prerank,cellular response to metal ion (GO:0071248),-0.34232880708965696,-1.4002226939588216,0.015021459227467811,0.3668102867871126,1.0,22/123,4.87%,MEF2C;ITPKB;B2M;SLC12A2;CLIC4;CDH1;PLCG2;MEF2A;MT1E;MT1F;MT1M;MT1G;MT1H;MT1A;MT1X;MT1B;MAPK3;IQGAP1;CAMK2D;MT2A;CDKN1B;CARF
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.41656798317323673,1.4001811080912883,0.06275303643724696,0.49023022036965924,1.0,10/46,7.89%,ALDH1A1;LGR4;PLCL1;NOVA1;ADAMTS5;ACTN3;PLCL2;ACOT11;DOCK7;RBPJ
prerank,regulation of innate immune response (GO:0045088),-0.39289550323204303,-1.4001172759330194,0.039603960396039604,0.3662203173747647,1.0,31/57,39.41%,GBP5;HSP90AB1;N4BP1;ERAP1;CASP8;DHX9;LRP8;TIRAP;DHX58;SAMHD1;AKIRIN2;PTPN6;SLC15A4;TNFAIP3;PTPN22;POLR3B;PTPN1;XIAP;TREM2;MUL1;PARP9;RIOK3;NLRC3;USP18;LYAR;TLR8;CCL5;FCGR2B;IFNAR2;CACTIN;ADAM8
prerank,positive regulation of macrophage activation (GO:0043032),-0.5074834610584373,-1.3998804027032266,0.0854368932038835,0.3659546880229303,1.0,5/17,11.83%,THBS1;LBP;IL33;HSPD1;TLR4
prerank,bone development (GO:0060348),0.4364232674813261,1.3994353648395241,0.0640495867768595,0.49024987540602866,1.0,7/39,4.04%,NOTUM;FGFR2;SULF1;SULF2;GJA1;SH3PXD2B;RANBP3L
prerank,response to amyloid-beta (GO:1904645),0.4317523418747041,1.399021344588627,0.08888888888888889,0.4893911048544045,1.0,10/44,13.33%,IGF1;LRP1;GJA1;CACNA2D1;CALCR;CACNB1;CHRNA7;ATP1A3;NGFR;GRIN2A
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.5432704519852234,-1.3983989410565152,0.10285714285714286,0.3683872261409539,1.0,5/15,17.95%,PLTP;SCARB1;ABCG1;APOE;LCAT
prerank,establishment of epithelial cell polarity (GO:0090162),-0.514957142133277,-1.3974704906211939,0.0831858407079646,0.36974226252610276,1.0,6/19,11.01%,CYTH3;PARD3;OPHN1;MSN;EZR;SIPA1L3
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4505534470535164,1.3973452618844195,0.09832635983263599,0.4918890747392264,1.0,9/34,8.38%,LGR4;LYN;TICAM1;BPIFB1;SMPDL3B;CD300LF;LRRC14;NLRP2B;GPR108
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.5355049113915136,-1.396740762841888,0.09217391304347826,0.37057845976228365,1.0,6/15,14.06%,KCNJ2;ATP1A1;KCNQ1;ATP1B1;KCNJ8;KCND3
prerank,protein catabolic process (GO:0030163),-0.38917236731018284,-1.3963594316814854,0.03875968992248062,0.3705342468947459,1.0,30/59,32.89%,MANBA;TPP1;DAB2IP;RNF41;HSPA8;FBXO17;IDE;DENND3;RIPK1;CTSD;UBE2G2;VCP;RNF5;APOE;UBE2G1;UCHL3;HSP90AA1;OGA;USE1;FBXO6;STT3B;NEU2;MAGEC2;FBXO2;PMAIP1;CAPN3;PRPF19;TRIM24;HTRA2;PSMA8
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.35424782635723373,1.3959447605154296,0.03680981595092025,0.49362961910566877,1.0,15/116,8.41%,ADCY7;ADCY2;ADCY1;GPHB5;ADCY5;HTR7;PRKACA;MC5R;LYN;ADM;PTGDR;IAPP;CALCR;GLP2R;HRH2
prerank,myeloid cell differentiation (GO:0030099),-0.40428637658641303,-1.3957948538097362,0.06554307116104868,0.3709801659652952,1.0,24/47,28.77%,RPS14;MFHAS1;ZBTB16;RPS19;SLC25A38;TAL1;TIRAP;INHBA;ATP5IF1;UFL1;JAK2;JAK3;HSPA9;RASGRP4;UBA5;SNRK;ALAS2;HCLS1;ZFPM1;ACIN1;CDKN2B;INHA;PTPN2;SPI1
prerank,regulation of ruffle assembly (GO:1900027),-0.47944512197338357,-1.3955906432932894,0.09124767225325885,0.3705769413918398,1.0,9/23,14.40%,CAV1;EPS8;PLEKHM1;EPS8L2;ABI3;PFN1;FAM98A;HRAS;NDEL1
prerank,cellular response to acid chemical (GO:0071229),-0.4606029249825282,-1.3952463912209832,0.07407407407407407,0.37051004424657646,1.0,18/27,35.27%,SH3BP4;KLF2;CAPN2;VEGFA;LAMTOR2;RRAGD;XBP1;RRAGA;SESN2;RRAGC;NSMF;RPTOR;LAMTOR5;LAMTOR1;CPEB4;LAMTOR3;GLRA1;IPO5
prerank,organelle fusion (GO:0048284),-0.4825213262721233,-1.395218666844394,0.06779661016949153,0.3697580325765988,1.0,15/22,41.07%,EEA1;MIEF1;BAX;CHCHD3;MIEF2;VPS11;OPA1;FIS1;STX4;MFF;MIGA1;THG1L;CYP26C1;GDAP1;MFN1
prerank,regulation of kinase activity (GO:0043549),0.36673871205593417,1.3946679161651778,0.040229885057471264,0.495167572857491,1.0,28/89,12.09%,EPHA7;LDB2;DDR2;NTRK3;FGFR2;PDGFRA;KIT;EPHA3;EPHA6;LMO4;DDR1;IRS2;AXL;PDGFRB;EPHB1;ROR1;RYK;ERBB3;FGFR4;EPHA8;ERBB4;EPHA5;ALK;MUSK;MST1R;MERTK;FGFR1;EPHA1
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.4833231850136318,1.393072327166801,0.1101511879049676,0.49768485957637654,1.0,2/24,0.19%,IGF1;ENPP1
prerank,histone H4 acetylation (GO:0043967),-0.4045203834112784,-1.3914377366646025,0.05389221556886228,0.377823682384352,1.0,14/47,18.53%,LEF1;MSL2;PHF20;TRRAP;JADE2;ING5;HCFC1;TRIM16;KANSL2;EPC1;NAA60;BRCA2;MCRS1;EP400
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.5383877422001975,-1.3906992823452105,0.10526315789473684,0.3787178357940601,1.0,4/15,7.08%,SMAD7;TGFB1;TGFB2;TGFB3
prerank,amide biosynthetic process (GO:0043604),-0.40947348531366073,-1.3906138888743873,0.0682261208576998,0.37808936635254414,1.0,8/47,8.60%,SGMS1;SGMS2;SPTLC2;DMD;DEGS2;SPTLC1;SPTSSB;ASAH2
prerank,striated muscle contraction (GO:0006941),0.40793957509541323,1.3906018016141262,0.05353319057815846,0.5022172053378039,1.0,9/53,7.88%,ATP1A2;SLC8A1;SCN3B;CHRNA1;TNNC1;TNNI3;CSRP3;KLHL41;TNNI1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.5667734794149069,-1.390111617899714,0.09107806691449814,0.3783551846809949,1.0,3/12,4.15%,ESR1;NCOR1;TGFB1
prerank,positive regulation of ERAD pathway (GO:1904294),-0.5604851492464161,-1.3898088152373722,0.09357798165137615,0.3782821546534188,1.0,5/13,14.24%,CAV1;TMEM259;RNF185;BCAP31;SGTA
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.5232147786861023,-1.3891044297237198,0.09895833333333333,0.3791473434055866,1.0,7/15,15.46%,TMSB4X;THBS1;NOTCH1;FGF1;HSPB1;FGF2;MET
prerank,negative regulation of immune effector process (GO:0002698),-0.5419345944203374,-1.3882249867105292,0.11879432624113476,0.3804151990737012,1.0,3/13,7.43%,CD55;RPS19;RC3H1
prerank,positive regulation of protein catabolic process (GO:0045732),-0.3611048066651993,-1.3877657783306883,0.03207547169811321,0.3806786245930857,1.0,35/84,22.58%,WWP1;GPC3;NEDD4L;FOXO1;DAB2IP;CDKN1B;RNF41;WWP2;MSN;EZR;IDE;EGLN2;TNFRSF1B;NDUFA13;PLK2;PTTG1IP;ATG7;VCP;OAZ2;RAB7A;ITCH;APOE;VPS11;SMURF1;SNF8;HSP90AA1;CSNK2A1;NSF;FZR1;TNFAIP3;PACSIN3;APC2;PLK3;STX5;DTL
prerank,response to laminar fluid shear stress (GO:0034616),-0.5912183118321614,-1.3875232201231362,0.10815602836879433,0.38031889066448643,1.0,5/10,5.71%,MAP2K5;KLF2;KLF4;SMAD7;SMAD6
prerank,regulation of receptor binding (GO:1900120),0.5855623750396819,1.3874312423650745,0.13958810068649885,0.5090417873861709,1.0,2/10,3.63%,GREM2;ATP2A2
prerank,collagen fibril organization (GO:0030199),0.3717231665369365,1.3868436242294606,0.05415860735009671,0.50863009436561,1.0,17/88,7.55%,COL4A6;COL4A5;COL13A1;COL1A2;DDR2;COL22A1;DPT;COL4A4;LUM;COL16A1;COL4A3;P4HA2;COL10A1;LOXL2;COL8A2;LOXL3;TGFBR1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.31180493801458803,-1.3867416320737158,0.004301075268817204,0.3812718326745512,1.0,67/234,18.12%,PRKCH;CAV1;SLCO3A1;RPS6KA5;ESR1;PLCG2;NOD1;NFKBIA;TFRC;MID2;FZD4;RPS3;CARD14;IRAK2;TRIM25;ZBTB7A;APP;UBB;PPARGC1B;SMO;PPIA;PRKCZ;PPARGC1A;UBC;RPS27A;VEGFA;IKBKB;RGCC;PSMA6;JUP;MBTPS2;EDN1;RIPK1;TNFRSF11A;HDAC4;DHX9;AKT1;TRIM14;FLOT1;DDRGK1;LRP8;TIRAP;CIB1;MAVS;TLR4;COPS5;STK36;TRIM62;TRAF1;AIM2;ARHGEF5;TRIM68;PHB2;EDA2R;TRIM5;SMARCA4;SRF;NOD2;CX3CR1;FLOT2;TAB2;HSPA1A;TCF3;RELA;KDM1A;CHUK;CD200
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3764023458025205,-1.3863737489547703,0.04174573055028463,0.3814620440878281,1.0,19/65,17.22%,LEF1;FOXP1;CBFA2T3;IL15;TGFBR2;MT1G;VEGFA;RARA;OSTM1;CASP8;PIR;TNFRSF11A;GLO1;CDK4;CSF1R;E2F1;EPHA2;CDKN1A;GAB2
prerank,regulation of fibroblast migration (GO:0010762),-0.49136227057685583,-1.3857615074421392,0.10076045627376426,0.38201625926548977,1.0,8/20,13.42%,THBS1;PTK2;TGFB1;PRR5L;RAC1;HAS1;PRKCE;FGF2
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.4311265966776913,-1.3854039901867539,0.07547169811320754,0.38197373066719176,1.0,12/35,18.67%,HEG1;RASIP1;DAB2IP;TGFB2;CCDC125;MYOC;MAPKAP1;TNFAIP1;ABL2;MET;KCTD10;SPRY1
prerank,mitochondrial fission (GO:0000266),-0.5213373222178526,-1.3852739689544566,0.09433962264150944,0.3814717570372411,1.0,10/16,27.81%,DNM3;MIEF1;MTFR1;OPA1;DNM1;DNM2;MTFR2;FIS1;MFF;MUL1
prerank,regulation of pH (GO:0006885),0.5899526148380938,1.3851510391690918,0.13082039911308205,0.5111036141607278,1.0,3/11,6.18%,ATP6V0A4;PDK4;SLC9A7
prerank,positive regulation of cell junction assembly (GO:1901890),0.40326127441058485,1.3849438068668054,0.05737704918032787,0.5096992986205321,1.0,16/56,8.00%,NRP1;SRPX2;GRID2;NRXN1;CLSTN2;CNTNAP2;SFRP1;PTPRD;IL1RAP;COL16A1;SYNDIG1;NLGN2;NLGN3;IL1RAPL1;EPHB1;NLGN1
prerank,cellular response to interferon-gamma (GO:0071346),-0.3558779721919034,-1.3848819256352902,0.03177966101694915,0.3816056545487447,1.0,32/88,27.96%,B2M;GBP5;CAMK2D;TRIM25;CD44;MT2A;MID1;GBP7;GAPDH;CCL15;RPL13A;TLR4;TRIM62;TRIM68;TRIM5;IRF9;OAS2;JAK2;HCK;IFNGR1;STAT1;IRF8;AQP4;LGALS9;CASP1;SYNCRIP;PRKCD;CCL2;AIF1;ICAM1;CAMK2G;SLC26A6
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.4030553132787702,1.3847847777433653,0.06707317073170732,0.5082591642385903,1.0,13/57,12.39%,IGF1;IL31RA;KIT;LYN;GHR;IL4;IL18;HES5;ERBB4;CNTF;IL6R;TSLP;PIBF1
prerank,regulation of cell migration (GO:0030334),-0.292724386973497,-1.3844310441323153,0.0022522522522522522,0.38190383186206084,1.0,89/382,13.42%,LEF1;PECAM1;PODXL;CAV1;FLT1;TMSB4X;IGF1R;FRMD5;ITGA6;DACH1;CLDN5;SEMA6A;CLIC4;SEMA3C;CDH1;THBS1;PTPRJ;NOTCH1;SEMA7A;ACTG1;FGF1;LIMCH1;RACK1;PTK2B;ACTN4;KDR;F3;PTK2;CYRIB;FOXO3;SLIT2;FERMT2;SMAD7;ADAM15;ANXA1;PLXNA4;IGFBP5;RNF41;TGFB1;SMO;ADAM10;NEDD9;PRR5L;ROBO4;RAC1;MINK1;CD151;AMOT;VEGFA;SH3RF2;CYP1B1;IFITM1;SPATA13;MYOC;ABI3;EDN1;PPM1F;INSR;PDGFC;ELP6;AKT1;TMSB10;PDGFA;LAMC2;VCL;ZMYND8;FAM107A;SEMA3G;RHOB;DDRGK1;WNT11;PLXNA1;MMP14;CD74;ULK4;CIB1;HSPA5;PLXND1;RCC2;DUSP3;SRCIN1;PIK3R3;NF1;ENG;CSF1R;ACVR1;ACE;HRAS;FGF2
prerank,positive regulation of phospholipase activity (GO:0010518),0.49096179067268503,1.384386581353151,0.10675381263616558,0.5074303289566211,1.0,7/22,6.21%,NTRK3;FGFR2;PLA2G5;PDGFRA;KIT;PDPK1;PDGFRB
prerank,response to iron ion (GO:0010039),0.5627667604045558,1.3842785315129933,0.1141552511415525,0.5058379713723524,1.0,2/12,3.46%,BMP6;BCL2
prerank,cellular amino acid catabolic process (GO:0009063),0.3709086602819105,1.3842356537338836,0.047619047619047616,0.5041020141686232,1.0,20/87,10.91%,HMGCLL1;ASPA;ALDH4A1;IL4I1;ABAT;PRODH;GLDC;ACADSB;ALDH7A1;BCKDHB;ALDH6A1;TDO2;KMO;DDO;GLS2;GLUL;HIBADH;KYNU;HNMT;DBT
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.5995155119684387,-1.3829480976094732,0.09747292418772563,0.38450620789585255,1.0,6/10,26.70%,PDE8A;RIPK1;GPR37L1;STK26;TXN;PARK7
prerank,negative regulation of blood pressure (GO:0045776),-0.5527689135217807,-1.3828452264020317,0.10163339382940109,0.38395411337373303,1.0,8/13,33.20%,NOS3;BMPR2;PRCP;GPR37L1;SCPEP1;NOS2;APLN;NOS1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.33812038450896603,1.3828267802534644,0.024439918533604887,0.5059106000801842,1.0,35/159,12.85%,ROBO1;GPC6;ROBO2;LRRC4C;SDK2;TENM3;GRID2;CDH8;CNTN4;PCDHB10;GPC4;DCHS1;CDH18;PTPRD;TENM2;PTPRT;CDH11;PCDHB13;NPTN;KIRREL3;CDH19;CDH20;CDH7;IL1RAPL1;NLGN1;ALCAM;TRO;UNC5D;CDH10;PLXNB2;CDHR3;AMIGO1;OBSL1;PCDHB16;CDH12
prerank,defense response to symbiont (GO:0140546),-0.3471667587859169,-1.3824921453912855,0.0465587044534413,0.3839691163554228,1.0,26/92,18.81%,IFIH1;ABCC9;NLRC5;LYST;CNOT7;IFITM1;IFITM3;TLR3;IFITM2;ZMYND11;IFIT1;ATG7;BCL2L1;MAVS;TTC4;TRIM56;SAMHD1;BNIP3L;TRIM5;OAS2;DDIT4;RELA;MLKL;RSAD2;STAT1;CGAS
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.4791759711622168,-1.3821780175637868,0.08759124087591241,0.3837669334159639,1.0,14/21,36.85%,VEGFA;NES;FZD3;DISC1;CX3CR1;KDM1A;DLL4;TOX;LRP2;CTNNB1;FZD9;SMARCD3;RASSF10;PROX1
prerank,regulation of JUN kinase activity (GO:0043506),-0.4291775125525473,-1.3818901621385815,0.07604562737642585,0.3835826497632738,1.0,9/33,8.84%,MAP3K5;RPS3;DAB2IP;TAOK3;EDN1;TNFRSF11A;AIDA;MAP3K11;DNAJA1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.5356189323995951,-1.3818668748034082,0.10283687943262411,0.38282584710286444,1.0,11/15,39.47%,SCARB1;MFSD2A;NR1H2;CNEP1R1;SIK1;SREBF1;C3;SLC27A1;LDLR;CTDNEP1;PLIN5
prerank,cellular response to chemokine (GO:1990869),-0.403590492881116,-1.381376909687862,0.07142857142857142,0.38320187548848184,1.0,5/46,2.78%,SLC12A2;ACKR3;PTK2B;LRCH1;WNK1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.4926011160316358,-1.3808266756413736,0.10131332082551595,0.3836754957150747,1.0,5/20,4.11%,ANO6;ENTPD1;NT5E;HSP90AB1;APP
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.5685935514887434,-1.3807717008024134,0.1037037037037037,0.38299328032735463,1.0,4/12,12.39%,CSGALNACT1;SLC35A3;FUT8;GFPT1
prerank,necroptotic process (GO:0070266),-0.5154701921387252,-1.3806334522943162,0.10925925925925926,0.3825186813446486,1.0,7/16,17.48%,TRPM7;IPMK;TLR3;RIPK1;TLR4;PGAM5;MLKL
prerank,negative regulation of innate immune response (GO:0045824),-0.42233456442912776,-1.3805132996745113,0.08159392789373814,0.38205568738695433,1.0,21/34,39.30%,NLRC5;RPS19;CNOT7;DHX58;YTHDF2;SAMHD1;USP15;TNFAIP3;TTLL12;FAM3A;MUL1;PTPN2;A2M;NLRC3;YTHDF3;USP18;LYAR;GRN;SUSD4;CACTIN;OAS3
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.4421359401652963,-1.3801399375222492,0.09195402298850575,0.38205758827860725,1.0,12/29,24.72%,RPS16;RPS14;NOP14;RPS21;RPS8;RPS19;DHX37;UTP4;PWP2;ABT1;TBL3;TSR1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.5782962905157043,-1.379996059292823,0.11320754716981132,0.38159749010584293,1.0,6/12,21.35%,CAV1;JUP;CTNNA3;DSG2;DSP;CACNA1C
prerank,regulation of leukocyte migration (GO:0002685),-0.5164179430515914,-1.3796191244672067,0.1036468330134357,0.38170783138053066,1.0,4/16,5.80%,ANXA1;RAC1;CD81;VEGFA
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.43951094643523136,-1.3791623700883366,0.07692307692307693,0.38194405436777545,1.0,15/33,22.90%,ACER2;DPP4;PTK2;JAM3;TGFB2;CYP1B1;FOXC2;CIB1;SYK;NEXMIF;EPHA2;RET;PLAU;ADA;PIK3CG
prerank,artery development (GO:0060840),0.4847266355125009,1.37913880808692,0.11839323467230443,0.5137537364623678,1.0,4/23,2.22%,ROBO1;NRP1;ROBO2;EFEMP2
prerank,cGMP metabolic process (GO:0046068),-0.5686609325045612,-1.3788941938107773,0.10777385159010601,0.38174396988897474,1.0,5/12,15.11%,NPR1;PDE2A;GUCY1B1;GUCY1A1;GUCY2C
prerank,manganese ion transport (GO:0006828),-0.54080170236204,-1.378838216837405,0.09982174688057041,0.3810960444533423,1.0,6/14,10.83%,TRPC3;TMEM165;ATP2C1;SLC39A8;TRPC6;TRPC4
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.2837923595236429,-1.3781046620764268,0.0022988505747126436,0.3819930204277576,1.0,140/532,18.20%,FN1;ADIPOR2;TMSB4X;B2M;ACKR3;RPS6KA5;LBP;PTPRJ;IL15;VIM;RAP1B;PTK2B;NOD1;ACTN4;LIFR;TNFRSF11B;NFKBIA;MAOA;F3;FOXO1;MAPK3;STX3;RAPGEF1;LAMA5;S1PR1;FOXO3;CARD14;IRAK2;HNRNPA2B1;CAMK2D;TRIM25;ANXA1;CD44;SOCS2;MT2A;CDKN1B;ADAR;TGFB1;UBB;MAP3K3;MSN;HSPA8;PPIA;INPP5D;ANXA2;MID1;ADIPOR1;UBC;RPS27A;LIMS1;CRK;VEGFA;IL33;IL1R1;STX1A;IKBKB;IFITM1;PITPNA;IFITM3;SHC1;MAP3K8;TNFRSF1B;PSMA6;RIPK1;TNFRSF11A;IL20RB;IFITM2;PSMB5;AKT1;CCL15;TWIST1;IFNAR1;IFIT1;CSNK2B;FCER1G;BCL6;PSMC4;TALDO1;JUNB;LRP8;TOLLIP;GRB10;CFL1;ABL2;HNRNPDL;BCL2L1;PSMC5;IL17RE;YWHAZ;SYK;TRIM62;PSMD14;TRAF1;IL18BP;CSF1R;AIM2;COMMD7;SAMHD1;FGF2;TRIM68;TNFRSF1A;RBX1;EDA2R;CISH;POU2F1;PSMD8;PIK3CA;TRIM5;SMARCA4;F13A1;CLCF1;TNFSF13;STAT5A;SMAD4;IRF9;NOD2;NDN;PSMC1;PTPN6;IL17RA;OAS2;CDKN1A;JAK2;HSP90AA1;PSMB4;TAB2;PSMD11;PSMD12;JAK3;HCK;GAB2;RELA;HSPA9;PELI1;CHUK;IFNGR1;RSAD2;STAT1;IRF8;SLA
prerank,modulation of chemical synaptic transmission (GO:0050804),0.35798818207127064,1.3780929946771396,0.04480651731160896,0.5146296767897207,1.0,27/107,13.03%,ATP1A2;LRRC4C;NRG3;GRID2;CLSTN2;RIMS1;CHRNB4;GRIK5;GRIK2;GRM1;DLGAP1;NLGN2;NLGN3;SYT1;GRID1;CPLX2;GRIK1;MAPK8IP2;NLGN1;STX1B;MCTP2;PTEN;CHRNA7;BAIAP3;CNTNAP4;DLG4;GRM4
prerank,myotube differentiation (GO:0014902),0.5252922934894904,1.3779939577543707,0.11974789915966387,0.5130520484827437,1.0,5/17,7.83%,IGF1;ADGRB3;ADAMTS5;ADAM12;SIX4
prerank,cellular response to chemical stress (GO:0062197),-0.356180156372604,-1.377916151082201,0.034482758620689655,0.3816404046173927,1.0,37/96,26.70%,CAV1;LRRC8D;FOXO1;FOXO3;PPIA;PRR5L;PPARGC1A;NCF2;ATF4;CHCHD2;MSRA;GPX1;FAS;ATG7;TRPV4;STX2;PIK3CA;VKORC1L1;ETV5;GSR;HSPA1A;CCS;CYBB;KEAP1;GPX8;HSPA1B;SESN2;ADNP2;ERO1A;SRXN1;NUDT2;PKD2;GPX3;AIF1;SOD1;STX4;PARK7
prerank,amino acid import across plasma membrane (GO:0089718),0.4824599590775441,1.3777587889967342,0.11471861471861472,0.511883148557174,1.0,5/24,1.84%,SLC1A3;SLC7A2;SLC6A9;SLC6A13;SLC22A4
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.5521082605317695,-1.3772066627095851,0.10583941605839416,0.38251133592146924,1.0,6/13,26.70%,RACK1;PDE8A;GPR37L1;MET;TXN;PARK7
prerank,regulation of protein modification process (GO:0031399),-0.39066004885982264,-1.3765448491017704,0.05742574257425743,0.3833127669065215,1.0,20/50,23.69%,FN1;PTK2;PPP1R16B;FNIP2;HSPB1;NDUFS4;WARS1;ATG7;HPF1;ABCA2;CCAR2;PIN1;PPP1R16A;CDH5;ROPN1L;CADM4;SESN2;SPRED3;PPIB;CCDC88A
prerank,positive regulation of inflammatory response (GO:0050729),-0.362622177590067,-1.3761567940143304,0.04480651731160896,0.38337549178296804,1.0,15/86,8.50%,LBP;IL15;NFKBIA;ETS1;VAMP7;APP;PDE2A;CD81;RPS19;IL33;GPR4;TLR3;NFKBIZ;RIPK1;DHX9
prerank,response to nutrient levels (GO:0031667),-0.50913772029039,-1.3756428854479141,0.10467289719626169,0.3837498164873104,1.0,8/17,31.66%,KCNB1;ATF4;FAM107A;EIF4G1;CD68;MEAK7;RPTOR;RPS6KB1
prerank,amino acid transport (GO:0006865),0.4058397283987709,1.3755951537192768,0.08678500986193294,0.5156984438707143,1.0,12/49,13.10%,SLC7A11;SLC6A12;SLC7A2;SLC43A1;SLC36A2;SLC38A1;SLC7A9;SLC25A47;SLC1A5;SLC38A3;SLC38A9;SLC38A6
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.5086905239404695,-1.3753238837591544,0.11090225563909774,0.38370375343021834,1.0,9/18,31.06%,MAPK3;MSN;EZR;VPS11;SNX3;RDX;MTMR2;SRC;SNX12
prerank,high-density lipoprotein particle assembly (GO:0034380),0.5984035596858228,1.375153182937506,0.12614678899082568,0.5149883693003285,1.0,2/10,2.74%,ABCA1;PRKACA
prerank,glycolipid metabolic process (GO:0006664),-0.3931245511086457,-1.3749450608613456,0.06095238095238095,0.38376296351869255,1.0,26/47,33.72%,ST3GAL6;ST3GAL4;ST6GALNAC3;ESYT2;SUMF2;HEXA;PSAP;ST8SIA6;SUMF1;ABCA2;ESYT3;NEU3;PIGW;SCCPDH;GLTP;NEU2;SMPD1;NAGA;NEU1;FUCA1;ARSA;B4GALNT1;SMPD2;HEXB;ST6GALNAC4;ST3GAL2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.5142212413769067,-1.3745277772842461,0.08695652173913043,0.3840083718980768,1.0,4/16,11.39%,ACKR3;TPT1;RPS3;BCL2L1
prerank,muscle tissue development (GO:0060537),-0.5401276839285938,-1.3740066794301968,0.11090573012939002,0.3844969895189999,1.0,6/13,12.81%,PGM5;SMO;STRA6;POGLUT1;NF1;ENG
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.37960071856194044,-1.373946590862437,0.03415559772296015,0.3838463133980545,1.0,19/67,7.62%,FLT1;NRP2;WASF2;DOCK1;PXN;CLEC14A;PTK2B;KDR;SHB;PTK2;VEGFC;DAB2IP;MAPKAPK3;RAC1;CRK;NCF2;VEGFA;HSPB1;FLT4
prerank,regulation of organelle organization (GO:0033043),-0.35754043335710667,-1.373683832005938,0.04921259842519685,0.38370786615656316,1.0,35/80,27.81%,CLIC4;F11R;MAPK3;PTK2;CAPN2;PDE2A;MSN;DIAPH1;EZR;CPLANE2;RHOT1;SPEF1;MIEF2;RHOT2;SURF4;MAVS;ARHGEF5;VPS11;MTM1;TBC1D25;ARMH3;EHD3;TJP1;TMEM33;CAMSAP3;FIS1;STX5;PDCD10;RDX;GOLPH3;PLXNB1;CAPN6;CENPV;MFF;MUL1
prerank,regulation of protein binding (GO:0043393),-0.33495864481501136,-1.3735162202242581,0.01761252446183953,0.3833827300349045,1.0,27/114,11.10%,CAV1;ACTB;CLDN5;B2M;RACK1;RPL11;APP;FKBP1A;CTSZ;RALB;PKD1;CRK;HIP1R;IDE;HDAC4;NES;AKT1;ADD1;NMD3;BAX;PRMT8;IFIT1;FLOT1;DISC1;CAMK1;GAS8;CTNNBIP1
prerank,basement membrane organization (GO:0071711),0.5425205465604148,1.3732849333593353,0.109375,0.5179437555094205,1.0,3/14,2.15%,FLRT2;NID2;NID1
prerank,regulation of sensory perception of pain (GO:0051930),-0.5700015376124857,-1.3731626880172567,0.125,0.3834995472791074,1.0,6/11,24.82%,CCN3;MGLL;ZFHX2;TMEM100;SPX;ATPSCKMT
prerank,canonical glycolysis (GO:0061621),-0.46519798231453746,-1.3729222322356045,0.10019646365422397,0.38247488324654944,1.0,10/24,24.46%,GPI;HK1;FOXK1;PKM;PFKP;GAPDH;PGK1;PFKL;PGAM1;ENO1
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.46519798231453746,-1.3729222322356045,0.10019646365422397,0.38247488324654944,1.0,10/24,24.46%,GPI;HK1;FOXK1;PKM;PFKP;GAPDH;PGK1;PFKL;PGAM1;ENO1
prerank,mitochondrion morphogenesis (GO:0070584),0.5674548142995379,1.3715502391936971,0.12946428571428573,0.5204570042773554,1.0,3/11,10.46%,PID1;NUBPL;PNPT1
prerank,negative chemotaxis (GO:0050919),0.44193851599784784,1.3712753217871976,0.09163346613545817,0.5193648367790348,1.0,5/33,5.02%,EPHA7;ROBO1;LRTM1;SEMA3A;SEMA3D
prerank,positive regulation of cell differentiation (GO:0045597),0.31467771381963583,1.3704336699848323,0.017110266159695818,0.5197256144803446,1.0,37/237,10.10%,IGF1;BMP6;TCF4;NELL1;WNT4;BMP2;PTN;AR;FBN2;DDR2;RIN2;ZEB1;PLA2G5;GJA1;GDNF;SMAD3;CCN4;SFRP1;RANBP3L;SP7;CTNNA2;OLFM1;CEBPB;AXIN2;BRINP1;BRINP3;LOXL2;MEDAG;TGFBR1;RRAS;SOX5;NRCAM;SMYD1;IL18;BMPR1A;FRZB;KCTD11
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5635623207195954,-1.3697378617528064,0.10357142857142858,0.3891009154125311,1.0,4/12,5.71%,FOXP1;NCOR1;ZBTB7A;HEYL
prerank,bile acid and bile salt transport (GO:0015721),-0.4579835562215524,-1.3687901808179832,0.08834586466165413,0.3905236328496269,1.0,4/24,1.30%,ABCC4;SLCO1C1;ATP8B1;SLCO2B1
prerank,cellular protein catabolic process (GO:0044257),-0.38356327481208763,-1.3687075967493187,0.06883365200764818,0.3899238542579385,1.0,20/59,15.00%,DAB2IP;CAPN2;FAP;CTSZ;CTSO;CTSC;IDE;CASP8;PSMA6;DENND3;RIPK1;AP2M1;CTSF;UBE2G2;CTSB;RNF5;RAB7A;BNIP3L;UBE2G1;AP2A1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.5421980743528052,1.3684780103342882,0.14107883817427386,0.5228769556545539,1.0,7/15,23.14%,IL4I1;TDO2;KMO;KYNU;GSTZ1;KYAT1;FAH
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.3908703075325314,-1.3683122975637394,0.049800796812749,0.3900285533551297,1.0,25/50,33.16%,NR3C2;NOD1;ACTN4;RPS3;APP;LIMS1;TLR3;TCIM;TLR4;PHB2;NOD2;EGFR;RELA;LAPTM5;TRIP6;LGALS9;TRAF6;PTP4A3;PDCD4;CD86;C1QTNF4;TERF2IP;RHOA;CD14;TRIM44
prerank,mitochondrion organization (GO:0007005),-0.3210418359326396,-1.3682581573193096,0.01440329218106996,0.38936616215268716,1.0,55/165,22.48%,DNM3;CXADR;NOS3;VPS13D;TRAK1;CAV2;MEF2A;ATP5F1D;PPARGC1A;MIEF1;TMEM70;CHCHD2;ATP5F1B;TRAK2;HCFC1;IMMP2L;BAX;CHCHD3;RHOT1;ESRRA;MIEF2;HSPD1;GABPA;RHOT2;BCL2L1;TIMM17A;MTFR1;HIGD2A;AGTPBP1;CHCHD4;TOMM22;BCAP31;PHB2;BNIP3L;NIPSNAP2;CHCHD10;MTM1;OPA1;ADCK1;HSD17B10;TIMM13;DNM1;SLC25A33;BIK;DNM2;HIGD1A;PTCD2;RAB32;TOMM5;HIGD1B;TIMM50;MTFR2;SLC25A4;FIS1;TIMM10
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.34708903730880625,1.367957260828261,0.05060728744939271,0.522438573345744,1.0,15/117,8.41%,ADCY7;ADCY2;ADCY1;GPHB5;ADCY5;HTR7;PRKACA;MC5R;LYN;ADM;PTGDR;IAPP;CALCR;GLP2R;HRH2
prerank,regulation of protein metabolic process (GO:0051246),-0.4077857296974474,-1.3670059447511136,0.07909604519774012,0.3915195370133856,1.0,8/44,4.20%,LTBP4;NEDD4L;MAP2K5;KLF2;KLF4;HSP90AB1;APP;FKBP1A
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.44987328242041863,-1.3665395422627846,0.1017274472168906,0.3918334665367348,1.0,13/28,20.34%,PTK2;DAB2IP;CTSC;DDRGK1;PSMC5;FMR1;SMURF1;ATP5IF1;OSBPL7;CDK5RAP3;LAPTM5;CCDC22;PSMC3
prerank,immunoglobulin mediated immune response (GO:0016064),-0.583704868669208,-1.366495743218305,0.10536779324055666,0.39115108098074985,1.0,3/10,10.67%,CD81;FCER1G;CD74
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.4980714082087695,1.3664402322898694,0.12139917695473251,0.5247682871114504,1.0,3/20,1.29%,WNT4;BMP2;BMP5
prerank,regulation of protein phosphorylation (GO:0001932),-0.3068596848455908,-1.3662493690049753,0.002257336343115124,0.3909431129780039,1.0,61/256,13.81%,FN1;TEK;PLCE1;PECAM1;OCLN;BMPER;SLCO3A1;CCND3;FGF1;LIMCH1;RACK1;LIMK2;KDR;MAPK3;TFRC;TBX1;NIBAN1;PTK2;VEGFC;SLIT2;CARD14;DAB2IP;FNIP2;APP;TGFB1;FAM20A;PPIA;PRR5L;RAC1;RALB;IGFBP3;CHP1;VEGFA;ATF4;PDE8A;HSPB1;BRD4;PRKDC;KRAS;RIPK1;FLT4;PPP2R5A;INSR;NDUFS4;AKT1;PDGFA;WARS1;FAS;FLOT1;CD74;VEGFD;IMPACT;CIB1;MAVS;PIK3R3;ENG;CSF1R;SMG8;HRAS;FGF2;FMR1
prerank,signal release from synapse (GO:0099643),0.4154492978857514,1.3644982970614306,0.10416666666666667,0.5281091253221261,1.0,12/43,13.59%,NRXN1;RIMS1;SYT1;CPLX2;OTOF;SNAP25;PDZD11;BRSK1;PTPRN2;STXBP3;GRM4;SNAPIN
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.3340774437546465,-1.363803461121336,0.03536345776031434,0.395953103593875,1.0,39/128,15.07%,CLDN5;DDX5;PARD3;ID1;PXN;TGFBR2;BMPR2;F11R;NLK;MAPK3;PTK2;SMAD9;FERMT2;SMAD7;COL3A1;TGFB1;FKBP1A;TGFB2;UBB;PRKCZ;UBC;RPS27A;SMAD6;TGFB3;USP9X;INHBA;HIVEP1;ZMIZ2;TMEM100;ENG;NRROS;ACVR1;USP15;ARHGEF18;RNF111;SMURF1;EID2;INHBB;SMAD4
prerank,membrane raft organization (GO:0031579),-0.5290622803031034,-1.3633846675751282,0.12727272727272726,0.39606927416976834,1.0,7/15,16.54%,ANXA2;NAXE;FLOT1;S100A10;EMP2;NPC1;FLOT2
prerank,negative regulation of fat cell differentiation (GO:0045599),0.44388615441620466,1.3633194410191178,0.10920770877944326,0.5295694592612873,1.0,4/34,2.72%,RORA;ENPP1;RUNX1T1;SMAD3
prerank,epithelial to mesenchymal transition (GO:0001837),0.4054749603646013,1.3632562343429604,0.08210526315789474,0.5278962799363589,1.0,11/47,7.89%,TGFBR3;WNT4;BMP2;TBX3;ROCK2;OLFM1;TGFBR3L;LOXL2;LOXL3;TGFBR1;RBPJ
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.33376303789786704,-1.3632346796051522,0.03592814371257485,0.39561505594831503,1.0,22/107,9.08%,ATP13A5;CAV1;SLC39A10;TPT1;MT1E;MT1F;MT1M;MT1G;MT1H;MT1A;MT1X;MT1B;TMEM165;MT2A;ATP2C1;SLC39A8;ATP2A3;ATP1B1;EDN1;CCL15;STIM2;SLC10A7
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.5765609652764262,-1.3629347951533621,0.12453531598513011,0.39552092443594816,1.0,5/11,21.74%,THBS1;CD34;GATA6;CD200;LGALS9
prerank,protein mono-ADP-ribosylation (GO:0140289),0.5720274784251431,1.3627846602286389,0.14096916299559473,0.5273197355768873,1.0,7/11,20.49%,PARP16;PARP11;PARP3;PARP12;TIPARP;PARP4;PARP8
prerank,global genome nucleotide-excision repair (GO:0070911),-0.4560209766410217,-1.3625264600750608,0.10207939508506617,0.39563055284460236,1.0,12/26,19.24%,UBB;UBC;RPS27A;ERCC1;CUL4A;GTF2H3;CHD1L;RBX1;RNF111;CETN2;GTF2H4;ERCC4
prerank,positive regulation of GTPase activity (GO:0043547),-0.31510488958785854,-1.3624251957954738,0.017057569296375266,0.3951084556042145,1.0,50/188,15.48%,DOCK9;PKP4;ITGA6;RAP1A;ARHGAP42;NET1;RACK1;SIPA1L1;TGM2;AGRN;F11R;CAV2;SGSM2;RALGAPA2;TBC1D8;RAPGEF1;ARHGAP27;ARHGEF15;GRTP1;FERMT2;BCAS3;LIMS1;ARHGAP25;CCDC125;TBC1D1;TBC1D12;BCR;TBC1D22A;RGS6;RALGAPB;SIPA1;CCL15;S100A10;WNT11;GMIP;ZC3H15;SIPA1L3;ABR;NF1;ARHGEF5;TBC1D9B;TBCK;HRAS;NDEL1;ERBB2;BCAR3;SNX18;RAP1GDS1;RAPGEF3;EPHA2
prerank,negative regulation of cyclase activity (GO:0031280),0.5304282901660838,1.3615724621333694,0.13606911447084233,0.528671085324147,1.0,4/14,16.27%,ADGRV1;EDNRB;DRD2;LTB4R2
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.5144770115984527,1.3614830351999854,0.11971830985915492,0.5270917147982237,1.0,3/16,2.75%,IGF1;ROCK2;PRKCA
prerank,insulin receptor signaling pathway (GO:0008286),-0.36964012752763986,-1.3614724840193193,0.0497131931166348,0.39661219012951643,1.0,22/69,16.19%,IGF1R;SORBS1;GAB1;NAMPT;GRB14;CAV2;FOXO1;ATP6V0B;SHC1;ATP6V0A2;IDE;INSR;AKT1;PIK3C2A;ATP6V0C;FOXC2;GRB10;PIK3R3;PIK3CA;BCAR3;PIK3R2;ATP6V1G1
prerank,sister chromatid segregation (GO:0000819),-0.43899647843039,-1.3614045057644253,0.07011070110701106,0.39602577344086864,1.0,15/31,32.42%,SMC4;ZW10;RB1;TOP2A;KIF18A;KNSTRN;KIF18B;NDC80;NSL1;CDCA8;SGO1;TOP2B;TUBG2;PLK1;ESPL1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.5629284749051802,-1.3613475506034958,0.09479553903345725,0.39538839822143934,1.0,8/11,35.49%,DKC1;CCT2;CCT3;CCT8;CCT7;CCT4;WRAP53;CCT6A
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.46081603733933596,-1.3612682582452724,0.07307692307692308,0.3947866866054047,1.0,4/25,1.81%,B2M;PLCG2;CD55;SLC7A5
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.46173892068195554,-1.3611476267412463,0.10460992907801418,0.3943485688320438,1.0,5/24,2.92%,MEF2C;CDON;MEF2A;CTNNA1;BOC
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.4268483010393261,1.3599206630067078,0.11627906976744186,0.5294439010148267,1.0,14/34,18.45%,GRID2;MPP2;GABRA2;NLGN3;MAPK8IP2;GABRA5;CHRNA4;GRIN2A;DRD2;GABRG1;GABRG3;GABRG2;GRIN2B;RAB3GAP1
prerank,positive regulation of synaptic transmission (GO:0050806),0.37624255891393577,1.3597263567544475,0.06407766990291262,0.528137396111292,1.0,20/72,13.41%,ADCY1;NRXN1;CLSTN2;RIMS1;MPP2;GRIK2;NPTN;NLGN2;NLGN3;SYT1;CACNG4;NLGN1;STX1B;SLC24A2;ADCY8;CHRNA7;BAIAP3;DLG4;GRIN2A;ZDHHC2
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.538187638368887,1.3593250148835425,0.12356979405034325,0.5273394676107549,1.0,4/15,8.78%,HECW2;ANAPC1;CDC23;CDC16
prerank,double-strand break repair via break-induced replication (GO:0000727),0.552405192949359,1.3584276810187488,0.1479028697571744,0.5280776661127499,1.0,6/12,22.61%,MCM3;GINS2;MCM2;CDC7;MCMDC2;MCM7
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.505526897349708,1.358405656419096,0.11982570806100218,0.526378769410769,1.0,2/17,1.66%,CAMK1D;DAPK2
prerank,positive regulation of neuron migration (GO:2001224),-0.5687815724493844,-1.3583440870061714,0.1286231884057971,0.4002978146863293,1.0,8/11,23.97%,SEMA6A;DAB2IP;SHTN1;PLAA;ARHGEF2;RAPGEF2;NIPBL;NSMF
prerank,positive regulation of apoptotic process (GO:0043065),-0.3004810524291549,-1.3573973573324196,0.004329004329004329,0.40176326751308905,1.0,86/293,19.75%,ANO6;ITGA6;MAP3K5;MCF2L;ARHGEF3;NET1;UNC13B;RACK1;TGM2;RASGRF2;ARL6IP5;FOXO1;TPD52L1;FOXO3;RPS3;SLIT2;DAB2IP;NGF;CRADD;FAP;MAP3K20;CTNNBL1;REST;TGFB2;UBB;TRIO;TNFSF10;HTT;IGFBP3;UBC;RPS27A;ING5;SOS2;HIP1R;BACE1;TNFAIP8;CYP1B1;ATF4;TGFB3;CASP8;RASSF2;RIPK1;MAP3K11;DNAJA1;BAX;PSENEN;CTSD;FAS;ITSN1;RHOB;BCL6;ATG7;HSPD1;GADD45G;PREX1;ABR;NF1;SOX4;RPS6;BAK1;RNPS1;E2F1;RPS6KA2;SPHK2;ARHGEF5;APH1A;BNIP3L;ARHGEF18;TOP2A;PHLDA3;PDCD2;BAD;DDX20;FOXL2;CCAR2;ARHGEF17;ECT2;ARHGEF12;ARHGEF4;CALHM2;ARHGEF2;ARHGEF6;PTRH2;DNM2;GADD45A;FGD2
prerank,regulation of neuron projection development (GO:0010975),0.3259052342930289,1.3569185840747695,0.03131115459882583,0.528449618060031,1.0,41/163,15.35%,CAMK1D;PTN;LPAR1;NTRK3;LRRC4C;TENM3;CSMD3;MAGI2;PTK7;KIF13B;EPHA3;SEMA3A;RIT2;GPC2;LYN;CTNNA2;NPTN;RAB29;DPYSL3;CAMK2B;IL1RAPL1;STX1B;ROR1;LRRC7;CDK5R1;PRKCI;PTEN;DCC;BRSK1;PLXNB2;FUT9;FBXO7;CBFA2T2;KIF1A;FRMD7;EP300;PPFIA2;PLPPR5;PAK1;PDLIM5;DENND5A
prerank,positive regulation of neutrophil migration (GO:1902624),0.493523978204467,1.3565537265324772,0.11889596602972399,0.5276445999887631,1.0,2/18,1.66%,CAMK1D;DAPK2
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.5189453975445623,-1.3564721817252503,0.12149532710280374,0.4031330469776895,1.0,13/16,44.74%,PVR;LAMP1;NECTIN2;RASGRP1;AP1G1;CADM1;SLAMF6;CD226;IL12A;CRTAM;KLRD1;CD160;KLRK1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.3964426650784,-1.355999696102205,0.07212475633528265,0.40347376021261433,1.0,18/47,16.56%,IGF1R;ARL6IP5;FOXO1;MAPK3;DAB2IP;TGFB2;PPIA;MID1;TAOK3;STK25;FAS;TAOK2;ULK4;COPS5;NOD2;EGFR;IGBP1;GREM1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.47520716445667466,-1.355987496384845,0.11610486891385768,0.402751911804401,1.0,10/20,29.38%,GATM;PLOD2;GCLM;GCLC;CNDP2;GGT1;MTHFS;GGCT;SLC27A1;MGST2
prerank,negative regulation of cell adhesion (GO:0007162),-0.36277634465237935,-1.3559417102548976,0.05791505791505792,0.4020874132825668,1.0,19/72,11.37%,PODXL;SEMA6A;ACER2;CDH1;NOTCH1;PTK2;FZD4;PLXNA4;TGFB1;JAM3;ARHGDIA;ADAM10;ARHGDIB;TGFBI;CYP1B1;FZD7;SIPA1;PLXNA1;PLXND1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.4126989368647078,-1.3553001064500765,0.07554671968190854,0.40281182432825346,1.0,16/40,19.90%,PTK2B;PTK2;RPL11;RPL23;FOXF2;RPS7;SGTA;SMURF1;UFL1;CSNK2A1;CSNK2A2;CDK5RAP3;LAPTM5;RPL5;CCDC22;UBE3A
prerank,positive regulation of telomerase activity (GO:0051973),-0.42701636090278006,-1.3545421361232997,0.07428571428571429,0.4038881270926154,1.0,10/33,16.56%,HMBOX1;KLF4;MAPK3;NEK7;HSP90AB1;DKC1;PNKP;CCT2;HSP90AA1;GREM1
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.4056192068066674,-1.353046399139229,0.09633911368015415,0.40670414005914035,1.0,13/43,14.53%,MEF2C;NOTCH1;TGFBR2;SOX17;TBX2;SMO;MICAL2;SOX18;ZIC3;HES1;ENG;ACVR1;SRF
prerank,cardiac conduction system development (GO:0003161),0.47153474770097287,1.353043308289137,0.12416851441241686,0.5350440102147691,1.0,6/24,12.13%,GJB6;GJA1;TBX18;CACNA1G;BMPR1A;MAML1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.5413885702748241,1.3529000745064972,0.13675213675213677,0.5337051280481436,1.0,4/13,16.27%,ADGRV1;EDNRB;DRD2;LTB4R2
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.3510791386217052,-1.352728052712256,0.049586776859504134,0.4067091154232009,1.0,37/87,26.57%,CDK6;FHL1;KLF4;RGCC;PSMA6;PSMB5;KANK2;RB1;FAM107A;PSMC4;CDK4;PSMC5;AVEN;PSMD14;RBX1;PSMD8;FBXL7;PSMC1;CDKN1A;PSMB4;PSMD11;PSMD12;CDKN2C;CUL1;CDK2AP2;PSMA1;PSMC3;RBL1;E2F7;PSMB1;PSMA2;PSMA4;PKD2;DCUN1D3;CCL2;CDKN2B;PSMB8
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.41542054551329405,-1.3527234827961978,0.08155339805825243,0.40596553708684463,1.0,12/36,13.81%,LEF1;TNRC6C;FZD6;NLK;FZD4;PLCB3;CALM1;FZD3;NFATC1;WNT11;PPP3CB;GNB1
prerank,neutrophil activation (GO:0042119),-0.5595037036630582,-1.3526156147352935,0.1068840579710145,0.4054385322553137,1.0,4/12,12.47%,IL15;FCER1G;PREX1;SYK
prerank,embryonic skeletal system development (GO:0048706),0.42845054894019846,1.3522322812078358,0.11178861788617886,0.5337248106103475,1.0,8/35,11.27%,SULF1;SULF2;PDGFRA;HOXC4;HOXB3;HOXC9;HOXB9;FUZ
prerank,positive regulation of cell communication (GO:0010647),0.4546755744821471,1.3519283972975058,0.10934393638170974,0.5326587679388035,1.0,8/28,15.33%,WLS;CLSTN2;RIMS1;GRIK2;SYT1;GATA3;DLG4;HCRT
prerank,T cell homeostasis (GO:0043029),-0.5779352290999563,-1.3513598152066966,0.13966480446927373,0.40757741330709185,1.0,5/10,17.16%,AKT1;FAS;PPP2R3C;ZC3H8;JAK3
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3343345367717382,1.350840895049389,0.036608863198458574,0.5336738464883349,1.0,19/129,8.59%,RNF220;LGR4;LRRK1;WLS;DAAM2;LYPD6;FGFR2;SEMA5A;TBL1XR1;PTK7;ZEB2;SFRP1;AXIN2;FRAT1;SMURF2;PSMA3;ADGRA2;PSMF1;PSMA7
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.4950428280719241,-1.350642296754211,0.132486388384755,0.40857027367358706,1.0,7/18,25.89%,JAM2;SLC39A8;ITGA4;CX3CR1;GOLPH3;SELP;ITGB7
prerank,hemopoiesis (GO:0030097),-0.3471190175064736,-1.3503240743794052,0.034764826175869123,0.4085416471522299,1.0,20/87,12.87%,MECOM;KITLG;TEK;FLT1;CD34;TGFBR2;KDR;HIPK1;TGFB1;TGFB2;ZBTB16;NOTCH4;ATF4;FLT4;TAL1;TIRAP;INHBA;YTHDF2;GLRX5;CSF1R
prerank,cellular response to BMP stimulus (GO:0071773),0.38329945035643714,1.3498432320644231,0.09147609147609148,0.5346225652566405,1.0,7/66,3.70%,BMP6;TGFBR3;ADAMTS12;BMP2;BMP5;SMAD3;SFRP1
prerank,protein auto-ADP-ribosylation (GO:0070213),0.5489552542553735,1.349414039743986,0.14847161572052403,0.5340189030412918,1.0,9/12,26.05%,PARP16;PARP11;PARP3;PARP12;TIPARP;PARP1;PARP8;TNKS;TNKS2
prerank,cellular response to amyloid-beta (GO:1904646),0.4394610693530681,1.3479356939933078,0.1016949152542373,0.536156140801494,1.0,8/35,13.33%,IGF1;LRP1;GJA1;CACNA2D1;CACNB1;ATP1A3;NGFR;GRIN2A
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.42122873132784167,-1.347833058118103,0.07222222222222222,0.4138860726019067,1.0,16/36,16.67%,SGMS1;TPD52L1;RPS3;DAB2IP;CRADD;NR4A2;PPIA;ING5;ASAH2;RB1;FAS;TRAF1;MADD;CX3CR1;CSNK2A1;CSNK2A2
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.5541669554379701,-1.346658718607233,0.12695652173913044,0.4158220972285759,1.0,5/11,24.31%,ITM2A;BACE2;ABCA2;NECAB3;NECAB2
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.5266117457048747,-1.346405804840765,0.11992619926199262,0.41558582355554263,1.0,3/14,7.35%,ANO6;THBS1;RGCC
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.5560449156207178,1.3458789692938773,0.15349887133182843,0.5398939565870783,1.0,3/12,4.18%,IL34;OCSTAMP;LYN
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.4943787788263894,1.3456591310356047,0.1315240083507307,0.5387589120766173,1.0,3/18,1.02%,IL34;PTN;DAAM2
prerank,myelination in peripheral nervous system (GO:0022011),-0.5478208627635206,-1.3453536153713106,0.11743119266055047,0.4172600069746256,1.0,8/13,29.58%,ADGRG6;PARD3;MYOC;NF1;SKI;SOD1;CNTNAP1;LGI4
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.5285503385831763,-1.344329846281875,0.13075506445672191,0.4188960691266255,1.0,6/14,9.84%,MEF2C;PRKG1;SLIT2;IGFBP5;IGFBP3;TRIB1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.49705426128705443,1.3441764636070728,0.13215859030837004,0.5409166615816552,1.0,5/19,7.75%,ENPP1;TPST1;SLC26A1;SULT6B1;PAPSS1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.2992247612213576,-1.343260957956445,0.008583690987124463,0.4207341584088925,1.0,64/259,15.55%,FGD5;ANO6;ABLIM1;ABCC4;DNM3;RAP1A;EXOC4;PARVB;EXOC6;NOTCH1;FNBP1L;RAP1B;RAB11A;OPHN1;CDC14A;FXYD5;EHD4;S1PR1;CD2AP;RAB8B;IFT20;CEP164;SHTN1;ABLIM3;RAC1;PKD1;MINK1;FGD6;EZR;SPATA13;EHD2;CEP162;IFT46;BBIP1;TMEM237;INPP5E;CPLANE2;NUDCD3;VCL;DISC1;CEP290;EMP2;RAB8A;SPEF1;FHDC1;EXOC1;ACTR3;NTN1;PCM1;STK36;CC2D2A;POC1B;ARL6;RFX2;ABLIM2;RAB11FIP3;CDC14B;RAB1A;KIF24;CCDC28B;SDCBP;DNAH5;STK26;EMP1
prerank,polyol metabolic process (GO:0019751),-0.39845437653584587,-1.342893467681094,0.0859375,0.4208890007892379,1.0,14/46,16.22%,PLCE1;ITPKB;PLCG2;PLCB3;CALM1;INPP5D;IPMK;INPP5A;ISYNA1;NUDT4;IP6K1;SYNJ1;IMPA2;MINPP1
prerank,potassium ion transport (GO:0006813),0.34280530580148777,1.3428422013267869,0.048484848484848485,0.5426076461161704,1.0,30/120,18.45%,SLC1A3;KCNK2;ATP1A2;NALCN;SLC24A3;ABCB8;CCDC51;SLC9A7;KCND2;KCNJ16;KCNJ3;KCND1;KCNJ5;SLC24A4;SLC24A2;KCNMA1;KCNJ14;KCNK10;KCNS3;KCNH7;KCNQ4;KCNJ6;KCNG2;KCNS1;ATP1B3;KCNN1;KCNG4;KCNC2;KCNH1;KCNH5
prerank,regulation of myotube differentiation (GO:0010830),-0.44734447718983367,-1.3425564238376502,0.1183206106870229,0.4210115393303207,1.0,7/24,10.49%,NOTCH1;CCN3;PIEZO1;HDAC9;ATP11A;HDAC4;MMP14
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.3321439994594388,-1.3420191642879449,0.03361344537815126,0.42143347397855574,1.0,29/112,18.83%,FOXP1;THBS1;LBP;CD34;PTPRJ;PLCG2;IFIH1;APP;IL33;RARA;HSPB1;TLR3;RIPK1;DHX9;TWIST1;TIRAP;MAVS;TLR4;SYK;SPHK2;NOD2;CX3CR1;PTPN6;OAS2;JAK2;VSIR;IFNGR1;TNFAIP3;ARHGEF2
prerank,atrial septum morphogenesis (GO:0060413),-0.5753704795308603,-1.3419118946798934,0.1371527777777778,0.4209243528267659,1.0,4/10,12.89%,BMPR2;TGFB2;SOX4;ACVR1
prerank,modified amino acid transport (GO:0072337),0.5131413063917563,1.341556476218551,0.15367483296213807,0.5443649290187257,1.0,5/15,11.94%,SLC16A12;SLC6A13;SLC7A9;SLC46A1;CTNS
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.32667170371875487,1.3413883894080167,0.04230769230769231,0.543087113381312,1.0,31/150,10.22%,TCF7L2;PIK3R1;AREG;FGFR2;SEMA5A;NRG1;PDGFRA;KL;KIT;PDPK1;OSBPL8;TGFA;P2RX4;NRG4;NRG2;MYORG;IRS2;IAPP;AXL;PDGFRB;RTN4;CALCR;TGFBR1;THPO;ERBB3;IGF2;IL18;FGFR4;GATA3;MYDGF;ERBB4
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.4440321684041638,-1.340481818407674,0.10825688073394496,0.42356235985031515,1.0,9/27,10.96%,AHNAK;DMD;PDE4D;CAMK2D;CALM1;FKBP1A;JPH2;JPH4;CACNB3
prerank,endocardial cushion development (GO:0003197),-0.48227608398812705,-1.3403358252203892,0.11516314779270634,0.42318350452294695,1.0,10/21,14.29%,NOS3;NOTCH1;BMPR2;TGFB2;TBX2;HEYL;CRELD1;ENG;ACVR1;HEY1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.4513753288867586,-1.3403003361214683,0.1266540642722117,0.42172482492504143,1.0,15/23,29.13%,PPP1R13B;PPP3CC;CASP8;YWHAZ;BBC3;E2F1;YWHAG;YWHAH;BAD;SFN;YWHAB;YWHAE;YWHAQ;PMAIP1;NMT1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.4513753288867586,-1.3403003361214683,0.1266540642722117,0.42172482492504143,1.0,15/23,29.13%,PPP1R13B;PPP3CC;CASP8;YWHAZ;BBC3;E2F1;YWHAG;YWHAH;BAD;SFN;YWHAB;YWHAE;YWHAQ;PMAIP1;NMT1
prerank,positive regulation of developmental growth (GO:0048639),-0.3911038467025887,-1.3401427914162076,0.08829568788501027,0.42133050166232594,1.0,14/49,14.84%,SEMA7A;NEDD4L;AGRN;ITSN2;NGF;SHTN1;INSR;PLAA;DBNL;NTN1;DBN1;SYT2;SMURF1;LIMK1
prerank,actin cytoskeleton reorganization (GO:0031532),0.37908766926377074,1.339875268786691,0.08280254777070063,0.5451591087238947,1.0,11/63,7.82%,AUTS2;NRP1;NRK;ANTXR1;PTK7;EFS;KIT;RAP2A;THSD7B;THSD7A;TNIK
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.4974425973023282,1.3398715490609392,0.13675213675213677,0.5434579284616973,1.0,3/19,11.25%,IGF1;RTN4;CHRNA7
prerank,regulation of neuron differentiation (GO:0045664),0.3635241439432298,1.3398070250576313,0.074,0.5419195515553864,1.0,17/76,11.68%,TCF4;BMP2;ZEB1;CNTN4;NREP;BRINP1;HES3;BRINP3;DTX1;SOX2;NLGN1;NRCAM;HES5;CDK5R1;KCTD11;ALK;FGFR1
prerank,neurotransmitter secretion (GO:0007269),0.4056445156323381,1.3390673898342524,0.11850311850311851,0.5422578037149991,1.0,12/44,13.59%,NRXN1;RIMS1;SYT1;CPLX2;OTOF;SNAP25;PDZD11;BRSK1;PTPRN2;STXBP3;GRM4;SNAPIN
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.5812735618213094,1.3387358236691536,0.14414414414414414,0.5413896438178885,1.0,6/10,22.63%,GABRA2;GABRA5;GABRG1;GABRG3;GABRG2;GABRB2
prerank,regulation of T cell chemotaxis (GO:0010819),-0.5451549316036769,-1.3386921286330316,0.11948529411764706,0.42390209381536703,1.0,2/11,4.67%,WNK1;ADAM10
prerank,translational elongation (GO:0006414),-0.3413153899858553,-1.338402708130434,0.04609218436873747,0.42378409676493917,1.0,39/101,25.36%,EEF1A1;RACK1;EEF2;PTCD3;MRPL52;EEF1D;MRPL51;MRPL38;EEFSEC;MRPL28;EEF1B2;MRPL43;TSFM;MRPL32;MRPL14;ERAL1;MRPS30;MRPS17;MRPL24;MRPL16;MRPL50;MRPL54;MRPS18C;MRPL47;MRPL35;MRPS18A;MRPS6;MRPL58;LTN1;MRPL13;TUFM;MRPL11;MRPL49;MRPL30;MRPS24;MRPL21;MRPL48;MRPL42;MRPL2
prerank,response to muramyl dipeptide (GO:0032495),-0.5425312706986307,-1.3380451356346699,0.12110726643598616,0.4238036206873866,1.0,5/12,22.11%,VIM;NOD1;NOD2;ARHGEF2;PTPN22
prerank,regulation of lymphocyte migration (GO:2000401),-0.5793010644453909,-1.3377569048013132,0.1263537906137184,0.42366756770487374,1.0,5/10,13.70%,JAM2;STK10;MSN;AKT1;WASL
prerank,positive regulation of defense response (GO:0031349),-0.34576619478866344,-1.3364341603026935,0.058704453441295545,0.42613358688985165,1.0,20/89,17.44%,MEF2C;IL15;NFKBIA;ETS1;GBP5;APP;PDE2A;IL33;GPR4;TLR3;NFKBIZ;RIPK1;DHX9;TLR4;TNFRSF1A;FEM1A;AKIRIN2;IL17RA;SLC15A4;NINJ1
prerank,regulation of microtubule depolymerization (GO:0031114),-0.44780532087572733,-1.3364100827376881,0.09665427509293681,0.4254422186079391,1.0,11/25,21.89%,STMN2;SPEF1;TRPV4;CIB1;KATNB1;MAP1B;ARHGEF2;MAP1A;TPX2;APC2;CAMSAP3
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.4793334409588227,1.3358421701806884,0.13279678068410464,0.5474392172232542,1.0,6/20,10.61%,GRK3;CRY1;GPRASP1;MGRN1;APLP1;BICD1
prerank,bicarbonate transport (GO:0015701),-0.4463256268957683,-1.335717718998017,0.1169811320754717,0.4263845609949814,1.0,7/25,12.60%,SLC4A10;SLC26A7;CA4;SLC39A8;SLC4A8;SLC4A2;CYB5R1
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.5365389387232742,-1.3355397743859327,0.13001912045889102,0.42606987658268625,1.0,8/13,23.95%,NFKBIA;PKD1;DBN1;MDFI;KEAP1;YWHAB;NFKBIE;PKD2
prerank,cellular response to interferon-beta (GO:0035458),-0.5155363604499299,-1.3353715917939994,0.11818181818181818,0.4257028942771125,1.0,5/14,18.13%,NDUFA13;IFITM2;UBE2G2;AIM2;STAT1
prerank,positive regulation of growth (GO:0045927),-0.36663383957601847,-1.3352032225039285,0.0741444866920152,0.42538029937615174,1.0,26/64,22.61%,RPS6KA3;TGFB2;ADAM10;MFSD2A;PPM1F;INSR;AKT1;PABIR1;H3-3A;AKAP6;MMP14;CIB1;FXN;ERBB2;CDKN2AIP;SDCBP;EGFR;CSNK2A1;DERL2;ZPR1;SLC25A33;BRAT1;DDX49;ADNP2;EIF4G1;HYAL1
prerank,negative regulation of chemotaxis (GO:0050922),0.43538028405433343,1.3351735364514552,0.12951167728237792,0.5474101013661613,1.0,6/31,5.02%,ROBO1;ROBO2;ANGPT2;SEMA5A;SEMA3A;SEMA3D
prerank,homeostasis of number of cells (GO:0048872),-0.5523887949312204,-1.3349469767649293,0.12660550458715597,0.42521856156380516,1.0,6/12,15.58%,NOS3;NOTCH1;CCN3;LPCAT3;OCIAD1;CX3CR1
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.42818689790836,-1.3345205532899234,0.09702970297029703,0.42554179276093246,1.0,13/29,20.51%,SHANK3;KANK3;CYRIB;SLIT2;KANK4;SSH2;HIP1R;PFN1;PIK3CA;SMAD4;SHANK1;TJP1;FKBP4
prerank,cellular response to ionizing radiation (GO:0071479),-0.3902958229712803,-1.3342091542789059,0.07722772277227723,0.425463991908788,1.0,24/47,30.23%,NET1;RPL26;MAP3K20;EEF1D;RAD1;RHOB;TMEM109;HRAS;RAD9B;HUS1;CDKN1A;RAD9A;CRYAB;KDM1A;ECT2;GADD45A;RHNO1;CLOCK;NIPBL;LIG4;RAD51AP1;TSPYL5;SWI5;TNKS1BP1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.4926111298238184,-1.333833337501061,0.13394495412844037,0.4255962361277964,1.0,13/16,35.23%,DDX5;DDX17;SRSF6;DHX9;SFPQ;CDK13;RBM17;SRSF9;PQBP1;SRSF1;HNRNPM;RSRC1;PUF60
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.4472858905786914,-1.3336441397497936,0.13060428849902533,0.42528888809049153,1.0,10/25,24.46%,GPI;HK1;FOXK1;PKM;PFKP;GAPDH;PGK1;PFKL;PGAM1;ENO1
prerank,negative regulation of receptor binding (GO:1900121),-0.5642669673641993,-1.3327941397481238,0.13274336283185842,0.4265249568664064,1.0,3/10,6.03%,B2M;ADAM15;ATP2A3
prerank,intestinal absorption (GO:0050892),-0.5216490841844263,-1.3327625697142353,0.13274336283185842,0.4258402562203606,1.0,3/13,5.02%,F11R;TJP2;KCNQ1
prerank,regulation of chondrocyte differentiation (GO:0032330),0.45520651444517646,1.332407675050042,0.14775160599571735,0.5529078940258123,1.0,6/24,8.47%,ADAMTS12;TRPS1;LOXL2;TGFBR1;SOX5;SCIN
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5629605867147387,1.3322670771089453,0.15777777777777777,0.5516134316346737,1.0,3/10,5.80%,HECW2;ATP1A2;HECW1
prerank,regulation of chemokine production (GO:0032642),-0.40669308993901876,-1.3316357530535083,0.10444874274661509,0.4277079923910382,1.0,8/36,14.43%,FOXP1;APP;IL33;TLR3;CD74;TLR4;CSF1R;SIGIRR
prerank,regulation of viral genome replication (GO:0045069),-0.3733490176467325,-1.3313814332858718,0.06944444444444445,0.4275767331092283,1.0,16/56,18.10%,IFIH1;ADAR;PPIA;CNOT7;IFITM1;IFITM3;N4BP1;SRPK1;IFITM2;IFIT1;FAM111A;MAVS;STAU1;NR5A2;OAS2;RSAD2
prerank,sprouting angiogenesis (GO:0002040),0.38639838705444907,1.331265559254754,0.08108108108108109,0.5525291732006046,1.0,6/51,2.79%,CCBE1;ROBO1;NRP1;SEMA5A;RECK;VEGFB
prerank,cAMP-mediated signaling (GO:0019933),0.47046587201382317,1.331075510499598,0.12984054669703873,0.551287287310325,1.0,4/24,1.77%,ADCY2;ADCY1;KSR1;PDE7B
prerank,negative regulation of response to stimulus (GO:0048585),-0.37274835018661634,-1.330480595728833,0.07962962962962963,0.4288887566628147,1.0,15/60,12.89%,CDK6;CD34;MAP2K5;KLF4;SLIT2;COL3A1;KLF7;LPCAT3;MAP3K3;IGFBP3;AQP11;TWIST1;PIM3;KIF26A;ACVR1
prerank,endocytic recycling (GO:0032456),-0.38550076501331376,-1.3294497496210695,0.08333333333333333,0.4307252217687818,1.0,28/50,38.16%,EHD4;DENND1A;VPS53;DENND1B;EHD2;LMTK2;RAB11B;RAB7A;RAB11FIP3;SNF8;VPS29;EHD1;EHD3;CCDC22;SNX3;ANKRD50;ARL4C;MICALL2;EPS15;VPS26C;SNX12;ENTR1;CMTM6;SNX27;DENND1C;SNX17;RAB17;WASHC1
prerank,negative regulation of myotube differentiation (GO:0010832),-0.5436956119326914,-1.3293110060309692,0.13636363636363635,0.4303042241072905,1.0,3/12,7.83%,NOTCH1;CCN3;HDAC4
prerank,smooth muscle cell differentiation (GO:0051145),-0.5424957675837044,-1.328475109243453,0.13138686131386862,0.4314983571924361,1.0,6/12,17.34%,MEF2C;MRTFB;GATA6;TMEM204;HEY1;MRTFA
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.34189695689769123,-1.3281238536647306,0.05652173913043478,0.4315697371858509,1.0,34/86,23.92%,KLF2;EGLN3;UBB;UBC;RPS27A;VEGFA;ATF4;EGLN2;PSMA6;PSMB5;PSMC4;EGLN1;LIMD1;IMPACT;PSMC5;PSMD14;RBX1;PSMD8;PSMC1;PSMB4;HSPA1A;PSMD11;PSMD12;CHEK1;ELOB;HIGD1A;PSMA1;PSMC3;PSMB1;ATF3;PSMA2;PSMA4;DNAJB1;HIF1AN
prerank,positive regulation of innate immune response (GO:0045089),-0.42965369664383324,-1.3275008126258854,0.10453648915187377,0.43226210979173973,1.0,9/30,16.33%,LBP;GBP5;NLRC5;RPS19;DHX9;MAVS;TRIM62;AKIRIN2;SLC15A4
prerank,endocardial cushion morphogenesis (GO:0003203),-0.4940398754251554,-1.3272417673081878,0.12710280373831775,0.4321504513694238,1.0,9/18,14.29%,NOS3;NOTCH1;TGFBR2;TGFB2;TBX2;HEYL;ENG;ACVR1;HEY1
prerank,positive regulation of catalytic activity (GO:0043085),-0.41025089049438507,-1.3271448570727973,0.09826589595375723,0.4316510088625409,1.0,11/37,15.24%,CAV1;MAPK3;BCAS3;PSENEN;PHACTR4;ABL2;CIB1;FXN;APH1A;CHTOP;NOD2
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.524993224083182,-1.327004477751536,0.17782026768642448,0.43123874603311035,1.0,7/13,24.41%,RACK1;DDRGK1;HSPA5;UFL1;BFAR;NCK1;PTPN1
prerank,positive regulation of kinase activity (GO:0033674),0.3421863380990033,1.3268035345660114,0.0784313725490196,0.5608644874880427,1.0,31/107,13.77%,EPHA7;DDR2;NTRK3;FGFR2;PDGFRA;KIT;PRKAG2;EPHA3;EPHA6;LMO4;DDR1;AXL;PDGFRB;EPHB1;ROR1;RYK;ERBB3;FGFR4;EPHA8;ERBB4;EPHA5;ALK;SNX9;MUSK;MST1R;MERTK;FGFR1;EPHA1;NBN;DAXX;MAPT
prerank,cardiac muscle contraction (GO:0060048),0.42599696580957913,1.3258141212141377,0.12526539278131635,0.5617335867779029,1.0,6/34,3.86%,ATP1A2;SLC8A1;SCN3B;TNNC1;TNNI3;CSRP3
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.5238985297403695,-1.3254893811116055,0.12810707456978968,0.43408917265068686,1.0,6/14,22.11%,CD55;TGFBR2;CD81;SYK;LGALS9;PTPN22
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.547988199108656,-1.3254122513347495,0.12966252220248667,0.4335137177363251,1.0,11/11,45.25%,CYC1;UQCRQ;UQCRB;UQCR11;UQCRH;UQCC3;UQCRFS1;UQCRC2;UQCRC1;UQCR10;CYCS
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.4833791759107843,1.3251156699990414,0.14193548387096774,0.5619026568693019,1.0,2/17,2.75%,BMP6;PRKCA
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.41098018749427134,1.3250941543914454,0.10570824524312897,0.5602505691665015,1.0,7/43,10.36%,ENPP1;PID1;PIP4K2A;AHSG;IGF2;PRKCB;PIP4K2B
prerank,positive regulation of protein secretion (GO:0050714),0.361898258866859,1.3246773023563865,0.08979591836734693,0.5596594208407751,1.0,4/69,0.70%,IGF1;BMP6;TCF7L2;WLS
prerank,cellular response to oxygen levels (GO:0071453),-0.567818715228587,-1.3241476986722092,0.14411247803163443,0.43585023821685087,1.0,7/10,31.65%,ATP6V0A2;NDUFS2;ATP6V1G1;ATP6AP1;ATP6V0D1;CCDC115;CPEB4
prerank,positive regulation of phospholipase C activity (GO:0010863),0.40588247720992043,1.323544958194118,0.09959349593495935,0.5608910785649727,1.0,11/40,12.66%,ARHGAP6;LPAR1;NTRK3;PDGFRA;KIT;GPR55;PDGFRB;ANG;FGFR1;GNA15;ITK
prerank,negative regulation of programmed cell death (GO:0043069),-0.2825852527178112,-1.32302756290233,0.009009009009009009,0.4378570361521196,1.0,114/355,22.96%,MECOM;LEF1;TEK;IGF1R;THBS1;TPT1;TAX1BP1;PTK2B;KDR;NFKBIA;FOXO1;TFRC;PTK2;RNF144B;RPL10;RPS6KA3;CARD14;ANXA1;CD44;NGF;SOCS2;TMBIM4;ARHGDIA;UBB;ADAM10;CD38;UBC;RPS27A;PTMA;SMAD6;VEGFA;TNFAIP8;RHBDD1;UFM1;IKBKB;SH3RF2;DCPS;SHC1;HSPB1;PRKDC;GATA6;ANXA4;RIPK1;FLT4;PLK2;KANK2;GLO1;AKT1;DNAJA1;FAS;PIM3;DDRGK1;WNT11;HSPD1;TCIM;CD74;CFL1;GRK5;CIB1;HSPA5;BCL2L1;PSMC5;HTATIP2;SERPINB9;AVEN;COPS5;YWHAZ;RAB7A;HIGD2A;ITCH;DHCR24;FXN;PHB2;BNIP3L;NUAK2;OPN3;FSTL1;HYPK;MET;HNRNPK;GPX4;EGFR;OPA1;GREM1;HSPA1A;HCK;RELA;CRYAB;HSPA9;XBP1;BABAM2;GCLC;RASA1;SOX9;ASNS;LAPTM5;MCL1;TMBIM6;HIGD1A;ANGPTL4;TJP1;FAIM2;THOC6;BFAR;HSPA1B;TAF9;IL6ST;TMEM14A;PLK3;TRIAP1;API5;PDCD10;BAG1;DSTYK
prerank,plasma membrane repair (GO:0001778),-0.5359237275316608,-1.3226991698883397,0.13259668508287292,0.437953818716298,1.0,8/13,31.28%,AHNAK2;MYOF;DYSF;ARL8B;MYH9;SMPD1;SYT7;RAB3A
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.36975746168735524,-1.3224655279496855,0.06786427145708583,0.4377395269678606,1.0,10/62,7.14%,MEF2C;CDK6;THBS1;TNRC6C;PTK2B;KMT2C;RBBP5;ZBTB16;MYL9;CBFB
prerank,positive regulation of biosynthetic process (GO:0009891),0.4063341646759569,1.3223148770857804,0.12008281573498965,0.5626740342261278,1.0,6/40,3.78%,WNT4;ZBTB20;PPARA;SLC5A3;CREB3L1;LARP6
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.48596104879477214,-1.322308799110959,0.13636363636363635,0.4373944242619388,1.0,11/17,32.78%,COX4I1;COX7C;COX6B1;COX15;COX6C;NDUFA4;COX10;COX8A;COX4I2;COX7A2L;COX5B
prerank,sensory perception of smell (GO:0007608),0.569677230149764,1.3222295880416617,0.1650943396226415,0.5612192106499667,1.0,4/11,14.70%,OMP;SLC24A4;UBR3;DRD2
prerank,ceramide catabolic process (GO:0046514),-0.5064955756642254,-1.3214385769626673,0.13609467455621302,0.4386773010272955,1.0,10/14,35.42%,ACER2;HEXA;ASAH2;ACER3;NEU3;NEU2;NAGA;NEU1;HEXB;NEU4
prerank,regulation of Rac protein signal transduction (GO:0035020),0.49867408813115743,1.3213329761856598,0.15367483296213807,0.5619296884694212,1.0,2/16,5.95%,AUTS2;ARHGAP24
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5009549814666711,-1.3213059593264187,0.1400709219858156,0.43824372638108966,1.0,4/16,23.38%,CLDN5;CLDN11;CLDN10;CLDN1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.522261506861153,-1.3207800760135529,0.13123844731977818,0.43872383014797334,1.0,7/14,33.38%,HTT;PRKAR2B;PRKAR2A;RAPGEF2;PKIG;ADRB2;PKIB
prerank,cGMP-mediated signaling (GO:0019934),0.5286581735139081,1.3205448769159114,0.1688888888888889,0.5624844893249311,1.0,1/13,0.05%,IRAG1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.42217123317913086,1.3202804697046029,0.11739130434782609,0.5615630178201446,1.0,6/35,6.28%,HMGCLL1;ACSS3;PAM;ALOX12;GGT7;SCD5
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.5579381727861055,-1.3202290818112885,0.1436077057793345,0.4392842008903691,1.0,9/11,39.47%,SCARB1;MFSD2A;NR1H2;CNEP1R1;SREBF1;SLC27A1;LDLR;CTDNEP1;PLIN5
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.37290100912367513,-1.3201275577786904,0.0872093023255814,0.43879535023665495,1.0,17/57,17.20%,MAP3K5;NOD1;ARL6IP5;REST;TNFSF10;CASP8;PPM1F;PERP;NDUFA13;SOX7;CTSD;SYK;BAK1;AIM2;BCAP31;BAD;FOXL2
prerank,gastrulation (GO:0007369),-0.5013236191042769,-1.31954392280077,0.14953271028037382,0.4395013977905185,1.0,5/15,24.00%,GPC3;LRP5;TASOR;SMAD2;MKKS
prerank,hyaluronan catabolic process (GO:0030214),0.48528903113949473,1.3194522605583865,0.15126050420168066,0.56196999685225,1.0,3/18,1.38%,CEMIP;HYAL3;SPAM1
prerank,positive regulation of cation channel activity (GO:2001259),-0.3960646902084178,-1.3192830405824003,0.10526315789473684,0.43942513537633854,1.0,15/40,27.52%,TMSB4X;SHANK3;CALM1;HTT;JPH2;AKAP6;GSTM2;CALM3;KCNIP2;PKD2;CASQ1;ATPSCKMT;CCL2;CTSS;GSTO1
prerank,protein localization to cell periphery (GO:1990778),-0.319960166053398,-1.3192583271538734,0.03643724696356275,0.4387429047287106,1.0,47/133,19.77%,CAV1;BSG;RAP1A;CDH1;TSPAN5;EFR3B;SPTBN1;RAB11A;F11R;RAMP2;EHD4;KCNB1;RAB8B;PACS1;CD81;EZR;IKBKB;EHD2;ATP1B1;JUP;FLOT1;S100A10;EMP2;RAB8A;TSPAN14;FCHO2;CACNB3;SLMAP;TNFRSF1A;SMURF1;TMEM88;TSPAN17;EPHA2;PACSIN1;AP4M1;FLOT2;RAMP1;RABEP1;RAB40B;PIGW;PRAM1;EHD1;EHD3;KCNB2;FYB2;PLEKHF1;RAPGEF2
prerank,heart development (GO:0007507),-0.316138201922252,-1.3182415208540945,0.04831932773109244,0.4405263275915755,1.0,30/150,5.80%,FN1;TEK;PLCE1;MEF2C;HEG1;CXADR;GPC3;NOTCH1;TGFBR2;BMPR2;MEF2A;RAMP2;TBX1;PTK2;SOX17;COL3A1;PDLIM1;CDKN1B;RBM20;TGFB1;FKBP1A;TGFB2;HDAC9;TBX2;NDUFV2;CRIP1;PKD1;STRA6;MICAL2;VEGFA
prerank,mitochondrion localization (GO:0051646),-0.4761350415524171,-1.318089688638593,0.12797074954296161,0.440136015849701,1.0,7/19,21.45%,TRAK1;MEF2A;TRAK2;NECTIN2;MTM1;BRAT1;TLE6
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.43870553577938265,-1.3180640977995266,0.12686567164179105,0.43944832202981127,1.0,13/25,29.75%,FOXO3;ETS1;PRKDC;TAL1;INHBA;HSPA1A;FAM210B;STAT1;HSPA1B;MAPK11;HMGB2;ABCB10;ANKRD54
prerank,inorganic cation transmembrane transport (GO:0098662),0.2966291393168798,1.317739424094025,0.029684601113172542,0.5649439183019924,1.0,39/268,9.95%,SLC1A3;KCNK2;ATP1A2;NALCN;SLC24A3;SCN7A;ATP6V0A4;SLC6A12;SLC8A1;SLC6A9;SLC6A13;SLC24A5;SCN3B;SLC30A10;ABCB8;ATP2A2;P2RX4;TRPM1;TRPM3;CCDC51;SLC39A6;SCN3A;SLC36A2;SLC9A7;KCND2;TRPM5;KCNJ16;TRPA1;ASIC2;CACNA1G;SCN2A;SLC41A1;SLC6A11;KCND1;DMAC2L;ATP6V1H;SLC6A1;SLC24A4;SLC24A2
prerank,filopodium assembly (GO:0046847),-0.4976280637907275,-1.31745513197555,0.1383177570093458,0.44029430066247427,1.0,6/16,10.17%,FGD5;DNM3;FGD6;EZR;SPATA13;SPEF1
prerank,negative regulation of apoptotic process (GO:0043066),-0.2770105130506477,-1.3163495844081714,0.0,0.4423109333733184,1.0,130/444,21.20%,PRKCH;LEF1;TEK;MEF2C;CAV1;IGF1R;THBS1;TPT1;NOTCH1;TAX1BP1;PTK2B;MAP2K5;KDR;NFKBIA;KLF4;FOXO1;MAPK3;TFRC;TBX1;PTK2;RNF144B;RPL10;RPS6KA3;CARD14;ANXA1;CD44;NGF;SOCS2;TMBIM4;SIX1;ARHGDIA;UBB;NR4A2;ADAM10;PPARGC1A;CD38;UBC;RPS27A;PTMA;SMAD6;VEGFA;TNFAIP8;RHBDD1;UFM1;IKBKB;SH3RF2;SHC1;HSPB1;TOX3;PRKDC;GATA6;TGFB3;FOXQ1;ANXA4;RIPK1;FLT4;GPX1;PLK2;ASAH2;GLO1;AKT1;FZD3;DNAJA1;RB1;FAS;PIM3;DDRGK1;WNT11;SFPQ;HSPD1;TCIM;CD74;CFL1;GRK5;CIB1;HSPA5;BCL2L1;MAEA;BEX3;HTATIP2;SERPINB9;AVEN;COPS5;YWHAZ;HIGD2A;ITCH;DHCR24;FXN;PHB2;APOE;BNIP3L;NUAK2;PIK3CA;OPN3;CLCF1;FSTL1;HYPK;HNRNPK;CX3CR1;EGFR;OPA1;IGBP1;GREM1;HSPA1A;CSNK2A1;CSNK2A2;HCK;RELA;AGAP2;CRYAB;HSPA9;XBP1;BABAM2;GCLC;RASA1;SOX9;ASNS;MCL1;TMBIM6;PTRH2;HIGD1A;ANGPTL4;TJP1;FAIM2;THOC6;SFN;HCLS1;BFAR;HSPA1B;TAF9
prerank,sulfur amino acid metabolic process (GO:0000096),-0.4452891847821314,-1.3161380386095056,0.11173184357541899,0.4421139045997682,1.0,10/24,25.22%,MTR;TXN2;CDO1;MSRA;SMS;CTH;GCLC;ADI1;AHCY;MTRR
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.4919929986368418,-1.3152915648081474,0.13944954128440368,0.4432880936431195,1.0,14/17,47.54%,PVR;LAMP1;NECTIN2;RASGRP1;AP1G1;CADM1;SLAMF6;CD226;IL12A;CRTAM;KLRD1;CD160;KLRK1;IL12B
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3315558026407658,-1.315243132213796,0.07042253521126761,0.442654385130001,1.0,38/104,22.71%,CRIM1;CAV1;BMPER;NOTCH1;TGFBR2;BMPR2;CCN3;SMAD9;SMAD7;ZBTB7A;PRDM16;TGFB1;FKBP1A;UBB;UBC;RPS27A;CD109;SMAD6;ASPN;IL17RD;HTRA4;SKIL;HTRA3;ACVR1;SMURF1;EID2;SMAD4;GREM1;HSPA1A;SKI;SPRY1;PIN1;BMPR1B;BAMBI;SMAD2;VEPH1;SPRED3;PEG10
prerank,regulation of protein kinase B signaling (GO:0051896),0.3098768025943348,1.3148195180045807,0.04826254826254826,0.5712474256732858,1.0,36/193,10.32%,TCF7L2;PIK3R1;AREG;NTRK3;FGFR2;SEMA5A;NRG1;MAGI2;PDGFRA;KL;PPARA;KIT;PDPK1;OSBPL8;TGFA;P2RX4;NRG4;NRG2;MYORG;IRS2;IAPP;AXL;PDGFRB;RTN4;CALCR;TGFBR1;RRAS;THPO;ERBB3;IGF2;IL18;FGFR4;GATA3;MYDGF;ERBB4;PTEN
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.5542008228816022,-1.314486213723695,0.13618677042801555,0.4438581081778891,1.0,5/11,20.08%,F11R;TJP2;RAB1A;RAPGEF2;TJP1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.3298963344638235,-1.3133834579998558,0.04743083003952569,0.44587111800890505,1.0,29/108,12.59%,MAP3K5;ACER2;RACK1;NOD1;ARL6IP5;F3;EGLN3;RPS3;NGF;CRADD;REST;TNFSF10;HIP1R;ATP2A3;CASP8;RIPK1;PPM1F;NDUFA13;SOX7;BAX;CTSD;FAS;HIP1;HSPD1;RPS27L;VCP;BEX3;SYK;BBC3
prerank,negative regulation of multicellular organismal process (GO:0051241),0.30673677529193444,1.3132971466947807,0.03333333333333333,0.5736263307129378,1.0,28/199,7.89%,ALDH1A1;ROBO1;LGR4;BMP2;PLCL1;LDLRAD4;NOVA1;BMP5;GJA1;ADAMTS5;TBX18;ROCK2;LRP4;SFRP1;WWC1;MCC;ADM;ACTN3;IL4;NLRP12;NPTN;PLCL2;FOXA2;LOXL2;ACOT11;SFMBT1;DOCK7;RBPJ
prerank,regulation of chromatin binding (GO:0035561),-0.559184146951116,-1.31300000729514,0.12867647058823528,0.4460805411480494,1.0,6/10,34.24%,HMBOX1;WAPL;BTAF1;DTX3L;PARP9;MED25
prerank,monocyte chemotaxis (GO:0002548),-0.41652863966328446,-1.312140857805657,0.12121212121212122,0.44745675235776744,1.0,5/32,8.71%,FLT1;ANXA1;RPS19;TNFRSF11A;CCL15
prerank,phosphatidylserine metabolic process (GO:0006658),0.4202939859363321,1.3113154997425007,0.12550607287449392,0.5773135871267345,1.0,4/32,3.16%,PLA2G5;OSBPL10;PLA2G4A;OSBPL8
prerank,sphingolipid catabolic process (GO:0030149),-0.5023172935311655,-1.311099239820073,0.15619047619047619,0.4493912903455832,1.0,5/15,13.30%,ACER2;ASAH2;SMPDL3A;ACER3;SGPL1
prerank,DNA replication initiation (GO:0006270),0.4122442378255674,1.3105130916097567,0.1257606490872211,0.5778026480609595,1.0,14/37,22.61%,MCM3;ORC4;RPA2;MCM2;MCM8;ORC1;POLE4;RPA1;ORC3;ORC5;CDC7;PRIM1;PRIM2;MCM7
prerank,synaptic vesicle cycle (GO:0099504),0.42927630083214197,1.3101259686113478,0.12526997840172785,0.5771125631970833,1.0,9/30,16.27%,RIMS1;SYNDIG1;CPLX2;OTOF;SNAP25;NLGN1;BRSK1;SNAPIN;PLD2
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.39243104622520764,1.31011609067574,0.09514563106796116,0.5754687915424392,1.0,10/46,11.61%,IGF1;TCF7L2;CCN4;PDGFRB;OGN;IL18;HES5;ANG;IL6R;PTGIR
prerank,blood vessel morphogenesis (GO:0048514),0.38058664050389956,1.310041203095698,0.11717171717171718,0.5740177607539482,1.0,10/54,7.89%,CCBE1;LAMA1;TGFBR3;NRP1;TNNI3;TGFBR3L;ADM;GLMN;TGFBR1;RBPJ
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.4835826828760426,1.30989337966945,0.16810344827586207,0.5728131121821535,1.0,2/17,0.31%,ROBO1;NRP1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.42037929965452886,1.309663435772568,0.11060948081264109,0.5717951858949443,1.0,7/33,10.32%,IGF1;PIK3R1;MYO16;SIRT2;ERBB3;GATA3;PTEN
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5618655062276517,1.3095792231392294,0.17045454545454544,0.5703407904500353,1.0,3/11,6.02%,PPARA;SLC30A10;ABCD2
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.3486699477661384,-1.3090146481253948,0.07722772277227723,0.45376779366223996,1.0,23/72,22.40%,ACER2;RPL26;CRADD;CDKN1B;CNOT7;RGCC;PLAGL1;PLK2;PCBP4;BAX;RPS27L;SOX4;E2F1;CDKN1A;E2F4;GADD45A;CNOT11;SFN;E2F7;SESN2;PLK3;TRIAP1;CNOT3
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.4441132602704159,-1.3088664438268942,0.12075471698113208,0.4533470258889024,1.0,11/26,19.64%,EEF1A1;IQGAP1;DAB2IP;PDE8A;DUSP3;ERBB2;PTPN12;EGFR;ZPR1;SOX9;KNSTRN
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.3883884170082922,-1.3086842116332658,0.11623246492985972,0.45307285304258377,1.0,18/48,20.42%,HIPK1;FNIP2;CRIP1;PRKDC;TNFRSF1B;DYRK2;BAX;RPS27L;BCL2L1;BAK1;E2F1;TMEM109;AEN;EPHA2;DDIT4;PHLDA3;MCL1;SFN
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.5013382488770268,1.3085825936931603,0.1788793103448276,0.5713048285882397,1.0,5/18,11.17%,CAMK1D;ADCY1;LPAR5;EPHA5;ADCY8
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.3520811927640858,-1.3081962843682897,0.08964143426294821,0.453466077001053,1.0,36/70,35.69%,B2M;NCF2;TAPBP;IKBKB;PSMA6;PSMB5;FCER1G;PSMC4;PSMC5;PSMD14;LNPEP;PSMD8;PSMC1;PSMB4;PSMD11;PSMD12;TAP2;CHUK;CYBB;PSMA1;PSMC3;PSMB1;PSMA2;PSMA4;PSMB8;CD36;PSMC6;PSMD6;SEC22B;IKBKG;PSMA8;NCF1;PSMB2;PSMD2;SNAP23;ITGAV
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.3522006648198559,-1.3080376015284858,0.06412825651302605,0.453115541376352,1.0,27/73,23.36%,KITLG;LMO2;GATA2;PRKDC;CBFB;PSMA6;PSMB5;TAL1;PSMC4;PSMC5;YTHDF2;PSMD14;ITCH;LDB1;PSMD8;SETD1A;PSMC1;PSMB4;PSMD11;PDCD2;PSMD12;TCF3;PSMA1;PSMC3;PSMB1;PSMA2;PSMA4
prerank,outflow tract septum morphogenesis (GO:0003148),0.44659851491345504,1.3075530605775878,0.1314655172413793,0.5725343844241495,1.0,4/24,1.12%,ROBO1;NRP1;ROBO2;FGFR2
prerank,positive regulation of histone acetylation (GO:0035066),-0.44312714786282514,-1.3074525584690744,0.13043478260869565,0.45379077421319586,1.0,7/23,15.07%,RPS6KA5;MAPK3;PPARGC1A;TADA2B;WBP2;SPHK2;SMAD4
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3208825563788269,1.3073025598118397,0.043052837573385516,0.5715951539750127,1.0,26/150,8.37%,ENPP1;PPM1E;ERRFI1;PID1;PTPN13;LDLRAD4;NTRK3;FBLN1;PDPK1;PRKAG2;DEPTOR;SFRP1;LYN;GPD1L;PMEPA1;CEP85;PRKN;NLRP12;GSTP1;PLPP3;IBTK;SIRT2;TRIM27;MEN1;CEP43;NLRP2B
prerank,limb development (GO:0060173),0.4311589181888668,1.3071926923778046,0.13577586206896552,0.5702286690548785,1.0,6/28,6.74%,SALL1;CHD7;LRP4;GLI3;ZNRF3;IFT122
prerank,protein phosphorylation (GO:0006468),-0.2741076627135056,-1.3060252914862525,0.0,0.45661835874420825,1.0,126/478,17.39%,PRKCH;TEK;ERG;FLT1;IGF1R;CDK6;MAP3K5;RPS6KA5;PRKG1;CDK17;TGFBR2;MAP4K3;PTK2B;BMPR2;LIMK2;KDR;HIPK1;PEAK1;NLK;MAPK3;WNK1;BMX;PTK2;STK10;NEK7;RPS6KA3;DAB2IP;SMAD7;CAMK2D;MAP3K1;RICTOR;MAP3K20;FNIP2;MAPKAPK3;APP;TGFB1;TGFB2;MAP3K3;FAM20A;ADAM10;PRKCZ;CSNK1G2;PKD1;MINK1;IGFBP3;CTBP1;NRBP1;TAOK3;IKBKB;RARA;CSNK1G3;ABI3;BCR;PRKDC;SRPK1;TLR3;RIPK1;FLT4;TRIB2;INSR;DYRK2;STK25;PLK2;AKT1;MAP3K11;GTF2H3;CDC42BPB;STK32B;PIM3;CSNK2B;LMTK2;VRK3;TRIB1;WNT11;TAOK2;CAMK1;CDK4;ABL2;RPS6KB2;VRK1;ULK3;GRK5;STK38;PRKCE;PKN3;HTATIP2;TLR4;PPP3CB;FRK;YWHAZ;SYK;STK36;CSF1R;ACVR1;RPS6KA2;FASTK;CDKL4;CDK10;USP15;TBCK;CAD;UHMK1;NUAK2;ABI1;ERBB2;LMTK3;COQ8A;LIMK1;PRKAG1;STK38L;CAB39;NEK3;STK26;PTPN6;NUAK1;EGFR;JAK2;MAST4;CSNK2A1;CSNK2A2;CDK13;MAP3K9;JAK3;HCK;GTF2H4;RET
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.38545330123536214,-1.3055131675677814,0.102803738317757,0.4571285546131704,1.0,24/43,31.99%,BRCC3;TAOK3;FOXN3;UIMC1;BABAM1;PABIR1;TAOK2;CDC14B;HUS1;CDKN1A;RAD17;FZR1;CHEK1;BABAM2;CDK5RAP3;DTL;MRNIP;TRIM39;MRE11;INTS3;CDK1;PLK1;CDC6;TICRR
prerank,regulation of response to external stimulus (GO:0032101),-0.31891055456636663,-1.3054310389562216,0.056112224448897796,0.45661187157379984,1.0,31/121,17.88%,FOXP1;CAV1;TMSB4X;SEMA7A;CD55;CYRIB;MGLL;ANXA1;CALM1;IL1R1;N4BP1;BRD4;ERAP1;GATA6;CASP8;PSMA6;ACE2;BCL6;LRP8;TIRAP;DHX58;PIK3AP1;SAMHD1;BCL6B;TRIM5;NOD2;UFL1;JAK2;HCK;RELA;DAGLB
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.4743726069169656,-1.3051787959652605,0.1366223908918406,0.4565405935824132,1.0,4/18,6.10%,CTNNA1;MFHAS1;CHP1;UFM1
prerank,regulation of stem cell proliferation (GO:0072091),0.49428114791692135,1.3047335794988624,0.17926565874730022,0.5750406713926158,1.0,2/17,1.64%,FBLN1;GJA1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.5390054627203162,-1.3043346614215416,0.17647058823529413,0.45788790578398103,1.0,5/11,14.06%,KCNJ2;ATP1A1;KCNQ1;ATP1B1;KCND3
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.485667299321493,1.3043225329117758,0.16252821670428894,0.5745771047983154,1.0,4/16,2.74%,ATP1A2;SLC8A1;ANK2;PRKACA
prerank,regulation of cellular pH (GO:0030641),-0.4218492717667788,-1.3042110223912005,0.12307692307692308,0.45749329678210215,1.0,12/29,27.96%,SLC4A10;SLC9A2;CHP1;ATP5F1B;SLC4A8;SLC4A2;SLC9B1;ATP6AP1;SLC9A5;SLC4A3;SLC9A4;SLC26A6
prerank,calcium ion transport (GO:0006816),0.3313923894228197,1.3042081793869298,0.07662835249042145,0.5732371887146723,1.0,23/113,10.03%,NALCN;SLC24A3;SLC8A1;CACNA1E;SLC24A5;CYP27B1;ITPR1;ANK2;GRIN3A;CACNA2D1;ATP2A2;P2RX4;TRPM1;TRPM3;ORAI2;CACNA1I;TRPM5;TRPA1;CACNA1G;CACNB2;SLC24A4;SLC24A2;CHRNA4
prerank,regulation of isotype switching (GO:0045191),0.5084081653104868,1.303812118361538,0.15584415584415584,0.5726012766498458,1.0,7/14,15.50%,SHLD2;IL4;KMT5C;PAXIP1;PARP3;RIF1;KMT5B
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.549734832755979,1.3036872138084588,0.16017316017316016,0.5713256065713122,1.0,5/11,12.77%,SNX33;LEPROT;TAX1BP3;LEPROTL1;ACTN2
prerank,muscle cell development (GO:0055001),0.41781961959481817,1.30321685125402,0.12783505154639174,0.57092864549567,1.0,6/30,3.57%,IGF1;SGCZ;SLC8A1;EFEMP2;ANK2;MEGF10
prerank,myotube cell development (GO:0014904),0.5571075673320894,1.3023952046848346,0.16382978723404254,0.5715954757213138,1.0,2/10,5.19%,IGF1;MYORG
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.500148875199122,-1.3023210462605697,0.1520572450805009,0.4614247609436439,1.0,7/16,20.78%,BMPR2;PLCB3;PRCP;ACE;GPR37L1;SPX;DDAH1
prerank,glycolytic process (GO:0006096),-0.4270153929346652,-1.3019427443574838,0.12375249500998003,0.4615665969939558,1.0,14/28,31.09%,GPI;HK1;PGM1;PKM;GAPDH;LDHA;PGK1;PFKL;PGAM1;PGAM4;ENO1;PFKFB1;PFKFB2;ALDOA
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.3359472264589207,-1.3011646347900079,0.05917159763313609,0.46272142173158465,1.0,18/91,7.03%,ABCG2;SLC39A10;MT1E;MT1F;MT1M;MT1G;MT1H;MT1A;MT1X;MT1B;ATOX1;TFRC;MT2A;APP;SLC39A8;SLC40A1;ATP6V0A2;FTL
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.40995715437966573,-1.3009716693847515,0.12121212121212122,0.4625708318684121,1.0,18/29,42.42%,HSP90AB1;NLRC5;CNOT7;MAVS;YTHDF2;SAMHD1;PTPN6;TTLL12;PTPN1;MUL1;PTPN2;YTHDF3;USP18;IFNAR2;CACTIN;OAS3;CDC37;STAT2
prerank,anion transmembrane transport (GO:0098656),0.3595551705650528,1.3009440625789255,0.11482254697286012,0.5740037919322105,1.0,11/67,7.55%,SLC1A3;SLC13A3;SLC16A12;SLC7A2;SLC6A9;SLC6A13;SLC13A4;MFSD12;SLC25A10;SLC25A13;SLC25A42
prerank,regulation of NMDA receptor activity (GO:2000310),0.41905946234845226,1.300385920494593,0.12526096033402923,0.5738493810060219,1.0,13/32,14.82%,SLC6A9;GRIA4;DLG2;DAPK1;CAMK2B;MAPK8IP2;NLGN1;LRRC7;GRIA3;DLG4;ACTN2;GRIN2A;GRIA1
prerank,regulation of filopodium assembly (GO:0051489),0.39998246353697553,1.300035269375832,0.162839248434238,0.5732176715949304,1.0,7/38,8.00%,PIK3R1;NRP1;DOCK11;GPM6A;TENM2;DPYSL3;NLGN1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.4348182029915157,-1.2998203042814962,0.12035398230088495,0.46464387619775455,1.0,8/26,15.41%,FOXP1;NCOR1;ZBTB7A;HEYL;KANK2;VPS11;SMARCA4;STRN3
prerank,glucose import (GO:0046323),-0.518787677253039,-1.2997848997108417,0.14365671641791045,0.4639845604861072,1.0,6/13,27.79%,SLC2A1;RAB4B;SLC2A3;SLC2A4;SLC2A10;SLC27A1
prerank,vascular transport (GO:0010232),0.34906407308361215,1.2997048815814076,0.1067193675889328,0.5725550363284605,1.0,16/81,5.51%,SLC1A3;ATP1A2;SLC24A3;SLC13A3;SLC16A12;SLC7A2;SLC6A9;LRP1;SLC6A13;SLC2A13;SLC5A3;LEPR;SLC29A1;ABCC2;SLC22A3;SLC38A1
prerank,positive regulation of chemokine production (GO:0032722),-0.38052266726604694,-1.2994741904961375,0.1067193675889328,0.46404214530457577,1.0,11/44,15.74%,APP;IL33;TLR3;TWIST1;CD74;TIRAP;MAVS;TLR4;SYK;CSF1R;IL17RA
prerank,B cell differentiation (GO:0030183),-0.3853436522344902,-1.2992691953142634,0.0925553319919517,0.4637840016028173,1.0,22/46,32.27%,PTPRJ;PLCG2;TPD52;ZBTB7A;HDAC9;IRF2BP2;HDAC4;HHEX;ITGA4;CLCF1;KLF6;JAK3;TCF3;ADGRG3;DCAF1;NFAM1;HDAC5;PTPN2;LYL1;CR2;SYVN1;BLNK
prerank,reticulophagy (GO:0061709),-0.5224995784891084,-1.2988731674661798,0.1480836236933798,0.4640450336425823,1.0,5/12,19.50%,UFM1;DDRGK1;UFL1;UFC1;UBA5
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.4631497479380447,-1.2988730503650399,0.14084507042253522,0.4633049299206643,1.0,6/20,17.61%,CDK6;PTK2B;ZBTB16;CIB1;LDB1;HSPA9
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.5020304394274911,1.2988150451740972,0.17970401691331925,0.5733203380142713,1.0,6/16,10.22%,IGF1;TGFBR3;FGFR2;RBPJ;BMPR1A;ERBB4
prerank,phospholipid translocation (GO:0045332),-0.42341380436322984,-1.2982545194080717,0.13793103448275862,0.46422317997710727,1.0,8/28,8.63%,ANO6;ATP10A;ATP8A1;ATP8B1;ATP11C;ATP11A;MFSD2A;ATP9B
prerank,organic acid transport (GO:0015849),0.34551502954633784,1.2980257375736464,0.07630522088353414,0.5737303503485799,1.0,18/94,8.74%,SLC7A11;SLC13A3;SLC6A12;SLC7A2;SLC43A1;SLC6A13;NCOA2;SFXN5;ABCC2;ACSL1;SLC36A2;SLC26A1;SLC38A1;SLC7A9;SLC25A10;SLC10A1;SLC25A47;NCOA1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.520591518662299,-1.297650346616407,0.16546762589928057,0.4650309596283832,1.0,9/13,34.32%,SVIP;UBE2G2;BCAP31;DERL2;EDEM2;ERLEC1;BRSK2;EDEM1;OS9
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.3330929593185204,-1.2974516940297576,0.060362173038229376,0.4647842151371529,1.0,34/101,17.76%,THBS1;VIM;RPL26;NFKBIA;KLF4;EEF2;NIBAN1;RPS4X;TGFB1;MSN;EZR;PRKDC;CASP8;PERP;AKT1;PTTG1IP;ATG7;EIF3D;RPS27L;LARP4B;INHBA;CIRBP;UPF3A;SOX4;BAK1;FMR1;VPS11;ERBB2;NR1H2;HSP90AA1;BAD;PCIF1;IST1;ZCCHC4
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.33137045759011513,-1.297286674276468,0.05858585858585859,0.46444739695640913,1.0,27/98,16.87%,SLCO1C1;THBS1;TGFBR2;NFKBIA;PPARD;KLF4;RNF41;TGFB1;ANXA2;VEGFA;ACLY;CHCHD2;RIPK1;INSR;AKT1;IFNAR1;ACE2;INHBA;AGPAT1;FMR1;APOE;RAB1A;NR1H2;CDKN1A;CBR1;GREM1;NSF
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.32587706278132844,-1.2972427947625205,0.061507936507936505,0.4638358801612391,1.0,46/96,34.22%,HNRNPA2B1;SRSF5;SRSF2;NUP93;SRSF6;HHEX;NUP54;NDC1;U2AF1;ZC3H11A;RNPS1;SRSF4;MAGOH;NUP188;CHTOP;NUP155;RANBP2;ALYREF;DDX39B;AGFG1;NUP37;CASC3;CPSF4;THOC6;SMG7;NUP160;DDX39A;NCBP2;SMG1;NUP43;SEH1L;EIF4E;NUP42;SEC13;NUP107;NUP98;THOC7;UPF1;SRSF9;GLE1;U2AF1L4;UPF3B;SMG6;RBM15B;SRSF1;NUP88
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.5037528260107796,1.2970608888664326,0.17634408602150536,0.5747998091025007,1.0,2/15,5.78%,IGF1;PRKN
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.4970219692872025,1.2969625074603113,0.18340611353711792,0.5734824552819425,1.0,4/15,13.72%,SH3D19;SNX33;SNX9;NRDC
prerank,regulation of protein localization to membrane (GO:1905475),0.4303146249313422,1.2969372609296055,0.13709677419354838,0.5719935633510823,1.0,8/28,10.48%,GPC6;AR;SLC5A3;GPC4;GPC2;PRKN;STX7;GPC5
prerank,programmed necrotic cell death (GO:0097300),-0.4653775166493803,-1.296689170217887,0.14842300556586271,0.46445984118190087,1.0,7/18,17.48%,TRPM7;IPMK;TLR3;RIPK1;TLR4;PGAM5;MLKL
prerank,vasculogenesis (GO:0001570),-0.4095038787309527,-1.2963696413007666,0.11507936507936507,0.46448321476342314,1.0,9/32,5.80%,CAV1;NOTCH1;TGFBR2;RASIP1;KDR;RAMP2;SOX17;TGFB1;VEGFA
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.5211630317067991,1.2957526432185873,0.18995633187772926,0.5734108994998912,1.0,1/13,0.09%,IGF1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.31027136242035686,-1.2952040987689148,0.04365079365079365,0.4666155359838197,1.0,49/145,22.58%,RAB11A;FHL1;DCTN2;TUBA1A;CEP164;PPP2R1A;PRKAR2B;CEP57;CEP192;BRD4;PSMA6;PSMB5;CEP70;DCTN3;CEP290;DCTN1;PSMC4;CDK4;CNTRL;PSMC5;TUBB4B;RCC2;AVEN;PCM1;PSMD14;HAUS1;NDE1;RBX1;PSMD8;FBXL7;CETN2;CEP72;PSMC1;YWHAG;HSP90AA1;PSMB4;PSMD11;PSMD12;CEP41;CUL1;CCND1;PSMA1;PSMC3;TPX2;TUBA4A;CENPF;PSMB1;PSMA2;DTL
prerank,organelle fission (GO:0048285),-0.43510971897558665,-1.2951634117153024,0.1553030303030303,0.46597921656565444,1.0,14/24,27.81%,DNM3;MIEF1;MTFR1;WASHC5;ACOT8;OPA1;DNM1;DNM2;MTFR2;PEX11G;FIS1;PEX11A;MFF;MUL1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.561347116300098,-1.2950754424113418,0.17391304347826086,0.46546009498466345,1.0,1/10,0.34%,CAV1
prerank,regulation of protein transport (GO:0051223),-0.4175355756375681,-1.295039671298308,0.1252408477842004,0.46483656722565486,1.0,14/27,31.06%,WWP2;HSPA8;CHP1;PPM1F;DNAJA1;NDEL1;SNX3;RHBDF2;PTPN1;NDFIP2;P3H1;NDFIP1;ATP13A2;SNX12
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.48934109982665613,1.294679199198395,0.16666666666666666,0.5746744080094952,1.0,3/16,1.83%,BMP2;SALL1;GDNF
prerank,negative regulation of viral transcription (GO:0032897),-0.5108403658172533,-1.2946595317144456,0.16998191681735986,0.4650296331099516,1.0,4/13,12.57%,MID2;IFITM3;TRIM14;TRIM62
prerank,Ras protein signal transduction (GO:0007265),-0.31693777333996087,-1.2943638382148357,0.05439330543933055,0.46501427446024773,1.0,43/137,16.06%,PLCE1;RREB1;RAP1A;RASGRP3;ARHGEF3;EPS8;RAP1B;RAPGEF1;SHOC2;EPS8L2;ARHGDIA;ARHGAP1;SHTN1;RAC1;RALB;ARHGDIB;SHC1;KRAS;ADGRG1;USP8;GRAP;RIT1;PLK2;RB1;RASSF1;TRIM28;GDI1;RHOB;PHACTR4;CFL1;RTKN;NF1;DBNL;NTN1;HRAS;FGF2;GNB1;CELSR1;RGL2;LIMK1;RAPGEF3;NCKAP1;CDKN1A
prerank,glutathione biosynthetic process (GO:0006750),-0.5346709018127704,-1.2941852090610177,0.13982300884955753,0.4646841407135534,1.0,6/11,29.38%,GCLM;GCLC;CNDP2;GGT1;GGCT;MGST2
prerank,response to unfolded protein (GO:0006986),-0.3711937660465755,-1.2939896114069498,0.11394891944990176,0.4644443344661719,1.0,25/48,29.96%,DAB2IP;HSP90AB1;HSPA8;RHBDD1;HSPB1;DNAJA1;BAX;HSPD1;HSPA5;BAK1;ERP44;HSPB8;HSPA4;HSP90AA1;HSPA1A;HSPA9;TMBIM6;HSPE1;HSPA1B;DNAJB1;PTPN1;STT3B;ERN1;DERL1;HSPA14
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.48201544204702723,1.2938812369164379,0.15466101694915255,0.5752177670151616,1.0,3/16,3.78%,WNT4;CREB3L1;LARP6
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.4445763463454766,-1.293636454246623,0.143646408839779,0.4645654811896132,1.0,3/22,4.15%,IL15;SLC7A5;TGFB1
prerank,renal absorption (GO:0070293),-0.5515177897829359,-1.2935924670768377,0.1720226843100189,0.46394737141291487,1.0,6/10,34.04%,KCNQ1;KLHL3;SLC15A2;HAS2;HYAL2;WNK4
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.3464708302019873,-1.2934631002295034,0.08506224066390042,0.4635338330936779,1.0,21/70,16.72%,HIPK1;DAB2IP;NGF;CRADD;RNF41;TGFB1;TGFB2;GABARAP;CASP8;TLR3;TNFRSF1B;RIPK1;BAX;FAS;INHBA;CIB1;BCL2L1;BAK1;TNFRSF1A;JAK2;BAD
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.5246103168480536,-1.2934059446412667,0.1800356506238859,0.4629511825476188,1.0,5/12,25.62%,LMO2;CTSB;GAS2L1;RDX;CTSS
prerank,T cell proliferation (GO:0042098),-0.5146316840906949,-1.2933326874548503,0.18267419962335216,0.4624075488418372,1.0,10/13,33.31%,CTPS1;MSN;PPP3CB;PIK3CG;RASGRP1;LILRB1;CADM1;DOCK8;LMBR1L;SLC11A1
prerank,response to interferon-beta (GO:0035456),-0.4463760614379644,-1.2925968606616205,0.14338235294117646,0.46353771764060514,1.0,7/22,18.13%,IFITM1;IFITM3;NDUFA13;IFITM2;UBE2G2;AIM2;STAT1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.38875354213896457,-1.2921914204001375,0.125,0.4638464133764711,1.0,13/38,16.53%,CAV1;CD34;KLF2;KLF4;HSP90AB1;RAC1;EDN1;INSR;AKT1;TLR4;CX3CR1;JAK2;HSP90AA1
prerank,mitotic nuclear membrane organization (GO:0101024),-0.36191597911170204,-1.2914412850776924,0.112,0.46429539847324436,1.0,27/51,31.06%,LBR;PPP2R1A;CHMP2B;NUP93;CC2D1B;NDC1;VRK1;PPP2R2A;NUP188;NUP155;IST1;NUP37;CHMP2A;REEP4;RANGAP1;NUP160;RCC1;NUP43;SEH1L;SEC13;NUP107;VPS4A;NUP98;CHMP7;BANF1;CDK1;UBE2I
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.36191597911170204,-1.2914412850776924,0.112,0.46429539847324436,1.0,27/51,31.06%,LBR;PPP2R1A;CHMP2B;NUP93;CC2D1B;NDC1;VRK1;PPP2R2A;NUP188;NUP155;IST1;NUP37;CHMP2A;REEP4;RANGAP1;NUP160;RCC1;NUP43;SEH1L;SEC13;NUP107;VPS4A;NUP98;CHMP7;BANF1;CDK1;UBE2I
prerank,regulation of developmental growth (GO:0048638),0.42516330040474093,1.2909782890704298,0.13991769547325103,0.5812709728124408,1.0,7/29,10.98%,IGF1;STAT5B;GHR;OLFM1;SIX4;NRCAM;MUSK
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3533247626230546,1.2905481511842782,0.09879032258064516,0.5808656005553653,1.0,15/69,11.68%,IGF1;PIK3R1;PLCL1;PDGFRA;MYO16;IRS2;PDGFRB;PLCL2;SIRT2;PLCH1;ERBB3;GATA3;PTEN;PLCD4;FGFR1
prerank,regulation of intracellular signal transduction (GO:1902531),-0.27494795243335335,-1.2897541139205762,0.006521739130434782,0.4678566591678861,1.0,113/420,19.75%,ARHGAP31;TEK;CHN2;VWF;SGMS1;PPP1R13B;TMSB4X;MCF2L;ARHGEF3;NET1;PLCG2;FGF1;RHOJ;PIP5K1B;OPHN1;RASGRF2;ARAP3;HIPK1;NFKBIA;STARD13;ARHGAP23;MAPK3;STARD8;ARHGAP17;ARHGAP26;PPP1R16B;DAB2IP;ARAP2;PHF20;RICTOR;TMBIM4;RPL11;RNF41;ARHGDIA;ARHGAP1;PDE2A;TRIO;MOB3B;RAC1;ARHGDIB;MINK1;CMKLR1;CHN1;ING5;CRK;ARHGAP25;SOS2;VEGFA;EZR;TAOK3;PRKAR2B;MYOC;USP7;HSPB1;BCR;RASSF2;RAD1;DYRK2;AKT1;NOP2;PIP4P1;RHOT1;CSNK2B;ITSN1;RHOB;MAPKAP1;AKAP6;TAOK2;GMIP;MTA2;RHOT2;MBD3;ULK4;PREX1;ABR;TRAF1;SPHK2;FBXL2;ARHGEF5;TBCK;RAD9B;ARHGEF18;SLC15A2;SMYD2;HUS1;PRKAG1;RPA3;UFL1;NUAK1;EGFR;RAD9A;PIK3R2;DDIT4;PRKAR2A;SLC15A4;RAD17;CSNK2A1;CSNK2A2;RBBP4;RELA;CHD4;ARHGEF17;ECT2;CHEK1;ARHGEF12;L3MBTL1;ARHGEF4;ARHGEF2;ARHGEF6;PIN1;RPL5;DEPDC7;FGD2
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.353392229776796,1.2894797498658863,0.09297520661157024,0.5821425749249579,1.0,13/77,7.80%,IGF1;TCF7L2;AR;BCL2;SH3RF1;CFLAR;PHIP;IL4;PRKN;GSTP1;TGFBR1;SCG2;MAPK8IP2
prerank,Rap protein signal transduction (GO:0032486),-0.5638411485196049,-1.2894404338087648,0.1559633027522936,0.46786888310888936,1.0,6/10,19.77%,RAP1A;RAP1B;RAPGEF1;PLK2;RAPGEF3;RAPGEF2
prerank,neuron migration (GO:0001764),0.37445190597549965,1.2890267707540237,0.11208791208791209,0.581739260756664,1.0,10/48,11.68%,AUTS2;NRP1;SEMA3A;GPM6A;SH3RF1;ASTN2;NRCAM;CDK5R1;LRP12;FGFR1
prerank,selective autophagy (GO:0061912),-0.36068061637292825,-1.2889728906059792,0.11026615969581749,0.46832638516367003,1.0,17/56,19.50%,VIM;MAP1LC3B;UBB;DYNC1LI2;UBC;RPS27A;UFM1;DDRGK1;KLHL3;RAB7A;PHB2;DYNC1LI1;UFL1;UFC1;AMBRA1;DYNLL2;UBA5
prerank,response to calcium ion (GO:0051592),-0.3187444899812395,-1.2883499138615107,0.0784313725490196,0.46918511307553673,1.0,21/102,14.48%,MEF2C;CAV1;ITPKB;CLIC4;THBS1;PLCG2;TRPC3;MEF2A;IQGAP1;CAMK2D;CALM1;ITPR3;CARF;CPNE8;ADD1;SLC25A12;HOMER1;CALM3;SYT2;CASQ2;PEF1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.4947046818576944,-1.288314067314085,0.16757741347905283,0.46855903300500507,1.0,8/16,27.79%,SCARB1;MFSD2A;PNPLA2;NR1H2;DAGLB;CNEP1R1;SREBF1;SLC27A1
prerank,pulmonary valve development (GO:0003177),-0.4661151604702104,-1.2876168620278192,0.15105162523900573,0.46950728859209895,1.0,12/18,14.29%,NOS3;NOTCH1;BMPR2;SLIT2;TGFB2;STRA6;SMAD6;HEYL;TNFRSF1B;NFATC1;TNFRSF1A;HEY1
prerank,blood vessel diameter maintenance (GO:0097746),-0.4025947204171801,-1.2874416321698499,0.14205607476635515,0.4691945388229635,1.0,9/34,18.94%,NOS3;EDNRA;KLF2;NPR1;EDN1;ACE2;ACE;GCLM;GCLC
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.3179530244574763,-1.2872395172175912,0.07510729613733906,0.46896451392086863,1.0,38/113,20.34%,ESR1;RASIP1;UNC13B;RACK1;RAP1B;TFRC;PIEZO1;RPS3;GBP5;DAB2IP;FERMT2;FNIP2;TGFB1;VEGFA;ERCC1;CUL4A;TAL1;GTF2H3;BAX;WARS1;CHD1L;PSMC4;VCP;TIRAP;PSMC5;TLR4;SYK;BAK1;SLF1;RBX1;RPA3;HSP90AA1;GTF2H4;ERCC4;CAPG;BIK;CDH5;PSMC3
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.4349234027732351,-1.2867015644843416,0.16539923954372623,0.46958471223590115,1.0,8/24,15.54%,PTK2B;UBB;PKD1;CTSC;GPX1;PSMD14;APOE;ATP5IF1
prerank,regulation of plasminogen activation (GO:0010755),0.5294620457095951,1.2860041065816226,0.1935483870967742,0.5880188552197202,1.0,3/12,5.86%,CLEC3B;SERPINE2;SERPINE1
prerank,acylglycerol metabolic process (GO:0006639),-0.3947148508128485,-1.2858253088891123,0.11553030303030302,0.47102005137018665,1.0,7/37,9.63%,CAV1;ABHD2;DGKH;MGLL;SEL1L;PNPLA2;PLAAT3
prerank,regulation of ATP metabolic process (GO:1903578),-0.3613265278482761,-1.2858207914441107,0.1047008547008547,0.47032412893257586,1.0,23/54,26.90%,ZBTB7A;UQCC2;NUP93;NUP54;NDC1;SPHK2;NUP188;NUP155;RANBP2;PRKAG1;ATP5IF1;JMJD8;NUP37;SLC25A33;NUP160;FIS1;PGAM1;NUP43;SEH1L;NUP42;SEC13;NUP107;NUP98
prerank,T cell differentiation in thymus (GO:0033077),0.51027285305696,1.2857785092517784,0.15904139433551198,0.5870193048556996,1.0,6/14,20.46%,GLI3;CCR6;RABL3;SHH;FADD;ZFP36L2
prerank,glucan biosynthetic process (GO:0009250),-0.5198304658287765,-1.2854110924118345,0.17190388170055454,0.4699470277072785,1.0,5/12,26.86%,GBE1;PGM1;PPP1R3C;PGM2;GYG1
prerank,glycogen biosynthetic process (GO:0005978),-0.5198304658287765,-1.2854110924118345,0.17190388170055454,0.4699470277072785,1.0,5/12,26.86%,GBE1;PGM1;PPP1R3C;PGM2;GYG1
prerank,positive regulation of cellular component organization (GO:0051130),-0.32195352342257816,-1.2852857304692529,0.058823529411764705,0.46955931932296985,1.0,33/107,13.85%,IGF1R;SHANK3;ATP10A;GPC3;NEDD4L;RACK1;TFRC;RPS3;DAB2IP;FNIP2;TGFB1;TGFB2;CD151;VEGFA;TGFB3;PLEKHM2;INSR;GPX1;TAL1;ADD1;BAX;RB1;WARS1;FLOT1;DCTN1;CAMK1;VCP;TIRAP;SURF4;SYK;BAK1;SLF1;APOE
prerank,cellular response to growth factor stimulus (GO:0071363),-0.3079191413605113,-1.2851403252770262,0.048484848484848485,0.46920032116783483,1.0,32/151,7.73%,MEF2C;FLT1;SEMA6A;RAP1A;EEF1A1;NOTCH1;TGFBR2;RACK1;BMPR2;MAP2K5;KDR;KLF4;MT1G;RAMP2;IQGAP1;TBX1;RAPGEF1;SMAD9;DAB2IP;SMAD7;ANXA1;CD44;TGFB1;PDE2A;LIMS1;VEGFA;SHC1;PDE8A;HSPB1;NR3C1;FLT4;STMN2
prerank,negative regulation of lyase activity (GO:0051350),0.4859439930040062,1.2849736612958942,0.18478260869565216,0.5876897214519685,1.0,4/16,16.27%,ADGRV1;EDNRB;DRD2;LTB4R2
prerank,regulation of necroptotic process (GO:0060544),-0.43425362090452746,-1.2849080163174882,0.13893967093235832,0.46911056972327614,1.0,11/23,21.89%,CASP8;RIPK1;YBX3;FLOT1;SDCBP;HSP90AA1;FLOT2;MLKL;PELI1;ARHGEF2;SLC25A4
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.3615312426740269,-1.2848519077529024,0.09607843137254903,0.46856279039242954,1.0,14/55,13.62%,CAV1;RACK1;TPD52L1;RPS3;DAB2IP;CRADD;TNFSF10;ING5;RIPK1;BAX;FAS;BCL2L1;BBC3;BCAP31
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.43391807063220755,1.2847373563993054,0.16598360655737704,0.5867841304508266,1.0,5/26,8.38%,LGR4;SMPDL3B;LRRC14;NLRP2B;GPR108
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.40092394766505407,1.284135674182837,0.1443089430894309,0.5868142277647039,1.0,20/37,25.32%,IFT81;DYNLL1;DYNC2H1;DYNC2I2;IFT122;DYNC2LI1;IFT74;IFT140;KIF3C;KIF3A;IFT43;DYNLRB2;IFT88;IFT57;WDR19;IFT172;WDR35;TRAF3IP1;TNPO1;SSX2IP
prerank,regulated exocytosis (GO:0045055),-0.29999182139884956,-1.2841230923557303,0.04276985743380855,0.4697476886361469,1.0,32/173,9.11%,FN1;VWF;ABCC4;PECAM1;TMSB4X;THBS1;SRGN;ACTN4;ARHGAP17;CYRIB;VEGFC;CALM1;VAMP7;APP;TGFB1;TGFB2;FAM3C;LHFPL2;CD109;RAB11FIP1;VEGFA;PSAP;STX1A;WDR1;ISLR;ACTN1;CD9;TGFB3;PCDH7;QSOX1;PDGFA;VCL
prerank,regulation of secretion (GO:0051046),0.5156068427656166,1.2839594016682192,0.2175824175824176,0.5857911211571788,1.0,4/13,8.73%,NRG1;OPRK1;SCIN;ERBB3
prerank,regulation of defense response to virus by host (GO:0050691),-0.409374266361063,-1.2837703667131672,0.138,0.4699518730757231,1.0,17/30,33.16%,DHX9;MAVS;ZDHHC1;AIM2;HSP90AA1;STAT1;TNFAIP3;CGAS;PTPN22;DTX3L;IFNLR1;MUL1;LILRB1;PARP9;PQBP1;TRAF3IP2;TRIM44
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.4220365817708799,1.283661874706581,0.15,0.5850587994175107,1.0,8/31,9.33%,TGFBR3;FGFR2;NRG1;TNNC1;TNNI3;TGFBR1;RBPJ;BMPR1A
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.4809545546720229,-1.2834971007353424,0.1866913123844732,0.469899130048719,1.0,12/15,42.42%,NLRC5;CNOT7;YTHDF2;SAMHD1;TTLL12;MUL1;PTPN2;YTHDF3;USP18;CACTIN;OAS3;STAT2
prerank,anterior/posterior pattern specification (GO:0009952),0.3802534264943509,1.283461143427725,0.11673151750972763,0.584056434178576,1.0,11/53,10.24%,BMP2;WLS;HOXC4;HOXB3;HOXC5;HES3;HOXC9;TGFBR1;HES5;HOXB9;HOXC6
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.32143090038877437,-1.283011514901899,0.07128712871287128,0.47030381889184086,1.0,34/100,21.72%,CBFA2T3;RACK1;RNF144B;SMAD7;HSP90AB1;RPL11;GABARAP;SH3RF2;N4BP1;USP7;GIPC1;TRIB2;CAMLG;PABIR1;FOXF2;TRIB1;DDRGK1;USP5;VCP;BAG5;UBXN1;RBX1;SDCBP;HECTD1;UFL1;HSPA1A;CCAR2;RNF19A;ELOB;MAP1A;KEAP1;HSPA1B;TAF9;TRIB3
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.5542337423408886,-1.2828875190403684,0.17424242424242425,0.4699048556460436,1.0,5/10,13.92%,ACER2;WNK1;JAM3;CYP1B1;NEXMIF
prerank,regulation of cell cycle (GO:0051726),-0.28550937995697545,-1.2828430713859855,0.018329938900203666,0.4693097386265072,1.0,77/271,19.70%,MECOM;PPP1R13B;CDK6;APBB2;AFAP1L2;THBS1;TTC28;NOTCH1;RACK1;JUND;CDC14A;IQGAP1;NEK7;DAB2IP;HSP90AB1;FAP;MAP3K20;RPRD1B;CDKN1B;TGFB1;TGFB2;RPL23;RPS15A;ADAM10;PKD1;CTBP1;RARA;GATA6;HCFC1;RGCC;PLAGL1;ASAH2;SIPA1;RB1;RASSF1;PIM3;RHOB;PHACTR4;JUNB;CDK4;CRLF3;PES1;INHBA;GRK5;MAEA;GADD45G;RPS6KA2;DHCR24;CDK10;HRAS;CDC14B;RNF20;UHMK1;MADD;GAS2L1;SDCBP;CDKN1A;FBXL3;CSNK2A1;CSNK2A2;LIN54;ANKRD17;RBBP4;MAPK12;CDKN2C;CHEK1;TSC2;L3MBTL1;TTLL12;PTPRK;CCND1;SRA1;SOX9;CDK5RAP3;TSPYL2;WDR12;GADD45A
prerank,heart process (GO:0003015),0.5148910107386735,1.2823966942798837,0.20095693779904306,0.5853939448303574,1.0,3/14,3.77%,SGCZ;SGCD;TNNI3
prerank,regulation of MAPK cascade (GO:0043408),0.3125363370055187,1.2817175222537036,0.07407407407407407,0.5856391374719232,1.0,27/157,9.72%,IGF1;EPHA7;TGFBR3;NRK;BMP2;KSR1;LPAR1;NTRK3;FGFR2;PELI2;KIT;ROCK2;RIT2;WWC1;LYN;IAPP;GSTP1;EPHB1;RRAS;SOX2;TNIK;THPO;ROR1;RYK;IGF2;EPHA8;MYDGF
prerank,aromatic amino acid family metabolic process (GO:0009072),0.5466897068389671,1.2815572779312507,0.1940928270042194,0.5845783290515237,1.0,4/10,22.18%,IL4I1;KYNU;PCBD1;KYAT1
prerank,vitamin D metabolic process (GO:0042359),0.5058687377699095,1.2815070980855945,0.19908466819221968,0.583196015598603,1.0,2/13,1.88%,VDR;CYP27B1
prerank,positive regulation of response to wounding (GO:1903036),-0.43351684116337247,-1.2814815042260672,0.15977443609022557,0.4719132748620549,1.0,5/24,3.66%,OCLN;ACTG1;SCARF1;PTK2;ANXA1
prerank,protein localization to plasma membrane (GO:0072659),-0.31294674928754695,-1.2802869566604693,0.05918367346938776,0.4741189930310758,1.0,45/129,19.77%,BSG;RAP1A;CDH1;TSPAN5;EFR3B;SPTBN1;RAB11A;F11R;RAMP2;EHD4;KCNB1;RAB8B;PACS1;CD81;GORASP2;EZR;IKBKB;EHD2;ATP1B1;JUP;FLOT1;S100A10;EMP2;RAB8A;TSPAN14;FCHO2;CACNB3;SLMAP;TNFRSF1A;SMURF1;TMEM88;TSPAN17;EPHA2;PACSIN1;FLOT2;RAMP1;RAB40B;PIGW;PRAM1;EHD1;EHD3;KCNB2;FYB2;PLEKHF1;RAPGEF2
prerank,embryonic organ development (GO:0048568),0.3634632522600449,1.2802758389935125,0.1254980079681275,0.5849489750522013,1.0,15/61,9.40%,COL13A1;SALL1;FGFR2;RARB;GDNF;GLI2;TEAD1;KIT;GLI3;PBX4;KMT2A;IFT122;RBPJ;BMPR1A;GATA3
prerank,heart looping (GO:0001947),-0.38992128497393086,-1.2802545779372707,0.14285714285714285,0.4734931900703468,1.0,11/39,14.53%,MEF2C;NOTCH1;TGFBR2;SOX17;TBX2;SMO;MICAL2;SOX18;ZIC3;ENG;SRF
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.3914436690311323,1.2799067550170518,0.14743589743589744,0.5844780227785701,1.0,10/41,15.16%,IL34;AREG;TGFA;STAP1;ERBB3;DLG4;BTC;DOK7;GPRC5B;FCGR1A
prerank,transport across blood-brain barrier (GO:0150104),0.34383997305162983,1.2798142837623077,0.11823647294589178,0.5832154079408328,1.0,16/83,5.51%,SLC1A3;ATP1A2;SLC24A3;SLC13A3;SLC16A12;SLC7A2;SLC6A9;LRP1;SLC6A13;SLC2A13;SLC5A3;LEPR;SLC29A1;ABCC2;SLC22A3;SLC38A1
prerank,protein mannosylation (GO:0035268),0.4444897509511474,1.2793707478384515,0.17429193899782136,0.58287901265397,1.0,9/22,19.04%,TMTC1;TMTC4;TMTC3;CRPPA;POMT2;DPY19L1;B4GAT1;DPM1;DPY19L4
prerank,regulation of protein kinase C signaling (GO:0090036),0.5123001887550482,1.279326279423798,0.17057569296375266,0.581550410469317,1.0,3/14,4.33%,ADGRV1;DGKD;GPD1L
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.3736760426549791,-1.2788994755097067,0.13133208255159476,0.47613991735388356,1.0,13/47,16.94%,NFKBIA;KLF4;RPL10;FOXO3;APP;TGFB1;EDN1;AKT1;INHBA;APOE;RBM4B;NR1H2;PCIF1
prerank,positive regulation of peptidase activity (GO:0010952),-0.4451762470732422,-1.27887998092771,0.16546762589928057,0.47548765148517086,1.0,7/20,17.70%,NDUFA13;PSENEN;DDRGK1;VCP;APH1A;VSIR;MAPK12
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.4032315779474184,1.2787493826307734,0.16768916155419222,0.5814762566847255,1.0,4/37,6.02%,ADCY7;PPARA;TICAM1;ABCD2
prerank,endothelial cell migration (GO:0043542),-0.3931248099369092,-1.2786381711386,0.12571428571428572,0.47533135363990053,1.0,15/37,14.99%,NOS3;DPP4;ID1;PXN;STARD13;CCN3;FAP;VEGFA;CYP1B1;GIPC1;SOX18;EMP2;PLXND1;PIK3CA;FSTL1
prerank,negative regulation of cellular process (GO:0048523),-0.2639408633534074,-1.27800321501653,0.004819277108433735,0.47625139915789994,1.0,140/521,19.87%,PODXL;ZBTB7C;PTPN14;PPP1R13B;CDK6;APBB2;ITGA1;JAM2;NOS3;CTTNBP2NL;CD34;PTPRJ;IGFBP7;IGFBP6;NOTCH1;SERTAD2;CBFA2T3;OSGIN2;RACK1;PTK2B;BMPR2;SH3BP4;FHL1;KLF4;CCN3;TBX1;SOX17;ETS1;SLIT2;DAB2IP;NPR1;FERMT2;ADAM15;NGF;PLXNA4;CDKN1B;APP;RNF41;REST;TGFB1;LPCAT3;ARHGDIA;TGFB2;TES;ADAM10;PLPP1;ARHGDIB;IGFBP3;CTBP1;ING5;DYSF;COL18A1;TGFBI;SMAD6;CNOT7;AQP11;PPP2R1A;NOTCH4;CYP1B1;IFITM1;ACTN1;PDE8A;WNT9A;CD9;TGFB3;ADGRG1;TNFRSF1B;RGCC;DUS2;TNFRSF21;SRSF6;NDUFA13;KANK2;SOX7;SIPA1;RB1;WARS1;WFDC1;CSNK2B;RHOB;BCL6;WNT11;SPEF1;MYBL1;PLXNA1;CRLF3;CCDC85B;GAS8;DIS3L2;INHBA;IMPACT;CIB1;PLXND1;FTH1;TMEM115;FRK;SOX4;CCN5;RPS6KA2;SPHK2;CDK10;P3H2;TMEM109;HRAS;FGF2;NDUFS3;BNIP3L;SMYD2;ABI1;SMARCA4;RAD18;OSGIN1;SMAD4;CDKN2AIP;SMARCA2;PTPN6;NR1H2;STRN;CDKN1A;JAK2;HSPA1A;RBBP4;CRYAB;CHMP2A;CDKN2C;DLL4;CCAR2;CD200;SKI;TSC2;NME6;PTPRK;RASA1;ESR2;PLXNA3;TSPYL2;TMBIM6;RAPGEF2;SNX3;MSX1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.5265759645749868,-1.2774317053390063,0.17293233082706766,0.47694009913945656,1.0,3/11,6.61%,RACK1;REST;ATF4
prerank,response to steroid hormone (GO:0048545),-0.41705439228156843,-1.2771687620007381,0.13837638376383765,0.47689987512694343,1.0,8/31,7.08%,CAV1;ABHD2;THBS1;ATP1A1;TGFB1;TGFB2;NR3C1;TGFB3
prerank,ventricular septum development (GO:0003281),0.3937397716355938,1.2769360220306156,0.15268817204301074,0.5847495056902926,1.0,4/37,0.61%,ROBO1;TGFBR3;ROBO2;SALL1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.41972867481931403,-1.2768356206765412,0.1647940074906367,0.47705589763162043,1.0,15/29,31.54%,DCUN1D5;SMAD7;DCUN1D1;BAG5;FEM1A;LIMK1;BMI1;PIN1;TRIB3;DCUN1D3;DTX3L;PARK7;MAGEC2;RPS2;PLK1
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.43311194242307716,-1.2766976585794976,0.15471698113207547,0.47670763025725627,1.0,4/24,7.67%,DACH1;BMPR2;RPS3;ERCC1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.5440957176541827,-1.2765187688450972,0.1857638888888889,0.4764355925084134,1.0,3/10,14.43%,MAP2K5;KLF4;SIGIRR
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.551935017633905,1.27621437309285,0.19856459330143542,0.5852114540118885,1.0,3/10,6.16%,ENPP1;ERRFI1;NLRP12
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3693798088785881,-1.2761492676522288,0.14147286821705427,0.47665336232827654,1.0,13/48,11.34%,LIMS2;RREB1;DOCK1;FERMT2;NEDD9;RAC1;LIMS1;CRK;MYOC;PRKDC;S100A10;CAPRIN1;CIB1
prerank,regulation of collagen biosynthetic process (GO:0032965),0.45068048411392375,1.2760361406629015,0.16089613034623218,0.5842057049119949,1.0,3/19,3.78%,WNT4;CREB3L1;LARP6
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.49572131490985927,1.2760203467587654,0.18004338394793926,0.582770890110126,1.0,5/14,11.27%,SULF1;SULF2;CREB3L1;GATA3;FUZ
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.33861559226315646,-1.275630635095319,0.10699588477366255,0.4771838141419281,1.0,30/72,27.27%,SHANK3;KANK3;CYRIB;SLIT2;HSPA8;PFDN5;KANK4;SSH2;HIP1R;STMN2;PFN1;SPEF1;CIB1;KATNB1;APOE;PIK3CA;SMAD4;CRYAB;ARHGEF2;SHANK1;CDH5;TPX2;APC2;CAMSAP3;PFDN6;PRKCD;STMN1;PFDN4;TREM2;CHADL
prerank,regulation of keratinocyte differentiation (GO:0045616),0.4432793639787449,1.2754937014089704,0.16812227074235808,0.5827385417948636,1.0,4/24,2.56%,ERRFI1;VDR;CYP27B1;ROCK2
prerank,response to fatty acid (GO:0070542),0.471168410827507,1.2754379010823629,0.17965367965367965,0.5814063556806703,1.0,4/17,6.08%,PID1;GLDC;PDK4;PDK3
prerank,regulation of RNA metabolic process (GO:0051252),-0.35198333568121637,-1.2753891314951926,0.10365853658536585,0.47706370746104015,1.0,15/59,12.97%,AHNAK;NOVA2;MBNL1;AHNAK2;HNRNPLL;RBM20;PTBP3;ZNF326;TNFRSF1B;RC3H1;PCBP4;FUS;YTHDF2;CLK1;FASTK
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.32274352410946233,1.2752819524910157,0.0935672514619883,0.5803180866761714,1.0,22/121,12.92%,IGF1;BMP6;NRP1;IL31RA;IL34;KIT;TNK2;LYN;GHR;IL4;ERBB3;IGF2;IL18;HES5;ERBB4;CNTF;TEC;IL6R;TSLP;PIBF1;DLG4;DOK7
prerank,regulation of protein catabolic process (GO:0042176),-0.32212106466715096,-1.2751368310752718,0.09411764705882353,0.47699380107812467,1.0,30/99,20.66%,WWP1;GPC3;EEF1A1;NEDD4L;FOXO1;DAB2IP;CDKN1B;RNF41;WWP2;IDE;EGLN2;NDUFA13;PLK2;ATG7;VCP;OAZ2;RAB7A;ITCH;SMURF1;SNF8;EGFR;CSNK2A1;NSF;AGAP2;FZR1;GFAP;TNFAIP3;PIN1;SNX3;APC2
prerank,neuromuscular synaptic transmission (GO:0007274),0.4639273949274336,1.2747536082062216,0.16129032258064516,0.5802339285605295,1.0,7/18,16.53%,CHRNA1;CHRNB4;RIMBP2;TBC1D24;STAC3;CHRNB1;FCHSD2
prerank,potassium ion transmembrane transport (GO:0071805),0.3139164728065666,1.2740504142724722,0.07115384615384615,0.580504358996953,1.0,33/135,18.45%,SLC1A3;KCNK2;KCNT2;ATP1A2;NALCN;SLC24A3;ABCB8;CCDC51;SLC9A7;KCND2;KCNJ16;KCNJ3;KCND1;KCNJ5;SLC24A4;SLC24A2;KCNJ14;KCNK10;ATP1A3;SLC12A3;KCNS3;KCNH7;KCNQ4;KCNJ6;KCNG2;KCNS1;ATP1B3;KCNJ9;KCNN1;KCNG4;KCNC2;KCNH1;KCNH5
prerank,gland development (GO:0048732),0.36893422084081956,1.2739406190126117,0.13417190775681342,0.5793334053889753,1.0,13/59,10.48%,TGFBR3;WNT4;SALL1;TBX3;FGFR2;NRG1;GLI2;DKK3;TGFBR1;SOX2;CITED2;PRKCSH;ARID5B
prerank,histone H2A ubiquitination (GO:0033522),0.47332188452007273,1.2737054157704082,0.1510791366906475,0.5784876716157628,1.0,3/17,5.39%,BCOR;DDB2;RNF2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.5417445877065032,-1.2729305755287343,0.16842105263157894,0.48185895611838925,1.0,4/10,22.11%,LBP;TIRAP;NINJ1;PTPN22
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5190429517072257,1.272842884424304,0.18526785714285715,0.5779591823006162,1.0,2/12,5.02%,FHL2;ACTN3
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5190429517072257,1.272842884424304,0.18526785714285715,0.5779591823006162,1.0,2/12,5.02%,FHL2;ACTN3
prerank,regulation of protein ubiquitination (GO:0031396),-0.31743926512428955,-1.2726612715090972,0.08669354838709678,0.48183534418031543,1.0,32/108,19.90%,CAV1;NXN;RPS3;SMAD7;HSP90AB1;FKBP1A;IVNS1ABP;UBB;CHP1;SH3RF2;N4BP1;DCUN1D1;FBXO4;CAMLG;AKT1;DNAJA1;FAM107A;FOXF2;PTTG1IP;BAG5;UBXN1;SPRTN;SOX4;PRMT3;UFL1;HSP90AA1;HSPA1A;TNFAIP3;USP4;CDK5RAP3;LAPTM5;UBE3A
prerank,regulation of neurogenesis (GO:0050767),-0.35692344754060434,-1.2725539751909292,0.11877394636015326,0.48144283683324346,1.0,13/55,15.58%,B2M;NOTCH1;TGM2;REST;BHLHE40;HEYL;FAIM;PRUNE1;YTHDF2;PCM1;HES1;HEY1;CX3CR1
prerank,negative regulation of ossification (GO:0030279),0.4399212300529472,1.2724900782665225,0.15982721382289417,0.5774094324248885,1.0,5/23,3.70%,ENPP1;BCOR;AHSG;LRP4;SFRP1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.39986793929448783,-1.2710733999380315,0.14587332053742802,0.4845722157447055,1.0,14/35,17.17%,TEK;ESAM;BAIAP2L1;PTK2B;F11R;ARHGDIA;BCAS3;ARHGDIB;ABI3;ABL2;CSF1R;HRAS;RAPGEF3;HCK
prerank,phosphorylation (GO:0016310),-0.2688031839420409,-1.27071627765115,0.01279317697228145,0.48481041694985255,1.0,105/384,19.00%,PRKCH;ERG;CDK6;MAP3K5;RPS6KA5;PRKG1;DGKH;CDK17;TGFBR2;MAP4K3;PTK2B;BMPR2;LIMK2;HIPK1;PEAK1;NLK;MAPK3;WNK1;BMX;STK10;NEK7;HK1;CAMK2D;MAP3K1;MAP3K20;FNIP2;APP;TGFB1;TGFB2;FAM20A;ADAM10;PRKCZ;CSNK1G2;MINK1;IGFBP3;CTBP1;NRBP1;TAOK3;IKBKB;RARA;BCR;PRKDC;SRPK1;TRIB2;INSR;DYRK2;STK25;PLK2;AKT1;MAP3K11;CDC42BPB;PIM3;LMTK2;TRIB1;WNT11;TOLLIP;TAOK2;CAMK1;CDK4;VRK1;LIMD1;GRK5;STK38;PRKCE;PKN3;PPP3CB;FRK;YWHAZ;SYK;STK36;PNKP;ACVR1;SPHK2;FASTK;CDKL4;CDK10;TBCK;CERKL;NUAK2;PIK3CA;ERBB2;LMTK3;COQ8A;LIMK1;PRKAG1;STK38L;NEK3;STK26;NUAK1;PGK1;JAK2;CSNK2A1;CDK13;DGKZ;MAP3K9;JAK3;HCK;RET;CHUK;TXK;CHEK1;POMK;MAP3K6;FAM20B;NADK
prerank,regulation of fat cell differentiation (GO:0045598),0.3527389940906831,1.2703601297690075,0.12048192771084337,0.5813441167523989,1.0,12/74,9.87%,RORA;ENPP1;BMP2;RUNX1T1;SMAD3;SFRP1;CEBPB;SIRT2;MEDAG;FTO;GATA3;FRZB
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.4612135474952879,-1.2701991460664293,0.15612648221343872,0.4854334284093904,1.0,2/18,0.49%,OCLN;SLC2A1
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.4501640386678196,-1.2697355870460352,0.18181818181818182,0.4858720516419492,1.0,9/19,22.73%,PLCE1;PPP3CC;EDN1;NFATC1;INPP5A;PPP3CB;ADGRB2;NFATC3;NMUR2
prerank,regulation of inflammatory response (GO:0050727),-0.29189310303940896,-1.2690580640842617,0.03640256959314775,0.4868367225399735,1.0,49/190,19.95%,TEK;FOXP1;TMSB4X;SEMA7A;IL15;NFKBIA;PPARD;KLF4;CCN3;MGLL;ETS1;ANXA1;APP;LPCAT3;PDE2A;MFHAS1;IL33;IL1R1;GPR4;BRD4;TLR3;TNFRSF1B;PSMA6;NFKBIZ;RIPK1;DHX9;RB1;ACE2;BCL6;TLR4;PIK3AP1;TNFRSF1A;APOE;FEM1A;BCL6B;NOD2;UFL1;IL17RA;JAK2;HCK;RELA;NINJ1;DAGLB;CD200;TNFAIP3;METRNL;PTGER4;CDH5;GGT1
prerank,positive regulation of cell killing (GO:0031343),-0.5101190227818578,-1.2680901906729043,0.198,0.4884875773429385,1.0,5/13,30.60%,RAC1;FZD7;SYK;NOX1;NOS2
prerank,positive regulation of exosomal secretion (GO:1903543),-0.4920296180008228,-1.2673542623060847,0.16216216216216217,0.4896701615224803,1.0,8/15,30.18%,RAB7A;TSG101;SDCBP;SNF8;CHMP2A;VPS4A;STAM;ATP13A2
prerank,sympathetic nervous system development (GO:0048485),0.47960537713448875,1.26727174839031,0.18640350877192982,0.5878310025629313,1.0,3/15,2.87%,NRP1;GDNF;SEMA3A
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.4066768564073777,1.2672561505473898,0.14861995753715498,0.5864448475600612,1.0,9/33,11.60%,TCF7L2;SEMA5A;PPARA;PDPK1;IL4;SERPINE1;SCG2;GATA3;YAP1
prerank,cellular response to drug (GO:0035690),-0.42486630690795824,-1.2663837158070774,0.16104868913857678,0.4913858691639195,1.0,7/25,8.88%,MEF2C;ACER2;TFRC;REST;KCNQ1;PPM1F;RBM22
prerank,response to ionizing radiation (GO:0010212),-0.3446211558956703,-1.266211822751267,0.11741682974559686,0.49106318920819064,1.0,35/70,32.05%,NET1;ANXA1;BRCC3;EEF1D;RAD1;UIMC1;BABAM1;RHOB;MTA1;RAD9B;HUS1;AEN;CDKN1A;RAD9A;ECT2;BABAM2;GADD45A;BRAT1;IKBIP;RHNO1;CLOCK;DCUN1D3;MRNIP;COP1;LIG4;RAD51AP1;FANCD2;SMPD1;SWI5;MYC;INTS3;TNKS1BP1;RNF8;TICRR;FIGNL1
prerank,cell junction assembly (GO:0034329),-0.32202222497865934,-1.2660814535799036,0.087890625,0.49069249697319045,1.0,15/100,5.33%,FN1;PKP4;ACTB;DNM3;SHANK3;ITGA6;CLDN5;LIMS2;CDH1;SPOCK2;ACTG1;OPHN1;FERMT2;SDK1;LIMS1
prerank,glycoprotein biosynthetic process (GO:0009101),0.346816029115401,1.2659030249853311,0.11666666666666667,0.5884813190181593,1.0,12/79,5.44%,IGF1;B3GALT1;CHST8;GAL3ST3;GAL3ST2;B3GALNT1;ST6GALNAC1;ST3GAL5;B3GNT7;ALG5;ST8SIA1;FUT4
prerank,phospholipid biosynthetic process (GO:0008654),-0.39407360733088853,-1.265746009655162,0.15163147792706333,0.4907577188225643,1.0,13/36,28.57%,SGMS1;SGMS2;SPHK2;FAR1;MBOAT1;PCYT2;NUS1;AGPAT5;CPNE3;FDPS;DHDDS;IDI1;PIP5K1A
prerank,embryonic digit morphogenesis (GO:0042733),0.4633615828812343,1.2655287843199552,0.1782608695652174,0.5880583158130374,1.0,3/18,3.50%,SALL1;TBX3;GLI3
prerank,negative regulation of viral release from host cell (GO:1902187),-0.5062763525540899,-1.265468923425614,0.1884328358208955,0.49073167821915514,1.0,3/13,14.45%,MID2;TRIM28;TRIM5
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.42470928310996525,1.2651155933387586,0.17757009345794392,0.5877200187434342,1.0,8/27,14.70%,LPAR1;GPR55;GPR174;GRM1;LPAR4;C3AR1;GNA15;DRD2
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.2740716731048896,-1.2649650990296541,0.008639308855291577,0.4912497778346485,1.0,87/348,16.60%,TEK;PECAM1;CAV1;SLCO3A1;RAP1A;RPS6KA5;PTPRJ;CCND3;IL15;PLCG2;FGF1;LIMCH1;RACK1;PTK2B;BMPR2;LIMK2;KDR;MAPK3;IQGAP1;TFRC;TBX1;NIBAN1;PTK2;CSPG4;VEGFC;CARD14;CD44;NGF;HSP90AB1;CALM1;FNIP2;APP;TGFB1;TGFB2;FAM20A;PPIA;RAC1;RALB;CD81;VEGFA;PDE8A;TGFB3;KRAS;RASSF2;RIPK1;FLT4;INSR;PDGFC;AKT1;PDGFA;FAS;FLOT1;CSNK2B;DDRGK1;LRP8;TAOK2;CAMK1;CD74;VEGFD;INHBA;MTCP1;CIB1;MAVS;PIK3R3;CALM3;ENG;CSF1R;ACVR1;HRAS;FGF2;FMR1;INHBB;ERBB2;PRKAG1;BCAR3;SMAD4;MMD;SDCBP;CAB39;RAPGEF3;LCP2;CX3CR1;EGFR;CDKN1A;JAK2;HSP90AA1;TAB2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.3712479377315594,-1.264275791617674,0.12476370510396975,0.4921961840020736,1.0,10/43,6.89%,DDX5;PPARD;KLF4;FOXO3;ETS1;REST;TGFB1;TGFB2;GATA2;NR3C1
prerank,cGMP biosynthetic process (GO:0006182),-0.5432350119593952,-1.263907172023179,0.2003577817531306,0.4923965702632906,1.0,4/10,15.11%,NPR1;GUCY1B1;GUCY1A1;GUCY2C
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.39716136340417046,-1.263890509231047,0.14990512333965844,0.49175059201501964,1.0,19/32,31.99%,BRCC3;TAOK3;FOXN3;UIMC1;BABAM1;TAOK2;CDC14B;CDKN1A;FZR1;CHEK1;BABAM2;CDK5RAP3;DTL;MRNIP;TRIM39;MRE11;CDK1;PLK1;TICRR
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.47461995580569,1.2637533673156793,0.18947368421052632,0.5898795392622869,1.0,3/18,4.18%,CAMK1D;PTN;LYN
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.39894485115667067,-1.2630929955616466,0.16792452830188678,0.49302819918738783,1.0,15/33,28.42%,PTPRJ;RPS3;CD81;EZR;RC3H1;DUSP3;NECTIN2;DGKZ;RELA;LAPTM5;PTPN22;PRKD2;BCL10;CARD11;PTPN2
prerank,positive regulation of neuron differentiation (GO:0045666),0.3833181634750046,1.263083699035406,0.16176470588235295,0.5902869634335369,1.0,10/40,14.11%,TCF4;BMP2;ZEB1;BRINP1;BRINP3;NRCAM;KCTD11;FGFR1;BRINP2;GPRC5B
prerank,growth hormone receptor signaling pathway (GO:0060396),0.48705814538298686,1.262847065185714,0.1939252336448598,0.5895293859171189,1.0,4/14,4.41%,PIK3R1;STAT5B;LYN;GHR
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.4998782119446703,-1.262459321281919,0.17688266199649738,0.4938635695890377,1.0,4/13,15.07%,NOTCH1;TGFBR2;CPE;SMAD4
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.46845337944284005,-1.2615516688219113,0.17782026768642448,0.49551789382111466,1.0,10/19,15.07%,NOTCH1;TGFBR2;BMPR2;TGFB2;SMAD6;HEYL;SOX4;ACVR1;HEY1;SMAD4
prerank,protein modification process (GO:0036211),-0.3321449687134867,-1.2614182867472294,0.10485436893203884,0.49515258534025514,1.0,25/76,22.09%,ST3GAL6;ST8SIA4;MANBA;PLOD2;WWP2;CSNK1G3;MSRA;PRKDC;UBE2L6;CPE;ATG3;ABL2;STK38;ICMT;MMP15;FBXL2;LOX;YES1;PHEX;FBXW2;MCRS1;UBL5;LCMT1;ADPRH;ERO1A
prerank,RNA export from nucleus (GO:0006405),-0.31534459539694215,-1.2611019254501055,0.073558648111332,0.4952604294376959,1.0,47/100,34.22%,HNRNPA2B1;SRSF5;SRSF2;NUP93;SRSF6;HHEX;NUP54;NDC1;U2AF1;ZC3H11A;RNPS1;SRSF4;MAGOH;NUP188;CHTOP;NUP155;RANBP2;ALYREF;DDX39B;AGFG1;HNRNPA1;NUP37;CASC3;CPSF4;THOC6;SMG7;NUP160;DDX39A;NCBP2;SMG1;NUP43;SEH1L;EIF4E;NUP42;SEC13;NUP107;NUP98;THOC7;UPF1;SRSF9;GLE1;U2AF1L4;UPF3B;SMG6;RBM15B;SRSF1;NUP88
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.3341923519149451,-1.26081278660385,0.10037878787878787,0.4952781682572231,1.0,26/80,17.20%,MAP3K5;THBS1;NOD1;MAP2K5;ARL6IP5;KLF4;RPS6KA3;CD44;NGF;REST;TNFSF10;VEGFA;PPM1F;GPX1;NDUFA13;SOX7;AKT1;CTSD;BEX3;SYK;DHCR24;BCAP31;IGBP1;CSNK2A1;BAD;FOXL2
prerank,ERBB2 signaling pathway (GO:0038128),0.409925130149401,1.2607920776216035,0.16317991631799164,0.5934305097919351,1.0,7/31,10.22%,PIK3R1;NRG1;PRKCA;NRG4;NRG2;ERBB3;ERBB4
prerank,inositol lipid-mediated signaling (GO:0048017),0.3704950254474547,1.2605517944600646,0.13535353535353536,0.5926232327423906,1.0,8/50,7.36%,IGF1;PIK3R1;PLCL1;PDGFRA;IRS2;PDGFRB;PLCL2;PLCH1
prerank,negative regulation of neuron projection development (GO:0010977),0.36529821817608243,1.2605277902061534,0.13168724279835392,0.5912911033739358,1.0,14/56,12.46%,LPAR1;LRP4;SEMA3A;MCF2;RTN4;RAB29;DPYSL3;BCL11A;NLGN1;STX1B;PTEN;DCC;NGFR;CBFA2T2
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.4422326462863643,-1.25969546797586,0.1657559198542805,0.49735525315172757,1.0,7/21,14.20%,ACTG1;LIMCH1;PEAK1;PTK2;VCL;DUSP3;LDB1
prerank,cation transport (GO:0006812),-0.29448535245520274,-1.259670783211056,0.05138339920948617,0.49672875654919385,1.0,31/167,14.36%,SLC47A1;PIEZO2;ANO6;SLC6A6;SLC12A2;KCNK5;ANO1;KCNJ2;NEDD4L;SLC9B2;SLC7A1;TRPM7;ABCC9;TRPM6;SLC5A6;PIEZO1;SLC38A5;SLC1A1;CHP1;KCNJ10;ATP1B1;TRPC6;SLC39A1;KCNJ8;KCNK9;KCNJ15;KCNA4;NDUFA9;SLC3A2;KCND3;SCN1A
prerank,positive regulation of axonogenesis (GO:0050772),0.38871391116916715,1.259583534176361,0.16735537190082644,0.5923704682790891,1.0,3/43,0.50%,PLXNA2;ROBO1;ROBO2
prerank,V(D)J recombination (GO:0033151),-0.519679388405687,-1.2588358251405662,0.19294990723562153,0.4980714296882994,1.0,6/11,33.90%,PRKDC;TCF3;DCAF1;LIG4;HMGB2;XRCC4
prerank,adipose tissue development (GO:0060612),-0.5316382914999644,-1.2583245785878212,0.18181818181818182,0.49864649973649416,1.0,4/11,6.35%,SPTLC2;NAMPT;LRP5;PGRMC2
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.40868600471488553,-1.2583080238081674,0.17475728155339806,0.4980080801413107,1.0,10/28,22.98%,OCLN;RPS3;RAC1;SLAIN2;DCTN1;MET;HSPA1A;ARL2;HSPA1B;CLIP1
prerank,embryonic heart tube development (GO:0035050),-0.48088921571504084,-1.2580561054166806,0.16607773851590105,0.49794234590856873,1.0,5/14,12.89%,SOX17;TBX2;SOX18;HES1;ACVR1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.33525645248515495,-1.2567454628263242,0.0989010989010989,0.5006035413493616,1.0,17/75,10.51%,MEF2C;ACTB;PARD3;OPHN1;MEF2A;KLF7;APP;SHTN1;MINK1;S100B;MFSD2A;BTBD3;RB1;LMTK2;RAB8A;S100A6;TAOK2
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.528148526317075,-1.2564018778532933,0.1844106463878327,0.5008373044303779,1.0,7/10,31.06%,WWP2;PPM1F;DNAJA1;SNX3;NDFIP2;NDFIP1;SNX12
prerank,regulation of cellular component size (GO:0032535),-0.4106146375497737,-1.2559612817425563,0.14821763602251406,0.5013174791598501,1.0,14/30,31.50%,EPS8;RIN3;MSN;RAC1;EZR;AP2M1;PPP1CA;PEX11G;RDX;PEX11A;RPTOR;LAMTOR5;ATP13A2;RAB3B
prerank,early endosome to late endosome transport (GO:0045022),-0.44337418523224403,-1.2557114435366246,0.192090395480226,0.5012348907753591,1.0,6/20,15.51%,EEA1;LMTK2;EMP2;KIF16B;RAB7A;SNF8
prerank,hyaluronan metabolic process (GO:0030212),0.441281298321641,1.2556621936338905,0.17745302713987474,0.6011891835280195,1.0,3/23,1.38%,CEMIP;HYAL3;SPAM1
prerank,regulation of cell division (GO:0051302),-0.3355885865892973,-1.255484362633638,0.11614173228346457,0.5011083084294524,1.0,36/72,32.88%,MLLT3;FGF1;RACK1;RAB11A;CALM1;ZFYVE26;PLK2;TAL1;PRDM15;CIB1;BCL2L1;CALM3;RAB11FIP3;CETN2;KLHL9;KLHL21;CDK2AP2;PIN1;KIF13A;PRPF40A;KIF18B;SFN;TLE6;PLK3;PLK5;SETD2;MYO19;MYC;HTR2B;DLL1;CSPP1;AURKA;PLK1;ENTR1;ESRRB;PIK3R4
prerank,cardiocyte differentiation (GO:0035051),0.5319610241391779,1.2552765307375469,0.2331002331002331,0.600819204330198,1.0,2/10,1.45%,BMP2;NRG1
prerank,regulation of muscle cell differentiation (GO:0051147),-0.4008111756286584,-1.2545482832459296,0.14466546112115733,0.5027090711749138,1.0,11/31,17.70%,MEF2C;CDON;MEF2A;CTNNA1;BOC;HDAC9;CAMK1;SPAG9;SRF;TCF3;MAPK12
prerank,regulation of lamellipodium organization (GO:1902743),-0.49039992221067324,-1.2543013279121216,0.1746641074856046,0.5026800365872417,1.0,9/14,38.56%,CD44;RAC1;EPHA2;DMTN;CARMIL1;CDC42;TWF2;CAPZB;VIL1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.33682610165876903,-1.2540691601190805,0.11663479923518165,0.5025645755021806,1.0,17/75,9.93%,TEK;CLDN5;SEMA6A;THBS1;KLF4;DAB2IP;NPR1;STAB1;TGFB2;COL4A2;SARS1;PTPRM;AMOT;RGCC;NAXE;HHEX;ISM1
prerank,response to interleukin-6 (GO:0070741),0.5343642573845189,1.2538293292839666,0.23433874709976799,0.603122682311343,1.0,4/10,6.83%,PID1;PTGIS;PTPRT;FOXA2
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.5045323553022848,-1.2534729824255606,0.17565217391304347,0.5033510036961346,1.0,7/12,33.78%,GCLM;GCLC;CNDP2;GGT1;GGCT;MGST2;BDH2
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5126355728967353,-1.252948893509163,0.18857142857142858,0.5039862693294702,1.0,5/11,16.28%,EGLN3;EGLN2;EGLN1;P3H2;CRTAP
prerank,leukocyte tethering or rolling (GO:0050901),-0.4634756050461473,-1.2525002650744166,0.19349005424954793,0.5044396640590937,1.0,11/17,44.47%,JAM2;ITGA4;CX3CR1;GOLPH3;SELP;ITGB7;ADD2;ROCK1;GCNT1;SELE;TNF
prerank,negative regulation of catalytic activity (GO:0043086),-0.42230545979913436,-1.2524144961649153,0.16314779270633398,0.5039313684331612,1.0,8/24,22.80%,NOTCH1;NES;IFIT1;ATP5IF1;APBA3;NOSIP;CCAR2;PPP1R12A
prerank,regulation of cardiac conduction (GO:1903779),0.35932693696084717,1.2520782812781723,0.15478615071283094,0.6063876339854563,1.0,10/54,6.17%,ATP1A2;SLC8A1;ITPR1;ANK2;PRKACA;CORIN;DMPK;ATP2A2;FXYD1;ASPH
prerank,cell part morphogenesis (GO:0032990),0.49875575606211464,1.251948780919506,0.22075055187637968,0.6053320114581798,1.0,3/13,10.46%,PID1;NUBPL;PNPT1
prerank,lymphocyte proliferation (GO:0046651),-0.4397652667822533,-1.2517467476691797,0.21072088724584104,0.5049256599225546,1.0,5/22,11.94%,MEF2C;CTPS1;MSN;HSPD1;PPP3CB
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.43538491181276406,-1.2513460653480384,0.18181818181818182,0.5052558060061065,1.0,4/22,10.39%,B2M;CD55;CYRIB;HSPD1
prerank,regulation of membrane depolarization (GO:0003254),-0.45855366245510054,-1.2506488939204832,0.18579234972677597,0.506184838785632,1.0,4/18,3.59%,NEDD4L;FHL1;SMAD7;CAMK2D
prerank,mesenchymal cell differentiation (GO:0048762),0.3683190529071188,1.2498014445099976,0.1419491525423729,0.6095990302224902,1.0,11/51,7.89%,TGFBR3;WNT4;BMP2;FGFR2;ROCK2;RANBP3L;TGFBR3L;LOXL2;LOXL3;TGFBR1;RBPJ
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.4369622689559721,-1.2492681131677672,0.17943925233644858,0.5089704911381625,1.0,6/21,12.93%,PDE4D;NT5E;PDE2A;NT5C1A;NUDT4;HINT1
prerank,axonal transport of mitochondrion (GO:0019896),-0.5305018957162918,-1.2489482066098208,0.20508166969147004,0.5091151436719628,1.0,4/11,16.10%,TRAK1;TRAK2;NEFL;OPA1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.5078517612900648,-1.2488705947659928,0.19811320754716982,0.5085968903943876,1.0,8/12,35.49%,DKC1;CCT2;CCT3;CCT8;CCT7;CCT4;WRAP53;CCT6A
prerank,actin filament network formation (GO:0051639),-0.5215653100164593,-1.2487767298940362,0.21880998080614203,0.5081249721155329,1.0,3/11,6.61%,COBL;PLS3;ACTN1
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.45932076676608685,-1.2484528686951852,0.19120458891013384,0.5082547063821374,1.0,5/17,12.47%,SLC7A5;PRKCZ;RARA;FCER1G;SYK
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.45289504490808685,-1.2483096599786112,0.188212927756654,0.5079421401170071,1.0,5/19,12.07%,LBP;TIRAP;PRKCE;TLR4;PIK3AP1
prerank,activation of phospholipase C activity (GO:0007202),0.4133968649650814,1.24825577619492,0.16033755274261605,0.6124535114930673,1.0,3/29,2.47%,ARHGAP6;LPAR1;GPR55
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.46648439635935524,-1.2477741180020208,0.2045889101338432,0.5086412131023307,1.0,7/17,15.24%,ARL6IP5;TGFB2;MID1;TAOK3;STK25;TAOK2;NOD2
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.3382303909904738,-1.2472259978854885,0.12109375,0.5093846407197357,1.0,34/67,35.69%,B2M;NCF2;TAPBP;IKBKB;PSMA6;PSMB5;PSMC4;PSMC5;PSMD14;PSMD8;PSMC1;PSMB4;PSMD11;PSMD12;TAP2;CHUK;CYBB;PSMA1;PSMC3;PSMB1;PSMA2;PSMA4;PSMB8;CD36;PSMC6;PSMD6;SEC22B;IKBKG;PSMA8;NCF1;PSMB2;PSMD2;SNAP23;ITGAV
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.39975599120751143,1.247190182517205,0.1649048625792812,0.6137729858089519,1.0,7/34,8.78%,IGF1;TGFA;PHIP;PDGFRB;CDC23;IGF2;CDC16
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.36298419985599106,-1.2471855537932228,0.13108614232209737,0.508805559030728,1.0,26/50,31.42%,THBS1;MAP2K5;KLF4;RPS6KA3;CD44;NGF;VEGFA;GPX1;AKT1;BEX3;DHCR24;IGBP1;CSNK2A1;SFN;TRIAP1;PLAUR;CARD16;XIAP;YWHAE;PARK7;LAMTOR5;RPS6KA1;PAK2;SRC;AQP1;DNAJB6
prerank,cortical cytoskeleton organization (GO:0030865),0.37848563772803895,1.247180705605863,0.13924050632911392,0.6123935714859324,1.0,12/41,15.71%,EPB41L3;ROCK2;RHOH;RHOBTB1;FMNL3;FHOD3;NLGN1;RHOBTB3;RHOF;LLGL1;RND1;RHOQ
prerank,glutamate receptor signaling pathway (GO:0007215),0.39606976270111216,1.246676803420606,0.15625,0.6123047330087666,1.0,11/37,13.33%,GRIA4;GRID2;GRIN3A;TRPM1;GRIK2;GRM1;GRIK1;CDK5R1;GRIA3;GRM4;GRIN2A
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.48835746564971283,-1.2465117355878708,0.1958955223880597,0.5097896187633657,1.0,4/14,10.18%,LIMS2;LIMS1;EMP2;PHACTR4
prerank,inhibitory synapse assembly (GO:1904862),0.5171710519476229,1.2463070315695526,0.2175732217573222,0.6118394743202721,1.0,2/11,5.45%,GABRA2;GABRB3
prerank,response to histamine (GO:0034776),0.5398137422096201,1.245910183750909,0.21603563474387527,0.6114650482183032,1.0,7/10,24.62%,GABRB3;HRH1;DRD2;GABRB1;GABRG2;GABRB2;DRD3
prerank,regulation of translation (GO:0006417),-0.2898285394750128,-1.245794869877113,0.07822410147991543,0.510878489556815,1.0,56/173,24.93%,THBS1;VIM;RPL26;RACK1;EEF2;NIBAN1;RPS4X;RPL10;FOXO3;RPS3;RPS6KA3;APP;IGFBP5;EIF4G3;EIF5B;CNOT7;HSPB1;PRKDC;GAPDH;NCL;DHX9;RPL13A;EIF3D;RPS27L;CAPRIN1;LARP4B;IMPACT;CIRBP;UPF3A;TSFM;SOX4;FMR1;ERBB2;RBM4B;PCIF1;LSM14A;ZCCHC4;GIGYF2;EIF5;PAIP2B;RPL5;TYMS;YTHDF1;EIF4A2;EIF1;PYM1;LTN1;MRPL13;EIF4G1;PAIP1;SYNCRIP;NCBP2;EIF4B;EIF4E;NSUN5;EIF4H
prerank,negative regulation of immune response (GO:0050777),0.30457820182813655,1.2451190978283238,0.08764940239043825,0.6121233822110483,1.0,21/154,11.61%,ADCY7;ADCY2;ADCY1;GPHB5;ADCY5;HTR7;PRKACA;MC5R;LYN;ADM;PTGDR;IAPP;SIRT2;CALCR;GLP2R;TRIM27;HRH2;RNF26;ADCY8;HTR4;PTGIR
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.38648544994377243,-1.2450072135851329,0.17992424242424243,0.5121698558365592,1.0,8/34,5.88%,TEK;FLT1;PTK2B;PTK2;DAB2IP;TNFAIP8L3;TGFB1;PIK3IP1
prerank,regulation of interleukin-10 production (GO:0032653),-0.3726291823480842,-1.2449986827335913,0.16827852998065765,0.5115090135672441,1.0,11/44,17.16%,CD34;PLCG2;PRKCZ;TRIB2;TNFRSF21;HSPD1;TLR4;SYK;NOD2;VSIR;JAK3
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.5032266754757834,-1.2446501695831471,0.196113074204947,0.5117228781470302,1.0,3/13,5.11%,RREB1;SIX1;SOX13
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.5157729235863521,-1.2443259873972314,0.20297951582867785,0.5118109785351427,1.0,7/11,19.25%,TGFBR2;LRP5;TBX1;PDGFA;CTNNBIP1;STAT1;SOX9
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5423468294736761,1.244313403885094,0.23042505592841164,0.6128612205294416,1.0,2/10,3.61%,SH3RF1;RUNX3
prerank,regulation of cell development (GO:0060284),-0.39227628004761395,-1.2437725407910976,0.1579961464354528,0.5124401250766971,1.0,11/36,15.58%,FOXO1;HDAC9;RPS19;BHLHE40;HEYL;AKT1;PRUNE1;YTHDF2;HES1;HEY1;CX3CR1
prerank,vascular process in circulatory system (GO:0003018),-0.49922276794384274,-1.2434153246486404,0.21492007104795738,0.5120312982705492,1.0,7/13,23.20%,NOS3;NPR1;ACE2;ACE;GCLM;GCLC;SCPEP1
prerank,regulation of tube diameter (GO:0035296),-0.49922276794384274,-1.2434153246486404,0.21492007104795738,0.5120312982705492,1.0,7/13,23.20%,NOS3;NPR1;ACE2;ACE;GCLM;GCLC;SCPEP1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.47277490954746226,1.2429040518067924,0.2043956043956044,0.6150662299058977,1.0,2/17,2.52%,PLA2G5;PLA2G4A
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.4047292899790363,1.2427449584454349,0.1901840490797546,0.6141128245140797,1.0,8/31,11.27%,FGFR2;PDGFRA;HOXC4;HOXB3;HOXC9;TGFBR1;HOXB9;FUZ
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.3323581503615402,1.2427196879310414,0.12617702448210924,0.6127787400398946,1.0,7/86,4.41%,IGF1;BMP6;EPHA7;NRP1;TNK2;SFRP1;GHR
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5244764819311727,1.2425262926998024,0.22988505747126436,0.6119318549007353,1.0,4/10,12.72%,STAT5B;LYN;GHR;PRLR
prerank,regulation of programmed cell death (GO:0043067),-0.2898807631786906,-1.2420337184528065,0.07510729613733906,0.5147868356438313,1.0,39/161,17.16%,MECOM;PPP1R13B;ACER2;TPT1;TGM2;ACTN4;RPS3;ZBTB7A;CRADD;IGFBP3;DCPS;TMEM219;ACTN1;TOX3;ANP32A;RIPK1;PERP;KANK2;AKT1;BAX;FAS;HIP1;BCL6;LRP8;VCP;PSMC5;HTATIP2;RTKN;CTSB;ACER3;BNIP3L;MADD;OSGIN1;STK26;PTPN6;JAK2;LGALS1;HSP90AA1;JAK3
prerank,cellular response to type I interferon (GO:0071357),-0.3748552187439194,-1.241326016921698,0.178714859437751,0.5151671123036409,1.0,24/41,39.99%,ADAR;IFITM1;IFITM3;IFITM2;IFNAR1;IFIT1;SAMHD1;IRF9;OAS2;RSAD2;STAT1;IRF8;PSMB8;EGR1;ISG20;IP6K2;XAF1;IRF6;IRF3;IRF2;IFNAR2;IRF5;OAS3;TYK2
prerank,type I interferon signaling pathway (GO:0060337),-0.3748552187439194,-1.241326016921698,0.178714859437751,0.5151671123036409,1.0,24/41,39.99%,ADAR;IFITM1;IFITM3;IFITM2;IFNAR1;IFIT1;SAMHD1;IRF9;OAS2;RSAD2;STAT1;IRF8;PSMB8;EGR1;ISG20;IP6K2;XAF1;IRF6;IRF3;IRF2;IFNAR2;IRF5;OAS3;TYK2
prerank,receptor internalization (GO:0031623),-0.3675011537309476,-1.2409801464884276,0.15546218487394958,0.5153572544394571,1.0,9/44,9.68%,CAV1;DNM3;ACKR3;RAMP2;TFRC;CD81;CD9;AP2M1;FCER1G
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.5090056900790567,-1.2409133149615903,0.20871143375680581,0.5148580292942349,1.0,3/11,3.49%,RIN3;CCN3;SLIT2
prerank,positive regulation of collagen metabolic process (GO:0010714),0.4580174258377141,1.2408342988073104,0.19831223628691982,0.6149405493996634,1.0,3/17,3.78%,WNT4;CREB3L1;LARP6
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.49174927186242817,1.240448146618642,0.23608017817371937,0.6146359295087583,1.0,5/13,15.10%,PDPK1;AKT3;IGF2;FGFR1;SIRT6
prerank,osteoclast differentiation (GO:0030316),-0.43213474728895424,-1.240132805700199,0.19056261343012704,0.5161705385435661,1.0,8/22,17.22%,FOXP1;ANXA2;OSTM1;TNFRSF11A;GLO1;CSF1R;EPHA2;GAB2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.41446865086303775,-1.2400168508194085,0.18761061946902655,0.5158071598410561,1.0,9/24,22.11%,ACKR3;TPT1;CD44;CD74;BCL2L1;KDM1A;CCAR2;TAF9;TRIAP1
prerank,intermediate filament organization (GO:0045109),-0.45807974256828216,-1.2399895973777646,0.1978021978021978,0.5151874270724585,1.0,6/17,22.22%,VIM;NEFL;MTM1;DSP;GFAP;KLHL24
prerank,entry into host (GO:0044409),-0.5004231426130835,-1.2399788105258722,0.19615384615384615,0.5145422692320308,1.0,8/13,36.32%,CDH1;PPIA;MET;CBLL1;CTNNB1;SRC;ITGAV;CBL
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.5121132460797817,-1.2397180199918423,0.20695970695970695,0.5145426370522083,1.0,6/11,21.89%,CASP8;RIPK1;YBX3;PELI1;ARHGEF2;SLC25A4
prerank,regulation of epidermal cell differentiation (GO:0045604),0.43976309085835164,1.2396245068675407,0.2080536912751678,0.6154773232151675,1.0,2/21,2.56%,ERRFI1;ROCK2
prerank,mitotic recombination (GO:0006312),0.4897501032030183,1.23883661826183,0.21238938053097345,0.6162602738080305,1.0,6/15,18.05%,DMC1;GEN1;TEP1;SMC6;NSMCE2;SMC5
prerank,establishment of protein localization to extracellular region (GO:0035592),0.3894866158644843,1.2384345096923435,0.1711340206185567,0.6159321776259706,1.0,12/39,16.60%,STEAP3;TANGO2;ABCA1;RAB3C;MON1A;SCG2;RAB10;LTBP2;SVBP;COPG2;AFM;MIA3
prerank,retinoic acid metabolic process (GO:0042573),0.4955629364326006,1.2382937033108699,0.23210412147505424,0.6149151343384474,1.0,1/14,0.53%,ALDH1A2
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.4363157912844107,-1.237863489127965,0.19672131147540983,0.5185568524169396,1.0,8/22,14.43%,CALM1;HTT;ATP1B1;JPH2;AKAP6;GSTM2;CALM3;VMP1
prerank,ERBB signaling pathway (GO:0038127),0.3412195640692267,1.2377404264109293,0.1396761133603239,0.6150220615517099,1.0,10/64,4.47%,PIK3R1;AREG;NRG1;PDPK1;PRKCA;SLC30A10;DGKD;TGFA;NRG4;NRG2
prerank,aorta morphogenesis (GO:0035909),0.4644768276184218,1.2377397105586745,0.21505376344086022,0.6136511122113467,1.0,7/17,11.37%,LRP1;EFEMP2;MYLK;PDGFRB;RBPJ;BMPR1A;ADAMTS9
prerank,membrane organization (GO:0061024),-0.2784636821403452,-1.237410332563395,0.05263157894736842,0.5190683972500754,1.0,63/227,21.60%,CERT1;ACTB;DNM3;ACTG1;SPTBN1;FNBP1L;MYOF;TFRC;FZD4;VAMP7;EPN1;LPCAT3;UBB;ATP2C1;IGF2R;HSPA8;UBC;RPS27A;CHP1;NAPA;DYSF;HIP1R;REPS2;CHMP2B;NUP93;AP2M1;ARPC5;A4GALT;PIK3C2A;ITSN1;HIP1;SGIP1;FCHO2;ACTR3;TOR1AIP1;MITD1;SYT2;EPN2;WASL;TMEM43;NPC1;NUP155;AP2A1;SLC2A8;SYNJ1;EGFR;OPA1;AGFG1;RABEP1;CHMP2A;VTI1B;REEP4;DNM1;PACSIN2;DNM2;CTTN;SNX3;TOR1AIP2;TMEM33;LPCAT2;CLTA;TIMM50;GLTP
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.3227050193724766,-1.2373740689939008,0.12024048096192384,0.5184858253940812,1.0,23/93,16.53%,CAV1;DMD;RACK1;TFRC;PDE4D;SMAD7;CD44;NGF;HSP90AB1;FNIP2;APP;TGFB1;VEGFA;RASSF2;PPM1F;AKT1;CAMK1;MTCP1;BCAR3;RAPGEF3;EGFR;DDIT4;HSP90AA1
prerank,leukotriene metabolic process (GO:0006691),0.4497366576370745,1.2371922441773624,0.2129032258064516,0.613767832734134,1.0,4/19,6.98%,PLA2G5;PLA2G4A;ALOX12;DPEP2
prerank,regulation of cardiac muscle contraction (GO:0055117),0.39268178493214734,1.2371306963593336,0.19027484143763213,0.612561958329985,1.0,6/34,3.87%,SLC8A1;ANK2;PRKACA;ATP2A2;TNNI3;P2RX4
prerank,mRNA export from nucleus (GO:0006406),-0.3117123488092298,-1.2364156227959102,0.10103092783505155,0.5203114357343125,1.0,48/102,34.22%,HNRNPA2B1;SRSF5;SRSF2;NUP93;SRSF6;ENY2;HHEX;NUP54;NDC1;U2AF1;ZC3H11A;RNPS1;SRSF4;MAGOH;NUP188;CHTOP;NUP155;RANBP2;ALYREF;DDX39B;AGFG1;NUP37;CASC3;CPSF4;THOC6;SMG7;NUP160;DDX39A;NCBP2;SMG1;NUP43;SEH1L;EIF4E;NUP42;SEC13;NUP107;NUP98;THOC7;UPF1;SRSF9;GLE1;U2AF1L4;UPF3B;SMG6;RBM15B;SRSF1;DDX19A;NUP88
prerank,positive regulation of transport (GO:0051050),-0.3235575416405585,-1.236049338644425,0.11623246492985972,0.5205368992034378,1.0,23/85,15.31%,ACTB;GPC3;IL15;NEDD4L;ANXA1;RAB27A;ANXA2;CHP1;CD151;HIP1R;GATA2;PLAA;BAX;FLOT1;FCER1G;BAK1;CAPN10;FMR1;APOE;LMAN2;TUB;MLC1;CHCHD10
prerank,striated muscle tissue development (GO:0014706),-0.4030081854761761,-1.2350165737698187,0.18297101449275363,0.5224608293971017,1.0,8/29,4.47%,MEF2C;CAV1;PGM5;MYL6;BMPR2;SIX1;TBX2;NDUFV2
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.3291785629994717,-1.2346359181683435,0.12180746561886051,0.5227275349824894,1.0,17/71,11.93%,CAPN2;FAP;RNF41;UBB;CTSZ;UBC;RPS27A;CTSO;RHBDD1;CTSC;IDE;CASP8;PSMA6;CTSF;VCP;USP9X;CTSB
prerank,positive regulation of type 2 immune response (GO:0002830),-0.49150125704639824,-1.2343807838700105,0.21042471042471042,0.5226786802617523,1.0,7/14,18.10%,PRKCZ;CD81;RARA;DENND1B;CD74;NOD2;RSAD2
prerank,regulation of interleukin-13 production (GO:0032656),-0.4899946407989012,-1.2343620291012345,0.2024866785079929,0.5220514604832289,1.0,5/13,12.95%,LEF1;PRKCZ;RARA;TNFRSF21;SPHK2
prerank,extracellular transport (GO:0006858),-0.5106584049567062,-1.2338278151256081,0.205607476635514,0.5227339332255485,1.0,8/12,26.99%,WWP2;ARRDC1;TSG101;CABYR;ROPN1L;ADCY10;SPAG17;SPA17
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.484492319071821,-1.2337112192985502,0.20222634508348794,0.5223405396999009,1.0,10/14,34.85%,RPL35;PES1;URB1;RPL7;WDR12;RPF2;FTSJ3;ZNHIT6;ZNHIT3;DDX18
prerank,positive regulation of neurogenesis (GO:0050769),0.3401221800064259,1.2336729001805389,0.1506849315068493,0.620411766257335,1.0,17/68,14.77%,PLXNA2;ROBO1;ROBO2;SERPINF1;PTPRD;NPTN;IL1RAPL1;CUX1;CDKL3;CUX2;PLXNB2;AMIGO1;OBSL1;NGFR;CAPRIN2;DRD2;MAP6
prerank,determination of heart left/right asymmetry (GO:0061371),-0.37082310282934555,-1.233451361233201,0.1761252446183953,0.5223086888597308,1.0,11/42,14.53%,MEF2C;NOTCH1;TGFBR2;SOX17;TBX2;SMO;MICAL2;SOX18;ZIC3;ENG;SRF
prerank,L-glutamate transmembrane transport (GO:0015813),0.5202584712925892,1.2330912758602024,0.23423423423423423,0.6205386721415207,1.0,1/10,0.06%,SLC1A3
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.4475964428114351,1.232508281076321,0.2191780821917808,0.6206834891933043,1.0,2/21,2.11%,SAMD4A;TUT4
prerank,regulation of mitotic nuclear division (GO:0007088),0.35420748050372625,1.2324137065735596,0.1787941787941788,0.6195448865223034,1.0,12/55,12.84%,IGF1;AURKAIP1;TGFA;PHIP;CUL9;PDGFRB;BORA;IGF2;TOM1L2;TOM1L1;OBSL1;BTC
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.3217628059160472,-1.2322979381788808,0.11560693641618497,0.5246557086562013,1.0,25/87,15.32%,ESAM;EPS8;PTK2B;F11R;IQGAP1;ARHGAP17;RICTOR;ARHGDIA;RAC1;ARHGDIB;CRK;HIP1R;EZR;ABI3;PDGFA;FAM107A;RHOB;TAOK2;ABL2;CSF1R;ARHGEF5;CDK10;CELSR1;PIK3CA;RAPGEF3
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.41798486728280587,-1.2320032861047092,0.19553072625698323,0.5247771844295307,1.0,9/25,15.96%,CAV1;CXADR;CAMK2D;CALM1;JUP;CTNNA3;CALM3;DSG2;DSP
prerank,ameboidal-type cell migration (GO:0001667),-0.3517909652021932,-1.2317191816520803,0.15,0.5247967881441994,1.0,15/51,14.85%,SEMA6A;SEMA3C;GPC3;SEMA7A;CCN3;TBX1;PDLIM1;AMOT;AKT1;SEMA3G;FAT2;PHACTR4;PKN3;SGPL1;ITGA4
prerank,negative regulation of protein transport (GO:0051224),-0.4197906619148377,-1.2314120938362505,0.18198529411764705,0.5248883715766817,1.0,12/25,31.62%,WWP2;PPM1F;DPH3;APOE;RSAD2;SNX3;CSK;RHBDF2;NDFIP2;NDFIP1;SNX12;HMGCR
prerank,mesenchyme development (GO:0060485),0.4668737775373593,1.231092670293664,0.22717149220489977,0.6217178583907459,1.0,3/15,7.55%,BMP2;FGFR2;TGFBR1
prerank,positive regulation of signaling receptor activity (GO:2000273),0.3880405501037631,1.2305684437950812,0.18614718614718614,0.6217416971753758,1.0,4/36,6.49%,NRP1;AREG;TGFA;NLGN3
prerank,regulation of cell differentiation (GO:0045595),-0.29356475439121144,-1.2305095753817414,0.10300429184549356,0.5265212438203151,1.0,39/148,16.71%,SLC6A6;CDK6;SMOC1;SPOCK2;DDX5;LTBP4;KLF4;TBX1;PTK2;RPS6KA3;SMAD7;NGF;HSP90AB1;SIX1;REST;TGFB1;DDX17;PPP2R1A;NOTCH4;UQCC2;ATF4;CBFB;MCRIP1;PHLDB1;EMP2;BCL6;CAMK1;OCIAD1;ZFHX2;NF1;BCL6B;HEY1;SRF;YWHAG;ZFHX3;FLOT2;GREM1;YWHAH;PDCD2
prerank,mesoderm development (GO:0007498),-0.4474699152986212,-1.2298627062546177,0.21915285451197053,0.5274813344443526,1.0,13/18,31.34%,TIE1;TBX1;BMX;MESD;VEGFA;FOXC2;JAK2;HCK;BTK;MEST;TCF15;GDF11;TBX6
prerank,positive regulation of cellular process (GO:0048522),-0.25259943165980764,-1.2298588682576799,0.029535864978902954,0.526822311025411,1.0,128/565,17.24%,FN1;LEF1;KITLG;CAV1;SLC6A6;FLT1;IGF1R;FRMD5;CLDN5;ACER2;THBS1;LBP;PTPRJ;NOTCH1;PARD3;IL15;DPP4;NAMPT;TRPC3;FGF1;TGFBR2;LRP5;PTK2B;TGM2;ACTN4;LIFR;KDR;STX3;TBX1;TBC1D8;PTK2;RPS4X;RPS9;RPS6KA3;VEGFC;ETS1;HSP90AB1;RPRD1B;CDKN1B;RAB27A;TGFB1;CNBP;TGFB2;RPL23;TBX2;RPS15A;DNAJA2;ADAM10;RAC1;CD81;RPS19;S100B;VEGFA;CNOT7;AQP11;ACLY;RARA;GATA2;MFSD2A;SHC1;HCFC1;TGFB3;KRAS;ADGRG1;TNFRSF1B;EDN1;FLT4;TNFRSF11A;HDAC4;INSR;PDGFC;TAL1;S1PR3;FZD7;AKT1;PDGFA;NOP2;PABIR1;LAMC2;FLOT1;FCER1G;H3-3A;EMP2;DDRGK1;AKAP6;MMP14;CDK4;VEGFD;GRK5;CIB1;S100A13;KMT2D;TLR4;FAM98A;SOX4;RPS6;ACER3;HES1;CSF1R;AGPAT1;CAPN10;HRAS;FGF2;FXN;FMR1;LMAN2;CHTOP;TUB;SRF;RAD18;MLC1;ERBB2;CLCF1;TNFSF13;CDKN2AIP;SDCBP;NSMCE4A;PTPN6;UFL1;EGFR;ZFHX3;GREM1;CSNK2A1;CDK13;ANKRD17;HCK;GAB2;RELA
prerank,regulation of spindle organization (GO:0090224),0.45530538508788027,1.229791008352056,0.2059447983014862,0.6223952881573248,1.0,7/18,19.45%,GNAI1;MAP9;BORA;FSD1;PARP3;NUMA1;NUP62
prerank,tRNA export from nucleus (GO:0006409),-0.37929306802209917,-1.229652020847575,0.17281553398058253,0.5259898507549217,1.0,14/32,26.90%,NUP93;NUP54;NDC1;NUP188;NUP155;RANBP2;NUP37;NUP160;NUP43;SEH1L;NUP42;SEC13;NUP107;NUP98
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.37929306802209917,-1.229652020847575,0.17281553398058253,0.5259898507549217,1.0,14/32,26.90%,NUP93;NUP54;NDC1;NUP188;NUP155;RANBP2;NUP37;NUP160;NUP43;SEH1L;NUP42;SEC13;NUP107;NUP98
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.4188730768691151,-1.229465606269546,0.181640625,0.5257830851916137,1.0,14/23,28.31%,UBB;UBC;RPS27A;CUL4A;COPS6;COPS5;RBX1;CETN2;COPS7A;COPS4;COPS7B;XPC;GPS1;RAD23B
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.48219418310694484,1.2285106809300985,0.21258134490238612,0.624334046282719,1.0,3/13,8.75%,IGF1;IRS2;IGF2
prerank,signal transduction by p53 class mediator (GO:0072331),-0.40544742777157944,-1.2283711692477026,0.1594488188976378,0.528057987850129,1.0,3/30,1.39%,PPP1R13B;ACER2;DDX5
prerank,aminoglycan biosynthetic process (GO:0006023),0.3721663340610565,1.2283561793707622,0.1673728813559322,0.6233821934225418,1.0,18/49,17.74%,GPC6;B3GALT1;B3GALNT1;GPC4;GPC2;B3GNT7;PXYLP1;HS2ST1;GPC5;B3GALT2;HSPG2;B3GALT5;HS6ST2;HS3ST6;HS3ST5;B3GNT6;B4GAT1;B4GALT7
prerank,cardiac cell development (GO:0055006),-0.5063854086539792,-1.2282798106495905,0.23843416370106763,0.5276046697963281,1.0,4/11,5.80%,CXADR;NOTCH1;MYH11;VEGFA
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.4422145609404621,-1.2281572147283497,0.19964349376114082,0.5272120833337834,1.0,6/19,16.38%,CSGALNACT1;EXTL3;NDST1;NDST3;HS3ST3B1;XYLT2
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.3687820750944931,-1.2281520664713668,0.17125984251968504,0.5265534346187379,1.0,11/39,13.86%,UTRN;NEDD4L;FXYD5;FHL1;WWP2;RIPK1;TRPC6;HOMER1;SPHK2;PHB2;CACNA1D
prerank,regulation of extracellular matrix organization (GO:1903053),0.481702251112327,1.2281195109399614,0.21560574948665298,0.6226127446895051,1.0,5/15,4.59%,DDR2;LRP1;EFEMP2;DDR1;AEBP1
prerank,protein O-linked mannosylation (GO:0035269),0.4516067059512488,1.2278222355351776,0.22098214285714285,0.6220880412658961,1.0,7/18,17.63%,TMTC1;TMTC4;TMTC3;CRPPA;POMT2;B4GAT1;DPM1
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.46041013114955776,1.2276632714255755,0.2112970711297071,0.621129119126297,1.0,5/18,11.25%,SLC2A13;ROCK2;LRRTM3;CASP3;CHRNA7
prerank,regulation of acute inflammatory response (GO:0002673),0.45839938055646173,1.2274816003371143,0.22580645161290322,0.6202755452375499,1.0,5/18,17.03%,IL4;GSTP1;OSMR;PTGES;KLKB1
prerank,TOR signaling (GO:0031929),-0.41493186075374333,-1.227260040903178,0.2,0.5281693569426329,1.0,14/26,31.66%,RICTOR;PRR5L;AKT1;MAPKAP1;RPS6KB2;RPS6;EIF4EBP1;MEAK7;CCDC88A;SMG1;RPTOR;CARD11;RHEBL1;RPS6KB1
prerank,amino acid transmembrane transport (GO:0003333),0.37401495407121815,1.226938575211496,0.17364016736401675,0.62032552506695,1.0,8/45,7.30%,SLC7A11;SLC6A13;SLC22A4;MFSD12;SLC36A2;SLC38A1;SLC7A9;SLC25A13
prerank,negative regulation of nuclear division (GO:0051784),0.5098652639821696,1.2261293996681943,0.226457399103139,0.6211220731199762,1.0,4/11,15.52%,AURKAIP1;TOM1L2;TOM1L1;FBXO5
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.3972978980922865,-1.2257617215244654,0.1878453038674033,0.5311275847144686,1.0,7/30,15.24%,CD34;PLCG2;PRKCZ;HSPD1;TLR4;SYK;NOD2
prerank,cellular modified amino acid catabolic process (GO:0042219),0.4772252795198443,1.2255354725002214,0.23376623376623376,0.62146091165676,1.0,3/15,5.95%,ALDH4A1;PRODH;GGT7
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.42999209073463107,-1.22550420951546,0.2038095238095238,0.5311475096727154,1.0,9/22,17.32%,UBB;UBC;RPS27A;CUL4A;GTF2H3;CHD1L;RBX1;CETN2;GTF2H4
prerank,response to glucose (GO:0009749),0.37044417545219316,1.2247962974452549,0.1799163179916318,0.6220598976346653,1.0,6/46,6.08%,TCF7L2;ZBTB20;NKX6-1;PRKACA;IRS2;PDK3
prerank,regulation of cellular component movement (GO:0051270),0.3602054202422081,1.224495611938662,0.17932489451476794,0.6215048889022992,1.0,12/49,10.22%,TGFBR3;MYCBP2;NRG1;ROCK2;LYN;NRG4;NRG2;TGFBR1;MEMO1;ZSWIM5;ERBB3;ERBB4
prerank,alpha-amino acid metabolic process (GO:1901605),0.3745899796344838,1.2243345816962965,0.19334719334719336,0.6206061256839502,1.0,18/45,22.76%,ASPA;ALDH18A1;KMO;SLC25A13;GLS2;GLUL;FOLH1;MTHFD1;ASS1;ASPG;DDAH2;NOX4;GPT2;GOT1;MTHFR;KYAT1;GOT2;MMUT
prerank,negative regulation of cell differentiation (GO:0045596),0.2920819388526112,1.223905023324775,0.0945945945945946,0.6204802913597607,1.0,27/181,9.40%,RORA;ENPP1;ADGRV1;ADAMTS12;RUNX1T1;LDLRAD4;TBX3;BMP5;ABCA1;CNTN4;PPARA;SMAD3;SFRP1;RANBP3L;HOXB8;HES3;DTX1;FOXA2;SIRT2;TGFBR1;MEN1;SOX2;ABCA5;NPHP3;IGF2;HES5;GATA3
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5255857541998814,-1.2230661810035777,0.21660649819494585,0.5367444224785908,1.0,5/10,17.76%,VEGFA;FZD3;DISC1;CX3CR1;KDM1A
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.282666045212716,-1.22293434222312,0.0718954248366013,0.5363606095543967,1.0,57/175,25.28%,TMSB4X;PTK2B;ACTN4;TNFRSF11B;NFKBIA;FOXO3;RPS3;CARD14;DAB2IP;LIMS1;IKBKB;TNFRSF1B;NPNT;PSMA6;RIPK1;TNFRSF21;TNFRSF11A;YBX3;PSMB5;DHX9;AKT1;CCL15;PSMC4;CIB1;PSMC5;PSMD14;TRAF1;AIM2;COMMD7;TNFRSF1A;EDA2R;PSMD8;TNFSF13;PSMC1;JAK2;PSMB4;PSMD11;PSMD12;RELA;CHUK;STAT1;ARHGEF2;HAS2;PSMA1;PSMC3;LTBR;TXNDC17;PSMB1;PSMA2;TNFSF13B;HYAL1;ADAMTS7;PSMA4;TRAF6;TNFRSF9;TNFRSF12A;CCL2
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.5214981996554249,-1.2228515905256057,0.244122965641953,0.5359129406471493,1.0,4/10,11.58%,NT5E;UPP2;NT5C;NT5C1A
prerank,calcium ion import across plasma membrane (GO:0098703),0.48031740548765967,1.2224040238103433,0.23214285714285715,0.6230446945539373,1.0,3/14,9.95%,SLC8A1;CACNA2D1;SLC24A2
prerank,positive regulation of cell growth (GO:0030307),-0.31335886315697936,-1.2222675973343884,0.1222879684418146,0.5366820498066776,1.0,37/96,22.61%,SEMA7A;NEDD4L;ITSN2;RPS6KA3;NGF;TGFB2;SHTN1;ADAM10;MFSD2A;EDN1;PLAA;AKT1;PABIR1;H3-3A;AKAP6;MMP14;CIB1;DBNL;NTN1;DBN1;SYT2;FXN;SMURF1;ERBB2;LIMK1;CDKN2AIP;SDCBP;EGFR;CSNK2A1;DERL2;SLC25A33;BRAT1;DDX49;UNC13A;ADNP2;EIF4G1;HYAL1
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.4666577577583677,1.2222371642478087,0.22937625754527163,0.6208206739427442,1.0,3/16,4.57%,ARHGAP6;PHLDB2;DLC1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.4666577577583677,1.2222371642478087,0.22937625754527163,0.6208206739427442,1.0,3/16,4.57%,ARHGAP6;PHLDB2;DLC1
prerank,regulation of mononuclear cell migration (GO:0071675),-0.41865055906911913,-1.2220158336877815,0.19160583941605838,0.5366474736604799,1.0,7/23,5.26%,THBS1;MAPK3;PTK2;STK10;SLIT2;MSN;CMKLR1
prerank,cellular response to inorganic substance (GO:0071241),-0.425033884427866,-1.2219994588462155,0.2034548944337812,0.536003090583414,1.0,3/21,4.93%,MTR;FOXO1;GUCY1B1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5205579469737829,1.2219255196875534,0.2647702407002188,0.6203176724798772,1.0,4/10,18.72%,KIT;LYN;BTLA;FGR
prerank,negative regulation of synaptic transmission (GO:0050805),0.42675536695465965,1.2216283312903828,0.2242152466367713,0.6198608287636448,1.0,12/23,25.98%,TMEM25;SLC24A2;PTEN;DRD2;SYT11;ACHE;PRRT1;GRIK3;STXBP1;DRD3;SHANK2;SLC24A1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.43950986896585964,1.2214450766374767,0.23201856148491878,0.6190385049213756,1.0,4/20,6.17%,SULF1;SULF2;CREB3L1;NPTN
prerank,protein localization to mitochondrion (GO:0070585),-0.5075032411544884,-1.2211656156823347,0.22820037105751392,0.5375058932299644,1.0,3/11,8.84%,HK1;AKT1;DNAJA1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.3746490486060828,1.2210690848859542,0.1983640081799591,0.61863537620079,1.0,3/45,1.29%,BMP6;BMP2;BMP5
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.5020843797187415,-1.2208535056850494,0.2379182156133829,0.537639330385252,1.0,4/11,29.63%,AKAP6;KCNIP2;TREM2;RNF207
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.48551749102473574,-1.220807361459921,0.22419928825622776,0.5370861905453543,1.0,4/14,8.39%,RFK;PAICS;ADSS2;IMPDH1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.34099384177967196,1.2205938645964942,0.1536926147704591,0.6186505622079636,1.0,10/65,7.55%,LTBP1;FBN1;FBN2;LDLRAD4;PPARA;PDPK1;SMAD3;PMEPA1;SMURF2;TGFBR1
prerank,heart morphogenesis (GO:0003007),0.36504589273828525,1.220401380296106,0.15315315315315314,0.6178725998198321,1.0,7/50,4.57%,TGFBR3;FLRT2;BMP2;TBX3;CHD7;OLFM1;DLC1
prerank,cellular response to heat (GO:0034605),-0.37334683893770165,-1.220025845174501,0.18568665377176016,0.5383649898686413,1.0,9/35,10.66%,THBS1;ANO1;FGF1;HSP90AB1;HSBP1;CLPB;TRPV4;TCIM;VCP
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.3960288292442591,-1.2190837146945201,0.1947565543071161,0.5400798527761032,1.0,16/29,35.73%,CAV1;THBS1;TNFSF10;RIPK1;INHBA;PPP2R1B;RET;LTBR;BCL10;TNFRSF12A;PMAIP1;HYAL2;PAK2;HTRA2;TNFSF12;GPER1
prerank,response to interferon-alpha (GO:0035455),-0.4605613260450746,-1.2181864672058922,0.20490367775831875,0.5417349056019177,1.0,5/16,9.33%,ADAR;IFITM1;IFITM3;IFITM2;IFNAR1
prerank,ventricular septum morphogenesis (GO:0060412),0.40346019542317113,1.2177907722085546,0.1987179487179487,0.6231556514726044,1.0,3/27,0.50%,ROBO1;TGFBR3;ROBO2
prerank,regulation of cell population proliferation (GO:0042127),-0.24570248790349924,-1.2177635364741206,0.017817371937639197,0.5422022647671612,1.0,167/691,18.32%,FN1;LEF1;KITLG;ZBTB7C;PTPN14;FLT1;IGF1R;CDK6;CLDN5;ITGA1;ACER2;NOS3;THBS1;PTPRJ;IGFBP7;IGFBP6;NOTCH1;CBFA2T3;IL15;DPP4;NAMPT;FGF1;TGFBR2;LRP5;PTK2B;BMPR2;SH3BP4;JUND;LIFR;KDR;KLF4;EGLN3;TFRC;STX3;TBX1;TBC1D8;PTK2;RPS4X;RPS9;VEGFC;ETS1;DAB2IP;NGF;SIX1;RPRD1B;CDKN1B;APP;RNF41;REST;TGFB1;CNBP;TGFB2;RPL23;TBX2;RPS15A;DNAJA2;TES;ADAM10;PLPP1;IGFBP3;CTBP1;CD81;LIMS1;ING5;COL18A1;SMAD6;S100B;VEGFA;CNOT7;AQP11;JAG2;RARA;CYP1B1;IFITM1;SHC1;RBFOX2;WNT9A;PRKDC;TGFB3;KRAS;ADGRG1;RGCC;JUP;EDN1;FLT4;TNFRSF11A;HDAC4;INSR;KANK2;PDGFC;S1PR3;SOX7;AKT1;PDGFA;NOP2;LAMC2;WARS1;HHEX;CSNK2B;ACE2;EMP2;BCL6;DDRGK1;JUNB;CDK4;GAS8;VEGFD;DIS3L2;INHBA;GRK5;CIB1;S100A13;FTH1;KMT2D;TMEM115;FRK;FAM98A;SOX4;RPS6;ACER3;HES1;ENG;CSF1R;RPS6KA2;CDK10;P3H2;HRAS;FGF2;FXN;BCL6B;SMYD2;EID2;ABI1;CHTOP;ERBB2;OSGIN1;CLCF1;TNFSF13;NPR3;STAT5A;SDCBP;SMARCA2;PTPN6;UFL1;NUAK1;EGFR;STRN;CDKN1A;JAK2;GREM1;HSPA1A;CSNK2A1;CDK13;RBBP4;HCK;GAB2;RELA;PGF;CDKN2C;DLL4;DERL2;XBP1;CD200;STAT1;SKI;TSC2;GLI1
prerank,postsynaptic membrane organization (GO:0001941),0.46529792837045625,1.2176287067492633,0.21945701357466063,0.6223367653716478,1.0,8/17,13.54%,NRXN1;LRP4;NLGN2;NLGN3;NLGN1;MUSK;DLG4;CHRNB1
prerank,mRNA transport (GO:0051028),-0.30519890568892305,-1.2174026727386733,0.1214574898785425,0.542429768325378,1.0,47/101,34.22%,HNRNPA2B1;SRSF5;SRSF2;NUP93;SRSF6;HHEX;NUP54;NDC1;U2AF1;ZC3H11A;RNPS1;SRSF4;MAGOH;NUP188;FMR1;CHTOP;NUP155;RANBP2;ALYREF;DDX39B;AGFG1;NUP37;CASC3;CPSF4;THOC6;SMG7;NUP160;DDX39A;NCBP2;SMG1;NUP43;SEH1L;EIF4E;NUP42;SEC13;NUP107;NUP98;THOC7;UPF1;SRSF9;GLE1;U2AF1L4;UPF3B;SMG6;RBM15B;SRSF1;NUP88
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.3980002490214865,-1.2171684493237747,0.1781609195402299,0.542381411293335,1.0,4/27,3.59%,UTRN;NEDD4L;FXYD5;CAMK2D
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.5289561982996807,-1.2170074905924648,0.21521335807050093,0.5420794762147773,1.0,4/10,18.12%,LRCH1;AKT1;WASL;CD200
prerank,inorganic anion transport (GO:0015698),-0.3433407331870739,-1.2170063394387858,0.16733870967741934,0.5414187356249416,1.0,7/53,3.02%,SLC4A10;ANO6;SLC26A7;CLIC4;ANO1;CLIC5;CLIC1
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.35724714947242975,-1.216954921155626,0.1700404858299595,0.5408854535531775,1.0,18/41,26.90%,ZBTB7A;NUP93;NUP54;NDC1;NUP188;NUP155;RANBP2;PRKAG1;JMJD8;NUP37;NUP160;PGAM1;NUP43;SEH1L;NUP42;SEC13;NUP107;NUP98
prerank,negative regulation of transmembrane transport (GO:0034763),-0.5304916221108167,-1.2169262902715512,0.23679417122040072,0.5402885298262944,1.0,3/10,8.61%,CTTNBP2NL;THBS1;AKT1
prerank,male gonad development (GO:0008584),0.3929173057594347,1.2165681857187751,0.19438877755511022,0.6237364265575714,1.0,7/34,9.40%,WNT4;AR;KIT;CSDE1;ADAM21;SIX4;GATA3
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.3403654860131701,-1.2161027496320276,0.15503875968992248,0.5417239523170474,1.0,23/56,23.98%,CCND3;RAB11A;ANXA1;BRD4;RGCC;ANAPC11;AKT1;RB1;LSM11;CDK4;RCC2;PHB2;EGFR;ANAPC7;ANKRD17;CDC27;CCND1;FGF10;LSM10;EIF4G1;DTL;HYAL1;RDX
prerank,ERAD pathway (GO:0036503),-0.32072513777615086,-1.215960443399503,0.14314115308151093,0.5414190451689613,1.0,39/83,34.41%,SEL1L;TRIM25;RHBDD1;FBXO17;DNAJB12;MAN1B1;RNF185;ERLIN2;UBE2G2;VCP;HSPA5;UBXN8;RNF5;FAF2;SEC61B;SGTA;RNF121;TMEM67;DERL2;AMFR;TMEM129;TMUB2;ERLEC1;SGTB;TMUB1;FBXO6;BRSK2;UBE4A;UBE2J2;STT3B;UBQLN2;FBXO2;DERL1;PSMC6;SYVN1;CCDC47;EDEM1;OS9;ANKZF1
prerank,positive regulation of hormone secretion (GO:0046887),-0.4532038921502858,-1.2156490630182728,0.20233463035019456,0.5415214719344142,1.0,3/17,9.39%,VAMP7;EDN1;SPP1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.5192841188577685,1.2148503663478738,0.23126338329764454,0.626871370418437,1.0,2/12,1.24%,PIK3R1;BCL2L11
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.5038724353332791,-1.2146485207944089,0.2309090909090909,0.543387106814832,1.0,2/11,3.67%,RREB1;CD44
prerank,UV protection (GO:0009650),-0.515239354947553,-1.2144688286526406,0.2476894639556377,0.5431935577404928,1.0,2/10,7.96%,SCARA3;GPX1
prerank,response to organophosphorus (GO:0046683),-0.4673795549800045,-1.2142379369331493,0.21195652173913043,0.5431154222076401,1.0,7/16,22.47%,TRPC3;ABCC9;TRIM16;NDUFS4;STAT1;TYMS;RFC3
prerank,negative regulation of MAPK cascade (GO:0043409),-0.31270882883168716,-1.2141748025022434,0.15,0.5426216775757605,1.0,33/87,30.10%,CAV1;SEMA6A;PTPRJ;FOXO1;DAB2IP;PPIA;PEBP1;EZR;PRDM15;UCHL1;STK38;DUSP3;TLR4;NF1;APOE;SMAD4;PIK3R2;IGBP1;SPRY1;PIN1;CDK5RAP3;SPRED3;DUSP4;PRKCD;PPEF2;PTPN1;SMPD1;DUSP1;SPRY4;DUSP6;PTPN2;MYC;HYAL2
prerank,positive regulation of sodium ion transport (GO:0010765),0.49424477746376094,1.2141700656674936,0.24267782426778242,0.6274536985311259,1.0,2/12,4.33%,SCN3B;GPD1L
prerank,neuron projection regeneration (GO:0031102),0.5125446250828436,1.2140473188477812,0.2535496957403651,0.6265464405619097,1.0,2/10,5.15%,PTN;NREP
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.4047969851220501,-1.2139162116137883,0.19324577861163228,0.5425709975871948,1.0,5/25,8.02%,CAV1;TMTC2;TRPM7;FAM20A;JPH2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.4892178858813957,1.2137747887563963,0.22197802197802197,0.6259752085808831,1.0,3/12,8.75%,IGF1;IRS2;IGF2
prerank,regulation of smooth muscle contraction (GO:0006940),-0.4327518775951545,-1.2137132717852295,0.22144112478031636,0.542432455937575,1.0,7/20,22.73%,PLCE1;CAV1;SRF;ATP2B1;KCNB2;CTTN;NMUR2
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.3053449205473725,-1.2134636401797407,0.125531914893617,0.5423486520899143,1.0,35/110,20.01%,RACK1;TFRC;RPS3;DAB2IP;FNIP2;TGFB1;HSPA8;PRKCZ;RALB;NAPA;VEGFA;HCFC1;SVIP;AIDA;TAL1;KIF9;BAX;RB1;WARS1;VCP;TIRAP;IMPACT;HSPA5;NCLN;SYK;BAK1;SLF1;APOE;HSP90AA1;HCK;CRYAB;GFAP;BIK;CDH5;LCMT1
prerank,membrane assembly (GO:0071709),0.3916144919776433,1.2132611358736733,0.1921487603305785,0.6259664514837655,1.0,11/34,10.39%,NRXN1;LRP4;PTPRD;UBXN2B;NLGN2;UBXN2A;NLGN3;IL1RAPL1;NLGN1;PTEN;TLCD2
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.46550180533376173,1.2128934847833805,0.24444444444444444,0.6256456610416313,1.0,4/15,6.38%,TNK2;DGKD;AAK1;SNAP91
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.37784752007402156,-1.2128454385578602,0.1786407766990291,0.5432611865444782,1.0,14/35,18.13%,MEF2C;CAV1;FLT1;THBS1;CAV2;PTPRM;ATP5F1A;RGCC;NF1;APOE;ATP5IF1;KRIT1;DLL4;STAT1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.511300245723816,-1.2128389633989964,0.2395644283121597,0.5426213700515581,1.0,5/11,18.29%,SERTAD2;ARID1A;ZMIZ2;CDCA4;CHEK1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.2552470068417052,-1.2126258482330006,0.0410958904109589,0.5424917779687045,1.0,91/417,14.46%,MECOM;LEF1;FOXP1;ELK3;DACH1;WWP1;RPS6KA5;ATP8B1;NOTCH1;CBFA2T3;ID1;ZHX3;HMBOX1;ID3;PPARD;KLF4;NCOR1;FOXO1;DAB2IP;ZBTB7A;CDKN1B;PRDM16;REST;TGFB1;KDM5C;HDAC9;WWP2;TBX2;HSPA8;KCTD1;FOXD1;ZBTB16;PFDN5;RLIM;SOX13;CD38;CTBP1;LIMS1;FOXK1;DPF2;BHLHE40;HEYL;DPF3;PHC2;CNOT7;MPHOSPH8;RARA;SHC1;RBFOX2;FOXN3;NR3C1;GATA6;CBX5;PPM1F;CIC;HDAC4;UIMC1;NDUFA13;ZMYND11;SOX7;RB1;TRIM28;TWIST1;HHEX;SOX18;FOXP2;ZC3H8;BCL6;WNT11;SFPQ;ZBTB18;CCDC85B;LIMD1;PHC1;SP3;CIPC;ZNF423;EPC1;HES1;E2F1;COMMD7;MLX;PHB2;CIART;MTERF3;POU2F1;PHF12;LDB1;HEY1;EID2;SMARCA4
prerank,acylglycerol homeostasis (GO:0055090),0.43524184203623545,1.2125815353252627,0.2356687898089172,0.6251208434678028,1.0,3/20,11.37%,RORA;IL18;PLA2G12B
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.31899938825001345,-1.2122725687912876,0.13026052104208416,0.5427706114404638,1.0,25/78,21.97%,CAV1;CBFA2T3;RACK1;RNF144B;SMAD7;GABARAP;SH3RF2;TRIB2;PABIR1;TRIB1;DDRGK1;USP5;VCP;BCAP31;RBX1;SGTA;HECTD1;HSPA1A;FZR1;RNF19A;ELOB;KEAP1;HSPA1B;TRIB3;PLK3
prerank,estrogen metabolic process (GO:0008210),-0.4750499368425765,-1.2122262631375014,0.23722627737226276,0.5422460121224273,1.0,4/15,18.04%,SULT1A1;CYP1B1;HSD17B10;HSD17B2
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.41265824071613666,1.212037365162176,0.20084566596194503,0.6252658659942516,1.0,2/24,0.26%,AUTS2;PIK3R1
prerank,negative regulation of cell motility (GO:2000146),0.30856230920882677,1.2118319062069673,0.16475095785440613,0.6245070773361069,1.0,25/108,12.38%,ROBO1;LDLRAD4;PODN;FBLN1;SULF1;MAGI2;MITF;RECK;RAP2A;SFRP1;PTPRT;DLC1;SPOCK3;SRGAP2;SRGAP3;SERPINE1;DPYSL3;CITED2;GATA3;PTEN;FUZ;EPHA1;AFDN;NAV3;NGFR
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5044513663426263,-1.211472897876904,0.2328519855595668,0.5434578121697238,1.0,2/11,2.70%,NOTCH1;FOXO1
prerank,protein secretion (GO:0009306),0.35374437172141854,1.2099100193780952,0.20041753653444677,0.6282565956965803,1.0,14/56,16.60%,WLS;STEAP3;TANGO2;ABCA1;RAB3C;MON1A;SCG2;RAB10;LTBP2;CYB5R4;SVBP;COPG2;PORCN;MIA3
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.5086438890945464,1.2098411529247532,0.23963133640552994,0.6271417854912897,1.0,3/11,5.34%,STAP1;TICAM1;CAMK4
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.3584463751608484,-1.2096554456139093,0.1825242718446602,0.5473443932774288,1.0,10/49,11.62%,MEF2C;THBS1;TNRC6C;KMT2C;RBBP5;MYL9;CBFB;H3-3A;CIB1;KMT2D
prerank,actin filament depolymerization (GO:0030042),0.5142609171092272,1.2094390504473553,0.24416135881104034,0.6268902656795325,1.0,1/11,0.13%,MICAL3
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.3104603798122396,-1.2093208370675623,0.12552301255230125,0.5474640774470921,1.0,26/88,15.51%,RACK1;TFRC;RPS3;DAB2IP;FNIP2;TGFB1;VEGFA;RGCC;ERCC1;TAL1;PFN1;BAX;WARS1;FLOT1;VCP;SYNPO;TIRAP;SYK;RAB7A;BAK1;SLX4;SLF1;TSG101;LIMK1;SDCBP;SNF8
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.5031441196483131,-1.2092121195158656,0.23971377459749552,0.5470715740447161,1.0,8/11,37.26%,JAK2;STAT1;IL6ST;IL12RB2;STAT4;IL27RA;CANX;IL12A
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.4292992703830371,-1.2091893182413138,0.2184557438794727,0.5464801860802185,1.0,3/20,7.35%,ANO6;THBS1;RGCC
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.2890352469213431,-1.2088001296297595,0.11290322580645161,0.5468165825116751,1.0,32/151,13.85%,TEK;BMPER;RAP1A;ACKR3;NOTCH1;SEMA7A;PTK2B;KDR;MAPK3;FERMT2;TNFAIP8L3;CD44;APP;TGFB1;MFHAS1;PRKCZ;SHC1;PDE8A;NPNT;FLT4;TNFRSF11A;PDGFC;CCL15;PDGFA;CD74;TIRAP;CIB1;CSF1R;HRAS;FGF2;PHB2;APOE
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.3687909928670265,-1.207873929445546,0.19765166340508805,0.5486452265764626,1.0,12/36,13.85%,MEF2C;THBS1;NOTCH1;SLIT2;DAB2IP;TGFB1;PTPRM;RGCC;JUP;CSNK2B;FGF2;APOE
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.4497217562969455,1.207701368532478,0.25116279069767444,0.63012878552452,1.0,2/17,0.74%,ATP1A2;AR
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.4819827875034943,-1.2075262938395888,0.24550898203592814,0.5488230558173478,1.0,11/14,26.34%,DAB2IP;BAX;DDRGK1;HSPA5;COPS5;BAK1;UFL1;TMEM33;BFAR;PTPN1;FICD
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.4925978380930791,-1.2074159434471576,0.2322357019064125,0.5484518473130114,1.0,2/12,4.75%,SORBS1;PRKCZ
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.3095946923659591,-1.2073235533667759,0.14763779527559054,0.5480390591492105,1.0,26/94,17.71%,RAB11A;DCTN2;TUBA1A;CEP164;PPP2R1A;PRKAR2B;CEP57;CEP192;CEP162;CEP70;DCTN3;CEP290;DCTN1;CNTRL;TUBB4B;PCM1;CC2D2A;HAUS1;NDE1;CETN2;KIF24;CEP72;YWHAG;HSP90AA1;TMEM67;CEP41
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.4158201080737258,-1.2071249978134575,0.20275590551181102,0.5478584916687135,1.0,9/22,22.63%,DDX5;RPS15;RPL23;UBB;RPS20;RPS7;CDK5RAP3;MSX1;SPRED3
prerank,positive regulation of T cell proliferation (GO:0042102),0.3473931445773549,1.2068502721289258,0.18786692759295498,0.6310278597286328,1.0,6/55,8.86%,IGF1;IGFBP2;IL4;CD274;IGF2;IL18
prerank,response to thyroid hormone (GO:0097066),-0.4784888242962919,-1.2063786677214334,0.24866785079928952,0.5490682139043926,1.0,5/13,25.62%,LMO2;CTSB;GAS2L1;RDX;CTSS
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.43156837573029,-1.2062854240401875,0.20112781954887218,0.5486370562185937,1.0,12/18,35.42%,MANBA;FBXO17;SAMHD1;OGA;FBXO6;STT3B;NEU2;NAGA;FBXO2;FUCA1;AOAH;NEU4
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.4348698431117945,1.2062455684683209,0.22055674518201285,0.6312784910638437,1.0,2/20,7.70%,WNT4;CRY1
prerank,cellular glucose homeostasis (GO:0001678),-0.3614290270839462,-1.205834014276108,0.1750503018108652,0.5492090056971627,1.0,9/41,5.39%,IGF1R;UNC13B;RACK1;LRRC8D;FOXO1;HK1;KCNB1;PPARGC1A;FOXK1
prerank,response to UV (GO:0009411),-0.3132639484405154,-1.2056927829245143,0.14699792960662525,0.5489039866096763,1.0,29/95,24.07%,SCARA3;RPL26;MAP4K3;USP1;RHBDD1;N4BP1;ATF4;GPX1;YY1;AKT1;CIRBP;SPRTN;BAK1;FMR1;EGFR;RELA;POLK;KDM1A;CCAR2;PTPRK;CCND1;ERCC4;COPS9;UBE2B;RHNO1;TRIAP1;DTL;PRKCD;DCUN1D3
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.3636951966239925,-1.2055213881166675,0.18604651162790697,0.5486758591279887,1.0,14/37,22.25%,CAV1;RACK1;RPS3;UBB;BAX;SFPQ;BCL2L1;RPS7;BBC3;BCAP31;BAD;MSX1;NCK1;FIS1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.3811676255451818,1.2048950368179547,0.20350109409190373,0.6335343165310705,1.0,8/37,10.32%,IGF1;GJA1;EFEMP2;TAFA5;DNMT1;BMPR1A;SOD2;PTEN
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.3954787581743824,-1.2045218693454331,0.21235521235521235,0.5506572428244183,1.0,12/29,20.05%,NAPA;RAB6B;GOSR1;COPG1;COG8;COPB2;COG5;COG3;GOLGA5;NSF;VTI1B;COG2
prerank,mitochondrial protein processing (GO:0034982),0.4888075143874059,1.2040652909129885,0.2516703786191537,0.6343809159390403,1.0,5/11,20.56%,OMA1;IMMP1L;YME1L1;PMPCA;AFG3L2
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.49246032958784425,-1.2040325312346833,0.2545454545454545,0.5512159525598298,1.0,3/12,3.99%,PTPRJ;F3;IFT20
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.321121224134936,-1.2034794188891056,0.15320910973084886,0.5519969690775642,1.0,25/76,21.72%,CBFA2T3;RACK1;PTK2;RNF144B;SMAD7;GABARAP;SH3RF2;TRIB2;PABIR1;TRIB1;DDRGK1;USP5;VCP;RBX1;SMURF1;HECTD1;HSPA1A;RNF19A;ELOB;CDK5RAP3;LAPTM5;CCDC22;KEAP1;HSPA1B;TRIB3
prerank,potassium ion homeostasis (GO:0055075),-0.41175551124966536,-1.203301606841394,0.20934579439252338,0.5518190622775412,1.0,5/23,7.01%,SLC12A7;SLC12A2;KCNJ2;ATP1A1;ATP1B1
prerank,muscle cell differentiation (GO:0042692),-0.3778276720999265,-1.2031441860471597,0.21521335807050093,0.5515361095267846,1.0,6/32,2.88%,NEBL;MEF2C;MRTFB;SYNE1;DMD;TBX1
prerank,xenobiotic transport (GO:0042908),-0.4421542913590326,-1.202992297235173,0.2351851851851852,0.5512767823368097,1.0,3/17,1.81%,ABCG2;SLC47A1;SLC7A5
prerank,histone H4-K8 acetylation (GO:0043982),-0.458548351252065,-1.2026508461076628,0.22831858407079647,0.5508690921662441,1.0,4/15,7.95%,PHF20;JADE2;HCFC1;KANSL2
prerank,histone H4-K5 acetylation (GO:0043981),-0.458548351252065,-1.2026508461076628,0.22831858407079647,0.5508690921662441,1.0,4/15,7.95%,PHF20;JADE2;HCFC1;KANSL2
prerank,negative regulation of biomineral tissue development (GO:0070168),0.4263567003533042,1.2021312425905704,0.23820224719101124,0.6380808175830254,1.0,4/21,2.56%,ENPP1;BCOR;AHSG;ROCK2
prerank,regulation of stem cell population maintenance (GO:2000036),0.44561414955550904,1.2020344315552025,0.25,0.6370911327210512,1.0,5/18,15.86%,PTN;TAF6L;LOXL2;TAF5L;NCOA3
prerank,anion transport (GO:0006820),-0.3767181738510964,-1.2019510333869503,0.21482889733840305,0.5519020585805479,1.0,5/33,2.19%,ABCG2;SLC26A7;SLCO2B1;LRRC8C;LRRC8D
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.4106668573829574,1.2018613043478632,0.22505307855626328,0.6362237369459789,1.0,4/23,7.86%,ERRFI1;CBLB;VPS25;ZFYVE28
prerank,heterochromatin organization (GO:0070828),-0.46821033224836395,-1.2017977559810562,0.2185792349726776,0.5516462068409701,1.0,2/14,4.10%,MECOM;PRDM16
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.4255083345676363,-1.2017958575361753,0.23106796116504855,0.5510029363405505,1.0,7/20,17.24%,TGFB1;ADAM10;RHBDD1;MBTPS2;PSENEN;APH1A;RELA
prerank,positive regulation of signaling (GO:0023056),0.382091272831097,1.2017939696846245,0.20682730923694778,0.6351435307784156,1.0,7/37,9.40%,WLS;CLSTN2;RIMS1;GRIK2;RAB29;SYT1;GATA3
prerank,cellular component assembly (GO:0022607),-0.26560644488322915,-1.2017457952440977,0.0931174089068826,0.5504872294853752,1.0,62/253,19.92%,ACTB;OCLN;SLC2A1;LIMS2;BAIAP2L1;PARVB;ACTG1;SPTBN1;PARD3;EPS8;RHOJ;PTK2B;OPHN1;PLS3;CD2AP;FERMT2;TGFB1;ZW10;NEDD9;RP1;PPARGC1A;RAC1;LIMS1;GORASP2;PPP2R1A;REPS2;EZR;TAPBP;QSOX1;STK25;ADD1;PDGFA;FAS;FAM107A;CEP290;SPEF1;CD74;GAS8;TEAD2;HAS1;YTHDF2;YWHAZ;HES1;TRAF1;CDAN1;WASL;VMP1;MDN1;SHROOM1;CHCHD10;NCKAP1;RBBP4;RTN3;RAD21;SKAP2;ELOB;SPAG16;SOX9;SHANK1;CAPG;WIPF1;HAS2
prerank,mitochondrial fusion (GO:0008053),-0.43947249609293526,-1.2015272704289781,0.22160148975791433,0.5503544809713018,1.0,11/18,41.07%,MIEF1;BAX;CHCHD3;MIEF2;OPA1;FIS1;MFF;MIGA1;THG1L;GDAP1;MFN1
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.3568976155145863,-1.2014896333141394,0.19348659003831417,0.5498019345322077,1.0,17/44,27.69%,PTPRJ;DAB2IP;AIDA;DNAJA1;UCHL1;STK38;NF1;APOE;SPRY1;CDK5RAP3;PTPN22;PRKCD;PTPN1;SMPD1;PDCD4;DUSP1;SPRY4
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.4568244047265436,1.2012328436565045,0.25656565656565655,0.6353343683727575,1.0,10/18,12.52%,NRXN1;RIMS1;NLGN2;NLGN3;NLGN1;STX1B;CUX2;PTEN;CHRNA7;DLG4
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.34912434971470774,-1.2011203247990767,0.19128787878787878,0.5500965940711166,1.0,25/52,29.13%,PPP1R13B;ABLIM3;PPP3CC;CASP8;YWHAZ;SAE1;BBC3;E2F1;VPS11;YWHAG;CSNK2A2;YWHAH;BAD;UBL5;SFN;FZD5;YWHAB;NPEPPS;MICALL2;UBE2J2;ATG13;YWHAE;YWHAQ;PMAIP1;NMT1
prerank,regulation of hemopoiesis (GO:1903706),0.506966313703861,1.2003346357840194,0.2537634408602151,0.636430798920698,1.0,2/10,9.71%,PTN;PRKCB
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.33479848417569397,-1.2002384165560769,0.1590909090909091,0.5516626392146694,1.0,20/57,19.29%,BRCC3;TAOK3;FOXN3;PRKDC;UIMC1;BABAM1;RPS27L;TAOK2;CDC14B;RAD9B;HUS1;EME2;CDKN1A;RAD9A;RAD17;FZR1;CHEK1;BABAM2;CCND1;CDK5RAP3
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.35245567147302226,-1.1999973775687214,0.2,0.5515798050895456,1.0,18/41,26.90%,ZBTB7A;NUP93;NUP54;NDC1;NUP188;NUP155;RANBP2;PRKAG1;JMJD8;NUP37;NUP160;PGAM1;NUP43;SEH1L;NUP42;SEC13;NUP107;NUP98
prerank,regulation of cytokinesis (GO:0032465),-0.3147439705770514,-1.199918955683692,0.1346153846153846,0.5511589097959642,1.0,41/78,34.19%,PKP4;RAB11A;CDC14A;CALM1;GIPC1;ZFYVE26;PLK2;KIF23;BCL2L1;PRKCE;CALM3;RAB11FIP3;CDC14B;CETN2;KLHL9;ECT2;KLHL21;PIN1;KIF13A;PRPF40A;E2F7;PLK3;CIT;PLK5;CENPV;RACGAP1;VPS4A;CDC42;SETD2;MYO19;CSPP1;AURKA;PLK1;CDC6;ENTR1;RHOA;PIK3R4;E2F8;OPN1MW;CUL3;PRC1
prerank,cell-cell junction organization (GO:0045216),-0.3130959880161907,-1.1995232824418443,0.16194331983805668,0.551529107352643,1.0,17/79,8.22%,PKP4;OCLN;CLDN5;LIMS2;CXADR;CDH1;CTNNA1;TJP2;TGFB1;TGFB2;SDK1;LIMS1;CDH4;TGFB3;JUP;GJC1;PVR
prerank,natural killer cell mediated immunity (GO:0002228),-0.4629092679393103,-1.1994750164992758,0.2648752399232246,0.5510122569109834,1.0,4/15,19.91%,LYST;PLEKHM2;TUBB4B;ARL8B
prerank,nucleoside catabolic process (GO:0009164),-0.4997204802274064,-1.1993013705143951,0.27060931899641577,0.5507527299079301,1.0,4/11,11.58%,NT5E;UPP2;NT5C;NT5C1A
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.4856438554593226,-1.1981209773690873,0.2541436464088398,0.5531873181977612,1.0,3/12,2.77%,PODXL;PROM1;IQGAP1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.3321390353271794,-1.1975321906966498,0.16865079365079366,0.5540698306510704,1.0,31/60,36.36%,HMBOX1;KLF4;MAPK3;NEK7;HSP90AB1;RGCC;FBXO4;DKC1;PNKP;FGF2;CCT2;HSP90AA1;GREM1;HNRNPA1;CCT3;CCT8;RFC3;RFC2;PRKD2;CCT7;DSCC1;CTNNB1;CHTF18;MYC;CCT4;PKIB;WRAP53;NVL;MAP2K7;CCT6A;MAPK15
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.2604745549115016,1.1972819084635093,0.06427221172022685,0.6432214429049231,1.0,69/390,12.72%,COL4A6;IGF1;EPHA7;PIK3R1;NRP1;IL31RA;FLRT2;ATP6V0A4;DDR2;NTRK3;ANGPT2;FGFR2;SULF1;NRG1;SULF2;PDGFRA;KL;EFS;KIT;MTSS1;ROCK2;EPHA3;TNK2;VEGFB;EPHA6;FLRT1;PDK4;DDR1;STAP1;PHIP;LYN;PTPRT;GHR;EFNA3;IRS2;AXL;PDGFRB;SHC4;SIRT2;CASP3;EPHB1;POLR1G;ROR1;PDGFD;RYK;ERBB3;IGF2;SH2D2A;POLR2G;FGFR4;EPHA8;CDK5R1;ATP6V1H;SH2D6;AHI1;ESRP1;ERBB4;EPHA5;BRK1;ALK;MUSK;MST1R;MERTK;FGFR1;EPHA1;GFRA2;NGFR;KALRN;PRLR
prerank,skin development (GO:0043588),-0.3269755656193139,-1.1964829798672498,0.16310679611650486,0.556170966560344,1.0,18/65,15.96%,ITGA6;CLIC4;LSR;COL5A2;ITGB4;ANXA1;COL3A1;PKD1;BCR;GATA6;PDGFA;COL5A3;DHCR24;HRNR;OPN3;MET;EPHA2;DSP
prerank,sterol transport (GO:0015918),-0.42520556504687046,-1.1963935782960564,0.24423076923076922,0.555723077845679,1.0,9/19,34.14%,CAV1;NPC1;LCAT;MSR1;OSBPL2;CD36;ARV1;OSBPL5;LDLR
prerank,chloride transport (GO:0006821),-0.315937289152993,-1.1961663116250887,0.16359918200409,0.5556153179123092,1.0,10/74,4.41%,SLC4A10;ANO6;SLC12A7;SLC26A7;SLC12A2;CLIC4;ANO1;CLIC5;CLIC1;SLC1A1
prerank,L-amino acid transport (GO:0015807),0.3998616637040167,1.1960474404177237,0.23956043956043957,0.6450258220363183,1.0,10/28,16.45%,SLC1A3;SLC7A2;SLC36A2;SLC7A9;SLC25A13;SLC38A3;CTNS;SLC1A2;SLC7A3;SLC25A18
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.43363023738642187,-1.1959119859319862,0.2198852772466539,0.5556053325774721,1.0,11/18,35.49%,CHP1;DKC1;CCT2;CCT3;CCT8;CCT7;PTP4A3;TREM2;CCT4;WRAP53;CCT6A
prerank,positive regulation of transferase activity (GO:0051347),0.2954519426660332,1.1957330253847918,0.11663479923518165,0.6444742477450939,1.0,37/142,13.81%,EPHA7;DDR2;NTRK3;FGFR2;PDGFRA;KIT;EPHA3;EPHA6;LMO4;DDR1;MAPKAPK5;AXL;PDGFRB;EPHB1;ROR1;RYK;ERBB3;IGF2;FGFR4;EPHA8;RFC5;TOPORS;PABPN1;ERBB4;EPHA5;ALK;HNRNPD;MUSK;MST1R;CHRNA7;MERTK;FGFR1;EPHA1;DCUN1D4;NBN;PARN;SERINC1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.3362515439768681,-1.195628264833027,0.1956521739130435,0.555676988063107,1.0,18/54,22.76%,TAX1BP1;RACK1;HIPK1;IKBKB;CASP8;RIPK1;SYK;TRAF1;TNFRSF1A;MADD;HSPA1A;CHUK;TNFAIP3;TRAIP;LAPTM5;HSPA1B;CASP1;CCDC3
prerank,amino acid import (GO:0043090),-0.41848631767436606,-1.1954855394649384,0.22448979591836735,0.5554342161988058,1.0,7/21,5.86%,SLC47A1;SLC6A6;SLC7A5;SLC7A1;SH3BP4;SLC1A1;SLC25A38
prerank,acidic amino acid transport (GO:0015800),0.44487338497008183,1.1950758017099352,0.21961620469083157,0.6448766724549446,1.0,3/17,1.64%,SLC1A3;SLC6A13;GJA1
prerank,negative regulation of interferon-beta production (GO:0032688),-0.5068417392980451,-1.1945845670615676,0.2482876712328767,0.5570990598764389,1.0,6/10,32.44%,REL;YY1;RELB;LILRB1;PTPRS;NLRC3
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.3731442166203444,1.1937800603161803,0.18219461697722567,0.6470183018722746,1.0,9/43,11.16%,IGF1;GJA1;CCN4;PDGFRB;DNMT1;IL18;HES5;BMPR1A;IL6R
prerank,tRNA transport (GO:0051031),-0.3657508506560096,-1.1934827047730463,0.18518518518518517,0.5592901010462155,1.0,14/35,26.90%,NUP93;NUP54;NDC1;NUP188;NUP155;RANBP2;NUP37;NUP160;NUP43;SEH1L;NUP42;SEC13;NUP107;NUP98
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.4674514820839006,-1.1931564163125696,0.22407407407407406,0.5595315009606305,1.0,4/14,5.26%,THBS1;MAPK3;PTK2;CMKLR1
prerank,actin polymerization or depolymerization (GO:0008154),0.35709352125695865,1.1931245346782962,0.2015810276679842,0.6475222472533753,1.0,3/50,0.24%,MICAL3;SVIL;ARHGAP6
prerank,sulfur compound catabolic process (GO:0044273),0.374523253769897,1.1918614972800616,0.20607375271149675,0.6496013150580026,1.0,10/38,13.07%,FMOD;DCN;LUM;GNS;OMD;GALNS;GGT7;OGN;VCAN;GLB1
prerank,regulation of protein kinase A signaling (GO:0010738),0.43359412507762085,1.1917115619290344,0.23333333333333334,0.6487640164110147,1.0,3/20,7.04%,ADGRV1;IAPP;CALCR
prerank,protein localization to vacuole (GO:0072665),-0.47418040583241927,-1.1915499718228217,0.25849056603773585,0.5630446092693863,1.0,4/13,14.52%,SH3BP4;CD81;GLMP;MFSD1
prerank,regulation of monocyte differentiation (GO:0045655),-0.4672139161365355,-1.1909229982155871,0.24640287769784172,0.5640316316962973,1.0,4/14,11.10%,FOXP1;CDK6;CD74;CTNNBIP1
prerank,neuron projection morphogenesis (GO:0048812),0.2946419831875406,1.190905590451085,0.142,0.649645816106527,1.0,28/137,10.64%,NRK;EPB41L3;FGFR2;CNTN4;CNTNAP2;LRP4;FLRT1;GPM6A;DOCK10;CTNNA2;SLITRK4;MYO16;SRGAP2;CTNND2;GAS7;EPHB1;DOCK7;MAPK8IP2;TNIK;NLGN1;ALCAM;NRCAM;RAB10;FARP1;RYK;PTEN;DCC;BRSK1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.41655571892636983,-1.1900186756324544,0.2437619961612284,0.5656850379759376,1.0,3/21,3.34%,CHST11;CSGALNACT1;CSPG4
prerank,carboxylic acid transport (GO:0046942),0.34444703583644787,1.1899137344171187,0.18653846153846154,0.6509628795093118,1.0,12/55,10.06%,SLC13A3;SLC6A12;SLC16A12;SLC6A9;SLC6A13;SLC17A1;SLC16A14;SLC36A2;SLC38A1;SLC25A10;SLC6A11;SLC1A5
prerank,mononuclear cell differentiation (GO:1903131),0.4024125675903705,1.189818992585394,0.23672566371681417,0.6499364587641551,1.0,4/24,5.90%,IL31RA;LYN;IL4;AXL
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.38155685135640593,-1.1897743494438375,0.24242424242424243,0.5656819611101884,1.0,8/29,11.83%,UBB;UBC;RPS27A;IKBKB;CASP8;TLR3;RIPK1;TLR4
prerank,BMP signaling pathway (GO:0030509),0.34278179721079016,1.1895491379063725,0.2033195020746888,0.6494092653006455,1.0,5/62,2.72%,BMP6;TGFBR3;BMP2;BMP5;SMAD3
prerank,proteoglycan biosynthetic process (GO:0030166),0.37920602171712553,1.1894531689890124,0.23043478260869565,0.6483898068251779,1.0,4/31,4.87%,IGF1;CHST8;GAL3ST3;PXYLP1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.44249327706895236,1.1893990661933636,0.2771618625277162,0.6472662562366589,1.0,11/17,24.66%,VIRMA;ZC3H3;CPEB3;CPEB1;CCNT1;CPSF7;CDK9;CPSF6;HSF1;NUDT21;CTR9
prerank,apoptotic process (GO:0006915),-0.271441542724271,-1.1889689880643515,0.09129511677282377,0.5671434118159875,1.0,55/203,20.05%,SEMA6A;TGFBR2;PTK2B;NFKBIA;PPARD;FOXO1;EGLN3;TBX1;ADAM15;FAP;RFK;APP;PPIA;ZBTB16;MAGI3;DPF2;PPP2R1A;CASP7;CASP8;RIPK1;DDX41;TNFRSF21;GAPDH;PLAGL1;AKT1;MAL;BAX;FAS;HIP1;RHOB;HSPD1;TAOK2;PRUNE2;TNFAIP1;PAEP;CIB1;BCL2L1;PRKCE;BAK1;BBC3;DHCR24;PIK3CA;MRPS30;NCKAP1;DDIT4;JAK2;BAD;CHEK1;TSC2;TRAIP;MAGEH1;ARHGEF6;BIK;GADD45A;BRAT1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.3810900832003173,-1.1887966877365495,0.22682445759368836,0.5669838110122993,1.0,17/30,35.47%,CAV1;PRKCZ;PPP2R1A;SRCIN1;PTPN6;CADM4;DMTN;PRKCD;PARP14;PTPN2;HYAL2;MVP;SH3BP5;NTF3;NF2;INPP5F;PPP2CA
prerank,meiosis I (GO:0007127),0.409904492189454,1.1886791618636436,0.2409090909090909,0.6479412272503294,1.0,4/23,7.93%,BCL2L11;MEIKIN;HSF2BP;ZSCAN21
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.34175376332753016,-1.1886696591700163,0.1898989898989899,0.5666555721533246,1.0,20/48,26.90%,ZBTB7A;PRDM16;NUP93;NUP54;NDC1;NUP188;NUP155;RANBP2;PRKAG1;JMJD8;NUP37;NUP160;RUBCNL;PGAM1;NUP43;SEH1L;NUP42;SEC13;NUP107;NUP98
prerank,response to growth factor (GO:0070848),-0.36393498035948413,-1.1886065411329347,0.2172211350293542,0.5661891343197157,1.0,23/41,33.47%,TGFBR2;RACK1;BMPR2;MAP2K5;KLF4;SHC1;GATA6;AKT1;CIB1;ACVR1;ERBB2;EPHA2;BMPR1B;CPNE3;LRP2;PLK5;CTNNB1;ACVRL1;MYC;RPS6KB1;HTRA2;NOS1;MAPK7
prerank,regulation of cellular senescence (GO:2000772),-0.3846296308243752,-1.187874610047937,0.22077922077922077,0.56747867196762,1.0,6/28,9.62%,CDK6;B2M;MAP3K3;ABI3;TWIST1;YPEL3
prerank,cellular response to starvation (GO:0009267),-0.28269248800842733,-1.1877538302236452,0.13559322033898305,0.5671846720339512,1.0,48/147,24.50%,MAP3K5;BMPR2;FOXO1;MAPK3;FOXO3;DAPL1;MAP1LC3B;ATP6V0B;HSPA8;RALB;GABARAP;MFSD2A;ATF4;FAS;ATP6V0C;ATG7;XPR1;IMPACT;HSPA5;MAP1LC3A;LAMTOR2;NUAK2;INHBB;GAS2L1;PRKAG1;STK26;NUAK1;RRAGD;CDKN1A;ATP6V1G1;HNRNPA1;XBP1;ASNS;WIPI2;TFEB;RRAGA;KLF10;RIPOR1;SESN2;VPS41;NUPR2;SIK1;RRAGC;CASTOR2;GABARAPL1;ATP6V0D1;BRSK2;SEH1L
prerank,histone H4-K16 acetylation (GO:0043984),-0.42689645915886026,-1.1875318102401822,0.2413793103448276,0.5671579266675248,1.0,5/19,7.95%,MSL2;PHF20;JADE2;HCFC1;KANSL2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.42895112495187687,-1.1870129518741197,0.24282982791587,0.5678176502451433,1.0,4/17,13.74%,CD55;TLR4;IL18BP;BTN3A3
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.3996720116634135,-1.1862688870327693,0.21951219512195122,0.5690905067390992,1.0,9/25,18.03%,ZNF326;ZMYND11;HMGN1;TSFM;LDB1;ALYREF;CCNK;DDX39B;CCAR2
prerank,amyloid-beta metabolic process (GO:0050435),-0.4490256297108307,-1.18591408229611,0.2596685082872928,0.5693441660349234,1.0,6/16,13.56%,BACE2;BACE1;IDE;PSENEN;ACE;APH1A
prerank,regulation of endopeptidase activity (GO:0052548),0.333976312045864,1.1858099076175468,0.19834710743801653,0.6542010886691945,1.0,17/59,19.70%,TIMP3;SERPINE2;AHSG;SERPINI2;SERPINF1;SPOCK3;SERPINE1;TIMP4;PSMA3;PSME3;NRDC;BIRC2;HDAC1;PSMB9;SERPING1;NCSTN;TIMP1
prerank,extracellular matrix assembly (GO:0085029),-0.4106021399951123,-1.1857525024255549,0.2602996254681648,0.5691295972131221,1.0,7/23,11.74%,RAMP2;TNXB;MYH11;TGFB1;NTN4;QSOX1;HAS1
prerank,pinocytosis (GO:0006907),0.5034506606205369,1.1853855910010191,0.2420814479638009,0.6540699179022355,1.0,2/10,2.79%,AHSG;SNX33
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.2959931136622083,-1.185365596817982,0.13978494623655913,0.5694958876741196,1.0,40/107,22.34%,MAP3K5;THBS1;RASGRF2;NIBAN1;SEL1L;DAB2IP;TMEM259;GORASP2;RHBDD1;ATP2A3;UFM1;ATF4;MBTPS2;DNAJB12;BAX;RNF185;FLOT1;DDRGK1;VCP;HSPA5;RNF5;BAK1;BBC3;ERP44;BCAP31;UFL1;PIK3R2;UFC1;CDK5RAP3;UBA5;TMEM33;PDIA4;THBS4;SELENOK;ERLEC1;TRIB3;CREB3L2;NCK1;ERO1A;ATF3
prerank,regulation of interleukin-17 production (GO:0032660),-0.37730838728417315,-1.1847528261152627,0.21978021978021978,0.5704282295981162,1.0,6/31,16.59%,IL15;SLC7A5;TGFB1;TLR4;NOD2;VSIR
prerank,organic hydroxy compound transport (GO:0015850),-0.357377427560864,-1.184658709910437,0.2028397565922921,0.5700475334261172,1.0,5/36,5.28%,ABCC4;SLCO1C1;ATP8B1;SLCO2B1;STRA6
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.38005711878386805,1.1846148995166386,0.22981366459627328,0.6548880000673319,1.0,5/35,5.02%,PLXNA2;NRP1;SEMA5A;SEMA3A;SEMA3D
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.29902838705685475,-1.1837160557176636,0.14757281553398058,0.5717736360992777,1.0,28/104,19.70%,ACTB;CCND3;LRP5;DAB2IP;CALM1;CDKN1B;RALB;HTT;TRIB2;AKT1;RB1;CCNG2;TRIB1;CAMK1;MTCP1;CIB1;CALM3;CSF1R;TSG101;CAB39;CCNF;SNF8;CCNK;CDKN1A;CDKN2C;CCND1;CDK5RAP3;GADD45A
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.44860856163807256,1.1836855088799458,0.22494432071269488,0.6560941916171242,1.0,4/16,8.66%,NRP1;PDGFRA;PDGFRB;PDGFD
prerank,regulation of transforming growth factor beta production (GO:0071634),0.4368456973600678,1.1834785775992995,0.23413566739606126,0.6553688561582514,1.0,3/18,4.99%,LTBP1;SMAD3;LRRC32
prerank,calcium ion import (GO:0070509),0.38901109485013424,1.183336762223691,0.23974082073434125,0.6545237875750493,1.0,7/28,8.28%,SLC8A1;CACNA1E;ATP2A2;CACNA1I;MICU3;CACNA1G;CACNB2
prerank,protein localization to cell surface (GO:0034394),-0.3824885867047654,-1.1832671783131352,0.21497120921305182,0.5723057238394528,1.0,11/26,20.91%,MESD;JAM3;RIC3;VCL;EMP2;WNT11;SMURF1;PTPRK;USP4;PTPRU;FGF10
prerank,granulocyte chemotaxis (GO:0071621),-0.33357020523726144,-1.1832184264257717,0.19405940594059407,0.5717898397449508,1.0,9/55,12.47%,BSG;CXADR;ANXA1;TGFB2;PPIA;EDN1;CCL15;FCER1G;SYK
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.4442916087739973,1.1831203421482446,0.25862068965517243,0.6538311768697498,1.0,5/16,13.88%,SHLD2;UBQLN4;RADX;SMCHD1;RIF1
prerank,potassium ion import across plasma membrane (GO:1990573),-0.35355743373946735,-1.182530619722699,0.2222222222222222,0.5729777489878087,1.0,10/41,12.14%,SLC12A7;SLC12A2;KCNJ2;ABCC9;ATP1A1;KCNJ10;ATP1B1;KCNJ8;KCNK9;KCNJ15
prerank,regulation of mitochondrial fusion (GO:0010635),0.4939348185359752,1.1824145482100226,0.25162689804772237,0.6544105881979704,1.0,3/11,5.78%,PID1;OMA1;PRKN
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.3866600291666115,1.182127673209443,0.2392638036809816,0.6539042955281992,1.0,6/30,6.47%,TGFBR3;SMAD3;DKK3;TGFBR3L;NREP;SMURF2
prerank,cellular protein modification process (GO:0006464),-0.2339372662015986,-1.1820698419937614,0.01832460732984293,0.5735437465457889,1.0,218/982,17.40%,PTPRB;FN1;PRKCH;ST3GAL6;PTPRG;ERG;ST3GAL4;PTPN14;CDK6;MAP3K5;ST8SIA4;GPC3;CTTNBP2NL;THBS1;RPS6KA5;PTPRJ;IGFBP7;PRKG1;CDK17;TGFBR2;MAP4K3;PTK2B;RAB11A;TGM2;BMPR2;LIMK2;HIPK1;PEAK1;NLK;EGLN3;MAPK3;LMO7;WNK1;MANBA;BMX;STK10;NEK7;CAMK2D;MAP3K1;ANXA1;SOCS2;PLOD2;MAP3K20;COL3A1;FNIP2;APP;IGFBP5;TGFB1;TGFB2;SUMF2;WWP2;RBBP5;KLHL5;FAM20A;MSLN;ADAM10;PRKCZ;SPARCL1;ZBTB16;CSNK1G2;CTDSP1;MINK1;IGFBP3;CTBP1;DCAF6;PTPRM;SSH2;PPP3CC;PTP4A2;PPP2R1A;KLHL2;RHBDD1;NRBP1;TAOK3;ST8SIA6;IKBKB;RARA;CSNK1G3;MGAT1;MSRA;FBXO17;BCR;NUCB1;PRKDC;SRPK1;PSMA6;PPM1F;TRIB2;DCUN1D1;PPP2R5A;CUL4A;CST3;INSR;QSOX1;MFGE8;DYRK2;FBXO4;STK25;PLK2;PSMB5;UBE2L6;AKT1;MAP3K11;CPE;WSB2;CDC42BPB;PNPLA2;SPP1;PIM3;LMTK2;ART3;TRIB1;ASB8;ATG7;RAB8A;WNT11;COPS6;PPP1CB;PSMC4;ATG3;TAOK2;CAMK1;CDK4;DAD1;ABL2;WDTC1;VRK1;RAB11B;UBE2F;GRK5;CHRDL1;FBXL14;PSMC5;STK38;PPP2R1B;PRKCE;PKN3;PPP5C;PPP3CB;KLHL3;FRK;COPS5;ICMT;YWHAZ;MMP15;SYK;STK36;FBXW10;PSMD14;FBXW5;SUMF1;ACVR1;FASTK;FBXL2;SERP2;ST6GALNAC2;CDKL4;CDK10;TBCK;PPP2R2A;PIGT;FUCA2;RBX1;APOE;CDC14B;FEM1A;NPC1;CISH;LOX;NUAK2;PSMD8;FBXL7;ERBB2;PTPN12;LMTK3;WSB1;F13A1;COQ8A;RAB1A;LIMK1;PRKAG1;COG3;FSTL1;STK38L;GLRX;PARP2;NEK3;CCNF;STK26;MTM1;PSMC1;PTPN6;UFL1;NUAK1;DSP;UCHL3;FBXL3;YES1;JAK2;LGALS1;PSMB4;PSMD11;CSNK2A1;F5;PHEX;CDK13;FBXL16;PSMD12;GAN;FBXW2;CTH;MAP3K9;JAK3;HCK;OGA;MCRS1;RET;RCE1
prerank,response to insulin (GO:0032868),0.3207647958668041,1.1817195545054662,0.18533604887983707,0.653714091994419,1.0,12/80,10.59%,ENPP1;PIK3R1;TBC1D4;PDPK1;MYO5A;IRS2;INSIG2;RAB10;PDE3B;C2CD5;PRKCI;LPIN3
prerank,regulation of fatty acid oxidation (GO:0046320),0.44919540730506946,1.1816785679332944,0.2559652928416486,0.6525791166445433,1.0,3/16,3.95%,PPARA;PRKAG2;PDK4
prerank,acute inflammatory response (GO:0002526),-0.4035021257825227,-1.1816732502209149,0.23220973782771537,0.5739095199049257,1.0,3/23,2.57%,ANO6;LBP;F3
prerank,cell-matrix adhesion (GO:0007160),-0.2979484268310082,-1.1814585204534243,0.156312625250501,0.5737992785415887,1.0,23/95,12.51%,FN1;ITGA1;THSD1;SORBS1;CD34;PEAK1;FERMT2;ITGB4;ADAM15;CD44;COL3A1;MSLN;RAC1;PKD1;BCAM;ACTN1;BCR;NPNT;VCL;EMP2;TAOK2;RCC2;ITGA7
prerank,lipoprotein transport (GO:0042953),0.49391732943005073,1.1812040320146817,0.28322440087145967,0.6526170368829842,1.0,5/10,18.91%,LRP1;PRKCB;MIA3;PPARG;UNC119B
prerank,positive regulation of protein binding (GO:0032092),-0.32905683727530083,-1.181063781375109,0.19367588932806323,0.574190680664159,1.0,13/56,9.46%,CAV1;CLDN5;B2M;RPL11;APP;FKBP1A;RALB;PKD1;HIP1R;IDE;ADD1;NMD3;FLOT1
prerank,positive regulation of chemotaxis (GO:0050921),0.3563840485552626,1.1810438238754035,0.24468085106382978,0.6517945092521907,1.0,6/43,6.21%,NRP1;PTN;NTRK3;SEMA5A;P2RX4;PDGFRB
prerank,response to lipopolysaccharide (GO:0032496),-0.2856708349289616,-1.181023722966408,0.15109343936381708,0.5736786807683542,1.0,54/138,33.31%,FOXP1;MEF2C;NOS3;LBP;VIM;SCARB1;RPS6KA3;DAB2IP;GCH1;MAPKAPK3;SMAD6;TNFRSF1B;OTUD5;TNFRSF11A;PLAA;IFNAR1;TRIB1;GGT5;TIRAP;TLR4;NOD2;CX3CR1;JAK2;TAB2;RELA;PELI1;XBP1;TNFAIP3;GGT1;LGALS9;CASP1;PTPN22;CD68;BCL10;TRAF6;CARD16;SELP;CCL2;SHPK;NOCT;PDCD4;CD86;LILRB1;UPF1;HMGB2;IRGM;NOS2;NLRP3;RHOA;CD14;SRR;NOS1;TNIP2;SLC11A1
prerank,regulation of gene expression (GO:0010468),-0.23414930492521052,-1.1809697093028972,0.025974025974025976,0.5731792427745022,1.0,171/903,14.45%,BNC2;FN1;LEF1;FOXP1;MEF2C;PRDM6;OCLN;CDK6;CLDN5;AHNAK;APBB2;RREB1;CDH1;NOS3;RPS6KA5;CD34;TNRC6C;ESR1;NOTCH1;ACTG1;NOVA2;PLCG2;RPL6;FGF1;SLC7A5;MBNL1;AHNAK2;RACK1;HMG20B;KDR;JMJD1C;KLF4;F3;NLK;RAMP2;MAPK3;TFRC;RPS3;SOX17;ETS1;NGF;VSX1;SIX1;HNRNPLL;RPL11;RAB27A;RBM20;APP;REST;TGFB1;CNBP;TRRAP;TGFB2;AFF4;RPL23;ZNF431;NFYA;PDE2A;WWP2;CRIP1;PPARGC1B;MSN;SMO;ADAM10;FOXD1;PFDN5;ASCC2;RLIM;PPARGC1A;REL;SOX13;MYOM1;SLC39A8;LIMS1;PRDM2;BHLHE40;ACTA2;VEGFA;IL33;CNOT7;PPP2R1A;EZR;TAPBP;PTBP3;GATA2;PRDM4;ATF4;FOXN3;ZNF326;NR3C1;ATP1B1;HCFC1;KRAS;CASP8;TLR3;RGCC;RC3H1;NFKBIZ;PPM1F;UBAP2;YBX3;HDAC4;ADAM19;INSR;GPX1;ATXN1L;SPIN1;SOX7;FZD7;NR2C2;YY1;AKT1;PCBP4;RB1;FUS;TRIM14;WARS1;TWIST1;SOX18;ESRRA;TDRD7;ACE2;BCL6;DDRGK1;WNT11;SFPQ;MYBL1;CD74;CDK4;MTA1;GABPA;SOX12;TEAD2;WTIP;HNRNPDL;INHBA;LIMD1;PRRX2;SP3;KMT2D;TLR4;SERPINB9;YTHDF2;CLK1;RPS7;PIK3R3;FAM98A;TOB2;SOX4;ZNF423;ENG;E2F1;TSKU;HINT1;FASTK;POGZ;HRAS;FGF2;TRIM68;MLX;BTN3A3;APOE;RNF20;PHF12;BCL6B;LDB1;NR5A2;HEY1;CAVIN4;HCFC2;TRIM5
prerank,defense response to tumor cell (GO:0002357),0.4947232194059854,1.1808704105027046,0.25663716814159293,0.651020504112527,1.0,3/10,5.92%,RBMS3;DLEC1;DAPK1
prerank,response to hexose (GO:0009746),0.408500702646011,1.1807850826573603,0.24611973392461198,0.649994455249552,1.0,2/25,5.58%,TCF7L2;IRS2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.4129519625020958,-1.180541112864735,0.24524714828897337,0.5736296449161441,1.0,8/22,24.46%,ESR1;MED24;PSMC4;PSMC5;SRF;MED14;PSMC3;MED13
prerank,miRNA metabolic process (GO:0010586),0.4240075731530923,1.180534081455826,0.25256673511293637,0.6494124690567088,1.0,9/20,22.17%,TUT4;LIN28B;KHSRP;PARN;XPO5;BCDIN3D;DROSHA;AGO2;DICER1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.49015459155645924,1.1804682426869744,0.28159645232815966,0.6483527227058141,1.0,2/11,0.56%,TGFBR3;BMP2
prerank,regulation of astrocyte differentiation (GO:0048710),0.4914239999932706,1.1799719775749076,0.2576419213973799,0.6484976156671651,1.0,3/12,8.88%,BMP2;SERPINE2;HES5
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.404334509707945,-1.1799491422544033,0.23880597014925373,0.5745022166813372,1.0,11/24,11.74%,TEK;PTPRJ;KDR;FERMT2;RAC1;LIMS1;VEGFA;MYOC;PPM1F;S100A10;DUSP3
prerank,regulation of immune response (GO:0050776),-0.28141054894651085,-1.1797650226856637,0.12778904665314403,0.5743464909479301,1.0,26/135,15.73%,FOXP1;CXADR;B2M;CD34;IL15;CLEC2D;COL3A1;FKBP1A;TGFB2;CD81;DENND1B;IFITM1;N4BP1;ERAP1;CASP8;PVR;BCL6;LRP8;ICAM2;TIRAP;DHX58;SYK;SAMHD1;ITGA4;NECTIN2;JAML
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.3966102853021376,-1.1797623117132394,0.21212121212121213,0.5737233666998404,1.0,7/26,11.10%,ADIPOR2;ADIPOR1;ELOVL5;ERLIN2;ACADL;ACADVL;WDTC1
prerank,muscle organ development (GO:0007517),0.3437559186015437,1.1791711387800563,0.21188118811881188,0.6493731631620735,1.0,7/54,4.42%,IGF1;LAMA2;VAMP5;ITGA11;SGCD;SGCE;EVC
prerank,sensory perception of chemical stimulus (GO:0007606),0.4589804078241954,1.1789936617136623,0.26136363636363635,0.6486401339560589,1.0,4/15,14.70%,OMP;SLC24A4;UBR3;DRD2
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.42099252296457806,1.1786924109926071,0.23819742489270387,0.6482206985195189,1.0,1/20,0.09%,IGF1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.4834310800409084,1.1784991430608844,0.29024943310657597,0.6475372716715418,1.0,2/12,1.79%,ADAMTS12;DCN
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.4589093668931775,-1.1784559645210821,0.27941176470588236,0.576392406740678,1.0,1/13,0.50%,TMSB4X
prerank,cellular response to interleukin-4 (GO:0071353),-0.5091472296608912,-1.1781619839085025,0.2600349040139616,0.5765227115112966,1.0,5/10,29.66%,LEF1;JAK3;XBP1;SHPK;TCF7
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.4719315842295813,-1.1780946120187947,0.261986301369863,0.5760567500322668,1.0,2/13,4.75%,SORBS1;PRKCZ
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.4984017519006213,-1.177970994818739,0.2611218568665377,0.5757151559490724,1.0,4/10,11.03%,UBB;UBC;RPS27A;DIS3L2
prerank,ganglion development (GO:0061548),0.4950116701111962,1.1779644306771078,0.26991150442477874,0.6477732505505722,1.0,3/11,7.76%,NRP1;SEMA3A;UNC5C
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.4928897150943757,-1.1774287204922635,0.25411334552102377,0.5765095955879921,1.0,5/11,19.84%,DHX9;WTIP;LIMD1;FMR1;PUM2
prerank,calcium ion import into cytosol (GO:1902656),0.4568182600061611,1.1772049673022766,0.2775229357798165,0.648468270616882,1.0,3/15,9.95%,SLC8A1;CACNA2D1;SLC24A2
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.296932417381553,-1.1771213659071718,0.15122873345935728,0.5766756210426941,1.0,30/101,15.90%,FLT1;CCND3;FGF1;CCNY;TPD52L1;DAB2IP;FERMT2;CALM1;TGFB1;RALB;PKD1;PIK3R6;VEGFA;RGCC;EDN1;PDGFC;AKT1;PDGFA;TCIM;CAMK1;MTCP1;CIB1;CALM3;CSF1R;HRAS;FGF2;ERBB2;CAB39;NOD2;EGFR
prerank,neutrophil migration (GO:1990266),-0.3305396393392327,-1.1770667215539694,0.192,0.5762052590578417,1.0,8/58,9.68%,PECAM1;BSG;CXADR;TGFB2;PPIA;EDN1;CCL15;FCER1G
prerank,lysosome localization (GO:0032418),-0.36266123613570406,-1.176426429880254,0.23180076628352492,0.5772584592693384,1.0,20/37,31.28%,PLEKHM1;PLEKHM2;BORCS5;PIP4P1;S100A13;FAM98A;NDEL1;SPAG9;VPS33A;ARL8B;TFEB;PIK3CG;BORCS6;KXD1;MILR1;MYH9;VPS33B;KIF5B;LAMTOR1;RAB3A
prerank,positive regulation of DNA replication (GO:0045740),0.4482502807130784,1.1763097694666131,0.2510729613733906,0.6496796830670403,1.0,4/16,7.51%,GLI2;STN1;BRPF3;ATAD5
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.468934109557949,-1.1762572656306294,0.29014598540145986,0.5770688791925602,1.0,5/13,19.90%,ELOVL7;ELOVL5;TECRL;ELOVL1;HACD4
prerank,peptidyl-proline modification (GO:0018208),-0.3988714432951903,-1.1760012620286293,0.236,0.5770535156089069,1.0,10/25,22.86%,FKBP5;FKBP1A;PPIA;PPIC;P3H2;PPIG;PIN1;NTMT1;FKBP4;PPIB
prerank,regulation of cell-cell adhesion (GO:0022407),-0.359489462512266,-1.175993471032791,0.21965317919075145,0.5764473993558946,1.0,8/39,5.20%,PTPRG;PODXL;CDH1;DPP4;PTK2;SMAD7;TGFB1;MINK1
prerank,vesicle transport along actin filament (GO:0030050),-0.4227136149110821,-1.175842715931455,0.2504638218923933,0.5761832134204918,1.0,3/19,2.25%,MYO1D;FNBP1L;ACTN4
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.3798986611807828,-1.1757354210994566,0.21305182341650672,0.5758410846461417,1.0,9/31,12.94%,SHANK3;SIPA1L1;ABI3;LRP8;CAPRIN1;CFL1;SRCIN1;DBNL;DBN1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.4082789102805562,-1.1755296659299064,0.24670433145009416,0.5757088505667846,1.0,11/21,23.71%,TGM2;MCUB;PDZD8;MCUR1;BCAP31;RAP1GDS1;MICU2;FIS1;SMDT1;SLC8B1;MCU
prerank,chloride transmembrane transport (GO:1902476),0.34924325242514964,1.1752522727887327,0.2125506072874494,0.6511763047866952,1.0,16/48,15.63%,SLC1A3;ANO7;GABRA2;GABRR3;GLRB;GABRB3;ANO3;GABRR2;CLCN1;GABRA5;SLC6A1;SLC12A3;ANO5;GLRA3;GABRG1;GABRB1
prerank,cell-cell junction assembly (GO:0007043),0.33643369439068016,1.1748575870027431,0.2,0.6510245346680122,1.0,14/63,6.69%,EPB41L3;TLN2;GJB6;GJA1;CDH8;PRKCA;DCHS1;CDH18;ARVCF;CDH11;CTNND2;CDH19;CDH20;CDH7
prerank,import into cell (GO:0098657),0.3567197044357808,1.174714646704655,0.22540983606557377,0.650224373647691,1.0,9/41,9.05%,SLC1A3;ATP1A2;SLC6A13;SLC22A4;SLC5A3;SLC29A1;SLC38A1;SNAP25;GLUL
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3962158111227465,1.1746203012981349,0.23758099352051837,0.6492762369847603,1.0,9/29,13.98%,LDLRAD4;BMP5;SFRP1;FOXA2;GATA3;PTEN;FUZ;ZNF750;NKX2-1
prerank,positive regulation of dendritic spine development (GO:0060999),-0.4193594913842703,-1.174484501150245,0.2720306513409962,0.5777731019660711,1.0,8/20,13.85%,SHANK3;LRP8;CAMK1;CAPRIN1;DBNL;DBN1;FMR1;APOE
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.27331339464476334,-1.174226822623425,0.12678936605316973,0.5778167034380096,1.0,65/184,26.57%,CDC14A;DCTN2;TUBA1A;CEP164;ZW10;UBB;PKD1;UBC;RPS27A;PPP2R1A;PRKAR2B;CEP57;CEP192;ANAPC15;RGCC;PSMA6;PSMB5;CEP70;ANAPC11;DCTN3;CEP290;DCTN1;PSMC4;CNTRL;PSMC5;TUBB4B;PCM1;PSMD14;E2F1;HAUS1;NDE1;CDC14B;PSMD8;CETN2;CEP72;PSMC1;PTPN6;YWHAG;ANAPC7;HSP90AA1;PSMB4;PSMD11;PSMD12;CDC27;CEP41;FZR1;CUL1;PSMA1;PSMC3;TPX2;ANAPC2;TUBA4A;CENPF;PSMB1;PSMA2;ANLN;PSMA4;CEP63;HAUS4;NEDD1;RIOK2;XPC;PLK5;YWHAE;PSMB8
prerank,positive regulation of cellular catabolic process (GO:0031331),0.2938258882420304,1.174097892149044,0.16,0.6494056398928415,1.0,14/132,6.11%,IGF1;SH3D19;ZBTB20;DCN;PPARA;TRIM38;SNX33;PIM2;PFKFB4;TICAM1;IRS2;DAPK1;ABCD2;LIN28B
prerank,positive regulation of protein export from nucleus (GO:0046827),0.4553827186410907,1.1740042393588144,0.26939655172413796,0.6484867284934046,1.0,5/15,18.59%,TCF7L2;XPO4;BAG3;EMD;TP53
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.4365304904674121,-1.1736611426816679,0.2909090909090909,0.5785501558333503,1.0,11/17,33.47%,PPIA;HSPB1;AKT1;SFPQ;BAG5;SOD1;TREM2;P4HB;VNN1;HTRA2;MAPK7
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.500627667587246,1.1735094053253126,0.289760348583878,0.647314058098299,1.0,10/10,49.97%,TULP1;CEP250;GRM6;RPE65;CACNA1F;GNAT2;CNGB1;CACNA2D4;REEP6;GNAT1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.500627667587246,1.1735094053253126,0.289760348583878,0.647314058098299,1.0,10/10,49.97%,TULP1;CEP250;GRM6;RPE65;CACNA1F;GNAT2;CNGB1;CACNA2D4;REEP6;GNAT1
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.34722405334013173,-1.1734870556484251,0.22310756972111553,0.5783399512468692,1.0,14/44,28.10%,BAIAP2L1;PTK2B;LMOD1;PFN1;PRKCE;NCKAP1;HCK;CDC42EP3;CTTN;NCK1;NCK2;CARMIL1;CDC42EP2;FCHSD1
prerank,maintenance of protein localization in organelle (GO:0072595),-0.4236220082443608,-1.1733253843983575,0.2559852670349908,0.5781004831780788,1.0,6/19,18.52%,HK1;AKT1;ARL2BP;HSPA5;CHCHD10;ARL2
prerank,hepaticobiliary system development (GO:0061008),0.4318261913217465,1.173150378629191,0.267223382045929,0.6470850848831987,1.0,5/20,10.48%,TGFBR3;WNT4;CITED2;PRKCSH;ARID5B
prerank,erythrocyte development (GO:0048821),-0.5056021783806341,-1.1728417844749044,0.2839506172839506,0.5787248830225257,1.0,5/10,33.45%,ZBTB7A;ALAS2;DMTN;ABCB10;LYAR
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.40319764405481684,-1.171658682489329,0.23508137432188064,0.5811308503529847,1.0,9/22,16.56%,CALM1;VEGFA;RASSF2;PDGFC;PDGFA;TAOK2;CALM3;ACE;GREM1
prerank,protein localization to synapse (GO:0035418),0.4792906396569653,1.1714850556348717,0.25925925925925924,0.6503336247268354,1.0,5/12,17.77%,NRXN1;NLGN2;NLGN1;DLG4;ZDHHC15
prerank,mesenchyme morphogenesis (GO:0072132),-0.44340067663976657,-1.1708298387214766,0.24858757062146894,0.5827096407594692,1.0,10/17,20.62%,NOS3;NOTCH1;TGFB2;TBX2;HEYL;ENG;ACVR1;HEY1;SOX9;SMAD2
prerank,supramolecular fiber organization (GO:0097435),-0.25299399623550123,-1.170824756388457,0.08647450110864745,0.5820978660886479,1.0,73/333,13.56%,SHROOM4;COL25A1;PGM5;ITGA6;TLL1;MYO1D;B2M;TSPAN5;COL12A1;TMOD3;VIM;COL5A2;COL6A2;ARHGAP17;TNXB;CD2AP;ITGB4;HSP90AB1;PLOD2;COL3A1;MYH11;MPRIP;APP;FKBP1A;TGFB2;COL4A2;UBB;ADAM10;RAC1;LAMA3;UBC;RPS27A;CHP1;CD151;ARHGAP25;COL18A1;TGFBI;COL6A1;HIP1R;BACE1;CYP1B1;COL4A1;LMOD1;ACTN1;FLII;COLGALT2;NEFL;SLAIN2;RIPK1;STMN2;CST3;MFGE8;UBE2L6;TMOD1;LAMC2;PSENEN;HIP1;H3-3A;RHOB;EMP2;DCTN1;TRPV4;TSPAN14;USP9X;CIB1;PLOD3;COL5A3;NF1;PCM1;KATNB1;DBN1;P3H2;APH1A
prerank,membrane protein proteolysis (GO:0033619),-0.36231169850208894,-1.1706198451152947,0.22242990654205608,0.5819492476501922,1.0,12/37,17.39%,BACE2;TGFB1;ADAM10;BACE1;RHBDD1;ERAP1;MBTPS2;ADAM19;PSENEN;APH1A;RELA;RET
prerank,positive regulation of monooxygenase activity (GO:0032770),0.3974846107711818,1.170594392305596,0.2605042016806723,0.6514289228638028,1.0,4/26,3.25%,GDNF;VDR;CYP27B1;POR
prerank,aggrephagy (GO:0035973),-0.38674674154950867,-1.1702162670595746,0.22745098039215686,0.582333649517384,1.0,5/27,5.26%,VIM;UBB;DYNC1LI2;UBC;RPS27A
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.3551916356010187,1.1701655301368312,0.2055084745762712,0.6513004555854719,1.0,4/46,2.72%,TCF7L2;PIK3R1;ZIC1;SMAD3
prerank,positive regulation of gene expression (GO:0010628),-0.24564660484419557,-1.1698651407663172,0.08053691275167785,0.5826053939567157,1.0,82/442,12.37%,FN1;LEF1;MEF2C;ACTB;OCLN;CLDN5;NOS3;THBS1;CD34;TNRC6C;DDX5;NOTCH1;ACTG1;IL15;PLCG2;VIM;RPL26;FGF1;KLF4;F3;RAMP2;MAPK3;EEF2;TFRC;NIBAN1;RPS4X;RPS3;ETS1;NGF;HNRNPLL;RPL11;RAB27A;RBM20;APP;TGFB1;RPL23;PDE2A;MSN;SMO;FOXD1;PPARGC1A;MYOM1;LIMS1;ACTA2;VEGFA;IL33;EZR;GATA2;ATF4;LURAP1;PRKDC;HCFC1;KRAS;TLR3;RGCC;RIPK1;PPM1F;GAPDH;ADAM19;AKT1;RBM22;WARS1;TWIST1;FLOT1;DDRGK1;WNT11;EIF3D;RPS27L;CD74;GABPA;LARP4B;INHBA;CIRBP;S100A13;WBP2;TLR4;SERPINB9;UPF3A;RPS7;PIK3R3;FAM98A;SOX4
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.442635689461885,1.1697791922149101,0.2866666666666667,0.6511889439743738,1.0,7/16,15.50%,SHLD2;SETMAR;KMT5C;SMCHD1;PARP3;RIF1;KMT5B
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.4951296977272698,-1.1696707036394245,0.2774674115456238,0.5824984486645683,1.0,2/11,3.66%,MEF2C;ANXA1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.4735436146100834,1.169105687635862,0.2752688172043011,0.6517424469641141,1.0,3/13,9.33%,BMP6;TGFBR1;BMPR1A
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.4358384061872361,1.1689844469186939,0.2665198237885463,0.6509103355754697,1.0,10/20,22.93%,HENMT1;AGO4;SNIP1;DROSHA;AGO3;AGO1;AGO2;DICER1;ZC3H7B;MRPL44
prerank,regulation of lipid kinase activity (GO:0043550),0.47915738108710443,1.1686771541978043,0.2853932584269663,0.6506300794883905,1.0,1/11,0.26%,PIK3R1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.4379149825613686,1.1685994288734585,0.2751540041067762,0.6496629528430999,1.0,2/18,1.24%,PIK3R1;BCL2L11
prerank,histone monoubiquitination (GO:0010390),0.40306519775802757,1.1685570885823846,0.25565610859728505,0.648630894453787,1.0,11/24,26.94%,BCOR;DDB2;RNF2;SKP1;PAF1;WAC;TRIM37;KDM2B;CTR9;RNF168;RYBP
prerank,cellular macromolecule catabolic process (GO:0044265),-0.3364422602239591,-1.1683365049890597,0.2205029013539652,0.5851447978214281,1.0,26/49,35.42%,MANBA;DAB2IP;MTREX;FBXO17;IDE;DENND3;RIPK1;PPP1R8;UBE2G2;RNF5;UBE2G1;OGA;RNASEH2C;DNASE1L2;FBXO6;DFFB;STT3B;NEU2;MAGEC2;FBXO2;XRN2;ISG20;SIDT2;HTRA2;RNASEH2A;NEU4
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.36123522306304157,-1.1680167593608133,0.23293172690763053,0.5853318179396612,1.0,7/39,7.35%,TEK;ANO6;THBS1;KDR;RAMP2;GATA2;RGCC
prerank,integrin-mediated signaling pathway (GO:0007229),-0.30925720071693735,-1.1677383016828469,0.19960861056751467,0.5854070828639821,1.0,13/73,5.09%,FN1;SEMA7A;DOCK1;PTK2B;PTK2;LAMA5;FERMT2;ITGB4;ADAM15;COL3A1;ADAM10;NEDD9;LAMA3
prerank,iron ion transport (GO:0006826),0.35364085835905024,1.1674630244192217,0.23613963039014374,0.6502967349193071,1.0,4/47,1.52%,CP;STEAP3;ATP6V0A4;HEPH
prerank,cellular response to ATP (GO:0071318),0.45937738423317154,1.1674144332496674,0.2701612903225806,0.6492672080958392,1.0,6/14,24.31%,P2RX4;HSP90B1;P2RY1;TAF1;PDXP;RYR3
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.30911604348838473,-1.1671652094220808,0.189453125,0.5862461796736649,1.0,20/73,12.59%,ACER2;RACK1;NOD1;F3;EGLN3;NGF;CRADD;TNFSF10;HIP1R;ATP2A3;CASP8;RIPK1;BAX;FAS;HIP1;HSPD1;RPS27L;VCP;BEX3;BBC3
prerank,regulation of RNA splicing (GO:0043484),-0.30952769304884614,-1.1671599128818737,0.1867704280155642,0.5856328391177523,1.0,20/69,19.60%,AHNAK;MBNL1;AHNAK2;HNRNPLL;RBM20;QKI;RPS13;PTBP3;ZNF326;SRPK1;RBM22;FUS;JMJD6;CLK1;FASTK;HNRNPK;HSPA1A;RPS26;ZPR1;TMBIM6
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.3429099698275555,-1.1671345950993093,0.21910112359550563,0.5850720345940171,1.0,20/46,30.13%,RAP1B;HNRNPA2B1;MSN;PPIA;ANXA2;PITPNA;TALDO1;CFL1;HNRNPDL;JAK2;HSPA9;IL12RB2;STAT4;SOD1;CDC42;PDCD4;GSTO1;P4HB;PLCB1;PAK2
prerank,autonomic nervous system development (GO:0048483),0.4210996597618955,1.1662180153883805,0.26153846153846155,0.6512246685849805,1.0,6/17,12.27%,NRP1;GDNF;SEMA3A;PHOX2A;GATA3;EDNRB
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.37752865655877077,-1.1660885003925272,0.23649906890130354,0.5871748241657194,1.0,10/30,16.62%,FLT1;MLLT3;KDR;TGFB1;FLT4;INHBA;CSF1R;ACE;UFL1;HOXB4
prerank,regulation of exit from mitosis (GO:0007096),-0.35793112436752705,-1.1659802353951034,0.2263056092843327,0.5868058905370228,1.0,12/38,17.23%,CDC14A;ZW10;UBB;UBC;RPS27A;ANAPC15;RGCC;ANAPC11;PHB2;CDC14B;ANAPC7;CDC27
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.31235490505809627,-1.1659528859569195,0.2037037037037037,0.5862444102576255,1.0,22/67,17.17%,TEK;FLT1;IGF1R;IL15;PTK2B;KDR;MAPK3;BMX;PTK2;ABI3;FLT4;INSR;ABL2;SYK;CSF1R;ABI1;ERBB2;PTPN6;EGFR;JAK2;JAK3;HCK
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.36308578117852464,-1.1659023584239754,0.23300970873786409,0.5857533528021832,1.0,9/35,17.06%,HMBOX1;MAPK3;NEK7;HNRNPA2B1;FBXO4;PNKP;CCT2;HNRNPA1;CCT3
prerank,regulation of viral life cycle (GO:1903900),-0.40674987468858176,-1.1654983486752835,0.25272727272727274,0.5861078144312504,1.0,8/21,14.90%,TRIM25;PPIA;TRIM14;TRIM62;TRIM68;TSG101;TRIM5;NECTIN2
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.47918541621820154,1.1652305505632992,0.2727272727272727,0.6526631350283908,1.0,4/12,12.12%,DCN;UST;DSE;VCAN
prerank,ncRNA export from nucleus (GO:0097064),-0.3536098398065104,-1.1649643836050279,0.2328767123287671,0.5868857443332562,1.0,16/36,27.43%,NUP93;NUP54;NDC1;NUP188;NUP155;RANBP2;NUP37;NUP160;NCBP2;NUP43;SEH1L;NUP42;SEC13;NUP107;NUP98;NPM1
prerank,lipid translocation (GO:0034204),-0.41211822851040725,-1.1648819521447644,0.26325757575757575,0.5864573145706306,1.0,6/21,8.63%,ATP10A;ATP8A1;ATP8B1;ATP11C;ATP11A;ATP9B
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.4327905521227925,1.1645363125833892,0.2955032119914347,0.6533025011318528,1.0,2/19,0.51%,CAMK1D;IL34
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.3021919646000779,-1.1643306916629683,0.19832985386221294,0.5872646814276264,1.0,40/88,33.18%,FBXO17;PSMA6;CUL4A;FBXO4;PSMB5;PSMC4;FBXL14;PSMC5;PSMD14;FBXW5;FBXL2;RBX1;PSMD8;FBXL7;CCNF;PSMC1;FBXL3;PSMB4;PSMD11;FBXL16;PSMD12;DMAC2;CUL1;PSMA1;PSMC3;PSMB1;PSMA2;PSMA4;FBXO6;FBXL18;PSMB8;FBXL8;FBXO2;FBXO38;FBXL15;PSMC6;PSMD6;FBXL4;PSMA8;PSMB2
prerank,negative regulation of cell migration (GO:0030336),0.29018565536840685,1.1637816030681627,0.16666666666666666,0.6541146183056259,1.0,19/137,5.86%,ROBO1;LDLRAD4;PODN;SULF1;LRP1;PHLDB2;MAGI2;GJA1;MITF;RECK;RAP2A;SFRP1;PTPRT;DLC1;MCC;IL4;SRGAP2;SRGAP3;SERPINE1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.4816356131885484,1.1632934313095689,0.31125827814569534,0.6541590606244708,1.0,3/12,6.02%,PPARA;IRS2;ABCD2
prerank,apoptotic cell clearance (GO:0043277),0.3713319640828406,1.1632356653378781,0.2478448275862069,0.6531951356085942,1.0,7/30,7.48%,LRP1;XKR4;MEGF10;RHOH;XKR6;RHOBTB1;TXNDC5
prerank,development of primary male sexual characteristics (GO:0046546),0.3769444109056912,1.1628474872420926,0.2591093117408907,0.6530303778926839,1.0,7/34,9.40%,WNT4;AR;KIT;CSDE1;ADAM21;SIX4;GATA3
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.3033223762644861,-1.1625248066717646,0.1891348088531187,0.591198425520169,1.0,27/85,21.72%,CBFA2T3;RACK1;RNF144B;DAB2IP;TMEM259;SMAD7;GABARAP;SH3RF2;TRIB2;PABIR1;RNF185;TRIB1;DDRGK1;USP5;VCP;PSMC5;RBX1;FMR1;HECTD1;HSPA1A;RNF19A;ELOB;OSBPL7;PSMC3;KEAP1;HSPA1B;TRIB3
prerank,transition metal ion homeostasis (GO:0055076),0.387709117285223,1.1623160212263401,0.2594142259414226,0.6532823833183155,1.0,4/28,5.78%,CP;HEPH;NEO1;PRKN
prerank,eye development (GO:0001654),0.3369327758571957,1.1623017927460555,0.21231422505307856,0.6521777892926521,1.0,5/54,4.13%,LAMA1;FBN1;FBN2;SH3PXD2B;PBX4
prerank,protein localization to membrane (GO:0072657),-0.26817278252837046,-1.1619719584330501,0.12629399585921325,0.5920497937923981,1.0,59/187,20.04%,CAV1;SHANK3;BSG;RAP1A;CDH1;TSPAN5;EFR3B;SPTBN1;RAB11A;AGRN;F11R;RAMP2;EHD4;KCNB1;FERMT2;RAB8B;PACS1;CD81;EZR;IKBKB;EHD2;ATP1B1;JUP;CPE;NUP54;NDC1;FLOT1;S100A10;EMP2;RAB8A;TSPAN14;FCHO2;CACNB3;RAB11B;SLMAP;TNFRSF1A;NPC1;SMURF1;NUP155;TMEM88;ITGA4;TSPAN17;EPHA2;PACSIN1;NRXN2;AP4M1;FLOT2;RAMP1;RABEP1;RAB40B;PIGW;PRAM1;EHD1;EHD3;KCNB2;FYB2;PLEKHF1;RAPGEF2;RAB32
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.40791017863529244,-1.161851652476772,0.2667844522968198,0.5917515661758046,1.0,3/21,2.38%,CAV1;PLTP;NFKBIA
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.45341011516188534,-1.1617577082662263,0.2717391304347826,0.5913708606948024,1.0,7/14,27.39%,PPM1F;PPP5C;PPP2R2A;PPP2R2D;PPP1CA;NCK1;DUSP1
prerank,positive regulation of T cell migration (GO:2000406),-0.412296515435846,-1.1617117967275543,0.2822878228782288,0.5908706394077468,1.0,3/20,4.67%,WNK1;APP;ADAM10
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.49005246700508576,-1.1616376571781788,0.2914285714285714,0.5904399743343481,1.0,4/10,20.34%,ESR1;PSMC4;PSMC5;PSMC3
prerank,fluid transport (GO:0042044),-0.46952318689793743,-1.1612807751617016,0.2768670309653916,0.5907353904901612,1.0,5/12,33.10%,AQP11;AQP4;SLC26A6;AQP1;SLC4A11
prerank,histone H3-K36 demethylation (GO:0070544),0.4861352806045679,1.160823186611226,0.2793791574279379,0.654936306458471,1.0,6/10,26.34%,KDM7A;KDM2A;PHF8;KDM4C;KDM2B;KDM4B
prerank,negative regulation of phosphorylation (GO:0042326),0.30860828620660136,1.1603901682126316,0.21604938271604937,0.6549410890101972,1.0,17/85,10.36%,PID1;PTPN13;NTRK3;FBLN1;PPARA;STAP1;LYN;DYNLL1;ACTN3;IRS2;PRKN;PLPP3;IBTK;MEN1;PPP1R15B;PTEN;ANKLE2
prerank,telomere maintenance (GO:0000723),0.341351334315119,1.1602870026665657,0.22424242424242424,0.6540670425343117,1.0,24/50,25.44%,STN1;BLM;RPA2;TEP1;ATM;NBN;PARP3;RIF1;RPA1;SMC6;PARP1;SP100;NSMCE2;SMC5;POLD4;POLD1;RTEL1;PCNA;POLD3;POLD2;DCLRE1B;TINF2;ATR;XRCC6
prerank,cardiac ventricle development (GO:0003231),-0.4230194275238578,-1.1602144015799951,0.27106227106227104,0.5927584838373068,1.0,10/20,18.01%,NOTCH1;PDE2A;STRA6;HEYL;HES1;ENG;HEY1;HECTD1;TMEM65;DLL4
prerank,liver development (GO:0001889),0.38121727902434965,1.1599812120370263,0.2558139534883721,0.6536534862431377,1.0,7/32,10.48%,TGFBR3;WNT4;CEBPB;CITED2;NPHP3;PRKCSH;ARID5B
prerank,B cell proliferation (GO:0042100),-0.4245510927225786,-1.1597810558811845,0.27153558052434457,0.5932629269653215,1.0,3/17,10.39%,MEF2C;CTPS1;HSPD1
prerank,positive chemotaxis (GO:0050918),0.43644255834640333,1.1596978074136082,0.2773109243697479,0.6532211260031141,1.0,2/17,1.22%,NRP1;SEMA5A
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.31892666722913365,-1.1589540799787477,0.2193158953722334,0.5947214178045138,1.0,25/67,26.60%,PODXL;CAV1;ATP8B1;TBC1D8;PPP1R16B;IFT20;RAC1;TBC1D1;TBC1D22A;ATG3;TBC1D9B;FMR1;EPHA2;TBC1D2;RABEP2;DCDC2;TBC1D15;DMTN;RDX;ODAD3;TBC1D17;FSCN1;TBC1D5;CDKL5;CDC42
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.3481044641088338,1.158647310380597,0.23983739837398374,0.6547205686576315,1.0,7/46,5.26%,PIK3R1;NRP1;LAMC3;ATRNL1;ANTXR1;RADIL;SRGAP2
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.44990728153152404,-1.1580769274106582,0.2669172932330827,0.5964004479241508,1.0,3/16,5.23%,MEF2C;BOC;IGFBP3
prerank,positive regulation of translation (GO:0045727),-0.3005188576218027,-1.1579345107954702,0.19383259911894274,0.5961267605041473,1.0,30/94,17.76%,THBS1;VIM;RPL26;EEF2;NIBAN1;RPS4X;RPS9;CNBP;UQCC2;PKM;PRKDC;YBX3;DHX9;EIF3D;RPS27L;LARP4B;RPS6KB2;CIRBP;YTHDF2;UPF3A;SOX4;COA3;FMR1;UHMK1;TRMT10C;ERBB2;RPUSD4;FASTKD3;PCIF1;ZCCHC4
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.48309892405681404,-1.1576962804638813,0.2870036101083033,0.5961352217977638,1.0,2/12,9.46%,CD44;FLOT1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.41682648495853053,1.1575431244395835,0.2806652806652807,0.656430879943895,1.0,1/21,0.09%,IGF1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3902759572672722,1.1567850113944376,0.26526315789473687,0.6572626136296948,1.0,14/29,22.93%,TUT4;SMAD3;AGO4;LIN28B;SNIP1;METTL3;DROSHA;AGO3;AGO1;AGO2;DICER1;ZC3H7B;PUS10;MRPL44
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.4441998891933786,1.1562216223056407,0.2802547770700637,0.657438450345036,1.0,2/15,2.21%,ADGRV1;KIT
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.4182242913935418,-1.155764069552967,0.27788649706457924,0.600353426712705,1.0,7/18,21.65%,SEC14L1;RNF125;DHX58;USP15;ANKRD17;PUM2;ZCCHC3
prerank,regulation of neuron death (GO:1901214),-0.3008870594455497,-1.1555017122463866,0.2051792828685259,0.6004182047228439,1.0,12/82,8.61%,MEF2C;MAP3K5;CD34;EGLN3;REST;UBB;CTSZ;PPARGC1A;CHP1;EGLN2;TNFRSF1B;AKT1
prerank,regulation of microtubule polymerization (GO:0031113),-0.34824380561702506,-1.1552814439147343,0.2455795677799607,0.6003377392428789,1.0,13/40,24.78%,OCLN;RPS3;RAC1;SLAIN2;STMN2;DCTN1;PRUNE1;MET;ARL2;CDH5;CAMSAP3;CLIP1;STMN1
prerank,regulation of dopamine secretion (GO:0014059),0.3926157363457199,1.1552232470064319,0.26495726495726496,0.6589304310209972,1.0,9/25,18.26%,GDNF;PRKN;SYT1;CHRNA4;SYT13;DRD2;SYT11;SYT12;SYT6
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.3132957174355988,-1.1548732387909946,0.19438877755511022,0.6007897479754177,1.0,17/70,11.89%,FN1;TEK;MEF2C;PARVB;PXN;OPHN1;PEAK1;LAMA5;FERMT2;RAC1;NTN4;ACTN1;ATF4;RB1;SIPA1L3;SRCIN1;YTHDF2
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.2481130629324869,-1.1548470492506426,0.10328638497652583,0.600239029793744,1.0,74/327,17.24%,BNC2;MEF2C;APBB2;RREB1;RPS6KA5;ESR1;NOTCH1;RPL6;ACTN4;JMJD1C;NLK;SOX17;VSX1;SIX1;REST;CNBP;TRRAP;ZNF431;NFYA;PPARGC1B;PFDN5;ASCC2;PPARGC1A;SOX13;SLC39A8;PRDM2;BHLHE40;PPP2R1A;ATF4;FOXN3;NR3C1;HCFC1;INSR;ATXN1L;SPIN1;SOX7;FZD7;NR2C2;RB1;FUS;SOX18;ESRRA;SFPQ;MYBL1;SOX12;TEAD2;WTIP;LIMD1;PRRX2;SP3;KMT2D;SOX4;ZNF423;ENG;E2F1;HINT1;MLX;RNF20;PHF12;LDB1;NR5A2;HCFC2;SOX6;SMARCA2;CELSR2;ZFHX3;DRAP1;BRCA2;SAP30L;ZNF22;LIN54;SP1;TCF3;RELA
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.23995589774164794,-1.1547686270403612,0.06807511737089202,0.5997937947698763,1.0,102/497,14.46%,MECOM;LEF1;FOXP1;ELK3;DACH1;WWP1;RPS6KA5;ATP8B1;NOTCH1;CBFA2T3;ID1;ZHX3;RACK1;HMBOX1;BMPR2;ID3;PPARD;KLF4;NCOR1;FOXO1;RPS3;DAB2IP;ZBTB7A;CDKN1B;PRDM16;IGFBP5;REST;TGFB1;KDM5C;HDAC9;WWP2;TBX2;HSPA8;KCTD1;FOXD1;ZBTB16;PFDN5;RLIM;SOX13;CD38;CTBP1;LIMS1;FOXK1;DPF2;BHLHE40;HEYL;DPF3;PHC2;CNOT7;MPHOSPH8;RARA;SHC1;RBFOX2;FOXN3;NR3C1;GATA6;CBX5;PPM1F;CIC;HDAC4;GAPDH;UIMC1;NCL;NDUFA13;ZMYND11;SOX7;RB1;TRIM28;TWIST1;HHEX;DBI;SOX18;FOXP2;ZC3H8;RPL13A;BCL6;WNT11;SFPQ;ZBTB18;CAPRIN1;CCDC85B;LIMD1;PHC1;SP3;CIPC;ZNF423;EPC1;HES1;E2F1;COMMD7;CDAN1;MLX;PHB2;FMR1;CIART;MTERF3;POU2F1;PHF12;LDB1;HEY1;EID2;SMARCA4
prerank,protein ADP-ribosylation (GO:0006471),0.38615096266934823,1.1547135940899411,0.25217391304347825,0.6591299923405939,1.0,14/28,24.28%,PARP16;SIRT2;PARP11;PARP3;PARP12;TIPARP;SIRT6;PARP4;PARP1;PARP8;SIRT3;ZC3HAV1;TNKS;SIRT1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.38022063982311355,-1.154516947720102,0.2672897196261682,0.5998019601295081,1.0,8/27,15.96%,CAV1;PDE4D;CAMK2D;JUP;CTNNA3;SRI;DSG2;DSP
prerank,regulation of aerobic respiration (GO:1903715),-0.4391309232232561,-1.1545095450393381,0.2774674115456238,0.5991983521176479,1.0,4/15,10.66%,CBFA2T3;UQCC2;IDE;VCP
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.43918521531092847,-1.154496643106364,0.30275229357798167,0.598001950971908,1.0,11/15,39.18%,AP3M1;AP3B1;DTNBP1;AP3M2;BLOC1S6;BLOC1S2;BLOC1S1;AP3D1;AP3B2;BLOC1S4;AP3S1
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.43918521531092847,-1.154496643106364,0.30275229357798167,0.598001950971908,1.0,11/15,39.18%,AP3M1;AP3B1;DTNBP1;AP3M2;BLOC1S6;BLOC1S2;BLOC1S1;AP3D1;AP3B2;BLOC1S4;AP3S1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.3959527365388546,1.1544584855615352,0.27839643652561247,0.6586291951508716,1.0,3/25,9.40%,IGF1;NSD1;GATA3
prerank,renal filtration (GO:0097205),0.5101724866759378,1.1541982827888062,0.31712962962962965,0.6581742941511309,1.0,5/10,15.44%,SULF1;SULF2;JCHAIN;TBC1D8B;MYO1E
prerank,carbohydrate transport (GO:0008643),-0.47708160044376574,-1.1541027729828983,0.28544776119402987,0.5983988446211579,1.0,8/11,42.82%,AQP11;SLC26A6;SLC2A2;SLC23A1;SLC23A2;AQP1;SLC2A5;AQP9
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.3591014336949078,-1.1540915292521798,0.241869918699187,0.5978074090098577,1.0,11/34,28.03%,SLC7A5;GPI;SPHK2;PHB2;CLCF1;NOD2;XBP1;LAPTM5;PTPN22;STX4;CD86
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.46592179083725094,-1.1540508793179944,0.29390018484288355,0.5972889974801208,1.0,8/12,35.70%,SEC63;HSPA5;SEC61B;SGTA;SGTB;SEC61A1;CHMP4B;CHMP4A
prerank,mitochondrion distribution (GO:0048311),-0.47585364140968456,-1.1540396753229665,0.2831858407079646,0.5966905053769573,1.0,4/12,15.51%,TRAK1;MEF2A;TRAK2;MTM1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.26659690855283286,-1.1538328405877951,0.12164948453608247,0.5965619828239869,1.0,26/182,6.56%,FOXP1;MEF2C;OCLN;CLDN5;CD34;TNRC6C;ESR1;NOTCH1;SLC7A5;RACK1;RIN3;KDR;KLF4;HSP90AB1;APP;REST;TGFB1;TGFB2;WWP2;SMO;ADAM10;REL;VEGFA;CNOT7;ANKRD13A;GATA2
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.4636957129850083,-1.1533023186418763,0.31607142857142856,0.5974078050308854,1.0,5/13,13.20%,IFIH1;DHX9;CD74;MAVS;AGPAT1
prerank,actin filament bundle organization (GO:0061572),-0.3594073076755135,-1.152700019042023,0.25627240143369173,0.598344516537528,1.0,7/33,9.37%,BAIAP2L1;EPS8;PLS3;NEDD9;EZR;ADD1;FAM107A
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.3080323083044618,-1.1526690882363757,0.1928721174004193,0.5978024377512149,1.0,28/74,23.92%,NOTCH1;EGLN3;UBB;UBC;RPS27A;VEGFA;EGLN2;PSMA6;PSMB5;PSMC4;EGLN1;LIMD1;PSMC5;PSMD14;RBX1;PSMD8;PSMC1;PSMB4;PSMD11;PSMD12;ELOB;HIGD1A;PSMA1;PSMC3;PSMB1;PSMA2;PSMA4;HIF1AN
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.471598194185272,-1.1524476667987802,0.288135593220339,0.5977446751391196,1.0,2/12,4.15%,PTPN14;TGFB1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.2989082051543032,-1.1521404806288755,0.18613861386138614,0.5979196228978136,1.0,20/90,12.47%,CAV1;ADIPOR2;IGF1R;GATM;PRDM16;PPARGC1B;PPARGC1A;ADIPOR1;CMKLR1;VEGFA;UCP2;KDM3A;PDGFC;DECR1;ACADL;EBF2;GRB10;FABP5;GADD45G;SYK
prerank,atrioventricular valve development (GO:0003171),-0.4484026491396893,-1.1520629285504829,0.2807971014492754,0.5975080706914829,1.0,5/14,5.71%,NOTCH1;TGFBR2;BMPR2;TGFB2;HEYL
prerank,cellular response to nutrient levels (GO:0031669),-0.31604832720983894,-1.1519130869244878,0.2250996015936255,0.5972548237440427,1.0,28/62,27.03%,BMPR2;FOXO1;KCNB1;MAP1LC3B;HSPA8;RALB;MFSD2A;FAM107A;ATG7;MAP1LC3A;INHBB;GAS2L1;STK26;RRAGD;XBP1;WIPI2;TFEB;RRAGA;KLF10;RIPOR1;VPS41;EIF4G1;NUPR2;CD68;RRAGC;SREBF1;CDKN2B;RPTOR
prerank,melanosome transport (GO:0032402),-0.41497698267661826,-1.1517075343043992,0.27223230490018147,0.596562458705339,1.0,6/18,13.65%,RAB11A;RAB27A;MREG;RAB11B;MLPH;ARL6
prerank,pigment granule transport (GO:0051904),-0.41497698267661826,-1.1517075343043992,0.27223230490018147,0.596562458705339,1.0,6/18,13.65%,RAB11A;RAB27A;MREG;RAB11B;MLPH;ARL6
prerank,RNA metabolic process (GO:0016070),0.28977509918219335,1.1515321792526427,0.21104536489151873,0.6639411192580268,1.0,42/127,23.01%,CELF2;ATXN1;NOVA1;RBMS1;ADARB2;HNRNPUL1;AGO4;DHX8;MPHOSPH10;FTO;RBM5;POLR2G;PCBP3;PABPN1;PNPT1;BICD1;HNRNPD;RNASE4;NOL9;THOC1;PARN;METTL3;DROSHA;RNASEL;PAPOLA;RNASEH1;AGO3;POLR2K;HNRNPF;POLR2D;AGO1;AGO2;ATXN2;RNASE3;DDX24;DICER1;RNASEH2B;TENT2;SETX;MRPL44;RBM39;POLR2B
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.4226714760468314,-1.1514037031973516,0.2902654867256637,0.5966702712638753,1.0,9/16,31.71%,RB1;POGZ;RAD21;BOD1;NIPBL;REC8;SGO1;DSCC1;NAA50
prerank,T cell mediated immunity (GO:0002456),-0.4524475441159475,-1.1510342365852948,0.29615384615384616,0.5970473801900575,1.0,3/13,13.74%,CD55;EMP2;BTN3A3
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3146212681621279,1.1509839437729474,0.21560574948665298,0.6642629377489372,1.0,18/74,14.01%,BMP2;LDLRAD4;BMP5;PHLDB2;EPHA3;SMAD3;SFRP1;OLFM1;AXIN2;FOXA2;LOXL2;TGFBR1;GATA3;PTEN;ZNF750;COL1A1;NKX2-1;EZH2
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3384876947106771,1.1508161020657426,0.24693877551020407,0.6635526104327931,1.0,4/56,1.29%,BMP6;BMP2;LDLRAD4;BMP5
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.3068457330664558,-1.1506878237871039,0.24,0.5973912310083359,1.0,26/72,24.83%,CARD14;REL;TLR3;PSMA6;PSMB5;AKT1;RELB;PSMC4;TIRAP;PSMC5;PSMD14;PSMD8;PSMC1;PSMB4;PSMD11;PSMD12;RELA;CHUK;CUL1;PSMA1;PSMC3;PSMB1;PSMA2;PSMA4;TRAF6;CARD10
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.45278557121203555,1.1502588950876198,0.30151843817787416,0.6639150563802941,1.0,7/15,16.28%,NLGN2;NLGN1;BAIAP3;CNTNAP4;DRD2;CLN3;ADRA1A
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.45695994988855887,-1.150128669649606,0.28186714542190305,0.5982178365187165,1.0,6/13,31.45%,SMUG1;UPP2;NT5C;NEIL1;TDG;DCTPP1
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.43655739373503133,-1.1495533372461466,0.30905861456483125,0.5991412175513097,1.0,3/16,5.11%,RREB1;SIX1;SOX13
prerank,cellular response to amino acid stimulus (GO:0071230),-0.36268086053053045,-1.1492929320775287,0.2381852551984877,0.5992609251401168,1.0,19/33,35.83%,SH3BP4;CAPN2;LAMTOR2;RRAGD;XBP1;RRAGA;SESN2;RRAGC;NSMF;CASTOR2;RPTOR;SESN1;LAMTOR5;LAMTOR1;CPEB4;LAMTOR3;GLRA1;IPO5;FYN
prerank,nerve growth factor signaling pathway (GO:0038180),-0.5000540020877585,-1.1492101328311632,0.30505415162454874,0.5988544812193746,1.0,3/10,3.68%,RAP1A;RAPGEF1;NGF
prerank,endothelial cell differentiation (GO:0045446),-0.46778289780539667,-1.1491435919707753,0.3088235294117647,0.5984176794887894,1.0,6/12,19.44%,TIE1;BMPR2;KDR;SOX18;FSTL1;EDF1
prerank,purine-containing compound salvage (GO:0043101),0.46970038253903545,1.1490532182228246,0.30699774266365687,0.6658522645576374,1.0,2/12,7.24%,AMPD3;GMPR
prerank,embryonic appendage morphogenesis (GO:0035113),-0.46147614113807756,-1.1488233959439862,0.2841918294849023,0.598609271986306,1.0,2/12,4.28%,MBNL1;TGFB2
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.38378816816681927,-1.14832382455405,0.28330206378986866,0.5993397845782319,1.0,8/26,14.92%,REST;PPIA;ATF4;PDE8A;HSPB1;AKT1;BAG5;GPR37L1
prerank,cellular respiration (GO:0045333),-0.3415225758548963,-1.1481276422487388,0.24564796905222436,0.5992491726310057,1.0,17/41,26.35%,ATP5F1D;PPARGC1A;NDUFS4;COX15;MTFR1;SURF1;ETFB;ETFDH;UQCRB;COX10;UQCRH;LYRM7;SDHB;SDHAF4;MTFR2;ETFRF1;COX4I2
prerank,ruffle organization (GO:0031529),-0.4400628955378415,-1.1478298091401662,0.27071823204419887,0.5994278541274715,1.0,11/16,37.61%,RAC1;CSF1R;AIF1;CARMIL1;PIP5K1A;PLEK;TPM1;LIMA1;INPP5K;CYFIP1;PLEKHA1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.43529853675741753,1.1478185515483101,0.30603448275862066,0.6678591362516288,1.0,3/18,5.22%,FBN1;GPR55;IL4
prerank,actin filament organization (GO:0007015),-0.2734536481336333,-1.147446775610852,0.13806706114398423,0.5998037879210433,1.0,51/151,26.60%,NEBL;SHROOM4;MYO1D;BAIAP2L1;TMOD3;COBL;EPS8;ARHGAP17;VILL;PLS3;CD2AP;MPRIP;NEDD9;RAC1;ARHGAP25;HIP1R;LMOD1;ACTN1;FLII;TMOD1;HIP1;RHOB;EMP2;TRPV4;DBN1;WASL;ABI1;GAS2L1;SHROOM1;SHROOM3;MYO1F;TPM3;MARCKSL1;ARHGEF2;TPM2;CAPG;RND2;GAS2;TPM4;TLE6;AVIL;RFLNB;DMTN;MCU;CORO7;ELMO3;INPPL1;AIF1;TMOD2;CARMIL1;CDC42
prerank,negative regulation of calcium ion transport (GO:0051926),0.45025766537438544,1.1474442408029515,0.2985386221294363,0.6676687503939035,1.0,2/15,7.75%,ATP1A2;TRIM27
prerank,mitotic sister chromatid segregation (GO:0000070),-0.2885766496798562,-1.1473695484590005,0.2056451612903226,0.5993721026097834,1.0,46/98,34.19%,RAB11A;DCTN2;SMC4;ZW10;CHMP2B;RB1;KIF23;CSNK2B;DIS3L2;POGZ;CSNK2A1;CSNK2A2;SMC2;KIF18A;CHMP2A;RAD21;BOD1;KNSTRN;NCAPH;KIF18B;NDC80;NSL1;NIPBL;NCAPG;REC8;KIF22;SPDL1;SEH1L;CDCA8;CEP55;SGO1;VPS4A;NCAPH2;KMT5A;EML3;TTN;CHMP7;TUBG2;CDK1;PLK1;NAA50;NCAPD2;ESPL1;PSRC1;CUL3;PRC1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.28081393299910473,1.1467124979676606,0.17829457364341086,0.6684015467361698,1.0,30/140,13.57%,LPAR1;PTGFR;SLC8A1;ADCY5;PDGFRA;GPR55;CACNA2D1;P2RX4;TRPM1;GPR174;CCR6;GRM1;ACKR2;ACKR4;CCR10;PTGDR;IAPP;NPTN;CALCR;LPAR4;CCR9;ADRA1D;C3AR1;ADCY8;ADRA1B;PTGIR;GNA15;DLG4;CXCR4;P2RY1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.4325427645532578,-1.146530144384196,0.3050847457627119,0.6008033586490309,1.0,6/17,22.11%,PTPRJ;EZR;DUSP3;DGKZ;LAPTM5;PTPN22
prerank,sensory perception of sound (GO:0007605),0.30498034833986953,1.146101023338647,0.2378167641325536,0.6688202060616444,1.0,12/88,9.86%,CEMIP;ADGRV1;ATP6V0A4;KIT;OTOS;ALDH7A1;COL4A3;PCDH15;EYA1;ROR1;LHFPL3;TMIE
prerank,regulation of microtubule-based process (GO:0032886),0.36440637492938344,1.1459577161392016,0.25103734439834025,0.6680895498792775,1.0,9/36,14.77%,PHLDB2;EPHA3;ATF5;KLHL42;MEMO1;BICD1;MAP10;MAPT;MAP6
prerank,positive regulation of cytokine production (GO:0001819),-0.2505017590036997,-1.1459342745873429,0.111358574610245,0.6017392096924332,1.0,110/292,31.16%,FOXP1;AFAP1L2;LBP;CD34;SPTBN1;IL15;PLCG2;SLC7A5;IFIH1;NOD1;F3;PDE4D;CYRIB;RPS3;GBP5;ANXA1;APP;TGFB1;PRKCZ;LRRFIP1;IL33;IL1R1;RARA;CYP1B1;ATF4;LURAP1;PRKDC;TLR3;RGCC;RIPK1;FLT4;DDX41;GAPDH;DHX9;TWIST1;FLOT1;FCER1G;HSPD1;CD74;TIRAP;DHX58;PAEP;S100A13;MAVS;TLR4;SYK;CSF1R;SPHK2;AGPAT1;POLR3E;RAB1A;POLR3A;NOD2;POU2F2;IL17RA;HSPA1A;RELA;XBP1;CD200;TXK;CGAS;ARHGEF2;PTGER4;LAPTM5;FZD5;HSPA1B;MAPK11;IL6ST;LGALS9;PTPN22;POLR3B;ZFPM1;PIK3CG;PRKD2;IL12RB2;BCL10;HILPDA;TRAF6;NFAM1;AIF1;C3;SOD1;PARK7;RASGRP1;CARD11;CTNNB1;CD86;LAMTOR5;TMEM106A;MRE11;NOX1;LILRB1;POLR2F;C1QTNF4;POLR1C;TLR6;PLCB1;CADM1;EGR1;HYAL2;LY9;HTR2B;TLR1;PQBP1;MBP;NOS2;TYROBP;TLR5;SCRIB;KAT2A
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.49828287987872316,1.1452641146637035,0.2890995260663507,0.6687717907503231,1.0,1/10,0.52%,ATP1A2
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.41563943798657244,-1.1447914329467985,0.27476635514018694,0.6040177583345887,1.0,3/17,6.75%,CAV1;KLF7;APOLD1
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.3198773554517483,-1.1445557356825955,0.2413127413127413,0.6040340023043927,1.0,17/59,18.29%,TGFBR2;HIPK1;NLK;WNK1;CAMK2D;PRKDC;DYRK2;AKT1;CDC42BPB;CSNK2B;LMTK2;ACVR1;CDK10;CAD;CSNK2A1;CSNK2A2;CHEK1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.3980371608997138,1.1445528072061848,0.2963709677419355,0.6695579198609408,1.0,11/26,12.52%,NRXN1;RIMS1;TMEM25;NLGN2;NLGN3;NLGN1;STX1B;CUX2;PTEN;CHRNA7;DLG4
prerank,actomyosin structure organization (GO:0031032),-0.3052081869212196,-1.1444517814028263,0.220675944333996,0.6037007522415472,1.0,16/75,11.01%,FRMD5;PGM5;SORBS1;TMOD3;F11R;PDLIM1;EPB41L4A;WDR1;LMOD1;FLII;FAM171A1;TMOD1;EPB41L5;CDC42BPB;TNFAIP1;FHDC1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4195916459132871,1.14440803167425,0.29978118161925604,0.6688157414853365,1.0,9/19,17.01%,PTPRD;CAMK2B;IL1RAPL1;CUX1;CDKL3;CUX2;OBSL1;CAPRIN2;CUL7
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.24582068082475528,-1.1443322391186268,0.12008733624454149,0.6034058149066508,1.0,63/348,12.23%,FN1;LEF1;MEF2C;OCLN;CLDN5;NOS3;CD34;TNRC6C;NOTCH1;ACTG1;PLCG2;FGF1;MAP2K5;KLF2;KLF4;F3;RAMP2;MAPK3;TFRC;RPS3;ETS1;NGF;RPL11;RAB27A;APP;TGFB1;RPL23;PDE2A;MSN;SMO;FOXD1;ANXA2;PPARGC1A;MYOM1;LIMS1;ACTA2;VEGFA;IL33;MPHOSPH8;EZR;GATA2;ATF4;HCFC1;KRAS;TLR3;RGCC;PPM1F;ADAM19;INSR;AKT1;WARS1;TRIM28;TWIST1;DDRGK1;WNT11;CD74;GABPA;INHBA;TLR4;SERPINB9;RPS7;PIK3R3;FAM98A
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.3880460134630492,-1.144247126472461,0.28709055876685935,0.6030476373025263,1.0,4/23,5.11%,TMSB4X;CCN3;HDAC7;ADIPOR1
prerank,actin crosslink formation (GO:0051764),-0.46115948945882984,-1.1438248491590293,0.3044280442804428,0.6035680542920037,1.0,2/12,1.81%,BAIAP2L1;EPS8
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.37290379649767996,-1.1435719042628476,0.26296296296296295,0.6036381263094613,1.0,7/25,11.83%,KLF2;KLF4;HSP90AB1;EDN1;INSR;AKT1;TLR4
prerank,positive regulation of MAPK cascade (GO:0043410),0.2640994534995705,1.143551421003807,0.17564870259481039,0.669991802849712,1.0,40/245,11.68%,IGF1;ROBO1;NRP1;IL34;BMP2;KSR1;LPAR1;NTRK3;FGFR2;PELI2;PLA2G5;PDGFRA;KIT;GPR55;ROCK2;PRKCA;SLC30A10;RIT2;WWC1;MAP3K12;IAPP;PDGFRB;CALCR;SOX2;THPO;ROR1;PDGFD;RYK;IGF2;KLHDC10;FGFR4;EPHA8;MYDGF;CCL25;ERBB4;ADRA1D;MST1R;CHRNA7;ADRA1B;FGFR1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.41879852176786764,-1.1434837584675717,0.2786885245901639,0.6032648742009081,1.0,9/17,31.05%,ZW10;RB1;KNL1;MTBP;BOD1;SPDL1;CENPA;BUB3;CDK1
prerank,regulation of cell motility (GO:2000145),-0.2834449494392382,-1.1429472320090721,0.19703389830508475,0.6039856043251242,1.0,33/121,14.73%,TMSB4X;FRMD5;CDK6;SPOCK2;FGF1;CYRIB;PLXNA4;TGFB1;CAVIN1;ROBO4;RAC1;MINK1;CRK;DIAPH1;AMOT;CCDC125;SPATA13;ABI3;AKT1;TMSB10;TWIST1;RHOB;PLXNA1;ABL2;PLXND1;RCC2;SRCIN1;NTN1;CSF1R;FGF2;LDB1;ERBB2;OSGIN1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.44736338574286927,1.1427568793221756,0.3002159827213823,0.6709429530899953,1.0,3/15,7.23%,MOXD1;SAT1;TPH2
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.4304210771949111,-1.142563220836483,0.29191321499013806,0.6043884879725119,1.0,11/17,28.95%,BAX;BCL2L1;BAK1;BBC3;BAD;SFN;TIMM50;GGCT;FIS1;MFF;FZD9
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.3442359079861052,1.1424810846312217,0.24947145877378435,0.6705837758684198,1.0,10/46,8.00%,ATP1A2;NRXN1;GRM1;NLGN2;NLGN3;SYT1;CACNG4;GRIK1;MAPK8IP2;NLGN1
prerank,regulation of synapse organization (GO:0050807),0.383110589995845,1.141750068427235,0.27292110874200426,0.6713243779683326,1.0,10/26,16.46%,CTNNA2;SLITRK4;ARHGAP22;CAMK2B;IL1RAPL1;SETD5;PDLIM5;CLN3;NEDD4;ABHD17C
prerank,organelle transport along microtubule (GO:0072384),-0.37053995733762535,-1.1417277935936634,0.2660377358490566,0.6060221504257371,1.0,11/31,14.84%,TRAK1;UBB;HTT;TRAK2;BORCS5;RHOT1;COPG1;RHOT2;NDE1;NDEL1;RAB1A
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.44083223750367134,-1.1416878859304838,0.2877959927140255,0.6055393577536619,1.0,4/15,20.54%,ENTPD1;ENTPD7;ENTPD6;ENTPD2
prerank,metanephric mesenchyme development (GO:0072075),0.49656243950771833,1.141447696024401,0.30561330561330563,0.6709975682544468,1.0,2/10,7.83%,WNT4;SIX4
prerank,brain development (GO:0007420),0.2854929938831755,1.1411810820185897,0.22672064777327935,0.6705351391834561,1.0,26/136,13.98%,EPHA7;ARNT2;ROBO2;ATXN1;ZIC1;CNTN4;AFF2;CNTNAP2;PBX4;CTNNA2;SPEF2;HES5;CDK5R1;PTEN;BBS2;PLXNB2;EEF1AKMT4-ECE2;EML1;AMIGO1;CTNS;HSPG2;PHF8;CXCR4;GRIN2A;TUBGCP2;NKX2-1
prerank,cellular copper ion homeostasis (GO:0006878),-0.4475001863647445,-1.1411097805430694,0.3121495327102804,0.6064370554856701,1.0,3/14,4.11%,ATOX1;MT2A;APP
prerank,positive regulation of macrophage differentiation (GO:0045651),0.4789570759342049,1.1407967076701446,0.30598669623059865,0.6704257544464737,1.0,2/11,2.75%,IL34;PRKCA
prerank,mitotic cell cycle phase transition (GO:0044772),-0.26189630819573484,-1.1407932638182345,0.14757709251101322,0.6066122645177581,1.0,66/203,25.47%,CDK6;CCND3;EPS8;DCTN2;CCNY;TPD52L1;TUBA1A;CDKN1B;CEP164;PPP2R1A;PRKAR2B;CEP57;CEP192;NES;CUL4A;PLK2;CEP70;RB1;CCNG2;DCTN3;CEP290;DCTN1;PPP1CB;CDK4;CRLF3;PPP1R12B;CNTRL;INHBA;TUBB4B;E2F3;PCM1;E2F1;ACVR1;HAUS1;NDE1;PPP2R2A;FBXL7;CETN2;CCNF;CEP72;YWHAG;ANAPC7;CDKN1A;FBXL3;HSP90AA1;CDC27;CEP41;CHMP2A;CDKN2C;CUL1;CCND1;DNM2;LCMT1;PPP2R2D;RCC1;TUBA4A;ARPP19;PLK3;PPP1R12A;EIF4EBP1;CEP63;BRSK2;EIF4E;HAUS4;SPDYA;NEDD1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.2346421140115362,1.1406843090143366,0.06597222222222222,0.6696189732217922,1.0,101/834,9.96%,AUTS2;IGF1;BMP6;TCF7L2;TCF4;RORA;PIK3R1;ARNT2;BMP2;LDB2;SALL1;PID1;CDK8;AR;TBX3;GLIS3;NR2F2;EPAS1;HLF;FGFR2;NFIA;BMP5;TBL1XR1;DCN;RARB;GDNF;VDR;GLI2;TEAD1;NCOA2;MITF;PPARA;HOXC4;NFAT5;NKX6-1;SMAD3;IL4I1;HOXB3;TFEC;STAT5B;KDM1B;ZEB2;GLI3;ZNF462;AKAP8L;TFCP2;CSRP3;KLF15;WWC1;SP7;PHIP;TFDP1;PHOX2A;CEBPB;IL4;MAML3;ZNF513;KMT2A;PRKN;SERPINE1;HNF4G;MLLT10;BCL2L12;ATF5;GABPB1;GABPB2;TAF6L;NFIX;FOXA2;ASXL3;SIRT2;ZNF296;PLAC8;LHX4;MEN1;SOX2;RARG;PCGF5;RBPJ;ZSCAN21;GLIS1;CITED2;RGMA;MLXIP;SENP1;CREB3L4;CREB3;NCOA1;IGF2;FOXD3;KAT8;IL18;ATOH8;NPAT;BMPR1A;GATA3;DVL3;MYDGF;HDAC8;AHI1;HOXC10
prerank,cellular response to interleukin-1 (GO:0071347),-0.274048015176607,-1.1406832515724945,0.1761006289308176,0.6063108834820347,1.0,44/143,23.36%,RPS6KA5;NOD1;NFKBIA;MAPK3;DAB2IP;IRAK2;UBB;MAP3K3;UBC;RPS27A;IL1R1;IKBKB;MAP3K8;PSMA6;RC3H1;PSMB5;CCL15;PSMC4;TOLLIP;PSMC5;PSMD14;RBX1;PSMD8;NOD2;PSMC1;PSMB4;TAB2;PSMD11;PSMD12;RELA;PELI1;CHUK;CUL1;SOX9;IRAK4;HAS2;PSMA1;PSMC3;MAPK11;PSMB1;PSMA2;HYAL1;ADAMTS7;PSMA4
prerank,regulation of striated muscle contraction (GO:0006942),0.37989724175360584,1.1406716653467037,0.2958715596330275,0.6685579062672943,1.0,5/27,7.88%,ATP1A2;ANK2;PRKACA;P2RX4;TNNI1
prerank,regulation of heart contraction (GO:0008016),0.3000926418371068,1.1405240818010531,0.23505154639175257,0.6678446231787539,1.0,12/90,6.17%,CELF2;ATP1A2;SLC8A1;ITPR1;ANK2;PRKACA;CORIN;DMPK;ATP2A2;P2RX4;FXYD1;ASPH
prerank,negative regulation of DNA recombination (GO:0045910),0.3523114873466786,1.140478221141283,0.2892561983471074,0.6668734722065189,1.0,14/43,21.20%,SHLD2;UBQLN4;RADX;BLM;POLR2G;SMCHD1;PARP3;DAXX;RIF1;POLR2K;POLR2D;FBH1;RTEL1;ZRANB3
prerank,T cell activation involved in immune response (GO:0002286),-0.4718243174548826,-1.1400801457800276,0.2919020715630885,0.6072829674119051,1.0,10/12,49.88%,FCER1G;CD74;ICAM1;LILRB1;SLC11A1;ITGAL;F2RL1;IFNK;LCP1;TNFSF18
prerank,positive regulation of myelination (GO:0031643),-0.4812075284766406,-1.1398890533528638,0.3069852941176471,0.6071831319683935,1.0,2/11,7.30%,PARD3;TNFRSF1B
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.2722794378377462,-1.1397373160383721,0.17446808510638298,0.6069484660066581,1.0,47/158,20.75%,NOD1;TFRC;MID2;TRIM25;FKBP1A;ATP2C1;MAP3K3;TNFSF10;REL;S100B;IKBKB;BRD4;LURAP1;EEF1D;CASP8;RIPK1;GAPDH;PLK2;TRIM14;CD74;TIRAP;S100A13;MAVS;PPP5C;MIB2;TRIM62;TRIM68;TNFRSF1A;EDA2R;TRIM5;NOD2;TMEM101;GPR89A;LGALS1;JMJD8;TAB2;ANKRD17;MIER1;RELA;PELI1;CHUK;ECT2;IRAK4;CCDC22;LTBR;TSPAN6;CANT1
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.4664827665056228,-1.1388658957979876,0.31047619047619046,0.6085634332864678,1.0,4/12,12.70%,NOTCH1;REST;YTHDF2;HES1
prerank,mitochondrion transport along microtubule (GO:0047497),-0.4533908582061983,-1.1382817313646632,0.294010889292196,0.6094632446695593,1.0,5/13,16.10%,UBB;NEFL;RHOT1;RHOT2;OPA1
prerank,cellular response to interleukin-12 (GO:0071349),-0.3299547448253605,-1.137608518971298,0.2513863216266174,0.6105778252574516,1.0,20/48,30.13%,RAP1B;HNRNPA2B1;MSN;PPIA;ANXA2;PITPNA;TALDO1;CFL1;HNRNPDL;JAK2;HSPA9;IL12RB2;STAT4;SOD1;CDC42;PDCD4;GSTO1;P4HB;PLCB1;PAK2
prerank,positive regulation of DNA binding (GO:0043388),0.36973399454257616,1.1372391949939515,0.27350427350427353,0.673969536095471,1.0,5/31,9.40%,IGF1;PRKN;SIRT2;PINX1;GATA3
prerank,negative regulation of secretion by cell (GO:1903531),-0.34826252361201526,-1.137106798907394,0.2607003891050584,0.6112452609201482,1.0,7/38,13.85%,STXBP6;NOTCH1;ANXA1;TNFRSF1B;DPH3;TNFRSF1A;APOE
prerank,negative regulation of receptor internalization (GO:0002091),-0.45527882626235877,-1.1365671239487427,0.31016042780748665,0.612007689460215,1.0,6/12,28.27%,RIN3;ANKRD13A;SDCBP;NECAB2;MTMR2;UBQLN2
prerank,positive regulation of stem cell differentiation (GO:2000738),0.42909506947333953,1.1363724975837515,0.30666666666666664,0.6752615896824761,1.0,4/16,10.19%,PTN;SP7;SOX5;LTBP3
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.310714775188939,-1.1362982164596829,0.23471400394477318,0.6120336878665062,1.0,21/66,15.90%,FLT1;MAP3K5;FGF1;TPD52L1;RPS3;DAB2IP;TGFB1;PIK3R6;VEGFA;TAOK3;EDN1;TNFRSF11A;PDGFC;MAP3K11;PDGFA;ARHGEF5;HRAS;FGF2;ERBB2;NOD2;EGFR
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.4052638875569912,-1.1362942273242267,0.3036053130929791,0.6114483392403334,1.0,7/21,25.43%,GPI;HK1;PGLS;TALDO1;RPIA;PGM2;SHPK
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3179388381131293,1.1353152338016523,0.2603305785123967,0.6768914965547433,1.0,14/72,9.72%,IGF1;PIK3R1;NTRK3;DCN;PDGFRA;KIT;LYN;IRS2;PDGFRB;ROR1;PDGFD;ERBB3;IL18;MYDGF
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.4072453753997835,-1.13525394200586,0.2887189292543021,0.6135123628474966,1.0,8/22,25.11%,BRD4;HMGN1;ALYREF;CCNK;DDX39B;CDK13;EAPP;ELL
prerank,defense response to protozoan (GO:0042832),-0.46927494911831535,-1.134879362571567,0.30363636363636365,0.6139015474860853,1.0,9/12,45.45%,LYST;GBP7;GBP4;SLC11A1;CD40;PF4;BATF;MYD88;IRF4
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.35852213789807064,-1.1347339613589966,0.26145038167938933,0.6136871472565253,1.0,10/33,18.32%,PLCG2;CDKN1B;PKD1;DDRGK1;TCIM;E2F1;PHB2;PTPN6;CDKN1A;GLI1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3353089453423198,1.1343623758926662,0.2475442043222004,0.67828072247305,1.0,8/51,7.82%,NRK;EPB41L3;CNTNAP2;GPM6A;MYO16;SRGAP2;GAS7;TNIK
prerank,negative regulation of protein kinase activity (GO:0006469),-0.2929415736942113,-1.1336026399587265,0.22700587084148727,0.6160090412125575,1.0,30/88,21.76%,PTPRB;CAV1;LRP5;DAB2IP;CDKN1B;ADAR;PPIA;CHP1;DBNDD2;HSPB1;PPM1F;TRIB2;AKT1;RB1;WARS1;TRIB1;DUSP3;SRCIN1;NF1;YWHAG;CDKN1A;TSC2;UBASH3B;CDK5RAP3;GADD45A;SFN;PTPRO;DTNBP1;TRIB3;PTPRQ
prerank,icosanoid biosynthetic process (GO:0046456),0.4785867291541598,1.1335007049989996,0.30786516853932583,0.6793951219164018,1.0,2/10,2.52%,PLA2G5;PLA2G4A
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.27580436594365326,-1.1333936476345357,0.19157894736842104,0.6159031130306426,1.0,56/125,33.18%,DCTN2;RPS27;MAP4;ZW10;DYNC1LI2;PLK2;RCC2;NDE1;NDEL1;KNL1;RANBP2;DYNC1LI1;CENPU;NUP37;KIF18A;MAD1L1;DYNLL2;RANGAP1;CENPI;NUP160;RCC1;NDC80;CENPF;RMDN1;NSL1;CENPN;CLIP1;EFHC2;SPDL1;CENPA;NUP43;SEH1L;CDCA8;STMN1;TBCE;SGO1;CENPO;SEC13;NUP107;BIRC5;WDR62;NUP98;SETD2;BUB3;XPO1;TUBG2;KIF11;NUF2;AURKA;BCCIP;PLK1;TACC3;ITGB3BP;ESPL1;CDC20;BUB1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.31576397088104047,1.1332952097188378,0.26260504201680673,0.6788052715000413,1.0,8/65,7.60%,RORA;EPAS1;PTGIS;SFRP1;MDM2;KCND2;SIRT2;SCN2A
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.39200366222187194,1.1332912984550543,0.29957805907172996,0.6777177128998022,1.0,4/24,5.02%,NRP1;SEMA5A;SEMA3A;SEMA3D
prerank,fatty acid beta-oxidation (GO:0006635),-0.32439271796402785,-1.133142502643278,0.2674199623352166,0.6159440482423485,1.0,23/51,30.07%,PPARD;ACAD11;ACAA2;ECHS1;ACOX3;DECR1;ACADL;ACADVL;CROT;ETFB;ETFDH;ECI1;ACOT8;MECR;HSD17B10;SLC27A2;ACOX1;AUH;GCDH;ACAT2;ABCD3;ACADS;HADH
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.4626498650179158,1.1330203210809966,0.3181818181818182,0.6773649857883227,1.0,5/13,13.20%,HYAL3;CACNA1I;SYT1;CACNA1G;SCAMP5
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.4069679337103519,-1.1323520811746794,0.2851782363977486,0.6173368485213248,1.0,7/21,13.56%,BACE2;ADAM10;BACE1;ERAP1;ADAM19;PSENEN;APH1A
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.347434913099984,-1.1323180361942,0.27056672760511885,0.6168318494207516,1.0,11/33,17.24%,KLF4;FOXO3;ETS1;TGFB1;TGFB2;GATA2;NR3C1;FGF2;SMARCA4;SRF;RELA
prerank,response to interleukin-4 (GO:0070670),-0.487855715814893,-1.1321854707195562,0.31993006993006995,0.616592596538897,1.0,5/10,29.66%,LEF1;JAK3;XBP1;SHPK;TCF7
prerank,protein localization to condensed chromosome (GO:1903083),-0.4594873223933825,-1.1321356161074136,0.300556586270872,0.6161202799122044,1.0,6/12,31.05%,ZW10;KNL1;MTBP;SPDL1;BUB3;CDK1
prerank,organic substance transport (GO:0071702),-0.276749625288163,-1.1316774690010485,0.19461697722567287,0.616650628665337,1.0,22/121,13.52%,ABCG2;SLC47A1;SLCO2A1;ATP8A1;PLTP;SLCO2B1;ARL6IP5;RAMP2;CUBN;CHMP2B;MFSD2A;SPNS2;CHKA;ARRDC1;NDC1;ABCG1;CEP290;RUFY1;RAB7A;MFSD2B;ABCA2;SLC22A6
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.38001978398565345,-1.1316759552658857,0.29213483146067415,0.6160598667872624,1.0,7/25,25.11%,BRD4;ZMYND11;NELFE;LDB1;CDK13;EAPP;ELL
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.36483918669868964,1.131560144317013,0.27729257641921395,0.6801026496207438,1.0,4/32,7.04%,CEMIP;PDPK1;P2RX4;CALCR
prerank,iron ion transmembrane transport (GO:0034755),-0.4881386154435159,-1.1315546216278711,0.32065217391304346,0.6157582714695706,1.0,6/10,38.61%,SLC39A8;SLC40A1;SLC25A28;ABCB6;ABCB7;SLC11A2
prerank,establishment of melanosome localization (GO:0032401),-0.39875466596547005,-1.1315322234206582,0.308529945553539,0.6152147061975975,1.0,6/19,13.65%,RAB11A;RAB27A;MREG;RAB11B;MLPH;ARL6
prerank,T cell migration (GO:0072678),-0.45705725917545315,-1.1312483163303646,0.3118081180811808,0.6153605856603619,1.0,3/13,4.55%,SLC12A2;S1PR1;MSN
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.33088863648110944,1.1307055448896897,0.2963709677419355,0.681124296490012,1.0,6/52,3.00%,PIK3R1;LRP1;DPP10;PDPK1;EPHA3;GNAI1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.39609897591133064,1.1305977805479661,0.30376940133037694,0.6803009856081033,1.0,4/21,2.74%,ATP1A2;SLC8A1;ANK2;PRKACA
prerank,organelle organization (GO:0006996),-0.23839697085151587,-1.1293862252907012,0.1257995735607676,0.6194917746280151,1.0,97/388,20.49%,PLCE1;FGD5;CAV1;CXADR;SEMA6A;SYNE1;NOS3;ATP8B1;VPS13D;FNBP1L;ARAP3;CAV2;SNX11;PI4K2A;ZW10;PPIA;NEDD9;BCAS3;PPARGC1A;HTT;BRWD3;RAB18;DIAPH1;GORASP2;FAM174B;MICAL2;FGD6;CHMP2B;TTC17;PDZD8;CHCHD2;ATP5F1B;HCFC1;MREG;ATL3;PLEKHM2;SPTSSB;KIF9;SIPA1;TRIP11;CDC42BPB;RHOT1;ATL2;PLAAT3;ESRRA;TRAPPC11;MIEF2;CFL1;GABPA;RHOT2;BAG5;WTIP;SIPA1L3;LIMD1;SURF4;YTHDF2;MTFR1;RAB7A;FAF2;AGTPBP1;WASL;PHB2;APOE;VPS11;DOP1B;NIPSNAP2;LMAN2;VMP1;RAB1A;NECTIN2;COG3;CHCHD10;GOLGA5;GOLGA8B;PACSIN1;OPA1;HPS3;MAST4;ADCK1;RANBP10;HSD17B10;CHMP2A;TNFAIP3;SLC25A33;TMED1;PACSIN2;PACSIN3;PLEKHF1;PTCD2;FGD2;STRIP2;TOR1AIP2;PRPF40A;RAB32;COG2;TMED5;ATP8B2
prerank,myelin assembly (GO:0032288),0.48783744788634165,1.1289466426975554,0.3203463203463203,0.6834263727848713,1.0,1/10,0.51%,EPB41L3
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.4491483518322595,-1.1286720495606724,0.3169291338582677,0.6206963243903859,1.0,5/14,21.61%,ENTPD1;ENTPD7;ENTPD6;ENTPD2;NUDT18
prerank,protein localization to cell junction (GO:1902414),-0.3857755690162127,-1.128641547824707,0.30994152046783624,0.6201665859424422,1.0,8/22,20.08%,HEG1;TJP2;FERMT2;JAM3;ARHGEF18;DSP;SHANK1;TJP1
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.3998609381713265,-1.128358032505646,0.3118279569892473,0.6202874183306235,1.0,8/20,17.75%,CASP8;RIPK1;FLOT1;SDCBP;HSP90AA1;FLOT2;MLKL;PELI1
prerank,genitalia development (GO:0048806),0.45922809723433894,1.128067039993442,0.31856540084388185,0.6845531036992744,1.0,2/12,2.30%,TBX3;CHD7
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.43644495941761474,-1.1278703149642666,0.30998248686514884,0.6208837599185673,1.0,3/13,7.43%,PRR5L;CNOT7;RC3H1
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.3430607000164979,-1.1271831453553307,0.2723735408560311,0.6221305639352622,1.0,11/39,16.59%,MYO1D;FNBP1L;ACTN4;TRAK1;HTT;TRAK2;NDE1;WASL;NDEL1;RAB1A;MYO1F
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.3724673061440893,-1.127178435540598,0.27392120075046905,0.6215544332405348,1.0,7/27,16.06%,DACH1;HMBOX1;BMPR2;RGCC;PDGFA;FGF2;CDKN1A
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.35999022181817414,-1.1270735388331654,0.2892249527410208,0.6212078464994042,1.0,8/30,11.83%,UBB;UBC;RPS27A;IKBKB;CASP8;TLR3;RIPK1;TLR4
prerank,ear morphogenesis (GO:0042471),0.40329110893661874,1.1266679782956806,0.2823779193205945,0.6870525271018816,1.0,3/20,2.30%,FGFR2;ZIC1;CHD7
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.3085188137423196,-1.1264992801638687,0.2446183953033268,0.6221897916239053,1.0,16/63,22.58%,MEF2C;IL15;SLC7A1;TFRC;ANXA1;CD38;CD81;CD74;TIRAP;CLCF1;JAK3;CD320;FGF10;IL6ST;NCK1;TNFSF13B
prerank,neutrophil chemotaxis (GO:0030593),-0.321142855361226,-1.1260931300051378,0.25748502994011974,0.6226462069995224,1.0,8/53,12.47%,BSG;CXADR;TGFB2;PPIA;EDN1;CCL15;FCER1G;SYK
prerank,response to amino acid (GO:0043200),-0.35734300625144877,-1.1258137398260946,0.2975517890772128,0.6227813170950103,1.0,19/31,35.27%,SH3BP4;CAPN2;LAMTOR2;RRAGD;XBP1;TMBIM6;RRAGA;SESN2;RRAGC;MEAK7;NSMF;RPTOR;GRIN1;LAMTOR5;LAMTOR1;CPEB4;LAMTOR3;GLRA1;IPO5
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.4581228120390124,-1.125802051106873,0.31365313653136534,0.6222149262849012,1.0,5/13,18.29%,SERTAD2;ARID1A;ZMIZ2;CDCA4;CHEK1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.3813931462344688,1.125681367033305,0.30603448275862066,0.688605620936981,1.0,8/25,12.78%,B3GALT1;B3GALNT1;B3GNT7;NDST4;HS2ST1;FUT9;B3GALT2;B3GALT5
prerank,nuclear membrane reassembly (GO:0031468),-0.3106223571429995,-1.1256547993586603,0.27655310621242485,0.6220173053933712,1.0,27/54,31.06%,LBR;PPP2R1A;CHMP2B;NUP93;CC2D1B;NDC1;VRK1;PPP2R2A;NUP188;NUP155;IST1;NUP37;CHMP2A;REEP4;RANGAP1;NUP160;RCC1;NUP43;SEH1L;SEC13;NUP107;VPS4A;NUP98;CHMP7;BANF1;CDK1;UBE2I
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.26767023444898114,-1.125539355663286,0.202991452991453,0.6217200712938629,1.0,39/153,17.97%,PRKCH;RPS6KA5;TGFBR2;HIPK1;NLK;WNK1;RPS6KA3;CAMK2D;RICTOR;MAPKAPK3;PRKCZ;CSNK1G2;PKD1;IKBKB;CSNK1G3;PRKDC;RIPK1;DYRK2;PLK2;AKT1;STK32B;LMTK2;VRK3;CAMK1;RPS6KB2;VRK1;ULK3;STK38;PRKCE;PKN3;RPS6KA2;UHMK1;STK38L;CAB39;MAST4;CSNK2A1;CSNK2A2;MAPK12;CHUK
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.42990549833079994,-1.1252558103575951,0.30654205607476637,0.6218262301604761,1.0,5/14,14.50%,SRSF6;PCBP4;RNPS1;SRSF4;SFSWAP
prerank,centromere complex assembly (GO:0034508),-0.34622042187718693,-1.12525255206018,0.28205128205128205,0.6212422757317199,1.0,19/36,33.93%,POGZ;KNL1;MIS18BP1;CENPU;RBBP4;CENPI;CENPF;CENPN;CENPA;CENPO;CENPV;NPM1;RUVBL1;SMARCA5;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.30876496466157916,-1.1252441160075848,0.25748502994011974,0.6206767650692383,1.0,31/65,33.18%,FHL1;PSMA6;PSMB5;PABIR1;PSMC4;PSMC5;AVEN;PSMD14;RBX1;PSMD8;FBXL7;PSMC1;PSMB4;PSMD11;PSMD12;CHEK1;CUL1;CDK5RAP3;PSMA1;PSMC3;PSMB1;PSMA2;PSMA4;VPS4A;PSMB8;INTS3;AURKA;PSMC6;PSMD6;PSMA8;PSMB2
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.3895985159305827,1.1252118493002132,0.3114406779661017,0.6886911040299427,1.0,2/23,2.32%,CEMIP;PRKAG2
prerank,cellular protein-containing complex assembly (GO:0034622),-0.26766082579988926,-1.1250392848621396,0.20045045045045046,0.620588718908646,1.0,62/159,27.31%,STXBP6;DMD;PXN;POMP;RPL38;HSP90AB1;TGFB1;FKBP1A;HIP1R;NUP93;AP2M1;DNAJB12;IMMP2L;DHX9;PIK3C2A;NDC1;CSNK2B;HIP1;SGIP1;HSPD1;FCHO2;TTC12;HIGD2A;CHCHD4;POGZ;ARL6;HSPA4;CCT2;CASQ2;EID2;SMAD4;GPX4;HSP90AA1;SRP19;HSPA1A;PSMD11;PTGES3L;CHMP2A;ARL2;HIGD1A;HIGD1B;SMAD2;CLTA;CENPF;PFDN6;NCK1;ANLN;NSG2;CLTB;PSMG2;MKKS;CENPA;CASQ1;EIF4B;EIF4H;TBCE;SMAD1;NCK2;EPS15;NUP107;NUP98;DNAJC28
prerank,acylglycerol biosynthetic process (GO:0046463),0.3816191942130242,1.1250376583605712,0.27455357142857145,0.6880661373076569,1.0,8/23,16.56%,AGMO;PLA2G4A;MOGAT3;LPIN3;ANG;MOGAT2;DGAT2;LPIN1
prerank,actin filament bundle assembly (GO:0051017),-0.35858748819908975,-1.1250064139963676,0.2937853107344633,0.620086548588997,1.0,7/33,9.37%,BAIAP2L1;EPS8;PLS3;NEDD9;EZR;ADD1;FAM107A
prerank,establishment of protein localization to organelle (GO:0072594),-0.30038107240089323,-1.1247268564354307,0.24693877551020407,0.6201926661065343,1.0,23/72,26.31%,RAB11A;HK1;NUP93;AKT1;LAMP1;PTTG1IP;E2F3;SYK;NUP188;PHB2;NUP155;TNPO3;TSPAN17;RPAIN;TSC2;NXT2;TNPO2;CD68;NEURL1B;FAM53A;IPO13;SEC13;NUP107
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.3679827231983664,1.1246132869923975,0.28778467908902694,0.6880843611111485,1.0,3/27,1.91%,IGF1;DDR2;PDGFRA
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.37152756906869777,-1.1245641883101136,0.2764811490125673,0.6200221906214257,1.0,12/26,30.38%,ITPR2;PLCG2;ITPR3;FGF2;HTR2A;CHERP;ERO1A;SLC8B1;PKD2;LETM1;HTR2C;HTR2B
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.3894092659191853,-1.12418734477204,0.3113207547169811,0.6203924370755136,1.0,8/22,22.11%,LBP;DAB2IP;MFHAS1;FLOT1;TIRAP;NINJ1;TNFAIP3;PTPN22
prerank,chromatin remodeling at centromere (GO:0031055),-0.35734625243682383,-1.124079041312987,0.29159212880143115,0.6200852350987274,1.0,17/31,33.93%,KNL1;MIS18BP1;CENPU;RBBP4;CENPI;CENPN;CENPA;CENPO;CENPV;NPM1;RUVBL1;SMARCA5;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,aortic valve development (GO:0003176),0.3531216486491405,1.1239634779840544,0.2923387096774194,0.6886789597088452,1.0,4/34,2.56%,ROBO1;ROBO2;BMP2;ROCK2
prerank,regulation of glycolytic process (GO:0006110),0.3148451831963558,1.123828306965465,0.2718253968253968,0.6879270276168663,1.0,6/68,5.02%,IGF1;ZBTB20;PPARA;PRKAG2;PFKFB4;ACTN3
prerank,tRNA metabolic process (GO:0006399),-0.4161760869196508,-1.1235468765646976,0.3061594202898551,0.6208756852725017,1.0,10/17,39.36%,SARS1;FARS2;TRPT1;RPP21;ADAT1;KARS1;THG1L;AARS1;YARS2;RPP30
prerank,cardiac muscle cell action potential (GO:0086001),0.3677033647361048,1.1235103028441573,0.2958963282937365,0.6877017722076678,1.0,5/30,3.16%,ATP1A2;SLC8A1;SCN3B;ANK2;CACNA2D1
prerank,epithelial structure maintenance (GO:0010669),-0.4759747047733829,-1.1234359307574209,0.34444444444444444,0.6206030258355639,1.0,5/11,35.62%,CXADR;NOD2;MUC13;PIWIL4;MUC6
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.37266615430012406,1.123352986303891,0.30472103004291845,0.6870238198571477,1.0,6/28,13.41%,ADCY1;PTN;CYP46A1;ADCY8;CHRNA7;ZDHHC2
prerank,dendrite morphogenesis (GO:0048813),0.35531304647003625,1.1232634738329357,0.2923387096774194,0.6861803907825501,1.0,11/35,12.52%,PTN;LRP4;DOCK10;CTNNA2;CTNND2;EPHB1;MAPK8IP2;FARP1;PTEN;CHRNA7;DLG4
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3470729612139118,1.1229105238844597,0.27755102040816326,0.6859879401900137,1.0,19/40,25.01%,SETMAR;GEN1;BLM;MCM9;FANCM;THOC1;CENPS;CDK9;ETAA1;POLD1;FBH1;DONSON;SMARCAL1;RTEL1;PCNA;ZRANB3;TIMELESS;RFWD3;ATR
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.323896623942487,1.122694011462218,0.27439024390243905,0.6854132389592686,1.0,16/57,14.82%,GRIA4;DLG2;SHISA9;DAPK1;DLGAP1;NLGN2;CAMK2B;CACNG4;MAPK8IP2;NLGN1;LRRC7;GRIA3;DLG4;ACTN2;GRIN2A;GRIA1
prerank,relaxation of cardiac muscle (GO:0055119),0.44408998164025554,1.1224967112893849,0.3333333333333333,0.6848285198146149,1.0,3/13,3.87%,ATP1A2;SLC8A1;P2RX4
prerank,macrophage migration (GO:1905517),0.4509058165545663,1.1224114117337818,0.3304535637149028,0.6839938196057557,1.0,4/13,20.29%,P2RX4;EDNRB;CKLF;TAFA4
prerank,regulation of macrophage activation (GO:0043030),-0.36200356252530486,-1.1224113023864135,0.29239766081871343,0.6226004357261963,1.0,8/30,11.83%,THBS1;LBP;MFHAS1;IL33;GPR137B;HSPD1;CD74;TLR4
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.32277875154634994,1.1223429510453482,0.2838709677419355,0.6831041148419363,1.0,3/51,0.56%,GREM2;FBN1;BMP2
prerank,protein deacylation (GO:0035601),0.3970597251372829,1.1223402835242768,0.3326271186440678,0.6820472241258586,1.0,7/23,16.46%,NOTUM;HDAC10;SIRT2;ABHD10;SIRT6;HDAC1;ABHD17C
prerank,stabilization of membrane potential (GO:0030322),0.4219391958903148,1.1218765747106356,0.29916317991631797,0.6822193952962792,1.0,1/16,0.16%,KCNK2
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.3025102271050176,-1.12180337473897,0.2729083665338645,0.6236053239112799,1.0,25/70,23.36%,LMO2;GATA2;PRKDC;CBFB;PSMA6;PSMB5;TAL1;PSMC4;PSMC5;YTHDF2;PSMD14;ITCH;LDB1;PSMD8;SETD1A;PSMC1;PSMB4;PSMD11;PSMD12;TCF3;PSMA1;PSMC3;PSMB1;PSMA2;PSMA4
prerank,blood vessel endothelial cell migration (GO:0043534),0.39099298031472496,1.1215101562927392,0.3224400871459695,0.6820990774856996,1.0,2/22,0.31%,ROBO1;NRP1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.4497553550748373,-1.121503860885382,0.3240901213171577,0.6237792192278866,1.0,10/12,52.25%,SLC11A1;IL12RB1;ZBTB1;CARD9;IL23A;IL12B;IL23R;CCR2;CLEC6A;IL1B
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.35983646946227554,-1.1213382427277758,0.3049907578558225,0.6235863062247168,1.0,7/26,11.83%,KLF2;KLF4;HSP90AB1;EDN1;INSR;AKT1;TLR4
prerank,nuclear migration (GO:0007097),0.4472807363319167,1.121191346715379,0.31072210065645517,0.6818203712975154,1.0,3/13,7.72%,CLMN;SYNE2;DOCK7
prerank,cellular response to unfolded protein (GO:0034620),-0.3809557072789507,-1.1208511274535886,0.294234592445328,0.6242395179849832,1.0,16/26,29.96%,DAB2IP;HSPA8;RHBDD1;BAX;HSPD1;HSPA5;BAK1;HSPB8;HSPA1A;HSPA9;TMBIM6;HSPA1B;PTPN1;ERN1;ABCB10;HSPA14
prerank,regulation of dephosphorylation (GO:0035303),-0.4361048249539335,-1.1201758570972942,0.31166347992351817,0.6254091922930788,1.0,10/15,40.32%,PPP1R16B;IGBP1;CDK5RAP3;PPP1R16A;SMG7;MTMR2;SRC;SMG6;INPP5K;MTMR3
prerank,ephrin receptor signaling pathway (GO:0048013),-0.2907744043494722,-1.120028858377301,0.2551984877126654,0.6252003392801848,1.0,27/82,19.42%,ACTB;ARHGEF28;ACTG1;SIPA1L1;ARPC1B;PTK2;RAC1;CHN1;CRK;ANKS1A;AP2M1;ARPC5;PSENEN;ITSN1;ACTR3;HRAS;APH1A;WASL;AP2A1;SDCBP;EPHA2;YES1;EPHB6;DNM1;EFNB3;RASA1;EFNB1
prerank,RNA destabilization (GO:0050779),0.42041017913852147,1.119772292537054,0.3063063063063063,0.6843347526150897,1.0,7/18,16.09%,ROCK2;LIN28B;FTO;RIDA;METTL16;RBM24;METTL3
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.34961281301970726,1.119273773433153,0.2751540041067762,0.6846190663018533,1.0,13/37,18.08%,TENM3;GRID2;DCHS1;PTPRD;TENM2;IL1RAPL1;NLGN1;ALCAM;AMIGO1;TENM1;ADGRL1;NECTIN3;TENM4
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.4444488251239797,-1.1191579338264437,0.3241758241758242,0.6268655088483174,1.0,7/12,37.07%,MAD1L1;BOD1;NDC80;RMDN1;SEH1L;NUF2;KIF2C
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.4545936709482217,-1.1191392950047767,0.30113636363636365,0.626335708362938,1.0,2/12,7.95%,IGF1R;INSR
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.33028529840387233,-1.1189944175036903,0.28107074569789675,0.6261468232292761,1.0,11/45,9.21%,PLCE1;RPS6KA5;GAB1;PTK2B;IQGAP1;PTK2;TGFB1;REPS2;SHC1;AKT1;PIK3C2A
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.2829108183956694,-1.1187144520742933,0.24742268041237114,0.6262798052192379,1.0,27/95,15.19%,CAV1;THBS1;LTBP4;TGFBR2;SMAD7;ZBTB7A;HSP90AB1;PRDM16;TGFB1;FKBP1A;UBB;UBC;RPS27A;CD109;SMAD6;GIPC1;ASPN;IL17RD;HTRA4;SKIL;HTRA3;ENG;RNF111;SMURF1;EID2;SMAD4;SDCBP
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.492352030810554,1.1183465061098234,0.33548387096774196,0.6859283691082659,1.0,4/10,26.01%,PRKN;AOC3;HDAC6;SNCA
prerank,regulation of macromolecule metabolic process (GO:0060255),0.26885700745437113,1.1181207814453846,0.2265625,0.6854346615767731,1.0,25/170,10.97%,IGF1;NELL1;NOVA1;SLC8A1;C1D;GDNF;AFF2;PRDM5;TRIM38;AFF1;ROCK2;ZNF462;IGF2BP2;ZNF513;PRDM9;TRIM27;SOX2;STX1B;FUBP1;CTCF;NPAT;PCBP3;KHSRP;HNRNPD;AHR
prerank,positive regulation of phosphatase activity (GO:0010922),-0.387557445568267,-1.1178382433791882,0.292817679558011,0.6279463037796884,1.0,4/21,3.75%,MEF2C;ITGA1;HSP90AB1;CALM1
prerank,cellular response to organic cyclic compound (GO:0071407),-0.2664816101808176,-1.1173727175586854,0.19444444444444445,0.6285289979527138,1.0,24/141,7.44%,MEF2C;ACTB;RAP1A;CDH1;ESR1;RAP1B;TGM2;ARL6IP5;CTNNA1;RAPGEF1;ATP1A1;IGFBP5;TGFB1;SLC1A1;PDE2A;MSN;KCNQ1;DIAPH1;EZR;CYP1B1;CASP7;NR3C1;NRIP1;JUP
prerank,cellular response to amino acid starvation (GO:0034198),-0.3012947258348474,-1.1170471675377662,0.27586206896551724,0.6288165314621388,1.0,28/71,33.68%,MAP3K5;MAPK3;DAPL1;ATP6V0B;ATF4;FAS;ATP6V0C;IMPACT;LAMTOR2;RRAGD;CDKN1A;ATP6V1G1;TFEB;RRAGA;SESN2;RRAGC;CASTOR2;ATP6V0D1;SEH1L;SEC13;RPTOR;SESN1;LAMTOR5;LAMTOR1;ATP6V0E2;ATP6V1C1;LAMTOR3;RNF152
prerank,regulation of cytokine production (GO:0001817),-0.26950662838085754,-1.1170010544018636,0.21669980119284293,0.628347265080193,1.0,25/126,14.75%,FOXP1;AFAP1L2;RPS6KA5;IL15;SRGN;IFIH1;ANXA1;HDAC9;IL33;N4BP1;LURAP1;CASP8;TNFRSF1B;RGCC;GAPDH;FLOT1;ACE2;BCL6;S100A13;TRIM56;PLD3;AGPAT1;BTN3A3;BCL6B;NLRP4
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.27954990873361174,-1.1166963248556643,0.2070393374741201,0.6285634348957048,1.0,35/119,18.06%,ITPKB;EFR3B;PLCG2;PIP5K1B;BMX;SOCS2;PI4K2A;INPP5D;PIK3R6;MTMR14;CDS1;MTMR12;PIGL;CDIPT;INPP5E;PIK3C2A;PITPNM2;PIGF;MBOAT7;RUFY1;RAB4A;PITPNM3;PIK3R3;FGF2;PITPNM1;IP6K1;CISH;PIK3CA;PIGC;MTM1;SYNJ1;PIK3R2;PIK3C2B;PIGW;FIG4
prerank,negative regulation of histone methylation (GO:0031061),0.48358575569515017,1.1163868639737367,0.3471264367816092,0.6888344312383368,1.0,4/10,20.91%,BCOR;DNMT1;MTF2;DNMT3B
prerank,Wnt signaling pathway (GO:0016055),-0.2836864077298166,-1.116165502590825,0.24361493123772102,0.6293180967968076,1.0,19/92,10.16%,LEF1;NXN;PLCG2;LRP5;FZD6;FZD4;FERMT2;UBB;NR4A2;CSNK1G2;UBC;RPS27A;CSNK1G3;WNT9A;FZD7;FZD3;CPE;DIXDC1;WNT11
prerank,regulation of transferase activity (GO:0051338),-0.4153528943712389,-1.1159132834794414,0.3247706422018349,0.6293743098479802,1.0,9/17,16.57%,HMBOX1;NLRC5;SPTSSB;EMP2;PPP1R3F;BAG5;FEM1A;LDB1;JMJD8
prerank,regulation of cartilage development (GO:0061035),0.4171146026079205,1.1155931411662081,0.3271461716937355,0.6897521318080025,1.0,4/18,8.47%,BMP2;TRPS1;SOX5;SCIN
prerank,protein stabilization (GO:0050821),-0.26340804216293884,-1.114930757561936,0.21610169491525424,0.6312480704834367,1.0,57/168,23.48%,NLK;SOX17;SEL1L;SMAD7;HSP90AB1;RPL11;RPL23;PPARGC1A;CHP1;HIP1R;USP7;ATP1B1;HCFC1;RASSF2;GAPDH;GLMP;COA8;PFN1;CAMLG;IFT46;LAMP1;FLOT1;HIP1;HSPD1;USP9X;BAG5;NCLN;RPS7;CDC37L1;SOX4;PHB2;CCT2;MFSD1;TMEM88;COG3;HYPK;CDKN1A;CRTAP;HSP90AA1;FLOT2;HSPA1A;CCT3;CRYAB;PIN1;RPL5;UBE2B;MSX1;TBL1X;HSPA1B;TAF9;ATP1B2;CCT8;PDCD10;BAG1;PPIB;WNT10B;PRKCD
prerank,regulation of vasculogenesis (GO:2001212),-0.4408653453798378,-1.1149008135203904,0.34594594594594597,0.6307470516159007,1.0,6/14,14.29%,RAP1A;CD34;KDR;EMP2;TMEM100;HEY1
prerank,response to amino acid starvation (GO:1990928),-0.30048337667408886,-1.1148332843579174,0.2836734693877551,0.6303334506108509,1.0,28/72,33.68%,MAP3K5;MAPK3;DAPL1;ATP6V0B;ATF4;FAS;ATP6V0C;IMPACT;LAMTOR2;RRAGD;CDKN1A;ATP6V1G1;TFEB;RRAGA;SESN2;RRAGC;CASTOR2;ATP6V0D1;SEH1L;SEC13;RPTOR;SESN1;LAMTOR5;LAMTOR1;ATP6V0E2;ATP6V1C1;LAMTOR3;RNF152
prerank,protein autoubiquitination (GO:0051865),0.3211374319859545,1.1145716193124409,0.2910602910602911,0.6913891944001037,1.0,7/61,7.51%,RNF220;SH3RF3;SH3RF1;MDM2;DDB2;PRKN;RNF181
prerank,regulation of protein kinase activity (GO:0045859),-0.279884811342198,-1.1145241872025562,0.228,0.6304854788919698,1.0,41/106,26.84%,PLCE1;RAP1A;PTK2B;IQGAP1;PTK2;PPIA;CHP1;DBNDD2;HSPB1;RASSF2;PPM1F;TRIB2;AKT1;RB1;WARS1;TRIB1;NF1;SMG8;PRKAG1;MMD;LCP2;YWHAG;CDKN1A;TAB2;AGAP2;ECT2;TSC2;UBASH3B;TSPYL2;RAPGEF2;SFN;DTNBP1;TRIB3;DBNDD1;MRNIP;SPDYA;CAMKK2;SOD1;MMD2;PARK7;ADCYAP1
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.3073955192194009,-1.1144856707150788,0.2928416485900217,0.6300054925713003,1.0,34/66,31.54%,CDH1;LIMK2;TFRC;FERMT2;TGFB1;JUP;AKT1;NMD3;RBM22;TRIM28;MAVS;DKC1;CCT2;PIK3R2;CCT3;MCRS1;ECT2;ZPR1;CDK5RAP3;MEPCE;HCLS1;SESN2;CCT8;PRKCD;DTX3L;CARD10;CCT7;PARK7;LAMTOR5;HYAL2;PARP9;CDK1;HDAC3;PLK1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.3673201164960657,-1.1144573403324238,0.32730560578661844,0.6294864137574857,1.0,4/27,4.22%,CAV1;PLTP;NFKBIA;LPCAT3
prerank,regulation of DNA damage checkpoint (GO:2000001),0.4747163797171654,1.1141115228191272,0.32905982905982906,0.6915443706673317,1.0,6/10,23.65%,CRY1;RPA2;THOC1;ETAA1;WDR76;RFWD3
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.342618574394447,1.1137414697544006,0.29653679653679654,0.6914462470953998,1.0,7/40,7.55%,TCF7L2;BMP2;SMAD3;OLFM1;AXIN2;LOXL2;TGFBR1
prerank,cell cycle G1/S phase transition (GO:0044843),-0.30077000099602696,-1.113727075045508,0.27070707070707073,0.6308968021140915,1.0,21/61,25.32%,CDK6;CDKN1B;CUL4A;PLK2;MAP3K11;RB1;CDK4;CRLF3;INHBA;E2F3;E2F1;ACVR1;CDKN1A;CDKN2C;CUL1;CCND1;RCC1;PLK3;EIF4EBP1;EIF4E;SPDYA
prerank,translesion synthesis (GO:0019985),-0.32785723962617086,-1.113699876704854,0.27977315689981097,0.630389407773939,1.0,15/42,23.62%,TRIM25;UBB;UBC;RPS27A;UBE2L6;VCP;SPRTN;REV3L;USP43;RPA3;POLK;POLDIP2;RFC3;DTL;RFC2
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.3769968017405057,-1.1136724831511031,0.3096085409252669,0.6298724514861812,1.0,12/22,38.01%,CHP1;UFM1;GDI1;RANGAP1;RAB23;DMTN;PARK7;BARD1;INSIG1;SIAH3;INPP5K;CABP1
prerank,positive regulation of cell cycle (GO:0045787),-0.30500862800483114,-1.1131213352582463,0.2556818181818182,0.6307304734191098,1.0,26/62,26.16%,CCND3;CCNY;CDKN1B;APP;TGFB2;RPS15A;PKD1;RARA;HCFC1;RGCC;TAL1;AKT1;CDK4;DUSP3;EGFR;ANKRD17;USP22;CHEK1;CCND1;ASNS;EIF4EBP1;PKD2;EIF4E;SPDYA;RAD23A;TTL
prerank,endothelial tube morphogenesis (GO:0061154),-0.4879913048535002,-1.113070910080702,0.3431192660550459,0.6302717416361029,1.0,7/10,32.37%,STARD13;CSNK2B;RHOB;PRKD2;CTNNB1;ACVRL1;RHOA
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.36480457167206565,-1.1130381566324747,0.29704797047970477,0.6297918774342991,1.0,7/26,15.21%,NEDD4L;FHL1;WWP2;ATP1B1;CACNA1D;CASQ2;CAB39
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.41101355309109383,1.1122520178103237,0.32091097308488614,0.6943251264614253,1.0,6/19,10.22%,TGFBR3;FGFR2;TGFBR1;RBPJ;BMPR1A;ERBB4
prerank,negative regulation of cellular protein localization (GO:1903828),0.3545594823918783,1.112147019862046,0.3070539419087137,0.6935590190554362,1.0,9/34,13.77%,ROCK2;SNX33;LEPROT;TAX1BP3;UBXN2B;LZTFL1;LEPROTL1;ACTN2;MAPT
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.23653977393359613,-1.1118011304332145,0.16546762589928057,0.6324014954238993,1.0,80/366,17.24%,BNC2;MEF2C;APBB2;RREB1;RPS6KA5;ESR1;NOTCH1;RPL6;JMJD1C;NLK;RPL10;FOXO3;SOX17;VSX1;SIX1;APP;REST;CNBP;TRRAP;ZNF431;NFYA;PPARGC1B;PFDN5;ASCC2;PPARGC1A;SOX13;SLC39A8;PRDM2;BHLHE40;PPP2R1A;ATF4;FOXN3;NR3C1;HCFC1;INSR;ATXN1L;SPIN1;SOX7;FZD7;NR2C2;PDGFA;RB1;FUS;SOX18;ESRRA;SFPQ;MYBL1;SOX12;TEAD2;WTIP;LIMD1;PRRX2;SP3;KMT2D;SOX4;ZNF423;ENG;E2F1;HINT1;MLX;RNF20;PHF12;LDB1;NR5A2;HCFC2;SOX6;RBM4B;SMARCA2;CELSR2;ZFHX3;DRAP1;BRCA2;SAP30L;ZNF22;LIN54;ANKRD17;PCIF1;SP1;TCF3;RELA
prerank,neuromuscular process (GO:0050905),0.4124071426893752,1.1115572583664863,0.3282608695652174,0.6940369728492988,1.0,3/16,2.36%,MYCBP2;NRXN1;CHRNA1
prerank,postreplication repair (GO:0006301),-0.3260542960836494,-1.1111620694385353,0.2926356589147287,0.633420125942619,1.0,16/45,24.75%,TRIM25;UBB;UBC;RPS27A;UBE2L6;VCP;SPRTN;USP43;RAD18;RPA3;POLK;UBE2B;RFC3;DTL;RFC2;NSMCE1
prerank,fatty acid oxidation (GO:0019395),-0.314813290430673,-1.111113788038124,0.2602739726027397,0.632981482666832,1.0,15/57,17.70%,ADIPOR2;PPARD;ACAD11;PPARGC1A;ADIPOR1;ACAA2;ECHS1;HACL1;DECR1;ACADL;ACADVL;CROT;ECI1;MECR;HSD17B10
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.40222436006445034,1.1110480179525,0.31759656652360513,0.6942979024781422,1.0,4/23,7.27%,ATP1A2;ANK2;CACNA2D1;CACNB1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.22175772753476328,-1.1108863991756248,0.0967741935483871,0.6329209724755044,1.0,154/807,14.46%,KLF12;MECOM;LEF1;FOXP1;ELK3;MEF2C;CAV1;PRDM6;DACH1;WWP1;RREB1;RPS6KA5;ATP8B1;ESR1;DDX5;NOTCH1;RPS14;CBFA2T3;ID1;NEDD4L;ZHX3;HMBOX1;ID3;MAP2K5;PPARD;MEF2A;KLF2;KLF4;NCOR1;FOXO1;RPL10;FOXO3;DAB2IP;SMAD7;ZBTB7A;IRF2BPL;KLF7;FNIP2;CDKN1B;PRDM16;REST;TGFB1;CNBP;KDM5C;HDAC9;RPL23;ZNF431;PDE2A;UBB;WWP2;TBX2;NR4A2;HSPA8;KCTD1;FOXD1;ZBTB16;PFDN5;RLIM;SARS1;SOX13;CD38;CTBP1;UBC;RPS27A;LIMS1;FOXK1;PRDM2;LRRFIP1;DPF2;BHLHE40;HEYL;DPF3;VEGFA;IL33;PHC2;CNOT7;MPHOSPH8;EZR;NOTCH4;RARA;SHC1;ATF4;KLF8;RBFOX2;FOXN3;NR3C1;GATA6;MXD4;HCFC1;CBFB;NRIP1;CBX5;EDN1;HDGF;IRF2BP2;PPM1F;CIC;HDAC4;UIMC1;NDUFA13;MOSPD1;ZMYND11;KANK2;SOX7;NR2C2;YY1;RB1;MAF1;TRIM28;TWIST1;HHEX;SOX18;HSBP1;FOXP2;ZC3H8;MXD1;BCL6;WNT11;SFPQ;FOXC2;SKIL;USP9X;MTA1;ZBTB18;CCDC85B;MTA2;TCF25;LIMD1;PHC1;IMPACT;SP3;CIPC;FRK;HIVEP1;ZNF423;EPC1;HES1;E2F1;COMMD7;MLX;PHB2;CIART;MTERF3;MIER2;LCOR;POU2F1;PHF12;BCL6B;LDB1;SMYD2;HEY1;EID2;HCFC2;SMARCA4
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.46335872477240836,-1.1104596370669642,0.34296028880866425,0.6334156472819061,1.0,3/11,8.02%,TPK1;CTPS2;SLC19A3
prerank,cytoplasmic translational initiation (GO:0002183),-0.4011713332239569,-1.1101840388355197,0.31906614785992216,0.6335879185768042,1.0,9/17,24.93%,EIF3D;EIF3I;EIF4A1;EIF2B3;EIF5;EIF4A2;EIF4G1;EIF4B;EIF4H
prerank,positive regulation of immune effector process (GO:0002699),-0.3682426845458598,-1.109861126670469,0.3,0.633839921184024,1.0,7/27,18.10%,LBP;PTPRJ;CD81;RPS19;DHX58;ANKRD17;XBP1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.4668757274911025,1.1096255631860361,0.3611111111111111,0.69697024158868,1.0,3/11,8.28%,CACNA2D1;CACNB1;CACNB2
prerank,striated muscle cell differentiation (GO:0051146),0.4208815424981288,1.1094785669540785,0.3362255965292842,0.6963039614864608,1.0,2/16,1.45%,BMP2;NRG1
prerank,cellular response to calcium ion (GO:0071277),-0.2945173772484769,-1.1089866035124643,0.27882599580712786,0.6354405914169189,1.0,10/67,8.73%,MEF2C;ITPKB;CLIC4;PLCG2;MEF2A;IQGAP1;CAMK2D;CARF;CPNE8;ADD1
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.22979072363796754,-1.1086231975558252,0.13225058004640372,0.635846108307525,1.0,119/509,17.39%,FN1;KITLG;TEK;VWF;CAV1;FLT1;IGF1R;NR3C2;THBS1;GAB1;PTPRJ;ESR1;PLCG2;FGF1;RACK1;NOD1;TGM2;ACTN4;KDR;CAV2;F3;RPS15;IQGAP1;TFRC;TBX1;MID2;PTK2;RPS3;DAB2IP;FERMT2;TNFAIP8L3;TRIM25;HSP90AB1;RICTOR;APP;TGFB1;FKBP1A;TGFB2;RPL23;ATP2C1;MAP3K3;MFHAS1;TNFSF10;RAC1;REL;LIMS1;S100B;VEGFA;IKBKB;MYOC;SHC1;BRD4;LURAP1;EEF1D;CASP8;TLR3;RIPK1;FLT4;GAPDH;INSR;PLK2;PDGFC;PDGFA;BAX;TRIM14;RPS20;HIP1;JCAD;WNT11;TCIM;CD74;TIRAP;DHX58;BCL2L1;S100A13;MAVS;TLR4;PPP5C;MIB2;PIK3AP1;TRIM62;BBC3;ENG;SPHK2;USP15;HRAS;FGF2;BCAP31;TRIM68;TNFRSF1A;PHB2;EDA2R;LAMTOR2;PIK3CA;TRIM5;ERBB2;GPR37L1;BCAR3;NOD2;MET;CX3CR1;PTPN6;TMEM101;RRAGD;EGFR;GPR89A;STRN;PIK3R2;JAK2;LGALS1;HSP90AA1;JMJD8;TAB2;BAD;ANKRD17;MIER1;GAB2;RELA;RET
prerank,thyroid hormone generation (GO:0006590),0.46984553843408394,1.1085832701670963,0.34146341463414637,0.6975887506727937,1.0,2/10,5.63%,CPQ;DIO2
prerank,tRNA aminoacylation (GO:0043039),-0.34330689625672395,-1.107829336202881,0.2966417910447761,0.6373166283629447,1.0,14/37,25.35%,QRSL1;SARS1;WARS2;CARS1;LARS2;WARS1;SARS2;GATC;TARS1;FARS2;IARS1;FARSB;GATB;GARS1
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.38159416028991877,-1.1077803448160837,0.3125,0.6368631343621419,1.0,8/21,21.89%,STMN2;SPEF1;CIB1;KATNB1;ARHGEF2;TPX2;APC2;CAMSAP3
prerank,regulation of histone modification (GO:0031056),0.448254893919687,1.1074943953601228,0.3333333333333333,0.6994465018106918,1.0,7/13,22.09%,AKAP8L;IGF2;SETD5;CDK9;AKAP8;UBE2N;MTHFR
prerank,organelle assembly (GO:0070925),-0.23526811817753487,-1.1069850946352748,0.15198237885462554,0.6383290473183678,1.0,90/384,19.34%,ABLIM1;ABCC4;PGM5;EXOC4;CD34;TMOD3;EXOC6;NOTCH1;FNBP1L;RAB11A;RPS23;CDC14A;NCOR1;EHD4;NEK7;RPS3;RAB8B;MAP1LC3B;IFT20;CEP164;ABLIM3;ATXN2L;PKD1;GORASP2;GABARAP;CHMP2B;LMOD1;CDS2;FLII;EHD2;CEP162;RC3H1;CDS1;TMOD1;IFT46;BBIP1;TMEM237;INPP5E;CPLANE2;NUDCD3;DISC1;CEP290;ATG7;RAB8A;ATG3;SYNPO;DHX37;FHDC1;LIMD1;EXOC1;CIRBP;YTHDF2;DBNL;ACTR3;PCM1;STK36;RAB7A;CC2D2A;HAUS1;POC1B;VPS36;POGZ;ARL6;RFX2;MAP1LC3A;RAB11FIP3;CDC14B;TSG101;VMP1;RAB1A;KIF24;CCDC28B;HPS1;GOLGA8B;DNAH5;SNF8;EMC6;TMEM67;LSM14A;IST1;CEP41;E2F4;CHMP2A;MAPRE2;AMBRA1;DYNLL2;EHD1;SPAG16;EHD3;TMEM231
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.2830654846325732,1.106820924866725,0.2608695652173913,0.7000998286722794,1.0,24/122,11.43%,IGF1;PRR16;AR;SAMD4A;SLC6A9;GLI2;LARP6;STN1;IL4;IRS2;NLRP12;PDGFRB;BRPF3;ATAD5;IGF2;PLD1;EIF3C;FGFR4;CPEB3;PLXNB2;HNRNPD;HSPH1;FXR2;PIWIL2
prerank,positive regulation of viral genome replication (GO:0045070),-0.35906894287630176,-1.1067372501910036,0.3237410071942446,0.6383913764374562,1.0,8/29,14.68%,ADAR;PPIA;CNOT7;SRPK1;IFIT1;STAU1;NR5A2;TOP2A
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.3026731996052839,-1.1066126139614578,0.2708757637474542,0.6381302727842313,1.0,30/62,36.75%,TGFB1;NUP93;DHX9;NUP54;NDC1;H3-3A;WTIP;LIMD1;NUP188;FMR1;NUP155;RANBP2;NUP37;PUM2;NUP160;EIF4G1;NUP43;SEH1L;NUP42;SEC13;NUP107;NUP98;POLR2F;POLR2C;POLR2L;POLR2I;NUP88;RAE1;NUP214;TRIM71
prerank,positive regulation of lipid localization (GO:1905954),0.45064178192232074,1.1065819472225893,0.3206751054852321,0.6996932275572869,1.0,1/11,1.35%,LRP1
prerank,positive regulation of T cell activation (GO:0050870),-0.3104813562109602,-1.1065192421871743,0.27235772357723576,0.6378025563714397,1.0,17/62,25.64%,IL15;SLC7A1;TFRC;CYRIB;ANXA1;CD81;HSPD1;NOD2;FLOT2;JAK3;XBP1;IL6ST;LGALS9;NCK1;CCL2;AIF1;NCK2
prerank,skeletal muscle organ development (GO:0060538),-0.3747050714750926,-1.1063875379539423,0.3182674199623352,0.6375682297154316,1.0,5/26,5.28%,MEF2C;CAV1;MYL6;SIX1;STRA6
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.33729390797087233,-1.1060998919461886,0.3236434108527132,0.6376917995226277,1.0,7/41,9.46%,PODXL;PIEZO1;SMAD7;CD44;ADAM19;DENND6A;FLOT1
prerank,cardiac muscle cell development (GO:0055013),0.39128651280838994,1.1060489996944591,0.30786516853932583,0.6999252018903892,1.0,9/20,15.27%,SLC8A1;PDGFRA;CSRP3;FHOD3;PDGFRB;ALPK3;OBSL1;MYLK3;PDLIM5
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.44917806992537634,-1.1059862785055565,0.34594594594594597,0.6374260858093309,1.0,2/12,4.11%,JAM2;APP
prerank,regulation of ERAD pathway (GO:1904292),-0.46426092844471784,-1.1059169420105766,0.3454861111111111,0.6370127676697362,1.0,4/11,11.48%,TMEM259;AQP11;RNF185;UBXN1
prerank,Golgi to lysosome transport (GO:0090160),-0.46068896385793057,-1.1058506984575502,0.34345351043643263,0.6366084095966379,1.0,5/11,19.45%,LAMP1;CCDC91;AP4M1;EHD3;LAPTM5
prerank,lymphocyte differentiation (GO:0030098),-0.2999577601511784,-1.1053835916969401,0.2718631178707224,0.6372127978638361,1.0,19/68,18.01%,PTPRJ;PLCG2;TPD52;ZBTB7A;HDAC9;JAG2;HDAC4;HHEX;RELB;LFNG;SOX4;ITGA4;CLCF1;GPR89B;GPR89A;KLF6;JAK3;TCF3;DLL4
prerank,lipid droplet organization (GO:0034389),-0.3841114896749965,-1.105297670847172,0.31401869158878504,0.6368571865472615,1.0,5/22,12.55%,PPIA;RAB18;CDS2;CDS1;FAF2
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.23476759840218894,1.1052705121591595,0.15077989601386482,0.7008357125360484,1.0,76/572,9.50%,BMP6;TCF7L2;FHL2;BMP2;LDB2;SALL1;AR;ATXN1;TBX3;GLIS3;MXI1;NR2F2;FGFR2;BCOR;ZEB1;TBL1XR1;TRPS1;RARB;VDR;GLI2;ZHX2;MITF;PPARA;PRDM5;NKX6-1;SMAD3;TFEC;KDM1B;ZEB2;GLI3;RUNX3;TBX21;MDM2;WWC1;TENM2;FNIP1;UXT;AEBP1;ZMYM5;FOSB;CEBPB;IL4;RNF2;JAZF1;PRKN;SUMO1;LIN37;HDAC10;SMURF2;NFIX;LOXL2;SIRT2;MBD2;ZHX1;CUX1;CRY1;TRIM27;MEN1;SOX2;RARG;RBPJ;NSD1;BCL11A;GLIS1;CITED2;IGF2;FOXD3;MIER3;HES5;ATN1;CTCF;KCNIP3;GATA3;CPEB3;BRMS1L;BRMS1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.4233765818279105,-1.1052634719080339,0.33805668016194335,0.6363772017313069,1.0,3/16,5.93%,CAV1;ADIPOR1;PPP2R1A
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.2848317264933557,1.1049876342257539,0.2637795275590551,0.7004487133391258,1.0,14/118,5.80%,SH3D19;HECW2;PID1;ADGRB3;LRRC4C;FGFR2;PHLDB2;GDNF;KIF13B;RAP2A;SFRP1;PHIP;ZMYM6;HECW1
prerank,cell differentiation in spinal cord (GO:0021515),-0.46923982843815115,-1.104850861195874,0.35517241379310344,0.6368655175628238,1.0,3/10,15.34%,SOX13;SOX4;SOX6
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.3507919633053584,-1.1048080369468947,0.32504780114722753,0.6364007013775511,1.0,7/33,9.84%,MEF2C;PRKG1;CDKN1B;IGFBP5;IGFBP3;TGFB3;TRIB1
prerank,glucose transmembrane transport (GO:1904659),-0.40611542272058837,-1.1041981141847013,0.32637571157495254,0.637318356210656,1.0,7/18,21.06%,SLC2A1;PPARD;RAB4B;SLC2A8;SLC2A3;SLC2A4;SLC2A9
prerank,relaxation of muscle (GO:0090075),0.43626115163285034,1.1041281372625813,0.35498839907192575,0.7016421610403366,1.0,3/13,3.87%,ATP1A2;SLC8A1;P2RX4
prerank,electron transport chain (GO:0022900),-0.4195679141908825,-1.1039107730995712,0.3532818532818533,0.6374706576010496,1.0,7/15,21.10%,PDIA5;ENOX2;PPARGC1A;ETFB;ETFDH;CYB561;SDHB
prerank,mitotic nuclear division (GO:0140014),-0.2946618535128112,-1.1036202663777903,0.294921875,0.6376318689513104,1.0,28/71,32.42%,EPS8;RAB11A;SMC4;ZW10;CEP192;NDE1;NDEL1;LSM14A;KIF18A;CHMP2A;MISP;KNSTRN;KIF18B;PPP2R2D;TPX2;NDC80;NSL1;SPICE1;CDCA8;SGO1;KIFC2;CHMP7;TUBG2;KIF11;BCCIP;PLK1;RHOA;ESPL1
prerank,positive regulation of secretion by cell (GO:1903532),0.3060220807879934,1.1030724471344682,0.2897959183673469,0.7032585630265032,1.0,5/70,4.33%,IGF1;BMP6;BMP2;P2RX4;CADPS
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.2408257821521974,-1.1025185064383487,0.21923937360178972,0.6397302924664842,1.0,61/308,15.34%,PRKCH;LEF1;CAV1;ADIPOR2;IGF1R;RREB1;LBP;IL15;TGFBR2;BMPR2;GATM;TFRC;NPR1;FERMT2;VAMP7;SIX1;PRDM16;REST;TGFB1;TGFB2;PPARGC1B;SMO;FOXD1;ZBTB16;PPARGC1A;ADIPOR1;CMKLR1;RPS19;VEGFA;UCP2;IL33;KDM3A;LURAP1;TGFB3;RGCC;TRIM16;GAPDH;PDGFC;NR2C2;TWIST1;FLOT1;DECR1;ACADL;EBF2;GRB10;FABP5;CFL1;INHBA;S100A13;GADD45G;SYK;TSKU;ACVR1;AGPAT1;FGF2;APOE;INHBB;ETV4;SMAD4;SDCBP;SOX6
prerank,regulation of cellular localization (GO:0060341),0.3300671081626264,1.1023633967077824,0.3121272365805169,0.7040433894594843,1.0,14/46,17.35%,ADCY5;WWC1;LYN;STXBP4;PRKN;FOXA2;DVL3;EPHA5;BRSK1;PARD6G;CDK16;TRIM46;NUMA1;PARP1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.35924956124235474,1.1023268804770217,0.304,0.7030835637997657,1.0,4/30,4.16%,ROBO1;LPAR1;GPR55;GPR174
prerank,glial cell development (GO:0021782),-0.3684490566459069,-1.1019931580958529,0.3223938223938224,0.6405124069997956,1.0,6/25,16.25%,CDK6;APP;NF1;SOX4;NRROS;EIF2B3
prerank,regulation of phosphate metabolic process (GO:0019220),0.41876564321642307,1.1019461319340083,0.3424036281179138,0.7030420405026051,1.0,3/16,6.88%,SRPX2;IL4;SIRT2
prerank,visual system development (GO:0150063),-0.3404113950607117,-1.101925977676966,0.3151750972762646,0.6401129599279742,1.0,11/37,19.29%,SMOC1;HIPK1;TGFB2;RAB18;FREM2;SMG9;SIPA1L3;CHRDL1;ADAMTS18;C1QA;BMPR1B
prerank,cellular response to oxidative stress (GO:0034599),-0.26948404538207077,-1.1019052863173107,0.251984126984127,0.6396085062258761,1.0,53/118,34.37%,PXN;FOXO1;MAPK3;FOXO3;RPS3;PPIA;PRR5L;PPARGC1A;NCF2;ATF4;CHCHD2;MSRA;GPX1;AKT1;STX2;VKORC1L1;ETV5;GSR;EGFR;HSPA1A;CCS;CHUK;PTPRK;CYBB;KEAP1;GPX8;HSPA1B;SESN2;ADNP2;ERO1A;SRXN1;NUDT2;PRKCD;PKD2;GPX3;CAMKK2;AIF1;SOD1;STX4;PARK7;ROMO1;ATP13A2;RBM11;JUN;ANKRD2;HTRA2;RAD52;NCF1;SLC4A11;FOS;TPM1;ABL1;MAPK9
prerank,response to estradiol (GO:0032355),-0.3579287089919053,-1.1015780363645056,0.32727272727272727,0.6398839027531735,1.0,11/31,19.95%,ESR1;ANXA1;SOCS2;TGFB1;NRIP1;GGT5;LCOR;STRN3;EGFR;FAM210B;GGT1
prerank,regulation of cellular respiration (GO:0043457),-0.4089699671298747,-1.1013779584453842,0.34990439770554493,0.6398168613106697,1.0,5/17,10.66%,CBFA2T3;PRDM16;IDE;IFNAR1;VCP
prerank,metal ion export (GO:0070839),0.35314421460110307,1.1012591194913837,0.30434782608695654,0.7037925049631559,1.0,2/31,0.52%,KCNT2;ATP1A2
prerank,positive regulation of reproductive process (GO:2000243),0.3605274710817241,1.1011659268127085,0.3080082135523614,0.7030116619688225,1.0,6/31,9.19%,HYAL3;SMURF2;PRDM9;CFAP69;SIRT2;PDE3A
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.33263300762973713,-1.1010761357131968,0.31086142322097376,0.640037855597093,1.0,15/39,23.84%,UBB;UBC;RPS27A;ERCC1;CUL4A;GTF2H3;CHD1L;RBX1;RPA3;GTF2H4;POLK;ERCC4;RFC3;RFC2;FAN1
prerank,protein acylation (GO:0043543),-0.33567765436354324,-1.0995102093157059,0.3001949317738791,0.6433862862903961,1.0,17/38,31.16%,FOXO1;ING5;ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC5;ZDHHC23;SELENOK;ZDHHC12;CLOCK;ZDHHC17;ZDHHC18;HHAT;ZDHHC3;NAA80;NAT9;KAT2A
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.4102141365765628,1.0992823027285044,0.3536036036036036,0.7067911653356032,1.0,3/17,4.33%,SCN3B;ANK2;GPD1L
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.4290038355256621,-1.0986390768409326,0.3376383763837638,0.6450053646263866,1.0,6/13,20.09%,PPARD;REST;SRF;RELA;SOX9;NFATC3
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.44870546612116025,1.0985543168566496,0.3282937365010799,0.707677980031853,1.0,1/11,1.60%,PLA2G5
prerank,regulation of fibrinolysis (GO:0051917),-0.4371950346850492,-1.0983929199693665,0.34464285714285714,0.64506852112876,1.0,3/13,3.79%,THBS1;THBD;FAP
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.42170801687015647,-1.0980159785128323,0.3431192660550459,0.6454507958736434,1.0,2/14,5.26%,THBS1;CMKLR1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.35093624045890703,1.0978175910233197,0.3105590062111801,0.7084939869233787,1.0,2/32,0.26%,AUTS2;PIK3R1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.40766215680480944,-1.0976656000849265,0.3435804701627486,0.645756697792745,1.0,4/17,7.08%,MEF2C;PRKG1;CDKN1B;TGFB3
prerank,water transport (GO:0006833),-0.4475204017576899,-1.0970709353407857,0.3473491773308958,0.6466751949966993,1.0,9/12,55.27%,AQP11;AQP4;AQP1;AQP9;AQP6;CFTR;AQP7;SLC5A1;PDPN
prerank,artery morphogenesis (GO:0048844),-0.35651168344030076,-1.0968143597740427,0.321011673151751,0.6467427075114348,1.0,11/30,12.81%,NOTCH1;BMPR2;TBX1;SMAD7;TGFB2;TBX2;STRA6;VEGFA;NF1;HES1;ENG
prerank,regulation of platelet aggregation (GO:0090330),0.4178350715379803,1.0966633379633874,0.34763948497854075,0.7104599772727123,1.0,4/17,4.18%,SERPINE2;ALOX12;PRKCA;LYN
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.28707076088034517,1.0962225245170056,0.2591093117408907,0.710552596998717,1.0,18/100,10.36%,IGF1;PIK3R1;PTPN13;NTRK3;DCN;PDGFRA;PIP4K2A;KIT;LYN;IRS2;PDGFRB;ROR1;PDGFD;ERBB3;IL18;MYDGF;PTEN;PIP4K2B
prerank,B cell mediated immunity (GO:0019724),-0.4670388599485367,-1.0961796146334095,0.3567362428842505,0.647794626981368,1.0,8/10,51.96%,FCER1G;CD74;TLR8;FCGR2B;CARD9;SLA2;MSH2;CD19
prerank,negative regulation of complement activation (GO:0045916),-0.47194534000776156,-1.0960448246354129,0.3559928443649374,0.6475623196889256,1.0,1/10,1.64%,CD55
prerank,regulation of autophagosome maturation (GO:1901096),0.4410372586901207,1.096020304102551,0.34309623430962344,0.7099365385579495,1.0,4/13,15.76%,PHF23;UBQLN4;CLEC16A;CLN3
prerank,aortic valve morphogenesis (GO:0003180),-0.3519510965926215,-1.0955023465382456,0.3247011952191235,0.6483976316251026,1.0,10/30,9.18%,NOS3;TIE1;NOTCH1;SLIT2;TGFB1;SMAD6;HEYL;NFATC1;RB1;TWIST1
prerank,copper ion transport (GO:0006825),0.4540416235964039,1.0954590634928802,0.35073068893528186,0.7103340436967842,1.0,4/11,18.16%,STEAP3;SLC31A2;COX17;STEAP4
prerank,negative regulation of insulin secretion (GO:0046676),-0.4033742727581492,-1.0948422092165588,0.35294117647058826,0.6495457413678969,1.0,6/17,14.67%,CCN3;KCNB1;KLF7;REST;PIM3;INHBB
prerank,regulation of cytoplasmic transport (GO:1903649),-0.46178673147708016,-1.0947011918399518,0.36727272727272725,0.6493295653117563,1.0,2/11,6.81%,MAPK3;USP7
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.4624863448058827,-1.094513363560509,0.3844660194174757,0.6492520807909418,1.0,4/11,7.56%,SCARA3;CASP8;TLR3;RIPK1
prerank,melanosome localization (GO:0032400),-0.3800610023817623,-1.0939370148581486,0.34398496240601506,0.6501290631020126,1.0,7/21,16.16%,RAB11A;RAB27A;MREG;RAB11B;MLPH;ARL6;VPS33A
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.4274050692805514,1.0939087352166577,0.32983193277310924,0.7133883139221098,1.0,4/15,9.37%,DDR2;LRP1;DDR1;FGFR4
prerank,membrane fusion (GO:0061025),-0.34082581358680175,-1.0938463387213377,0.3141263940520446,0.6497908800982233,1.0,11/33,19.67%,DNM3;MYOF;CHP1;NAPA;DYSF;OPA1;NSF;RABEP1;VTI1B;DNM1;DNM2
prerank,positive regulation of cell cycle process (GO:0090068),0.2849933707398906,1.093784467814147,0.29918032786885246,0.7126393325033883,1.0,17/91,14.87%,IGF1;SVIL;TGFA;PHIP;UBXN2B;PDGFRB;SIRT2;GEN1;IGF2;MAP10;AURKC;CDC25B;BTC;RANBP1;DRD2;SPAST;USP19
prerank,cellular response to sterol (GO:0036315),0.44233304134474694,1.0936750576555174,0.3803418803418803,0.7118790514293561,1.0,3/13,9.69%,RORA;INSIG2;GRAMD1B
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.29061885996480563,-1.0936030617518884,0.29549902152641877,0.6498681419581227,1.0,14/75,12.14%,SLC12A7;SLC9A2;SLC12A2;SLC39A10;KCNJ2;ABCC9;ATP1A1;SLC39A8;KCNJ10;ATP1B1;TRPV4;KCNJ8;KCNK9;KCNJ15
prerank,positive regulation of protein transport (GO:0051222),-0.29590359706851693,-1.0934991359066604,0.2935606060606061,0.6495577424736425,1.0,19/67,13.05%,UNC13B;RACK1;CD2AP;TGFB1;TGFB2;ATP2C1;PPIA;PRR5L;BCAS3;MYOM1;CHP1;EZR;TGFB3;ABCG1;CEP290;EXOC1;OAZ2;PCM1;ARHGEF5
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.3342120078014893,-1.0934543980286229,0.3150943396226415,0.6491151611209074,1.0,6/33,5.46%,PTPRG;THBS1;SLIT2;DAB2IP;ADIPOR1;PTPRM
prerank,cellular response to leucine starvation (GO:1990253),-0.4628813369576734,-1.0933188153124782,0.35543278084714547,0.6489016723798811,1.0,7/10,44.53%,IMPACT;RRAGD;SESN2;SESN1;GCN1;SESN3;LARS1
prerank,B cell receptor signaling pathway (GO:0050853),-0.35052407494274385,-1.0928464213573201,0.31477927063339733,0.6495552286018611,1.0,6/32,12.47%,MEF2C;PLCG2;BMX;CD38;BAX;SYK
prerank,actin filament-based transport (GO:0099515),-0.385667941695202,-1.0926066228807707,0.3452830188679245,0.6495895612545735,1.0,3/21,2.25%,MYO1D;FNBP1L;ACTN4
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.31772435471268046,-1.0924983555508987,0.3346693386773547,0.6493036217633077,1.0,24/48,38.11%,SLC7A5;PDE4D;CYRIB;IL1R1;TLR3;HSPD1;TLR4;TXK;FZD5;LGALS9;PTPN22;ZFPM1;IL12RB2;RASGRP1;LILRB1;SCRIB;SLAMF6;CD14;SLC11A1;TLR8;CD226;IL12A;CRTAM;IL12RB1
prerank,morphogenesis of an epithelium (GO:0002009),-0.3734896421057452,-1.0922638603354526,0.30784708249496984,0.649347055229889,1.0,5/25,9.11%,ACTB;ACTG1;LAMA5;LAMA3;VCL
prerank,protein neddylation (GO:0045116),-0.43756158823024405,-1.092185297563738,0.36007827788649704,0.6489526208585049,1.0,4/13,13.76%,DCUN1D5;DCUN1D1;UBE2F;RBX1
prerank,negative regulation of mitochondrion organization (GO:0010823),0.3552511558148607,1.0920249961449624,0.32217573221757323,0.7151161134947597,1.0,4/33,5.78%,IGF1;OMA1;IAPP;PRKN
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.3476628199254287,-1.0919006615954525,0.32741617357001973,0.6491073720629739,1.0,16/32,36.36%,HMBOX1;MAPK3;NEK7;FBXO4;PNKP;CCT2;HNRNPA1;CCT3;CCT8;CCT7;CTNNB1;CCT4;PKIB;MAP2K7;CCT6A;MAPK15
prerank,response to organic cyclic compound (GO:0014070),-0.3093747453537101,-1.0918764017096056,0.2862523540489642,0.6486008514179513,1.0,11/52,10.53%,ESR1;ARL6IP5;ANXA1;SOCS2;IGFBP5;TGFB1;SLC1A1;CYP1B1;TLR3;SPP1;GGT5
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.35156937634148305,-1.0917127766052461,0.34655172413793106,0.6478753509815449,1.0,16/29,33.93%,KNL1;MIS18BP1;CENPU;RBBP4;CENPI;CENPN;CENPA;CENPO;NPM1;RUVBL1;SMARCA5;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,CENP-A containing chromatin organization (GO:0061641),-0.35156937634148305,-1.0917127766052461,0.34655172413793106,0.6478753509815449,1.0,16/29,33.93%,KNL1;MIS18BP1;CENPU;RBBP4;CENPI;CENPN;CENPA;CENPO;NPM1;RUVBL1;SMARCA5;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,mesonephros development (GO:0001823),-0.4626377870191119,-1.0911479381180973,0.3802559414990859,0.6487738101778443,1.0,2/11,4.81%,FGF1;ZBTB16
prerank,aminoglycan metabolic process (GO:0006022),0.4490462080617585,1.0910692324852134,0.36796536796536794,0.7166457297473916,1.0,4/10,22.24%,GAL3ST3;B4GALT7;B3GAT1;B3GALT6
prerank,regulation of lamellipodium assembly (GO:0010591),0.34817651570391667,1.0908527264865504,0.3228511530398323,0.7161394536813493,1.0,2/34,0.26%,AUTS2;PIK3R1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.2947470236650497,-1.090357456601378,0.30754352030947774,0.6502326641496922,1.0,16/73,16.53%,CAV1;TFRC;CD44;NGF;HSP90AB1;FNIP2;APP;TGFB1;VEGFA;AKT1;CAMK1;MTCP1;BCAR3;RAPGEF3;EGFR;HSP90AA1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.3638061313570293,1.0903264578503975,0.33111111111111113,0.7164470154580214,1.0,5/27,7.30%,SLC1A3;SLC7A2;SLC6A9;SLC38A1;SLC25A13
prerank,negative regulation of anoikis (GO:2000811),-0.4244332252973939,-1.0902538374905926,0.36231884057971014,0.6499168099947468,1.0,3/14,3.05%,CAV1;NOTCH1;PTK2
prerank,positive regulation of cell population proliferation (GO:0008284),0.236604044215814,1.0899174610269375,0.23440453686200377,0.7164918146533346,1.0,62/423,11.76%,IGF1;BMP6;TCF7L2;TGFBR3;IL31RA;IL34;BMP2;PID1;PTN;AREG;AR;TBX3;DDR2;NTRK3;PTGFR;FGFR2;BMP5;PRTN3;NRG1;GJA1;GDNF;PDGFRA;CCN4;BCL2;MEGF10;SFRP1;MDM2;TGFA;PHIP;LYN;IL13RA1;IL4;IRS2;PDGFRB;TGFBR1;GLP2R;THPO;RBPJ;CEP43;OSMR;PDGFD;ERBB3;IGF2;IL18;HES5;BMPR1A;FGFR4;HOXC10;PRKCI;ERBB4;CNTF;PTEN;ADRA1D;FAM98B;LAMC1;ESM1;IL6R;MST1R;CHRNA7;YAP1;FGFR1;TSLP
prerank,folic acid-containing compound metabolic process (GO:0006760),0.39674896785234554,1.0899017314105146,0.3618421052631579,0.7154844561987987,1.0,8/19,23.52%,ALDH1L1;FPGS;SLC46A1;MTHFD1;MTHFD1L;SLC19A1;MTHFR;MTHFD2L
prerank,positive regulation of binding (GO:0051099),-0.2807790311707149,-1.089737713760688,0.2729083665338645,0.6507214794979583,1.0,18/84,9.46%,CAV1;CLDN5;B2M;HMBOX1;NGF;RPL11;APP;FKBP1A;RALB;PKD1;HIP1R;RARA;IDE;DHX9;DPH3;ADD1;NMD3;FLOT1
prerank,linoleic acid metabolic process (GO:0043651),0.4131497839399417,1.0892754718454614,0.3393258426966292,0.7161122446494544,1.0,3/17,6.25%,ALOX12;ACSL1;GSTP1
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.44207776787997227,-1.0890672152302223,0.3657243816254417,0.6519040111673187,1.0,6/12,20.44%,MAOA;OAZ2;AMD1;DDC;SMS;SRM
prerank,response to estrogen (GO:0043627),-0.3486236702489911,-1.0888241252305622,0.3278084714548803,0.651963502348534,1.0,11/31,11.85%,CAV1;ESR1;TRIM25;RBBP5;BCAS3;RARA;PELP1;KMT2D;WBP2;NCOA4;SERPINB9
prerank,receptor-mediated endocytosis (GO:0006898),-0.2630455812868276,-1.0887366885786258,0.28865979381443296,0.6516354469770581,1.0,21/132,10.60%,CAV1;DNM3;ACKR3;FNBP1L;SCARB1;SCARF1;CAV2;RAMP2;TFRC;ARHGAP27;CUBN;STAB1;IGF2R;CD81;HIP1R;CD9;AP2M1;INSR;FCER1G;SGIP1;FCHO2
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.3709171545238603,1.0887082132108927,0.3422222222222222,0.7166060300603638,1.0,2/24,2.52%,PLA2G5;PLA2G4A
prerank,sarcomere organization (GO:0045214),0.36388171230707206,1.0886487827363578,0.3236514522821577,0.7156949109650211,1.0,9/27,15.61%,CSRP3;FHOD3;SIX4;CSRP2;ACTN2;SYNPO2L;TNNT3;MYLK3;CSRP1
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.2825001494751413,-1.088638313313829,0.29116465863453816,0.6513197440542868,1.0,24/88,15.54%,TEK;CAV1;THBS1;NRP2;TIE1;BMPR2;KDR;CAV2;F3;PPP1R16B;VEGFC;PTPRM;VEGFA;ATP5F1A;RGCC;FLT4;AKT1;VEGFD;NF1;FGF2;EMC10;APOE;STAT5A;ATP5IF1
prerank,toxin transport (GO:1901998),0.47044059491765133,1.088572559300878,0.3284823284823285,0.7148601855393331,1.0,3/10,6.77%,ANTXR1;SLC22A3;RAB29
prerank,regulation of cilium movement (GO:0003352),0.4679268481000973,1.0884467636361213,0.35864978902953587,0.7141908737574685,1.0,3/10,11.05%,CFAP43;CCDC65;DNAH11
prerank,positive regulation of B cell proliferation (GO:0030890),-0.35315670294252977,-1.088404043098552,0.330188679245283,0.651312828566975,1.0,8/29,17.42%,MEF2C;TFRC;CD38;CD81;CD74;TIRAP;CLCF1;CD320
prerank,cellular response to hormone stimulus (GO:0032870),0.2976552651361255,1.0883552571089146,0.2689075630252101,0.7133788066085734,1.0,8/69,4.41%,ROBO2;ATP1A2;AR;OCSTAMP;NCOA2;STAT5B;SFRP1;GHR
prerank,monocarboxylic acid metabolic process (GO:0032787),0.27613706086128814,1.0883045128680022,0.2992565055762082,0.7124763708841142,1.0,12/117,7.15%,IGF1;ALDH1A2;PPARA;ALDH4A1;ALOX12;PCCA;ABAT;ACADSB;BAAT;CPT1C;MSMO1;ACOT11
prerank,steroid metabolic process (GO:0008202),0.30081525859905384,1.0880635029657428,0.30927835051546393,0.7120454008613335,1.0,15/72,18.75%,CYP7B1;VDR;CYP27B1;CYP27A1;CYP2A6;BAAT;MSMO1;CYP46A1;PRLR;GBA2;SHH;CYP51A1;CYP26B1;HSD17B14;FDX2
prerank,adherens junction organization (GO:0034332),-0.3132707789046125,-1.0878185677604904,0.3152610441767068,0.6522995139085086,1.0,11/48,9.11%,ACTB;CDH1;CTNNA1;RAMP2;FERMT2;SMAD7;JAM3;CDH4;JUP;PVR;VCL
prerank,protein deubiquitination (GO:0016579),-0.24338225681628187,-1.0877473451795954,0.22435897435897437,0.6519134929177568,1.0,102/242,33.37%,ACTB;ESR1;IFIH1;NFKBIA;MINDY2;SMAD7;MINDY1;TRRAP;UBB;EIF3F;USP1;USP46;UBC;RPS27A;FOXK1;BRCC3;IL33;USP7;HCFC1;USP8;PSMA6;RIPK1;OTUD5;UIMC1;PSMB5;ENY2;BABAM1;YY1;USP3;RHOT1;OTUB1;PSMC4;UCHL1;USP5;VCP;USP9X;TADA2B;PSMC5;COPS5;PSMD14;USP15;PSMD8;SMAD4;PSMC1;UCHL3;WDR48;PSMB4;PSMD11;PSMD12;MCRS1;RCE1;TNFAIP3;USP22;USP49;BABAM2;USP4;SNX3;PSMA1;PSMC3;SMAD2;KEAP1;JOSD1;TADA3;USP38;PSMB1;PSMA2;PSMA4;INO80D;TRAF6;TFPT;SMAD1;RAD23A;PSMB8;TAF10;BARD1;RUVBL1;FOXO4;RAD23B;STAM2;STAM;POLB;JOSD2;USP14;USP35;MYC;CDK1;PSMC6;KAT2A;PSMD6;STAMBP;NLRP3;MYSM1;ADRB2;RHOA;IKBKG;PSMA8;FOXK2;USP18;CDC20;PSMB2;TNIP2;USP12
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.4759946421736645,-1.0874929265461115,0.358974358974359,0.6519971502515725,1.0,7/10,39.62%,SVIP;UBE2G2;DERL2;ERLEC1;INSIG1;OS9;UBAC2
prerank,Golgi to plasma membrane transport (GO:0006893),-0.3197210777194756,-1.087424755012202,0.3152804642166344,0.6516100893343324,1.0,5/47,1.48%,STXBP6;EXOC4;EXOC6B;EXOC6;SPTBN1
prerank,digestive tract morphogenesis (GO:0048546),0.4298431856476963,1.0871294437564742,0.3492407809110629,0.7134260400209536,1.0,2/14,1.91%,FGFR2;PDGFRA
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.36933953660385294,1.08701320972947,0.3522975929978118,0.7126748667510084,1.0,9/25,18.45%,GRID2;MPP2;NLGN3;MAPK8IP2;CHRNA4;GRIN2A;DRD2;GRIN2B;RAB3GAP1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3257748301083643,-1.0869253396619436,0.30980392156862746,0.6522666738099405,1.0,6/39,3.59%,UTRN;DMD;NEDD4L;FXYD5;WNK1;CAMK2D
prerank,receptor signaling pathway via STAT (GO:0097696),0.368874813807471,1.0868573231193701,0.3304904051172708,0.7120611125015779,1.0,4/25,7.87%,IL31RA;STAT5B;GHR;THPO
prerank,mitotic DNA replication (GO:1902969),0.46737514868482033,1.0867492685730928,0.37193763919821826,0.7113188168063979,1.0,2/10,9.80%,MCM3;MCM2
prerank,vitamin transport (GO:0051180),-0.3507131007884624,-1.0865768857747462,0.3481624758220503,0.6526144916011675,1.0,7/29,17.42%,ABCG2;SLC5A6;CUBN;SLC52A3;SLC2A8;SLC52A2;CD320
prerank,phospholipid catabolic process (GO:0009395),-0.36448746533983534,-1.0861012839398447,0.3428030303030303,0.6532466595956962,1.0,8/24,28.48%,GPCPD1;SMPDL3A;ENPP6;GDE1;PLA2G4F;ENPP2;SMPD1;PLA2G4B
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.3410588187161792,1.0859623141026118,0.33820459290187893,0.7123130298311633,1.0,2/40,1.24%,IGF1;BCL2L11
prerank,regulation of cell communication (GO:0010646),-0.3423324181761876,-1.0859183586237404,0.33455882352941174,0.6531601526364903,1.0,12/35,15.83%,CXADR;IGFBP7;MGLL;CAMK2D;ANXA1;SOCS2;CRK;GRK5;NCLN;CASQ2;SRI;YWHAG
prerank,myeloid cell development (GO:0061515),-0.39929010510649293,-1.0857057468032552,0.3479020979020979,0.6531556230708171,1.0,3/18,4.77%,FOXP1;APP;ANXA2
prerank,carnitine shuttle (GO:0006853),0.45285362066453116,1.0857047911084712,0.3541666666666667,0.7119491499591629,1.0,4/11,17.14%,PRKAG2;CPT2;ACACA;PRKAB2
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.34719607584763246,-1.0855003676013733,0.3481624758220503,0.653130660962329,1.0,4/30,4.38%,CHST11;CSGALNACT1;CSPG4;HEXA
prerank,establishment of protein localization to membrane (GO:0090150),-0.2977424628674708,-1.0852034147564384,0.30612244897959184,0.6533323380938256,1.0,17/66,15.90%,PARD3;RAB11A;GORASP2;AQP11;NACA;ATG3;TAOK2;SEC63;ZDHHC9;RAB11B;ZDHHC1;ICMT;ARL6;ZDHHC20;NPC1;SDCBP;EGFR
prerank,chromatin remodeling (GO:0006338),-0.27400559355726195,-1.0846899396751353,0.287109375,0.6540739356506649,1.0,37/100,32.05%,ACTB;ESR1;ZBTB7A;KDM5C;HCFC1;HDAC4;RB1;CHD1L;ARID1A;BAZ1A;MTA2;MBD3;TADA2B;GATAD1;SATB2;HCFC2;SMARCA4;SMARCA2;GATAD2B;KDM6A;RBBP4;CHD4;SOX9;EZH1;SMARCC1;POLE3;HDAC5;CHRAC1;NPM1;RUVBL1;SMARCA5;SMARCD2;MYC;NPM3;KAT2A;HNRNPC;MYSM1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.4383979056791134,-1.0843403939496876,0.3664259927797834,0.6543880645525101,1.0,4/13,15.83%,LPCAT3;AQP11;MBTPS2;NR1H2
prerank,lipoprotein localization (GO:0044872),0.4472177782083028,1.084233194146772,0.3638392857142857,0.7146905192987671,1.0,5/11,18.91%,LRP1;PRKCB;MIA3;PPARG;UNC119B
prerank,histone H3 acetylation (GO:0043966),-0.32395970845640093,-1.0840225294892267,0.34122287968441817,0.6545745853122952,1.0,15/40,28.77%,LEF1;JADE2;ING5;TRIM16;NAA60;LDB1;BRCA2;TAF9;TADA3;BRPF1;POLE3;TAF10;KAT6B;TAF5;SPI1
prerank,cellular response to estrogen stimulus (GO:0071391),0.42911165643739946,1.0839935410679733,0.3574766355140187,0.7143124103068609,1.0,3/14,3.70%,AR;OCSTAMP;SFRP1
prerank,stem cell differentiation (GO:0048863),0.3386431248148251,1.0838303513038288,0.3420479302832244,0.7136849402885995,1.0,6/39,4.55%,FGFR2;KIT;GPM6A;SFRP1;SP7;SOX21
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.401423007777469,1.0837530183150137,0.3514644351464435,0.7128625032258321,1.0,3/17,4.15%,NRP1;NTRK3;STAP1
prerank,cellular iron ion homeostasis (GO:0006879),0.3109318916246257,1.0831751706315804,0.31837606837606836,0.7133324425129395,1.0,3/55,1.52%,BMP6;CP;HEPH
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.3751101457904589,-1.0830536747820705,0.35892514395393477,0.6563958826756879,1.0,6/22,21.24%,SLC7A5;TNFRSF1B;SPHK2;NOD2;LAPTM5;BTK
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.33785158290576356,-1.0828781972722457,0.3543307086614173,0.6562627534567635,1.0,10/35,18.35%,ITGA1;HSP90AB1;CALM1;FKBP1A;HTT;CSNK2B;CALM3;NUAK1;PPP6R3;BOD1
prerank,regulation of cellular response to stress (GO:0080135),-0.2665329446664594,-1.0822827437380267,0.29324894514767935,0.6572406476652315,1.0,44/115,27.43%,MAPK3;CAMK2D;HSP90AB1;HSPA8;ATF4;CHCHD2;NUP93;MBTPS2;NUP54;NDC1;HSBP1;BAG5;HSPB8;NUP188;NUP155;RANBP2;RPA3;NUAK1;HSP90AA1;HSPA1A;NUP37;CRYAB;CCAR2;AMFR;MCL1;FKBP4;NUP160;HSPA1B;ATF3;EIF4G1;BAG1;DNAJB1;SMG1;RSL1D1;NUP43;SEH1L;NUP42;SEC13;NUP107;YWHAE;NUP98;RPTOR;CAMK2G;NPM1
prerank,positive regulation of macroautophagy (GO:0016239),-0.31501530915092113,-1.0822693122080878,0.3187250996015936,0.6567135516661518,1.0,14/48,21.89%,SPTLC2;VPS13D;KDR;RALB;HTT;SPTLC1;SCOC;EPM2A;HSPB8;BNIP3L;TSC2;RAB3GAP2;SESN2;SLC25A4
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.24915349712341478,-1.0821647071859908,0.27637130801687765,0.6564481541693058,1.0,36/190,12.21%,CAV1;TMSB4X;THBS1;PTPRJ;ESR1;RACK1;SH3BP4;CCN3;PDE4D;CYRIB;CD2AP;SLIT2;DAB2IP;HDAC7;PDE2A;ADIPOR1;PEBP1;ARHGAP25;PIK3IP1;CASP8;RIPK1;NDUFA13;ZMYND11;AKT1;CARD19;TWIST1;PRDM15;TNFAIP8L1;MAPKBP1;WTIP;EPM2A;LIMD1;CIB1;BCL2L1;DUSP3;NF1
prerank,protein targeting (GO:0006605),-0.2684693155650475,-1.0821486095302788,0.28969957081545067,0.6559312989809717,1.0,49/118,33.13%,RASSF9;PARD3;TRAK1;RPL11;AQP11;GABARAP;TRAK2;GIPC1;SPCS1;HACL1;NACA;ATG3;AKAP6;TAOK2;SEC63;ZDHHC9;TIMM17A;ZDHHC1;ICMT;KATNB1;TOMM22;BCAP31;ARL6;ZDHHC20;SDCBP;AP4M1;TIMM13;TOMM5;ZFAND2B;ZDHHC23;ZDHHC12;FIS1;TIMM10;CACNG3;TIMM8B;ZDHHC18;ZDHHC3;TIMM10B;MFF;SEC61A1;GOLGA7B;NACAD;PEX6;ZDHHC24;CHM;SRPRA;EDEM1;NCF1;VPS37C
prerank,COPII-coated vesicle budding (GO:0090114),0.30791739495909526,1.0818815362708274,0.30174081237911027,0.7156873032740406,1.0,18/68,18.79%,AREG;SEC24D;TGFA;SCFD1;TRAPPC6B;GOLGA2;TMED10;SCAP;SEC31A;SEC24A;SEC23A;TRAPPC3;TBC1D20;GRIA1;SAR1B;MIA3;GOSR2;TFG
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.47526612395156775,-1.0816468520503975,0.3694029850746269,0.6566043438695174,1.0,1/10,0.24%,ANO6
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.4215407705269272,-1.0814565665873994,0.3650485436893204,0.6565266318769579,1.0,7/13,35.11%,CD81;BCAP31;TMEM30A;EDEM2;TMEM30B;EDEM1;SEC16B
prerank,respiratory system development (GO:0060541),0.3504203490718917,1.0814439295123728,0.3592436974789916,0.7158061360733532,1.0,8/32,13.98%,FGFR2;GLI2;CHD7;SPEF2;LOXL3;NPHP3;SMCHD1;NKX2-1
prerank,negative regulation of protein catabolic process (GO:0042177),0.3312351978882468,1.0812120067335158,0.32677165354330706,0.7154096160490575,1.0,13/40,21.28%,NELL1;TIMP3;SIRT2;TIMP4;FMN2;PRKCG;SF3B3;CYP51A1;IRAK3;AZIN2;TIMP1;SNRNP70;RGP1
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.4104623040348147,-1.0811416504053755,0.36580882352941174,0.6567224629158988,1.0,8/16,33.20%,NOS3;GUCY1B1;GUCY1A1;APOE;DDAH1;CD36;NOS2;NOS1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.3001157557991646,1.0810242464923818,0.3067226890756303,0.7148812247044366,1.0,7/68,7.26%,ENPP1;AMPD3;TPST1;ACSM5;BAAT;ACOT11;SULT6B1
prerank,regulation of sodium ion transport (GO:0002028),0.3461931175142421,1.0809412508868281,0.33958333333333335,0.7141227991464612,1.0,15/34,23.19%,SCN3B;NKAIN2;P2RX4;GPD1L;NKAIN3;DRD2;NEDD4;WNK3;FGF12;PER1;DLG1;ATP2B4;CNKSR3;RANGRF;SCN5A
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.4579049376465746,1.0809195352705407,0.35147392290249435,0.7131857708710753,1.0,7/10,26.01%,KLF15;NOC2L;THAP7;TAF7;SET;SIRT1;SNCA
prerank,inorganic anion transmembrane transport (GO:0098661),0.3038234911838817,1.0809124347322139,0.3360323886639676,0.71220331824936,1.0,19/63,15.66%,SLC1A3;ANO7;GABRA2;GABRR3;GLRB;SLC20A2;GABRB3;ANO3;GABRR2;SLC25A10;CLCN1;GABRA5;SLC6A1;SLC12A3;ANO5;GLRA3;GABRG1;GABRB1;SLC25A30
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3332148830869801,1.0808537604507182,0.3311965811965812,0.7113523456036391,1.0,5/43,8.04%,IGF1;IL4;GSTP1;TRIM27;CD274
prerank,protein sumoylation (GO:0016925),-0.3088359385250753,-1.0807342019329242,0.3250517598343685,0.657145938649984,1.0,20/49,26.90%,IFIH1;STX1A;NUP93;TRIM28;NUP54;NDC1;SAE1;SUMO3;NUP188;NUP155;RANBP2;UBA2;NUP37;RANGAP1;NUP160;NUP43;SEH1L;NUP42;NUP107;NUP98
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.4678879945611933,-1.0805775067804275,0.39626168224299063,0.6570093406196855,1.0,6/10,19.25%,TGFBR2;LRP5;TBX1;PDGFA;STAT1;SOX9
prerank,pulmonary valve morphogenesis (GO:0003184),-0.403541256115602,-1.0801439658644842,0.36220472440944884,0.6575567059159133,1.0,8/17,8.70%,NOS3;NOTCH1;SLIT2;TGFB2;STRA6;SMAD6;HEYL;NFATC1
prerank,heart trabecula morphogenesis (GO:0061384),-0.3989569215720019,-1.080006513849639,0.35294117647058826,0.6573614634040877,1.0,6/18,4.28%,TEK;ADGRG6;NOTCH1;S1PR1;FKBP1A;TGFB2
prerank,peptidyl-serine modification (GO:0018209),-0.25163637784964077,-1.080001653241158,0.2753623188405797,0.6568214170278409,1.0,41/166,17.97%,PRKCH;RPS6KA5;TGFBR2;HIPK1;WNK1;RPS6KA3;CAMK2D;RICTOR;MAPKAPK3;PRKCZ;CSNK1G2;PKD1;IKBKB;CSNK1G3;PRKDC;DYRK2;PLK2;AKT1;STK32B;LMTK2;VRK3;CAMK1;RPS6KB2;VRK1;ULK3;HPF1;STK38;POGLUT1;PRKCE;PKN3;RPS6KA2;UHMK1;STK38L;CAB39;PARP2;MAST4;CSNK2A1;CSNK2A2;POGLUT3;MAPK12;CHUK
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.3527323059427218,-1.0797443117349996,0.3465346534653465,0.656913525473879,1.0,6/28,8.87%,DAB2IP;NGF;CRADD;GABARAP;CASP8;BAX
prerank,cellular potassium ion homeostasis (GO:0030007),-0.427015692594213,-1.079743976442777,0.3785211267605634,0.6563651836329157,1.0,4/13,7.01%,SLC12A2;KCNJ2;ATP1A1;ATP1B1
prerank,generation of neurons (GO:0048699),0.254966357890815,1.079554274111064,0.28867924528301886,0.713642757640445,1.0,28/190,11.68%,AUTS2;NRP1;WNT4;SEMA3A;GPM6A;SH3RF1;RUNX3;ARTN;PTPRD;ASTN2;HES3;CASP3;IL1RAPL1;LHX4;DOCK7;SIX4;NRCAM;RYK;HES5;ATOH8;CDK5R1;BRSK1;PLXNB2;FUT9;EML1;LRP12;YAP1;FGFR1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.32475221786459835,1.0795442420456982,0.3492723492723493,0.7126637783396443,1.0,6/43,7.86%,ERRFI1;AREG;CBLB;TGFA;VPS25;ZFYVE28
prerank,defense response to bacterium (GO:0042742),-0.2712303038229041,-1.079537479103231,0.300990099009901,0.6563351129710435,1.0,36/105,31.16%,LBP;NOD1;RPL30;RPL39;STAB1;LYST;RPS19;GBP7;SHC1;TLR3;FCER1G;PGLYRP1;TIRAP;MAVS;TLR4;SYK;RAB1A;CFP;NOD2;OAS2;ANKRD17;MR1;ANXA3;LYZL4;LCN2;PRKCD;SELP;TREM2;STAB2;TLR6;HMGB2;ROMO1;IRGM;NOS2;AQP1;GBP4
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.40671582851895016,-1.0792848316945685,0.36379613356766255,0.6563958649064611,1.0,6/15,15.46%,TMSB4X;KDR;VEGFA;HSPB1;FGF2;MET
prerank,cardiolipin metabolic process (GO:0032048),0.4306568450408872,1.079257759544248,0.38424821002386633,0.7124030814886795,1.0,2/13,2.52%,PLA2G5;PLA2G4A
prerank,nitrogen compound transport (GO:0071705),0.2683321282621561,1.0788540363885109,0.29313543599257885,0.712388667162424,1.0,14/141,6.48%,SLC7A11;SLC6A12;SLC7A2;SLC43A1;TXNIP;SLC6A13;SLC22A4;SLC35F3;LRP1B;ABCC2;SLC36A2;SLC22A3;SLC38A1;SLC7A9
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.3401341681716832,1.0786567891091612,0.3169164882226981,0.7118850224231038,1.0,5/39,1.96%,NRP1;BMP2;SALL1;GDNF;GLI2
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.31802618048134873,-1.0786330741203973,0.312015503875969,0.65748377738957,1.0,9/47,8.61%,RREB1;LRP5;PPARD;SIX1;ZBTB16;SOX13;CMKLR1;CDS1;AKT1
prerank,negative regulation of cellular component movement (GO:0051271),0.41231216981154717,1.078311425279122,0.36752136752136755,0.7117460271318878,1.0,3/15,4.84%,TGFBR3;FBLN1;SPOCK3
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.3462384038132875,1.0782218145327853,0.348643006263048,0.7109908590288461,1.0,2/38,2.75%,BMP6;PRKCA
prerank,regulation of oxidoreductase activity (GO:0051341),-0.4262978613752607,-1.0781844126503728,0.38419117647058826,0.6580395057785575,1.0,3/13,17.84%,ABL2;NOD2;ECSIT
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.4666600009835228,-1.078111213231152,0.3747779751332149,0.6576745523660983,1.0,3/10,13.81%,CALM1;CALM3;FMR1
prerank,cilium assembly (GO:0060271),-0.23607963990117725,-1.077865814910593,0.25,0.6576978016127231,1.0,70/296,19.34%,ABLIM1;ABCC4;EXOC4;EXOC6;NOTCH1;FNBP1L;RAB11A;CDC14A;DCTN2;EHD4;TUBA1A;RAB8B;IFT20;CEP164;ABLIM3;RP1;PKD1;PPP2R1A;PRKAR2B;CEP57;CEP192;EHD2;CEP162;CEP70;IFT46;TRIP11;BBIP1;TMEM237;INPP5E;CPLANE2;NUDCD3;DISC1;DCTN3;CEP290;DCTN1;RAB8A;CNTRL;GAS8;FHDC1;EXOC1;TUBB4B;ACTR3;PCM1;STK36;CC2D2A;HAUS1;POC1B;NDE1;ARL6;RFX2;RAB11FIP3;CDC14B;CETN2;RAB1A;KIF24;CCDC28B;CEP72;DNAH5;YWHAG;HSP90AA1;TMEM67;CEP41;E2F4;RPGRIP1;DYNLL2;EHD1;SPAG16;IFT27;EHD3;TMEM231
prerank,phospholipid homeostasis (GO:0055091),0.45532165796046703,1.0776110103669427,0.3728448275862069,0.7115675639666265,1.0,2/11,10.39%,ABCA1;TLCD2
prerank,carnitine metabolic process (GO:0009437),0.44925623812724286,1.0776023048098449,0.34872979214780603,0.7105986047412971,1.0,3/12,6.64%,BBOX1;CPT1C;CPT2
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.4470648234622143,1.077482002944608,0.37299771167048057,0.7099427842332342,1.0,1/12,0.73%,AKR1B1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.4388171083634548,-1.077464413957849,0.36432637571157495,0.6581863129132955,1.0,5/12,21.30%,DMD;WNK1;ATP1B1;GLRX;ATP1B2
prerank,negative regulation of developmental process (GO:0051093),-0.29004791168227184,-1.0773423109754134,0.3191489361702128,0.6579504963318304,1.0,13/69,7.93%,CDK6;NOS3;NOTCH1;TFRC;TBX1;ARHGEF15;KLF7;TGFB1;TBX2;VAT1;NOTCH4;RC3H1;CST3
prerank,positive regulation of coagulation (GO:0050820),-0.4670553479692108,-1.0772275198867134,0.38738738738738737,0.6571497225973058,1.0,3/10,9.11%,ST3GAL4;THBS1;ENPP4
prerank,positive regulation of hemostasis (GO:1900048),-0.4670553479692108,-1.0772275198867134,0.38738738738738737,0.6571497225973058,1.0,3/10,9.11%,ST3GAL4;THBS1;ENPP4
prerank,negative regulation of phosphatase activity (GO:0010923),-0.3606110322100817,-1.0772177626762183,0.33088235294117646,0.6566355744330239,1.0,4/25,6.33%,FKBP1A;TGFB2;CHP1;SH3RF2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.2940181098342173,1.0771210675889147,0.3107569721115538,0.7098362354177365,1.0,12/86,9.33%,BMP6;BMP2;SULF1;BMP5;ZEB2;UBE2O;TGFBR1;MEN1;RBPJ;CITED2;HES5;BMPR1A
prerank,protein kinase B signaling (GO:0043491),0.37687742927887385,1.0769903797967348,0.359504132231405,0.7092258537293348,1.0,1/23,0.09%,IGF1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.4046693237385868,1.0769217660843105,0.3362637362637363,0.7084160053874955,1.0,2/18,3.69%,IL4I1;TBX21
prerank,positive regulation of autophagy (GO:0010508),-0.28575523385049034,-1.07691171704339,0.30876494023904383,0.6568490876719754,1.0,24/81,21.97%,SH3BP4;KDR;FOXO1;MID2;FOXO3;HTT;SVIP;PLK2;SCOC;TRIM14;PIK3C2A;EPM2A;TRIM68;PHB2;BNIP3L;TRIM5;UFL1;BAD;TSC2;TMEM59;PLEKHF1;TFEB;SESN2;PLK3
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.4359766961720771,-1.0768490762516483,0.38848920863309355,0.6564534426449157,1.0,6/12,22.11%,RPL26;CD44;CD74;KDM1A;TAF9;TRIAP1
prerank,cellular response to nitrogen compound (GO:1901699),0.39063641717142855,1.0767485183817873,0.36116910229645094,0.7078976282090002,1.0,7/20,22.88%,ROCK2;BLM;DAXX;EPG5;ATP2B4;HSF1;TIMELESS
prerank,2-oxoglutarate metabolic process (GO:0006103),0.4353622308082767,1.0763824109014937,0.3805309734513274,0.7078666780875227,1.0,6/13,22.27%,ADHFE1;PHYH;D2HGDH;GPT2;GOT1;GOT2
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.2125685274294379,1.076371669737446,0.14086687306501547,0.7069303751050947,1.0,208/1668,10.48%,AUTS2;IGF1;BMP6;TCF7L2;TCF4;RORA;PIK3R1;ARNT2;FHL2;ZBTB20;BMP2;LDB2;MAF;SALL1;PID1;CDK8;AR;ATXN1;TBX3;GLIS3;MXI1;NR2F2;EPAS1;HLF;FGFR2;NFIA;BCOR;BMP5;ZEB1;HIVEP2;TBL1XR1;TRPS1;DCN;RARB;GDNF;VDR;PRRX1;RBAK;GLI2;TEAD1;ZIC1;NCOA2;ZHX2;TBX18;MITF;PPARA;HOXC4;KIT;PRDM5;NFAT5;DLX3;NKX6-1;IKZF4;SMAD3;IL4I1;HOXB3;TFEC;CREB5;STAT5B;CREB3L1;KDM1B;ZEB2;ZKSCAN2;HOXC5;GLI3;RUNX3;ZNF462;TBX21;AKAP8L;MDM2;TGFA;TFCP2;CSRP3;KLF15;WWC1;VRTN;TENM2;SP7;FNIP1;PBX4;UXT;PHIP;TFDP1;KDM7A;SOX21;AEBP1;PKNOX2;ZNF35;HDX;HOXC8;ZMYM5;CAMTA1;FOSB;PHOX2A;HOXB8;CEBPB;ZNF292;EBF1;ZNF112;IL4;GTF2H2;RNF2;MAML3;JAZF1;ZNF513;MNAT1;HES3;KMT2A;PRKN;SUMO1;SERPINE1;ZKSCAN7;HNF4G;MLLT10;LIN37;BBX;AGO4;MED12L;HOXC9;BCL2L12;ATF5;GABPB1;GABPB2;TAF6L;HDAC10;SMURF2;BAZ1B;ZNF394;NFIX;FOXA2;ASXL3;LOXL2;SIRT2;ZNF296;DMRTA2;MBD2;ZHX1;PLAC8;SP5;LHX4;DMTF1;CUX1;ZNF697;CRY1;TRIM27;MEN1;SOX2;RFX7;SIX4;RARG;PCGF5;KTI12;RBPJ;ZSCAN21;HTATSF1;TNRC6A;NSD1;BCL11A;SAFB2;GLIS1;PPM1D;SOX5;CITED2;RGMA;MLXIP;VGLL3;SENP1;CREB3L4;CREB3;NCOA1;IGF2;FOXD3;KAT8;MIER3;IL18;HES5;ATN1;CTCF;ZBTB45;ATOH8;KCNIP3;NPAT;BMPR1A;GATA3;BRWD1;DVL3;ZIC4;CPEB3;BRMS1L;BRMS1;ZSCAN12;PCGF6;PRKCB;MYDGF;HDAC8;CCNL1;AHI1;HOXC10;HOXB9;SOD2;CUX2;SKOR2;HOXC6;TNIP3;PTEN;PAX1;CCNH;ARID5B
prerank,aminoglycan catabolic process (GO:0006026),0.3661594984275287,1.0763646907585267,0.354,0.7059760543340362,1.0,7/28,13.07%,GPC6;GPC4;GPC2;GNS;GPC5;HSPG2;GLB1
prerank,regulation of cytoskeleton organization (GO:0051493),-0.26814952476105247,-1.075878283704302,0.30639097744360905,0.6582844811833289,1.0,20/108,10.51%,CLIC4;SORBS3;F11R;MAPK3;IQGAP1;ARHGAP17;PTK2;CAPN2;RICTOR;RAC1;CRK;DIAPH1;HIP1R;EZR;PDGFA;PHLDB1;FAM107A;RHOB;SPEF1;TAOK2
prerank,negative regulation of cellular component organization (GO:0051129),0.2934214593015936,1.0758780687022522,0.36182902584493043,0.7062846100237474,1.0,6/74,5.74%,BMP6;AR;EPHA3;SNX33;DNAJB8;IAPP
prerank,sensory perception of pain (GO:0019233),0.3792148952875787,1.0749159028401352,0.3378684807256236,0.7077973007414953,1.0,5/21,12.33%,P2RX4;OPRK1;TRPA1;CHRNA4;PTGES
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.31866868275393284,-1.074557991728081,0.3339517625231911,0.6610785558788242,1.0,14/48,14.26%,DMD;PTK2B;PDE4D;CAMK2D;CALM1;FKBP1A;DIAPH1;JPH2;AKAP6;JPH4;GSTM2;CALM3;CASQ2;SRI
prerank,MAPK cascade (GO:0000165),-0.2328650832408388,-1.0744347948918072,0.23991507430997877,0.6608258546961104,1.0,82/295,20.34%,KITLG;TEK;MEF2C;SHANK3;MAP3K5;RASAL2;RASGRP3;SPTBN1;FGF1;RASGRF2;KDR;MEF2A;MAPK3;PTK2;RGL1;DAB2IP;SHOC2;CALM1;MAP3K20;TGFB1;UBB;MAP3K3;MINK1;UBC;RPS27A;PEBP1;TAOK3;IKBKB;SHC1;MAP3K8;KRAS;NEFL;PSMA6;SPTAN1;PSMB5;PDGFA;IL17RD;PPP1CB;PSMC4;TAOK2;ZDHHC9;BCL2L1;PSMC5;PPP5C;NF1;ICMT;PSMD14;HRAS;FGF2;RBX1;LAMTOR2;LYPLA1;PSMD8;PIK3CA;ERBB2;RGL2;MET;PSMC1;EGFR;PIK3R2;JAK2;PSMB4;PSMD11;PSMD12;JAK3;RGL3;RET;RCE1;MAPK12;CHUK;ARL2;CUL1;RASGRP4;RASA1;SOX9;PTGER4;IL3RA;RAPGEF2;FGF9;PSMA1;CSF2RB;PSMC3
prerank,neural crest cell migration (GO:0001755),0.33983664974245253,1.0741973255146096,0.3665943600867679,0.7086489925337162,1.0,6/36,5.02%,NRP1;SEMA5A;GDNF;SEMA3A;RADIL;SEMA3D
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.35587064659750156,1.0739049418183249,0.3668763102725367,0.708429685645955,1.0,6/31,12.29%,IL4I1;LYN;CEBPB;GLMN;CD274;ATM
prerank,Notch signaling involved in heart development (GO:0061314),-0.46292522301709965,-1.073695558853563,0.3704379562043796,0.6621438920910946,1.0,4/11,18.01%,NOTCH1;HEYL;HEY1;DLL4
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.39522588611354587,1.0735819538106137,0.3723849372384937,0.7082586588269516,1.0,5/19,15.78%,AR;NAB2;ICE1;TENM1;ICE2
prerank,cell projection organization (GO:0030030),-0.34267824745919157,-1.073194095016641,0.36666666666666664,0.6628779754439921,1.0,12/30,30.93%,PARVB;RHOJ;RAC1;PDGFA;NCKAP1;PACSIN2;CAPG;ATP1B2;KIF17;CDC42;PLEK;RAC3
prerank,regulation of gene silencing by RNA (GO:0060966),-0.30735278682737044,-1.0728937560599947,0.3130081300813008,0.662497422943644,1.0,26/50,36.75%,NUP93;NUP54;NDC1;H3-3A;NUP188;FMR1;NUP155;RANBP2;NUP37;PUM2;NUP160;EIF4G1;NUP43;SEH1L;NUP42;SEC13;NUP107;NUP98;POLR2F;POLR2C;POLR2L;POLR2I;NUP88;RAE1;NUP214;TRIM71
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.30735278682737044,-1.0728937560599947,0.3130081300813008,0.662497422943644,1.0,26/50,36.75%,NUP93;NUP54;NDC1;H3-3A;NUP188;FMR1;NUP155;RANBP2;NUP37;PUM2;NUP160;EIF4G1;NUP43;SEH1L;NUP42;SEC13;NUP107;NUP98;POLR2F;POLR2C;POLR2L;POLR2I;NUP88;RAE1;NUP214;TRIM71
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.3888208327098799,1.0728624729392098,0.3453389830508475,0.709092657504958,1.0,6/21,15.56%,BCL2L11;CREB3L1;PRKN;CREB3;TXNDC12;DDIT3
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.3776799469319021,-1.072670181171482,0.3557692307692308,0.6625267763640813,1.0,10/22,28.17%,NOP14;RPS21;ERI1;PES1;URB1;EXOSC8;WDR12;ABT1;FTSJ3;EXOSC9
prerank,nucleotide-excision repair (GO:0006289),-0.27092861531797685,-1.072469450653838,0.280561122244489,0.6624968720053849,1.0,42/101,29.49%,UBB;UBC;RPS27A;USP7;ISY1;ERCC1;CUL4A;GTF2H3;CHD1L;COPS6;XAB2;HMGN1;COPS5;PNKP;SLX4;RBX1;RNF111;CETN2;HUS1;XRCC1;RPA3;BRCA2;GTF2H4;POLK;TCEA1;ERCC4;RFC3;COPS7A;COPS4;RFC2;FAN1;COPS7B;POLL;RAD23A;XPC;LIG4;GPS1;AQR;RAD23B;POLR2F;POLB;PRPF19
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.3085096529941847,-1.0723570896588819,0.32170542635658916,0.6622369454289136,1.0,22/47,30.77%,THBS1;PLCG2;TGFBR2;RAB27A;RNF41;TGFB1;RIPK1;ACE2;TLR4;SYK;CDKN1A;CBR1;GADD45A;PRKCD;SOD1;DCXR;GRIN1;TLR6;ROMO1;CD36;TYROBP;XDH
prerank,sensory perception of mechanical stimulus (GO:0050954),0.29000188038732205,1.072302124413905,0.32007952286282304,0.7096062275851946,1.0,12/85,9.86%,CEMIP;ADGRV1;ATP6V0A4;OTOS;P2RX4;ALDH7A1;COL4A3;PCDH15;EYA1;ROR1;LHFPL3;TMIE
prerank,nucleotide biosynthetic process (GO:0009165),-0.3852295721018505,-1.0718527417571977,0.36450381679389315,0.6628772717207465,1.0,5/18,13.26%,ME1;PRPS2;PRPS1;PRPS1L1;RRM1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.35067344238932624,1.0717191621183089,0.36174636174636177,0.7101308479189432,1.0,5/32,6.85%,ZBTB20;PPARA;PRKAG2;PDK4;ASXL3
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.42381152353437085,-1.0716809505079063,0.3942857142857143,0.662792777364277,1.0,2/13,1.72%,DDX5;RPL26
prerank,vasodilation (GO:0042311),-0.41780489921397507,-1.071639066220718,0.3955637707948244,0.6623627549719988,1.0,2/13,2.50%,NOS3;KLF2
prerank,positive regulation of vasculogenesis (GO:2001214),-0.46351277648272515,-1.0713814687316041,0.3835125448028674,0.6624997145293338,1.0,3/10,2.32%,RAP1A;CD34;KDR
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.3296824545170141,-1.07111741470536,0.346,0.6626364506616161,1.0,13/38,20.13%,NOS3;THBS1;TNFSF10;CASP8;FAIM;RIPK1;GPX1;FAS;BCL2L1;MADD;TNFAIP3;ARHGEF2;FAIM2
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.3225485901795687,-1.0710699957267018,0.34210526315789475,0.6622122794450395,1.0,12/41,14.29%,MEF2C;NOTCH1;TGFBR2;SMAD7;TGFB1;FKBP1A;TGFB2;HEYL;CPE;SOX4;ENG;HEY1
prerank,sulfate transport (GO:0008272),-0.4123390103432584,-1.0702448076742224,0.37523809523809526,0.6637281212619572,1.0,2/14,1.05%,SLC26A7;SLC26A2
prerank,positive regulation of macrophage migration (GO:1905523),-0.3810698198243263,-1.070238142687574,0.3927893738140417,0.6632048589951401,1.0,4/19,5.26%,THBS1;MAPK3;PTK2;CMKLR1
prerank,nucleic acid-templated transcription (GO:0097659),-0.3266967158591627,-1.070227367246899,0.3624031007751938,0.6626880407307467,1.0,21/42,34.69%,MEF2A;NR4A2;PTMA;XAB2;PPP5C;EPC1;RNPS1;E2F1;POLR3A;MED20;PWP1;MLF1;RRAGC;HOXD3;TAF1B;POLR2F;POLR2C;POLR2L;POLR2I;TERT;FUBP3
prerank,negative regulation of cell population proliferation (GO:0008285),-0.22954608024208406,-1.0700183592665422,0.2583518930957684,0.6626675869658701,1.0,66/351,13.37%,ZBTB7C;PTPN14;CDK6;ITGA1;B2M;NOS3;PTPRJ;IGFBP7;IGFBP6;NOTCH1;CBFA2T3;PTK2B;BMPR2;SH3BP4;KLF4;CCN3;ETS1;DAB2IP;NGF;FAP;CDKN1B;APP;IGFBP5;RNF41;REST;TGFB1;TGFB2;TES;PLPP1;IGFBP3;CTBP1;ING5;COL18A1;SMAD6;CNOT7;AQP11;CYP1B1;IFITM1;GATA2;WNT9A;GATA6;TGFB3;ADGRG1;RGCC;KANK2;SOX7;WARS1;CSNK2B;TRIB1;GAS8;DIS3L2;CTNNBIP1;INHBA;CIB1;FTH1;E2F3;TMEM115;FRK;NF1;SOX4;HES1;E2F1;RPS6KA2;CDK10;P3H2;HRAS
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.26981460338462737,-1.069984326484175,0.2973523421588595,0.6622441812688044,1.0,39/109,24.64%,PLCG2;MAPK3;MAP3K1;CALM1;RAC1;IKBKB;SHC1;PSMA6;PSMB5;NFATC1;FCER1G;PSMC4;PSMC5;PPP3CB;SYK;PSMD14;PSMD8;PIK3CA;LCP2;PSMC1;PIK3R2;PSMB4;TAB2;PSMD11;PSMD12;GAB2;RELA;CHUK;CUL1;NFATC3;PSMA1;PSMC3;BTK;PSMB1;PSMA2;LAT2;PSMA4;BCL10;TRAF6
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.35849939110568096,-1.0699266878819036,0.3622350674373796,0.6618316915559629,1.0,13/24,33.16%,MAVS;ZDHHC1;AIM2;HSP90AA1;STAT1;CGAS;PTPN22;DTX3L;LILRB1;PARP9;PQBP1;TRAF3IP2;TRIM44
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.3822366493784056,1.0697268337995252,0.34375,0.7132418018323287,1.0,4/21,7.04%,EYA2;GDNF;BCL2;EYA1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.3822366493784056,1.0697268337995252,0.34375,0.7132418018323287,1.0,4/21,7.04%,EYA2;GDNF;BCL2;EYA1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.3262235201286955,-1.0696742638425267,0.3492647058823529,0.6619114030121475,1.0,14/37,23.62%,UBB;UBC;RPS27A;ERCC1;CUL4A;GTF2H3;CHD1L;RBX1;RPA3;GTF2H4;POLK;ERCC4;RFC3;RFC2
prerank,nucleoside salvage (GO:0043174),-0.45932491680195964,-1.0691802564329145,0.4172794117647059,0.6625498947285385,1.0,9/10,51.54%,UPP2;TK2;UPP1;DCK;UCK2;TK1;UCK1;UCKL1;HPRT1
prerank,cellular response to cytokine stimulus (GO:0071345),-0.22537101404022414,-1.0689762481267668,0.2448512585812357,0.6625314908134267,1.0,107/416,19.92%,FN1;LEF1;ST3GAL6;PTPN14;SLC12A2;LBP;PTPRJ;VIM;LIFR;MAOA;LRCH1;F3;MT1X;FOXO1;WNK1;STX3;RAPGEF1;LAMA5;S1PR1;FOXO3;RPS3;GBP5;DAB2IP;IRAK2;ANXA1;SOCS2;MT2A;CDKN1B;TGFB1;PDE2A;UBB;HSPA8;INPP5D;UBC;RPS27A;CRK;VEGFA;IL1R1;STX1A;GBP7;IKBKB;SHC1;TNFRSF1B;NPNT;RC3H1;RIPK1;TNFRSF21;YBX3;GAPDH;NDUFA13;IL20RB;IFITM2;DHX9;ASAH2;AKT1;CCL15;TWIST1;IFNAR1;IFIT1;RPL13A;BCL6;UBE2G2;AKAP6;JUNB;LRP8;GRB10;ABL2;CIB1;BCL2L1;TLR4;YWHAZ;SYK;IL18BP;CSF1R;AIM2;FGF2;TNFRSF1A;POU2F1;SIGIRR;PIK3CA;PTPN12;F13A1;CLCF1;STAT5A;NDN;PTPN6;CDKN1A;JAK2;HSP90AA1;JAK3;HCK;GAB2;RELA;CHUK;IFNGR1;XBP1;STAT1;IRF8;SLA;AQP4;ARHGEF2;CCND1;SOX9;MCL1;IRAK4;IL3RA;HAS2
prerank,positive regulation of organelle organization (GO:0010638),-0.33722091245739694,-1.0688149761543997,0.3591682419659735,0.6624074478015655,1.0,15/32,32.82%,SORBS3;ANXA1;ANXA2;PPARGC1A;ATL3;SURF4;SHCBP1L;SYNJ1;RAB3GAP2;DOC2B;LIG4;TREM2;IRGM;ADRB2;HTRA2
prerank,cellular response to interleukin-2 (GO:0071352),-0.4426704805895767,-1.0683258587256037,0.39748201438848924,0.6625791793249646,1.0,5/11,17.16%,PTK2B;SHC1;SYK;STAT5A;JAK3
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.4426704805895767,-1.0683258587256037,0.39748201438848924,0.6625791793249646,1.0,5/11,17.16%,PTK2B;SHC1;SYK;STAT5A;JAK3
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3293236476898386,1.0679661956040405,0.3382978723404255,0.7167764662477277,1.0,8/44,10.00%,CYP7B1;PRKAG2;ALOX12;CYP27A1;BAAT;MSMO1;INSIG2;CYP46A1
prerank,proton transmembrane transport (GO:1902600),0.33594219239062245,1.0678462596312384,0.3497854077253219,0.7160942253888677,1.0,9/36,16.17%,ATP1A2;ATP6V0A4;SLC36A2;DMAC2L;ATP6V1H;SLC46A1;ATP1A3;UCP3;HVCN1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.28186058121755436,1.0673892445380901,0.3284132841328413,0.7163112239660717,1.0,24/95,15.57%,CEMIP;GPC6;FMOD;DCN;UST;GPC4;LUM;GPC2;B3GNT7;PXYLP1;OMD;OGN;HS2ST1;GPC5;DSE;CHST1;CHSY3;VCAN;HSPG2;HS6ST2;HS3ST6;HS3ST5;CHSY1;ST3GAL1
prerank,regulation of cell adhesion (GO:0030155),-0.2588543107281736,-1.0673850735643495,0.3114754098360656,0.6644832150818238,1.0,24/129,11.89%,PKP4;PODXL;FRMD5;PTPRJ;PTK2B;TGM2;STX3;PTK2;PLXNA4;ARHGDIA;ADAM10;ARHGDIB;MINK1;TGFBI;VEGFA;PPP2R1A;GPR4;ADGRG1;SIPA1;PPP1CB;PLXNA1;ABL2;PLXND1;YTHDF2
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.2865827486260579,1.067269702871461,0.3306930693069307,0.7156213408959224,1.0,7/78,2.63%,PIK3R1;PID1;AR;LRP1;DPP10;PDPK1;EPHA3
prerank,response to purine-containing compound (GO:0014074),-0.3980066361654518,-1.0670131282879802,0.37454545454545457,0.6648707815012319,1.0,3/17,8.14%,TRPC3;ABCC9;NDUFS4
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.4527542239666603,1.0665124676386024,0.3874458874458874,0.7165127258759256,1.0,1/10,0.32%,NELL1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.24437898145033807,-1.0662718255469694,0.2928416485900217,0.6662584598262274,1.0,54/208,18.29%,ESR1;PLCG2;NOD1;TFRC;MID2;DAB2IP;TRIM25;FKBP1A;ATP2C1;MAP3K3;TNFSF10;REL;S100B;IKBKB;HSPB1;BRD4;LURAP1;EEF1D;CASP8;RIPK1;GAPDH;PLK2;ZMYND11;TRIM14;CARD19;MAPKBP1;CD74;TIRAP;S100A13;MAVS;PPP5C;MIB2;TRIM62;TRAF1;SPHK2;TRIM68;TNFRSF1A;EDA2R;TRIM5;NOD2;UFL1;TMEM101;GPR89A;LGALS1;JMJD8;TAB2;ANKRD17;MIER1;RELA;PELI1;CHUK;STAT1;TNFAIP3;ECT2
prerank,regulation of mRNA catabolic process (GO:0061013),-0.26112412019916625,-1.0660820021301343,0.31157894736842107,0.6661984332829362,1.0,39/121,23.48%,VIM;UBB;HSPA8;PRR5L;UBC;RPS27A;CNOT7;HSPB1;ANP32A;PSMA6;RC3H1;PSMB5;AKT1;PCBP4;PSMC4;PSMC5;YTHDF2;YWHAZ;PSMD14;FMR1;PSMD8;TNFSF13;PSMC1;PSMB4;HSPA1A;PSMD11;PSMD12;EXOSC8;SERBP1;PUM2;PSMA1;PSMC3;YTHDF1;PSMB1;PSMA2;EIF4G1;YWHAB;PSMA4;PRKCD
prerank,determination of bilateral symmetry (GO:0009855),-0.36297136312905737,-1.0660070270384931,0.3978102189781022,0.6658389494544049,1.0,9/24,24.23%,NOTCH1;TBX1;ZIC3;ARL6;DNAH5;ODAD2;PKD2;MKKS;ODAD3
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.32322599724933204,-1.0652814084170403,0.3527272727272727,0.6671819839307693,1.0,18/38,33.93%,H3-3A;KNL1;MIS18BP1;CENPU;RBBP4;CENPI;CENPN;CENPA;CENPO;NPM1;RUVBL1;SMARCA5;ASF1B;OIP5;ITGB3BP;CENPX;CENPW;RBBP7
prerank,mitochondrial translational elongation (GO:0070125),-0.2778361358836137,-1.0652605193713274,0.34791252485089463,0.6666989776717996,1.0,32/88,25.36%,PTCD3;MRPL52;MRPL51;MRPL38;MRPL28;MRPL43;TSFM;MRPL32;MRPL14;ERAL1;MRPS30;MRPS17;MRPL24;MRPL16;MRPL50;MRPL54;MRPS18C;MRPL47;MRPL35;MRPS18A;MRPS6;MRPL58;MRPL13;TUFM;MRPL11;MRPL49;MRPL30;MRPS24;MRPL21;MRPL48;MRPL42;MRPL2
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.286986931212251,1.0647897089872256,0.33137254901960783,0.7200551870561482,1.0,11/84,11.36%,IGF1;SAMD4A;IGF2BP2;DAPK1;RTN4;NANOS3;CPEB3;DDX6;RIDA;CHRNA7;FXR2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.4499890533712559,1.0643758409166895,0.3708609271523179,0.7201953569933996,1.0,2/11,4.18%,PRKCA;LYN
prerank,response to cytokine (GO:0034097),-0.25661656748751027,-1.0642902587070011,0.3153526970954357,0.6685228183765186,1.0,39/141,17.24%,LEF1;PTPN14;MAP4K3;LIFR;IRAK2;GCH1;ANXA1;COL3A1;MAPKAPK3;ADAR;APP;ADAM10;REL;IL1R1;IFITM1;IFITM3;CASP8;RIPK1;TNFRSF11A;HDAC4;IFITM2;ASAH2;RELB;AKAP6;GGT5;CD74;BCL2L1;IL18BP;TRIM56;CSF1R;SIGIRR;SRF;PTPN12;PTPN6;TIMP2;JAK2;IGBP1;JAK3;RELA
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.4333697769050726,1.0642221393193854,0.4009009009009009,0.7196010382755947,1.0,4/12,18.68%,NUGGC;BLM;NBN;WRNIP1
prerank,regulation of BMP signaling pathway (GO:0030510),-0.2852883756083756,-1.0642091221063963,0.34423076923076923,0.6681745679989949,1.0,21/73,20.62%,CRIM1;BMPER;NOTCH1;BMPR2;SMAD9;SMAD7;FOXD1;SMAD6;SKIL;HTRA3;ZNF423;ENG;SMURF1;FSTL1;SMAD4;GREM1;SKI;BMPR1B;CDH5;BAMBI;SMAD2
prerank,negative regulation of ATP metabolic process (GO:1903579),0.4012059549735184,1.0636483173140734,0.3708609271523179,0.720077925181889,1.0,3/17,5.02%,PID1;PPARA;ACTN3
prerank,catecholamine metabolic process (GO:0006584),0.4147639684990011,1.0630539415456257,0.3930131004366812,0.720613630050836,1.0,3/14,14.70%,PRKN;COMT;DRD2
prerank,photoreceptor cell development (GO:0042461),-0.41885576452837187,-1.0629765888065867,0.4052631578947368,0.6707837990205984,1.0,4/14,9.89%,RP1;VEGFA;MFSD2A;CEP290
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3073136738048157,1.062940034990031,0.365234375,0.7180295530855929,1.0,14/61,15.32%,AREG;SEC24D;TGFA;SCFD1;TRAPPC6B;GOLGA2;TMED10;SEC31A;SEC24A;SEC23A;TRAPPC3;TBC1D20;GRIA1;SAR1B
prerank,COPII vesicle coating (GO:0048208),0.3073136738048157,1.062940034990031,0.365234375,0.7180295530855929,1.0,14/61,15.32%,AREG;SEC24D;TGFA;SCFD1;TRAPPC6B;GOLGA2;TMED10;SEC31A;SEC24A;SEC23A;TRAPPC3;TBC1D20;GRIA1;SAR1B
prerank,vesicle coating (GO:0006901),0.3073136738048157,1.062940034990031,0.365234375,0.7180295530855929,1.0,14/61,15.32%,AREG;SEC24D;TGFA;SCFD1;TRAPPC6B;GOLGA2;TMED10;SEC31A;SEC24A;SEC23A;TRAPPC3;TBC1D20;GRIA1;SAR1B
prerank,regulation of macrophage differentiation (GO:0045649),0.4166047288844764,1.0629064542652138,0.3968609865470852,0.7171627901584647,1.0,2/15,2.75%,IL34;PRKCA
prerank,glucose homeostasis (GO:0042593),-0.2779344102585361,-1.062887742730452,0.34552845528455284,0.6704709882508854,1.0,11/83,5.39%,ADIPOR2;IGF1R;LRRC8D;FOXO1;HK1;KCNB1;BACE2;KLF7;PPARGC1A;ADIPOR1;FOXK1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.30188349937057524,-1.0618112481133974,0.3590733590733591,0.6725884424977576,1.0,12/54,15.21%,CAV1;KCNJ2;NEDD4L;FHL1;WWP2;KCNQ1;KCNJ10;AKAP6;KCNJ15;GNB1;CACNA1D;CAB39
prerank,positive regulation of lipid storage (GO:0010884),-0.3754137639629953,-1.061778548619217,0.37009345794392523,0.6721336545857928,1.0,11/21,44.32%,SCARB1;PLIN3;EHD1;MSR1;HILPDA;C3;IKBKE;PLIN5;CIDEA;APOC4;SREBF2
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.2146800746815992,1.0611337587542027,0.20446735395189003,0.7205616884480855,1.0,117/1082,9.45%,AUTS2;IGF1;BMP6;TCF7L2;TCF4;RORA;PIK3R1;WNT4;IL31RA;ARNT2;BMP2;LDB2;SALL1;PID1;CDK8;AR;TBX3;GLIS3;NR2F2;EPAS1;HLF;FGFR2;NFIA;BMP5;TBL1XR1;DCN;RARB;GDNF;VDR;GLI2;TEAD1;ZIC1;NCOA2;MITF;PPARA;HOXC4;NFAT5;NKX6-1;SMAD3;IL4I1;HOXB3;TFEC;CREB5;STAT5B;KDM1B;ZEB2;GLI3;PIM2;RUNX3;ZNF462;TBX21;SFRP1;AKAP8L;TFCP2;CSRP3;KLF15;SP7;PBX4;PHIP;TFDP1;PHOX2A;MAP3K12;CEBPB;IL4;CAMK4;MAML3;ZNF513;KMT2A;PRKN;SERPINE1;HNF4G;MLLT10;BCL2L12;ZNF318;ATF5;GABPB1;GABPB2;TAF6L;TRIP4;NFIX;FOXA2;ASXL3;SIRT2;ZNF296;PLAC8;LHX4;TGFBR1;TP53INP2;MEN1;SOX2;SIX4;RARG;PCGF5;RBPJ;ZSCAN21;NSD1;GLIS1;CITED2;RGMA;MLXIP;SENP1;CREB3L4;CREB3;NCOA1;IGF2;FOXD3;KAT8;IL18;HES5;CXXC1;CTCF;ATOH8;BLM;NPAT;BMPR1A;GATA3;DVL3
prerank,protein complex oligomerization (GO:0051259),-0.27609892929437035,-1.060628941144638,0.3182674199623352,0.6744998802241368,1.0,29/85,26.49%,LRRC8C;LRRC8D;EHD4;MAT2A;AQP11;ATL3;KCNC3;FUS;PRMT8;ATL2;JMJD6;HOMER1;OPA1;NINJ1;POLQ;CHMP2A;ECT2;EHD1;EHD3;TRMT61B;UPB1;CLDN1;MCU;PKD2;BCL10;ALAD;RNF112;LRRC8A;ZNHIT6
prerank,triglyceride homeostasis (GO:0070328),0.3649714472017009,1.0604744214858044,0.3674321503131524,0.7212327101445866,1.0,1/26,0.18%,RORA
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.42759747531288456,-1.0603486142394691,0.39233576642335766,0.6747081142820981,1.0,3/12,7.43%,ELF1;CBFB;RC3H1
prerank,regulation of sequestering of triglyceride (GO:0010889),0.4054605305896827,1.0603194536129215,0.3758099352051836,0.7206672233289669,1.0,2/15,3.16%,PPARA;OSBPL8
prerank,regulation of cell death (GO:0010941),-0.270445275207125,-1.059943620287484,0.33535353535353535,0.6751754860758489,1.0,30/94,22.57%,ACER2;CCN3;FERMT2;CDKN1B;UBB;CTSZ;CHP1;PDE8A;TNFRSF1B;DUS2;SRSF6;WNT11;SPEF1;IMPACT;SOX4;ACER3;CCN5;DHCR24;TMEM109;FGF2;BNIP3L;RAD18;HSPA1A;CRYAB;CHMP2A;HSPA1B;SNCG;NCK1;ADNP2;EIF4G1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3196369391516246,1.0597718527282296,0.3757828810020877,0.7211965138069945,1.0,5/44,3.70%,PPM1E;NRP1;LPAR1;ROCK2;SFRP1
prerank,ion transport (GO:0006811),0.27436071643240245,1.0596543251747779,0.3372093023255814,0.7205347008295163,1.0,16/111,7.25%,SLC1A3;SLC24A3;SLC8A1;SLC24A5;SLC17A1;VDAC2;CNGB3;TRPM3;CHRNB4;GLRB;SLC20A2;SLC36A2;SLC26A1;SLC9A7;SLC25A10;TRPA1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.31034305596542217,-1.0593215557370315,0.3550863723608445,0.6762373230668494,1.0,12/50,19.70%,ACTB;CCND3;HSP90AB1;CDKN1B;CCNG2;CCNF;CCNK;CDKN1A;CDKN2C;CCND1;CDK5RAP3;GADD45A
prerank,positive regulation of metabolic process (GO:0009893),-0.2686901333847755,-1.0589018605276197,0.33537832310838445,0.6767738840630265,1.0,23/103,13.20%,CAV1;ADIPOR2;IGF1R;GATM;PRDM16;PPARGC1B;PPARGC1A;ADIPOR1;CMKLR1;VEGFA;UCP2;ACLY;KDM3A;INSR;PDGFC;DECR1;ACADL;EBF2;GRB10;FABP5;GADD45G;SYK;AGPAT1
prerank,regulation of vacuole organization (GO:0044088),-0.390336554162837,-1.0587102529413124,0.4093567251461988,0.6767663698860621,1.0,8/20,28.27%,IFT20;ANXA2;TBC1D12;LAPTM4B;MTM1;ADPRH;ENO1;UBQLN2
prerank,mitochondrial translation (GO:0032543),-0.26943769013921226,-1.0586050231668125,0.33669354838709675,0.6764911152042595,1.0,36/104,25.36%,QRSL1;PTCD3;MRPL52;MRPL51;MRPL38;LARS2;MRPL28;MRPL43;TSFM;GATC;MRPL32;MRPL14;ERAL1;MRPS30;MRPS17;MRPL24;MRPL16;MRPL50;MRPL54;MRPS18C;MRPL47;MRPL35;MRPS18A;MRPS6;MRPL58;MRPL13;TUFM;MRPL11;MRPL49;GATB;MRPL30;MRPS24;MRPL21;MRPL48;MRPL42;MRPL2
prerank,negative regulation of protein modification process (GO:0031400),-0.281088069152205,-1.0584917175397817,0.3384321223709369,0.6762253974325975,1.0,18/79,11.34%,OCLN;DMD;NIBAN1;PPP1R16B;SLIT2;DAB2IP;TGFB1;MFHAS1;PPIA;PRR5L;IGFBP3;CHP1;PRKDC;WARS1;DBI;PPP1R8;IMPACT;CIB1
prerank,oligosaccharide biosynthetic process (GO:0009312),0.3884147023894768,1.0583729129611426,0.3982494529540481,0.7228504932103181,1.0,7/20,12.78%,B3GALT1;ST6GALNAC5;FUT4;ST6GALNAC6;FUT9;B3GALT2;B3GALT5
prerank,central nervous system development (GO:0007417),0.24163482044852053,1.058089112055234,0.3062015503875969,0.7226280108111234,1.0,46/250,13.98%,EPHA7;ARNT2;ROBO2;ATXN1;TBX3;CHST8;ZIC1;CNTN4;AFF2;CHD7;CNTNAP2;PBX4;PRKN;GSTP1;LOXL3;ASIC2;GRIK1;ADGRA2;NRCAM;SCIN;HES5;ATN1;ZIC4;CDK5R1;AHI1;PTEN;ANKLE2;PLXNB2;EEF1AKMT4-ECE2;RPS6KA6;EML1;EIF2B5;AMIGO1;CTNS;VCAN;COX7B;HSPG2;PHF8;GBA2;PAX8;CXCR4;GRIN2A;CNTN6;TUBGCP2;POU6F2;NKX2-1
prerank,female gonad development (GO:0008585),0.38542853484243167,1.0580158125585386,0.39400428265524623,0.7218639711025459,1.0,5/19,11.46%,NR2F2;KIT;CEBPB;ANG;EIF2B5
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.4007753610679,-1.0579184827652568,0.3925233644859813,0.67714761835855,1.0,4/15,9.37%,ANXA1;REST;NR3C1;FAM107A
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.42009618870067156,1.0578694212396889,0.3907563025210084,0.7212670926970269,1.0,5/13,10.22%,TGFBR3;FGFR2;RBPJ;BMPR1A;ERBB4
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.2983997572637064,-1.057753309321274,0.34930139720558884,0.6770344391676556,1.0,24/57,28.43%,KDR;TNFSF10;PPARGC1A;HTT;MIEF1;HIP1R;BAX;MIEF2;BAK1;BBC3;CHCHD10;BAD;ADCK1;BIK;FIS1;MCU;PLAUR;CAMKK2;PARK7;TREM2;HRK;MFF;MUL1;PMAIP1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.4247747173828086,-1.0577060576640305,0.4245810055865922,0.676617313377429,1.0,6/12,25.42%,ERLIN2;ACADL;ACADVL;WDTC1;TRIB3;APOC1
prerank,dermatan sulfate metabolic process (GO:0030205),0.4223606619881794,1.0575111936581054,0.3824175824175824,0.7212682079161791,1.0,4/13,12.12%,DCN;UST;DSE;VCAN
prerank,positive regulation of protein import into nucleus (GO:0042307),0.35450809398303496,1.0570518128647968,0.3622881355932203,0.7215016921382825,1.0,3/28,2.72%,PIK3R1;ZIC1;SMAD3
prerank,membrane lipid metabolic process (GO:0006643),-0.3797273820948651,-1.057048135478708,0.37373737373737376,0.6777801436008087,1.0,6/22,13.50%,ST3GAL6;SPTLC1;CYP1B1;B4GALT4;SPHK2;CERKL
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.38752687912573813,-1.057041562830718,0.3939393939393939,0.677257038662293,1.0,4/18,7.03%,CAV1;NEDD4L;CAMK2D;SLC43A2
prerank,lung epithelium development (GO:0060428),0.4589241567339717,1.0563108904941785,0.407158836689038,0.7223686732949273,1.0,1/10,0.48%,ERRFI1
prerank,copper ion homeostasis (GO:0055070),-0.3954528425150639,-1.0559690854452253,0.38533834586466165,0.6793232135583245,1.0,3/17,4.11%,ATOX1;MT2A;APP
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.44751386918273006,-1.0558399917391772,0.4084249084249084,0.6790820677825614,1.0,4/11,14.01%,ITPKB;IPMK;FGF2;IP6K1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.35885088580257507,-1.0558392388399622,0.37884615384615383,0.6785483226182871,1.0,10/24,25.93%,DAB2IP;HHEX;GRB10;EPN2;TMEM204;ITGB3;CADM4;PRKD2;PTPN1;PDCD6
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.3637811388121665,1.055413449931635,0.36086956521739133,0.7236610270989231,1.0,2/23,1.45%,IGF1;NRG1
prerank,response to sterol (GO:0036314),0.4433363244630024,1.0551039107470452,0.3870967741935484,0.7235242770299745,1.0,2/11,7.55%,RORA;TGFBR1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.4122494871315452,-1.0547883248106815,0.3953488372093023,0.6805724535440297,1.0,6/13,25.93%,DAB2IP;HHEX;EPN2;CADM4;PTPN1;PDCD6
prerank,glycoprotein metabolic process (GO:0009100),-0.3006667339244197,-1.0546976798560204,0.36398467432950193,0.6802595698295094,1.0,9/53,9.02%,ST3GAL4;ST6GALNAC3;ST8SIA4;MANBA;GANC;ST8SIA6;FBXO17;MAN1B1;FUT8
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.4302776941037586,-1.0546178621088549,0.4032846715328467,0.6799300380995242,1.0,4/12,23.74%,ACLY;ACO1;IDH3A;ACO2
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.37964158882970706,-1.0545651926528468,0.38764044943820225,0.679520798575894,1.0,3/20,1.46%,SEMA6A;SEMA3C;SEMA7A
prerank,negative regulation of double-strand break repair (GO:2000780),0.34713271879726443,1.0541894860199632,0.3683083511777302,0.7249951932637004,1.0,7/30,13.88%,SHLD2;UBQLN4;TRIP12;RADX;OTUB2;SMCHD1;RIF1
prerank,pentose-phosphate shunt (GO:0006098),-0.4544156492110434,-1.05416534311942,0.41760299625468167,0.6800228165679827,1.0,5/11,25.43%,PGLS;TALDO1;RPIA;PGM2;SHPK
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.4444996624260841,-1.053846473619389,0.38235294117647056,0.6802657465210292,1.0,4/11,8.18%,MAP3K5;ARL6IP5;CYP1B1;STK25
prerank,chondrocyte differentiation (GO:0002062),0.3513564040909816,1.0538248985047445,0.3893617021276596,0.7249914706695343,1.0,6/32,8.88%,BMP2;SULF1;SULF2;RUNX3;SOX5;HES5
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.3595681928139348,1.0537122956177836,0.3854625550660793,0.7242971354429636,1.0,7/21,16.30%,SULF1;SULF2;HS6ST3;HS2ST1;HS6ST2;HS3ST5;HPSE
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.34139008252082514,-1.0536952969999192,0.38461538461538464,0.6801350884328607,1.0,11/30,20.13%,NOS3;TNFSF10;CASP8;FAIM;RIPK1;GPX1;FAS;BCL2L1;TNFAIP3;ARHGEF2;FAIM2
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.3366845710204564,-1.0536885132289615,0.39,0.6796272276995722,1.0,12/31,21.17%,DAB2IP;HSPA8;RHBDD1;DNAJB12;BAX;HSPA5;BAK1;HSPB8;HSPA1A;HSPA9;TMBIM6;HSPA1B
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.2723582490933104,-1.0530078716670626,0.35477178423236516,0.680757007569159,1.0,20/94,12.93%,PPP1R13B;MAP3K5;DDX5;ARL6IP5;DAB2IP;FNIP2;CRIP1;ATP2A3;CYP1B1;ATF4;PRKDC;TNFRSF1B;PPM1F;CUL4A;BAX;BCL2L1;BAK1;BBC3;E2F1;HINT1
prerank,regulation of insulin secretion (GO:0050796),0.27200971201167445,1.05261227575277,0.33976833976833976,0.7260932439416459,1.0,15/101,7.90%,TCF7L2;ADCY5;RAPGEF4;CACNA1E;ITPR1;PRKCA;SFRP1;STXBP4;FAM3D;IRS2;PRKN;NLGN2;FOXA2;TM7SF3;SNAP25
prerank,mitotic spindle organization (GO:0007052),-0.24838337073729888,-1.052489028997164,0.33544303797468356,0.681522557505078,1.0,63/153,33.18%,RAB11A;DCTN2;RPS27;MAP4;ZW10;DYNC1LI2;CEP192;PLK2;KIF23;VCP;RCC2;NDE1;NDEL1;KNL1;RANBP2;DYNC1LI1;CENPU;LSM14A;NUP37;KIF18A;MAD1L1;DYNLL2;MISP;RANGAP1;CENPI;TPX2;NUP160;RCC1;NDC80;CENPF;RMDN1;NSL1;CENPN;CLIP1;SPICE1;EFHC2;SPDL1;CENPA;NUP43;SEH1L;CDCA8;STMN1;TBCE;SGO1;KIFC2;CENPO;SEC13;NUP107;BIRC5;WDR62;NUP98;BUB3;XPO1;TUBG2;KIF11;NUF2;AURKA;BCCIP;PLK1;ITGB3BP;RHOA;CDC20;BUB1
prerank,icosanoid secretion (GO:0032309),-0.42533787894254693,-1.0523817806867406,0.36991150442477877,0.681271196880579,1.0,2/12,3.66%,ABCC4;ANXA1
prerank,sterol metabolic process (GO:0016125),0.3045405939826705,1.052066633242763,0.36608863198458574,0.7264444154763602,1.0,10/60,10.00%,CYP7B1;ABCA1;PRKAG2;CYP27A1;IL4;MSMO1;INSIG2;ABCA5;SCAP;CYP46A1
prerank,epithelial cell migration (GO:0010631),-0.324519411697103,-1.0513757467286637,0.3596153846153846,0.6831817486756319,1.0,13/37,14.99%,NOS3;DPP4;PXN;STARD13;FAP;CYP1B1;GIPC1;KANK2;FAT2;PLXND1;PKN3;PIK3CA;FSTL1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.43417179074036505,-1.0509113686076426,0.43233743409490333,0.683774442450722,1.0,7/11,49.71%,NFKBIZ;IL12RB1;CARD9;IL23A;IL12B;IL23R;CLEC6A
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.37583952077309957,-1.0508777988500058,0.395985401459854,0.6833331985590715,1.0,5/20,7.01%,SLC12A2;KCNJ2;NEDD4L;ATP1A1;ATP1B1
prerank,positive regulation of TOR signaling (GO:0032008),-0.31841616835646863,-1.0507407396499515,0.37373737373737376,0.683112489370574,1.0,18/40,32.71%,RICTOR;GPR137B;PIP4P1;LAMTOR2;PIK3CA;RRAGD;RRAGA;RRAGC;GOLPH3;SEH1L;SIK3;SEC13;RPTOR;TREM2;LAMTOR5;LAMTOR1;HDAC3;LAMTOR3
prerank,negative regulation of wound healing (GO:0061045),-0.34410745517659586,-1.0505484425041332,0.40816326530612246,0.6830742940182165,1.0,8/28,13.85%,SLC12A2;CD34;THBD;CD109;CRK;EDN1;FGF2;APOE
prerank,vasoconstriction (GO:0042310),-0.4424327494147263,-1.0505106742259724,0.430939226519337,0.6826435480857259,1.0,4/11,9.21%,EDNRA;ACTA2;EDN1;PIK3C2A
prerank,calcium ion transmembrane transport (GO:0070588),0.28082065621351815,1.049821309543501,0.3702213279678068,0.7312027526748629,1.0,16/86,9.95%,NALCN;SLC24A3;SLC8A1;SLC24A5;CACNA2D1;ATP2A2;P2RX4;TRPM1;TRPM3;TRPM5;MICU3;TRPA1;CACNA1G;PARL;SLC24A4;SLC24A2
prerank,transepithelial transport (GO:0070633),-0.4005073592000538,-1.049749769777769,0.3889908256880734,0.6839610113171776,1.0,4/15,4.41%,ABCG2;CXADR;SLC12A2;SLC1A1
prerank,skeletal muscle tissue development (GO:0007519),0.3398429535745691,1.0495597238667866,0.3673036093418259,0.7309347609315746,1.0,6/32,7.83%,SVIL;CSRP3;CFLAR;MYORG;KLHL41;SIX4
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.31149814458691416,-1.0495206465262386,0.37398373983739835,0.684023809309513,1.0,9/44,13.81%,ANO6;KCNJ2;WNK1;KCNQ1;KCNJ10;ATP1B1;AKAP6;KCNJ15;GNB1
prerank,sulfur compound biosynthetic process (GO:0044272),-0.2659855957545627,-1.049228662906604,0.356,0.684217371716435,1.0,30/104,22.23%,ST3GAL6;ST3GAL4;CHST11;CSGALNACT1;SLC26A2;CSPG4;TPK1;MAT2A;GGTA1;CDO1;GSTA4;SLC10A7;B4GALT4;GGT5;GSTM2;GSTA3;SLC35B3;GSTM1;SLC35D2;GSTO2;CTH;GCLM;MGST3;GCLC;CNDP2;GGT1;B3GNT3;GGCT;GSTK1;CHPF
prerank,positive regulation of developmental process (GO:0051094),0.25518347825451676,1.048882794831397,0.3290441176470588,0.7316978093625939,1.0,40/164,18.14%,BMP2;PTN;AR;BMP5;PHLDB2;GJA1;NRXN1;DCN;GDNF;GRIP1;SHLD2;CEBPB;PRKN;SMURF2;RTN4;FOXA2;CAMK2B;KMT5C;NLGN1;SOX5;BMPR1A;DVL3;CPEB3;PAXIP1;ALK;FGFR1;DLG4;RIF1;SYDE1;ADGRL1;KMT5B;FBXO5;NCOA3;DAG1;NUMA1;LLPH;SHH;VLDLR;ZDHHC15;ZDHHC6
prerank,positive regulation of dendrite development (GO:1900006),0.44570037092968373,1.0487678995706757,0.3925233644859813,0.7310313632601158,1.0,2/10,1.29%,PTN;BMP5
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.32222806456746705,-1.048739203520008,0.3980392156862745,0.684962140263619,1.0,10/35,17.16%,CAV1;NOTCH1;NLK;ADIPOR1;CYP1B1;CRLF3;OCIAD1;HES1;JAK2;JAK3
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.24596640086725,1.048676739401956,0.3234714003944773,0.7302850958178415,1.0,29/214,11.25%,EPHA7;TGFBR3;NRP1;BMP2;NTRK3;FBLN1;FGFR2;TIMP3;PLA2G5;PDGFRA;GPR55;PRKCA;SLC30A10;LYN;MAP3K12;PDGFRB;GSTP1;CALCR;EPHB1;RRAS;THPO;ROR1;PDGFD;FGFR4;CCL25;ERBB4;PTEN;RPS6KA6;CHRNA7
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.2449810757221046,-1.0485556104396927,0.3410526315789474,0.6849049119859861,1.0,44/166,16.97%,SORBS1;THBS1;VIM;RPL26;SCARB1;KLF2;KLF4;EEF2;NIBAN1;RPS4X;HSP90AB1;PPARGC1A;CHP1;MFSD2A;GIPC1;PRKDC;RGCC;EDN1;INSR;DYRK2;DHX9;AKT1;NMD3;ELOVL5;EIF3D;RPS27L;LARP4B;CIRBP;TLR4;UPF3A;SOX4;PAOX;FGF2;FMR1;LDB1;ERBB2;OPN3;BCAR3;STAR;NR1H2;EGFR;HSP90AA1;PCIF1;SP1
prerank,positive regulation of endocytosis (GO:0045807),-0.3106844247776414,-1.0482641700163395,0.3550863723608445,0.6851133287735793,1.0,8/45,10.12%,ANO6;B2M;GPC3;NEDD4L;CD151;FLOT1;HIP1;SGIP1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.2186064781686547,-1.047729856295832,0.255125284738041,0.6858494622891163,1.0,121/476,20.67%,MECOM;LEF1;MEF2C;MAP3K5;AFAP1L2;RREB1;MLLT3;CDH1;ESR1;NOTCH1;FLI1;LRP5;PPARD;KLF2;KLF4;FOXO1;ELF1;TBX1;FZD4;FOXO3;SOX17;ETS1;SIX1;PRDM16;REST;TGFB1;CNBP;NFYA;ZBTB16;PPARGC1A;CD38;ING5;FOXK1;ACTA2;NOTCH4;IKBKB;RARA;SHC1;ATF4;KDM3A;BRD4;GATA6;HCFC1;TGFB3;TRIM16;MED24;HDAC4;SPIN1;TAL1;ENY2;FZD7;AKT1;NFATC1;TRIM28;HHEX;SOX18;MAP3K2;FOXF2;ARID1A;SPP1;JMJD6;CEP290;ZIC3;WNT11;MYBL1;FOXC2;CD74;CRLF3;TEAD2;INHBA;ILF2;SP3;PSMC5;WBP2;PPP3CB;SOX4;ZNF423;EPC1;HES1;TRIM56;E2F1;ACVR1;FGF2;APOE;RNF20;RNF111;NR5A2;HEY1;SMARCA4;SMAD4;SMARCA2;NR1H2;EGFR;ZFHX3;ETS2;RAI1;BRCA2;YWHAH;SP1;KLF6;TCF3;FOXL2;RELA;RET;CHUK;STAT1;USP22;GLI1;ZBTB48;MED14;PHF5A;SOX9;ESR2;EDF1;DNM2;TBL1X;BAMBI;RXRB;TFEB;SMAD2;SFR1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.30025807421850526,-1.0475511840863778,0.38953488372093026,0.6857553227766914,1.0,18/53,23.36%,PSMA6;PSMB5;PSMC4;PSMC5;OAZ2;PSMD14;PSMD8;PSMC1;NQO1;PSMB4;PSMD11;PSMD12;PSMA1;PSMC3;PSMB1;PSMA2;BCKDK;PSMA4
prerank,androgen receptor signaling pathway (GO:0030521),-0.4379259748791408,-1.0472170283248599,0.40942028985507245,0.6860060175597796,1.0,5/11,9.38%,DDX5;DDX17;PLPP1;KDM3A;ARID1A
prerank,negative regulation of mRNA processing (GO:0050686),-0.3959490883705678,-1.0469235870950184,0.38301886792452833,0.6861367954666958,1.0,5/15,14.50%,SRSF6;PCBP4;RNPS1;SRSF4;SFSWAP
prerank,regulation of cytoplasmic translation (GO:2000765),-0.4135589573488191,-1.046860647119719,0.4200743494423792,0.6857542327827378,1.0,5/14,13.81%,CNBP;PKM;YBX3;DHX9;FMR1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.3386083701144119,1.046793970383455,0.38253638253638256,0.7340587990477283,1.0,6/30,7.58%,GJA1;SCN3B;ANK2;CACNA2D1;GPD1L;CACNA1G
prerank,regulation of postsynapse organization (GO:0099175),-0.34372733878967837,-1.046742674405294,0.3694029850746269,0.6855110542813191,1.0,6/28,12.60%,SHANK3;SIPA1L1;ABI3;CFL1;SRCIN1;HOMER1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.29107662061735,-1.0467281627343652,0.3877159309021113,0.6850182599326063,1.0,27/58,34.10%,PAXX;ZBTB7A;BRCC3;PRKDC;ERCC1;UIMC1;BABAM1;HERC2;PSMD14;DCLRE1C;CYREN;POLQ;BABAM2;ERCC4;POLL;LIG4;BARD1;MRE11;POLB;HMGB2;PRPF19;RNF8;NSD2;ATP23;RAD50;XRCC4;POLA1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.2914402497459858,-1.0465781124069202,0.3737957610789981,0.6848837092204815,1.0,19/62,19.60%,ACKR3;TPT1;PPIA;HSPB1;YBX3;NDUFA13;AKT1;DNAJA1;PTTG1IP;BAG5;BCL2L1;NDUFS3;OPA1;HSPA1A;CCAR2;XBP1;ARHGEF2;MCL1;TMBIM6
prerank,Golgi organization (GO:0007030),-0.2600119215183189,-1.0460809533997806,0.39959839357429716,0.6855502213287661,1.0,51/112,31.05%,SYNE1;ATP8B1;PI4K2A;ZW10;BCAS3;HTT;GORASP2;FAM174B;ATL3;PLEKHM2;STK25;TRIP11;ATL2;TRAPPC11;BAG5;FHDC1;VRK1;SURF4;YWHAZ;LMAN2;VMP1;RAB1A;COG3;GOLGA5;GOLGA8B;GCC2;VTI1B;TMED1;COG2;TMED5;ATP8B2;PLK3;STX5;PDCD10;RAB43;GOLPH3;GOLPH3L;TMED3;LMAN2L;PLK5;GOLGB1;CDC42;DNAJC28;STX16;ATP8B4;VAMP4;HACE1;SPTBN5;DYM;TRAPPC12;CDK1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.20089265649815127,-1.045964812649519,0.18233618233618235,0.6853317429952759,1.0,338/1646,18.71%,BNC2;KLF12;MECOM;LEF1;FOXP1;ELK3;ERG;MEF2C;ZBTB7C;DACH1;MAP3K5;APBB2;AFAP1L2;WWP1;NR3C2;TBX15;RREB1;MLLT3;CDH1;RPS6KA5;ATP8B1;ESR1;DDX5;KLF3;NOTCH1;CBFA2T3;ID1;RPL6;FLI1;DACH2;ZHX3;CDK17;LRP5;TEAD4;HMBOX1;ID3;JUND;TRAK1;PPARD;JMJD1C;MEF2A;KLF2;KLF4;NCOR1;NLK;FOXO1;ELF1;TBX1;ZBTB46;FZD4;SMAD9;ZSCAN29;FOXO3;RPS6KA3;SOX17;ETS1;DAB2IP;SMAD7;CAMK2D;BRD3;ZBTB7A;VSX1;IRF2BPL;PHF20;KLF7;SIX1;CDKN1B;PRDM16;REST;TGFB1;CNBP;KDM5C;LHX6;TRRAP;ARID3B;HDAC9;DDX17;ZNF431;NFYA;WWP2;TBX2;PPARGC1B;NR4A2;HSPA8;KCTD1;FOXD1;ZBTB16;PFDN5;CARF;ASCC2;RLIM;PPARGC1A;REL;BRWD3;SOX13;CTDSP1;TFCP2L1;SLC39A8;CD38;CTBP1;LIMS1;ING5;FOXK1;BRD9;CRK;PRDM2;LRRFIP1;DPF2;BHLHE40;SMAD6;HEYL;ACTA2;DPF3;VEGFA;PHC2;CNOT7;PPP2R1A;MPHOSPH8;USF2;AEBP2;NOTCH4;IKBKB;RARA;GATA2;SHC1;ATF4;KLF8;RBFOX2;KDM3A;FOXN3;ZNF326;BRD4;NR3C1;TOX3;GATA6;MXD4;HCFC1;TGFB3;CBFB;SAFB;ZNF276;FOXQ1;ANXA4;CBX5;HDGF;IRF2BP2;PPM1F;TRIM16;CIC;MED24;HDAC4;UIMC1;INSR;ATXN1L;PLAGL1;MKX;NDUFA13;CC2D1B;ZMYND11;SPIN1;TAL1;ENY2;SOX7;FZD7;DHX9;NR2C2;YY1;AKT1;NFATC1;NOP2;RB1;FUS;TRIM28;TWIST1;HHEX;MED27;SOX18;MAP3K2;FOXF2;ARID1A;SPP1;PRDM15;FOXP2;ESRRA;ZC3H8;JMJD6;ZFP14;MXD1;RELB;CEP290;BCL6;ZIC3;MED6;WNT11;SFPQ;JUNB;HSPD1;TCIM;SP110;MYBL1;BAZ1A;FOXC2;EBF2;CD74;CRLF3;ZBTB18;CCDC85B;GABPA;SOX12;TEAD2;WTIP;INHBA;ILF2;LIMD1;PHC1;PRRX2;SP3;TADA2B;ZNF83;OLIG1;PSMC5;KMT2D;WBP2;E2F3;HTATIP2;TOX2;MED29;ZFHX2;PPP3CB;IFRD1;CIPC;HIVEP1;TSFM;SOX4;PLAGL2;ZMIZ2;ZNF423;ZNF471;EPC1;HES1;GRHL1;TRIM56;ENG;E2F1;ACVR1;HINT1;COMMD7;TOX4;ABCA2;SATB2;ZNF569;FGF2;MLX;RFX2;PHB2;CIART;APOE;MTERF3;ZNF367;RNF20;LCOR;FOXD2;POU2F1;PHF12;BCL6B;RNF111;LDB1;NR5A2;MRGBP;HEY1;PURG;EID2;HCFC2;SMARCA4;SRF;ERBB2;ETV4;STAT5A;SMAD4;IRF9;SOX6;HNRNPK;SNF8;SMARCA2;ETV5;POU2F2;NR1H2;RFX5;EGFR;CCNK;GMEB2;CDKN1A;CELSR2;ZNF76;ZFHX3;ETS2;ZBTB2;ZNF319;DRAP1;RAI1;BRCA2;HOXB4;YWHAH;SAP30L;ZNF22;LIN54;SP1;KLF6;TCF3;ZNF32;FOXL2;RELA;RET;SCML2;MED8;NR6A1;CRYAB;MED20;DRGX;KDM1A;E2F4;RAD21;CHD4;CHUK;CCAR2;STAT1;IRF8;USP22;GLI1;ZNF568;ZFPM2;ZFP1;ZBTB48;L3MBTL1;MED14;ARID4B;ZBTB40;PHF5A
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.2459826351779605,-1.0455272143280947,0.36983471074380164,0.6859273162114293,1.0,51/163,25.13%,MEF2C;PTPRJ;PLCG2;WNK1;PDE4D;BMX;INPP5D;CD38;IKBKB;DENND1B;PSMA6;RC3H1;NFKBIZ;TNFRSF21;PSMB5;PSMC4;PSMC5;SYK;PSMD14;BTN3A3;PSMD8;PIK3CA;LCP2;PSMC1;PIK3R2;EIF2B3;PSMB4;SPG21;TAB2;PSMD11;PSMD12;RELA;CHUK;TXK;PRAM1;CUL1;FYB2;PSMA1;PSMC3;BTK;NCK1;PSMB1;PTPN22;CSK;PSMA2;LAT2;PSMA4;PRKD2;BCL10;TRAF6;NFAM1
prerank,catecholamine biosynthetic process (GO:0042423),-0.43613442062619945,-1.045129806486253,0.40540540540540543,0.6863961396889492,1.0,3/11,11.94%,GCH1;TGFB2;DDC
prerank,regulation of interleukin-1 production (GO:0032652),-0.4025346452149183,-1.0449667162273508,0.4177215189873418,0.6862821512986002,1.0,2/15,3.66%,FOXP1;ANXA1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.4424309402119545,-1.044726541804562,0.4089285714285714,0.6863695416956384,1.0,2/11,1.96%,MLLT3;RSPO3
prerank,cellular glucan metabolic process (GO:0006073),0.441421878559481,1.0443906203838287,0.41304347826086957,0.7391817785834979,1.0,2/11,2.58%,PRKAG2;PHKA1
prerank,negative regulation of response to wounding (GO:1903035),-0.37236289483521817,-1.0443733578497072,0.3985239852398524,0.686692088256441,1.0,10/19,36.89%,CD109;CRK;FGF2;RTN4RL1;RTN4R;CERS2;ALOX5;PTPRS;INPP5F;KLK8
prerank,endoderm development (GO:0007492),-0.4169557856865906,-1.0441777794118785,0.40950639853747717,0.6866500717064828,1.0,6/13,29.78%,SOX17;SOX7;KIF16B;DUSP4;DUSP1;TBX20
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.33323038488469237,-1.0440530225334288,0.38791423001949316,0.6864582198945491,1.0,14/32,23.97%,ITGA1;PPP1R16B;HSP90AB1;CALM1;TGFB1;PPIA;PPP2R5A;CALM3;CDCA2;PIN1;CDH5;CNEP1R1;PRKCD;NSMF
prerank,secretion (GO:0046903),0.41094578616008787,1.0436067961996813,0.41163793103448276,0.7401933796789383,1.0,5/14,13.69%,SLC22A4;RIMS1;PRKCI;FBLN5;GUCA1B
prerank,protein K63-linked deubiquitination (GO:0070536),-0.3370276823310496,-1.0432771746516512,0.3961904761904762,0.6878398416036345,1.0,9/31,18.78%,BRCC3;USP7;USP8;OTUD5;UIMC1;BABAM1;PSMD14;TNFAIP3;BABAM2
prerank,neuron projection development (GO:0031175),0.2550991577428814,1.0430459336657096,0.338,0.7406676867772211,1.0,33/168,13.77%,ADGRV1;NRK;EPB41L3;GDNF;CNTN4;CNTNAP2;GPM6A;DOCK10;GPRIN2;LYN;GPRIN1;MYO16;SRGAP2;CTNND2;GAS7;TBC1D24;EPHB1;DOCK7;TNIK;NLGN1;PPP1R9A;RYK;EPHA8;CAMSAP1;CDK5R1;PTEN;LRP12;ATXN10;DLG4;RASGRF1;CDK16;SNAPIN;MAPT
prerank,response to glucocorticoid (GO:0051384),-0.34043737518806316,-1.0429221283797818,0.40117416829745595,0.6881786615296406,1.0,5/26,9.37%,SLIT2;ANXA1;REST;NR3C1;FAM107A
prerank,cardiac muscle cell differentiation (GO:0055007),0.37037294513160135,1.0428262472239398,0.4053452115812918,0.7402859075270277,1.0,3/21,1.45%,BMP2;SLC8A1;NRG1
prerank,protein autophosphorylation (GO:0046777),0.25311239183297446,1.042824605506735,0.361376673040153,0.7393461971028688,1.0,34/157,12.66%,DDR2;FGFR2;DAPK2;STK17B;PDGFRA;KIT;PDPK1;PIM2;DDR1;LYN;AAK1;MAPKAPK5;MAP3K12;CAMK4;DAPK1;PDGFRB;CAMK2B;EPHB1;TNIK;MAK;STK33;FGFR4;EPHA8;ERBB4;MAP3K10;TEC;MEX3B;ALK;MUSK;EEF2K;FGFR1;EPHA1;ATM;ITK
prerank,regulation of protein secretion (GO:0050708),-0.25516855401467375,-1.0428172640548452,0.3683206106870229,0.6879029958276902,1.0,17/119,7.08%,ITPR2;SLC2A1;SLC12A2;RAP1A;DPP4;UNC13B;KCNB1;CD2AP;ITPR3;TGFB1;TGFB2;PPIA;MYOM1;EZR;STX1A;UQCC2;TGFB3
prerank,cell projection assembly (GO:0030031),-0.36224934600768954,-1.0425260755222918,0.4013961605584642,0.6881031697527796,1.0,4/22,8.84%,PARVB;RHOJ;RAC1;PDGFA
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.2990488417341537,1.04220245582455,0.3783783783783784,0.7400377335028427,1.0,8/59,6.31%,ROBO1;ROBO2;SDK2;TENM3;CNTN4;PTPRT;NPTN;KIRREL3
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.3535568810812193,-1.0421276942041238,0.3996282527881041,0.6885798644472098,1.0,3/24,3.49%,ANO6;CCN3;SLIT2
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.2795945025631167,-1.04196812395241,0.3821138211382114,0.6884493748116564,1.0,29/82,26.31%,DCTN2;TUBA1A;CEP164;PPP2R1A;PRKAR2B;CEP57;CEP192;CEP70;DCTN3;CEP290;DCTN1;CNTRL;TUBB4B;PCM1;HAUS1;NDE1;CETN2;CEP72;YWHAG;HSP90AA1;CEP41;TPX2;TUBA4A;CENPF;CEP63;HAUS4;NEDD1;NEK10;YWHAE
prerank,oligosaccharide metabolic process (GO:0009311),0.31242077587341877,1.0419314008478617,0.3927855711422846,0.7397803227221452,1.0,9/46,5.76%,B3GALT1;ST6GALNAC5;GAL3ST3;AMY1C;AMY1B;AMY1A;ST8SIA1;FUT4;ST6GALNAC6
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.33376548129823486,1.0418089168363764,0.3910386965376782,0.7391269267421404,1.0,3/33,2.75%,IL34;OCSTAMP;PRKCA
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.27894027245897596,-1.0417922362823644,0.38323353293413176,0.6883940703905698,1.0,25/75,27.69%,HEG1;PTPRJ;RASIP1;LRP5;DAB2IP;CDKN1B;PRKAR2B;AKT1;RB1;HHEX;UCHL1;STK38;NF1;APOE;PRKAR2A;SPRY1;CDK5RAP3;GADD45A;PRKCD;CDKN1C;PTPN1;PKIG;SMPD1;DUSP1;SPRY4
prerank,neutral amino acid transport (GO:0015804),0.3488380119401245,1.0416059593301625,0.4384133611691023,0.738710324257431,1.0,9/28,13.10%,SLC6A9;SLC43A1;SLC36A2;SLC38A1;SLC7A9;SLC1A5;SLC38A3;CTNS;SLC38A6
prerank,error-free translesion synthesis (GO:0070987),-0.35342197867253766,-1.0413367610326867,0.42134831460674155,0.6889844658305407,1.0,9/22,23.62%,UBB;UBC;RPS27A;VCP;SPRTN;RPA3;POLDIP2;RFC3;RFC2
prerank,regulation of organelle assembly (GO:1902115),-0.27923854389345915,-1.0410112574615664,0.37214137214137216,0.6892535784340033,1.0,29/72,28.65%,TBC1D8;IFT20;MSN;ATXN2L;TBC1D1;EZR;TBC1D12;TBC1D22A;PLK2;KIF9;ATG3;TBC1D9B;VPS11;TSG101;HCK;TBC1D2;RABEP2;ADPRH;DCDC2;TBC1D15;SPICE1;RDX;ODAD3;TBC1D17;TBC1D5;CDKL5;NPM1;UBQLN2;STAM
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.3583353258877355,-1.0406608228944014,0.4018867924528302,0.6896057982832615,1.0,8/20,22.25%,TGM2;CAMK2D;BAX;BAK1;BCAP31;RAP1GDS1;SELENOK;FIS1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.4154651940262899,-1.0396138295633026,0.40118577075098816,0.6917065050467079,1.0,7/13,35.11%,CD81;GCC2;TMEM30A;BRSK2;TMEM30B;INSIG1;SEC16B
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.26861168635132854,-1.0395432626440095,0.37575757575757573,0.6913701103793412,1.0,40/84,35.85%,UBB;UBC;RPS27A;ANAPC15;PSMA6;PSMB5;ANAPC11;RB1;PSMC4;PSMC5;PSMD14;PSMD8;PSMC1;ANAPC7;PSMB4;PSMD11;PSMD12;CDC27;FZR1;PSMA1;PSMC3;ANAPC2;PSMB1;PSMA2;PSMA4;PSMB8;BUB3;AURKA;CDK1;PSMC6;PSMD6;PLK1;ANAPC10;PSMA8;CDC20;PSMB2;CUL3;UBE2C;PSMD2;UBA52
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.37587261135123196,-1.039021982902193,0.39571150097465885,0.6921200662537699,1.0,8/20,22.86%,FKBP5;FKBP1A;PPIA;PPIC;PPIG;PIN1;FKBP4;PPIB
prerank,cellular response to peptide (GO:1901653),0.30212390922896887,1.0390172413191687,0.38306451612903225,0.7444927013838207,1.0,5/56,3.78%,IGF1;LRP1;GJA1;CACNA2D1;MDM2
prerank,lymphocyte mediated immunity (GO:0002449),-0.42463645268521616,-1.038913369649058,0.4393939393939394,0.6918784057769707,1.0,2/12,13.74%,CD55;BTN3A3
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.38485998866964055,-1.0388834817250792,0.42034548944337813,0.6914334440014157,1.0,5/17,11.37%,NOTCH3;NOTCH1;HEYL;NOTCH4;PLXND1
prerank,alanine transport (GO:0032328),-0.4474913125524589,-1.0388438962728677,0.4221824686940966,0.691022062825348,1.0,1/10,0.37%,SLC6A6
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.22439531332646895,-1.0386904196395053,0.3297644539614561,0.6908951401228659,1.0,102/336,26.23%,FOXP1;ACER2;FOXO1;MAPK3;PAXX;RPS3;DCUN1D5;FNIP2;TRRAP;CRIP1;RBBP5;MTREX;TAOK3;CBX1;SUSD6;PRKDC;TNFRSF1B;CBX5;ERCC1;RAD1;CUL4A;DYRK2;YY1;GTF2H3;BAX;USP3;CHD1L;TRIM28;OTUB1;FAM111A;HERC2;BCL6;TAOK2;VCP;CIB1;BCL2L1;HPF1;SPRTN;BAK1;PNKP;E2F1;SLX4;SAMHD1;SLF1;FMR1;RAD9B;RAD18;HUS1;TOP2A;CDKN2AIP;NSMCE4A;PARP2;EPHA2;RPAIN;UFL1;CCNK;CDKN1A;RAD9A;WDR48;RAD17;GTF2H4;MAPK12;POLQ;POLK;CHEK1;PWWP3A;TRAIP;ZBTB40;BABAM2;CGAS;CCND1;ERCC4;MCL1;GADD45A;UBE2B;BRAT1;SFN;TAF9;UBA1;CHCHD6;PLK3;CCDC13;RFC3;DTL;NIPBL;NUPR2;EID3;RFC2;FAN1;ASH2L;CEP63;EXO1;FBXO6;MRNIP;DTX3L;ALKBH7;SPDYA;POLE3;XIAP;XPC;PLK5;RAD51AP1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.4645302753178816,1.0385287718331067,0.40582959641255606,0.7447560518891669,1.0,5/10,22.93%,HENMT1;DROSHA;AGO2;DICER1;MRPL44
prerank,RNA splicing (GO:0008380),-0.26153241911779745,-1.0383876895099655,0.3784860557768924,0.6911116970151836,1.0,26/95,19.35%,MBNL1;IVNS1ABP;PPARGC1A;PRPF8;PPP2R1A;SRSF2;SNRNP48;SRPK1;DHX15;FUS;SNRPD3;U2AF1;SFPQ;RNPS1;ZRSR2;SRSF4;MAGOH;DDX23;SF3A3;DDX39B;PPIG;SNRPG;CCAR2;SCAF11;PDCD7;LSM1
prerank,positive regulation of lipid metabolic process (GO:0045834),0.36345240906005216,1.0381416414726652,0.38125,0.7447982057634458,1.0,2/22,2.11%,ZBTB20;PPARA
prerank,regulation of signal transduction (GO:0009966),0.24399227395287545,1.0380287413005156,0.3761996161228407,0.7441299584132022,1.0,21/190,7.80%,RORA;IGFBP2;GRK3;FGFR2;SULF1;SEMA5A;GPHB5;IFT81;GDNF;ZIC1;DHRS3;RGS20;KCTD8;TSPAN15;SENP2;NLRP12;DTX1;YJEFN3;TULP3;FRMPD1;MAPK8IP2
prerank,protein modification by small protein removal (GO:0070646),-0.23091596285315139,-1.0378486029378438,0.3333333333333333,0.69198979293392,1.0,106/252,33.37%,ACTB;ESR1;IFIH1;NFKBIA;SMAD7;TRRAP;UBB;EIF3F;USP1;USP46;UBC;RPS27A;FOXK1;BRCC3;IL33;USP7;HCFC1;USP8;PSMA6;RIPK1;OTUD5;UIMC1;PSMB5;BABAM1;YY1;USP3;RHOT1;OTUB1;COPS6;PSMC4;UCHL1;USP5;VCP;USP9X;TADA2B;PSMC5;COPS5;PSMD14;USP15;PSMD8;SMAD4;PSMC1;UCHL3;WDR48;PSMB4;PSMD11;PSMD12;MCRS1;RCE1;TNFAIP3;USP22;USP49;BABAM2;USP4;SNX3;PSMA1;PSMC3;SMAD2;KEAP1;USPL1;JOSD1;TADA3;USP38;PSMB1;PSMA2;COPS7A;COPS4;PSMA4;INO80D;COPS7B;TRAF6;TFPT;SMAD1;RAD23A;SENP5;GPS1;PSMB8;TAF10;BARD1;RUVBL1;FOXO4;RAD23B;STAM2;STAM;POLB;JOSD2;USP14;USP35;MYC;CDK1;PSMC6;KAT2A;PSMD6;STAMBP;NLRP3;MYSM1;ADRB2;RHOA;IKBKG;PSMA8;FOXK2;USP18;CDC20;PSMB2;TNIP2;USP12
prerank,phosphate ion transport (GO:0006817),0.3891731016842957,1.0375795620404316,0.4051172707889126,0.744411716866595,1.0,3/16,7.18%,SLC17A1;SLC20A2;SLC25A10
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.28096691091631676,-1.037310500554952,0.4015444015444015,0.6928311668788378,1.0,31/72,32.12%,UBB;UBC;RPS27A;USP7;ISY1;ERCC1;CUL4A;GTF2H3;COPS6;XAB2;HMGN1;COPS5;RBX1;XRCC1;RPA3;GTF2H4;POLK;TCEA1;ERCC4;RFC3;COPS7A;COPS4;RFC2;COPS7B;GPS1;AQR;POLR2F;PRPF19;POLR2C;POLR2L;POLR2I
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.44547608656776516,1.0371387519460933,0.4175365344467641,0.7445876471493732,1.0,2/10,6.37%,BMP6;PLG
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.3890823591337082,1.0369242829252165,0.4127659574468085,0.7441972487988148,1.0,5/18,8.00%,NRXN1;NLGN2;NLGN3;CACNG4;NLGN1
prerank,cognition (GO:0050890),-0.3075657987667992,-1.0363331009151429,0.3965183752417795,0.6947039908933244,1.0,11/42,16.11%,ST3GAL4;SHROOM4;APP;DGCR2;STRA6;CHMP2B;MFSD2A;FAM107A;NF1;DOP1B;GPR155
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.38328204366573093,-1.0362691068429524,0.4099264705882353,0.6943264907171186,1.0,7/17,19.53%,SEL1L;RHBDD1;VCP;FAF2;SEC61B;DERL2;TMEM129
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.35003404470723753,-1.035985916909918,0.4226086956521739,0.694528457127323,1.0,8/24,23.95%,ITPR2;PLCG2;ITPR3;FGF2;HTR2A;CHERP;ERO1A;PKD2
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.3498556153510309,1.0353702786913626,0.3951965065502183,0.7472093826896274,1.0,7/29,14.95%,TENT5A;GDNF;AXIN2;DHX34;TENT5B;NBAS;RBM24
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.22517886897526626,-1.0353583482475441,0.34120171673819744,0.6955530552341268,1.0,95/314,25.38%,WWP1;NEDD4L;SEL1L;TRIM25;UBB;WWP2;ZNRF1;UBC;RPS27A;FBXO17;ANAPC15;PSMA6;CUL4A;DNAJB12;NHLRC3;FBXO4;PSMB5;ANAPC11;MAN1B1;PLAA;KCTD5;RB1;RNF185;ERLIN2;UBE2G2;PSMC4;UCHL1;VCP;MTA1;TNFAIP1;HSPA5;MAEA;UBXN1;FBXL14;PSMC5;UBXN8;RNF5;FAF2;PSMD14;FBXW5;FBXL2;ITCH;RBX1;FEM1A;SEC61B;SGTA;SMURF1;PSMD8;UBE2G1;FBXL7;CCNF;PSMC1;ANAPC7;FBXL3;RNF121;PSMB4;PSMD11;TMEM67;KCTD10;FBXL16;PSMD12;CDC27;DMAC2;PELI1;FZR1;DERL2;AMFR;CUL1;TMEM129;UBE2B;TBL1X;ZSWIM8;KCTD2;PSMA1;PSMC3;ZFAND2B;ANAPC2;TMUB2;BFAR;SGTB;PSMB1;LTN1;PSMA2;CLOCK;TMUB1;FBXL19;PSMA4;RNF187;PCNP;FBXO6;FBXL18;UBE4A;UBE2J2;COP1;RAD23A
prerank,regulation of telomerase activity (GO:0051972),-0.3015996650218302,-1.0350152079258712,0.3984375,0.6958793825332237,1.0,24/45,37.49%,HMBOX1;KLF4;MAPK3;NEK7;HSP90AB1;DKC1;PNKP;CCT2;HSP90AA1;GREM1;ERCC4;CTNNB1;MYC;SRC;PIF1;SMG6;CCT4;PKIB;WRAP53;NVL;MAP2K7;CERS1;MAPK15;GRHL2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.3163434227062401,-1.0346464810738087,0.42401500938086306,0.6962499156283849,1.0,14/34,28.42%,PTPRB;PTPRJ;DUSP3;PTPN12;PTPN6;UBASH3B;PTPRO;PTPRQ;PTPN22;DUSP4;PTPN1;DUSP1;DUSP6;PTPN2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3553780796627109,-1.0345208988569068,0.40555555555555556,0.6960478820614474,1.0,10/24,19.60%,RACK1;LPCAT3;AQP11;BCL2L1;UBXN1;NR1H2;OPA1;HSPA1A;XBP1;TMBIM6
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.4277205606572436,1.03451772415055,0.43506493506493504,0.7484168865451131,1.0,5/12,16.60%,PPARA;FUT4;FUT9;ASS1;MIA3
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.3022503304289367,-1.0343302053583494,0.404296875,0.6960298128745801,1.0,18/45,31.73%,GBP5;APP;HSPB1;CASP8;TRIM16;TLR4;AIM2;NOD2;JAK2;FZD5;LGALS9;CASP1;TMEM106A;TLR6;EGR1;CD36;TYROBP;NLRP3
prerank,protein localization to kinetochore (GO:0034501),-0.40149374242048447,-1.034154808403194,0.42015209125475284,0.6959517393170938,1.0,7/14,31.05%,ZW10;RCC2;KNL1;MTBP;SPDL1;BUB3;CDK1
prerank,zinc ion transmembrane transport (GO:0071577),-0.3600926982826109,-1.033955611172876,0.4080145719489982,0.6959174869359314,1.0,6/22,14.05%,SLC39A10;SLC39A8;SLC30A6;SLC39A1;SLC39A11;SLC39A7
prerank,epithelial cell-cell adhesion (GO:0090136),-0.4336405694357407,-1.0336742555011738,0.42134831460674155,0.6960759555753492,1.0,6/11,21.89%,CCN3;JUP;VCL;DSP;THBS4;CAMSAP3
prerank,cellular response to UV (GO:0034644),-0.27199249905132056,-1.0336361041745075,0.38653846153846155,0.6956625991666529,1.0,30/76,30.64%,RPL26;CRIP1;RHBDD1;N4BP1;ATF4;ERCC1;YY1;IMPACT;BAK1;FMR1;OPN3;CDKN1A;POLK;KDM1A;CHEK1;PTPRK;ERCC4;COPS9;RHNO1;TRIAP1;HYAL1;PRKCD;CARD16;XPC;SMPD1;NPM1;PPID;MYC;HYAL2;AQP1
prerank,regulation of cell cycle process (GO:0010564),-0.2617939724379339,-1.0334500803709934,0.37448559670781895,0.6955875974265876,1.0,45/104,34.39%,RAB11A;CAV2;CALM1;RPRD1B;ZFYVE26;PLK2;BCL2L1;YTHDF2;CALM3;RAB11FIP3;CETN2;CSNK2A1;CSNK2A2;CDK13;MAD1L1;KLHL9;ECT2;CHEK1;L3MBTL1;KLHL21;PIN1;SOX9;KNSTRN;KIF13A;PRPF40A;MKI67;RCC1;PLK3;DCUN1D3;PLK5;TTL;CDKN2B;RACGAP1;CDC42;SETD2;CTNNB1;MYO19;KIF11;AURKA;PLK1;ENTR1;PIK3R4;BUB1;PRC1;CCDC8
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.4000141560143821,-1.0332593327873836,0.41821561338289964,0.6955460289155768,1.0,7/15,28.09%,RAD9B;HUS1;EME2;RAD9A;RAD17;FANCD2;MRE11
prerank,cellular response to organic substance (GO:0071310),0.26389917127180174,1.033133239107609,0.3913857677902622,0.7509350802393272,1.0,20/116,10.18%,ROBO2;PID1;PTPN13;CLEC3B;NCOA2;NFAT5;SMAD3;STAT5B;SFRP1;GHR;IL1RL2;NLRP12;DPYSL3;IL1RAPL1;TGFBR1;NCOA1;IL18;BMPR1A;PTPN4;KHSRP
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.40025839260025553,-1.032586158163728,0.43933823529411764,0.6966451457295179,1.0,10/15,36.10%,SEL1L;VCP;FAF2;SEC61B;DERL2;TMEM129;DERL1;SYVN1;OS9;AUP1
prerank,action potential (GO:0001508),0.3172828380211529,1.0325505419883165,0.41855203619909503,0.7514559014479636,1.0,10/44,12.06%,SCN7A;SCN3B;CHRNA1;SCN3A;CACNA1I;KCND2;CACNA1G;SCN2A;CHRNA4;GNA15
prerank,apoptotic mitochondrial changes (GO:0008637),-0.32197762169372274,-1.0321716461393564,0.4291417165668663,0.6971454395876971,1.0,13/32,22.25%,BAX;ATG3;HSPD1;BCL2L1;BAK1;BBC3;BAD;CCAR2;BIK;SFN;TIMM50;GGCT;FIS1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.44517359233855724,-1.032052604292343,0.43423423423423424,0.6969135526534903,1.0,2/10,3.51%,SEMA6A;DAB2IP
prerank,negative regulation of neuron death (GO:1901215),-0.26577188621376807,-1.0320005414154527,0.37755102040816324,0.6965354908443678,1.0,13/93,8.61%,MEF2C;CD34;PTK2B;NGF;SIX1;REST;PPARGC1A;ATF4;TOX3;TGFB3;TNFRSF1B;FOXQ1;AKT1
prerank,glycine transport (GO:0015816),0.4355875773011978,1.0318288318689703,0.4142538975501114,0.7523468521754968,1.0,2/10,5.32%,SLC6A9;SLC36A2
prerank,regulation of phospholipase C activity (GO:1900274),0.4017647878490908,1.031558116955643,0.4224137931034483,0.7520799629391416,1.0,6/15,11.68%,NTRK3;PDGFRA;KIT;PDGFRB;BICD1;FGFR1
prerank,epithelium development (GO:0060429),0.2694198154045193,1.0315493720623967,0.39271255060728744,0.7511591104963893,1.0,7/107,2.46%,WNT4;ERRFI1;ALDH1A2;BMP2;SALL1;FGFR2;DLX3
prerank,telomere organization (GO:0032200),0.30998342569810095,1.031447372723512,0.4151696606786427,0.7504775404345351,1.0,21/43,25.44%,STN1;BLM;RPA2;ATM;NBN;PARP3;RIF1;RPA1;PARP1;SP100;POLD4;POLD1;RTEL1;PCNA;DOT1L;POLD3;POLD2;DCLRE1B;TINF2;ATR;XRCC6
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.24734301304111034,-1.0314326226578974,0.4094650205761317,0.6974407860759062,1.0,54/148,28.91%,PPP1R13B;HIPK1;RPS15;PHF20;RICTOR;RPL11;RPL23;ING5;USP7;RAD1;DYRK2;AKT1;NOP2;PIP4P1;CSNK2B;RPS20;MAPKAP1;MTA2;MBD3;RAD9B;SMYD2;HUS1;PRKAG1;RPA3;NUAK1;RAD9A;RAD17;CSNK2A1;CSNK2A2;RBBP4;CHD4;CHEK1;L3MBTL1;PIN1;CDK5RAP3;RPL5;TPX2;TAF9;RHNO1;MAPK11;PLK3;RFC3;BRPF1;RFC2;EXO1;RPF2;TAF10;KMT5A;DNA2;BARD1;MRE11;TAF5;ATRIP;RPL37
prerank,N-glycan processing (GO:0006491),-0.37587988501062614,-1.0311656059946375,0.4288389513108614,0.697596216053131,1.0,5/18,9.02%,ST8SIA4;GANC;ST8SIA6;MAN1B1;FUT8
prerank,regulation of steroid metabolic process (GO:0019218),0.36564587079964533,1.0307046671887774,0.42526315789473684,0.7513486728556154,1.0,1/23,0.18%,RORA
prerank,defense response to fungus (GO:0050832),-0.3854167391239148,-1.0306410250242812,0.4064748201438849,0.6984262860115602,1.0,5/17,24.33%,PLCG2;GAPDH;CX3CR1;FAM3A;BCL10
prerank,positive regulation of intracellular transport (GO:0032388),-0.3139503630107045,-1.030614023112435,0.4322820037105751,0.697962441195035,1.0,12/38,22.53%,PRR5L;BCAS3;EHD2;CEP290;OAZ2;PCM1;CAPN10;MLC1;EHD1;RIPOR1;PLK3;PDCD10
prerank,negative regulation of cation channel activity (GO:2001258),-0.3452009423023465,-1.0303771099859969,0.4209558823529412,0.698054335771884,1.0,7/26,14.26%,CALM1;FKBP1A;GSTM2;CALM3;FMR1;CASQ2;SRI
prerank,mammary gland epithelium development (GO:0061180),0.4062948080539811,1.030257649512507,0.41596638655462187,0.7515343465736861,1.0,1/14,0.33%,WNT4
prerank,cation transmembrane transport (GO:0098655),0.31239556917824807,1.030167868618515,0.40124740124740127,0.7508330952935878,1.0,8/44,7.31%,ATP1A2;SLC7A2;SLC6A9;TRPM1;TRPM3;MFSD12;TRPM5;ASIC2
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.43396553774350693,-1.0300816007300588,0.42777777777777776,0.6982325982366472,1.0,3/10,16.53%,HSP90AB1;RB1;HSP90AA1
prerank,regulation of B cell proliferation (GO:0030888),-0.2991330279706873,-1.0296659224760858,0.40441176470588236,0.6987055097664848,1.0,8/44,10.99%,MEF2C;TFRC;CD38;CD81;RC3H1;TNFRSF21;CD74;TIRAP
prerank,positive regulation of protein import (GO:1904591),0.33862477631096244,1.029501542035468,0.3974358974358974,0.7515298966040237,1.0,3/30,2.72%,PIK3R1;ZIC1;SMAD3
prerank,cellular response to hexose stimulus (GO:0071331),-0.3557538033694173,-1.0294769374265187,0.416015625,0.6986586196238841,1.0,4/23,3.37%,IGF1R;UNC13B;RACK1;KCNB1
prerank,cellular metal ion homeostasis (GO:0006875),-0.2577951027841899,-1.0291982745889185,0.3800813008130081,0.6988030396818892,1.0,17/102,10.26%,ATP13A5;CAV1;SLC12A2;TPT1;KCNJ2;NEDD4L;ATP1A1;TMEM165;ATP2C1;ATP2A3;ATP1B1;EDN1;LETM2;CCL15;STIM2;SLC10A7;TRPV4
prerank,cholesterol biosynthetic process (GO:0006695),-0.3288872017650636,-1.0291687712098578,0.39517625231910947,0.6983722557102438,1.0,15/31,33.58%,LBR;ACLY;ACAA2;DHCR24;TM7SF2;SC5D;FDPS;LSS;IDI1;PLPP6;ACAT2;EBP;INSIG1;HMGCR;ARV1
prerank,mesoderm formation (GO:0001707),-0.3809007212635828,-1.0290114577712866,0.41935483870967744,0.6982454443805093,1.0,2/17,3.61%,BMPR2;ITGB4
prerank,cellular sodium ion homeostasis (GO:0006883),0.39531301490801973,1.0287728808431917,0.3926940639269406,0.7524636081370815,1.0,2/15,1.19%,ATP1A2;SLC8A1
prerank,organelle disassembly (GO:1903008),-0.3181297918651608,-1.0286119777171732,0.42777777777777776,0.6987292701904109,1.0,19/33,37.05%,KLC1;UFM1;KIF9;DDRGK1;VCP;VRK1;UFL1;UFC1;UBA5;PLK3;STX5;PLK5;KIF5B;CDK1;MTIF2;MCTS1;DYRK3;PELO;ULK1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.40030080642064636,1.0283716175619342,0.43680709534368073,0.7525273071940417,1.0,4/15,8.60%,DAAM2;SFRP1;ZNRF3;NPHP3
prerank,spinal cord development (GO:0021510),-0.4153222270738359,-1.0281507689679237,0.43875685557586835,0.6994249984897823,1.0,5/12,12.37%,VIT;PKD1;SOX12;NF1;SOX4
prerank,endomembrane system organization (GO:0010256),-0.23757110214602759,-1.0276500532920492,0.38413361169102295,0.7001138020429865,1.0,37/178,15.40%,SYNE1;ATP8B1;SPTBN1;SRGN;CAV2;MYOF;PI4K2A;ZW10;BCAS3;HTT;DYSF;GORASP2;FAM174B;CHMP2B;USP8;NUP93;ATL3;PLEKHM2;A4GALT;SPTSSB;TRIP11;ATL2;TRAPPC11;BAG5;SURF4;ALS2CL;VPS11;DOP1B;LMAN2;VMP1;NUP155;RAB1A;COG3;WASHC5;GOLGA5;GOLGA8B;LAPTM4B
prerank,regulation of neuron migration (GO:2001222),-0.34473186939184497,-1.0275568285782477,0.41838649155722324,0.6998479189582274,1.0,12/26,23.97%,SEMA6A;DAB2IP;COL3A1;SHTN1;ADGRG1;PLAA;ULK4;NEXMIF;ARHGEF2;RAPGEF2;NIPBL;NSMF
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.3106930320729663,1.0268373568135474,0.3890020366598778,0.7554576697582803,1.0,17/44,20.57%,ROCK2;NANOS3;TNRC6A;FTO;POLR2G;CPEB3;KHSRP;RIDA;PNPT1;TNRC6B;METTL16;RBM24;METTL3;TOB1;ZFP36L2;CNOT8;AGO2
prerank,neural crest cell development (GO:0014032),0.31355808327774454,1.0268124820695619,0.3894736842105263,0.7545819670495854,1.0,6/44,5.02%,SEMA5A;NRG1;GDNF;SEMA3A;RADIL;SEMA3D
prerank,signal transduction in response to DNA damage (GO:0042770),-0.29565399159810224,-1.0259297141348247,0.3924843423799583,0.7033572818398393,1.0,22/49,34.27%,ACER2;MAP3K20;RAD1;E2F1;HUS1;RAD9A;RAD17;CHEK1;GADD45A;E2F7;RHNO1;SESN2;TRIAP1;CLOCK;CEP63;FBXO6;ATRIP;PRPF19;CDC5L;CLSPN;MAD2L2;ABL1
prerank,lysine metabolic process (GO:0006553),-0.4205958918060524,-1.0257885712938333,0.4404332129963899,0.702678184133042,1.0,5/12,19.66%,DLD;HYKK;OGDH;DLST;AASS
prerank,lysine catabolic process (GO:0006554),-0.4205958918060524,-1.0257885712938333,0.4404332129963899,0.702678184133042,1.0,5/12,19.66%,DLD;HYKK;OGDH;DLST;AASS
prerank,leukotriene biosynthetic process (GO:0019370),0.4020911352857779,1.0257796852653518,0.410958904109589,0.7562351344650645,1.0,3/14,5.95%,PLA2G5;PLA2G4A;GGT7
prerank,protein localization to Golgi apparatus (GO:0034067),-0.33563161606490144,-1.0255260419988683,0.4514285714285714,0.70278416144051,1.0,4/27,3.99%,VPS13D;VPS13A;GBP5;IFT20
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.37693166063476885,1.0255097277914094,0.39555555555555555,0.7560033383403197,1.0,5/20,10.34%,BCL2;IL4;CASP3;ERBB3;DCC
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.3819823452477715,-1.0249967878312811,0.4123134328358209,0.7035724034881458,1.0,13/16,48.22%,TRIB2;TNFRSF21;VSIR;JAK3;LILRB1;DLL1;TYROBP;FCGR2B;PDCD1LG2;IL23A;FOXP3;IL12B;IL23R
prerank,regulation of acrosome reaction (GO:0060046),-0.44359330494101085,-1.0247155779297576,0.43014705882352944,0.7037933219736171,1.0,7/10,54.11%,CACNA1H;PLCB1;GLRA1;SERPINA10;FAM170B;PRSS37;PLA2G10
prerank,steroid biosynthetic process (GO:0006694),0.29709555809192706,1.0240447386172726,0.39751552795031053,0.7588043292809582,1.0,10/56,13.12%,CYP7B1;PRKAG2;HSD11B2;CYP27A1;BAAT;MSMO1;INSIG2;CYP46A1;PRLR;OSBP
prerank,dopamine metabolic process (GO:0042417),-0.37204273414278655,-1.0239885726744715,0.426497277676951,0.7050909501305875,1.0,3/18,4.28%,MAOA;GCH1;TGFB2
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.3956655596198234,-1.0239447126935166,0.4431818181818182,0.7046806024443442,1.0,4/14,13.14%,NOS3;EDN1;ACE2;ACE
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.38599204698679723,-1.0239334047050412,0.4216417910447761,0.7041921819987502,1.0,3/17,3.75%,ITGA1;HSP90AB1;CALM1
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.3506042073579728,-1.0236076527420563,0.4302788844621514,0.7044596743228811,1.0,6/23,13.81%,TGM2;MAPK3;KCNQ1;ATF4;GABPA;GNB1
prerank,endosome organization (GO:0007032),-0.30018716266508166,-1.0232385191099054,0.45571955719557194,0.7048588195438621,1.0,16/41,24.80%,RAB27A;PI4K2A;EEA1;CHMP2B;USP8;CLCN3;ALS2CL;VPS11;WASHC5;LAPTM4B;DNM1;PLEKHF1;SNX3;ANXA8L1;ANXA8;PHETA2
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.38540243492685783,1.0231961528417122,0.41983122362869196,0.7600642381270081,1.0,3/15,5.58%,PPARA;ADM;IRS2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.25081599058367415,1.0227706282471076,0.40313111545988256,0.7602357373545663,1.0,30/142,16.28%,ATP1A2;LPAR1;PTGFR;SLC8A1;ADCY5;PDGFRA;SMAD3;PRKACA;CCR6;ACKR2;ACKR4;CCR10;PTGDR;IAPP;NPTN;CALCR;CCR9;ADRA1D;C3AR1;ADCY8;ADRA1B;PTGIR;DLG4;CXCR4;P2RY1;DRD2;HCRTR1;CLN3;TRPC1;ADRA1A
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.31718946580995866,1.0226637708508761,0.4106382978723404,0.7595915160210304,1.0,4/41,7.75%,IGF1;IL4;GSTP1;TRIM27
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.35911040086173857,1.0226315755880289,0.42217484008528783,0.758754983223534,1.0,2/23,2.52%,PLA2G5;PLA2G4A
prerank,nucleoside phosphate catabolic process (GO:1901292),0.41302516509615916,1.0225740458888617,0.4312896405919662,0.7579765438540419,1.0,1/13,0.19%,ENPP1
prerank,nuclear transport (GO:0051169),-0.377678918114704,-1.0225476078978226,0.42911877394636017,0.7060707760231043,1.0,12/16,43.21%,ANP32A;NXT2;PSIP1;NUP98;NPM1;XPO1;BANF1;RBM15B;RSRC1;HMGA1;NXT1;NUTF2
prerank,glutathione derivative metabolic process (GO:1901685),-0.3692753777830185,-1.0224241347868284,0.44919786096256686,0.7053523035520046,1.0,11/20,30.03%,GSTA4;GSTM2;GSTA3;GSTM1;GSTO2;MGST3;GSTK1;GSTM5;GSTO1;MGST2;ESD
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.3692753777830185,-1.0224241347868284,0.44919786096256686,0.7053523035520046,1.0,11/20,30.03%,GSTA4;GSTM2;GSTA3;GSTM1;GSTO2;MGST3;GSTK1;GSTM5;GSTO1;MGST2;ESD
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.38897430168057384,-1.0222878358127117,0.4314079422382672,0.7051680070363968,1.0,6/15,27.52%,VCP;HNRNPA1;GSTO2;ATF3;MKNK2;GSTO1
prerank,cytoskeleton organization (GO:0007010),0.25886548099826856,1.0222811573221706,0.4085603112840467,0.7577771776437655,1.0,21/114,12.14%,MICAL3;SH3D19;EPB41L3;FGD4;RHOH;PHIP;RHOBTB1;ZMYM6;FMNL3;ANK1;TNIK;FGD1;AJUBA;RHOBTB3;BRWD1;CAMSAP1;PRKCI;CECR2;MICAL1;OBSL1;RHOF
prerank,regulation of cholesterol esterification (GO:0010872),-0.4428553093558002,-1.0221752419079948,0.4314079422382672,0.7049523363761713,1.0,6/10,33.75%,ABCG1;ABCA2;APOE;APOC1;LAMTOR1;STARD4
prerank,protein localization to centrosome (GO:0071539),-0.3798001527249486,-1.0219830282486593,0.43795620437956206,0.7048800956846144,1.0,7/17,27.49%,DCTN2;CEP192;NUDCD3;PCM1;NEDD1;GOLGB1;CEP83
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.37965566670241424,-1.0215464207441312,0.4532803180914513,0.7054540134269808,1.0,7/16,28.05%,GPR137B;PIP4P1;RRAGD;RRAGA;SEH1L;SIK3;LAMTOR5
prerank,lipoprotein catabolic process (GO:0042159),0.4245637392347378,1.021543152361412,0.4345991561181435,0.7587200677165198,1.0,2/11,9.82%,NOTUM;ABHD10
prerank,positive regulation of phagocytosis (GO:0050766),0.3041919636861639,1.021482379954591,0.4091858037578288,0.7579445048441337,1.0,5/47,4.15%,CAMK1D;PLA2G5;AHSG;C4B;STAP1
prerank,response to peptide hormone (GO:0043434),0.3068087679266221,1.0212878633299223,0.39870689655172414,0.7574953824418474,1.0,4/43,3.05%,TGFBR3;ROCK2;GNAI1;STAT5B
prerank,protein polymerization (GO:0051258),-0.283557070912374,-1.021204498735615,0.4007936507936508,0.7057828238074415,1.0,22/55,26.69%,COBL;RAC1;DIAPH1;TTC17;FAM107A;WASHC3;TRPV4;PREX1;ARL6;WASL;CASQ2;WASHC5;GPX4;JAK2;CHMP2A;PIN1;MSRB2;MICALL2;CORO7;CASQ1;AIF1;MAP7D3
prerank,cilium organization (GO:0044782),-0.23269727808194693,-1.021073009944517,0.41422594142259417,0.7056055249458909,1.0,41/209,15.41%,ABLIM1;ABCC4;EXOC4;EXOC6;NOTCH1;FNBP1L;RAB11A;CDC14A;EHD4;RAB8B;IFT20;CEP164;ABLIM3;PKD1;TTC17;EHD2;CEP162;IFT46;BBIP1;TMEM237;INPP5E;CPLANE2;NUDCD3;DISC1;CEP290;RAB8A;FHDC1;EXOC1;ACTR3;PCM1;STK36;CC2D2A;POC1B;ARL6;RFX2;RAB11FIP3;CDC14B;RAB1A;KIF24;CCDC28B;DNAH5
prerank,negative regulation of autophagosome assembly (GO:1902902),0.41302799711825156,1.0208803833608078,0.4375,0.7575741195077172,1.0,2/13,4.27%,PHF23;SCFD1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.397522689284474,-1.020853154487003,0.4413919413919414,0.7056790420898382,1.0,10/14,36.88%,RPS3;CD81;NECTIN2;RELA;PRKD2;BCL10;CARD11;IKBKG;CD226;TESPA1
prerank,negative regulation of cell activation (GO:0050866),-0.3929724248009804,-1.0206308221200884,0.4390681003584229,0.7057051960960109,1.0,5/14,18.12%,NOS3;THBD;PDGFA;APOE;CD200
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.4322401572861226,-1.0205811227597887,0.4426807760141093,0.7053270199130428,1.0,3/10,7.48%,SMAD7;RC3H1;NFKBIZ
prerank,regulation of mitotic cell cycle (GO:0007346),-0.2379946231831632,-1.0200210427675807,0.38537549407114624,0.7061787765591064,1.0,53/171,23.64%,AFAP1L2;TTC28;CAV2;IQGAP1;NEK7;CDKN1B;APP;TGFB1;ANAPC15;PSMA6;PSMB5;TAL1;ANAPC11;ASAH2;RB1;PIM3;PSMC4;MAEA;PSMC5;DUSP3;PSMD14;CDK10;RNF20;PSMD8;SDCBP;PSMC1;ANAPC7;PSMB4;PSMD11;CDK13;PSMD12;CDC27;FZR1;USP22;L3MBTL1;CUL1;TTLL12;PIN1;SRA1;CDK5RAP3;ASNS;PSMA1;PSMC3;ANAPC2;MKI67;RCC1;PSMB1;PSMA2;BTG3;EIF4EBP1;SIK1;PSMA4;CDKN1C
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.36719297344728613,-1.0199866407569864,0.45454545454545453,0.7057495134987513,1.0,4/18,9.37%,ANXA1;REST;NR3C1;FAM107A
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.28859238294547496,-1.0191110237075012,0.423828125,0.70743385351331,1.0,20/55,23.36%,FHL1;PSMA6;PSMB5;PSMC4;PSMC5;AVEN;PSMD14;RBX1;PSMD8;FBXL7;PSMC1;PSMB4;PSMD11;PSMD12;CUL1;PSMA1;PSMC3;PSMB1;PSMA2;PSMA4
prerank,sodium ion export across plasma membrane (GO:0036376),0.4024148165355808,1.0187797886722818,0.4266666666666667,0.7619689970600727,1.0,1/13,0.52%,ATP1A2
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.27315075945830947,1.0185289336440333,0.402,0.7616409422839711,1.0,6/80,4.06%,AUTS2;PIK3R1;NRP1;DOCK11;GPM6A;TENM2
prerank,regulation of peptide hormone secretion (GO:0090276),-0.27882595596415183,-1.0183787020998676,0.4294117647058823,0.7087209000434488,1.0,8/67,6.35%,ITPR2;SLC2A1;RAP1A;DPP4;KCNB1;ITPR3;STX1A;UQCC2
prerank,myoblast fusion (GO:0007520),0.42564133428243267,1.0182215791881166,0.43870967741935485,0.7614872883829289,1.0,3/12,5.56%,ADGRB3;ADAMTS5;ADAM12
prerank,regulation of anoikis (GO:2000209),-0.36468202129847926,-1.017962244249799,0.4336917562724014,0.7092268348033534,1.0,3/19,3.05%,CAV1;NOTCH1;PTK2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.3310924158372951,1.017589060958668,0.41964285714285715,0.7620981756458891,1.0,2/32,2.31%,CEMIP;PDPK1
prerank,negative regulation of chemokine production (GO:0032682),-0.40328330127318474,-1.0175619816013632,0.4448742746615087,0.7097592630322818,1.0,2/14,2.56%,MAP2K5;KLF4
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.4046794547191256,-1.0175561667074817,0.45373665480427045,0.7092597278299847,1.0,5/13,6.40%,TGFBR2;KDR;VEGFA;NOTCH4;COL4A1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.32119162227979203,-1.0172772495622564,0.4397031539888683,0.7094174045991154,1.0,11/32,24.78%,STMN2;SPEF1;CIB1;KATNB1;ARHGEF2;CDH5;TPX2;FKBP4;APC2;CAMSAP3;STMN1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.26451104054602576,-1.0168388969352748,0.4179389312977099,0.7099650116796904,1.0,31/79,30.21%,KLC1;DCTN2;DYNC1LI2;OSBPL1A;AP2M1;KIF23;CTSD;CTSF;FCER1G;DCTN3;DCTN1;CD74;KIF26A;RAB7A;DYNC1LI1;AP2A1;KIF18A;DYNLL2;SEC24B;DNM2;CLTA;KIF22;AP1S2;ACTR1B;CTSS;SEC13;RACGAP1;AP2A2;AP1G1;DCTN4;KIF11
prerank,macromolecule catabolic process (GO:0009057),-0.3361784010905669,-1.0163132060004263,0.4185185185185185,0.7108120546938498,1.0,6/26,16.01%,TPP1;TGFB1;IDE;KIF16B;SMURF1;UCHL3
prerank,positive regulation by host of viral transcription (GO:0043923),-0.3862519184036374,-1.0157167375335323,0.4335154826958106,0.711733501356878,1.0,1/15,0.13%,LEF1
prerank,regulation of protein sumoylation (GO:0033233),-0.37731797562188085,-1.0153810433356185,0.4423791821561338,0.712072114559897,1.0,9/17,33.82%,HDAC4;SAE1;UBA2;PARK7;MUL1;CTNNB1;CAPN3;EGR1;RASD2
prerank,Rho protein signal transduction (GO:0007266),-0.2941893721112555,-1.015144009271232,0.40636704119850187,0.7121303643139598,1.0,16/53,14.84%,ARHGEF3;EPS8;RHOJ;EPS8L2;ARHGDIA;ARHGAP1;SHTN1;ARHGDIB;ADGRG1;RHOB;PHACTR4;CFL1;RTKN;NTN1;CELSR1;LIMK1
prerank,regulation of protein polymerization (GO:0032271),-0.3130716927408092,-1.0146651707997432,0.431640625,0.7128077602090667,1.0,13/35,22.16%,ESAM;PFN1;PRUNE1;DBNL;DBN1;HSP90AA1;ARL2;RASA1;CTTN;HCLS1;ARHGAP18;CAMSAP3;PLEKHG2
prerank,regulation of execution phase of apoptosis (GO:1900117),0.4206517491672632,1.0145852840595588,0.4399092970521542,0.768799506342144,1.0,3/11,6.88%,PTGIS;DLC1;SIRT2
prerank,myofibril assembly (GO:0030239),0.3093138060961289,1.0144824692948582,0.4166666666666667,0.7681651151516833,1.0,14/42,15.61%,PDGFRA;CSRP3;CFLAR;KLHL41;FHOD3;PDGFRB;SIX4;CSRP2;OBSL1;ACTN2;SYNPO2L;TNNT3;MYLK3;CSRP1
prerank,regulation of T cell differentiation (GO:0045580),0.32968789257665776,1.0144022840611155,0.4264069264069264,0.7674368186320794,1.0,7/33,16.09%,TBX21;RHOH;IL4;CAMK4;GATA3;CLPTM1;METTL3
prerank,cellular response to gamma radiation (GO:0071480),-0.36872562620085364,-1.0142896902646004,0.44155844155844154,0.7132112658213674,1.0,6/17,17.76%,RPL26;MAP3K20;TMEM109;HRAS;CRYAB;KDM1A
prerank,snRNA metabolic process (GO:0016073),-0.3782679132818639,-1.0141297778080938,0.42095914742451157,0.7130990441133055,1.0,10/17,36.58%,MTREX;INTS8;INTS1;RBM7;MEPCE;INTS12;INTS2;INTS3;ZCCHC8;INTS4
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.25628709498560037,-1.0138612589262668,0.4065040650406504,0.7127671272053098,1.0,48/104,35.83%,RPS6KA5;PLCG2;IKBKB;KRAS;PSMA6;PSMB5;FCER1G;RELB;PSMC4;ICAM2;PSMC5;SYK;PSMD14;HRAS;PSMD8;PSMC1;PSMB4;TAB2;PSMD11;PSMD12;RELA;CHUK;CUL1;PSMA1;PSMC3;PSMB1;NRAS;PSMA2;PSMA4;PRKCD;BCL10;TRAF6;PSMB8;CARD11;PAK2;SRC;TYROBP;PSMC6;PSMD6;MUC1;IKBKG;PSMA8;PSMB2;MUC13;PSMD2;CREBBP;MUC6;FYN
prerank,cellular response to lectin (GO:1990858),-0.25628709498560037,-1.0138612589262668,0.4065040650406504,0.7127671272053098,1.0,48/104,35.83%,RPS6KA5;PLCG2;IKBKB;KRAS;PSMA6;PSMB5;FCER1G;RELB;PSMC4;ICAM2;PSMC5;SYK;PSMD14;HRAS;PSMD8;PSMC1;PSMB4;TAB2;PSMD11;PSMD12;RELA;CHUK;CUL1;PSMA1;PSMC3;PSMB1;NRAS;PSMA2;PSMA4;PRKCD;BCL10;TRAF6;PSMB8;CARD11;PAK2;SRC;TYROBP;PSMC6;PSMD6;MUC1;IKBKG;PSMA8;PSMB2;MUC13;PSMD2;CREBBP;MUC6;FYN
prerank,regulation of coagulation (GO:0050818),-0.430699383936789,-1.013574083009297,0.45765765765765765,0.7129987064203338,1.0,1/11,0.34%,CAV1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.2651852457396333,-1.0132876394552648,0.4228571428571429,0.7126423424191918,1.0,31/78,30.21%,KLC1;DCTN2;DYNC1LI2;OSBPL1A;AP2M1;KIF23;CTSD;CTSF;FCER1G;DCTN3;DCTN1;CD74;KIF26A;RAB7A;DYNC1LI1;AP2A1;KIF18A;DYNLL2;SEC24B;DNM2;CLTA;KIF22;AP1S2;ACTR1B;CTSS;SEC13;RACGAP1;AP2A2;AP1G1;DCTN4;KIF11
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.2651852457396333,-1.0132876394552648,0.4228571428571429,0.7126423424191918,1.0,31/78,30.21%,KLC1;DCTN2;DYNC1LI2;OSBPL1A;AP2M1;KIF23;CTSD;CTSF;FCER1G;DCTN3;DCTN1;CD74;KIF26A;RAB7A;DYNC1LI1;AP2A1;KIF18A;DYNLL2;SEC24B;DNM2;CLTA;KIF22;AP1S2;ACTR1B;CTSS;SEC13;RACGAP1;AP2A2;AP1G1;DCTN4;KIF11
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.34271279827805196,-1.013244240507635,0.4220532319391635,0.7122447620656469,1.0,9/24,19.19%,B2M;TAPBP;ERAP1;IDE;FCER1G;ACE;BCAP31;TAP2;SEC24B
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.2776401141616917,-1.0130051734407353,0.44731610337972166,0.7123399616726265,1.0,17/65,18.67%,ITGA1;AFAP1L2;PTPRJ;DAB2IP;EPN1;MVB12B;HIP1R;AKT1;HIP1;DUSP3;SHKBP1;TSG101;PTPN12;BCAR3;EGFR;NEU3;SPRY1
prerank,positive regulation of vasoconstriction (GO:0045907),-0.4041158767106108,-1.012992178925971,0.4369114877589454,0.7118592831430156,1.0,1/13,0.34%,CAV1
prerank,neurogenesis (GO:0022008),-0.3020132865155439,-1.0129425191063224,0.4235294117647059,0.7114728702821838,1.0,7/43,7.25%,CDK6;TRAK1;ANXA1;SIX1;TGFB2;TRAK2;BTBD3
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.3171756277713239,-1.0128670917970297,0.4321223709369025,0.7111626323161488,1.0,12/31,22.00%,CNOT7;DCPS;HBS1L;DIS3L2;EDC4;NT5C3B;EXOSC8;DCP1B;LSM2;LSM1;LSM3;LSM7
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.31573466956311735,-1.0128101115511268,0.4348697394789579,0.7107886375084188,1.0,18/36,34.00%,MAP3K20;RAD1;E2F1;RAD9B;HUS1;RAD9A;RAD17;CHEK1;RHNO1;CLOCK;CEP63;FBXO6;DNA2;ATRIP;PRPF19;CDC5L;CDC6;CLSPN
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.41752490120227803,-1.0126468100863295,0.46366782006920415,0.7106904538210284,1.0,3/12,8.39%,PAICS;ADSS2;IMPDH1
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.2668934758468348,-1.0125744395208571,0.43520309477756286,0.7103684448249143,1.0,17/76,17.64%,TEK;SORBS3;BAIAP2L1;PTK2B;BCAS3;WDR1;LMOD1;EDN1;NES;PFN1;SYNPO;PRKCE;HRAS;LIMK1;NCKAP1;HCK;CDC42EP3
prerank,regulation of mRNA metabolic process (GO:1903311),-0.42453911613409556,-1.0118966585285591,0.45709281961471104,0.7114748701728146,1.0,3/11,8.50%,SRPK1;SAFB;DHX9
prerank,protein localization to phagophore assembly site (GO:0034497),0.43249300309237115,1.0117997362765716,0.4559139784946237,0.7731123631801968,1.0,4/11,21.45%,WDR45B;WIPI1;ATG9A;WDR45
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.431395518038314,-1.0117698260083772,0.4575645756457565,0.7113172564764363,1.0,5/10,31.38%,ST6GAL1;AMDHD2;RENBP;GNPDA1;GNE
prerank,cellular response to glucose starvation (GO:0042149),-0.30601917927528066,-1.0116022008994605,0.4392712550607287,0.7112205963167748,1.0,18/41,34.41%,FOXO3;ATF4;IMPACT;HSPA5;NUAK2;PRKAG1;NUAK1;HNRNPA1;XBP1;ASNS;SESN2;SIK1;BRSK2;SESN1;PMAIP1;CPEB4;PIK3R4;ATG14
prerank,regulation of response to oxidative stress (GO:1902882),0.4192778358044083,1.0115977743798101,0.4351648351648352,0.7726825217262887,1.0,3/11,14.84%,PRKN;GGT7;STOX1
prerank,post-translational protein modification (GO:0043687),-0.21950066374360613,-1.011384583057073,0.411214953271028,0.7112681055814407,1.0,108/332,27.17%,FN1;GPC3;IGFBP7;RAB11A;LMO7;SOCS2;APP;IGFBP5;SUMF2;RBBP5;KLHL5;MSLN;ADAM10;SPARCL1;ZBTB16;IGFBP3;DCAF6;PTP4A2;KLHL2;RHBDD1;FBXO17;NUCB1;PSMA6;DCUN1D1;CUL4A;CST3;QSOX1;MFGE8;FBXO4;PSMB5;WSB2;PNPLA2;SPP1;ASB8;RAB8A;COPS6;PSMC4;WDTC1;RAB11B;UBE2F;CHRDL1;FBXL14;PSMC5;KLHL3;COPS5;ICMT;FBXW10;PSMD14;FBXW5;SUMF1;FUCA2;RBX1;APOE;FEM1A;CISH;PSMD8;FBXL7;WSB1;RAB1A;FSTL1;CCNF;PSMC1;UCHL3;FBXL3;LGALS1;PSMB4;PSMD11;F5;FBXL16;PSMD12;GAN;FBXW2;KLHL9;KLHL21;ELOB;CUL1;PRSS23;CCDC22;PSMA1;VWA1;PSMC3;KEAP1;PSMB1;PSMA2;KCTD7;DTL;COPS7A;COPS4;FBXL19;PSMA4;COPS7B;DCUN1D3;TULP4;FBXO6;FBXL18;KCTD6;CHGB;COP1;EVA1A;STT3B;FBXO40;C3;LAMB2;GPS1;PSMB8;DSCC1;FBXL8;SERPINC1
prerank,ether lipid biosynthetic process (GO:0008611),0.4397322290040289,1.011217132141009,0.45454545454545453,0.7726800943804091,1.0,2/10,2.62%,PLA2G4A;CHPT1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.2541349926038086,-1.0112151480901834,0.42362525458248473,0.7111740422274478,1.0,48/105,35.83%,RPS6KA5;PLCG2;IKBKB;KRAS;PSMA6;PSMB5;FCER1G;RELB;PSMC4;ICAM2;PSMC5;SYK;PSMD14;HRAS;PSMD8;PSMC1;PSMB4;TAB2;PSMD11;PSMD12;RELA;CHUK;CUL1;PSMA1;PSMC3;PSMB1;NRAS;PSMA2;PSMA4;PRKCD;BCL10;TRAF6;PSMB8;CARD11;PAK2;SRC;TYROBP;PSMC6;PSMD6;MUC1;IKBKG;PSMA8;PSMB2;MUC13;PSMD2;CREBBP;MUC6;FYN
prerank,acetyl-CoA metabolic process (GO:0006084),-0.3842336991176395,-1.0111903988763136,0.4577205882352941,0.7107391212525076,1.0,2/15,6.15%,HMGCS2;ACLY
prerank,negative regulation of gene expression (GO:0010629),-0.22032211410194733,-1.0110640615168187,0.4087912087912088,0.7105309029321563,1.0,71/302,19.73%,FOXP1;MEF2C;OCLN;CLDN5;RPS6KA5;CD34;TNRC6C;ESR1;NOTCH1;SRGN;SLC7A5;RACK1;KDR;KLF4;NCOR1;RPS3;APP;IGFBP5;REST;TGFB1;TGFB2;HDAC9;WWP2;SMO;ADAM10;REL;RPS13;VEGFA;CNOT7;MPHOSPH8;AEBP2;PTBP3;N4BP1;GATA2;RGCC;GAPDH;NCL;YY1;RB1;H3-3A;RPL13A;DDRGK1;CAPRIN1;DIS3L2;YTHDF2;EPC1;ENG;HRAS;FGF2;FMR1;APOE;TASOR;BMI1;FLOT2;HSPA1A;PCIF1;LSM14A;RBBP4;CNPY2;RPS26;ATP2B1;RNH1;DLL4;GIGYF2;LSM2;PAIP2B;PTGER4;TMBIM6;MSR1;PTRH2;TYMS
prerank,regulation of cation channel activity (GO:2001257),0.2681477624513737,1.0110388273002067,0.41286307053941906,0.7722128077962923,1.0,23/89,15.37%,FGF14;GRIA4;ANK2;PRKACA;DLG2;SHISA9;DAPK1;NLGN2;CAMK2B;CACNG4;CACNB1;MAPK8IP2;CACNB4;NLGN1;CACNB2;LRRC7;GRIA3;DLG4;ACTN2;GRIN2A;GRIA1;JPH1;KCNS1
prerank,peptidyl-tyrosine modification (GO:0018212),-0.28176678197898497,-1.0107028156433437,0.42570281124497994,0.7109112051241588,1.0,18/56,17.17%,TEK;FLT1;PTK2B;KDR;PTK2;ABI3;FLT4;INSR;ABL2;SYK;CSF1R;ABI1;ERBB2;PTPN6;EGFR;JAK2;JAK3;HCK
prerank,cellular response to pH (GO:0071467),-0.3762369391912024,-1.0104884594562622,0.44532803180914515,0.7109369940314787,1.0,5/17,26.90%,CHP1;RAB11B;IMPACT;HYAL1;RAB11FIP5
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.2913252619288866,-1.0104444047961292,0.45038167938931295,0.7105485848749568,1.0,17/50,23.36%,PSMA6;PSMB5;PSMC4;PSMC5;OAZ2;PSMD14;PSMD8;PSMC1;NQO1;PSMB4;PSMD11;PSMD12;PSMA1;PSMC3;PSMB1;PSMA2;PSMA4
prerank,positive regulation of cartilage development (GO:0061036),0.37783858786478464,1.010407675981684,0.4152173913043478,0.7728529930566227,1.0,3/17,8.32%,BMP2;LOXL2;SOX5
prerank,Fc receptor signaling pathway (GO:0038093),-0.25398981103583634,-1.0100685585996088,0.43259557344064387,0.711026307418027,1.0,39/110,24.64%,PLCG2;MAPK3;MAP3K1;CALM1;RAC1;IKBKB;SHC1;PSMA6;PSMB5;NFATC1;FCER1G;PSMC4;PSMC5;PPP3CB;SYK;PSMD14;PSMD8;PIK3CA;LCP2;PSMC1;PIK3R2;PSMB4;TAB2;PSMD11;PSMD12;GAB2;RELA;CHUK;CUL1;NFATC3;PSMA1;PSMC3;BTK;PSMB1;PSMA2;LAT2;PSMA4;BCL10;TRAF6
prerank,lung development (GO:0030324),0.33230828630692777,1.00970312187712,0.4343220338983051,0.7737140560951076,1.0,5/33,8.60%,ERRFI1;FGFR2;GLI2;LOXL3;NPHP3
prerank,regulation of peptidase activity (GO:0052547),-0.36622315126496974,-1.0094942555884603,0.45,0.7119201585371758,1.0,3/19,8.14%,CAV1;CST3;NDUFA13
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.39809614714709896,1.0094466852858237,0.41379310344827586,0.7734424508009509,1.0,5/14,15.50%,SHLD2;KMT5C;PAXIP1;RIF1;KMT5B
prerank,second-messenger-mediated signaling (GO:0019932),0.2739464891563551,1.0091315813548898,0.4197002141327623,0.7733505832987236,1.0,13/82,9.87%,RCAN2;PDPK1;DGKD;P2RX4;CCR6;ACKR2;ACKR4;CCR10;HRH1;CHRM3;PPP1R9A;CCR9;MCTP2
prerank,C21-steroid hormone metabolic process (GO:0008207),0.36344302257464545,1.0088063559204843,0.4335511982570806,0.7732857658866009,1.0,2/20,10.00%,AKR1B1;CYP46A1
prerank,cellular calcium ion homeostasis (GO:0006874),-0.24101654339387857,-1.0087765687941033,0.42738589211618255,0.7132268505851715,1.0,22/133,11.49%,ATP13A5;CAV1;TPT1;TRPC3;CAV2;MCUB;CAMK2D;TMEM165;SLC35G1;ATP2C1;ATP2A3;PDZD8;ATP1B1;EDN1;CCL15;STIM2;BAX;SLC10A7;TRPC6;TRPV4;TRPC4;ATP2B3
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.2982443634484154,-1.0086365219242375,0.44274809160305345,0.713085404638457,1.0,13/42,23.62%,TRIM25;UBB;UBC;RPS27A;UBE2L6;VCP;SPRTN;USP43;RPA3;POLK;RFC3;DTL;RFC2
prerank,RNA interference (GO:0016246),0.3906242826665768,1.0084310374252132,0.42795698924731185,0.7732985246147013,1.0,8/17,22.93%,HENMT1;AGO4;DROSHA;AGO3;AGO1;AGO2;DICER1;MRPL44
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.3313046284303509,-1.0083876685048656,0.4418604651162791,0.7131762067429551,1.0,10/29,17.32%,UBB;UBC;RPS27A;CUL4A;GTF2H3;CHD1L;RBX1;CETN2;RPA3;GTF2H4
prerank,regulation of dendrite extension (GO:1903859),-0.3664445271369726,-1.0083467528237688,0.4435946462715105,0.7127742209920492,1.0,5/18,14.32%,NEDD4L;ITSN2;PLAA;SYT2;SMURF1
prerank,chromatin organization (GO:0006325),-0.24557185332618,-1.0083230358623767,0.41416309012875535,0.7123511483729519,1.0,47/132,32.05%,MECOM;ESR1;ZBTB7A;PRDM16;KDM5C;HCFC1;SAFB;HDAC4;RB1;CHD1L;ARID1A;BAZ1A;MTA2;TADA2B;GATAD1;HMGN1;CDAN1;SATB2;HCFC2;SMARCA4;HMGN2;SMARCA2;KDM6A;RBBP4;PWWP3A;L3MBTL1;SOX9;SETDB1;EZH1;SMARCC1;PHF19;CHD1;FAM50A;SETD2;HDAC5;CHRAC1;NPM1;RUVBL1;SMARCA5;SMARCD2;SPI1;HMGB2;MYC;NPM3;KAT2A;HDAC3;MYSM1
prerank,protein glycosylation (GO:0006486),-0.2461701347448943,-1.0081515467652025,0.434,0.7123228858292998,1.0,42/125,25.93%,ST3GAL6;ST3GAL4;EOGT;ST8SIA4;TRAK1;PLOD2;TMEM165;SLC39A8;AQP11;ST8SIA6;MGAT1;C1GALT1C1;FUT8;GALNT10;KRTCAP2;DAD1;POGLUT1;PLOD3;GFPT1;SERP2;ST6GALNAC2;NPC1;COG3;TMEM258;OGA;POMK;NUS1;ALG9;B3GNT3;B3GNT8;ALG12;ALG1;PGM3;LARGE1;MPI;RPN2;POMGNT2;GCNT4;GALNT6;STT3B;GALNT9;ALG2
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.32097713311622444,-1.0073788679524855,0.4269449715370019,0.713653447507776,1.0,14/29,30.76%,CNOT7;DCPS;HBS1L;EDC4;NT5C3B;EXOSC8;DCP1B;LSM2;LSM1;LSM3;LSM7;DIS3;EXOSC9;LSM6
prerank,regulation of endocytic recycling (GO:2001135),-0.41505847801178997,-1.007335670682357,0.4561717352415027,0.7132706540082929,1.0,4/11,18.85%,ARHGAP1;EHD2;RAB11B;EHD1
prerank,protein-DNA complex disassembly (GO:0032986),-0.377164290573762,-1.0070497068099376,0.46950092421441775,0.7134632934244304,1.0,9/16,37.31%,RPL23;ARID1A;SMARCA4;SMARCC1;SMARCD2;MYC;SMARCD3;NFE2;HMGA1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.3446216291826729,-1.0069482510188132,0.44464609800362975,0.7132138039654625,1.0,5/22,14.26%,AHNAK;DMD;CACNB3;FMR1;SRI
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.3634973699008428,1.0068569768645952,0.439918533604888,0.7762894737668433,1.0,3/21,9.33%,BMP6;TGFBR1;BMPR1A
prerank,positive regulation of protein kinase activity (GO:0045860),-0.24023348926306987,-1.0065160807763158,0.4475806451612903,0.7137575404967714,1.0,33/148,16.60%,RAP1A;TGFBR2;PTK2B;IQGAP1;PTK2;DAB2IP;HSP90AB1;CALM1;TGFB2;NEDD9;RALB;MINK1;VEGFA;TAOK3;RASSF2;INSR;EMP2;LRP8;TAOK2;CAMK1;MTCP1;CIB1;SRCIN1;CALM3;CSF1R;ACE;PRKAG1;MMD;CAB39;LCP2;CDKN1A;HSP90AA1;TAB2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.29864575243826724,1.0059316799895885,0.40828402366863903,0.7777543078394744,1.0,7/52,8.91%,CELF2;RBFOX1;NOVA1;SRSF12;KHDRBS1;CELF4;RBM5
prerank,positive regulation of B cell activation (GO:0050871),-0.2919762590556237,-1.0056427605770046,0.4291417165668663,0.7154846218736192,1.0,13/50,18.10%,MEF2C;TFRC;CD38;CD81;PPP2R3C;MMP14;CD74;TIRAP;SYK;CLCF1;NOD2;CD320;XBP1
prerank,protein polyglutamylation (GO:0018095),0.42591538129971,1.0055859148122128,0.4172043010752688,0.7777449250920304,1.0,2/11,5.71%,TTLL11;TTLL9
prerank,calcium ion homeostasis (GO:0055074),0.2607630453696531,1.0055488334421787,0.41941747572815535,0.7769235051010887,1.0,10/95,3.86%,SLC24A3;SLC8A1;SLC24A5;CYP27B1;ANK2;DMPK;ATP13A3;ATP2A2;TNNI3;CSRP3
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.3860478720483021,1.0054116612588788,0.42857142857142855,0.776347747652636,1.0,2/14,7.55%,ADAMTS12;TGFBR1
prerank,negative regulation of myoblast differentiation (GO:0045662),0.40804063355388487,1.0052445396179086,0.44759825327510916,0.775847264992256,1.0,2/13,1.61%,TBX3;PRICKLE1
prerank,protein dephosphorylation (GO:0006470),-0.24059547641456858,-1.0052410596838728,0.4204081632653061,0.7160100758696032,1.0,44/135,26.42%,PTPRB;PTPRG;PTPN14;CTTNBP2NL;PTPRJ;RPRD1B;CTDSP1;PTPRM;SSH2;PPP3CC;PPP2R1A;PPM1F;PPP2R5A;PPP1CB;PPP2R1B;DUSP3;PPP5C;PPP3CB;PPP2R2A;CDC14B;PTPN12;MTM1;PTPN6;UBLCP1;PPP2R5E;DUSP11;UBASH3B;PTPRK;PPP2R2D;PTPRO;PTPRU;PPP1CA;TIMM50;NCK1;PTPN22;PPP1R12A;DUSP4;PPM1M;PPEF2;PTPN1;RPRD1A;PPP2R5B;PDP1;MTMR2
prerank,positive regulation of heart rate (GO:0010460),0.3799868007864482,1.0047979436289747,0.430406852248394,0.7759858641507561,1.0,5/17,11.59%,SCN3B;ATP2A2;ADM;ADRA1D;ADRA1B
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.42550120923791857,-1.0047029846810156,0.4663023679417122,0.7167897765710959,1.0,7/11,29.86%,NDUFA13;TIMM29;TIMM13;TIMM10;TIMM8B;TIMM10B;ROMO1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.33027145050365825,-1.0045694088349113,0.4429657794676806,0.7165698970802248,1.0,12/27,28.43%,DDX5;CD44;TWIST1;PTTG1IP;CD74;SMYD2;KDM1A;MSX1;SPRED3;SNAI2;KMT5A;PMAIP1
prerank,regulation of DNA binding (GO:0051101),-0.2942320309983902,-1.0041528019692025,0.4406779661016949,0.7171141921283113,1.0,15/44,20.04%,LEF1;NFKBIA;ZBTB7A;NGF;TGFB1;SMO;CSNK2B;HES1;E2F1;SUMO3;JAK2;KDM1A;SKI;EDF1;MDFI
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.42934072859103334,-1.0038432672524795,0.46846846846846846,0.717394539115046,1.0,6/10,43.82%,CX3CR1;LGALS9;LILRB1;FCGR2B;CEACAM1;KLRD1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.29567277266809616,1.003728639088427,0.4214876033057851,0.7777573379195164,1.0,5/51,3.70%,PPM1E;NRP1;LPAR1;ROCK2;SFRP1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.22299287647312802,-1.003247433632323,0.45030425963488846,0.7183697676538745,1.0,108/264,34.94%,DDX5;NOVA2;HNRNPA2B1;CTNNBL1;DDX17;HSPA8;PRPF8;DNAJC8;SRSF5;MTREX;SRSF2;SNRNP48;SNRPC;SNRPA;DCPS;ISY1;SRPK1;DDX41;SRSF6;DHX9;DHX15;RBM22;FUS;SNRPD3;U2AF1;SFPQ;XAB2;RNPS1;ZRSR2;RBM6;SRSF4;MAGOH;DDX23;RBM4B;ALYREF;HNRNPK;SF3A3;EFTUD2;DDX39B;CDK13;HNRNPA1;PCBP1;DDX20;SMN1;GTF2F1;SNRPG;SCAF11;PDCD7;USP49;PHF5A;PNN;CASC3;LSM2;UBL5;SRRM2;RBM19;PRPF40A;TGS1;CPSF4;CHERP;CD2BP2;LSM3;DDX39A;LSM7;RBM14;RBM17;SYNCRIP;NCBP2;CSTF2T;PABPC1;SF3A1;SNRPB;CLNS1A;SF3A2;HNRNPR;WBP11;AQR;POLR2F;SNRPB2;GTF2F2;HNRNPA3;PRPF19;SRSF9;HNRNPH3;PQBP1;LSM6;CDC5L;HNRNPC;U2AF1L4;SF3B5;SNRNP25;POLR2C;POLR2L;POLR2I;WBP4;PCF11;ESS2;UPF3B;SNUPN;RBM15B;SRSF1;TRA2B;HNRNPM;ZCCHC8;HNRNPH1;SMNDC1;RSRC1;SRSF10
prerank,aerobic respiration (GO:0009060),-0.3603443008538366,-1.003143638450539,0.45454545454545453,0.7181303460114032,1.0,7/20,21.71%,ATP5F1D;MTFR1;SURF1;UQCRB;UQCRH;SDHB;MTFR2
prerank,respiratory chain complex IV assembly (GO:0008535),-0.35263456913092406,-1.0030182028518437,0.4424131627056673,0.7179428328993609,1.0,12/21,32.32%,COA8;COX15;TIMM21;COA3;SURF1;FASTKD3;COX10;SCO1;PET100;BCS1L;COA6;SCO2
prerank,hexose transmembrane transport (GO:0008645),-0.3500517611289747,-1.0029981184188226,0.4563106796116505,0.7174915281637837,1.0,8/21,28.42%,SLC2A1;PPARD;SLC2A8;SLC2A3;SLC2A4;SLC2A9;SLC2A10;SLC2A2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.3347201418523492,-1.00273812035215,0.45436507936507936,0.7176129584819009,1.0,3/27,3.34%,CHST11;CSGALNACT1;CSPG4
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.2854912776265737,-1.0024749857348878,0.44029850746268656,0.7177460988383353,1.0,10/51,12.87%,ANO6;THBS1;MAPK3;PTK2;VEGFC;CMKLR1;VEGFA;VEGFD;MOSPD2;CSF1R
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.42678912276687764,-1.0023668063035078,0.45607476635514016,0.7175221772458097,1.0,4/10,29.32%,IQSEC1;MAPRE2;FGF10;EPB41L4B
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.4244688266856817,-1.0022869406588875,0.4722753346080306,0.7171949751547144,1.0,4/10,20.59%,SEC14L1;RNF125;DHX58;TSPAN6
prerank,response to reactive oxygen species (GO:0000302),-0.2801665028431457,-1.0021994045970262,0.44129554655870445,0.7169124760199906,1.0,25/54,34.37%,PXN;MAPK3;RPS3;GPX1;STK25;COA8;AKT1;APOE;STK26;EGFR;CHUK;PTPRK;PLK3;PDCD10;HYAL1;PKD2;CAMKK2;SOD1;ROMO1;HYAL2;JUN;NCF1;FOS;TPM1;MAPK9
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.28484396566429665,1.0021824711340204,0.4550898203592814,0.7807876457765713,1.0,10/59,14.26%,ALDH1A2;CYP7B1;CYP27A1;ACSM5;BAAT;CYP46A1;NDUFAB1;OSBP;ACACA;MCAT
prerank,monocyte differentiation (GO:0030224),0.4262482070698115,1.0018805565242501,0.4588744588744589,0.7806639357049718,1.0,1/10,0.35%,IL31RA
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.3880777399159938,-1.0018576091079234,0.44299065420560746,0.7172368319814064,1.0,6/15,23.53%,RAB18;ATL2;RTN3;REEP4;TMEM33;ZFYVE27
prerank,DNA strand elongation (GO:0022616),0.3642278329861562,1.0015090205005048,0.47689075630252103,0.7807168810110859,1.0,8/18,22.67%,MCM3;GINS2;NBN;POLD3;MCMDC2;POLD2;MCM7;DCLRE1B
prerank,endoplasmic reticulum organization (GO:0007029),-0.2719433704718761,-1.0014178390549595,0.4356060606060606,0.7177864314487349,1.0,25/72,28.70%,CAV2;APP;LPCAT3;SHTN1;RAB18;STX1A;ATL3;SPTSSB;ATL2;SEC61B;SGTA;DOP1B;LMAN2;RTN3;REEP4;TOR1AIP2;TMEM33;TLE6;STX5;UBE2J2;RNF112;LMAN2L;TRAM1;SEC61A1;VAMP2
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.2670094583556013,-1.0013682256616803,0.44467640918580376,0.717398438280844,1.0,25/80,18.02%,THBS1;VIM;RPL26;RACK1;EEF2;NIBAN1;RPS4X;PRKDC;ABCG1;EIF3D;RPS27L;LARP4B;CIRBP;UPF3A;SOX4;SPHK2;ABCA2;TNFRSF1A;FMR1;ERBB2;PCIF1;SP1;RELA;ZCCHC4;IFNGR1
prerank,regulation of fibroblast proliferation (GO:0048145),-0.2905303958657901,-1.0011294087320208,0.45724907063197023,0.717505080181088,1.0,15/45,16.06%,FN1;CDK6;DAB2IP;NDUFS4;PDGFC;DHX9;PDGFA;S100A6;CD74;CDK4;FTH1;NF1;E2F1;BMI1;CDKN1A
prerank,sodium ion homeostasis (GO:0055078),0.35056227761531733,1.0009962363151623,0.45147679324894513,0.7811034266329017,1.0,2/21,1.19%,ATP1A2;SLC8A1
prerank,potassium ion export across plasma membrane (GO:0097623),0.3989584081736406,1.0007501589912111,0.46799116997792495,0.7808253330711767,1.0,1/13,0.40%,KCNT2
prerank,response to ATP (GO:0033198),-0.3625265956472393,-1.0003778360120554,0.4568627450980392,0.7188440128171475,1.0,2/18,2.13%,TRPC3;ABCC9
prerank,negative regulation of heart contraction (GO:0045822),0.41862101141172686,1.0000704722528826,0.45041322314049587,0.7816736538475006,1.0,1/11,0.52%,ATP1A2
prerank,negative regulation of nervous system development (GO:0051961),-0.3738227454475776,-0.9999309515180632,0.45750452079566006,0.7194240526485323,1.0,3/17,4.13%,B2M;NOTCH1;REST
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.2854624906309906,-0.9999088756736814,0.4507042253521127,0.7189966797580121,1.0,19/51,31.73%,GBP5;APP;HSPB1;CASP8;TRIM16;S100A13;TLR4;AIM2;NOD2;JAK2;FZD5;LGALS9;CASP1;TMEM106A;TLR6;EGR1;CD36;TYROBP;NLRP3
prerank,regulation of myoblast differentiation (GO:0045661),-0.31701822175430544,-0.9998727022582486,0.45901639344262296,0.7186005420530243,1.0,5/32,5.23%,MEF2C;NOTCH1;BOC;TGFB1;IGFBP3
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.38604095103118463,-0.9997998004729717,0.48484848484848486,0.7182771984929752,1.0,4/15,15.83%,PPARD;PPARGC1A;ELOVL5;NR1H2
prerank,regulation of p38MAPK cascade (GO:1900744),-0.3099519522610048,-0.9997978624115861,0.45387453874538747,0.7177902733731633,1.0,18/35,33.07%,DAB2IP;MFHAS1;MINK1;VEGFA;EZR;ULK4;GADD45G;EMC10;GADD45A;LGALS9;PTPN22;TREM2;DUSP1;RASGRP1;SPI1;XDH;PJA2;NCF1
prerank,SNARE complex assembly (GO:0035493),-0.43458020012104936,-0.9995060341932768,0.4805194805194805,0.7180224038027894,1.0,1/10,0.99%,STXBP6
prerank,Notch signaling pathway (GO:0007219),-0.2757605809835039,-0.9994473445972666,0.4496124031007752,0.7176773902334664,1.0,18/59,18.13%,SORBS2;NOTCH3;NOTCH1;ADAM10;HEYL;JAG2;NOTCH4;DTX3;PSENEN;PLXND1;ZNF423;HES1;ITCH;APH1A;HEY1;DTX2;DLL4;STAT1
prerank,axon development (GO:0061564),0.26740648053739596,0.9993872678963941,0.42038216560509556,0.7824975666353162,1.0,18/78,14.70%,FGFR2;SEMA5A;CNTN4;CTNNA2;SLITRK4;NREP;RTN4;DOCK7;NRCAM;RAB10;RYK;CDK5R1;DCC;BRSK1;AMIGO1;LLGL1;MAPT;DRD2
prerank,positive regulation of response to external stimulus (GO:0032103),-0.24171374565753967,-0.999289710248537,0.46265560165975106,0.7175615413851822,1.0,28/128,17.44%,THBS1;IL15;NFKBIA;SCARF1;STX3;THBD;ETS1;GBP5;APP;TGFB1;PDE2A;IL33;GPR4;TLR3;NFKBIZ;RIPK1;PPM1F;DHX9;DHX58;TLR4;USP15;TNFRSF1A;FEM1A;AKIRIN2;IL17RA;SLC15A4;ANKRD17;NINJ1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.29063713391815266,0.999147996490759,0.4435483870967742,0.7821876499239686,1.0,9/53,12.80%,HTR7;MC5R;CHRM2;HRH1;CHRM3;HRH2;HTR4;PTGIR;HTR5A
prerank,negative regulation of cell division (GO:0051782),0.4123949921041703,0.9991169542916477,0.44026548672566373,0.7813588861876952,1.0,2/11,9.24%,TXNIP;BLM
prerank,wound healing (GO:0042060),0.28229212784481683,0.99907047150497,0.4306418219461698,0.780549540749581,1.0,6/62,4.00%,IGF1;NRG1;PDGFRA;SMAD3;PPL;CFLAR
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.34585787450457706,0.9988586836285441,0.477124183006536,0.7801526859507633,1.0,2/23,1.66%,CAMK1D;DAPK2
prerank,connective tissue development (GO:0061448),-0.31188671700568454,-0.9988367262621636,0.46741154562383613,0.7181870315489908,1.0,9/35,10.05%,SPTLC2;NAMPT;LRP5;CD44;ZBTB16;PKD1;PGRMC2;TRIP11;DDRGK1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3847953096353142,0.9984483366969713,0.4288888888888889,0.7802473639289135,1.0,3/16,5.22%,PID1;PPARA;IL4
prerank,response to interferon-gamma (GO:0034341),-0.26862714351715355,-0.99820119243705,0.47346938775510206,0.7192332354100965,1.0,19/67,25.60%,GBP5;GCH1;GBP7;IFITM1;IFITM3;GAPDH;IFITM2;CCL15;RPL13A;CD74;TLR4;STAT1;IRF8;AQP4;LGALS9;CASP1;SYNCRIP;CCL2;AIF1
prerank,positive regulation of bone resorption (GO:0045780),-0.4167621914762463,-0.998020925134831,0.4498069498069498,0.7191642401988867,1.0,4/11,12.47%,PLEKHM1;TNFRSF11A;SPP1;SYK
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.3317790049336017,-0.997918422056131,0.4601113172541744,0.7189094461130114,1.0,9/27,27.58%,CYRIB;ETS1;CD44;HSPD1;RELA;HAS2;TRAF6;CCL2;SKAP1
prerank,motor neuron axon guidance (GO:0008045),-0.38332885691016383,-0.9975432138710976,0.4849557522123894,0.7193231332842713,1.0,5/15,12.36%,SLIT2;RAC1;CHN1;LAMC2;NTN1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.3192424877523831,0.9972370964221928,0.44516129032258067,0.7823814181008227,1.0,9/32,16.24%,RIMS1;CHRNB4;CPLX2;STX1B;MCTP2;BAIAP3;SNAPIN;HCRT;SYT11
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.40882248827093676,0.9972009897944808,0.46017699115044247,0.7815591555953502,1.0,2/12,6.25%,AR;GSTP1
prerank,exit from mitosis (GO:0010458),-0.4045793729847824,-0.9970752741770128,0.4906015037593985,0.7199671375637523,1.0,7/12,37.58%,EPS8;CHMP2A;PPP2R2D;CHMP7;UBE2C;CHMP4B;SIRT7
prerank,protein depolymerization (GO:0051261),0.3433895529900712,0.9969480344003282,0.4472573839662447,0.7812837470297623,1.0,2/27,2.88%,MICAL3;NCKAP5
prerank,spermatid development (GO:0007286),-0.3191945780049466,-0.9967777990811856,0.4653284671532847,0.7202018241865341,1.0,13/32,34.44%,JAM2;CEP57;CIB1;TDRD5;RFX2;NECTIN2;IQCG;MKKS;SYCP3;CDYL;RNF8;DPY19L2;CCDC63
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.36332237126201905,0.9962998702564492,0.43790849673202614,0.7820368241569561,1.0,8/19,24.07%,AMPD3;GMPR;APRT;POLD1;POLD3;POLD2;AMPD2;DGUOK
prerank,RNA processing (GO:0006396),0.2394503082318541,0.9960920030688877,0.4474187380497132,0.7816535312098464,1.0,26/176,12.93%,CELF2;ATXN1;NOVA1;RBMS1;TUT4;AURKAIP1;PRKACA;SNRPN;ADARB2;AKAP8L;SNRPA1;RNPC3;HNRNPUL1;LIN28B;DHX8;MPHOSPH10;RBM5;SLU7;PABPN1;KHSRP;BICD1;HNRNPD;PIWIL2;NOL9;THOC1;RP9
prerank,DNA damage checkpoint signaling (GO:0000077),-0.32615665130577187,-0.9959430120663088,0.44227005870841485,0.7217268955906354,1.0,14/28,30.94%,MAP3K20;RAD1;E2F1;HUS1;RAD9A;RAD17;CHEK1;RHNO1;CLOCK;CEP63;FBXO6;ATRIP;PRPF19;CDC5L
prerank,positive regulation of dendrite extension (GO:1903861),-0.3732500047838911,-0.9958070859640598,0.4678362573099415,0.721571641682402,1.0,5/17,14.32%,NEDD4L;ITSN2;PLAA;SYT2;SMURF1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.37924461914393626,0.9957302470463826,0.46203904555314534,0.781623540533343,1.0,2/17,3.16%,ANK2;CACNA2D1
prerank,regulation of transport (GO:0051049),0.31427866946953575,0.9956171987469522,0.4563894523326572,0.7809876912681823,1.0,5/36,5.78%,NRP1;LEPR;WWC1;SCFD1;PRKN
prerank,import into nucleus (GO:0051170),-0.2654698787983101,-0.9953748270756199,0.45491803278688525,0.7221182490187252,1.0,24/73,26.31%,NUP93;AKT1;SNRPD3;PTTG1IP;E2F3;HTATIP2;SYK;NUP188;PHB2;NUP155;TNPO3;RPAIN;HNRNPA1;DDX20;SMN1;SNRPG;TSC2;NXT2;TNPO2;FAM53A;SNRPB;IPO13;SEC13;NUP107
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.42547511368004637,-0.9948461227556366,0.5027829313543599,0.7223749272644184,1.0,3/10,7.83%,CBFA2T3;NCOR1;HDAC4
prerank,negative regulation of glycolytic process (GO:0045820),-0.42547511368004637,-0.9948461227556366,0.5027829313543599,0.7223749272644184,1.0,3/10,7.83%,CBFA2T3;NCOR1;HDAC4
prerank,mRNA polyadenylation (GO:0006378),0.33464863230040853,0.9948144108513104,0.44635193133047213,0.7813113577791821,1.0,15/26,28.50%,PAPOLB;FIP1L1;SYMPK;PNPT1;SCAF8;PAPOLA;GRSF1;PAF1;MTPAP;TENT2;WDR33;CLP1;TENT4B;LEO1;AHCYL1
prerank,RNA polyadenylation (GO:0043631),0.33464863230040853,0.9948144108513104,0.44635193133047213,0.7813113577791821,1.0,15/26,28.50%,PAPOLB;FIP1L1;SYMPK;PNPT1;SCAF8;PAPOLA;GRSF1;PAF1;MTPAP;TENT2;WDR33;CLP1;TENT4B;LEO1;AHCYL1
prerank,positive regulation of lipid catabolic process (GO:0050996),0.3736391604114426,0.9934489801311163,0.4553376906318083,0.7838381749368404,1.0,3/19,6.02%,PPARA;IRS2;ABCD2
prerank,positive regulation of natural killer cell activation (GO:0032816),0.397972519803258,0.9931788331343833,0.4517543859649123,0.7836229951407397,1.0,3/13,8.86%,TICAM1;AXL;IL18
prerank,mitotic metaphase plate congression (GO:0007080),-0.28236516375836446,-0.9927364873028808,0.45742574257425744,0.7268844606476419,1.0,25/51,37.68%,RAB11A;DCTN2;ZW10;CHMP2B;KIF18A;MAD1L1;CHMP2A;BOD1;NDC80;RMDN1;KIF22;SPDL1;SEH1L;CDCA8;CEP55;VPS4A;EML3;CHMP7;NUF2;PSRC1;CUL3;CHMP4B;CHMP4A;KIF2C;CCNB1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.42760762842201216,-0.9925588768968954,0.48873483535528595,0.7268294208598943,1.0,3/10,6.15%,OPHN1;MSN;EZR
prerank,glutamine family amino acid catabolic process (GO:0009065),0.3848950575181735,0.992472184020552,0.45045045045045046,0.7844669244132123,1.0,4/13,9.05%,ALDH4A1;PRODH;GLS2;GLUL
prerank,cartilage development (GO:0051216),0.297204284062913,0.9923887536422622,0.4725050916496945,0.7837786930885149,1.0,5/49,3.61%,BMP2;SULF1;HYAL3;SULF2;RUNX3
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.33916227380591624,-0.9919282785500466,0.4652908067542214,0.7278691132657257,1.0,11/23,30.33%,HSP90AB1;NLRC5;NR1H2;JAK2;IFNGR1;STAT1;TXK;PARP14;PTPN2;IRGM;PARP9
prerank,iron ion homeostasis (GO:0055072),0.2832159305089203,0.9916150527151973,0.4547413793103448,0.7847836735608851,1.0,3/58,1.52%,BMP6;CP;HEPH
prerank,negative regulation of T cell differentiation (GO:0045581),0.42516349951330124,0.991536361826204,0.48187633262260127,0.784086165910154,1.0,2/10,12.19%,GLI3;LAG3
prerank,regulation of MAP kinase activity (GO:0043405),-0.2571792943820763,-0.9913704706323988,0.49,0.728823729889886,1.0,39/92,27.75%,FLT1;PTPRJ;FGF1;TPD52L1;DAB2IP;TGFB1;PIK3R6;VEGFA;EDN1;TRIB2;PDGFC;PDGFA;TRIB1;UCHL1;STK38;NF1;HRAS;FGF2;APOE;TSG101;ERBB2;NOD2;SNF8;EGFR;SPRY1;CDK5RAP3;TRIB3;PDCD10;PIK3CG;PRKCD;PPEF2;PTPN1;NEK10;PIK3R5;SMPD1;FGF18;DUSP1;SPRY4;RASGRP1
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.24763327552962305,-0.9912229557409176,0.46311475409836067,0.7286738131820997,1.0,31/109,18.06%,PLCG2;PIP5K1B;BMX;PLCB3;PI4K2A;INPP5D;PIK3R6;MTMR14;CDS1;MTMR12;CDIPT;INPP5E;PIP4P1;PIK3C2A;PLAAT3;PITPNM2;MBOAT7;RUFY1;RAB4A;PITPNM3;PIK3R3;CSF1R;FGF2;PITPNM1;PIK3CA;MTM1;SYNJ1;PIK3R2;PIK3C2B;PIGW;FIG4
prerank,regulation of protein localization (GO:0032880),-0.2740222868276781,-0.9912048259715469,0.4877126654064272,0.7282231357010653,1.0,19/58,19.80%,RACK1;TRIM25;HSP90AB1;FKBP1A;USP8;PLEKHM2;PPM1F;TRIM14;CTSD;CEP290;CAMK1;TRIM68;TRIM5;MMD;UFL1;HSP90AA1;KDM1A;TMEM231;ITGB3
prerank,regulation of neuron apoptotic process (GO:0043523),-0.25263894904111733,-0.9908498527576851,0.4819277108433735,0.7285500941573051,1.0,15/96,7.36%,MEF2C;PTK2B;EGLN3;FOXO3;KCNB1;NGF;SIX1;TGFB2;PPARGC1A;BACE1;ATF4;TOX3;TGFB3;EGLN2;FOXQ1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.3784668983671538,-0.990779518360044,0.48867924528301887,0.7282415007912616,1.0,6/14,35.98%,YBX3;TIRAP;BOLL;HNRNPC;ANGEL2;DAZL
prerank,ncRNA metabolic process (GO:0034660),0.3132925357840894,0.9907163255111333,0.45454545454545453,0.7852750905824812,1.0,12/37,22.17%,TUT4;HENMT1;KHSRP;PIWIL2;PARN;XPO5;MAPT;BCDIN3D;DROSHA;NIFK;AGO2;DICER1
prerank,regulation of histone acetylation (GO:0035065),-0.30673199035886034,-0.9900229614953511,0.4742647058823529,0.7295076778354943,1.0,8/33,18.29%,RPS6KA5;MAPK3;PPARGC1A;CTBP1;CAMK1;TADA2B;RAPGEF3;CHEK1
prerank,protein-containing complex assembly (GO:0065003),-0.2187653885754918,-0.9899572562295674,0.49176954732510286,0.7291787937627078,1.0,65/259,20.88%,FN1;LEF1;ANO6;OCLN;SLC2A1;DMD;PARD3;PTK2B;TLE4;CD2AP;FERMT2;TRRAP;ZW10;RBBP5;CTSZ;ADAM10;PPARGC1A;NAPA;PYGO2;PPP2R1A;REPS2;TAPBP;TLE3;CTSC;CASP8;RIPK1;AP2M1;DNAJB12;DHX9;FAS;CSNK2B;CD74;TEAD2;KMT2D;DBNL;HES1;TRAF1;AIM2;WASL;TNFRSF1A;RBX1;SMARCA4;PEF1;FBXL7;MCFD2;RAB1A;MDN1;CHCHD10;TRAPPC5;OPA1;F5;BAD;NSF;SKAP2;PPP6R3;ELOB;CUL1;SEC24B;SOX9;SHANK1;CAPG;WIPF1;TRAPPC2;TLE2;TRAPPC2L
prerank,canonical Wnt signaling pathway (GO:0060070),0.2774349890615324,0.9899426622785175,0.4738955823293173,0.7863481607769013,1.0,16/68,15.97%,TCF7L2;WNT4;SFRP1;FRAT1;PLPP3;RARG;RYK;GATA3;DVL3;FRZB;PTEN;FZD10;WNT6;WNT5B;TCF7L1;PORCN
prerank,replicative senescence (GO:0090399),0.40388171789214816,0.9898641470352988,0.4820295983086681,0.7856588507337618,1.0,4/12,18.59%,PLA2R1;SERPINE1;ATM;TP53
prerank,cellular response to purine-containing compound (GO:0071415),0.4258654103080546,0.9898501006022862,0.46320346320346323,0.7848031831156441,1.0,1/10,1.19%,SLC8A1
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.2910095227725125,-0.9896452995095739,0.4627450980392157,0.7294703024001822,1.0,13/45,18.74%,DDX5;HNRNPLL;RBM20;TGFB1;RIPK1;NMD3;RBM22;ZC3H18;HRAS;EGFR;HSPA1A;RELA;ZPR1
prerank,erythrocyte differentiation (GO:0030218),-0.29619627716365515,-0.9894664154417303,0.5057471264367817,0.7294123535779199,1.0,22/44,29.70%,RPS14;MFHAS1;RPS19;VEGFA;SLC25A38;TAL1;INHBA;ATP5IF1;UFL1;JAK2;JAK3;HSPA9;CDK5RAP3;UBA5;ALAS2;HCLS1;ZFPM1;DMTN;ACIN1;INHA;PTPN2;ABCB10
prerank,positive regulation of vascular permeability (GO:0043117),-0.400443454158822,-0.989303380076081,0.48628884826325414,0.7293113599686404,1.0,6/12,10.26%,OCLN;TJP2;TGFB1;PDE2A;VEGFA;TRPV4
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.41707910233844864,-0.9892170687259363,0.49335863377609107,0.7290565959157078,1.0,2/11,5.11%,CAV1;ADIPOR1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.3918884321587717,0.9892124697441358,0.4703296703296703,0.7855651623128397,1.0,3/14,6.02%,PPARA;IRS2;ABCD2
prerank,cellular response to virus (GO:0098586),-0.3111977703112331,-0.9888524055755293,0.46047430830039526,0.7294096945882881,1.0,16/30,37.26%,IFIH1;BAX;FMR1;POU2F2;HSP90AA1;CHUK;MAPK11;LGALS9;VWCE;IRGM;RIOK3;EIF5A;IRF3;POU2AF1;CCL5;IL12A
prerank,membrane lipid catabolic process (GO:0046466),-0.4172465985768882,-0.9887828136692546,0.47755834829443444,0.7291037167356361,1.0,7/10,30.99%,CYP1B1;SGPL1;ENPP2;NAGA;MGST2;FUCA1;SMPD2
prerank,carbohydrate biosynthetic process (GO:0016051),0.359856722798388,0.9883329646112066,0.5,0.7869615043969013,1.0,7/21,12.78%,B3GALT1;ST6GALNAC5;FUT4;ST6GALNAC6;FUT9;B3GALT2;B3GALT5
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.39069844313231794,0.9883035280201496,0.4726477024070022,0.7861431939740537,1.0,7/15,23.99%,TRPM1;GRM1;GRM4;HOMER2;GRIK3;DAGLA;GRM5
prerank,negative regulation of cartilage development (GO:0061037),0.38820567604779044,0.9880541410148288,0.44541484716157204,0.7858782726586051,1.0,2/13,7.55%,ADAMTS12;TGFBR1
prerank,histone H3-K4 methylation (GO:0051568),0.33910369499705617,0.9880451830044694,0.47415730337078654,0.7850177474818352,1.0,9/26,16.33%,WDR5B;KMT2A;PRDM9;SETMAR;MEN1;CXXC1;PAXIP1;DYDC2;WDR82
prerank,barbed-end actin filament capping (GO:0051016),0.3568842845581285,0.9875798444747995,0.4636752136752137,0.7844705764013201,1.0,1/18,0.15%,SVIL
prerank,actin filament capping (GO:0051693),0.3568842845581285,0.9875798444747995,0.4636752136752137,0.7844705764013201,1.0,1/18,0.15%,SVIL
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.37654227533008566,-0.9872830935549819,0.4696969696969697,0.7320843512398255,1.0,7/14,33.40%,CARD14;TLR3;TIRAP;TRAF6;CARD10;TLR6;TNFSF15
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3118232731766903,0.9870093246304902,0.4805194805194805,0.7849552252158036,1.0,5/38,6.49%,RORA;RHOH;NLRP12;GSTP1;TLE1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.2601648075442493,-0.9860639507286324,0.47904191616766467,0.7345406511432014,1.0,31/80,27.56%,KLC1;ZW10;KDELR1;HTT;NAPA;TAPBP;ARF5;RAB6B;ATP9B;KIF23;ERGIC1;COPG1;KIF26A;SURF4;TMEM115;COPB2;LMAN2;RAB1A;COG3;NSF;KIF18A;USE1;KIF1C;KIF22;GOLPH3;GOLPH3L;TMED3;RACGAP1;DNAJC28;COPZ2;ARF3
prerank,vasculature development (GO:0001944),0.3725864218431272,0.9860064229921807,0.47326732673267324,0.7865863923700378,1.0,3/16,6.21%,ERRFI1;PDGFRA;PDGFRB
prerank,regulation of translational initiation (GO:0006446),-0.2675858693173151,-0.9856780243840891,0.4834307992202729,0.7350133837342928,1.0,31/63,33.35%,EIF4G3;EIF5B;ATF4;HSPB1;RPS6KB2;IMPACT;YTHDF2;FMR1;UHMK1;EIF5;PAIP2B;YTHDF1;EIF4A2;EIF1;NCK1;ATF3;EIF4G1;PAIP1;EIF4EBP1;NCBP2;EIF4B;EIF4H;NCK2;NPM1;BOLL;PAIP2;GLE1;RPS6KB1;MIF4GD;YTHDF3;MTIF2
prerank,negative regulation of axonogenesis (GO:0050771),0.3324279003819167,0.9845427711650611,0.4660831509846827,0.7893630360660273,1.0,9/27,16.31%,LRP4;MCF2;RTN4;CDKL3;PTEN;DCC;NGFR;ULK2;TRIM46
prerank,mitochondrial translational termination (GO:0070126),-0.25708084617835647,-0.9845283716044301,0.502,0.7372728309855108,1.0,30/88,25.36%,PTCD3;MRPL52;MRPL51;MRPL38;MRPL28;MRPL43;MRPL32;MRPL14;ERAL1;MRPS30;MRPS17;MRPL24;MRPL16;MRPL50;MRPL54;MRPS18C;MRPL47;MRPL35;MRPS18A;MRPS6;MRPL58;MRPL13;MRPL11;MRPL49;MRPL30;MRPS24;MRPL21;MRPL48;MRPL42;MRPL2
prerank,positive regulation of protein depolymerization (GO:1901881),-0.40958739786069026,-0.9845069465842082,0.4877126654064272,0.7368301163243215,1.0,5/11,12.69%,WDR1;STMN2;NES;TRPV4;KATNB1
prerank,protein K48-linked ubiquitination (GO:0070936),-0.27822792832956145,-0.9844209562708279,0.4714285714285714,0.7365395459742813,1.0,27/54,36.17%,NEDD4L;ZNRF1;UBE2Q2;UBE2G2;KLHL3;RNF5;ITCH;RBX1;UBE2G1;PELI1;TNFAIP3;AMFR;UBE2B;UBE3A;BFAR;RNF187;DTX3L;FBXO38;HACE1;RNF8;SYVN1;UBE2T;RNF152;CUL3;UBE2C;UBE2R2;RNF6
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.3674412588043918,-0.9837925464172086,0.48188405797101447,0.7375359415385714,1.0,2/16,7.95%,IGF1R;INSR
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.3259836512126639,-0.9837685355744631,0.497164461247637,0.7370916437001864,1.0,11/28,25.73%,STMN2;PRUNE1;GAS2L1;MAP1B;ARL2;MAPRE2;MAP1A;FKBP4;CAMSAP3;STMN1;SKA3
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4202778312780484,-0.983582825141748,0.48440366972477067,0.737028355366697,1.0,2/10,4.11%,SHANK3;APP
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.4005431577868659,0.9835349933168308,0.4671201814058957,0.7910465202015916,1.0,3/12,8.43%,ABCA1;PPARA;ABCA5
prerank,rRNA 3'-end processing (GO:0031125),-0.42501711901414785,-0.9832859352502539,0.5036630036630036,0.7372628702793977,1.0,3/10,16.94%,RPS21;ERI1;EXOSC8
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.23453512474067206,-0.9831698211161614,0.5,0.7370652864007438,1.0,50/144,24.02%,PPP1R13B;CDH1;KCNB1;TGFB1;ABLIM3;PRR5L;BCAS3;CHP1;CD81;MIEF1;PPP3CC;CASP8;JUP;RBM22;TRIM28;CEP290;MIEF2;CAMK1;CIB1;MAVS;OAZ2;YWHAZ;PCM1;SAE1;BBC3;E2F1;HRAS;VPS11;ERBB2;RAPGEF3;YWHAG;PIK3R2;CSNK2A2;YWHAH;BAD;TMEM30A;ECT2;ZPR1;UBL5;SFN;FZD5;HCLS1;RIPOR1;PLK3;FIS1;PDCD10;YWHAB;NPEPPS;PRKCD;MICALL2
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.41865357527561975,0.9830749757475419,0.4954545454545455,0.7913278991588646,1.0,3/10,15.04%,LYN;AXL;CXCL12
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.31181254572454714,-0.9826261549049538,0.4681238615664845,0.7379215562523064,1.0,8/30,14.46%,FOXP1;DDX5;NCOR1;ZBTB7A;HEYL;H3-3A;TRIM68;SMARCA4
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.33763876044138574,0.9825695157190796,0.4692982456140351,0.7917619768886575,1.0,2/25,0.74%,NRP1;AR
prerank,protein deneddylation (GO:0000338),-0.4246214928636193,-0.982454130146702,0.5055762081784386,0.737858646550394,1.0,6/10,26.21%,COPS6;COPS5;COPS7A;COPS4;COPS7B;GPS1
prerank,neural tube closure (GO:0001843),0.3090848149390315,0.9821610324409308,0.47368421052631576,0.7919093182137841,1.0,10/34,14.28%,PRICKLE1;LMO4;DLC1;IFT122;DVL3;PLXNB2;FUZ;GRHL3;MTHFD1;MTHFD1L
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.37722987872283775,-0.9818248198606557,0.47227191413237923,0.7388792277191892,1.0,4/15,15.74%,GBP5;TLR4;NOD2;IL17RA
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.38969324499092395,-0.9816344969256267,0.509090909090909,0.7388248962155732,1.0,9/14,19.50%,GAB1;KDR;VEGFC;VEGFA;FLT4;VEGFD;PIK3CA;PGF;NUS1
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.31578324437839544,-0.9814511174182836,0.4936936936936937,0.7387698764249983,1.0,2/29,0.95%,ANO6;JAM2
prerank,negative regulation of protein secretion (GO:0050709),-0.30038817789014344,-0.9813871922376006,0.47718631178707227,0.7384330286261764,1.0,10/38,18.12%,CCN3;KCNB1;REST;RAB11FIP1;DPH3;RAB11FIP3;APOE;INHBB;RSAD2;CD200
prerank,negative regulation of cilium assembly (GO:1902018),-0.3994828054853759,-0.9813594002149775,0.5088652482269503,0.7380062658117136,1.0,3/12,13.22%,LIMK2;MAP4;CDK10
prerank,positive regulation of axon extension (GO:0045773),0.3595010197008508,0.9810761638640765,0.47912087912087914,0.7938259276295327,1.0,2/22,1.22%,NRP1;SEMA5A
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.3252376995490761,-0.9810633496659797,0.49411764705882355,0.7382159716331511,1.0,6/24,11.36%,NOTCH1;KLF2;VEGFA;ATF4;MBTPS2;HSPA5
prerank,cortical actin cytoskeleton organization (GO:0030866),0.3514739323296653,0.9810293228711713,0.4773662551440329,0.7930509550788047,1.0,5/20,15.71%,ROCK2;FMNL3;FHOD3;LLGL1;RHOQ
prerank,positive regulation of organelle assembly (GO:1902117),0.3037034514437391,0.9810166311268091,0.49284253578732107,0.7921967301143908,1.0,13/44,24.10%,ASAP1;PIP4K2A;PIP4K2B;STX18;FUZ;LRSAM1;NUMA1;RAB3GAP1;NUP62;BBS4;G3BP1;PDCD6IP;CNOT2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.3855228093301847,-0.9809458344672544,0.49913344887348354,0.7379886001644852,1.0,6/13,27.99%,CHP1;UFM1;RANGAP1;RAB23;PARK7;BARD1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.25630499000534046,-0.9808401971571487,0.5237113402061856,0.7377486461097881,1.0,20/84,15.49%,DDX5;NOVA2;MBNL1;ZBTB7A;REST;DDX17;QKI;RBFOX2;SRPK1;SRSF6;NCL;PCBP4;JMJD6;CIRBP;RNPS1;SRSF4;MAGOH;FMR1;SFSWAP;HNRNPK
prerank,error-prone translesion synthesis (GO:0042276),-0.34709942962196616,-0.980523001483208,0.4847908745247148,0.7380103624228953,1.0,8/21,23.62%,UBB;UBC;RPS27A;REV3L;RPA3;POLK;RFC3;RFC2
prerank,plasma membrane tubulation (GO:0097320),-0.3921523301519111,-0.9797164529126691,0.4855595667870036,0.7395371555246769,1.0,6/13,19.65%,FNBP1L;CAVIN2;EHD2;PACSIN1;PACSIN2;PACSIN3
prerank,folic acid metabolic process (GO:0046655),0.3644212626559311,0.9793829028971072,0.46405228758169936,0.7954593887471191,1.0,8/18,23.52%,ALDH1L1;FPGS;SLC46A1;MTHFD1;MTHFD1L;SLC19A1;MTHFR;MTHFD2L
prerank,response to alcohol (GO:0097305),0.32431487831693845,0.9793370321805065,0.47058823529411764,0.7946861123269168,1.0,3/27,7.55%,TGFBR3;GRIN3A;TGFBR1
prerank,ganglioside metabolic process (GO:0001573),-0.34985459603501096,-0.9790911696090874,0.507380073800738,0.7404863655200341,1.0,4/20,6.25%,ST6GALNAC3;ST8SIA4;HEXA;ST8SIA6
prerank,anterograde axonal transport (GO:0008089),-0.30144033689808947,-0.978882849512804,0.48659003831417624,0.7404887761110619,1.0,7/37,8.94%,TRAK1;AP3M1;AP3B1;HSPB1;TRAK2;NEFL;KIF1B
prerank,regulation of receptor internalization (GO:0002090),-0.3101999383703893,-0.9786011660039583,0.4815533980582524,0.7406807728113693,1.0,8/35,16.56%,RIN3;VEGFA;ANKRD13A;INSR;FLOT1;FMR1;SDCBP;GREM1
prerank,RNA transport (GO:0050658),-0.26398776449726374,-0.9778654945712221,0.4911242603550296,0.7419700519543772,1.0,18/71,16.85%,TGFBR2;HNRNPA2B1;SRSF5;SRSF2;SRSF6;FLOT1;U2AF1;ZC3H11A;RNPS1;SRSF4;MAGOH;NUP188;FMR1;CHTOP;NUP155;ALYREF;DDX39B;HNRNPA1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.3839885571275652,-0.9777438654242542,0.4991055456171735,0.7417723354073044,1.0,5/14,14.08%,NT5E;UPP2;NT5C;NT5C1A;CAD
prerank,fatty acid elongation (GO:0030497),-0.3916072314594481,-0.9777313094482507,0.5167910447761194,0.7413185712080615,1.0,4/13,19.90%,ELOVL7;ELOVL5;ELOVL1;HACD4
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.32037180272774224,-0.9770722079801497,0.5047984644913628,0.7424421662643753,1.0,13/28,27.57%,MAP3K5;DAB2IP;ATP2A3;ATF4;BAX;BAK1;BBC3;SELENOK;TRIB3;ERO1A;BRSK2;TMEM117;ERN1
prerank,dephosphorylation (GO:0016311),-0.2310662192716854,-0.9770037809303276,0.4921259842519685,0.7421082622466225,1.0,50/147,27.89%,PTPRB;PTPRG;PTPN14;CTTNBP2NL;PTPRJ;PLPP1;CTDSP1;PTPRM;SSH2;PPP3CC;PPP2R1A;PPM1F;PPP2R5A;NT5C;PPP1CB;PPP2R1B;DUSP3;PPP5C;PPP3CB;PNKP;PPP2R2A;CDC14B;PTPN12;MTM1;PTPN6;DUSP23;UBLCP1;PPP2R5E;DUSP11;PTPRK;PLPP2;PTPRO;PTPRU;PPP1CA;TIMM50;PTPN22;PPP1R12A;ACP6;DUSP4;PPM1M;PPEF2;SGPP1;PTPN1;PPP2R5B;PDP1;MTMR2;THNSL2;DUSP1;PLPP6;DUSP6
prerank,tRNA processing (GO:0008033),-0.2683009641495998,-0.9767911684427408,0.5058823529411764,0.7421253971314191,1.0,28/61,35.01%,SARS1;THUMPD1;TRMT9B;QTRT2;URM1;TRMT10C;FARS2;TRDMT1;QTRT1;TSEN54;TRPT1;RPP21;CPSF4;TRMT6;AARS2;RTCB;ANKRD16;ADAT1;METTL1;ADAT2;CTU2;RTRAF;KARS1;TSEN2;RPP40;TYW5;THG1L;AARS1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.25553193958978493,0.9765910060920615,0.45857418111753373,0.8007069399114065,1.0,9/98,4.19%,CEMIP;PIK3R1;LRP1;DPP10;PDPK1;EPHA3;SLC5A3;BCL2;TFDP1
prerank,response to retinoic acid (GO:0032526),-0.27066638691292655,-0.9750007605832952,0.4849624060150376,0.745811628716423,1.0,12/59,10.92%,ACER2;PTK2B;TBX1;FZD4;RARA;WNT9A;GATA6;TRIM16;NDUFA13;FZD7;WNT11;ABL2
prerank,regulation of cholesterol transport (GO:0032374),0.35732754945135475,0.9748536265913262,0.475,0.8042134275352494,1.0,4/20,8.43%,LRP1;YJEFN3;ABCB4;ABCA5
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.3189781353886213,0.9748162118025233,0.47443762781186094,0.8034145213020958,1.0,4/32,5.86%,ARHGAP6;PHLDB2;DLC1;SERPINE1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.3646581087520243,-0.9744800590554394,0.5109090909090909,0.7465634141320089,1.0,4/16,11.58%,NT5E;UPP2;NT5C;NT5C1A
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.3594550837699412,-0.9740391394407792,0.5236363636363637,0.7471392589381931,1.0,5/18,15.70%,RAP1A;RAP1B;SLC4A8;FMR1;RIMS4
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.4153513615068297,0.9738353812217081,0.4966887417218543,0.8049334871908989,1.0,2/10,5.80%,HECW2;HECW1
prerank,peptidyl-threonine modification (GO:0018210),-0.26502953263021567,-0.9737032778269928,0.5158730158730159,0.747453963823012,1.0,16/66,16.67%,TGFBR2;HIPK1;NLK;WNK1;CAMK2D;PRKDC;DYRK2;AKT1;CDC42BPB;CSNK2B;LMTK2;ACVR1;CDK10;CAD;CSNK2A1;CSNK2A2
prerank,non-motile cilium assembly (GO:1905515),0.317195445529448,0.97366328935193,0.49056603773584906,0.8044578767302617,1.0,13/30,24.83%,TMEM17;TTC8;C2CD3;IFT122;FUZ;PIBF1;ARL13B;IFT88;IFT57;BBS4;TMEM107;TMEM80;CSNK1D
prerank,cardiac myofibril assembly (GO:0055003),0.37246265457478783,0.973624377618266,0.47980997624703087,0.8036871749816031,1.0,6/15,15.17%,PDGFRA;CSRP3;FHOD3;PDGFRB;OBSL1;MYLK3
prerank,negative regulation of platelet activation (GO:0010544),-0.36890298781169484,-0.9734386870320028,0.5107632093933464,0.747579281824522,1.0,7/16,16.72%,NOS3;PRKG1;THBD;CD9;PDGFA;APOE;ADAMTS18
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.4150227800277968,-0.972595490832758,0.5027124773960217,0.7491642897999312,1.0,5/10,14.33%,CALM1;CACNB3;CALM3;SRI;NIPSNAP2
prerank,glycerophospholipid metabolic process (GO:0006650),-0.258352523094046,-0.9719593095211504,0.49521988527724664,0.7502102500741851,1.0,26/75,32.84%,GPCPD1;DGKH;PLCB3;PIGL;PIGF;CSF1R;FAR1;PIGC;ENPP6;SYNJ1;LCAT;PLA1A;PIGW;GDE1;CPNE3;PLA2G4F;ACP6;PLA2G4B;PIP5K1A;PLCB1;ABHD6;PLEK;SERINC5;PIGM;PLCB2;PLA2G7
prerank,ubiquinone biosynthetic process (GO:0006744),-0.37366608112555677,-0.971863898788933,0.512962962962963,0.7499390992089029,1.0,6/15,21.78%,PDSS2;COQ6;NDUFA9;COQ8A;COQ7;UBIAD1
prerank,histone H4 deacetylation (GO:0070933),-0.42887173109069,-0.9716646288657969,0.5330739299610895,0.749910636287466,1.0,3/10,7.83%,REST;HDAC9;HDAC4
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.29879393491066997,0.9714153354512586,0.5,0.8083478763763204,1.0,5/39,9.59%,TCF7L2;IRS2;NLGN2;TM7SF3;AIMP1
prerank,regulation of phagocytosis (GO:0050764),0.28201644684610716,0.9712733921358366,0.5348837209302325,0.8078130068440847,1.0,4/53,2.20%,CAMK1D;PRTN3;PLA2G5;AHSG
prerank,regulation of melanin biosynthetic process (GO:0048021),0.41030815206839844,0.9712126108217374,0.49107142857142855,0.8070816174978099,1.0,3/10,11.94%,ZEB2;MFSD12;CTNS
prerank,activation of GTPase activity (GO:0090630),-0.25328416296086925,-0.9708556097799232,0.5235294117647059,0.7513853474244478,1.0,35/89,24.45%,ARHGAP42;SIPA1L1;SGSM2;RALGAPA2;TBC1D8;ARHGEF15;GRTP1;BCAS3;ARHGAP25;CCDC125;TBC1D1;TBC1D12;BCR;TBC1D22A;RALGAPB;SIPA1;GMIP;SIPA1L3;ABR;ARHGEF5;TBC1D9B;TBCK;EPHA2;TBC1D25;TBC1D2;ECT2;RANGAP1;APC2;ADPRH;TBC1D15;ARHGAP45;RAP1GAP;NGEF;TBC1D30;TBC1D17
prerank,central nervous system neuron axonogenesis (GO:0021955),0.38927302398821906,0.9708109334539236,0.4835680751173709,0.8071757318503352,1.0,3/12,10.32%,MYCBP2;EPHB1;PTEN
prerank,T cell receptor signaling pathway (GO:0050852),-0.23116524319292625,-0.9705838698147083,0.5141700404858299,0.7515345053602096,1.0,43/138,24.64%,PTPRJ;PLCG2;WNK1;PDE4D;INPP5D;IKBKB;DENND1B;PSMA6;RC3H1;NFKBIZ;TNFRSF21;PSMB5;PSMC4;PSMC5;PSMD14;BTN3A3;PSMD8;PIK3CA;LCP2;PSMC1;PIK3R2;EIF2B3;PSMB4;TAB2;PSMD11;PSMD12;RELA;CHUK;TXK;PRAM1;CUL1;FYB2;PSMA1;PSMC3;NCK1;PSMB1;PTPN22;CSK;PSMA2;PSMA4;PRKD2;BCL10;TRAF6
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.21347062523034083,-0.9703458501022822,0.5565217391304348,0.7515923980067064,1.0,39/291,11.28%,MEF2C;ACTB;RAP1A;LBP;ESR1;MTR;VIM;PXN;RAP1B;PTK2B;TGM2;SH3BP4;FOXO1;MAPK3;TBX1;RAPGEF1;FZD4;RPS3;SLIT2;DAB2IP;CAPN2;IGFBP5;PDE2A;GUCY1B1;KCNQ1;EZR;WNT9A;NRIP1;TNFRSF1B;NDUFA13;FZD7;PLAA;AKT1;WNT11;AKAP6;VCP;ABL2;TIRAP;IMPACT
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.4047628507825919,-0.9702936670432472,0.5072992700729927,0.7512332021426732,1.0,5/11,16.56%,MEF2C;TGFB1;FZD7;SOX6;GREM1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.3916734257839062,-0.9699905392378848,0.503690036900369,0.7514641745407356,1.0,5/13,17.76%,CD44;TWIST1;PTTG1IP;CD74;KDM1A
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.2856284699952305,-0.9694686987843352,0.4934823091247672,0.7522320127404143,1.0,9/42,17.91%,ACTB;ARID1A;MTA2;MBD3;SMARCA4;SMARCA2;GATAD2B;RBBP4;CHD4
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.3124502018326403,-0.969417341576894,0.533210332103321,0.7518634221856157,1.0,14/30,33.58%,LBR;ACLY;ACAA2;DHCR24;TM7SF2;FDPS;LSS;IDI1;PLPP6;ACAT2;EBP;INSIG1;HMGCR;ARV1
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.22437924607697043,-0.9692339329364875,0.504835589941973,0.7518353464023212,1.0,42/198,16.22%,PTPRB;PLCE1;ITPKB;PLCG2;LIMK2;GPI;MAPK3;HK1;PLCB3;TNFAIP8L3;CALM1;TGFB1;INPP5D;PLPP1;IPMK;PFKP;NT5C;PLAA;AKT1;PIP4P1;PLAAT3;TOLLIP;INPP5A;ISYNA1;LIMD1;DUSP3;PPP3CB;GFPT1;PNKP;NUDT4;SPHK2;AGPAT1;CERKL;IP6K1;PIK3CA;COQ8A;GPX4;SYNJ1;PGK1;DUSP23;IMPA2;MINPP1
prerank,neuron development (GO:0048666),0.24022609882322002,0.9690988851596483,0.5150905432595574,0.8105781332228107,1.0,32/141,14.72%,TENM3;GDNF;GLI2;CNTN4;CNTNAP2;GPM6A;RUNX3;GPRIN2;TENM2;PBX4;LYN;GPRIN1;TBC1D24;DOCK7;NLGN1;PPP1R9A;RYK;EPHA8;CAMSAP1;CDK5R1;EPHA5;ALK;ATP8A2;LRP12;ATXN10;GBA2;RASGRF1;CDK16;SNAPIN;MAPT;SAMD14;TENM1
prerank,response to UV-A (GO:0070141),-0.3835707632750106,-0.9690320919694312,0.5194085027726433,0.7518608447649026,1.0,8/14,36.80%,AKT1;OPN3;EGFR;CCND1;PPID;MMP1;CERS1;MMP3
prerank,positive regulation of transmembrane transport (GO:0034764),-0.3810390350514612,-0.9683522665613498,0.4963235294117647,0.752980892979864,1.0,1/13,0.24%,ANO6
prerank,regulation of potassium ion transport (GO:0043266),0.3095007407274861,0.9682604880202492,0.5033557046979866,0.8117395906961014,1.0,7/31,14.70%,KCNIP4;DPP10;ANK2;KCNIP3;ACTN2;DPP6;DRD2
prerank,protein hydroxylation (GO:0018126),-0.37102560217606856,-0.9679782687652029,0.5172413793103449,0.753382122900438,1.0,4/15,13.32%,EGLN3;PLOD2;PLOD3;P3H2
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.38050432551929614,0.9678785927628172,0.4978723404255319,0.8118127365733211,1.0,1/14,1.41%,OCSTAMP
prerank,regulation of dendritic spine development (GO:0060998),-0.3447885919135664,-0.9676145969841246,0.5169172932330827,0.7537442423702748,1.0,5/19,13.85%,MEF2C;SHANK3;CAMK1;FMR1;APOE
prerank,autophagy of nucleus (GO:0044804),0.36464104199279096,0.9672899242910299,0.4693446088794926,0.8124664228298584,1.0,7/16,21.76%,WDR45B;WIPI1;ATG12;ULK2;ATG9A;WDR45;ATG5
prerank,regulation of cell size (GO:0008361),0.3444462371530152,0.9668698175796075,0.5324384787472036,0.8126016463423122,1.0,4/23,10.32%,PRR16;DEPTOR;RARG;PTEN
prerank,secondary palate development (GO:0062009),0.3792789746802507,0.9666025256404343,0.4923413566739606,0.8124473143063415,1.0,3/14,4.99%,TGFBR3;CHD7;LRRC32
prerank,phagosome-lysosome fusion (GO:0090385),0.41893798615177974,0.9665388532355816,0.5382882882882883,0.811714515957998,1.0,4/10,20.19%,PLA2G5;CLN3;RAB20;RAB7B
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.3408541822905853,0.9662785373337343,0.5100222717149221,0.8114731658140412,1.0,1/22,0.31%,PPM1E
prerank,chromosome condensation (GO:0030261),-0.29661724471259765,-0.9659378894909272,0.5,0.7571837646133914,1.0,19/36,32.40%,SMC4;RB1;CSNK2B;TOP2A;CSNK2A1;CSNK2A2;SMC2;NCAPH;NCAPG;DFFB;ACIN1;NCAPH2;BANF2;KMT5A;TTN;BANF1;CDK1;PLK1;NCAPD2
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.2776478152095285,-0.9655153734718912,0.53,0.7576830408191396,1.0,23/53,29.76%,OPHN1;DAB2IP;HSP90AB1;UBB;PKD1;GPX1;FOXF2;DDRGK1;PSMC5;PSMD14;FMR1;APOE;UFL1;OSBPL7;PSMC3;ALAD;RAD23A;F8A1;TREM2;RAD23B;ECSCR;XPO1;USP14
prerank,regulation of AMPA receptor activity (GO:2000311),-0.3203741095991226,-0.9654828477891709,0.5113636363636364,0.757273576821234,1.0,3/25,5.20%,MEF2C;SHANK3;MINK1
prerank,peptidyl-lysine dimethylation (GO:0018027),0.35548498658776945,0.9653480802570964,0.5021008403361344,0.812903125926698,1.0,5/18,11.54%,KMT2A;PRDM9;SETMAR;SETD7;EHMT2
prerank,regulation of cholesterol efflux (GO:0010874),-0.3141539419698408,-0.9652266530237578,0.5018518518518519,0.7573605884557832,1.0,7/30,15.83%,CAV1;PLTP;NFKBIA;NAXE;ABCA2;APOE;NR1H2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.26627032105742743,0.9652115230852782,0.538135593220339,0.8123621026172804,1.0,7/75,2.94%,NRP1;BMP2;SEMA5A;PDPK1;PRKCA;VEGFB;AKT3
prerank,monoacylglycerol metabolic process (GO:0046462),0.37890997942504756,0.9648193398808192,0.47435897435897434,0.8124366612843786,1.0,4/13,14.89%,PLA2G4A;MOGAT3;MOGAT2;DGAT2
prerank,positive regulation of RNA splicing (GO:0033120),0.322270625295737,0.9647891844995392,0.497907949790795,0.8116307863313728,1.0,4/29,7.83%,PIK3R1;DAZAP1;TRA2A;CELF4
prerank,inorganic ion transmembrane transport (GO:0098660),-0.3981047960489516,-0.964745071979677,0.5070921985815603,0.7580119107866868,1.0,7/12,32.34%,ABCC9;KCNJ8;CACNA1H;ABCC8;PKD2;TRPM4;P2RX3
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.3789585419870428,-0.9644504934778377,0.4896421845574388,0.7582328803810578,1.0,5/14,16.69%,UQCC2;COA3;TRMT10C;RPUSD4;FASTKD3
prerank,protein localization to nucleus (GO:0034504),-0.24250406484754694,-0.9641663540336326,0.5445134575569358,0.7584432221818935,1.0,30/102,26.31%,ZBTB7A;SIX1;RPL11;NUP93;AKT1;HHEX;PTTG1IP;ARL2BP;E2F3;SYK;TOR1AIP1;NUP188;PHB2;NUP155;TNPO3;CHCHD10;RPAIN;TSC2;ARL2;MSX1;TOR1AIP2;CNEP1R1;NXT2;TNPO2;FAM53A;RPF2;IPO13;SEC13;NUP107;YWHAE
prerank,regulation of lipid metabolic process (GO:0019216),0.2551084808894034,0.9639667594855976,0.4932562620423892,0.8128062562948084,1.0,6/88,2.32%,RORA;TBL1XR1;CHD9;NCOA2;PPARA;PRKAG2
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.3042489630541874,-0.9638633602089174,0.5103969754253308,0.7586879937987238,1.0,10/33,21.68%,FOXO3;ETS1;PRKDC;TAL1;INHBA;HSPA1A;FAM210B;STAT1;HSPA1B;MAPK11
prerank,protein maturation (GO:0051604),-0.24951974750120356,-0.9633002136987965,0.5215686274509804,0.7595182935052358,1.0,18/95,16.93%,TSPAN5;NNAT;SRGN;F3;ADAM10;BACE1;ADAM19;CPE;PSENEN;HSPD1;TSPAN14;MMP14;LMF2;NAA60;APH1A;TSPAN17;PHEX;CCS
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.25352324253631675,-0.9630827299492306,0.5076335877862596,0.7595364258066981,1.0,23/79,20.89%,CRIM1;BMPER;THBS1;NOTCH1;BMPR2;SMAD9;SLIT2;DAB2IP;SMAD7;SMAD6;HHEX;SKIL;HTRA3;FGF2;EPN2;SMURF1;SMAD4;GREM1;SKI;SPRY1;BMPR1B;BAMBI;CADM4
prerank,dicarboxylic acid catabolic process (GO:0043649),0.3899464617001084,0.9628796669901089,0.5384615384615384,0.8146314029142864,1.0,3/13,9.05%,ASPA;DDO;GLUL
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.3484941643434221,-0.9625091597593071,0.4981203007518797,0.76042553794725,1.0,3/18,6.15%,CD34;HDAC7;EZR
prerank,glutamate metabolic process (GO:0006536),0.357347458239915,0.9622088670746012,0.512087912087912,0.8155010900446489,1.0,5/19,10.92%,ALDH18A1;PRODH;GLS2;GLUL;FPGS
prerank,regulation of mitochondrial translation (GO:0070129),-0.34341391517622766,-0.9621484844656261,0.5,0.7607737150623298,1.0,6/21,16.69%,UQCC2;TSFM;COA3;TRMT10C;RPUSD4;FASTKD3
prerank,chemokine-mediated signaling pathway (GO:0070098),-0.28424863265232747,-0.9615028360381159,0.5099206349206349,0.7617565643356375,1.0,5/42,11.34%,ACKR3;PTK2B;WNK1;CCL15;CIB1
prerank,regulation of cation transmembrane transport (GO:1904062),0.3145468258102136,0.9612754859294277,0.49455337690631807,0.8169646501969045,1.0,12/29,23.19%,KCNIP4;DPP10;KCNIP3;DPP6;WNK3;FGF12;DLG1;ATP2B4;PDZK1;KCNAB2;RANGRF;SCN5A
prerank,positive regulation of T cell differentiation (GO:0045582),0.3076520876950944,0.9611349260265919,0.4979166666666667,0.8164251345954973,1.0,5/36,5.22%,GLI2;IL4I1;GLI3;RHOH;IL4
prerank,cellular response to glucose stimulus (GO:0071333),-0.3083097385794594,-0.961132862013648,0.5274509803921569,0.7621034410141435,1.0,4/30,3.37%,IGF1R;UNC13B;RACK1;KCNB1
prerank,mRNA metabolic process (GO:0016071),-0.2485120869092668,-0.9610876653627594,0.5291828793774319,0.7617229581429629,1.0,31/90,27.72%,DDX5;HNRNPA2B1;PPARGC1A;PRPF8;SRSF5;SRSF2;DHX15;SNRPD3;LSM11;U2AF1;SFPQ;DIS3L2;YTHDF2;SRSF4;SF3A3;HSPA1A;RNH1;SNRPG;SCAF11;LSM2;LSM3;HSPA1B;TBRG4;LSM10;NCBP2;SF3A1;SNRPB;SF3A2;HNRNPR;ERN1;KIN
prerank,"phagocytosis, engulfment (GO:0006911)",-0.2973967893460056,-0.9608455421902281,0.5103578154425612,0.7618475841686567,1.0,5/36,5.58%,THBS1;DOCK1;VAMP7;RAC1;ARHGAP25
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.29230241814578345,-0.9606320792770068,0.5239005736137667,0.7618678142818559,1.0,13/39,15.24%,TSPAN5;NOS3;NOTCH1;CCN3;TGFB2;NEPRO;JAG2;NOTCH4;TSPAN14;TM2D3;POGLUT1;EPN2;NOD2
prerank,fat cell differentiation (GO:0045444),0.26936187702712505,0.9603588194482574,0.5342465753424658,0.8174720253156019,1.0,5/57,6.30%,TCF7L2;PID1;OSBPL8;SENP2;ATF5
prerank,cellular response to radiation (GO:0071478),-0.2905565176111997,-0.9599978164056252,0.5243664717348928,0.7628629584039945,1.0,21/40,33.33%,NET1;EEF1D;RAD1;RHOB;RAD9B;HUS1;OPN3;CDKN1A;RAD9A;ECT2;GADD45A;RHNO1;CLOCK;LIG4;RAD51AP1;SWI5;TNKS1BP1;RRH;FIGNL1;OPN1MW3;OPN1MW
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.23652017207564605,-0.9599109539773171,0.5615866388308977,0.7625775354949134,1.0,44/128,27.15%,DCTN2;CCNY;TPD52L1;TUBA1A;CEP164;PPP2R1A;PRKAR2B;CEP57;CEP192;NES;CEP70;DCTN3;CEP290;DCTN1;PPP1CB;PPP1R12B;CNTRL;TUBB4B;PCM1;HAUS1;NDE1;PPP2R2A;FBXL7;CETN2;CEP72;YWHAG;CDKN1A;FBXL3;HSP90AA1;CEP41;CUL1;DNM2;LCMT1;TUBA4A;ARPP19;PLK3;PPP1R12A;CEP63;BRSK2;HAUS4;NEDD1;YWHAE;CDKN2B;FBXL8
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.36360912650151667,-0.9598648821592607,0.515370705244123,0.7622001632429654,1.0,3/15,12.33%,ARPC1B;ARPC5;ACTR3
prerank,T cell differentiation (GO:0030217),0.29321629910939684,0.9596273527179275,0.504,0.8184095957425302,1.0,5/40,3.93%,KIT;CHD7;LEPR;GLI3;RHOH
prerank,branched-chain amino acid catabolic process (GO:0009083),0.34622327596796676,0.9594244675658498,0.48210526315789476,0.8171812630870592,1.0,10/20,20.73%,ACADSB;BCKDHB;ALDH6A1;HIBADH;DBT;ACAD8;IVD;MCCC2;BCAT1;BCAT2
prerank,branched-chain amino acid metabolic process (GO:0009081),0.34622327596796676,0.9594244675658498,0.48210526315789476,0.8171812630870592,1.0,10/20,20.73%,ACADSB;BCKDHB;ALDH6A1;HIBADH;DBT;ACAD8;IVD;MCCC2;BCAT1;BCAT2
prerank,sodium ion import across plasma membrane (GO:0098719),-0.36290042831316416,-0.9592644432266149,0.5028571428571429,0.7631258278264527,1.0,2/17,0.94%,SLC9A2;SLC12A2
prerank,negative regulation of DNA replication (GO:0008156),-0.37910677762236217,-0.9592532267398701,0.5186567164179104,0.7626585861960692,1.0,4/13,19.57%,CDAN1;RAD17;WAPL;TSPYL2
prerank,neuromuscular process controlling balance (GO:0050885),0.3935774575667812,0.959134504880855,0.49333333333333335,0.8170085259799077,1.0,4/12,16.10%,NRXN1;PCDH15;CLN3;CLRN1
prerank,macrophage differentiation (GO:0030225),0.3845060199223185,0.958897646148228,0.49137931034482757,0.8167008800470513,1.0,1/13,0.35%,IL31RA
prerank,positive regulation of cellular protein localization (GO:1903829),-0.2597249366151544,-0.9584807973294844,0.5196687370600414,0.7639973963798128,1.0,30/69,32.03%,LIMK2;TFRC;STX3;FERMT2;HSP90AB1;TGFB1;RIC3;GPR137B;AKT1;DDRGK1;GAS8;CDK5RAP3;MAP1A;SESN2;NDC80;MEAK7;CCDC88A;NECAB2;DTX3L;CARD10;STX4;PARK7;LAMTOR5;PARP9;TRAPPC12;TYROBP;CDK1;PARD6A;PLK1;ENTR1
prerank,macroautophagy (GO:0016236),-0.23856179581407735,-0.9584363830340519,0.5345528455284553,0.7636178889009041,1.0,34/118,20.25%,PLEKHM1;MAP1LC3B;VAMP7;GABARAP;CHMP2B;MTMR14;LIX1L;TECPR1;PLAA;CSNK2B;ATG7;ATG3;VCP;ULK3;KLHL3;VPS36;TOMM22;MAP1LC3A;MTERF3;PGAM5;TSG101;PRKAG1;SNF8;VPS33A;CSNK2A1;CSNK2A2;VPS16;CHMP2A;VTI1B;AMBRA1;DYNLL2;ARL8B;TOMM5;WIPI2
prerank,B cell homeostasis (GO:0001782),0.4113671297361817,0.9582302490959265,0.49673202614379086,0.817536714401905,1.0,3/10,4.18%,DOCK11;DOCK10;LYN
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.2736668502707117,0.958052296785364,0.5078431372549019,0.8170986417290553,1.0,9/59,10.95%,TCF7L2;CDK8;MITF;CEBPB;AGO4;TNRC6A;PPM1D;PTEN;TNRC6B
prerank,histone modification (GO:0016570),0.244415222970756,0.9578930091379347,0.5447316103379721,0.816609709115269,1.0,24/109,15.91%,EYA2;TBL1XR1;PRDM5;MAP3K12;TAF6L;HDAC10;BAZ1B;SIRT2;EYA1;NSD1;ATXN7;KAT8;MIER3;BRMS1L;BRMS1;EHMT2;NEK11;AURKC;NSD3;EZH2;EP300;KAT5;PADI1;HDAC1
prerank,membrane repolarization (GO:0086009),-0.37306309885768546,-0.9577221029049128,0.5173674588665448,0.764779106179561,1.0,4/15,7.01%,KCNJ2;ATP1A1;KCNQ1;ATP1B1
prerank,aspartate family amino acid metabolic process (GO:0009066),0.3595826661619541,0.9575635021812698,0.5033112582781457,0.8165517943826094,1.0,9/18,22.27%,ASPA;SLC25A13;FOLH1;MTHFD1;ASS1;ASPG;GOT1;MTHFR;GOT2
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.38765619717843736,0.957336978158149,0.5132743362831859,0.8162462730091369,1.0,2/13,3.26%,BCL2L11;VDAC2
prerank,regulation of neutrophil migration (GO:1902622),-0.406125188375305,-0.9572494061762353,0.5365418894830659,0.765435976127652,1.0,2/10,5.00%,JAM3;RAC1
prerank,regulation of protein localization to centrosome (GO:1904779),0.4169733249659822,0.9571655994661571,0.4925373134328358,0.8157891831079452,1.0,4/10,20.96%,UBXN2B;BICD1;NUP62;APC
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.3301315085659688,-0.9568644035483052,0.5173674588665448,0.7658564176684027,1.0,12/23,36.10%,SEL1L;VCP;SURF4;FAF2;SEC61B;DERL2;TMEM129;SEC13;DERL1;SYVN1;OS9;AUP1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.3124224511463142,-0.9567475629770382,0.5273722627737226,0.7656334123846681,1.0,8/27,25.47%,CTPS1;CTPS2;RRM1;GLRX;GSR;TYMS;NME1;AK9
prerank,protein modification by small protein conjugation (GO:0032446),-0.20506235343081378,-0.9563172850036993,0.614190687361419,0.7661559074477733,1.0,90/361,20.02%,WWP1;NEDD4L;RACK1;IFIH1;LMO7;MSL2;DCUN1D5;RNF41;UBB;WWP2;RLIM;UBC;RPS27A;KLHL2;UFM1;STX1A;UBE2Q2;USP7;RNF38;PRKDC;NUP93;TRIM47;DCUN1D1;CUL4A;FBXO4;ANAPC11;DTX3;TRIM14;TRIM28;ARRDC1;NUP54;NDC1;HERC2;ATG7;DDRGK1;UBE2G2;ATG3;USP5;VCP;USP9X;TNFAIP1;UBE2F;KLHL3;MIB2;SAE1;TRIM62;FBXW5;FBXL2;ITCH;SUMO3;TRIM68;NUP188;RBX1;URM1;RNF20;VPS11;RNF111;SMURF1;TRIM5;UBE2G1;NUP155;RANBP2;RAD18;FBXL7;CCNF;TSPAN17;UFL1;ANAPC7;UCHL3;DTX2;FBXL3;UBA2;KCTD10;UFC1;GAN;CDC27;NUP37;KLHL9;KLHL21;TRAIP;ELOB;AMFR;CUL1;RANGAP1;CDK5RAP3;UBA5;TMEM129;CCDC22;UBE2B;ZSWIM8
prerank,regulation of phosphorylation (GO:0042325),0.24313087903186845,0.9562147906310378,0.5429141716566867,0.8172982433686504,1.0,18/120,11.08%,NRP1;SRPX2;LDB2;AR;PRKAG2;FNIP1;STAP1;PHIP;LYN;DYNLL1;IL4;GLMN;SIRT2;NUP205;NUP35;ANKLE2;PLXNB2;ANG
prerank,DNA methylation or demethylation (GO:0044728),0.3486821865000144,0.9558768803887734,0.5031185031185031,0.8164184595019097,1.0,6/19,21.39%,PPM1D;DNMT1;EHMT2;TEX15;DNMT3B;ATF7IP
prerank,DNA alkylation (GO:0006305),0.3486821865000144,0.9558768803887734,0.5031185031185031,0.8164184595019097,1.0,6/19,21.39%,PPM1D;DNMT1;EHMT2;TEX15;DNMT3B;ATF7IP
prerank,diacylglycerol metabolic process (GO:0046339),-0.33183978916007817,-0.9557484168075567,0.5447470817120622,0.7670249949467375,1.0,2/23,1.75%,PLCE1;DGKH
prerank,positive regulation of stem cell proliferation (GO:2000648),0.36634728507415937,0.9557064527527624,0.5212765957446809,0.8159631240213875,1.0,4/17,14.20%,GJA1;THPO;LTBP3;N4BP2L2
prerank,protein polyubiquitination (GO:0000209),-0.2081522862257742,-0.9552826812431353,0.6148936170212767,0.7677154602934955,1.0,89/297,24.87%,WWP1;NEDD4L;LMO7;RNF144B;HERC6;RNF41;UBB;WWP2;ZNRF1;RLIM;UBC;RPS27A;UBE2Q2;RNF125;FBXO17;CBFB;RNF114;PSMA6;RC3H1;NHLRC3;FBXO4;PSMB5;UBE2L6;ANAPC11;TRIM14;UBE2G2;PSMC4;FBXL14;PSMC5;KLHL3;MIB2;UBE2Q1;RNF5;FBXW10;TRIM62;PSMD14;FBXW5;TRAF1;TRIM56;LNPEP;ITCH;TRIM68;RBX1;RNF20;SMURF1;PSMD8;TRIM5;UBE2G1;FBXL7;WSB1;CCNF;HECTD1;PSMC1;ANAPC7;FBXL3;PSMB4;PSMD11;FBXL16;PSMD12;FBXW2;CDC27;PELI1;FZR1;TNFAIP3;RNF19A;ZNRF2;AMFR;CUL1;TMEM129;UBE2B;UBE3A;PSMA1;PSMC3;BLMH;ANAPC2;BFAR;PSMB1;PSMA2;DTL;NPEPPS;FBXL19;PSMA4;RNF187;FBXO6;FBXL18;DTX3L;TRAF6;UBE4A;UBE2J2
prerank,extracellular matrix disassembly (GO:0022617),-0.2726708914779882,-0.9549630189103598,0.5230769230769231,0.7679760747981064,1.0,10/53,12.42%,BSG;TLL1;CAPN2;ADAM15;CD44;ADAM10;KIF9;FLOT1;MMP14;MMP15
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.3875524595264763,-0.9548137088525667,0.5115830115830116,0.7678454396893886,1.0,9/13,46.32%,IRAK2;PIK3AP1;IRAK4;TRAF6;PIK3R4;TNIP2;PIK3C3;MYD88;UNC93B1
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.2647949744861805,-0.9545386700678392,0.5634920634920635,0.7680025276761587,1.0,18/64,19.48%,MGLL;EPHX1;LTA4H;CYP1B1;GPX1;HACL1;ASAH2;ELOVL5;ACADL;GSTM2;CPT1A;ACSL5;FAAH;GPX4;ACOT8;DAGLB;ELOVL1;ACOT2
prerank,chemical homeostasis (GO:0048878),-0.2639481317296482,-0.9544450107990112,0.5621301775147929,0.7677363360267537,1.0,10/61,12.14%,SLC4A10;NEDD4L;WNK1;AQP11;USF2;SLC4A8;ACOX3;PNPLA2;KLHL3;SLC4A2
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.355183642727938,-0.95416627444338,0.5231053604436229,0.7679730703761001,1.0,2/16,3.44%,ST3GAL4;ETS1
prerank,cardiac muscle cell contraction (GO:0086003),-0.3434161493736252,-0.9541144592895985,0.5358490566037736,0.7676151869905716,1.0,8/19,21.35%,KCNJ2;ATP1A1;CAMK2D;CACNA1D;SCN1A;PIK3CA;SCN2B;CACNA1C
prerank,establishment of skin barrier (GO:0061436),-0.37194499031858863,-0.9539286868678264,0.519927536231884,0.7670889803413923,1.0,7/15,29.88%,LSR;HRNR;MET;SFN;CLDN1;STMN1;ALOXE3
prerank,regulation of water loss via skin (GO:0033561),-0.37194499031858863,-0.9539286868678264,0.519927536231884,0.7670889803413923,1.0,7/15,29.88%,LSR;HRNR;MET;SFN;CLDN1;STMN1;ALOXE3
prerank,protein import into nucleus (GO:0006606),-0.25881325730996463,-0.9537779433378104,0.5460122699386503,0.7669247583258194,1.0,22/66,26.31%,RPL23;NUP93;KPNA1;AKT1;NUP54;PTTG1IP;E2F3;SYK;NUP188;PHB2;NUP155;RANBP2;TNPO3;RPAIN;TSC2;KPNA4;NXT2;TNPO2;FAM53A;IPO13;SEC13;NUP107
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.3889176257927154,-0.95348692076385,0.527306967984934,0.7671229416787375,1.0,4/12,22.52%,MPHOSPH8;TRIM28;TASOR;SETDB1
prerank,peptide metabolic process (GO:0006518),-0.2554895622069557,-0.9534423741741468,0.5330812854442344,0.7667450466696337,1.0,19/75,15.79%,DMD;TPP1;BACE2;BACE1;LTA4H;ERAP1;IDE;SPCS1;GPX1;CPE;GSTA4;CARNMT1;GSTM2;SEC11A;GSTA3;LNPEP;ACE;GSTM1;GSR
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.27634535880863637,-0.9532928773786193,0.5538160469667319,0.7666196196074663,1.0,9/49,13.77%,SGMS1;CAV1;RACK1;NDUFA13;BAX;BCL2L1;BBC3;BCAP31;NDUFS3
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.40421622933420787,-0.9521177134574027,0.5473684210526316,0.7684028307868188,1.0,5/10,31.58%,AP2M1;AP2A1;CLTA;AP2A2;AP2B1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.40421622933420787,-0.9521177134574027,0.5473684210526316,0.7684028307868188,1.0,5/10,31.58%,AP2M1;AP2A1;CLTA;AP2A2;AP2B1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.40214084241273895,-0.952054351555103,0.5425742574257426,0.7680697634803483,1.0,7/11,31.69%,MFHAS1;TIRAP;TNFAIP3;TREM2;TLR6;TLR1;PJA2
prerank,cellular component disassembly (GO:0022411),-0.27251369020510985,-0.9514221671078226,0.5344827586206896,0.7691415552380515,1.0,10/53,12.42%,BSG;TLL1;CAPN2;ADAM15;CD44;ADAM10;KIF9;FLOT1;MMP14;MMP15
prerank,RNA stabilization (GO:0043489),0.3086703058388259,0.9512769104007344,0.5280172413793104,0.8260474639974598,1.0,7/33,14.95%,TENT5A;GDNF;AXIN2;PHAX;TENT5B;PARN;RBM24
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.3216044431991409,0.9510900390381947,0.5057471264367817,0.8256607503864298,1.0,4/24,9.13%,PID1;LEPR;SLC25A13;NDUFS1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3181787195546816,0.9507278931939896,0.5299334811529933,0.8257387367632134,1.0,7/31,10.12%,PARD3B;DLG2;RAP2A;ANK1;PDZD11;LRRC7;PRKCI
prerank,positive regulation of histone modification (GO:0031058),-0.2967656896382937,-0.9505921291744228,0.5324675324675324,0.7706359481659463,1.0,8/33,17.76%,RPS6KA5;MAPK3;PPARGC1A;CTBP1;TADA2B;FMR1;CHTOP;KDM1A
prerank,intracellular protein transport (GO:0006886),-0.20793334359673474,-0.950495532693127,0.6228813559322034,0.7703646877992714,1.0,105/304,29.26%,RASSF9;TRAK1;SGSM2;STX3;TBC1D8;GRTP1;RPL11;TGFB1;AP3B1;SYNRG;PKD1;CHP1;NAPA;RAB18;FAM91A1;TBC1D1;TBC1D12;STX1A;GABARAP;TRAK2;GIPC1;NUP93;TBC1D22A;ARF5;RAB6B;AKT1;PTTG1IP;HERC2;AKAP6;CD74;STX2;SURF4;E2F3;RAB24;SYK;RAB7A;KATNB1;COPB2;ARL4A;VPS36;TBC1D9B;TBCK;ARL6;NUP188;PHB2;SMURF1;NUP155;TNPO3;RAB1A;AP2A1;SNF8;RPAIN;VPS33A;AP4M1;YWHAH;NSF;TBC1D25;TBC1D2;VPS29;CCHCR1;TSC2;ARHGEF2;EHD1;IFT27;TMED1;LAPTM5;CTTN;KIF13A;RAB32;RAB3GAP2;TMED5;RAB23;ADPRH;ARL4C;CAMSAP3;TBC1D15;STX5;NXT2;TNPO2;RAB43;STXBP2;TBC1D30;CACNG3;FAM53A;TBC1D17;TBC1D5;RAB5C;TMED3;PDCD6;IPO13;NUP42;SEC13;NUP107;STX4;BCS1L;NPM1;COPZ2;ARF3;RTN2;STX16;VPS26C;STAM;VPS33B;XPO1;STRADB
prerank,cell junction maintenance (GO:0034331),0.36998587646886977,0.9498723317787334,0.5266666666666666,0.8269128162908135,1.0,3/14,11.05%,PRTN3;NLGN2;CBLN2
prerank,regulation of establishment of planar polarity (GO:0090175),-0.24400321382341236,-0.9491799537004493,0.5768463073852296,0.7730490475311873,1.0,42/88,33.18%,FZD6;FZD4;RAC1;PSMA6;AP2M1;PSMB5;FZD7;PFN1;FZD3;WNT11;SPEF1;PSMC4;PSMC5;PSMD14;CELSR1;SMURF1;PSMD8;AP2A1;PSMC1;CELSR2;PSMB4;PSMD11;PSMD12;PSMA1;PSMC3;FZD5;PSMB1;PSMA2;PSMA4;VANGL2;PSMB8;CDC42;AP2A2;WNT7A;PSMC6;PARD6A;PSMD6;AP2B1;RHOA;PKHD1;PSMA8;PSMB2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.3121625231638067,-0.9491722026113117,0.5276190476190477,0.772582641482316,1.0,8/29,15.83%,SORBS1;SCARB1;CHP1;MFSD2A;AKT1;ELOVL5;APOE;NR1H2
prerank,pharyngeal system development (GO:0060037),0.37121783901165933,0.9487544357164479,0.5032537960954447,0.8287704035535506,1.0,5/15,9.40%,BMP5;TGFBR1;SIX4;BMPR1A;GATA3
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.33628870711719006,-0.9485776382146303,0.5365853658536586,0.7730098492510256,1.0,8/21,19.24%,ERCC1;CUL4A;GTF2H3;CHD1L;RBX1;RPA3;GTF2H4;ERCC4
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.33628870711719006,-0.9485776382146303,0.5365853658536586,0.7730098492510256,1.0,8/21,19.24%,ERCC1;CUL4A;GTF2H3;CHD1L;RBX1;RPA3;GTF2H4;ERCC4
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.394775594445843,0.9483795720862435,0.49287169042769857,0.8288325391816355,1.0,3/11,9.51%,NOVA1;IGF2BP2;PCBP3
prerank,arachidonic acid metabolic process (GO:0019369),-0.2901187690121498,-0.9479893134069649,0.5478927203065134,0.7738300546796985,1.0,10/35,17.88%,PTGDS;MGLL;EPHX1;CYP1B1;GPX1;PTGS1;FAAH;GPX4;CBR1;DAGLB
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.33290722823343655,-0.9479504611212519,0.5463320463320464,0.7734266728774154,1.0,9/22,19.77%,RAP1A;RAPGEF1;NGF;STMN2;AKT1;CIB1;KIDINS220;EHD1;RAPGEF2
prerank,gene silencing by miRNA (GO:0035195),-0.3046417291079246,-0.9475143052797512,0.5431372549019607,0.7739469474337525,1.0,6/32,11.19%,TNRC6C;ADAR;CNOT7;NOTCH4;WTIP;LIMD1
prerank,cholesterol transport (GO:0030301),-0.2756343162260311,-0.9472453241322234,0.5219123505976095,0.7740757837829316,1.0,19/45,34.14%,CAV1;SCARB1;ABCG1;STARD5;TSKU;APOE;NPC1;STAR;LCAT;MSR1;SERAC1;APOC1;VPS4A;SOAT2;OSBPL2;CD36;STARD4;OSBPL5;LDLR
prerank,synaptic vesicle endocytosis (GO:0048488),0.31046127671320833,0.9472049146263404,0.5212981744421906,0.8308716136770602,1.0,7/33,8.00%,DNAJC6;STON1;SNAP91;NLGN2;NLGN3;SYT1;NLGN1
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.39868602710446155,-0.9463777745206269,0.5344506517690876,0.775657915828705,1.0,6/10,40.32%,MFSD2A;PHB2;MTMR2;GNB3;ABCA3;MTMR3
prerank,positive regulation of exocytosis (GO:0045921),-0.2940112012864777,-0.9462881980705845,0.5415860735009671,0.7753759228182439,1.0,14/35,33.67%,RAB27A;RAB7A;TSG101;SDCBP;SNF8;CHMP2A;RAB3D;RAB2B;ATP6AP1;VPS4A;STAM;ATP13A2;RAB3A;RAB15
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.31816609686727754,-0.9462468612759227,0.5527272727272727,0.7745067068278579,1.0,6/23,15.19%,THBS1;HSP90AB1;GIPC1;RNF111;SMAD4;SDCBP
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.31816609686727754,-0.9462468612759227,0.5527272727272727,0.7745067068278579,1.0,6/23,15.19%,THBS1;HSP90AB1;GIPC1;RNF111;SMAD4;SDCBP
prerank,phosphatidic acid metabolic process (GO:0046473),0.2857465311326483,0.9462342663625397,0.5213849287169042,0.832420346987442,1.0,12/48,20.54%,PLA2G5;PLA2G4A;DGKD;GPD1L;PLD1;GNPAT;DDHD2;PLD2;ABHD5;LCLAT1;PLA2G12A;PLA2G6
prerank,positive regulation of telomere maintenance (GO:0032206),-0.30436516189462226,-0.9461829291822634,0.5515267175572519,0.7741638818388893,1.0,6/31,12.93%,MAPK3;NEK7;HNRNPA2B1;ERCC1;PNKP;SLX4
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.21819603103822588,-0.94563159311207,0.6055776892430279,0.7749794919431189,1.0,48/172,20.84%,PLCG2;DGKH;PIP5K1B;BMX;TAMM41;PI4K2A;LPCAT3;INPP5D;PIK3R6;MFSD2A;CDS2;MTMR14;CDS1;MTMR12;CDIPT;CHKA;INPP5E;PIK3C2A;CSNK2B;PITPNM2;MBOAT7;RUFY1;RAB4A;PITPNM3;PIK3R3;CEPT1;AGPAT1;FGF2;PITPNM1;FAR1;PIK3CA;MTM1;SYNJ1;PCYT2;PIK3R2;CSNK2A1;CSNK2A2;DGKZ;PIK3C2B;LCAT;FIG4;GPD1;PCYT1A;ABHD8;AGPAT5;LPCAT2;CPNE3;CHAT
prerank,innate immune response in mucosa (GO:0002227),0.3997064500225109,0.9452067251109653,0.5328638497652582,0.8340211455955442,1.0,2/10,5.64%,IL4;BPIFB1
prerank,cellular response to osmotic stress (GO:0071470),-0.3259999220411111,-0.9451085128020459,0.5257142857142857,0.7757591700352089,1.0,11/21,35.66%,LRRC8D;YBX3;TRPV4;CAB39;ARHGEF2;PKD2;CAPN3;LRRC8E;AQP1;SLC4A11;OXSR1
prerank,tyrosine metabolic process (GO:0006570),0.392698935848358,0.9449649087620376,0.5144124168514412,0.8337468486244926,1.0,2/11,15.00%,IL4I1;GSTZ1
prerank,negative regulation of kinase activity (GO:0033673),0.27171560433156755,0.9447767954896493,0.5458089668615984,0.8333749933311492,1.0,9/62,8.17%,PPM1E;PDPK1;PRKAG2;DEPTOR;IRS2;CEP85;GSTP1;TRIM27;CEP43
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.31375798745097727,0.9447543533521923,0.5286624203821656,0.8325575288384174,1.0,5/27,8.86%,ABCA1;PLA2G5;PPARA;ABCA5;IL18
prerank,vacuolar acidification (GO:0007035),0.3316900337180248,0.9446015923667954,0.5089285714285714,0.8320740273709879,1.0,6/21,20.12%,ATP6V0A4;ATP6V1H;CLN3;DMXL1;DMXL2;TCIRG1
prerank,outer dynein arm assembly (GO:0036158),-0.365648307008981,-0.9442633639609489,0.5462794918330308,0.7772664333317554,1.0,8/14,36.48%,DNAH8;ODAD1;DNAH5;ODAD2;ODAD3;DNAH17;CCDC63;DNAAF4
prerank,peptidyl-arginine modification (GO:0018195),-0.36257135498589965,-0.9442572006835546,0.5478424015009381,0.7767974817251464,1.0,3/15,9.98%,PRMT8;ART3;KRTCAP2
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.3932769932707545,-0.9437786495577143,0.5155963302752293,0.7774678874938776,1.0,3/11,7.43%,SMAD7;ANXA1;RC3H1
prerank,glycine metabolic process (GO:0006544),0.3777834013787641,0.9437359133985178,0.5011086474501109,0.8334091673060358,1.0,3/12,10.29%,GLDC;BAAT;RIDA
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.3662463721132988,-0.9437241606044013,0.5538194444444444,0.7771131283284717,1.0,3/14,6.15%,OPHN1;MSN;EZR
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.38904022280216793,-0.9435213404537923,0.5457875457875457,0.7770756510731988,1.0,4/12,13.03%,PROM1;VEGFA;CEP290;AGTPBP1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.3257469736146582,-0.9434626224764243,0.5320388349514563,0.776715894357837,1.0,7/23,21.97%,FAR2;ELOVL7;ELOVL5;ACSL5;FAR1;ELOVL1;ACSF3
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.374386570535258,0.9433080446844994,0.5063829787234042,0.8335819293217902,1.0,4/13,13.41%,ADCY1;ADCY8;CHRNA7;ZDHHC2
prerank,negative regulation of T cell proliferation (GO:0042130),0.3173861970550445,0.9429932847691719,0.5157894736842106,0.8334815137472987,1.0,4/28,8.04%,IL4I1;CEBPB;GLMN;CD274
prerank,DNA replication checkpoint signaling (GO:0000076),-0.3535937090522733,-0.9429919248959046,0.5632183908045977,0.7773165763574633,1.0,8/16,34.00%,RAD9B;HUS1;RAD9A;RAD17;DNA2;CDC6;TICRR;CLSPN
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.37564242992911656,-0.9429568829082251,0.5449640287769785,0.7764464475652337,1.0,4/13,17.16%,IL15;SHC1;STAT5A;JAK3
prerank,cellular response to interleukin-15 (GO:0071350),-0.37564242992911656,-0.9429568829082251,0.5449640287769785,0.7764464475652337,1.0,4/13,17.16%,IL15;SHC1;STAT5A;JAK3
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.3168320088069173,0.9429539229926017,0.5415778251599147,0.8327073737812614,1.0,3/29,5.58%,IGF1;LYN;IRS2
prerank,fibrinolysis (GO:0042730),0.37657877925004646,0.9428549502360575,0.5294117647058824,0.8320879297862016,1.0,2/13,6.37%,SERPINE1;PLG
prerank,regulation of blood circulation (GO:1903522),0.29910070592995486,0.9426640371219309,0.5144628099173554,0.831727837543468,1.0,3/34,6.10%,CELF2;DMPK;FXYD1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.3135140606631984,0.9424189873605651,0.5,0.8314743890215918,1.0,3/29,4.41%,IL31RA;STAT5B;GHR
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.2923302111513409,-0.9422213696363183,0.539047619047619,0.7776538312194843,1.0,10/38,15.96%,CAV1;KCNJ2;CAMK2D;KCNQ1;JUP;CTNNA3;CACNA1D;KCND3;DSG2;DSP
prerank,maturation of 5.8S rRNA (GO:0000460),0.34492090597340785,0.9418191493294339,0.5462184873949579,0.8320330767832905,1.0,2/17,1.35%,MPHOSPH6;C1D
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.35058815645948505,-0.9413439491057677,0.538878842676311,0.7792666964070336,1.0,9/17,36.59%,NUS1;ALG9;ALG12;ALG1;DHDDS;ALG2;ALG3;MPDU1;ALG6
prerank,cytosolic calcium ion transport (GO:0060401),-0.3114425201230735,-0.9406930409482577,0.5911602209944752,0.7803237236378773,1.0,15/28,23.71%,MCUB;ITPR3;SLC35G1;ATP2A3;MCUR1;JPH2;JPH4;CACNB3;ATP2B3;ATP2B1;MICU2;JPH3;CACNA1C;SMDT1;MCU
prerank,tRNA wobble base modification (GO:0002097),-0.3620335474695032,-0.9403700786235143,0.53584229390681,0.7806308352210592,1.0,5/14,27.68%,TRMT9B;DPH3;URM1;ADAT2;CTU2
prerank,DNA double-strand break processing (GO:0000729),0.3474486532756141,0.9403534010321033,0.5189873417721519,0.8348903904691451,1.0,7/18,19.11%,RNF138;SETMAR;BLM;ATM;NBN;KAT5;UBE2N
prerank,negative regulation of autophagy (GO:0010507),-0.2635712421026549,-0.9402089318279061,0.5650485436893203,0.7805228708514904,1.0,18/54,24.98%,RASIP1;DAPL1;EIF4G3;FOXK1;QSOX1;AKT1;ATG7;PIK3CA;MET;TAB2;MCL1;RRAGA;PTPN22;EIF4G1;RUBCN;SMG1;EIF4E;WDR6
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.2858094707828965,0.9399614745209569,0.5346938775510204,0.8349650070899853,1.0,11/46,19.72%,PLA2G5;PLA2G4A;DGKD;GPD1L;PLD1;GNPAT;DDHD2;PLD2;ABHD5;LCLAT1;PLA2G12A
prerank,negative regulation of cell projection organization (GO:0031345),0.2762693786357967,0.9390277040202031,0.5358565737051793,0.836342148163075,1.0,11/48,18.02%,LPAR1;SEMA3A;RAB29;DPYSL3;STX1B;PTEN;DCC;CBFA2T2;DENND5A;PTPN9;GRIN2B
prerank,actin nucleation (GO:0045010),-0.3297279076010977,-0.9386677583161582,0.545631067961165,0.7836091387223274,1.0,4/21,12.33%,ARPC1B;LMOD1;ARPC5;ACTR3
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.2488808094335048,-0.9383688043016438,0.597165991902834,0.78380782156026,1.0,33/80,31.54%,CAV1;DCUN1D5;SMAD7;FKBP1A;UBB;DCUN1D1;FBXO4;FAM107A;PTTG1IP;MTA1;SPRTN;RBX1;PEF1;BMI1;KDM1A;PIN1;CDK5RAP3;LAPTM5;UBE3A;TRIB3;DCUN1D3;BCL10;TRAF6;XIAP;PDCD6;TSPYL5;NDFIP2;MAGEC2;DERL1;RPS2;NDFIP1;HDAC3;PLK1
prerank,synaptic vesicle localization (GO:0097479),0.3759476789242182,0.9381509138724696,0.532258064516129,0.8376214589371562,1.0,5/13,15.98%,KIF5C;SYNDIG1;NLGN1;SNAPIN;TMEM230
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.23286466157837676,0.9381183237252855,0.5793499043977055,0.8368286678244993,1.0,15/124,9.87%,TCF7L2;WNT4;PRICKLE2;ARHGEF19;PRICKLE1;SFRP1;AGO4;SMURF2;TNRC6A;PSMA3;PSMF1;PSMA7;RYK;DVL3;FRZB
prerank,negative regulation by host of viral transcription (GO:0043922),-0.3807253735542758,-0.9380768010410778,0.5343811394891945,0.783983694707296,1.0,7/12,37.29%,REST;PSMC3;POU2F3;JUN;CCL5;CCL4;INPP5K
prerank,excitatory postsynaptic potential (GO:0060079),0.3413208373772954,0.9380528287991683,0.5327510917030568,0.8361314401544262,1.0,7/19,18.45%,GRID2;MPP2;MAPK8IP2;GRIN2A;DRD2;GRIN2B;RAB3GAP1
prerank,regulation of mast cell activation (GO:0033003),0.40322728823473064,0.9377481295493815,0.5165562913907285,0.8360408325202213,1.0,4/10,16.15%,LYN;CD300LF;TSLP;CRLF2
prerank,sulfur amino acid catabolic process (GO:0000098),-0.4049822403115078,-0.9371084764756008,0.5508771929824562,0.7857724843027408,1.0,7/10,44.25%,TXN2;CTH;BLMH;MTRR;MPST;TST;GADL1
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.29111340836700167,-0.9367491777735125,0.560546875,0.7861039934038772,1.0,18/37,39.76%,ENTPD1;MTREX;PPP1R8;ENTPD7;ENTPD6;ENTPD2;RNASEH2C;DNASE1L2;NUDT18;DFFB;XRN2;ISG20;SIDT2;RNASEH2A;ADPRM;NUDT15;NCBP1;NUDT16
prerank,positive regulation of leukocyte migration (GO:0002687),0.3143406947452998,0.93672617024865,0.5403050108932462,0.8375723266819539,1.0,3/27,11.16%,PTN;IL4;IL6R
prerank,histone methylation (GO:0016571),0.3204439373519785,0.9364089798759341,0.5440180586907449,0.8374761302832683,1.0,6/26,14.01%,NSD1;SMYD1;SMYD3;EHMT2;NSD3;EZH2
prerank,nuclear export (GO:0051168),-0.24566257447058112,-0.9364072194290558,0.6097087378640776,0.7863780822488758,1.0,23/80,21.66%,TGFB1;PKD1;CHP1;SRSF5;SRSF2;SRSF6;U2AF1;ZC3H11A;RNPS1;SRSF4;MAGOH;NUP188;SMURF1;CHTOP;NUP155;ALYREF;RITA1;DDX39B;HNRNPA1;CCHCR1;CASC3;THOC6;DDX39A
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.396508937448809,-0.9358478015725198,0.5577617328519856,0.7871625289064511,1.0,3/10,6.38%,ACTN4;TBX1;RARA
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.3755950408050494,0.9358156296094196,0.548936170212766,0.8380074844592017,1.0,4/13,17.21%,GLI2;CAMK4;CLPTM1;SHH
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.34321089403333377,0.9357627941097688,0.5581395348837209,0.8372654675298248,1.0,3/19,6.83%,BMP6;PLG;FOXA2
prerank,steroid hormone biosynthetic process (GO:0120178),0.3087664844814043,0.9357547144750538,0.5577342047930284,0.8364247642716688,1.0,1/29,0.73%,AKR1B1
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.35428537442522057,-0.9357106068279595,0.5551470588235294,0.7870004730837229,1.0,5/15,23.21%,MVB12B;ERBB2;PTPN12;EGFR;RHBDF2
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.34208070572986726,0.9356065821320294,0.5323590814196242,0.8359271565933255,1.0,4/19,10.12%,PARD3B;DLG2;LRRC7;PRKCI
prerank,negative regulation of hemostasis (GO:1900047),0.3866711636046858,0.9355617323460781,0.5412026726057907,0.8351792819456908,1.0,3/12,5.86%,SERPINE2;APOH;SERPINE1
prerank,glutathione metabolic process (GO:0006749),-0.288551125018846,-0.9352917211268182,0.5571955719557196,0.7874582855719503,1.0,16/38,26.70%,GPX1;GSTA4;GGT5;GSTM2;GSTA3;GSTM1;GSR;GCLM;GCLC;CNDP2;GGT1;GGCT;GSTK1;GSTM5;SOD1;PARK7
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.2772608368278917,0.935038186187828,0.5590717299578059,0.8356086626381999,1.0,5/52,2.63%,PIK3R1;LRP1;DPP10;PDPK1;EPHA3
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.34108025321060065,-0.9345796218719037,0.5769230769230769,0.7886591069401956,1.0,8/18,19.29%,DAB2IP;MSN;EZR;PTTG1IP;VPS11;HSP90AA1;ATRAID;CDK5RAP3
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.20928979313684093,-0.9342253529031598,0.68,0.7889974561387212,1.0,99/241,35.23%,DDX5;NOVA2;HNRNPA2B1;CTNNBL1;HSPA8;PRPF8;DNAJC8;SRSF5;MTREX;SRSF2;SNRNP48;SNRPC;SNRPA;ISY1;DDX41;SRSF6;DHX9;DHX15;RBM22;FUS;SNRPD3;U2AF1;SFPQ;XAB2;RNPS1;ZRSR2;RBM6;SRSF4;MAGOH;DDX23;RBM4B;ALYREF;HNRNPK;SF3A3;EFTUD2;DDX39B;HNRNPA1;PCBP1;GTF2F1;SNRPG;PDCD7;USP49;PHF5A;PNN;CASC3;LSM2;UBL5;SRRM2;RBM19;PRPF40A;CPSF4;CHERP;CD2BP2;LSM3;DDX39A;LSM7;RBM14;RBM17;SYNCRIP;NCBP2;CSTF2T;PABPC1;SF3A1;SNRPB;SF3A2;HNRNPR;WBP11;AQR;POLR2F;SNRPB2;GTF2F2;HNRNPA3;PRPF19;SRSF9;HNRNPH3;PQBP1;LSM6;CDC5L;HNRNPC;U2AF1L4;SF3B5;SNRNP25;POLR2C;POLR2L;POLR2I;WBP4;PCF11;ESS2;UPF3B;RBM15B;SRSF1;TRA2B;HNRNPM;ZCCHC8;HNRNPH1;SMNDC1;RSRC1;SRSF10;PUF60
prerank,negative regulation of cell cycle (GO:0045786),0.25971151011337756,0.9340554877782319,0.556237218813906,0.8371861096004235,1.0,12/73,10.95%,BMP2;NR2F2;SMAD3;RUNX3;BRINP1;BRINP3;MEN1;NLRP2B;GATA3;CHMP1A;PTEN;HPGD
prerank,mitotic cytokinesis (GO:0000281),-0.27617201218636295,-0.9338212282069622,0.5584905660377358,0.7894966868308883,1.0,23/47,32.91%,SPTBN1;USP8;KIF23;RHOB;RTKN;MITD1;SNX18;ECT2;RASA1;ANLN;CNTROB;EFHC2;ARL3;CIT;CENPA;CEP55;STMN1;RACGAP1;TRIM36;PLK1;STAMBP;ESPL1;UNC119
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.3408517351641704,0.9337323240006516,0.5550660792951542,0.8371396595777107,1.0,7/18,22.61%,MCM3;GINS2;PCNA;POLD3;MCMDC2;POLD2;MCM7
prerank,calcineurin-mediated signaling (GO:0097720),-0.4008697698177126,-0.9329837153798104,0.5716981132075472,0.7904681030259493,1.0,5/10,20.09%,PPP3CC;NFATC1;PPP3CB;ADGRB2;NFATC3
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.4008697698177126,-0.9329837153798104,0.5716981132075472,0.7904681030259493,1.0,5/10,20.09%,PPP3CC;NFATC1;PPP3CB;ADGRB2;NFATC3
prerank,T cell activation (GO:0042110),-0.25521900142792153,-0.9327118197784441,0.5850860420650096,0.790580521632229,1.0,16/69,15.93%,CXADR;DPP4;CTPS1;CD44;FKBP1A;MSN;JAG2;CASP8;HSPD1;CD74;LFNG;PPP3CB;SOX4;JAML;GPR89B;GPR89A
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.3798767194231817,-0.9325638226623445,0.548689138576779,0.7904514504593972,1.0,5/12,16.56%,CCN3;SLIT2;AKT1;WASL;GREM1
prerank,mRNA destabilization (GO:0061157),0.293757431023408,0.9324095670633459,0.5378151260504201,0.8395073865110475,1.0,13/38,22.47%,TUT4;ROCK2;FTO;CPEB3;KHSRP;RIDA;METTL16;RBM24;METTL3;POLR2D;ZFP36L2;TARDBP;RC3H2
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.3945209485143524,-0.9323949557658252,0.5456171735241503,0.7903435110759465,1.0,3/11,26.23%,GPX1;GPX3;PRDX4
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.37593732512573064,-0.9323624761847046,0.5641509433962264,0.7899219779051218,1.0,4/13,20.29%,CYRIB;PVR;NECTIN2;MR1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.28756588686669204,-0.9321114742743853,0.5785582255083179,0.7900190927698589,1.0,10/33,19.50%,ESR1;DDX5;UFM1;CBFB;H3-3A;DDRGK1;TRIM68;UFL1;KDM1A;UBA5
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.39231559289153084,0.9318595193125739,0.5717488789237668,0.8400105573835901,1.0,3/11,10.44%,VCPIP1;RTN4;STX18
prerank,epidermal cell differentiation (GO:0009913),-0.28213575113398204,-0.9318283254093666,0.5597722960151803,0.7902228634658136,1.0,13/41,28.57%,CLIC4;ANXA1;BCR;GATA6;OPN3;EPHA2;DSP;GLI1;EVPL;CERS3;SCEL;CTNNB1;PIP5K1A
prerank,actin filament polymerization (GO:0030041),-0.30136570307948557,-0.9316264600187092,0.5447470817120622,0.7901969268282635,1.0,14/29,25.60%,COBL;RAC1;DIAPH1;TTC17;FAM107A;WASHC3;PREX1;WASL;WASHC5;JAK2;MSRB2;MICALL2;CORO7;AIF1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.3256336558362086,-0.9309638890308631,0.5343511450381679,0.7912277057415331,1.0,8/20,25.28%,LBP;TGFB1;PRKCE;TLR4;HCK;PTPN22;BCL10;CCL2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.2872092276047078,-0.9308732482431976,0.5950095969289827,0.7909720095147416,1.0,8/38,13.14%,CAV1;APP;NEDD9;SHC1;LRP8;SRCIN1;CSF1R;ACE
prerank,positive regulation of embryonic development (GO:0040019),0.3373410632499644,0.9306935493082499,0.5242105263157895,0.8419789428341934,1.0,2/19,6.83%,WNT4;FOXA2
prerank,triglyceride metabolic process (GO:0006641),0.27816131775693265,0.9303401700970833,0.5698689956331878,0.8419778900061353,1.0,9/48,16.56%,AGMO;APOH;APOBR;MOGAT3;LPIN3;MOGAT2;DGAT2;FABP4;LPIN1
prerank,cytosolic transport (GO:0016482),-0.23102024289366138,-0.9297529268216967,0.6258064516129033,0.7931372232411882,1.0,38/108,28.75%,MYO1D;VPS13A;VPS53;EEA1;RAB6B;LAMP1;LMTK2;GOSR1;EMP2;DCTN1;TMEM87B;HEATR5A;KIF16B;CCDC91;RAB7A;DOP1B;SPAG9;AP2A1;SNF8;GCC2;AP4M1;VPS29;TBC1D23;VTI1B;EHD3;LAPTM5;STX5;VPS54;CORO7;TBC1D17;PHETA2;TBC1D5;PREPL;EPS15;ERC1;SNX2;STX16;AP1G1
prerank,cellular response to insulin stimulus (GO:0032869),0.23573025233390965,0.9296909267604646,0.5983935742971888,0.8427016896600139,1.0,17/124,10.59%,ENPP1;PIK3R1;ATP6V0A4;TBC1D4;PDPK1;MYO5A;PDK4;PHIP;IRS2;INSIG2;RAB10;IGF2;PDE3B;C2CD5;ATP6V1H;PRKCI;LPIN3
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.31914176010057144,-0.9293922185514036,0.5614366729678639,0.7935012896625769,1.0,10/24,26.69%,STMN2;TRPV4;KATNB1;KIF24;KIF18A;PIN1;KIF18B;STMN1;NCKAP5L;MAP7D3
prerank,eye photoreceptor cell development (GO:0042462),-0.3594715840537217,-0.9291635433808539,0.5505415162454874,0.7935652271443983,1.0,4/15,18.58%,RP1;VEGFA;CEP290;RPGRIP1
prerank,establishment of vesicle localization (GO:0051650),-0.34305228697051726,-0.9291635410449023,0.5864527629233511,0.7930842785218866,1.0,3/18,4.02%,RAB11A;LIMK2;RAB27A
prerank,regulation of platelet activation (GO:0010543),0.33632709296992225,0.9287863112953915,0.537525354969574,0.8440422758129607,1.0,4/21,4.18%,PDGFRA;PLA2G4A;PRKCA;LYN
prerank,cellular response to interleukin-6 (GO:0071354),0.31346295124860707,0.9285773653861398,0.5671641791044776,0.8437074828983991,1.0,5/26,11.60%,PID1;PTGIS;PTPRT;IL6R;YAP1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.3299845763817426,0.9285369340717952,0.5408805031446541,0.8429566782169693,1.0,5/22,16.27%,ADGRV1;EDNRB;CRHR1;DRD2;LTB4R2
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.34013468317369433,-0.9284768479288831,0.5749063670411985,0.7942116523090502,1.0,2/18,0.50%,MEF2C;FLT1
prerank,cilium movement (GO:0003341),-0.27000496705002086,-0.9284113565903677,0.5812133072407045,0.7938794251252312,1.0,28/47,43.76%,SPEF1;ODAD1;GAS8;DNAH5;CABYR;ROPN1L;CFAP251;ODAD2;CAMSAP3;ADCY10;SPAG17;ODAD3;ZBBX;SPA17;CFAP70;DNAH17;CFAP206;CCDC63;CFAP91;TEKT5;CFAP54;DNAAF4;DNAH1;RSPH6A;DNAAF1;DNAI3;DNHD1;RSPH4A
prerank,maintenance of protein location in nucleus (GO:0051457),-0.3348940039116462,-0.927985095532779,0.5626168224299065,0.7944070294803407,1.0,8/20,31.66%,SYNE1;ARL2BP;CHCHD10;ARL2;RANGAP1;PARK7;BARD1;TAF3
prerank,primary neural tube formation (GO:0014020),0.3033233360494112,0.9278537854871158,0.5481171548117155,0.8438015334302716,1.0,9/30,14.28%,PRICKLE1;LMO4;DLC1;IFT122;PLXNB2;FUZ;GRHL3;MTHFD1;MTHFD1L
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.3386094951103258,-0.9277402864044764,0.575,0.7945104333211518,1.0,7/19,28.10%,GPX1;GPX3;PRDX4;SOD1;PARK7;ACOX1;NOX1
prerank,regulation of cell morphogenesis (GO:0022604),0.303085979079771,0.9274466279645452,0.5585215605749486,0.8438956527688567,1.0,4/30,9.45%,SH3D19;PHIP;ZMYM6;CAMSAP1
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.3610703796711059,-0.927416580520003,0.5743119266055046,0.7947314898195706,1.0,6/15,30.99%,RACK1;SPHK2;TNFRSF1A;PRKCD;ORMDL1;SMPD2
prerank,substrate-dependent cell migration (GO:0006929),0.3740436709868883,0.9272330215060366,0.5408388520971302,0.8435370764531184,1.0,2/14,1.81%,NRP1;ITGA11
prerank,regulation of calcium ion transport (GO:0051924),0.27162436833287174,0.9270945615901572,0.591182364729459,0.8429999165326815,1.0,8/54,8.89%,ANK2;CACNA2D1;BCL2;P2RX4;MYLK;CAMK2B;CACNB2;SARAF
prerank,regulation of interferon-gamma production (GO:0032649),-0.2506965845505153,-0.9270154607075743,0.5923694779116466,0.7951634586417227,1.0,30/71,38.11%,SLC7A5;PDE4D;CYRIB;IL1R1;RARA;TLR3;HSPD1;INHBA;TLR4;VSIR;TXK;LAPTM5;FZD5;LGALS9;PTPN22;ZFPM1;IL12RB2;INHA;RASGRP1;LILRB1;SCRIB;SLAMF6;CD14;SLC11A1;TLR8;CD226;IL12A;CRTAM;PDCD1LG2;IL12RB1
prerank,plasma membrane organization (GO:0007009),-0.2595886344582906,-0.9269588569994405,0.6062992125984252,0.7948185120460155,1.0,9/61,7.92%,ANO6;SPTBN1;FNBP1L;AHNAK2;CAVIN2;MYOF;DYSF;EHD2;A4GALT
prerank,lipoprotein biosynthetic process (GO:0042158),0.3883673117003232,0.9268132393735078,0.5350701402805611,0.8428069487770713,1.0,6/11,23.57%,WDR45B;WIPI1;ATG10;PORCN;WDR45;UGCG
prerank,positive regulation of protein acetylation (GO:1901985),-0.3788943132857042,-0.9267924332366351,0.5549242424242424,0.7947257079105181,1.0,3/12,15.32%,DIP2B;CAMK1;RAPGEF3
prerank,translational termination (GO:0006415),-0.23787794620736843,-0.9266221364403923,0.6178217821782178,0.7946489118535749,1.0,30/95,25.36%,PTCD3;MRPL52;MRPL51;MRPL38;MRPL28;MRPL43;MRPL32;MRPL14;ERAL1;MRPS30;MRPS17;MRPL24;MRPL16;MRPL50;MRPL54;MRPS18C;MRPL47;MRPL35;MRPS18A;MRPS6;MRPL58;MRPL13;MRPL11;MRPL49;MRPL30;MRPS24;MRPL21;MRPL48;MRPL42;MRPL2
prerank,phasic smooth muscle contraction (GO:0014821),0.40203297872811905,0.9263619992023034,0.5413043478260869,0.8430251859835732,1.0,3/10,14.70%,GDNF;EDNRB;DRD2
prerank,cell cycle G2/M phase transition (GO:0044839),-0.22740126668281888,-0.9260528043260757,0.6278586278586279,0.7954653128192978,1.0,44/129,27.15%,DCTN2;CCNY;TPD52L1;TUBA1A;CEP164;PPP2R1A;PRKAR2B;CEP57;CEP192;NES;CEP70;DCTN3;CEP290;DCTN1;PPP1CB;PPP1R12B;CNTRL;TUBB4B;PCM1;HAUS1;NDE1;PPP2R2A;FBXL7;CETN2;CEP72;YWHAG;CDKN1A;FBXL3;HSP90AA1;CEP41;CUL1;DNM2;LCMT1;TUBA4A;ARPP19;PLK3;PPP1R12A;CEP63;BRSK2;HAUS4;NEDD1;YWHAE;CDKN2B;FBXL8
prerank,protein-containing complex subunit organization (GO:0043933),0.23864316018373932,0.9258268667947203,0.5859213250517599,0.8434897322210482,1.0,26/109,14.09%,TEAD1;MITF;RIMS1;MDM2;IL1RAP;JCHAIN;MAGI1;MNAT1;KMT2A;SLC7A9;FANCC;GPAA1;TUBGCP4;PPIH;HES5;KNTC1;LPXN;NUP205;NUP35;LAMC1;SNX9;YAP1;LLGL1;DLG4;TUBGCP2;TRAF2
prerank,glutamine family amino acid metabolic process (GO:0009064),0.2969622210569324,0.9255533058787104,0.5636743215031316,0.8432926615618641,1.0,6/33,10.92%,ALDH18A1;ALDH4A1;PRODH;GLS2;GLUL;FPGS
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.37987373187184686,0.9255127515849412,0.5308370044052864,0.8425264210672269,1.0,2/12,3.29%,DOCK11;DOCK10
prerank,peptide catabolic process (GO:0043171),-0.31568396864177195,-0.9254641104719332,0.5651340996168582,0.7963083430371102,1.0,7/23,13.14%,TPP1;LTA4H;ERAP1;IDE;GGT5;LNPEP;ACE
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3172244766401704,0.9239675638795349,0.5600858369098712,0.8454049533321084,1.0,4/26,6.02%,PPARA;SLC5A3;SLC30A10;ABCD2
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.2472507055504274,-0.9239623209119135,0.6428571428571429,0.7993593914927292,1.0,8/75,7.86%,PLCE1;RGS3;RGS5;MGLL;CALM1;GIT2;EDN1;RGS6
prerank,positive regulation of ion transport (GO:0043270),0.2702283633860872,0.9238599125085247,0.5834970530451866,0.8448061537566447,1.0,7/48,8.28%,GDNF;SCN3B;ANK2;P2RX4;GPD1L;MYLK;CACNB2
prerank,calcium import into the mitochondrion (GO:0036444),-0.3946756520298523,-0.9238090625606514,0.5742049469964664,0.7992151830034122,1.0,5/10,23.71%,MCUB;MCUR1;MICU2;SMDT1;MCU
prerank,protein targeting to mitochondrion (GO:0006626),-0.26662966545259337,-0.9236992044240186,0.6140350877192983,0.7989843259861947,1.0,19/52,27.63%,NDUFA13;IMMP2L;HSPD1;TIMM17A;TIMM21;CHCHD4;TOMM22;TIMM29;BCAP31;HSPA4;HSP90AA1;TIMM13;TOMM5;TIMM50;FIS1;TIMM10;TIMM8B;TIMM10B;MFF
prerank,regulation of interleukin-1 beta production (GO:0032651),0.25998332595380313,0.9229930069875758,0.6085192697768763,0.8459906248243423,1.0,6/66,8.37%,IGF1;ORM2;NLRP12;GSTP1;GSDMD;NLRP2B
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.34161892263047233,-0.9222078012186735,0.5766283524904214,0.8019511412289955,1.0,4/17,7.05%,KCNB1;RAB27A;STX1A;SLC4A8
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.2630758445546532,-0.9221615064788783,0.5864811133200796,0.8015833367968747,1.0,19/52,28.48%,EXTL3;PDIA5;TPP1;SHC1;HDGF;ADD1;DCTN1;ACADVL;HSPA5;GFPT1;XBP1;KLHDC3;TSPYL2;HYOU1;YIF1A;ATP6V0D1;PPP2R5B;ERN1;PLA2G4B
prerank,epithelial cell differentiation (GO:0030855),-0.24020481291853446,-0.9219747253871877,0.6454720616570327,0.8015027955327143,1.0,26/88,22.22%,KDR;TBX1;TPP1;ANXA1;SIX1;VEGFA;GATA6;ANXA4;FZD7;AKT1;TDRD7;TOLLIP;ACADVL;CTSB;CPT1A;TAGLN2;FSTL1;PGK1;CBR1;TAGLN;E2F4;GLI1;EDF1;E2F7;GSTK1;CASP6
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.3067782876750042,-0.9214197543873245,0.5719769673704415,0.802261678349289,1.0,8/26,19.41%,SHANK3;ACTG1;RAC1;PFN1;SYNPO;LIMK1;PTGER4;SHANK1
prerank,pore complex assembly (GO:0046931),-0.3348354581657067,-0.9209560233106209,0.5777777777777777,0.8028520242560299,1.0,4/19,9.44%,ANO6;ADAM10;NUP93;NDC1
prerank,negative regulation of protein depolymerization (GO:1901880),0.3173732918046792,0.9207075018075508,0.5659955257270693,0.8506874474270965,1.0,4/24,12.31%,PLEKHH2;ATXN7;CAMSAP1;NAV3
prerank,negative regulation of cellular senescence (GO:2000773),-0.36728343272280495,-0.9206942378569481,0.5726795096322241,0.8029967549985905,1.0,3/13,9.18%,CDK6;MAP3K3;TWIST1
prerank,regulation of chemotaxis (GO:0050920),0.3023393238411082,0.9196724007577896,0.5783664459161147,0.8522870802032185,1.0,6/30,8.25%,MYCBP2;PDGFRA;P2RX4;PDGFRB;ADGRA2;ZSWIM5
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.2798224659479367,-0.9195044904470724,0.5977011494252874,0.8051648449126853,1.0,7/37,15.19%,RIN3;NCOR1;ANKRD13A;EDN1;ABCA2;APOE;SDCBP
prerank,positive regulation of endopeptidase activity (GO:0010950),0.3106047722088918,0.9194700981660319,0.5717255717255717,0.8519319290635755,1.0,3/26,4.77%,ROCK2;LYN;EFNA3
prerank,spindle assembly (GO:0051225),-0.2482199745739115,-0.9193296919962617,0.6195028680688337,0.8050762305627193,1.0,22/67,32.37%,RAB11A;NCOR1;NEK7;RPS3;CEP192;HAUS1;GOLGA8B;LSM14A;MAPRE2;MISP;TPX2;RCC1;SPICE1;CEP63;HAUS4;KIFC2;SAC3D1;TUBGCP6;KIF11;BCCIP;HDAC3;RHOA
prerank,embryonic limb morphogenesis (GO:0030326),0.2910827259393579,0.9190890493837004,0.5818965517241379,0.8519625918655203,1.0,3/34,3.50%,SALL1;TBX3;GLI3
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.37823269099389106,0.9190512272282991,0.5668103448275862,0.8512038003068132,1.0,3/12,6.78%,RIMS1;UNC13C;SYT1
prerank,establishment of spindle localization (GO:0051293),-0.3605500910754198,-0.9189660933378143,0.5457943925233645,0.8053859136893825,1.0,5/14,35.96%,MAP4;CFL1;TLE6;ESPL1;NLRP5
prerank,positive regulation of isotype switching (GO:0045830),0.3521969760149145,0.9188885737190805,0.5323275862068966,0.8507727499298956,1.0,6/15,15.50%,SHLD2;IL4;KMT5C;PAXIP1;RIF1;KMT5B
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.26106385615888805,0.9187066098834586,0.5742574257425742,0.8503591398325957,1.0,9/60,10.95%,TCF7L2;CDK8;CEBPB;AGO4;TNRC6A;PPM1D;PAXIP1;PTEN;TNRC6B
prerank,tube closure (GO:0060606),0.2980766118557049,0.9182947235686644,0.5571428571428572,0.8505179946836334,1.0,9/31,14.28%,PRICKLE1;LMO4;DLC1;IFT122;PLXNB2;FUZ;GRHL3;MTHFD1;MTHFD1L
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.3902206219208163,0.9179942268704923,0.5674418604651162,0.8504174799280375,1.0,5/10,23.01%,CPEB3;CPEB1;PAF1;HSF1;NUDT21
prerank,regulation of protein import into nucleus (GO:0042306),0.2898727279741231,0.9174297269000513,0.562753036437247,0.8508942946820166,1.0,3/36,2.72%,PIK3R1;ZIC1;SMAD3
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.2857195084361911,-0.9169396655430014,0.5813492063492064,0.809475444250949,1.0,15/36,30.33%,NLRC5;EDN1;RIPK1;CD74;MAVS;AGPAT1;HSPA1A;TXK;LAPTM5;HSPA1B;CASP1;C1QTNF4;PARP14;IRGM;PARP9
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.3784535843363308,-0.9165889718073887,0.5561694290976059,0.809764333244349,1.0,8/11,56.03%,RTP3;RTP4;TAS1R2;GNAT3;GNAT2;PIGR;TAS1R3;PKD2L1
prerank,regulation of trophoblast cell migration (GO:1901163),0.35964428805296766,0.9161389756621526,0.5611353711790393,0.8531163718391627,1.0,5/14,20.57%,GJA1;SMURF2;SYDE1;TIMP1;AGO2
prerank,limb morphogenesis (GO:0035108),0.3241006257840557,0.9158339170932542,0.5600907029478458,0.8530201935960555,1.0,2/20,3.50%,TBX3;GLI3
prerank,protein K48-linked deubiquitination (GO:0071108),-0.3189111845276221,-0.9157870658728855,0.5722326454033771,0.8110859118746161,1.0,6/23,10.62%,MINDY2;MINDY1;USP8;OTUD5;OTUB1;USP5
prerank,regulation of axon extension (GO:0030516),-0.2837405909198041,-0.9156080936412954,0.5957446808510638,0.8110083891163946,1.0,22/37,36.53%,SEMA7A;SHTN1;DIP2B;SEMA3G;DBNL;NTN1;DBN1;APOE;LIMK1;DNM2;CTTN;ZFYVE27;RTN4R;CDKL5;ISLR2;PTPRS;ABL1;MAG;MAP3K13;TWF2;RNF6;MAP2
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.3980120383396253,0.9154007114833376,0.5668103448275862,0.8531575075766133,1.0,2/10,2.60%,SERPINE2;ALOX12
prerank,body fluid secretion (GO:0007589),0.346128333772709,0.915264337026492,0.5222929936305732,0.85261015644662,1.0,4/15,13.69%,SLC22A4;ERBB4;PRLR;GUCA1B
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.3282763090953636,-0.915229395348383,0.580110497237569,0.8113915119309733,1.0,7/21,19.51%,RPL11;RPL23;RPS7;CDC14B;RAB1A;FZR1;RPL5
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.33446998637284764,-0.9150841827167959,0.5860805860805861,0.8112483404951428,1.0,6/18,18.10%,NOTCH1;CCN3;HDAC4;FZD7;SOX6;XBP1
prerank,long-chain fatty acid import into cell (GO:0044539),-0.3854016720112681,-0.9146961279492932,0.5625,0.8116724968735378,1.0,6/10,31.66%,SLC2A1;SPX;SLC27A2;SLC27A1;CD36;RPS6KB1
prerank,DNA duplex unwinding (GO:0032508),-0.26453249542015395,-0.9145063612553455,0.6089494163424124,0.8115879886951028,1.0,12/50,18.00%,ANXA1;UBB;UBC;RPS27A;CUL4A;DHX9;GTF2H3;CHD1L;RBX1;CETN2;GTF2H4;ASCC3
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.3950595399187573,-0.9139540503235316,0.5911602209944752,0.8122984295741722,1.0,3/10,6.50%,RACK1;KDR;MYOC
prerank,positive regulation of viral life cycle (GO:1903902),-0.3136367370306222,-0.9139482062313934,0.5908221797323135,0.8118294061429494,1.0,10/22,30.55%,CHMP2B;CD74;FMR1;TSG101;LGALS1;CHMP2A;LGALS9;VPS4A;P4HB;KPNA6
prerank,O-glycan processing (GO:0016266),-0.2590137394707785,-0.9137185901538261,0.5995975855130785,0.8118702370189483,1.0,20/54,35.95%,ST3GAL4;ST6GAL1;C1GALT1C1;GALNT10;GXYLT1;ST6GALNAC2;B3GNT3;B3GNT8;GALNT5;GCNT4;GALNT6;GALNT9;GALNT1;MUC1;ST6GALNAC4;ST3GAL2;B3GNT2;MUC13;MUC6;B4GALT5
prerank,epidermis development (GO:0008544),0.26129706026495325,0.9136364504877355,0.6111111111111112,0.8555565402824732,1.0,3/56,3.63%,SVEP1;FGFR2;ATP2A2
prerank,modulation by host of symbiont process (GO:0051851),-0.29158230860753903,-0.9135966246665891,0.564,0.8116585633455242,1.0,15/31,37.29%,LEF1;REST;SMARCA4;CX3CR1;SP1;NAPEPLD;CHD1;POU2F3;AQP1;JUN;SAP30;CCL5;HPN;CCL4;INPP5K
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.36653161335506607,0.9130100530785127,0.5790598290598291,0.8561775594656182,1.0,3/13,5.22%,PID1;PPARA;IL4
prerank,bile acid metabolic process (GO:0008206),0.3107638650195324,0.9121882894169917,0.5676855895196506,0.8573319317533445,1.0,6/27,13.12%,CYP7B1;CYP27A1;BAAT;CYP46A1;GBA2;OSBP
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.3158147549689409,0.9113958338519883,0.5477707006369427,0.8583519642051018,1.0,1/24,0.14%,EPHA7
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.3203002309227184,0.9106377262932427,0.5692963752665245,0.8594175322544105,1.0,7/23,16.40%,GJA1;GDNF;SIX4;PAX8;SIRT6;WNT5B;LIF
prerank,methylguanosine-cap decapping (GO:0110156),-0.38864686938703547,-0.9106334820837956,0.5831702544031311,0.8178296072993407,1.0,5/10,19.35%,DCPS;PNRC2;EDC4;DCP1B;LSM1
prerank,protein palmitoylation (GO:0018345),-0.2908534722451337,-0.9105365800088275,0.6097087378640776,0.8175616379514912,1.0,13/30,31.27%,ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC5;ZDHHC23;SELENOK;ZDHHC12;ZDHHC17;ZDHHC18;HHAT;ZDHHC3;GOLGA7B;ZDHHC24
prerank,determination of left/right symmetry (GO:0007368),-0.28410620332608316,-0.9101686852798453,0.6003976143141153,0.8178903809920095,1.0,10/36,24.23%,NOTCH1;TBX1;SMO;ZIC3;ARL6;DNAH5;ODAD2;PKD2;MKKS;ODAD3
prerank,regulation of endocytosis (GO:0030100),-0.2536592401275806,-0.9100147377058171,0.6078431372549019,0.8177537135476981,1.0,23/61,26.50%,GPC3;NEDD4L;OPHN1;CD151;HIP1R;FLOT1;HIP1;RAB4B;ABL2;RUFY1;RAB4A;APOE;PACSIN1;TSC2;PACSIN2;PACSIN3;RUBCN;PTPN1;CBLL1;RAB5C;ZFYVE16;MTMR2;SMPD1
prerank,establishment of spindle orientation (GO:0051294),-0.29465054114112954,-0.9094824921749788,0.6027131782945736,0.8184462876529532,1.0,10/28,24.19%,MAP4;ZW10;HTT;DCTN1;NDE1;NDEL1;MISP;NDC80;SPDL1;CENPA
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.3117673831717802,-0.9093772776042406,0.6072106261859582,0.8182070660201677,1.0,7/25,17.80%,AFAP1L2;HIP1R;AKT1;HIP1;SHKBP1;BCAR3;NEU3
prerank,DNA methylation (GO:0006306),0.3209999913606758,0.9089577248732295,0.5810526315789474,0.8625106831197771,1.0,7/23,23.50%,PPM1D;DNMT1;EHMT2;TEX15;DNMT3B;ATF7IP;ZFP57
prerank,respiratory electron transport chain (GO:0022904),-0.35194669774683557,-0.908882612884974,0.5932203389830508,0.8188077471786035,1.0,7/14,26.02%,PPARGC1A;SLC25A12;ETFB;ETFDH;SDHB;SLC25A22;ETFRF1
prerank,protein transport (GO:0015031),0.20253480335658486,0.90869739846658,0.7309833024118738,0.8623153760968514,1.0,74/332,17.99%,WLS;STEAP3;VAMP5;ATP6V0A4;TBC1D4;RABGAP1L;TANGO2;LRP1;ABCA1;TXNIP;ARCN1;SNX33;LRP1B;RAB3C;SCFD1;MON1A;VPS26B;SYNDIG1;RAB5B;RAB29;TBC1D2B;SCG2;STX1B;RAB10;TMED10;SLU7;SEC31A;CHMP1A;PRKCB;ATP6V1H;STX7;LTBP2;BBS2;SNX9;KIF3A;TBC1D10C;DNAJC27;HSP90B1;EIF2D;OPTN;TBC1D8B;STXBP3;NGFR;SYS1;STX12;SCAMP5;SCAMP2;RUNDC1;RPGR;RAB38;SCFD2;ATP6V1B2;SAR1B;TBC1D10A;SVBP;RAB20;COPG2;ARRDC2;SCG5;AFM;SNX8;TMED9;ARL1;MIA3;LRSAM1;SGSM3;COPZ1;RABL3;SNX6;RAB19;VLDLR;PPARG;TBC1D9;TRIM23
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.36619536994732715,0.908245802257011,0.5527522935779816,0.8625241204471129,1.0,3/12,11.55%,NINL;BICD1;KIF3A
prerank,termination of RNA polymerase I transcription (GO:0006363),0.30301947103631927,0.9078877124481168,0.5644820295983086,0.8625332684914794,1.0,7/30,13.98%,POLR1A;GTF2H2;MNAT1;POLR1G;POLR1B;CCNH;TTF1
prerank,protein K11-linked ubiquitination (GO:0070979),0.30820560616231585,0.9075854469967103,0.5675675675675675,0.862389890348715,1.0,10/27,21.78%,PRKN;ANAPC1;UBE2E3;CDC23;CDC16;RNF26;UBE2E2;ANAPC5;CDC26;UBE2S
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.25541564485297563,-0.9070582909089385,0.6475095785440613,0.8223686957361438,1.0,17/53,24.75%,DDX5;RPS3;BRCC3;UIMC1;BABAM1;DHX9;TRIM28;FMR1;NSMCE4A;EGFR;CCAR2;BABAM2;MSX1;FGF10;SPRED3;PRKCD;NSMCE1
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.3547671780471489,-0.9068234900526991,0.5854545454545454,0.822430138413382,1.0,5/15,10.91%,KDR;F3;VEGFC;VEGFA;VEGFD
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.3685631594787615,-0.906577357846028,0.5883424408014571,0.8225016554922511,1.0,5/12,35.62%,TLR4;NOD2;SOX9;MUC13;MUC6
prerank,smoothened signaling pathway (GO:0007224),0.29328240893400975,0.9063388376192824,0.584051724137931,0.8644498986430742,1.0,11/32,20.48%,TMEM17;GLI2;GLI3;GPC2;HES5;MAP3K10;EVC2;ARL13B;SHH;DISP3;DISP2
prerank,thymus development (GO:0048538),-0.36572768664611055,-0.9061599324066717,0.5884543761638734,0.822953710672653,1.0,5/13,26.43%,TBX1;SIX1;HES1;FGF10;SOD1
prerank,cellular protein localization (GO:0034613),-0.19906105460412146,-0.9057151361569753,0.7796976241900648,0.8234727993614638,1.0,100/285,28.26%,OCLN;ESAM;DMD;ID1;SGSM2;STX3;TBC1D8;GRTP1;MESD;FERMT2;JAM3;RIC3;AP3B1;SYNRG;NAPA;RAB18;AMOT;FAM91A1;TBC1D1;TBC1D12;STX1A;TBC1D22A;ARF5;RAB6B;CPE;CPLANE2;VCL;HHEX;ITSN1;HERC2;EMP2;WNT11;CD74;GAS8;STX2;RAB24;COPB2;ARL4A;TBC1D9B;TBCK;ARL6;LAMTOR2;CELSR1;CEP68;SMURF1;RAB1A;COG3;AP2A1;PACSIN1;RRAGD;EGFR;VPS33A;AP4M1;YWHAH;NSF;TBC1D25;TBC1D2;VPS29;ARHGEF2;EHD1;PTPRK;IFT27;USP4;TMED1;LAPTM5;CTTN;KIF13A;RAB32;RAB3GAP2;WIPI2;TMED5;PTPRU;FGF10;RRAGA;RAB23;ADPRH;ARL4C;TBC1D15;STX5;NIPBL;RRAGC;RAB43;STXBP2;TBC1D30;TBC1D17;ATG13;TBC1D5;RAB5C;TMED3;PDCD6;SEC13;STX4;TM9SF2;MYO7A;NPM1;COPZ2;ARF3;CTNNB1;STX16;VPS26C
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.3215201139701135,-0.9055205086239538,0.6120527306967984,0.8234031209407,1.0,1/21,0.34%,CAV1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.26855927077640807,-0.9044624230085239,0.5996343692870201,0.8252406998629496,1.0,10/40,16.56%,B2M;ANXA2;VEGFA;INSR;HIP1;SGIP1;WASL;FMR1;HNRNPK;GREM1
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.2711892705588112,-0.904143770355935,0.62152133580705,0.8254782964646082,1.0,5/40,10.99%,LBP;RPL39;GBP7;PGLYRP1;TIRAP
prerank,DNA recombination (GO:0006310),0.28329685651565484,0.9040610319713992,0.6078838174273858,0.8689876815355507,1.0,7/37,14.56%,DMC1;HDAC10;GEN1;RAD51B;BLM;RAD51C;RPA1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.3531133281902331,-0.9040098484874132,0.6098039215686275,0.825301058243158,1.0,1/15,0.12%,PRKCH
prerank,cellular amide metabolic process (GO:0043603),0.23336648833107038,0.9038589340698368,0.6244897959183674,0.8685961227463482,1.0,19/102,14.28%,PCCA;ACSM5;CPZ;AEBP1;BAAT;DNPEP;CPXM1;PLPP3;ACOT11;PDZD11;NSMAF;ALDH1L1;FPGS;THOP1;SLC46A1;MTHFD1;PLAAT5;ACSL6;MTHFD1L
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.29978502357043824,-0.9035045136888241,0.6052104208416834,0.8259129050825278,1.0,4/25,5.26%,PLCG2;TMBIM4;HTT;CMKLR1
prerank,organonitrogen compound catabolic process (GO:1901565),0.26088357626468434,0.9033590530322729,0.6334745762711864,0.868947032230541,1.0,10/57,10.96%,PLA2G5;PLA2G4A;IL4I1;CPQ;ANPEP;CLPX;ENPEP;RIDA;NAALADL1;TRHDE
prerank,regulation of chromosome segregation (GO:0051983),-0.3455460142417412,-0.9031417478419302,0.5781544256120528,0.8262264425975656,1.0,11/16,41.55%,RAD18;CSNK2A1;CSNK2A2;PUM2;MKI67;CDC6;BUB1;KIF2C;IHO1;RMI2;AURKB
prerank,mitotic chromosome condensation (GO:0007076),-0.2957091517732512,-0.903090176367954,0.5961904761904762,0.8258445196620156,1.0,14/26,32.40%,SMC4;RB1;CSNK2B;CSNK2A1;CSNK2A2;SMC2;NCAPH;NCAPG;NCAPH2;KMT5A;TTN;CDK1;PLK1;NCAPD2
prerank,transition metal ion transport (GO:0000041),0.28788272475216337,0.9029280541694577,0.5886075949367089,0.8691252023184182,1.0,4/35,6.82%,CP;HEPH;SLC30A10;SLC31A2
prerank,regulation of axon regeneration (GO:0048679),0.35636971670749995,0.9029061472292234,0.5661605206073753,0.8683332970238069,1.0,1/12,0.69%,PTN
prerank,negative regulation of leukocyte migration (GO:0002686),0.3935525819029256,0.9028418324736299,0.5735930735930735,0.8676474183240582,1.0,1/10,1.29%,BMP5
prerank,transferrin transport (GO:0033572),-0.2860768164159089,-0.9027067697767893,0.6231060606060606,0.826196734065843,1.0,8/33,11.26%,TFRC;ATP6V0B;ARHGAP1;ATP6V0A2;ATP6V0C;LMTK2;RAB11B;REP15
prerank,regulation of mRNA processing (GO:0050684),-0.28162304086566814,-0.9021948336413803,0.60431654676259,0.8268489635080979,1.0,8/32,20.20%,QKI;SRPK1;SAFB;DHX9;JMJD6;HNRNPK;PTCD2;CPSF4
prerank,negative regulation of lipid storage (GO:0010888),0.32858827907898674,0.9017133709068057,0.5958333333333333,0.869430247613529,1.0,3/19,3.16%,ABCA1;PPARA;OSBPL8
prerank,negative regulation of neuron differentiation (GO:0045665),0.3218727740128092,0.9016420938710012,0.5639913232104121,0.8687688882556941,1.0,5/22,8.88%,CNTN4;HES3;DTX1;SOX2;HES5
prerank,smooth muscle contraction (GO:0006939),0.34608486635131175,0.9014643704105307,0.5645514223194749,0.8683091104343778,1.0,3/14,6.15%,SLC8A1;ROCK2;MYLK
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.31754060299336895,-0.9009439272003544,0.601145038167939,0.8290769194494545,1.0,6/22,22.11%,PTPRJ;EZR;DUSP3;DGKZ;LAPTM5;PTPN22
prerank,positive regulation of calcium ion transport (GO:0051928),-0.2791700287229249,-0.9003581241403038,0.601593625498008,0.8298831144042719,1.0,7/36,13.86%,CAV1;TRPC3;STIM2;TRPC6;ORAI1;SPHK2;CACNA1D
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.29684756240365967,-0.9003435864825435,0.6164623467600701,0.8294236844894134,1.0,6/29,6.25%,LEF1;TLE4;TRRAP;RBBP5;PYGO2;TLE3
prerank,GTP metabolic process (GO:0046039),-0.3452271889657287,-0.8996630049329607,0.5898366606170599,0.8304734757896274,1.0,4/15,21.16%,IMPDH1;ENTPD7;OPA1;RAB23
prerank,myeloid dendritic cell activation (GO:0001773),0.352132366648,0.8996255650056756,0.5764705882352941,0.8718379275896846,1.0,3/12,12.82%,IL4;CAMK4;DOCK2
prerank,acute-phase response (GO:0006953),0.3747629653390896,0.8995779878420047,0.5601750547045952,0.8711019966978872,1.0,4/12,15.61%,AHSG;CEBPB;IL6R;CRP
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.34279694845041186,-0.8991748140576667,0.59245960502693,0.8310395433047199,1.0,4/16,7.92%,ST6GALNAC3;ST8SIA4;ST8SIA6;A4GALT
prerank,brain morphogenesis (GO:0048854),0.3614942836295219,0.8990404848801791,0.5828092243186582,0.8715320163196529,1.0,4/12,10.66%,CTNNA2;SPEF2;PTEN;BBS2
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.34561029392193915,-0.898975568743786,0.5988593155893536,0.8309988322561943,1.0,2/14,6.29%,CAV1;NOTCH4
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.2436920761567379,-0.8988493106570163,0.6468253968253969,0.8307761050328065,1.0,17/78,19.70%,ACTB;CCND3;CCNY;CDKN1B;PKD1;RGCC;AKT1;HHEX;CCNG2;CCNF;EGFR;CCNK;CDKN1A;CDKN2C;CCND1;CDK5RAP3;GADD45A
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.3702491286929608,-0.8986168225893268,0.6068840579710145,0.8308024913206284,1.0,3/12,11.83%,PLCG2;RAB27A;TLR4
prerank,mRNA modification (GO:0016556),0.3185580596455454,0.8984735462219957,0.5763052208835341,0.8720585624472921,1.0,7/22,19.23%,VIRMA;RPUSD2;METTL16;PUS7;METTL3;METTL8;PUS1
prerank,sensory organ development (GO:0007423),-0.25779177124290104,-0.8984376739957808,0.6304347826086957,0.8307245497179434,1.0,9/51,11.43%,SMOC1;HIPK1;TGFB2;STRA6;RAB18;FREM2;SMG9;SIPA1L3;CHRDL1
prerank,ganglioside biosynthetic process (GO:0001574),-0.34992698349621,-0.8983630053606371,0.596745027124774,0.8304181808260261,1.0,3/15,6.25%,ST6GALNAC3;ST8SIA4;ST8SIA6
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.3926102399621179,-0.898329217624652,0.5948434622467772,0.8295308752425359,1.0,3/10,13.75%,RACK1;SPHK2;TNFRSF1A
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.3926102399621179,-0.898329217624652,0.5948434622467772,0.8295308752425359,1.0,3/10,13.75%,RACK1;SPHK2;TNFRSF1A
prerank,negative regulation of coagulation (GO:0050819),0.35004164442016783,0.8982986527998181,0.6021739130434782,0.871613908887547,1.0,3/14,5.86%,SERPINE2;APOH;SERPINE1
prerank,regulation of actomyosin structure organization (GO:0110020),0.35460956452024656,0.8982985337951314,0.5668202764976958,0.8707782302389687,1.0,3/13,8.33%,ROCK2;ASAP3;ALMS1
prerank,negative regulation of transposition (GO:0010529),0.34653287566506646,0.8980857881414736,0.5663157894736842,0.8704343348372463,1.0,3/16,14.33%,TUT4;PIWIL2;TEX15
prerank,dendritic spine organization (GO:0097061),-0.293824693632304,-0.8978133307849374,0.6196078431372549,0.8301528870496122,1.0,2/26,0.54%,IGF1R;SHANK3
prerank,regulation of cellular metabolic process (GO:0031323),0.27291050744433776,0.8976194500518205,0.6217948717948718,0.8706737825197995,1.0,5/45,6.08%,PID1;PPARA;PDK4;PRKN;PDK3
prerank,negative regulation of cellular catabolic process (GO:0031330),0.2508704367691352,0.8973958625041306,0.6308316430020284,0.8703210365474497,1.0,8/63,9.04%,NELL1;TIMP3;LEPR;BCL2;DAP;SIRT2;TIMP4;GOLGA2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.37011954977948325,0.8973637671178494,0.581447963800905,0.8695545863018594,1.0,2/13,3.61%,GLI3;RUNX3
prerank,cardiac atrium morphogenesis (GO:0003209),-0.33779590779270596,-0.8971531925416866,0.6204379562043796,0.8311714857300642,1.0,3/16,4.28%,NOTCH1;BMPR2;TGFB2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.32019899770570354,0.8970777716270381,0.6008230452674898,0.8693466389957157,1.0,2/21,3.16%,ANK2;CACNA2D1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.3814738204016227,-0.8967495770422039,0.6152380952380953,0.8315852868724646,1.0,8/10,42.64%,PPP2R1A;PARP14;PTPN2;NF2;INPP5F;PPP2CA;SOCS3;SH2B3
prerank,positive regulation of chromatin organization (GO:1905269),-0.3561339496121992,-0.8966617535615551,0.5898366606170599,0.8313021246398978,1.0,3/12,16.96%,TAL1;H3-3A;MIER1
prerank,polyol biosynthetic process (GO:0046173),0.33847576742587315,0.8965712220754637,0.5509259259259259,0.8696995880226512,1.0,3/16,3.30%,CYP27B1;CYP27A1;ITPKC
prerank,cell-cell junction maintenance (GO:0045217),0.37662129616149487,0.896344612250749,0.5720620842572062,0.8693993690986666,1.0,2/11,6.39%,PRTN3;NLGN2
prerank,mRNA splice site selection (GO:0006376),0.29786008683277276,0.8961342538628446,0.6175213675213675,0.8690447351271442,1.0,4/30,9.31%,CELF2;SRSF12;CELF4;SLU7
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.29765804626885073,0.8958579663630334,0.5856832971800434,0.8688492105035558,1.0,7/28,15.50%,SHLD2;SETMAR;KMT5C;SMCHD1;PARP3;RIF1;KMT5B
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.3021786487033701,-0.895731204382963,0.6042471042471043,0.8328672931131228,1.0,10/24,29.21%,UBB;UBC;RPS27A;XRCC1;RPA3;POLK;RFC3;RFC2;LIG4;POLB
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.2678146284501647,-0.8957148776847661,0.6115384615384616,0.8324121248393533,1.0,21/45,37.33%,RPL10;FOXO3;APP;RC3H1;TDRD7;RBM4B;PCIF1;PUM2;ZC3H7A;MEX3D;EIF4E;METTL18;RBM3;ZC3H10;PARP9;NANOS1;LARP4;ATG14;TRIM71;EIF2A;CYFIP1
prerank,homologous chromosome segregation (GO:0045143),0.31814908211957427,0.8956071824414596,0.5812356979405034,0.8685586100253708,1.0,3/20,11.11%,MEIKIN;PRDM9;FMN2
prerank,regulation of cell cycle phase transition (GO:1901987),-0.2270068496606698,-0.8955450085977881,0.6974459724950884,0.8322858438750069,1.0,38/91,33.18%,CDKN1B;ANAPC15;PSMA6;PSMB5;ANAPC11;PSMC4;TCIM;PSMC5;PSMD14;PSMD8;PSMC1;ANAPC7;CDKN1A;PSMB4;PSMD11;PSMD12;CDC27;FZR1;CUL1;PSMA1;PSMC3;ANAPC2;PSMB1;PSMA2;PSMA4;TRIM39;NEK10;XPC;PSMB8;BUB3;CDK1;PSMC6;PSMD6;PLK1;ANAPC10;PSMA8;CDC20;PSMB2
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.3168673829948075,0.8952668675757998,0.6038135593220338,0.8685236412851849,1.0,8/23,12.72%,KIT;GHR;IL4;HES5;OCIAD2;ERBB4;PIBF1;PRLR
prerank,hippo signaling (GO:0035329),0.31211588272017216,0.8951742204636336,0.5810276679841897,0.8679060257222447,1.0,4/26,7.02%,TEAD1;DCHS1;WWC1;CASP3
prerank,neuron differentiation (GO:0030182),0.2156627547868585,0.895144831833943,0.724007561436673,0.8671563343711812,1.0,21/165,11.07%,WNT4;TENM3;GLI2;RUNX3;PTPRD;TENM2;PBX4;PHOX2A;FOXA2;CASP3;IL1RAPL1;LHX4;TGFBR1;RYK;ATOH8;CDK5R1;EPHA5;BRSK1;FUT9;ALK;ATP8A2
prerank,response to light stimulus (GO:0009416),0.26002068601600453,0.8940319183780432,0.6167023554603854,0.8689112026448791,1.0,7/55,7.77%,GPR88;DDB2;TRPM1;GTF2H2;COPS3;CRY1;MEN1
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.35971929074838915,-0.8937176665313088,0.6236749116607774,0.8357642574403641,1.0,3/13,4.55%,STX3;HSP90AB1;RIC3
prerank,regulation of amyloid-beta clearance (GO:1900221),0.34282896439189237,0.892534403624376,0.5944798301486199,0.871534339410959,1.0,2/16,5.22%,LRP1;IL4
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.3021084591988792,-0.8924821565867754,0.6164383561643836,0.837958593919228,1.0,9/25,20.62%,NOTCH1;BMPR2;FOXD1;ZNF423;ENG;SMAD4;BMPR1B;CDH5;SMAD2
prerank,bile acid biosynthetic process (GO:0006699),0.31491559000041947,0.892279504144265,0.5973451327433629,0.8712910930491939,1.0,5/24,13.12%,CYP7B1;CYP27A1;BAAT;CYP46A1;OSBP
prerank,glycerol metabolic process (GO:0006071),0.3718005963131438,0.8916557489293843,0.5460829493087558,0.8719451136997663,1.0,7/10,30.61%,GOT1;PDXP;COQ3;GK;ANGPTL3;TKFC;COQ2
prerank,protein homotrimerization (GO:0070207),0.3427411304947251,0.8915550764462097,0.5849462365591398,0.870522306679905,1.0,5/14,19.14%,SLC1A5;PNPT1;SLC1A2;STEAP4;MIF
prerank,protein trimerization (GO:0070206),0.3427411304947251,0.8915550764462097,0.5849462365591398,0.870522306679905,1.0,5/14,19.14%,SLC1A5;PNPT1;SLC1A2;STEAP4;MIF
prerank,negative regulation of secretion (GO:0051048),0.38634587675836884,0.8913221408811608,0.5873015873015873,0.8702549285242608,1.0,2/10,8.73%,NRG1;ERBB3
prerank,negative regulation of blood coagulation (GO:0030195),-0.2712447264334216,-0.8910661858476548,0.6092843326885881,0.8404775166246589,1.0,6/38,8.84%,NOS3;CD34;F3;THBD;EDN1;PDGFA
prerank,regulation of autophagy (GO:0010506),-0.20235028525610121,-0.8908044790297638,0.7392241379310345,0.8405577471986628,1.0,60/216,25.24%,ACER2;EXOC4;EEF1A1;RASIP1;SH3BP4;FOXO1;MID2;FOXO3;DAPL1;ATP6V0B;EIF4G3;FOXK1;PSAP;GPR137B;ATP6V0A2;HSPB1;SVIP;GAPDH;PLK2;AKT1;TRIM14;PIK3C2A;ATP6V0C;RAB8A;UCHL1;ABL2;EXOC1;FBXL2;TRIM68;LAMTOR2;TRIM5;PRKAG1;MET;UFL1;RRAGD;PIK3R2;ATP6V1G1;TAB2;CSNK2A2;BAD;VPS29;GFAP;OSBPL7;MCL1;TMEM59;PLEKHF1;TFEB;FZD5;KEAP1;RRAGA;TRIB3;PTPN22;EIF4G1;RUBCN;RRAGC;TPCN2;ATP6V0D1;EIF4E;WDR6;ATG13
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.3709274058952724,-0.8906617219590862,0.6098418277680141,0.8403780774491171,1.0,5/11,26.42%,MSN;EZR;VPS11;RDX;MTMR2
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.2645574857409505,-0.8901553656411069,0.6619718309859155,0.8409901731706071,1.0,16/46,27.63%,HK1;AKT1;HSPD1;TIMM17A;TIMM21;CHCHD4;TOMM22;BCAP31;TIMM13;TOMM5;TIMM50;FIS1;TIMM10;TIMM8B;TIMM10B;MFF
prerank,regulation of T cell proliferation (GO:0042129),-0.24264311197342148,-0.8899653027958117,0.6747967479674797,0.8409018184775437,1.0,6/61,7.74%,IL15;SLC7A1;TFRC;ANXA1;TNFRSF1B;TNFRSF21
prerank,protein-DNA complex assembly (GO:0065004),0.23038833390591423,0.8898700621283004,0.6942800788954635,0.8727399844886713,1.0,28/116,20.02%,TCF4;DMC1;MCM3;ORC4;DDB2;GTF2H2;MNAT1;PSMA3;PSMF1;PSMA7;RPA2;MCM2;CCNH;MCM8;PSME3;ORC1;DAXX;SPTY2D1;RPA1;PSMD1;PSMB9;SART3;PARP1;ORC3;PSMD13;NAP1L2;ORC5;PSMD9
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.3078531742353769,-0.8892013898986535,0.618595825426945,0.8420918292833809,1.0,6/22,24.94%,ATF4;NCL;SMARCA4;ERBB2;PWP1;UTP15
prerank,peptide hormone secretion (GO:0030072),-0.29273573847184076,-0.8891949557768606,0.6518518518518519,0.8416207412585974,1.0,15/26,45.15%,LTBP4;ANXA1;EDN1;RAB1A;PARK7;ADCYAP1;CAMK2G;SNX19;EXOC3L1;VIP;SLC30A8;FAM3B;NEUROD1;IL6;GAL
prerank,polyamine metabolic process (GO:0006595),-0.35602806604711845,-0.8891690707910034,0.6071428571428571,0.8411898481390173,1.0,6/13,22.37%,OAZ2;AMD1;PAOX;SMS;SRM;DHPS
prerank,keratan sulfate metabolic process (GO:0042339),0.2902395638071441,0.8885248967049979,0.6302521008403361,0.8749970243632964,1.0,8/31,10.62%,FMOD;LUM;B3GNT7;GNS;OMD;GALNS;OGN;CHST1
prerank,regulation of vasoconstriction (GO:0019229),-0.29106080546588986,-0.8877123594457217,0.6325757575757576,0.8438571200960365,1.0,7/27,23.73%,CAV1;BMPR2;ACE2;ACE;ATP2B1;TBXA2R;SMTNL2
prerank,dicarboxylic acid metabolic process (GO:0043648),0.26319347638494506,0.887366117211385,0.6199186991869918,0.8768302685997922,1.0,12/52,14.28%,ALDH18A1;ADHFE1;PHYH;D2HGDH;ALDH1L1;FPGS;MDH2;SDHA;SLC46A1;MTHFD1;ASS1;MTHFD1L
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.31499235886020516,0.8871007383307736,0.6129707112970711,0.8766082131487635,1.0,6/19,17.29%,CHRNB4;CHRNA4;CHRFAM7A;CHRNA7;CHRNB1;ACHE
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.3202171603145525,-0.8862112056313469,0.6412213740458015,0.846617035932489,1.0,3/18,4.13%,CCN3;KCNB1;REST
prerank,prostanoid biosynthetic process (GO:0046457),-0.330443145068977,-0.8861024716170746,0.5963963963963964,0.8463687344770352,1.0,5/15,17.88%,PTGDS;EDN1;CD74;PTGS1;DAGLB
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.3071521360993407,0.8860419530435895,0.6206896551724138,0.8781643886128039,1.0,6/24,9.40%,SEMA5A;PDPK1;IL4;SERPINE1;SCG2;GATA3
prerank,positive regulation of insulin secretion (GO:0032024),0.2769783587008806,0.8858526647469503,0.6260504201680672,0.8777691341315352,1.0,6/36,11.28%,TCF7L2;IRS2;NLGN2;TM7SF3;ADCY8;BAIAP3
prerank,DNA conformation change (GO:0071103),0.33075883460103395,0.8853953649388671,0.6145374449339207,0.8779820311886437,1.0,3/17,8.26%,TOP1;TOP3A;TOP1MT
prerank,regulation of actin filament-based process (GO:0032970),0.24245913654561102,0.8853487700933822,0.6783505154639176,0.8772623672921163,1.0,16/70,15.71%,LRP1;ARHGEF19;ROCK2;EPHA3;RHOH;DLC1;RHOBTB1;PDGFRB;RHOBTB3;EPHA5;GRHL3;RHOF;FZD10;PAK1;RND1;RHOQ
prerank,proteolysis (GO:0006508),-0.19753225423649728,-0.8852493817037799,0.7963709677419355,0.847686001962799,1.0,44/252,13.56%,DPP4;SRGN;F3;TPP1;BACE2;CAPN2;FAP;CTSZ;ADAM10;CTSO;BACE1;CASP7;ERAP1;CTSC;IDE;CASP8;SPCS1;PSMA6;PRCP;ADAM19;PSMB5;CPE;LACTB;CAPN15;PSENEN;CTSD;CTSF;FAM111A;PSMC4;HTRA4;LRP8;MMP14;GGT5;HTRA3;CAPN5;CTSB;SPRTN;MMP15;DPP8;FBXL2;LNPEP;ACE;CAPN10;APH1A
prerank,icosanoid metabolic process (GO:0006690),-0.2655410073705048,-0.8852430116187646,0.6596558317399618,0.8472166181645532,1.0,12/40,19.95%,MGLL;EPHX1;LTA4H;CYP1B1;GPX1;PON3;GGT5;PTGS1;FAAH;GPX4;DAGLB;GGT1
prerank,fatty acid catabolic process (GO:0009062),-0.24298299062713996,-0.8847138157612277,0.6819047619047619,0.847852223759628,1.0,15/67,17.70%,ABHD2;PPARD;ACAD11;ACAA2;ECHS1;HACL1;DECR1;ACADL;ACADVL;CROT;FAAH;ECI1;ACOT8;MECR;HSD17B10
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.3003928814606299,-0.8846893355018982,0.6312741312741312,0.8474076371693204,1.0,2/23,0.94%,SLC12A7;SLC12A2
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.2508885083185438,-0.8846042045713626,0.6710526315789473,0.8470938112915541,1.0,26/56,32.91%,SPTBN1;USP8;KIF23;DCTN3;RHOB;RTKN;MITD1;SNX18;IST1;ECT2;RASA1;ANLN;EFHC2;ARL3;CIT;CENPA;CEP55;STMN1;RACGAP1;VPS4A;TRIM36;PLK1;STAMBP;RHOA;ESPL1;UNC119
prerank,positive regulation of nervous system process (GO:0031646),-0.3253630347331943,-0.8845562192105546,0.621414913957935,0.8467198595396798,1.0,3/18,7.30%,PARD3;UNC13B;TNFRSF1B
prerank,negative regulation of proteolysis (GO:0045861),0.28468996001256464,0.8845090402964915,0.6425531914893617,0.8782933461643441,1.0,3/34,7.52%,TIMP3;SERPINE2;TIMP4
prerank,regulation of primary metabolic process (GO:0080090),-0.21448296067741193,-0.8844069024516087,0.7228915662650602,0.8465585723264565,1.0,42/126,26.73%,PPARD;NCOR1;TNFAIP8L3;NFYA;PLPP1;ADIPOR1;PSAP;PSMA6;PSMB5;LACTB;PSMC4;PSMC5;OAZ2;PSMD14;APOE;PSMD8;TM7SF2;PSMC1;SC5D;NQO1;PSMB4;PSMD11;PSMD12;SP1;EDF1;TBL1X;TGS1;PSMA1;PSMC3;HELZ2;OPA3;RUBCNL;PSMB1;FDPS;PSMA2;PSMA4;SREBF1;LSS;SIN3B;PSMB8;IDI1;NFYB
prerank,negative regulation of developmental growth (GO:0048640),0.2899440485053386,0.8838347856378094,0.6273684210526316,0.8789055841479496,1.0,9/30,16.31%,WWC1;RTN4;CDKL3;PTEN;DCC;BBS2;ULK2;NKD1;TRIM46
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.2978672755996985,0.8836644034074354,0.6372745490981964,0.8784584523099035,1.0,7/26,13.44%,ADCY5;STXBP4;FOXA2;EPHA5;ADCY8;BAIAP3;CDK16
prerank,cellular response to estradiol stimulus (GO:0071392),-0.3279964283314756,-0.8836398082700943,0.6171003717472119,0.847699051013405,1.0,11/18,38.71%,ESR1;NRIP1;LCOR;EGFR;FAM210B;SSTR2;POU4F1;RAMP3;GPER1;CRHBP;SSTR1
prerank,regulation of stem cell differentiation (GO:2000736),-0.22809658592364707,-0.8835579499072002,0.714,0.8473772446508248,1.0,24/89,17.17%,NOTCH1;LMO2;GATA2;PRKDC;CBFB;PSMA6;PSMB5;TAL1;PSMC4;OCIAD1;PSMC5;YTHDF2;PSMD14;HES1;ITCH;LDB1;PSMD8;SETD1A;PSMC1;PSMB4;HOXB4;PSMD11;PSMD12;TCF3
prerank,regulation of mRNA stability (GO:0043488),-0.21129739582962453,-0.8834626156518298,0.758985200845666,0.8470938515592521,1.0,46/145,23.48%,VIM;UBB;HSPA8;UBC;RPS27A;HSPB1;ANP32A;PSMA6;RC3H1;PSMB5;AKT1;PCBP4;FUS;PSMC4;CIRBP;PSMC5;YTHDF2;YWHAZ;PSMD14;E2F1;FMR1;PSMD8;TNFSF13;PSMC1;PSMB4;HSPA1A;PSMD11;FASTKD3;PSMD12;EXOSC8;GIGYF2;TENT5D;SERBP1;PUM2;PSMA1;PSMC3;YTHDF1;MEX3D;TBRG4;PSMB1;PSMA2;EIF4G1;YWHAB;PAIP1;PSMA4;PRKCD
prerank,response to gamma radiation (GO:0010332),-0.2935346258752752,-0.8833917323719763,0.6318785578747628,0.8467740703605725,1.0,11/24,30.07%,RPL26;MAP3K20;TMEM109;HRAS;CRYAB;KDM1A;DCUN1D3;LIG4;FANCD2;TSPYL5;MYC
prerank,regulation of neurotransmitter transport (GO:0051588),0.3392889482451391,0.8827993155967288,0.6120092378752887,0.8796770971200694,1.0,4/16,9.87%,RIMS1;CHRNB4;CPLX2;MCTP2
prerank,positive regulation of neuron death (GO:1901216),-0.2607467730668775,-0.8826782642414003,0.6814671814671814,0.8477617783312115,1.0,11/46,16.77%,MAP3K5;FOXO3;REST;TGFB2;BACE1;ATF4;BAX;TLR4;NF1;DDIT4;C1QA
prerank,polarized epithelial cell differentiation (GO:0030859),-0.35746409359169373,-0.8824270182619576,0.6409807355516638,0.8477916578392617,1.0,3/13,6.15%,OPHN1;MSN;EZR
prerank,histone acetylation (GO:0016573),-0.23813594074631872,-0.8824043162248736,0.7286012526096033,0.847364041355194,1.0,20/69,28.77%,LEF1;PHF20;TRRAP;JADE2;ING5;TRIM16;EPC1;NAA60;MRGBP;BRCA2;EP400;TAF9;TADA3;BRPF1;POLE3;TAF10;RUVBL1;KAT6B;TAF5;SPI1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.31836329241954686,-0.8821271094111228,0.6205607476635514,0.8474680245419252,1.0,5/20,6.61%,NOTCH1;SMAD9;CARF;VEGFA;ATF4
prerank,protein deacetylation (GO:0006476),0.2705512030371976,0.8820864274754949,0.6515748031496063,0.8804599177655221,1.0,7/41,9.50%,TBL1XR1;PRDM5;HDAC10;SIRT2;MIER3;BRMS1L;BRMS1
prerank,glucose metabolic process (GO:0006006),-0.24847567059846334,-0.8819676781268546,0.68,0.8473319791816588,1.0,11/58,16.27%,LRP5;PPARD;GPI;PGM1;PPARGC1A;ATF4;GAPDH;SLC25A12;PGK1;SLC25A1;GALM
prerank,megakaryocyte differentiation (GO:0030219),0.37268554807034415,0.881894746167488,0.6017316017316018,0.8800506931377721,1.0,2/11,7.87%,KIT;THPO
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.36006655820761746,0.8817922552210935,0.6169772256728778,0.8786539146245139,1.0,1/12,1.00%,FBLN1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.36006655820761746,0.8817922552210935,0.6169772256728778,0.8786539146245139,1.0,1/12,1.00%,FBLN1
prerank,regulation of RNA export from nucleus (GO:0046831),0.3681886466919334,0.8817317382258865,0.6,0.8779652220671064,1.0,2/11,6.61%,AKAP8L;KHDRBS1
prerank,nucleotide metabolic process (GO:0009117),-0.3015222166584238,-0.8816382438399714,0.623352165725047,0.847527982117293,1.0,13/23,46.39%,ME1;CTPS2;NMNAT3;PARK7;NMNAT2;FHIT;CMPK2;DCK;ENPP3;DCTD;AK7;NUDT5;AK1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.273794743958219,0.8808417593379433,0.6268343815513627,0.8791209947433306,1.0,18/40,23.65%,CRY1;RADX;RPA2;FXR2;ANKLE1;MAPT;IER3;CDK9;FBXO5;ETAA1;WRNIP1;UBE2N;NEK4;WDR76;ARMT1;NPAS2;UBE2V2;RFWD3
prerank,negative regulation of histone modification (GO:0031057),-0.3472772196832815,-0.8802205646123136,0.6183745583038869,0.8500894399828187,1.0,4/14,19.66%,CTBP1;TWIST1;SPHK2;AASS
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.3731004363275091,-0.8802123438288729,0.64030131826742,0.8491392879426073,1.0,2/11,6.29%,TNRC6C;NOTCH4
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.3731004363275091,-0.8802123438288729,0.64030131826742,0.8491392879426073,1.0,2/11,6.29%,TNRC6C;NOTCH4
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.3316323807515497,-0.8801689936064129,0.6293577981651376,0.8487504141932075,1.0,9/15,35.49%,DKC1;CCT2;CCT3;CCT8;CCT7;RUVBL1;CCT4;NOP10;CCT6A
prerank,calcium ion transport into cytosol (GO:0060402),0.30924193433487235,0.8799081896053188,0.5973451327433629,0.8803922859478983,1.0,3/21,4.10%,SLC8A1;CACNA2D1;TRPM1
prerank,multivesicular body organization (GO:0036257),-0.2785543326619584,-0.8798966231140689,0.6634241245136187,0.8488668771182468,1.0,8/31,17.86%,RAB11A;RAB27A;CHMP2B;VPS36;TSG101;SNF8;IST1;CHMP2A
prerank,response to tumor necrosis factor (GO:0034612),0.23177787398783292,0.8796437207192019,0.7100371747211895,0.8801864622605644,1.0,11/91,10.29%,ADAMTS12;PID1;HYAL3;OCSTAMP;SFRP1;GGT7;CXCL16;CASP3;GATA3;CCL25;YTHDC2
prerank,negative regulation of ion transport (GO:0043271),-0.2968563293924323,-0.8794372400254288,0.650887573964497,0.8493471766869782,1.0,12/24,38.43%,PTK2B;WNK1;CASQ2;PACSIN3;LILRB1;NOS1;CD33;WNK4;ADRA2A;INPP5K;HRH3;VIP
prerank,response to muscle stretch (GO:0035994),0.3394756470379809,0.8793739287120464,0.6182669789227166,0.8799779281568859,1.0,2/15,3.86%,SLC8A1;CSRP3
prerank,positive regulation of ATPase activity (GO:0032781),-0.2613848444385415,-0.8793101697520654,0.6673003802281369,0.8491404028583099,1.0,18/41,35.42%,ATP1B1;PFN1;DHX9;TOR1AIP1;DNAJC9;CHTOP;VMP1;DYNLL2;TOR1AIP2;FGF10;ATP1B2;DNAJB1;DNAL4;UHRF1;ATP2A1;TPM1;MYL3;MSH6
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.30694714157397485,-0.8788938658120652,0.654510556621881,0.849053208439844,1.0,9/22,31.27%,ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC23;ZDHHC12;ZDHHC18;ZDHHC3;GOLGA7B;ZDHHC24
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.30694714157397485,-0.8788938658120652,0.654510556621881,0.849053208439844,1.0,9/22,31.27%,ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC23;ZDHHC12;ZDHHC18;ZDHHC3;GOLGA7B;ZDHHC24
prerank,nuclear membrane disassembly (GO:0051081),0.34946887523278364,0.8786747806444197,0.6072961373390557,0.8807099726309547,1.0,5/14,19.53%,PRKCA;AKAP8L;PRKCB;LPIN1;CCNB2
prerank,carboxylic acid metabolic process (GO:0019752),-0.2775592101102602,-0.8786457633554788,0.6597353497164461,0.8491087541496916,1.0,5/33,10.63%,SLC2A1;CSGALNACT1;ST6GAL1;PON3;CARNMT1
prerank,regulation of mitochondrial fission (GO:0090140),-0.29917458024900595,-0.878357925694178,0.6434108527131783,0.8492116332059126,1.0,11/24,30.82%,KDR;CYRIB;MIEF1;MIEF2;INF2;FIS1;MCU;MFF;MUL1;MYO19;AURKA
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.26524607375585696,-0.8779337401499571,0.6837121212121212,0.8496330038947713,1.0,12/41,18.46%,MGLL;EPHX1;CYP1B1;GPX1;ELOVL5;GSTM2;PTGS1;FAAH;GPX4;ACOT8;DAGLB;ELOVL1
prerank,vesicle transport along microtubule (GO:0047496),-0.3057714931613491,-0.877756203228421,0.6641074856046065,0.8495597186196847,1.0,8/23,22.02%,TRAK1;HTT;TRAK2;NDE1;NDEL1;RAB1A;KIF13A;KIF1C
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.3292062019691799,0.8775140270086224,0.6194503171247357,0.8824787092026806,1.0,5/17,16.28%,ADRA1D;ADRA1B;DRD2;ADRB3;ADRA1A
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.3098563827557632,-0.8767361440680429,0.6397748592870544,0.8512060917302633,1.0,5/20,16.07%,FAR2;ACLY;PPT2;FAR1;SLC25A1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.33463890270579133,-0.8766643121825394,0.6398537477148081,0.8508521524407526,1.0,3/15,12.41%,DCTN2;CEP192;PCM1
prerank,DNA replication (GO:0006260),0.22830248317878174,0.8766421763432276,0.7038461538461539,0.8835584482932143,1.0,29/105,20.81%,RBMS1;MCM3;ORC4;TOP1;TOP3A;TOP1MT;BLM;RPA2;MCM2;RFC5;MCM9;MCM8;ATM;ORC1;NBN;BRIP1;RPA1;KAT5;ORC3;WRNIP1;POLD4;ORC5;POLD1;NT5M;SET;CDC7;DONSON;DUT;RFC1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.21803145006482957,0.8762388176844176,0.7330754352030948,0.8835962202462758,1.0,14/138,7.89%,RORA;AR;TBL1XR1;RARB;VDR;TEAD1;PPARA;GTF2H2;MAML3;MNAT1;HNF4G;HDAC10;RARG;RBPJ
prerank,peptidyl-lysine trimethylation (GO:0018023),0.2975089529649471,0.8761854193419204,0.6198704103671706,0.882914834659408,1.0,11/26,25.86%,KMT2A;PRDM9;KMT5C;SETD5;KMT5B;WDR82;VCPKMT;SETD4;SUV39H2;CTR9;METTL21C
prerank,protein localization to chromatin (GO:0071168),-0.32719345893456453,-0.8760965324632886,0.6307977736549165,0.8515280276443304,1.0,8/18,31.54%,ESR1;TASOR;WAPL;RAD21;NIPBL;MRNIP;CHMP7;PLK1
prerank,mRNA 3'-end processing (GO:0031124),-0.2330588527489732,-0.8755906594220152,0.6892655367231638,0.8520950801011781,1.0,23/78,25.64%,RPRD1B;APP;SRSF5;SRSF2;SRSF6;LSM11;U2AF1;ZC3H11A;RNPS1;SRSF4;MAGOH;CHTOP;ALYREF;DDX39B;CASC3;CPSF4;THOC6;PAPOLG;DDX39A;NCBP2;CSTF2T;PABPC1;RPRD1A
prerank,protein targeting to membrane (GO:0006612),-0.22944542046936497,-0.8754392997019524,0.7541322314049587,0.8518983864781287,1.0,46/83,42.40%,PARD3;RAB8B;AQP11;NACA;ATG3;TAOK2;SEC63;ZDHHC9;ZDHHC1;ICMT;ARL6;ZDHHC20;SGTA;SDCBP;SRP19;SSR2;ZDHHC23;SGTB;ZDHHC12;FIS1;ZDHHC18;ZDHHC3;TRAM1;PEX14;SEC61A1;GOLGA7B;NACAD;ABCD3;ZDHHC24;CHM;SRPRA;NCF1;VPS37C;CHMP4B;CHMP4A;SLC25A17;RTP3;RABGEF1;ACBD5;RTP4;ZDHHC19;GDAP1;ABCD1;PEX26;PEX13;SSR1
prerank,replication fork processing (GO:0031297),0.276130940786027,0.8742793734534257,0.6745182012847966,0.8863946662836221,1.0,14/38,21.20%,ZGRF1;SETMAR;GEN1;BLM;FANCM;THOC1;CENPS;CDK9;ETAA1;FBH1;SMARCAL1;RTEL1;PCNA;ZRANB3
prerank,lipid droplet formation (GO:0140042),-0.37576698671992875,-0.8742082023508975,0.6446886446886447,0.8539789556937917,1.0,2/10,7.87%,CDS2;CDS1
prerank,regulation of nervous system development (GO:0051960),0.27540993810839387,0.8741389282214643,0.6632653061224489,0.885900809654659,1.0,7/37,11.60%,PTN;HES3;SIRT2;DOCK7;NPHP3;HES5;YAP1
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.3603403310412099,-0.8739399629789768,0.6351851851851852,0.8540449788065775,1.0,5/12,24.49%,PTK2B;DIAPH1;CASQ2;UBASH3B;CASQ1
prerank,P-body assembly (GO:0033962),-0.3531557587961673,-0.8737859983444735,0.660482374768089,0.8538604316795809,1.0,4/12,20.87%,RC3H1;LIMD1;LSM14A;LSM3
prerank,heterocycle biosynthetic process (GO:0018130),0.3435693619572511,0.8735728617534257,0.6164079822616408,0.8863412528114519,1.0,1/14,2.13%,MOCS2
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.346302643976356,-0.8734185658999688,0.6431159420289855,0.8541800283298583,1.0,2/13,2.92%,NOP14;RPS21
prerank,detection of calcium ion (GO:0005513),-0.3481897049978633,-0.8733721608754687,0.6087786259541985,0.8537905404418913,1.0,4/13,22.21%,CALM1;CALM3;CASQ2;KCNIP2
prerank,ATP transport (GO:0015867),0.36823534681286796,0.872981086643135,0.5899122807017544,0.8868038771273633,1.0,3/10,16.20%,SLC25A42;SLC25A24;CD47
prerank,negative regulation of axon extension (GO:0030517),-0.28467851291858587,-0.8725461998474664,0.6771037181996086,0.8550301905652017,1.0,5/30,9.57%,SEMA6A;SEMA3C;SEMA7A;DIP2B;SEMA3G
prerank,synaptic vesicle exocytosis (GO:0016079),0.2687538557617823,0.8721590238853401,0.6410256410256411,0.8878107336340457,1.0,9/40,13.59%,RIMS1;UNC13C;SYT1;CPLX2;OTOF;SNAP25;STX1B;SNAP47;SNAPIN
prerank,regulation of catabolic process (GO:0009894),-0.3144798755632688,-0.8721010442105954,0.6576576576576577,0.8554349084607031,1.0,2/18,3.79%,NEDD4L;FAP
prerank,regulation of urine volume (GO:0035809),-0.37824366494437656,-0.8717422229762137,0.6353591160220995,0.8556891675266057,1.0,6/10,37.29%,NPR1;NPR3;HAS2;HYAL2;TFAP2B;INPP5K
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.3057382983842384,-0.8715674273224133,0.6551059730250481,0.8555931130249415,1.0,10/22,36.85%,GATA2;NES;KDM1A;DLL4;SHCBP1;TOX;FZD9;RASSF10;TRIM71;PROX1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.28874295342517553,-0.8715585797500923,0.6630630630630631,0.8551280421786293,1.0,7/26,14.26%,CALM1;FKBP1A;GSTM2;CALM3;FMR1;CASQ2;SRI
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.2980307359853066,0.8710101280518278,0.6422018348623854,0.8896119689303448,1.0,4/26,7.04%,EYA2;GDNF;BCL2;EYA1
prerank,cellular response to retinoic acid (GO:0071300),0.26303079559630993,0.8708619882685699,0.6688453159041394,0.8891189575019626,1.0,11/42,15.24%,PTK7;EPHA3;LYN;ZNF35;BRINP1;BRINP3;ATM;FZD10;BRINP2;WNT6;WNT5B
prerank,response to interleukin-1 (GO:0070555),0.23939113182180208,0.8706060461161196,0.6927710843373494,0.8888971121550506,1.0,5/73,3.70%,ADAMTS12;HYAL3;PRKCA;PTGIS;SFRP1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.33201888382268674,0.8704891124789076,0.6317991631799164,0.888330899894278,1.0,5/15,14.28%,FGFR2;PDGFRA;TGFBR1;MTHFD1;MTHFD1L
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.3231511295948984,-0.8704746515378289,0.6610800744878957,0.8568622134044633,1.0,4/18,10.98%,PPIA;HSPB1;AKT1;BAG5
prerank,blood circulation (GO:0008015),-0.24970199646440677,-0.8704650399152315,0.7158671586715867,0.8564014491349029,1.0,14/49,18.94%,NOS3;MYOF;TBC1D8;NPR1;GUCY1B1;GUCY1A1;GPX1;ACE2;ACE;F5;GCLM;DLL4;STAT1;GCLC
prerank,negative regulation of response to external stimulus (GO:0032102),0.226303565586129,0.8700740079142161,0.714828897338403,0.8884310094420478,1.0,14/105,10.75%,RORA;GRID2;PPARA;PTGIS;CTNNA2;IL4;SMPDL3B;SERPINE1;NLRP12;SIRT2;GATA3;RNF26;PTEN;TNFAIP6
prerank,negative regulation of cell aging (GO:0090344),-0.3298625209347656,-0.869884184202057,0.6414414414414414,0.857125678175115,1.0,3/16,9.18%,CDK6;MAP3K3;TWIST1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.28447678000772175,-0.8696517415438172,0.6794171220400729,0.8571477908329371,1.0,6/26,10.60%,FNBP1L;ITSN2;AP2M1;ITSN1;SGIP1;FCHO2
prerank,lipid biosynthetic process (GO:0008610),0.23963364153755531,0.86961137519674,0.7241379310344828,0.8886405755856717,1.0,15/77,17.56%,PAM;ACSM5;ACSL1;SCD5;NDUFAB1;PRLR;GNPAT;ACSL6;ACACA;MCAT;FADS1;SCD;OLAH;CYP51A1;ACSS2
prerank,cellular response to superoxide (GO:0071451),-0.3766379316305233,-0.8694831396633216,0.6362038664323374,0.857004429800282,1.0,1/10,1.07%,NOS3
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.3145872188958418,-0.8690865234392277,0.6347197106690777,0.8573226889665132,1.0,6/18,18.88%,ACTB;SPTBN1;MMP14;ABCA2;VTI1B;MISP
prerank,neurotrophin signaling pathway (GO:0038179),-0.30787533696735686,-0.8687767920205091,0.6385767790262172,0.8574503466570453,1.0,3/21,3.68%,RAP1A;RAPGEF1;NGF
prerank,sensory perception of light stimulus (GO:0050953),0.23224038274989262,0.8678409924641527,0.7337278106508875,0.8916498541281949,1.0,18/87,17.56%,ADGRV1;DHRS3;TRPM1;PCDH15;CRYBA1;ATXN7;GUCY2F;BBS2;ATF6;POU6F2;COL1A1;RPGR;COL11A1;RP2;CLRN1;MYO9A;ZIC2;PAX6
prerank,proteasome assembly (GO:0043248),-0.3631062186027974,-0.867527115730468,0.615530303030303,0.8595247126099663,1.0,3/11,23.78%,POMP;PSMD11;PSMG2
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.3787200453758012,-0.8662938856092007,0.6314814814814815,0.8615724493653004,1.0,5/10,18.29%,CAMK1;SPHK2;SMAD4;RAPGEF3;CHEK1
prerank,positive regulation of cellular respiration (GO:1901857),-0.3603979171635941,-0.8657426651078053,0.6434782608695652,0.8622398080302661,1.0,5/11,26.71%,IFNAR1;VCP;IL10RB;PARK7;IFNLR1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.28478847714053285,-0.8653411160783718,0.6568047337278107,0.8625919706026712,1.0,19/29,44.74%,CYRIB;PVR;LAMP1;NECTIN2;RASGRP1;AP1G1;SPI1;CADM1;NOS2;TYROBP;SLAMF6;CD226;IL12A;CRTAM;IL12RB1;IL23A;KLRD1;CD160;KLRK1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.34815222882722235,-0.8651692245482137,0.6378676470588235,0.8624844621226274,1.0,2/12,11.94%,ANO1;PPP3CB
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.2983026083474244,-0.8649683856293915,0.6852886405959032,0.8623834575481367,1.0,13/23,29.86%,NDUFA13;BAX;TOMM22;TIMM29;HSPA4;HSP90AA1;BAD;TIMM13;TIMM10;TIMM8B;TIMM10B;PMAIP1;ROMO1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.31539112216090426,0.8648064806542575,0.6470588235294118,0.897389656641109,1.0,2/19,2.74%,PTGFR;PRKACA
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.34035710706517336,0.8646363585857696,0.6415929203539823,0.8969542229939237,1.0,4/14,12.60%,CREB3L1;PRKN;CREB3;TXNDC12
prerank,double-strand break repair (GO:0006302),-0.2039731466121298,-0.8645112466676824,0.7791932059447984,0.862835128201872,1.0,65/158,34.10%,PAXX;BRCC3;PRKDC;ZFYVE26;ERCC1;UIMC1;BABAM1;YY1;HERC2;SFPQ;VCP;MTA1;CIB1;HPF1;UBXN1;PPP5C;PSMD14;SLX4;SAMHD1;REV3L;DCLRE1C;HUS1;XRCC1;RPA3;PARP2;EME2;CYREN;MMS22L;BRCA2;POLQ;RAD21;BABAM2;AP5Z1;ERCC4;HELQ;SFR1;FAN1;POLL;DTX3L;NSMCE1;LIG4;RAD51AP1;DNA2;BARD1;MRE11;SMARCA5;POLB;HMGB2;PRPF19;RECQL;MEIOB;SWI5;EXD2;TNKS1BP1;RNF8;PARP9;NSD2;RMI1;ATP23;RAD52;RAD50;AUNIP;XRCC4;MAD2L2;POLA1
prerank,positive regulation of lipid transport (GO:0032370),0.34989319939570673,0.8642316427410996,0.6044444444444445,0.8969921987042144,1.0,2/12,8.34%,LRP1;ABCB4
prerank,histone deacetylation (GO:0016575),0.2684439704440261,0.864105572476198,0.6954813359528488,0.896454077200847,1.0,8/43,9.77%,TBL1XR1;PRDM5;HDAC10;SIRT2;MIER3;BRMS1L;BRMS1;HDAC8
prerank,regulation of protein neddylation (GO:2000434),-0.3754727777595441,-0.863954535320025,0.6373626373626373,0.8634916385527117,1.0,6/10,24.07%,DCUN1D5;RPL11;DCUN1D1;COPS9;RPL5;DCUN1D3
prerank,sterol biosynthetic process (GO:0016126),-0.27200651296169664,-0.8639486558842997,0.6793168880455408,0.8630237640427242,1.0,16/33,33.58%,LBR;ACLY;ACAA2;DHCR24;TM7SF2;SC5D;CH25H;FDPS;LSS;IDI1;PLPP6;ACAT2;EBP;INSIG1;HMGCR;ARV1
prerank,gluconeogenesis (GO:0006094),-0.2628744936608215,-0.8634741073801426,0.662109375,0.8635303821735589,1.0,8/39,16.07%,GPI;PGM1;PPARGC1A;ATF4;GAPDH;SLC25A12;PGK1;SLC25A1
prerank,triglyceride catabolic process (GO:0019433),-0.3112884617584056,-0.8618709235071564,0.6726618705035972,0.8663118110979392,1.0,2/19,10.77%,PNPLA2;FABP5
prerank,inner dynein arm assembly (GO:0036159),0.36486316846598027,0.8618506922304521,0.6347438752783965,0.900487667834705,1.0,10/10,63.54%,CCDC39;CFAP73;CCDC40;DNAAF5;CFAP100;ZMYND10;DNAI3;DNAAF1;DNAH1;DNAAF4
prerank,superoxide metabolic process (GO:0006801),-0.2831348942602355,-0.8614131328920692,0.6616541353383458,0.8667384145496639,1.0,5/29,12.84%,SH3PXD2A;NOS3;NCF2;PREX1;NRROS
prerank,positive regulation of protein sumoylation (GO:0033235),-0.37050600324951855,-0.8605518568100763,0.6611111111111111,0.8679664650712093,1.0,5/10,33.82%,HDAC4;SAE1;UBA2;MUL1;RASD2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.24150367487129626,-0.8603332529304001,0.7269076305220884,0.8679613856594405,1.0,13/55,19.70%,THBS1;TGFBR2;RNF41;RAC1;CYP1B1;RIPK1;ACE2;SPHK2;CDKN1A;COQ7;CBR1;SLC25A33;GADD45A
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.3154141818086923,0.8602711994425678,0.646551724137931,0.9030704450246524,1.0,4/19,9.40%,RHOH;IL4;AXL;GATA3
prerank,regulation of cellular biosynthetic process (GO:0031326),0.28735571409233923,0.8601227251277628,0.6631578947368421,0.9025668408913933,1.0,6/28,11.94%,MITF;PRKAG2;PDK4;MFSD12;FGFR4;CTNS
prerank,regulation of myelination (GO:0031641),-0.2860991760854178,-0.8590932368466422,0.6722532588454376,0.8699198242306124,1.0,4/25,7.74%,JAM2;PARD3;TNFRSF1B;TNFRSF21
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.34171575309283747,-0.8586753418067486,0.688212927756654,0.8702596803995064,1.0,4/13,12.47%,CD81;CD9;FCER1G;SYK
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.3340808974692709,0.8586274129840831,0.6530172413793104,0.9048855577131335,1.0,3/16,7.83%,DAZAP1;TRA2A;CELF4
prerank,midbody abscission (GO:0061952),-0.3174890426972053,-0.8585720001429511,0.6505576208178439,0.8699855677459416,1.0,10/17,43.34%,CHMP2B;MITD1;CHMP2A;CEP55;VPS4A;CHMP7;CHMP4B;CHMP4A;CHMP4C;CHMP1B
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.26578067157794594,0.8580435150988083,0.6638297872340425,0.9052979607344658,1.0,4/39,4.65%,PIK3R1;PIP4K2A;ITPKC;EFR3A
prerank,chromosome organization (GO:0051276),-0.21777045709397944,-0.8574030499210332,0.7690582959641256,0.8718952444367529,1.0,41/99,30.49%,ZBTB7A;UBB;UBC;RPS27A;SAFB;CUL4A;HHEX;H3-3A;COPS6;GATAD1;HMGN1;COPS5;CDAN1;RBX1;LDB1;SMARCA4;NUP155;CETN2;TOP2A;HMGN2;PWWP3A;L3MBTL1;NDC80;COPS7A;COPS4;COPS7B;EZH1;CDCA8;PHF19;POLE3;XPC;LIG4;CENPV;GPS1;FAM50A;HDAC5;RAD23B;HMGB2;TOP2B;MYC;NUF2
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.32021346736778483,-0.8572510370378388,0.6867256637168142,0.871709900840565,1.0,1/17,0.24%,ANO6
prerank,regulation of hormone secretion (GO:0046883),-0.3212261761308116,-0.8564897240184469,0.6331569664902998,0.8726586921748379,1.0,2/15,7.54%,ANXA1;EDN1
prerank,dendritic spine morphogenesis (GO:0060997),0.34054612887012803,0.8564792008334248,0.6352201257861635,0.9078520203180711,1.0,5/15,12.52%,DOCK10;CTNND2;EPHB1;PTEN;DLG4
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.23130012686183649,0.8564442538191187,0.7415506958250497,0.9071034090426102,1.0,16/88,13.51%,SH3D19;DNAJC6;SORCS1;AP4B1;MYO5A;SCFD1;ACBD3;ARFGEF2;GBF1;TXNDC5;RAB10;CCDC93;LLGL1;SYS1;VPS35L;SCAMP2
prerank,regulation of centriole replication (GO:0046599),0.31882703325599404,0.8562674852916042,0.6268980477223427,0.9066601458592686,1.0,8/17,23.74%,CEP295NL;MDM1;ALMS1;NUP62;CEP295;TRIM37;CEP76;KAT2B
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.1975801340305299,-0.8562089887611134,0.8495762711864406,0.8727605730524257,1.0,46/173,22.28%,SPTBN1;CD55;DCTN2;VAMP7;ZW10;KDELR1;DYNC1LI2;CTSZ;NAPA;NRBP1;CTSC;ATL3;SPTAN1;TRIP11;ATL2;ERGIC1;GOSR1;DCTN3;TRAPPC11;COPG1;DCTN1;TMEM115;COG8;COPB2;BCAP31;LMAN2;PEF1;MCFD2;COG5;RAB1A;COG3;DYNC1LI1;TRAPPC5;F5;NSF;VTI1B;DYNLL2;SEC24B;TMED1;COG2;TMED5;TRAPPC2;TRAPPC2L;USE1;TEX261;STX5
prerank,transcription by RNA polymerase II (GO:0006366),0.19291506588229224,0.8561001569612327,0.8595825426944972,0.9062033949329399,1.0,66/305,19.60%,RORA;MAF;AR;GLIS3;TBL1XR1;RARB;VDR;PRRX1;TEAD1;PPARA;TFCP2;TFDP1;PMF1;GTF2H2;MAML3;MNAT1;HNF4G;HSF2BP;HDAC10;DTX1;NFIX;RPAP1;FIP1L1;RARG;RBPJ;SNAPC3;SOX5;SYMPK;POLR2G;PHAX;PABPN1;PAX1;CCNH;YAP1;SNAPC1;MAML1;INTS7;ICE1;SCAF8;PGR;TAF5L;NRBF2;CCNT1;CPSF7;INTS9;CDK9;ICE2;HDAC1;PAX5;PARP1;ESRRG;PPARG;MED4;ELL2;GTF2B;TAF15;ELOA;PAPOLA;RPRD2;TAF7;GTF2E2;E2F2;POLR2K;TAF1C;NR1D2;POLR2D
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.29620435739888257,-0.8557285832132322,0.6718446601941748,0.8732040433883753,1.0,9/24,25.00%,MPHOSPH8;AEBP2;H3-3A;EPC1;TASOR;BMI1;RBBP4;CREBZF;PHF19
prerank,negative regulation of cell cycle process (GO:0010948),0.2452810752534486,0.8554468566168819,0.720164609053498,0.9067149174417594,1.0,18/61,21.19%,AURKAIP1;UXT;TFDP1;L3MBTL2;RNF2;APAF1;PCGF6;TOM1L2;TOM1L1;EHMT2;PPP1R10;EZH2;FBXO5;YAF2;ZFYVE19;CDC7;MGA;PCGF2
prerank,negative regulation of transport (GO:0051051),0.24729103367354227,0.8552650715781365,0.7060041407867494,0.9062897053226953,1.0,8/51,10.32%,PRTN3;NRG1;EPHA3;SNX33;PRKN;ERBB3;YRDC;PTEN
prerank,photoperiodism (GO:0009648),-0.27362625152866904,-0.8550715912188744,0.6686274509803921,0.8740460892875318,1.0,10/28,30.50%,BHLHE40;PPP1CB;MTA1;RBM4B;FBXL3;PPP1CA;CLOCK;SIK1;FBXL8;CRY2
prerank,glycosaminoglycan metabolic process (GO:0030203),0.24940338402459167,0.8549387658372779,0.7087378640776699,0.9061786642422422,1.0,12/54,14.74%,GPC6;GPC4;GPC2;PXYLP1;GNS;HS2ST1;GPC5;HSPG2;HS6ST2;GLB1;HS3ST6;HS3ST5
prerank,phagolysosome assembly (GO:0001845),0.3542846094295646,0.8547624839855412,0.6577181208053692,0.9057711739969079,1.0,4/12,20.19%,PLA2G5;CLN3;RAB20;RAB7B
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.33033562866722027,-0.8541367620055238,0.6421845574387948,0.8754225816525589,1.0,4/14,11.72%,SEMA7A;PLCG2;CD74;MAVS
prerank,regulation of protein targeting to membrane (GO:0090313),-0.27959805519588055,-0.8539115121878931,0.6726907630522089,0.8753786795251846,1.0,8/28,14.68%,KCNB1;CHP1;MIEF1;GDI1;MIEF2;CIB1;HRAS;ERBB2
prerank,tRNA modification (GO:0006400),-0.2369934402219929,-0.8533456748376681,0.7642436149312377,0.8760426111611701,1.0,26/62,35.01%,DUS2;THUMPD1;TRMT9B;QTRT2;URM1;TRDMT1;QTRT1;TYW1;TRMT61B;TRMT6;AARS2;TRMT44;TYW3;PUSL1;ANKRD16;WDR6;METTL1;ADAT2;CTU2;METTL2A;METTL2B;THADA;TRMT13;TYW5;THG1L;AARS1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.3718572636082922,0.8530737299566615,0.6321353065539113,0.9084711914206328,1.0,1/10,1.22%,SEMA5A
prerank,metanephros development (GO:0001656),0.29036937154481723,0.8530369002206855,0.6778242677824268,0.9077341087713762,1.0,2/26,1.83%,ROBO2;GDNF
prerank,steroid catabolic process (GO:0006706),0.35973449037401106,0.8528030495800537,0.6299559471365639,0.9074428695340548,1.0,1/10,1.88%,CYP27B1
prerank,quinone biosynthetic process (GO:1901663),-0.332011974422279,-0.8519094556716736,0.6709796672828097,0.8783831164070215,1.0,5/14,21.78%,PDSS2;COQ6;COQ8A;COQ7;UBIAD1
prerank,regulation of myoblast fusion (GO:1901739),0.3405726048254053,0.851904006789439,0.6247240618101545,0.908530074567824,1.0,3/11,12.92%,CFLAR;IL4;CD53
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.28651805472635744,-0.8516270915435494,0.6480769230769231,0.8784429839872524,1.0,6/24,11.39%,TGFB1;ABI3;AP2M1;PPP2R5A;GDI1;BCL2L1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.2544039062527298,0.8516065794122395,0.697286012526096,0.9083311208824075,1.0,6/46,11.10%,FBLN1;TIMP3;LYN;GSTP1;PTEN;RPS6KA6
prerank,long-chain fatty acid transport (GO:0015909),0.2795500253922178,0.8511872569832482,0.650103519668737,0.9084149177192801,1.0,9/30,17.79%,PRKAG2;ACSL1;ABCD2;CPT2;ACACA;FABP4;PRKAB2;SLC27A4;PPARG
prerank,histone mRNA catabolic process (GO:0071044),0.32380540112302064,0.850632315671379,0.6604938271604939,0.908761354815665,1.0,7/15,26.24%,TUT4;ATM;MTPAP;TENT2;SSB;XRN1;TENT4B
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.2711861653800979,-0.8506201452479997,0.6970873786407767,0.8799273681591251,1.0,2/30,2.16%,DACH1;BMPR2
prerank,cholesterol homeostasis (GO:0042632),0.24357587701109595,0.8502424144032559,0.710172744721689,0.9087739607643919,1.0,3/64,1.40%,RORA;CYP7B1;ABCA1
prerank,peptidyl-lysine modification (GO:0018205),-0.21738533121225648,-0.849958105719388,0.7894736842105263,0.8807416912904089,1.0,32/99,26.90%,NNAT;IFIH1;PLOD2;HDAC9;STX1A;NUP93;HDAC4;TRIM28;NUP54;NDC1;PLOD3;SAE1;SUMO3;NUP188;LOX;NUP155;RANBP2;UBA2;CTH;NUP37;RANGAP1;USPL1;NUP160;NUP43;SEH1L;ATPSCKMT;SENP5;NUP42;NUP107;PARK7;EEF1AKMT3;NUP98
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.31036822611319637,-0.8498078749188924,0.6762452107279694,0.8805413772828848,1.0,9/18,42.09%,ATF4;MAF1;ERBB2;UTP15;POLR2L;LYAR;SIRT7;FLNA;RASL11A
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.2803316997057369,-0.8487978517991197,0.6829745596868885,0.8820699930873196,1.0,7/26,11.83%,CDK6;RARA;GPR137B;TLR3;C1QC;INHBA;TLR4
prerank,positive regulation of phospholipid transport (GO:2001140),-0.37123944739043235,-0.8484799495885386,0.6697247706422018,0.8821968599856869,1.0,4/10,22.11%,DBI;APOE;TMEM30A;TRIAP1
prerank,Golgi ribbon formation (GO:0090161),-0.33829387704848524,-0.8473305014058814,0.6839285714285714,0.8838831897263728,1.0,7/13,28.92%,TRIP11;FHDC1;GCC2;TMED5;GOLPH3;STX16;VAMP4
prerank,proteasomal protein catabolic process (GO:0010498),-0.19250883990911125,-0.8471468152624785,0.8579881656804734,0.883757614527776,1.0,56/201,25.38%,WWP1;NEDD4L;SEL1L;RNF41;WWP2;ZNRF1;RHBDD1;PSMA6;CUL4A;DNAJB12;NHLRC3;PSMB5;PLAA;KCTD5;RNF185;PSMC4;UCHL1;VCP;MTA1;TNFAIP1;MAEA;UBXN1;PSMC5;RNF5;PSMD14;FBXW5;ITCH;RBX1;SMURF1;PSMD8;UBE2G1;PSMC1;PSMB4;PSMD11;KCTD10;PSMD12;PELI1;UBE2B;TBL1X;ZSWIM8;KCTD2;PSMA1;PSMC3;ZFAND2B;BFAR;ERLEC1;PSMB1;PSMA2;CLOCK;FBXL19;PSMA4;RNF187;PCNP;BRSK2;COP1;RAD23A
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.328871881601294,0.8468355300264224,0.6674157303370787,0.9149990568420181,1.0,4/15,12.12%,DCN;UST;DSE;VCAN
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.21944990098595554,-0.8467103670680193,0.7675350701402806,0.8841144269259603,1.0,40/85,33.18%,FZD6;FZD4;RAC1;PSMA6;AP2M1;PSMB5;FZD7;PFN1;FZD3;WNT11;PSMC4;PSMC5;PSMD14;CELSR1;SMURF1;PSMD8;AP2A1;PSMC1;CELSR2;PSMB4;PSMD11;PSMD12;PSMA1;PSMC3;FZD5;PSMB1;PSMA2;PSMA4;VANGL2;PSMB8;CDC42;AP2A2;WNT7A;PSMC6;PARD6A;PSMD6;AP2B1;RHOA;PSMA8;PSMB2
prerank,negative regulation of locomotion (GO:0040013),-0.342626146647597,-0.8466475551457685,0.6758241758241759,0.883746614405553,1.0,4/12,11.74%,FRMD5;CRK;CCDC125;DUSP3
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.224397379739862,-0.8464447606049772,0.7821782178217822,0.8836445279877795,1.0,24/76,27.81%,CAV1;DCUN1D5;SMAD7;FKBP1A;UBB;DCUN1D1;HDAC4;FBXO4;FAM107A;PTTG1IP;SPRTN;SAE1;WDR48;UBA2;CDK5RAP3;LAPTM5;UBE3A;DCUN1D3;BCL10;TRAF6;XIAP;TSPYL5;NDFIP2;MUL1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.32564187640022657,-0.8458680161275609,0.6587771203155819,0.8842923253663102,1.0,3/15,5.80%,SIX1;SMO;VEGFA
prerank,sterol homeostasis (GO:0055092),0.24184843785532867,0.8455904647543633,0.72,0.9168110359237288,1.0,3/65,1.40%,RORA;CYP7B1;ABCA1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.3129357454944893,0.8453591027724018,0.6758474576271186,0.91648785208475,1.0,9/20,25.93%,NR2F2;MEN1;PTEN;CDK5RAP1;IPO7;APC;LATS2;HEXIM1;LATS1
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.22963875112409912,-0.8448716550803519,0.7801556420233463,0.8856574493616622,1.0,8/69,7.36%,MEF2C;PTK2B;NGF;SIX1;PPARGC1A;TOX3;TGFB3;FOXQ1
prerank,organic cation transport (GO:0015695),0.30346944785694224,0.8440448790111648,0.6868250539956804,0.9184220390543233,1.0,4/20,9.48%,SLC22A4;SLC22A3;SLC25A42;SLC44A1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.2930053455232988,0.8435477792077126,0.6590909090909091,0.9186592952355811,1.0,1/24,0.21%,CEMIP
prerank,myelination (GO:0042552),-0.24613588879001266,-0.8434445233656691,0.7455968688845401,0.8878614628189722,1.0,10/46,14.04%,ADGRG6;PARD3;CMTM8;MYOC;TNFRSF21;MAL;PLLP;NF1;ACER3;MALL
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.2639426961566477,-0.8434410717047321,0.7295238095238096,0.8873843327611537,1.0,6/35,10.12%,B2M;RAC1;HIP1R;FLOT1;HIP1;SGIP1
prerank,RNA modification (GO:0009451),-0.2385869524436951,-0.8431211844043828,0.7549407114624506,0.8875313784819497,1.0,19/54,27.68%,ADAR;THUMPD1;TRMT9B;NOP2;JMJD6;QTRT2;URM1;TRDMT1;QTRT1;MEPCE;TRMT6;AARS2;MRM2;ANKRD16;NSUN5;METTL1;FTSJ3;ADAT2;CTU2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.3452063113340724,0.842674337709124,0.6529284164859002,0.9196115554605025,1.0,3/12,8.87%,GPAA1;INSIG2;KDELR3
prerank,axonal transport (GO:0098930),-0.2643088283829238,-0.8425305410710617,0.7185741088180112,0.8881596606854972,1.0,17/36,39.18%,AP3M1;AP3B1;NEFL;KIF1B;DCTN1;OPA1;DTNBP1;AP3M2;SOD1;DST;BLOC1S6;BLOC1S2;BLOC1S1;AP3D1;AP3B2;BLOC1S4;AP3S1
prerank,protein ubiquitination (GO:0016567),0.18123536910889199,0.8424784330206021,0.9490909090909091,0.9192175562958443,1.0,84/471,17.07%,RNF220;SH3RF3;HECW2;PDZRN3;MYCBP2;EPAS1;PELI2;TRIM38;DTX4;FBXO24;SPSB1;BCL2;SH3RF1;MDM2;DDB2;ZNRF3;DZIP3;TRIP12;RNF43;RNF138;KLHL41;VCPIP1;PRKN;HECW1;CUL9;UBE2O;SMURF2;DTX1;KLHL42;ASB2;FBXO25;RNF181;KLHL25;TRIM27;UBE2E3;PSMA3;CDC23;PSMF1;PSMA7;CDC16;CUL2;MGRN1;TOPORS;SPOP;AKTIP;RNF26;UBR3;MIB1;SIAH2;FBXO7;PPIL2;UNKL;THOP1;RNF217;BTRC;RNF146;PSME3;RNF122;SASH1;ARIH2;TRIM63;BIRC2;TRAF2;FBXO44;ASB1;UBA6;UBE2E2;HECTD2;RNF34;PEX10;KLHL22;SKP1;FBXO31;UBE3C;PSMD1;FBXO28;NEDD4;PSMB9;LRSAM1;TRIM35;HLTF;NFE2L2;CUL7;SKP2
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.27710734148231325,-0.8419370818766334,0.7243947858472998,0.888797255712725,1.0,10/28,22.16%,ESAM;WDR1;PFN1;DBNL;DBN1;RASA1;CTTN;HCLS1;ARHGAP18;PLEKHG2
prerank,protein alkylation (GO:0008213),-0.28954241642073864,-0.8418979157841955,0.7027522935779816,0.8883887270160942,1.0,5/22,13.77%,SNRPD3;PRMT8;EEF2KMT;FAM98A;PRMT3
prerank,regulation of protein export from nucleus (GO:0046825),0.2946701068054344,0.8418039898544378,0.6702355460385439,0.9197887757812075,1.0,1/23,0.17%,TCF7L2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.3475321306167178,-0.8417937986875438,0.6588868940754039,0.8880873761165002,1.0,5/11,22.11%,CD44;CD74;KDM1A;TAF9;TRIAP1
prerank,DNA metabolic process (GO:0006259),0.19154544518986064,0.8417048420853425,0.879182156133829,0.91918059184664,1.0,72/270,22.88%,TCF7L2;DMC1;MCM3;ORC4;DDB2;MPG;STN1;AXIN2;MNAT1;TOP1;SUMO1;SETMAR;TOP3A;FANCC;GEN1;KMT5C;MEN1;RAD51B;TOP1MT;DNMT1;BLM;RPA2;MCM2;RFC5;CHRNA4;RAD51C;MCM8;ATM;ORC1;NBN;POLE4;PARP3;CENPS;RIF1;SMARCB1;BACH1;ENDOV;RPA1;PDS5A;KMT5B;KAT5;PARP4;POLI;NUDT1;INIP;PARP1;SP100;ORC3;POLD4;RNASEH1;PDS5B;UBE2N;ORC5;POLD1;CDC7;SMARCAL1;RTEL1;RFC1;PCNA;TOP3B;DOT1L;ZRANB3;GLRX2;POLD3;PRIM1;SMC1A;PRIM2;UBE2V2;POLD2;MCM7;DCLRE1B;TIMELESS
prerank,neuron apoptotic process (GO:0051402),0.3084579473986741,0.841485760490421,0.6716417910447762,0.9188175030290027,1.0,6/19,13.27%,BCL2;SCN2A;ERBB3;ATN1;NGFR;DIABLO
prerank,mitotic cytokinetic process (GO:1902410),-0.30091604067281075,-0.8413853100885332,0.6968576709796673,0.8883652674702978,1.0,10/20,35.70%,CHMP2B;MITD1;CHMP2A;CNTROB;CEP55;VPS4A;CHMP7;RHOA;CHMP4B;CHMP4A
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.3489301588748208,-0.8413372687120532,0.6503623188405797,0.887967615973337,1.0,4/11,22.52%,MPHOSPH8;TRIM28;TASOR;SETDB1
prerank,metal ion transport (GO:0030001),-0.21870938597306377,-0.8412900666683734,0.7855711422845691,0.8875853523550638,1.0,14/86,13.86%,CAV1;TPT1;TRPC3;TRPM7;RAMP2;ATP2C1;SLC39A8;ATP2A3;TRPV4;TRPC4;CACNB3;NIPAL3;SLC3A2;CACNA1D
prerank,endochondral bone morphogenesis (GO:0060350),0.3549127811015309,0.8412452329810055,0.6428571428571429,0.9184896728028087,1.0,1/11,0.29%,COL13A1
prerank,pyroptosis (GO:0070269),-0.3229225420355669,-0.8412233174718675,0.6979742173112339,0.8872296621840321,1.0,5/15,27.06%,CASP8;DHX9;AIM2;CASP1;TREM2
prerank,synaptic vesicle recycling (GO:0036465),0.2750064893013106,0.8410484130243411,0.7067510548523207,0.9181086960457558,1.0,6/31,8.00%,STON1;NLGN2;NLGN3;TBC1D24;SYT1;NLGN1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.3239150062780724,-0.8407993146859993,0.6690265486725664,0.8875267124631813,1.0,5/15,18.85%,EHD2;FLOT1;CAMK1;RAPGEF3;EHD1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.26151809171585483,0.8405841589085911,0.7145790554414785,0.9183107364698815,1.0,3/39,3.81%,ERRFI1;AREG;TGFA
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.31825013421994885,-0.840267297080807,0.6888489208633094,0.8880474099513987,1.0,11/16,38.90%,SLX4;TOP2A;EME2;ERCC4;TOP2B;MEIOB;RMI1;MSH4;CENPX;EME1;SHOC1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.2738103611213442,0.8400530958097916,0.701271186440678,0.9185763359670155,1.0,3/33,3.81%,AREG;DGKD;TGFA
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.20370872196414638,0.8397357241151685,0.8330058939096268,0.9183974010555939,1.0,16/166,7.89%,RORA;AR;TBL1XR1;RARB;VDR;TEAD1;PPARA;POLR1A;GTF2H2;MAML3;MNAT1;HNF4G;HDAC10;POLR1G;RARG;RBPJ
prerank,regulation of chromatin organization (GO:1902275),-0.32623344006671073,-0.8391005775104408,0.6801470588235294,0.8897645082568846,1.0,4/14,20.69%,MLLT3;HPF1;SETD1A;MKI67
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.2955921513125834,-0.8389813371446242,0.6884955752212389,0.8895065993129037,1.0,8/19,29.93%,UAP1L1;GFPT1;AMDHD2;RENBP;PGM3;MPI;GNPDA1;UAP1
prerank,keratinocyte differentiation (GO:0030216),-0.27586086578128194,-0.8389430956729661,0.7191650853889943,0.8890949303916984,1.0,18/29,43.77%,CLIC4;ANXA1;BCR;OPN3;EPHA2;DSP;EVPL;CERS3;SCEL;PIP5K1A;KRT10;ST14;ACER1;WNT16;JAG1;TGM1;SPRR1A;EXPH5
prerank,regulation of cellular protein localization (GO:1903827),0.25528291596684777,0.8388552521378779,0.7215686274509804,0.9194295474682571,1.0,7/45,10.48%,GPC6;GPC4;GPC2;VCPIP1;GBF1;DVL3;GPC5
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.32800898647024906,0.8388251068615379,0.6696629213483146,0.9186859905911379,1.0,2/13,3.61%,PARP16;PTGIS
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.22732974425478006,0.8387150776511728,0.7453416149068323,0.9181201638692144,1.0,16/76,14.70%,LPAR1;GPR55;GPR174;CHRM2;OPRK1;GRM1;HRH1;LPAR4;NMBR;ADRA1D;C3AR1;ADRA1B;GNA15;ACTN2;P2RY1;DRD2
prerank,positive regulation of cell death (GO:0010942),-0.23495778662631417,-0.8386547869494021,0.7473903966597077,0.8891461960374217,1.0,4/59,4.00%,SLC6A6;MAP3K5;ACER2;CDKN1B
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.2611853746104236,-0.8385469801111561,0.7322834645669292,0.8888797335452439,1.0,5/32,9.75%,RPL30;RPL39;RPS19;GAPDH;PGLYRP1
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.3178433361133175,-0.8385252094981834,0.6841121495327103,0.8884424064756637,1.0,3/15,4.28%,STOX2;RICTOR;TGFB2
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.33033456400607264,-0.8384983394398846,0.6977186311787072,0.8880167082976957,1.0,6/13,28.75%,LAMP1;SYK;SPHK2;GAB2;STX4;AP1G1
prerank,histone H2A acetylation (GO:0043968),-0.3164733271924045,-0.8379709426312425,0.6908752327746741,0.8885497573893986,1.0,4/16,18.53%,TRRAP;EPC1;SPHK2;EP400
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.27972544755355366,-0.8379098753905365,0.719626168224299,0.8881913253115947,1.0,2/26,0.35%,ST3GAL6;ST3GAL4
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.32209435662650365,0.8377988028310628,0.6674107142857143,0.9191930003736791,1.0,2/16,6.03%,ANK2;GBF1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.3358542448507768,-0.8359615374574512,0.7258064516129032,0.8914351997412449,1.0,5/13,20.67%,PRPF8;DDX20;LSM2;USP4;CD2BP2
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.32122637688831884,0.8359343887192342,0.6808510638297872,0.9220887510513696,1.0,3/15,5.78%,BCL2;MDM2;PRKN
prerank,receptor recycling (GO:0001881),-0.36422794997169955,-0.8357683010912997,0.6904315196998124,0.8912864882317203,1.0,5/10,24.80%,LMTK2;RAB11B;REP15;EHD3;PHETA2
prerank,mRNA processing (GO:0006397),-0.18434775453319086,-0.8357131456515169,0.9352226720647774,0.8909154163535424,1.0,102/287,32.57%,DDX5;NOVA2;HNRNPA2B1;RPRD1B;CTNNBL1;HSPA8;PPARGC1A;PRPF8;DNAJC8;SRSF5;MTREX;SRSF2;SNRNP48;SNRPC;SNRPA;ISY1;DDX41;SRSF6;DHX9;DHX15;GTF2H3;RBM22;FUS;SNRPD3;U2AF1;SFPQ;XAB2;ZC3H11A;RNPS1;ZRSR2;RBM6;SRSF4;MAGOH;DDX23;CHTOP;RBM4B;ALYREF;HNRNPK;SF3A3;EFTUD2;DDX39B;HNRNPA1;PCBP1;GTF2H4;GTF2F1;SNRPG;SCAF11;PDCD7;USP49;PHF5A;PNN;CASC3;LSM2;UBL5;SRRM2;RBM19;PRPF40A;CPSF4;CHERP;THOC6;CD2BP2;LSM3;DDX39A;TBRG4;LSM7;RBM14;RBM17;SYNCRIP;NCBP2;CSTF2T;PABPC1;SF3A1;SNRPB;RPRD1A;SF3A2;HNRNPR;THOC7;ERN1;KIN;WBP11;AQR;POLR2F;SNRPB2;GTF2F2;HNRNPA3;PRPF19;SRSF9;HNRNPH3;PQBP1;LSM6;CDC5L;HNRNPC;U2AF1L4;SF3B5;SNRNP25;POLR2C;POLR2L;POLR2I;WBP4;PCF11;ESS2;UPF3B
prerank,motile cilium assembly (GO:0044458),0.3368667945907041,0.8354348049252746,0.6680584551148225,0.9222691145200098,1.0,4/12,23.21%,DNAAF3;BBOF1;RSPH9;CCDC39
prerank,carbohydrate homeostasis (GO:0033500),-0.2275750072094029,-0.8350494512264044,0.7900990099009901,0.8916573661767938,1.0,6/67,5.11%,ADIPOR2;IGF1R;KCNB1;BACE2;KLF7;ADIPOR1
prerank,histone exchange (GO:0043486),-0.2553530361951993,-0.8345700287797296,0.7158469945355191,0.8920601557642437,1.0,17/37,33.93%,KNL1;MIS18BP1;CENPU;RBBP4;CENPI;CENPN;CENPA;CENPO;NPM1;RUVBL1;SMARCA5;OIP5;RNF8;ITGB3BP;CENPX;CENPW;RBBP7
prerank,positive regulation of interleukin-13 production (GO:0032736),0.36110248947041645,0.834108490948572,0.648471615720524,0.9241051692002861,1.0,4/10,11.76%,IL4;IL18;GATA3;TSLP
prerank,regulation of store-operated calcium entry (GO:2001256),-0.3547406076028278,-0.8340809913850018,0.6984126984126984,0.8924711513889396,1.0,5/10,29.12%,HOMER1;CD84;SLC8B1;CASQ1;GRAMD2A
prerank,microtubule-based transport (GO:0099111),-0.3370887937985626,-0.8333841060182058,0.6939890710382514,0.8932536250409405,1.0,6/12,26.99%,HTT;CABYR;ROPN1L;ADCY10;SPAG17;SPA17
prerank,ovarian follicle development (GO:0001541),0.3336199553470704,0.8332838882732695,0.6767895878524945,0.924896452137535,1.0,4/13,11.46%,KIT;CEBPB;ANG;EIF2B5
prerank,regulation of macroautophagy (GO:0016241),-0.20994527061187887,-0.8332023403199065,0.814663951120163,0.8931216762392193,1.0,38/105,32.85%,EXOC4;KDR;ATP6V0B;ATP6V0A2;GAPDH;QSOX1;AKT1;SCOC;ATP6V0C;UCHL1;EPM2A;EXOC1;BNIP3L;LAMTOR2;PIK3CA;PRKAG1;RRAGD;ATP6V1G1;TBC1D25;TSC2;RRAGA;SESN2;RRAGC;SMG1;ATP6V0D1;ATG13;RPTOR;SESN1;ERN1;LAMTOR5;UBQLN2;ATG101;LAMTOR1;ATP13A2;ATP6V0E2;ATP6V1C1;LAMTOR3;IKBKG
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.30249242489859757,0.8331259772585811,0.6779324055666004,0.9244009998330942,1.0,9/20,20.57%,AGO4;HELZ;TNRC6A;AJUBA;TNRC6B;AGO3;AGO1;CNOT8;AGO2
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.2139122588050627,-0.8329610124305405,0.8077709611451943,0.8930939935599507,1.0,24/83,25.32%,CDK6;CDK17;CDKN1B;BRD4;CUL4A;PLK2;RB1;CDK4;CRLF3;INHBA;E2F3;E2F1;ACVR1;CDKN1A;CDKN2C;CUL1;CCND1;TYMS;RCC1;PLK3;CDK15;EIF4EBP1;EIF4E;SPDYA
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.2920526597184914,0.8327846727064924,0.6968421052631579,0.9242811308287892,1.0,6/22,11.76%,KIT;GHR;HES5;OCIAD2;ERBB4;TSLP
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.32159226470772895,0.8327535478889205,0.6361655773420479,0.9235304491416831,1.0,15/15,67.87%,NYNRIN;RNASEH1;DICER1;ZC3H12B;POP1;LACTB2;ZC3H12A;POP7;ZC3H12C;SLFN14;KHNYN;NUDT16;RPP30;ZC3H12D;RPP40
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.3216362516882121,-0.8325289645710667,0.6867030965391621,0.8934259615865269,1.0,5/15,18.28%,SMAD7;FKBP1A;CSNK2B;ACVR1;SKI
prerank,prostaglandin biosynthetic process (GO:0001516),-0.3018914453350419,-0.8322706340281375,0.6972972972972973,0.8934639993862337,1.0,6/18,17.88%,PTGDS;EDN1;CD74;PTGS1;CBR1;DAGLB
prerank,regulation of multicellular organismal development (GO:2000026),0.2862387242026658,0.8322470611416505,0.6982758620689655,0.9237427602694744,1.0,3/25,9.40%,PTN;TRIP12;GATA3
prerank,protein O-linked glycosylation (GO:0006493),-0.21355078199763727,-0.8320507818035916,0.8127572016460906,0.8933888127073998,1.0,27/96,25.83%,ST3GAL4;EOGT;TMTC2;TRAK1;PLOD2;ST6GAL1;ST8SIA6;C1GALT1C1;GALNT10;GXYLT1;POGLUT1;PLOD3;ST6GALNAC2;FKRP;POGLUT3;OGA;POMK;B3GNT3;B3GNT8;PGM3;LARGE1;GALNT5;SDF2L1;POMGNT2;GCNT4;GALNT6;GALNT9
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.3272966029106138,0.8319458147438201,0.6886993603411514,0.9235439446641147,1.0,3/14,15.73%,ANK2;ACTN2;ATP1B3
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.3293798627934711,-0.8317375682138223,0.691743119266055,0.893495687099228,1.0,6/13,28.13%,ATG7;SAE1;UBA2;UBA5;UBA1;UBA7
prerank,response to peptide (GO:1901652),0.2721146994893514,0.8303196158544317,0.6985138004246284,0.9259304293900205,1.0,8/33,18.20%,GNAI1;STAT5B;CALCR;CHRNA7;EIF2B5;EIF2B2;MMP2;ERBIN
prerank,peptidyl-lysine methylation (GO:0018022),0.27892937906627524,0.8301712494997618,0.7182203389830508,0.9254120238355601,1.0,5/26,11.54%,METTL21A;SMYD1;SETD7;SMYD3;EHMT2
prerank,epiboly involved in wound healing (GO:0090505),-0.3143490210894267,-0.8300731198514365,0.687037037037037,0.8960535650383744,1.0,9/16,42.58%,CD44;CD151;MRTFA;PDCD10;TMEFF2;RHOA;CEACAM1;FLNA;ARHGAP35
prerank,negative regulation of hormone secretion (GO:0046888),0.35613690375970136,0.8299222470294058,0.6666666666666666,0.9251218004011537,1.0,1/10,1.64%,GJA1
prerank,response to organonitrogen compound (GO:0010243),-0.25160625858669483,-0.8298840971841297,0.7485380116959064,0.8959390354620704,1.0,10/38,24.42%,SEL1L;RHBDD1;DNAJB12;RNF185;VCP;RNF5;ERLEC1;RRAGC;MEAK7;BRSK2
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.21451547770395019,-0.829882090551333,0.8127490039840638,0.8954624797678757,1.0,23/91,19.65%,SCARB1;RAB11A;OPHN1;MAPK3;RAB8B;HIP1R;USP7;CPLANE2;HIP1;RAB8A;RAB4B;ABL2;RAB11B;RUFY1;RAB4A;SYK;PACSIN1;LGI3;NSF;HCK;TSC2;PACSIN2;PACSIN3
prerank,respiratory tube development (GO:0030323),0.2786212356617055,0.829824007834709,0.7072649572649573,0.9245377310892849,1.0,4/28,8.60%,FGFR2;GLI2;LOXL3;NPHP3
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.3424626489276862,0.8292568517525869,0.6780045351473923,0.9248355054784211,1.0,3/11,15.04%,AXL;MERTK;CXCL12
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.2816063383543034,-0.8289567754783878,0.7121495327102804,0.8966594021934975,1.0,9/23,24.19%,ZW10;HTT;DCTN1;NDE1;NDEL1;MISP;NDC80;SPDL1;CENPA
prerank,protein localization to organelle (GO:0033365),-0.20245396519067865,-0.8287349418082212,0.8739837398373984,0.8966085004913484,1.0,34/133,23.74%,RAB11A;GBP5;ZBTB7A;SIX1;RPL11;IFT20;APP;STX1A;DHX9;DNAJA1;HHEX;LAMP1;DDRGK1;TOLLIP;TULP2;ZNF423;TOR1AIP1;ARL6;SEC61B;CEP68;SGTA;TUB;COG3;TSPAN17;GCC2;TMEM30A;EHD1;PACSIN2;MSX1;CNEP1R1;RIPOR1;STX5;CD68;ARL3
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.3071493714012476,-0.8285344611406709,0.6986817325800376,0.8965067885406026,1.0,4/18,11.64%,NUP93;ENY2;HHEX;ZC3H11A
prerank,DNA repair (GO:0006281),-0.18185087779995443,-0.8281680226663859,0.9245689655172413,0.8966801976944236,1.0,106/284,34.36%,TRRAP;UBB;USP1;ASCC2;UBC;RPS27A;BRCC3;SMUG1;PRKDC;ERCC1;RAD1;UIMC1;BABAM1;GTF2H3;USP3;CHD1L;TRIM28;FAM111A;HERC2;VCP;MTA1;CIB1;HPF1;UBXN1;PPP5C;SPRTN;PNKP;SLX4;RAD9B;DCLRE1C;RAD18;CETN2;HUS1;XRCC1;NSMCE4A;RPA3;PARP2;RPAIN;EME2;RAD9A;WDR48;BRCA2;RAD17;GTF2H4;POLQ;POLK;RAD21;ASCC3;NEIL1;CHEK1;PWWP3A;TRAIP;BABAM2;ERCC4;GADD45A;UBE2B;APEX2;RHNO1;RFC3;EID3;RFC2;FAN1;POLL;EXO1;FBXO6;DTX3L;NSMCE1;RAD23A;XPC;TDG;LIG4;RAD51AP1;FANCD2;PARK7;SETD2;NPM1;DNA2;BARD1;MRE11;RAD23B;SMARCA5;ATRIP;UPF1;POLB;RECQL;EXD2;INTS3;FAAP24;TNKS1BP1;RNF8;PARP9;NSD2;CDK1;TICRR;UBE2T;NEIL3;POLE;RAD52;RAD50;CENPX;FANCF;XRCC4;MAD2L2;POLA1;ABL1;RNASEH2A
prerank,activin receptor signaling pathway (GO:0032924),0.3285244008086325,0.8277598161943681,0.6729957805907173,0.927018537775678,1.0,2/15,7.55%,SMAD3;TGFBR1
prerank,serine family amino acid metabolic process (GO:0009069),-0.31199477657718766,-0.827428016818331,0.7008849557522124,0.8975372187503985,1.0,9/16,35.52%,SARS1;CDO1;SEPHS2;CTH;GCLC;THNSL2;SRR;SHMT2;DAO
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.32983456683210166,-0.8273493999523548,0.7,0.8971922711114424,1.0,8/13,40.96%,ANAPC15;DYNC1LI1;LCMT1;NDC80;DUSP1;CDK5RAP2;CCNB1;PCID2
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.2893607861718544,0.8272855930014191,0.6926503340757239,0.927105913551587,1.0,4/23,10.75%,SETMAR;CASP3;EXOG;CECR2
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.24304388548490008,0.8271800338095233,0.7309941520467836,0.9265207061259878,1.0,4/48,8.37%,ROBO1;STAP1;GSTP1;NLRP2B
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.339476909209644,-0.8271203456938053,0.6954954954954955,0.8971357172716511,1.0,8/12,40.67%,UPP2;TK2;CAD;UMPS;UPP1;DCK;UCK2;TK1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.35062662819087387,-0.8269470791207462,0.699288256227758,0.8969655416598963,1.0,1/10,0.72%,CSGALNACT1
prerank,neuron fate commitment (GO:0048663),0.3283323401537625,0.8266725520870365,0.6898876404494382,0.9267163750520273,1.0,5/14,19.92%,TGFBR1;MYT1L;SHH;PAX6;POU3F2
prerank,regulation of muscle contraction (GO:0006937),-0.27923361027557614,-0.8263323014923875,0.7476808905380334,0.8976513738205424,1.0,2/26,0.34%,PLCE1;CAV1
prerank,mitochondrion disassembly (GO:0061726),0.266122310535212,0.8259169091973043,0.7199170124481328,0.9273606639894327,1.0,12/34,21.76%,WDR45B;WIPI1;PRKN;ATG12;FBXO7;FUNDC1;ULK2;FUNDC2;ATG9A;USP30;WDR45;ATG5
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.3395165800687445,-0.8254685580679966,0.7190812720848057,0.8987693505777096,1.0,3/12,11.03%,STX3;STX1A;STX2
prerank,peptidyl-glutamic acid modification (GO:0018200),0.28596228936340123,0.8248482617167975,0.6929824561403509,0.9286386023375539,1.0,3/24,5.71%,TTLL11;AGBL4;TTLL9
prerank,smooth muscle tissue development (GO:0048745),-0.3573830167958142,-0.8247365866292629,0.6914498141263941,0.8996463216659843,1.0,4/10,12.81%,SMO;STRA6;NF1;ENG
prerank,inflammatory response (GO:0006954),0.19503314686461135,0.8244605024842457,0.8771266540642723,0.9286179120279205,1.0,24/195,12.25%,ADCY1;BMP2;PTGFR;SCUBE1;HYAL3;KIT;TPST1;ADM;CEBPB;IL4;PTGDR;HRH1;PPBP;LOXL3;SCG2;IL18;CCL25;CXCL1;TNFAIP6;C3AR1;ADCY8;PTGIR;TNFRSF4;HSPG2
prerank,histone ubiquitination (GO:0016574),-0.2949232878862399,-0.8242667532460787,0.7486338797814208,0.8999826040770069,1.0,8/21,30.27%,PHC1;RNF20;USP22;UBE2B;DTX3L;RNF40;UHRF1;RNF8
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.22484633151289035,0.8235242765310907,0.7957894736842105,0.929688773075581,1.0,4/72,2.98%,FLRT2;FGFR2;KL;FLRT1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.32407742830815156,-0.823416030031496,0.696917808219178,0.9009890550954814,1.0,6/13,34.86%,GLRX5;ISCA2;NFU1;ISCA1;CISD3;YAE1
prerank,phospholipid dephosphorylation (GO:0046839),0.25793774483955095,0.822875066617199,0.7453416149068323,0.9301490527404679,1.0,9/37,17.70%,MTMR7;PLPP3;PLPPR1;PTEN;PLPP4;MTMR10;PLPPR5;OCRL;MTMR9
prerank,protein insertion into ER membrane (GO:0045048),-0.25186892798316146,-0.8228618821056672,0.7490774907749077,0.9014936368847356,1.0,13/37,28.71%,APP;STX1A;CAMLG;EMC10;SEC61B;SGTA;EMC6;EMC9;STX5;UBE2J2;TRAM1;VAMP2;EMC1
prerank,negative regulation of defense response (GO:0031348),0.22703706873943297,0.8227283149869572,0.7953667953667953,0.9296349544805833,1.0,10/77,10.75%,RORA;PPARA;PTGIS;IL4;SMPDL3B;NLRP12;SIRT2;GATA3;RNF26;TNFAIP6
prerank,microglial cell activation (GO:0001774),-0.2910330514531137,-0.8224974874332944,0.7086466165413534,0.9016378099588057,1.0,14/21,46.51%,APP;CX3CR1;JAK2;C1QA;IFNGR1;AIF1;TREM2;TYROBP;GRN;ITGB2;C5AR1;TNF;CX3CL1;CLU
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.3366400685593239,-0.8224268498444987,0.708185053380783,0.9012852135344385,1.0,2/12,4.95%,CTPS1;CTPS2
prerank,spliceosomal snRNP assembly (GO:0000387),-0.2569620557786686,-0.8223930574732927,0.75,0.90085452364918,1.0,19/38,39.10%,PRPF8;SNRPC;SNRPD3;DDX20;SMN1;SNRPG;LSM2;USP4;TGS1;CD2BP2;SNRPB;CLNS1A;PRPF19;SNUPN;SRSF10;SNRPE;SNRPF;GEMIN2;PRPF6
prerank,negative regulation of bone remodeling (GO:0046851),-0.3357977389811851,-0.8221589160168876,0.6973684210526315,0.9007933180813894,1.0,4/11,18.50%,GPR137B;GREM1;TNFAIP3;UBASH3B
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.2642865329746632,-0.822032943127345,0.7387218045112782,0.9005547491255085,1.0,13/32,28.45%,LPCAT3;MFSD2A;CHKA;CSNK2B;CEPT1;CSNK2A1;CSNK2A2;LCAT;PCYT1A;CHAT;PEMT;SLC27A1;LPIN2
prerank,protein tetramerization (GO:0051262),-0.22533720188183212,-0.8217954289382907,0.7862903225806451,0.9004700821147882,1.0,23/67,31.40%,B2M;KCNJ2;GBP5;PKD1;KCNC3;GLS;HOMER1;SAMHD1;ALDH1A3;CTH;HSD17B10;AQP4;UPB1;FARSB;ACOT13;PKD2;CBY1;GRIN1;OSBPL2;GNMT;ALDOA;TRPM4;KRT10
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.36091011781894977,0.8217334422605755,0.6748329621380846,0.9306950394835165,1.0,2/10,1.88%,VDR;CYP27B1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.3523224037652584,0.8213164455222846,0.6659340659340659,0.9306855531411009,1.0,4/10,18.59%,RPS6KA6;KAT5;SP100;TP53
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.22200119686784947,0.8212263799905898,0.7910750507099391,0.9300565540692584,1.0,11/88,12.27%,NELL1;SAMD4A;SERPINE2;IGF2BP2;DAPK1;NANOS3;CPEB3;DDX6;RIDA;FXR2;EDNRB
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.28330154104554617,-0.8211385059566303,0.7396226415094339,0.9011891564442022,1.0,8/23,28.20%,RARA;INHBA;TLR4;VSIR;LAPTM5;LGALS9;INHA;LILRB1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.34294128848437655,0.8210700749425929,0.6908315565031983,0.9295685638572044,1.0,5/11,18.59%,CREB3L1;CEBPB;ATF6;DDIT3;TP53
prerank,hexose biosynthetic process (GO:0019319),0.2456781535804745,0.8209945400021317,0.7725409836065574,0.9289187623652586,1.0,7/42,11.49%,AKR1B1;SLC25A10;SLC25A13;CRY1;ALDOB;MDH2;ENO2
prerank,regulation of cholesterol storage (GO:0010885),0.31647021717610263,0.8203756830968779,0.70042194092827,0.929292137397984,1.0,2/15,2.11%,ABCA1;PPARA
prerank,neural tube development (GO:0021915),0.3192646207321125,0.8201269698755894,0.6824324324324325,0.9289684101638406,1.0,1/15,0.53%,ALDH1A2
prerank,DNA dealkylation (GO:0035510),0.3441667624738274,0.8200855261938963,0.6682027649769585,0.9274787396568739,1.0,2/10,8.82%,MPG;FTO
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.3441667624738274,0.8200855261938963,0.6682027649769585,0.9274787396568739,1.0,2/10,8.82%,MPG;FTO
prerank,regulation of B cell apoptotic process (GO:0002902),0.3366084698824589,0.8192238182978164,0.6842105263157895,0.9283407695164803,1.0,4/12,11.70%,FNIP1;LYN;IRS2;NOC2L
prerank,positive regulation of tissue remodeling (GO:0034105),0.349788676892698,0.818966954142832,0.6609071274298056,0.928031012720837,1.0,2/10,8.86%,ROCK2;IL18
prerank,positive regulation of calcium ion import (GO:0090280),0.33196625672758584,0.8183601724135635,0.67590618336887,0.9283947321727316,1.0,3/12,15.04%,PDGFRB;CALCR;CXCL12
prerank,negative regulation of protein processing (GO:0010955),-0.33417792726538326,-0.818213642571871,0.6950354609929078,0.9058896289499602,1.0,2/12,4.59%,THBS1;CTSZ
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.3027280542060152,-0.8179691587452086,0.7176258992805755,0.9058338050422305,1.0,6/18,22.58%,RAB11A;BRD4;CDK4;RCC2;CCND1;DTL
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.2324730763490892,-0.8176724018670094,0.7760314341846758,0.9058762162327608,1.0,21/51,36.36%,HMBOX1;MAPK3;NEK7;FBXO4;PNKP;CCT2;HNRNPA1;CCT3;CCT8;CCT7;CTNNB1;SRC;PIF1;HNRNPC;SMG6;CCT4;PKIB;DCP2;MAP2K7;CCT6A;MAPK15
prerank,DNA geometric change (GO:0032392),-0.27997182580446395,-0.8176222619377249,0.7481060606060606,0.9054970118700254,1.0,10/24,33.06%,HNRNPA2B1;ANXA1;DHX9;ASCC3;DNA2;MRE11;HMGB2;RECQL;PIF1;RAD50
prerank,glycoprotein catabolic process (GO:0006516),0.30536696978532674,0.8173951054489826,0.6821862348178138,0.9294167552954885,1.0,1/17,0.43%,ADAMTS12
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.3354186469212129,-0.8167664344512364,0.7170138888888888,0.9065511549182735,1.0,5/12,38.06%,TMEM165;VPS33A;CCDC115;GRN;TMEM199
prerank,endodermal cell fate commitment (GO:0001711),-0.35247459740769965,-0.8164002426079658,0.7092592592592593,0.9067062677278944,1.0,1/10,3.39%,SOX17
prerank,glycerophospholipid catabolic process (GO:0046475),-0.26795001108407746,-0.8162475662708882,0.7317554240631163,0.9064814359894348,1.0,1/27,0.10%,GPCPD1
prerank,regulation of TORC1 signaling (GO:1903432),-0.25620185616124763,-0.8158329936738064,0.7530120481927711,0.9067361526212094,1.0,11/33,28.05%,GPR137B;PIP4P1;RRAGD;RRAGA;SESN2;RRAGC;CASTOR2;SEH1L;SIK3;SESN1;LAMTOR5
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.27602890355011,0.8158103192028877,0.7235421166306696,0.9316114822518028,1.0,27/27,72.44%,NYNRIN;RNASE4;PARN;NHP2;RNASEH1;DICER1;XRN1;TOE1;ZC3H12B;POP1;LACTB2;CPSF3;ZC3H12A;POP7;RNASE1;ZC3H12C;SLFN14;RNASE6;TRIR;KHNYN;NUDT16;RPP30;CSTF3;PDE12;PCF11;ZC3H12D;ERN1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.29928667946751963,-0.8157388882451049,0.7142857142857143,0.9064251543999132,1.0,8/18,26.97%,COA8;TIMM21;COA3;SURF1;FASTKD3;SCO1;PET100;BCS1L
prerank,regulation of neuron projection arborization (GO:0150011),0.316216782971412,0.8152253759232463,0.7,0.9319047648546909,1.0,4/15,16.45%,GRIP1;DVL3;DLG4;MYO9A
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.30793733431073916,0.8149801258745333,0.6876355748373102,0.9315989597864058,1.0,3/17,9.94%,NKX6-1;ATOH8;AHI1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.3150351833414952,-0.8146806197723729,0.7048903878583473,0.9077942312058751,1.0,6/14,37.22%,FUS;WDR48;MRNIP;RAD51AP1;WRAP53;FANCB
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.3056565689272427,0.813831213625379,0.708779443254818,0.9329933115748943,1.0,3/16,18.50%,PRKCA;PDE6G;MRAP2
prerank,regulation of establishment of protein localization (GO:0070201),-0.322852971825504,-0.8137194368949595,0.7174311926605504,0.9089995324939296,1.0,3/13,9.89%,DNAJA1;CTSD;CEP290
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.26488030126230133,0.8133923777303408,0.7561475409836066,0.9330257581563123,1.0,6/32,10.47%,POLR1A;GTF2H2;MNAT1;POLR1G;POLR1B;CCNH
prerank,positive regulation of telomere capping (GO:1904355),-0.3068680607186097,-0.8126811426574262,0.7431192660550459,0.9103549578916592,1.0,2/17,3.15%,MAPK3;NEK7
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.271490847518867,-0.8124627595451993,0.7504621072088724,0.9102615416334071,1.0,7/25,17.05%,DMD;WNK1;ATP1B1;COA8;TRPC6;GLRX;NDUFA4
prerank,zinc ion transport (GO:0006829),-0.28485238179547484,-0.8124182065350162,0.7195571955719557,0.9098579246214727,1.0,5/21,14.05%,SLC39A8;SLC30A6;SLC39A1;SLC39A11;SLC39A7
prerank,visual perception (GO:0007601),0.2172862353064592,0.8123858187606305,0.8380566801619433,0.9341099121124736,1.0,16/84,17.56%,ADGRV1;DHRS3;TRPM1;CRYBA1;ATXN7;GUCY2F;BBS2;ATF6;POU6F2;COL1A1;RPGR;COL11A1;RP2;MYO9A;ZIC2;PAX6
prerank,muscle filament sliding (GO:0030049),-0.24851577772343478,-0.8120990598104497,0.7649325626204239,0.9094528203245241,1.0,3/38,1.70%,DMD;VIM;MYL6
prerank,actin-myosin filament sliding (GO:0033275),-0.24851577772343478,-0.8120990598104497,0.7649325626204239,0.9094528203245241,1.0,3/38,1.70%,DMD;VIM;MYL6
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.33413136285505685,-0.812094180601875,0.7244701348747592,0.9089840897768083,1.0,3/12,5.80%,SIX1;SMO;VEGFA
prerank,organophosphate biosynthetic process (GO:0090407),-0.2514287762872684,-0.8119025289832605,0.7702448210922788,0.9088309102125962,1.0,7/37,16.13%,ITPKB;TPK1;IPMK;FGF2;IP6K1;MBOAT1;PCYT2
prerank,fatty acid transport (GO:0015908),-0.3011627032112471,-0.8118100711270337,0.7579143389199255,0.9085042186116387,1.0,8/17,30.34%,PPARD;MFSD2A;FABP5;APOE;SLC27A1;SLC27A6;CD36;CPT1B
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.28885572797169823,-0.8117958733725023,0.726078799249531,0.9080541398113583,1.0,10/18,35.49%,DKC1;CCT2;CCT3;CCT8;CCT7;RUVBL1;CCT4;NOP10;DCP2;CCT6A
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.31961806703580653,-0.8116223444681969,0.7379679144385026,0.9078758742260894,1.0,2/13,5.87%,TNRC6C;CNOT7
prerank,bone morphogenesis (GO:0060349),-0.31682178781595594,-0.8116099556281481,0.7359855334538878,0.9074187952716221,1.0,2/14,2.16%,LRP5;BMPR2
prerank,transcription by RNA polymerase III (GO:0006383),0.2754559334538912,0.811252544190194,0.74,0.9353641000896196,1.0,13/27,24.06%,SNAPC3;GTF3C3;GTF3C2;SNAPC1;GTF3C6;ICE1;GTF3C4;ICE2;POLR3H;POLR2K;POLR3GL;CRCP;POLR3K
prerank,regulation of B cell differentiation (GO:0045577),0.3033785299601405,0.810824927737028,0.6762749445676275,0.9353508384569598,1.0,2/17,3.70%,IL4I1;SFRP1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.31044579468307015,-0.8104516773719488,0.7458866544789763,0.9085019816451155,1.0,2/15,5.87%,TNRC6C;CNOT7
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.31044579468307015,-0.8104516773719488,0.7458866544789763,0.9085019816451155,1.0,2/15,5.87%,TNRC6C;CNOT7
prerank,autophagosome assembly (GO:0000045),0.23798328327550666,0.8095938686749573,0.7824267782426778,0.936823370278176,1.0,11/52,13.53%,ATP2A2;WDR45B;WIPI1;UBXN2B;UBXN2A;ATG12;TP53INP2;ATG16L2;TMEM41B;STX12;ULK2
prerank,peripheral nervous system development (GO:0007422),0.2856248976552571,0.8079475606604297,0.7158351409978309,0.9389664883365729,1.0,5/23,11.13%,GDNF;ARTN;ASIC2;ERBB3;NFASC
prerank,intestinal lipid absorption (GO:0098856),-0.33544187629527356,-0.8077698006976856,0.7137809187279152,0.9126257003664524,1.0,7/11,52.60%,SOAT2;CD36;LDLR;LIMA1;AKR1C1;ABCG5;NPC1L1
prerank,regulation of cilium assembly (GO:1902017),-0.2232049167204901,-0.8077628234464642,0.831041257367387,0.9121599108599131,1.0,19/62,25.82%,LIMK2;TBC1D8;IFT20;HTT;TBC1D1;TBC1D22A;ATG3;TBC1D9B;CDK10;TBC1D2;RABEP2;DCDC2;TBC1D15;CCDC88A;TBC1D30;ODAD3;TBC1D17;TBC1D5;CDKL5
prerank,regulation of lipase activity (GO:0060191),0.3238119153744742,0.8076877150132179,0.6910755148741419,0.9386266263581339,1.0,13/13,67.65%,PCSK6;SNCA;LIPC;ANGPTL3;LMF1;RHOC;APOA2;PCSK5;LPL;ANGPTL8;PLIN5;FURIN;RHOA
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.3095590381715242,0.8074537449097297,0.7182795698924731,0.9382831258059672,1.0,7/15,24.72%,CASP3;NGFR;BCAR1;FRS2;SORT1;NTRK2;BDNF
prerank,macrophage chemotaxis (GO:0048246),0.3429996698102233,0.8069157278869485,0.6754385964912281,0.9384517857743124,1.0,3/10,20.29%,EDNRB;CKLF;TAFA4
prerank,arachidonate transport (GO:1903963),0.3412442156044932,0.8066549612104645,0.6852678571428571,0.9373330299055019,1.0,1/10,1.60%,PLA2G5
prerank,arachidonic acid secretion (GO:0050482),0.3412442156044932,0.8066549612104645,0.6852678571428571,0.9373330299055019,1.0,1/10,1.60%,PLA2G5
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.3100222902317476,-0.8063852663934137,0.7315315315315315,0.9140021694648031,1.0,6/15,32.44%,GBP5;TLR4;TREM2;TLR6;CD36;NLRC3
prerank,regulation of B cell activation (GO:0050864),0.2799382532461985,0.806314526268488,0.7323008849557522,0.9371210812801778,1.0,3/25,10.97%,IL4I1;IL4;AHR
prerank,regulation of amyloid fibril formation (GO:1905906),-0.3034169038370873,-0.8060728526434356,0.7332089552238806,0.9140391684258461,1.0,7/15,27.06%,APP;PFDN5;APOE;CRYAB;PFDN6;PFDN4;TREM2
prerank,negative regulation of T cell activation (GO:0050868),0.257279289273718,0.8060165638172636,0.7656903765690377,0.936866880331014,1.0,5/35,12.26%,IL4I1;CEBPB;GLMN;CD274;PAG1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.33633681612528343,-0.8058519728232405,0.7297297297297297,0.913935045626268,1.0,4/10,19.29%,ZBTB16;SOX6;SOX9;BMPR1B
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.3470818615810823,0.8057633779151044,0.6804347826086956,0.9365195876009069,1.0,4/10,9.97%,PDE3A;PDE3B;PDE11A;MGRN1
prerank,positive regulation of potassium ion transport (GO:0043268),-0.24753495106427292,-0.8057326529953941,0.7956349206349206,0.9136517817757295,1.0,7/38,13.81%,KCNJ2;FHL1;KCNQ1;KCNJ10;AKAP6;KCNJ15;GNB1
prerank,ubiquinone metabolic process (GO:0006743),-0.31198023816236414,-0.8054297779206853,0.7304832713754646,0.9136948772931364,1.0,5/15,21.78%,PDSS2;COQ6;COQ8A;COQ7;UBIAD1
prerank,regulation of tissue remodeling (GO:0034103),0.30869519507814075,0.8049141055561304,0.7194092827004219,0.9371741929846152,1.0,3/18,8.86%,DDR2;LEPR;IL18
prerank,regulation of proteolysis (GO:0030162),-0.23754422997745772,-0.8046348809914109,0.8,0.9145449049600562,1.0,10/48,17.00%,CAV1;LTBP4;CASP8;CST3;PERP;AKT1;BAK1;ITCH;BAD;IST1
prerank,regulation of viral transcription (GO:0046782),-0.24565805289211143,-0.8045700105681479,0.7839851024208566,0.9141860020694925,1.0,6/39,12.57%,MID2;IFITM3;DHX9;TRIM14;NELFE;TRIM62
prerank,negative regulation of neurogenesis (GO:0050768),-0.25357484136753694,-0.8045664290291683,0.7821229050279329,0.9137171651454598,1.0,10/34,19.77%,B2M;NOTCH1;REST;ARHGDIA;GDI1;NF1;PCM1;YWHAH;EFNB3;RAPGEF2
prerank,cellular response to alkaloid (GO:0071312),0.2991861954470356,0.8042155246990356,0.7186858316221766,0.9377106598184789,1.0,3/17,9.24%,SLC8A1;CASP3;BLM
prerank,protein localization to chromosome (GO:0034502),-0.2528343020110289,-0.804212800937537,0.7802607076350093,0.9138531046307485,1.0,13/34,31.54%,ESR1;TPP1;RB1;SLF1;WAPL;RAD21;BOD1;CENPA;MRNIP;SLF2;CHMP7;TERF2IP;PLK1
prerank,prostaglandin metabolic process (GO:0006693),-0.2641369406264691,-0.8035636792899319,0.7634011090573013,0.91448089840557,1.0,7/26,17.88%,PTGDS;EDN1;PLAA;CD74;PTGS1;GSTM1;DAGLB
prerank,regulation of protein localization to cell surface (GO:2000008),0.26045126012683395,0.8029190885468857,0.7404921700223713,0.9392639868031287,1.0,5/33,6.03%,SNX33;LEPROT;GPD1L;TAX1BP3;GBF1
prerank,positive regulation of dephosphorylation (GO:0035306),-0.262622343004072,-0.8026357514157739,0.7652671755725191,0.9155265551246233,1.0,12/27,23.97%,PPP1R16B;CALM1;TGFB1;PPIA;PPP2R5A;CALM3;CDCA2;PIN1;CDH5;CNEP1R1;PRKCD;NSMF
prerank,positive regulation of DNA recombination (GO:0045911),0.267620284079124,0.802631228092133,0.7450110864745011,0.9389902809980707,1.0,7/27,17.35%,SHLD2;PRDM9;KMT5C;PAXIP1;RIF1;KMT5B;PARP1
prerank,ESCRT complex disassembly (GO:1904896),-0.34212026354900843,-0.8022824940210526,0.7102272727272727,0.9151495439423778,1.0,5/10,29.69%,CHMP2B;IST1;CHMP2A;VPS4A;CHMP7
prerank,ESCRT III complex disassembly (GO:1904903),-0.34212026354900843,-0.8022824940210526,0.7102272727272727,0.9151495439423778,1.0,5/10,29.69%,CHMP2B;IST1;CHMP2A;VPS4A;CHMP7
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.29225440263229946,0.8019587789431483,0.7133757961783439,0.9394238254843807,1.0,2/20,5.80%,HECW2;HECW1
prerank,mitochondrial transcription (GO:0006390),-0.34313303687540736,-0.8019371788498585,0.7228915662650602,0.9152505076570715,1.0,2/10,18.96%,FOXO3;SLC25A33
prerank,response to axon injury (GO:0048678),0.2998321589973188,0.8014177193186531,0.7246376811594203,0.9395879159668031,1.0,3/18,6.91%,P2RX4;NREP;DPYSL3
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.2666549532798094,0.8013156877724255,0.7747368421052632,0.938976034157241,1.0,2/29,2.52%,PLA2G5;PLA2G4A
prerank,aspartate family amino acid catabolic process (GO:0009068),0.30492956524887704,0.8012057467601905,0.7521739130434782,0.9384143872404044,1.0,3/19,8.31%,ASPA;ALDH7A1;DDO
prerank,regulation of Golgi organization (GO:1903358),-0.2952937185373541,-0.8010373993562154,0.7387033398821218,0.9162353773239093,1.0,6/17,22.53%,MAPK3;ARMH3;EHD3;CAMSAP3;STX5;PDCD10
prerank,lipid catabolic process (GO:0016042),-0.29144072014266953,-0.8010160471958819,0.7415094339622641,0.9157982983008013,1.0,6/18,31.79%,PLAAT3;ACADL;PLA1A;LIPH;HSD11B1;LIPE
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.3330262190350432,-0.8006225492526863,0.7382297551789078,0.9155038387656638,1.0,4/11,24.43%,INPP5A;SYNJ1;IMPA2;INPP5B
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.3330262190350432,-0.8006225492526863,0.7382297551789078,0.9155038387656638,1.0,4/11,24.43%,INPP5A;SYNJ1;IMPA2;INPP5B
prerank,regulation of feeding behavior (GO:0060259),0.33244843151624365,0.800234112440703,0.7081545064377682,0.9393470876204625,1.0,1/11,2.84%,LEPR
prerank,presynaptic endocytosis (GO:0140238),0.27817865228050154,0.8000115392651522,0.7198275862068966,0.9389618580203358,1.0,5/24,8.00%,STON1;NLGN2;NLGN3;SYT1;NLGN1
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.22200416140749157,-0.7991500760662067,0.8467583497053045,0.917480774076968,1.0,18/61,23.36%,CAV1;PSMA6;PSMB5;PSMC4;PSMC5;OAZ2;PSMD14;PSMD8;PSMC1;NQO1;PSMB4;PSMD11;PSMD12;PSMA1;PSMC3;PSMB1;PSMA2;PSMA4
prerank,regulation of sister chromatid cohesion (GO:0007063),0.3277167409079971,0.798970694046069,0.7062634989200864,0.9399997521806904,1.0,3/12,9.77%,AXIN2;CTCF;HDAC8
prerank,mucosal immune response (GO:0002385),0.3073480252483803,0.7988154748059009,0.744874715261959,0.9395102843288854,1.0,2/15,5.64%,IL4;BPIFB1
prerank,cochlea morphogenesis (GO:0090103),0.3431103328808211,0.7987127037544393,0.6839729119638827,0.9388959725407282,1.0,1/10,2.08%,TBX18
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.32023885932304513,0.7984473885113632,0.728051391862955,0.9386062013040539,1.0,2/15,1.88%,VDR;CYP27B1
prerank,positive regulation of cell division (GO:0051781),0.24890072522445997,0.7980810152095218,0.7777777777777778,0.9384954248147852,1.0,2/38,1.12%,SVIL;FGFR2
prerank,cellular response to hypoxia (GO:0071456),-0.195142803794151,-0.7979834000020734,0.8947368421052632,0.9189336224411324,1.0,40/126,25.20%,EGLN3;UBB;UBC;RPS27A;VEGFA;ACAA2;GATA6;EGLN2;RGCC;PSMA6;PSMB5;TWIST1;PSMC4;EGLN1;LIMD1;PSMC5;PSMD14;RBX1;BNIP3L;PSMD8;PSMC1;PGK1;PSMB4;PSMD11;BAD;PSMD12;ELOB;HIGD1A;PSMA1;PSMC3;PLK3;PSMB1;PSMA2;NPEPPS;PSMA4;HYOU1;HIF1AN;HILPDA;ANGPT4;CARD16
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.3212836864543129,0.7979524354513329,0.7130242825607064,0.9379468245041825,1.0,6/13,23.12%,PTPRT;PIGU;TSLP;CRLF2;DOT1L;EGF
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.2731080165399805,-0.7979153652614432,0.7777777777777778,0.9185703100077259,1.0,3/23,7.83%,CBFA2T3;NCOR1;HDAC4
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.3228690486253906,0.7973698519064102,0.6900212314225053,0.9381808337585736,1.0,4/12,19.53%,PRKCA;PRKCB;LPIN1;CCNB2
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.32535984722119116,-0.7966984442932511,0.7504332755632582,0.9200749628859843,1.0,3/12,13.23%,LPCAT3;MBTPS2;ABCA2
prerank,regulation of TOR signaling (GO:0032006),-0.21640336340499738,-0.7966310276953377,0.8513513513513513,0.919703153490784,1.0,24/67,32.75%,SH3BP4;RICTOR;TNFAIP8L1;EPM2A;TBCK;LAMTOR2;PIK3CA;RRAGD;DDIT4;TSC2;RRAGA;RRAGC;GOLPH3;SEH1L;PDCD6;SEC13;RPTOR;TREM2;LAMTOR5;FAM83D;LAMTOR1;HDAC3;LAMTOR3;PKHD1
prerank,stem cell development (GO:0048864),0.3006906046489663,0.7956952092175311,0.7085953878406709,0.9403155540050286,1.0,1/16,1.45%,NRG1
prerank,positive regulation of secretion (GO:0051047),-0.3278231138432834,-0.79486679860673,0.7294332723948812,0.9220743421455988,1.0,2/11,18.10%,NPR1;XBP1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.34129163439999577,-0.7946734252439533,0.7428571428571429,0.9219211578759429,1.0,5/10,26.60%,RCC2;ECT2;KNSTRN;RACGAP1;CDC42
prerank,regulation of telomere capping (GO:1904353),-0.27286245369778217,-0.794607937311292,0.7513812154696132,0.9215566514327429,1.0,4/23,12.68%,MAPK3;NEK7;USP7;PNKP
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.32609763771087596,-0.7944333503994541,0.7782026768642447,0.9213708278601719,1.0,5/12,26.03%,PRKDC;RPS27L;CCND1;PLK3;PLK5
prerank,transport along microtubule (GO:0010970),-0.3152678079928528,-0.7943537442079075,0.7314814814814815,0.9210252735193305,1.0,3/13,10.02%,APP;BORCS5;COPG1
prerank,autophagosome organization (GO:1905037),0.2346784899168105,0.7941415998487635,0.8012422360248447,0.9422296792807905,1.0,11/50,13.53%,ATP2A2;WDR45B;WIPI1;UBXN2B;UBXN2A;ATG12;TP53INP2;ATG16L2;TMEM41B;STX12;ULK2
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.25237678281886977,0.7940938336453898,0.7515657620041754,0.9415246827841149,1.0,8/36,14.01%,UXT;TFDP1;L3MBTL2;RNF2;APAF1;PCGF6;EHMT2;EZH2
prerank,GPI anchor biosynthetic process (GO:0006506),0.2605390034455995,0.7936681686766199,0.7755511022044088,0.9414916194075202,1.0,11/30,22.84%,GPAA1;PIGU;PIGH;PIGP;PIGX;PGAP3;PIGN;DPM1;MPPE1;PGAP1;PIGB
prerank,negative regulation of macroautophagy (GO:0016242),0.27002278365486515,0.7928924352150589,0.7474120082815735,0.9420397485954508,1.0,3/26,4.27%,PHF23;UBQLN4;SCFD1
prerank,nucleosome assembly (GO:0006334),-0.25358143895527735,-0.79261370370019,0.7736943907156673,0.9233613722302741,1.0,10/31,29.34%,H3-3A;NAA60;RBBP4;SOX9;NPM1;KAT6B;SMARCA5;ANP32B;ASF1B;HMGB2
prerank,androgen metabolic process (GO:0008209),-0.28901129036362205,-0.7924041473984341,0.7351851851851852,0.9232144046641749,1.0,12/18,52.68%,SPP1;HSD17B10;HSD17B7;SRD5A2;HSD3B2;CYP19A1;DHRS9;SRD5A3;SRD5A1;HSD17B6;HSD17B3;AKR1D1
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.19630025392484768,-0.7911161585156141,0.9145631067961165,0.924722674820824,1.0,13/124,8.90%,FRY;FRYL;RAB11A;OPHN1;STX3;APP;MAP4;RAC1;PTPRM;MYOC;TTC17;STMN2;RB1
prerank,camera-type eye morphogenesis (GO:0048593),0.33930782143704186,0.7905781714052528,0.7319819819819819,0.9451677805123295,1.0,2/10,6.74%,TENM3;IFT122
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.2677071155473714,0.7904261736665825,0.7578947368421053,0.9446501538616621,1.0,7/26,18.37%,HECW2;CDC23;CDC16;DLGAP5;FBXO5;NSMCE2;ANAPC5
prerank,regulation of cellular catabolic process (GO:0031329),0.22576533796564843,0.7899960121719056,0.8253358925143954,0.9446078087953111,1.0,12/62,15.56%,DAPK2;ITPR1;PIP4K2A;PRKN;DAPK1;KAT8;PIP4K2B;RAB39B;ATM;MAPT;EP300;DDIT3
prerank,pre-replicative complex assembly (GO:0036388),-0.2147076635437564,-0.7898360951356649,0.8390342052313883,0.9262606076615904,1.0,19/64,23.77%,UBB;UBC;RPS27A;PSMA6;PSMB5;PSMC4;PSMC5;PSMD14;PSMD8;PSMC1;PSMB4;PSMD11;PSMD12;PSMA1;PSMC3;PSMB1;PSMA2;PSMA4;MCM5
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.2756844335495676,-0.7894923063353274,0.7767527675276753,0.9263219209862369,1.0,7/21,21.83%,SMO;GAS8;ULK3;TUBD1;STK36;GLI1;DCDC2
prerank,neural crest cell differentiation (GO:0014033),-0.2867049182341238,-0.7889481480174297,0.7443181818181818,0.9266920297123908,1.0,1/18,0.32%,MEF2C
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.31141660521655373,-0.788942682536983,0.7734082397003745,0.9262244470287625,1.0,8/13,43.43%,OAS2;JAK2;STAT1;IL6ST;IL27RA;CANX;TYK2;EBI3
prerank,establishment of mitotic spindle localization (GO:0040001),-0.2546220369299014,-0.787679545202727,0.7917448405253283,0.9277555185152091,1.0,9/28,24.19%,ZW10;HTT;DCTN1;NDE1;NDEL1;MISP;NDC80;SPDL1;CENPA
prerank,microtubule anchoring at centrosome (GO:0034454),0.3280651015632674,0.786976189949245,0.7074829931972789,0.9488961776128325,1.0,4/10,21.45%,NINL;KIF3A;CCDC68;BBS4
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.254161529828622,0.7867872223393821,0.7794117647058824,0.9484436624430914,1.0,7/32,15.52%,CDK14;TFDP1;NPAT;ORC1;CDK16;BACH1;FBXO5
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.25470143534269507,0.7867858747345696,0.7983539094650206,0.9476720486302918,1.0,5/30,12.98%,VAMP5;RAB10;BBS2;OPTN;SYS1
prerank,cobalamin metabolic process (GO:0009235),-0.29500212838543494,-0.7863825510833281,0.7699619771863118,0.929276797717152,1.0,4/17,17.42%,MTR;CUBN;MMADHC;CD320
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.25299237898987836,-0.7858601230875828,0.7864077669902912,0.9295847515609459,1.0,9/27,30.50%,BHLHE40;PPP1CB;MTA1;RBM4B;FBXL3;PPP1CA;SIK1;FBXL8;CRY2
prerank,transcription by RNA polymerase I (GO:0006360),0.2524278120256601,0.7856746255283019,0.8106995884773662,0.9487135295032901,1.0,10/34,20.19%,POLR1A;GTF2H2;MNAT1;POLR1G;POLR1B;CCNH;TTF1;POLR2K;TAF1C;TAF1
prerank,Golgi to endosome transport (GO:0006895),-0.2939164535737724,-0.7855769845075986,0.7606679035250464,0.9295567427846192,1.0,7/16,26.26%,VPS13A;KIF16B;DOP1B;AP2A1;AP4M1;CORO7;EPS15
prerank,"transcription, DNA-templated (GO:0006351)",-0.1817563789718899,-0.7849544435463524,0.9596602972399151,0.9300190733439889,1.0,39/207,19.79%,RREB1;MLLT3;DDX5;MEF2A;FOXO3;AFF4;IVNS1ABP;NFYA;NR4A2;PTMA;GTF3C5;GTF2E1;ATF4;CBFB;PIR;TRIP11;GTF2H3;XAB2;NELFE;PPP5C;EPC1;RNPS1;E2F1;BTF3;POLR3A;IRF9;CCNK;GMEB2;DRAP1;SMN1;GTF2H4;MED20;GTF2F1;XBP1;TCEA1;ELOB;SLC25A33;GTF3C1;PWP1
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.28385682098453546,-0.784576233010557,0.7546468401486989,0.9301245238911733,1.0,8/19,32.82%,HTT;CSNK2A2;FZD5;CAMKK2;SREBF1;PARK7;ATP13A2;HTRA2
prerank,positive regulation of viral process (GO:0048524),-0.22030563122344993,-0.7844827352460078,0.8447937131630648,0.9297945454608991,1.0,21/60,32.12%,ADAR;PPIA;CNOT7;SRPK1;DHX9;IFIT1;NELFE;STAU1;RAB7A;NR5A2;GTF2F1;PABPC1;RAD23A;VPS4A;PPID;POLR2F;GTF2F2;KPNA6;POLR2C;POLR2L;POLR2I
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.3310569985510075,0.7841088276059051,0.7244444444444444,0.9505975618847046,1.0,2/11,8.04%,RUNX3;CD274
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.334904432251906,-0.7840990160828721,0.7513711151736746,0.9298830206425527,1.0,4/10,16.62%,MLLT3;ACE;UFL1;HOXB4
prerank,AMP metabolic process (GO:0046033),-0.3055682211116981,-0.7839602750167952,0.7660714285714286,0.9296202264035079,1.0,6/13,25.47%,NT5E;ADSS2;NT5C1A;ADSS1;NUDT2;AK9
prerank,Rac protein signal transduction (GO:0016601),-0.2919931415522121,-0.7835843243966438,0.7569060773480663,0.9297092852425266,1.0,4/18,15.57%,EPS8;RAC1;DBNL;NCKAP1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.342670232945267,0.7834481938215712,0.7315436241610739,0.9509063799154875,1.0,2/10,13.01%,KLF15;SETD5
prerank,placenta development (GO:0001890),-0.3176930988756811,-0.7830042092089493,0.75,0.9300923581316217,1.0,2/12,7.87%,PTK2;ADAM19
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.31338236659956475,-0.7823017626213178,0.7651376146788991,0.9306848413985721,1.0,7/12,35.12%,SEPHS2;CTH;GGT1;SERINC3;SERINC5;SRR;PSAT1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.33525836565497863,-0.7822091287563868,0.7495256166982922,0.930349745064916,1.0,3/10,16.56%,MAPK3;FAS;GREM1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.2728723350099281,-0.781993074843554,0.7992565055762082,0.9302216581513668,1.0,10/22,33.18%,PSMA6;PSMB5;PSMB4;PSMA1;PSMB1;PSMA2;PSMA4;PSMB8;PSMA8;PSMB2
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.3134838399165254,-0.7819533637936955,0.762962962962963,0.9298025294581304,1.0,3/13,9.28%,CSPG4;HEXA;IDUA
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.25419710715884586,-0.7819100239697644,0.806390977443609,0.9293914089307248,1.0,10/26,33.45%,TRIB1;MAPKBP1;DHX58;ITCH;SIGIRR;TNFAIP3;CARD16;MUL1;NLRC3;LYAR
prerank,protein autoprocessing (GO:0016540),-0.2870515273781583,-0.7818315437801354,0.7631578947368421,0.9290623149436537,1.0,7/17,32.82%,FAM111A;SPRTN;FXN;CASP1;MYRF;PIDD1;HTRA2
prerank,C-terminal protein amino acid modification (GO:0018410),0.3223746370429105,0.781778577780694,0.7440860215053764,0.9529106416921297,1.0,3/11,11.50%,AGBL4;ATG12;FOLH1
prerank,regulation of histone deacetylation (GO:0031063),-0.30691242879062297,-0.7817100153223755,0.7438162544169611,0.9287725910636161,1.0,5/13,25.00%,CAMK2D;CTBP1;SPHK2;NIPBL;APLNR
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.2956711261029281,0.7810041618708254,0.7532467532467533,0.9533848398204611,1.0,3/16,12.73%,LEPROT;VPS25;LEPROTL1
prerank,regulation of ion transport (GO:0043269),0.21308687837355517,0.7809992152018338,0.8540772532188842,0.9526217956324765,1.0,23/76,19.20%,GDNF;NKAIN2;P2RX4;PRKN;SYT1;KCNJ16;KCNJ3;NKAIN3;KCNJ5;CHRNA4;KCNJ14;SYT13;KCNJ6;DRD2;NEDD4;SYT11;SYT12;KCNJ9;SNX6;VAMP3;SYT6;PER1;HTR1A
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.32907507808196257,0.7809870265132223,0.70509977827051,0.9518660909112644,1.0,4/10,24.28%,DNMT1;RIF1;DNMT3B;SIRT1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.3121557170627872,-0.78079892036201,0.7853309481216458,0.9296524719211647,1.0,1/13,0.21%,SLC4A10
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.258818078241688,-0.7806291950731634,0.8033088235294118,0.9294407346685981,1.0,15/26,42.80%,ST3GAL4;ST8SIA6;RRM1;SCCPDH;LARGE1;GOLPH3;ALG2;ST3GAL2;TPI1;B4GALT5;ALG6;RRM2;TNIP1;GAL3ST4;GCNT1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.2970032678555493,-0.7804841570262809,0.768270944741533,0.9291931446968756,1.0,2/15,5.87%,TNRC6C;CNOT7
prerank,microtubule depolymerization (GO:0007019),-0.29322605021449866,-0.7803912959621694,0.8068592057761733,0.9288626599061557,1.0,7/17,25.79%,STMN2;KATNB1;KIF24;KIF18A;KIF18B;STMN1;NCKAP5L
prerank,cellular response to light stimulus (GO:0071482),-0.2126482352653532,-0.7802020491095709,0.8523622047244095,0.9286783776013198,1.0,17/66,23.48%,RPL26;RHBDD1;N4BP1;ATF4;YY1;BAK1;GNB1;FMR1;OPN3;POLK;KDM1A;PTPRK;ERCC4;COPS9;RHNO1;TRIAP1;PRKCD
prerank,regulation of gastrulation (GO:0010470),0.30817641045006944,0.7798811111565239,0.7413793103448276,0.9529003052764207,1.0,2/14,6.83%,PHLDB2;FOXA2
prerank,intracellular pH reduction (GO:0051452),-0.24723900674857696,-0.7797718384403867,0.8205128205128205,0.928845115969412,1.0,8/33,16.19%,ATP6V0B;ATP6V0A2;CLCN3;ATP6V0C;RAB7A;GPR89B;GPR89A;ATP6V1G1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.2898437921420116,-0.7796906722620152,0.7711069418386491,0.9284984732498825,1.0,10/16,33.82%,SNRPC;DCPS;RBM22;DDX23;SFSWAP;NCBP2;PSIP1;WBP11;WBP4;SRSF1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.2786019674961325,-0.7793440803455187,0.8210922787193974,0.9285548839240308,1.0,7/20,23.71%,MCUB;MCUR1;PHB2;MICU2;SMDT1;SLC8B1;MCU
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.21245178222555397,0.7785834052149733,0.8601694915254238,0.9543051895115063,1.0,8/72,11.09%,ENPP1;DCP1A;DDB2;GTF2H2;SETMAR;RPA2;RFC5;RNASE4
prerank,modification-dependent protein catabolic process (GO:0019941),-0.17895125124739206,-0.7785245150388087,0.967741935483871,0.9293211202238814,1.0,45/193,21.29%,NEDD4L;RNF144B;TRIM25;UBB;RLIM;UBC;RPS27A;RNF125;ANAPC15;RNF114;RC3H1;UBE2L6;ANAPC11;ARRDC1;RNF185;UBE2G2;TOLLIP;FBXL14;PCYOX1;KLHL3;RNF5;PSMD14;ITCH;RBX1;FEM1A;UBL7;RNF20;RNF111;SMURF1;UBE2G1;FBXL7;ANAPC7;PSMD11;KCTD10;CDC27;FZR1;XBP1;RNF19A;AMFR;PCYOX1L;UBE2B;ANAPC2;KEAP1;BFAR;UBA1
prerank,regulation of DNA repair (GO:0006282),-0.23288951120077062,-0.7783355019593113,0.8458574181117534,0.9291417093796811,1.0,7/44,9.16%,RPS3;USP1;BRCC3;UIMC1;BABAM1;DHX9;TRIM28
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.2561708234664843,-0.7782637030105356,0.8067375886524822,0.9287799740802891,1.0,8/27,28.45%,CHKA;PLAAT3;CEPT1;PCYT2;NAPEPLD;SELENOI;SLC27A1;LPIN2
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.29395750940971266,-0.7771889939593267,0.7624309392265194,0.929889494747323,1.0,6/17,18.01%,NOTCH1;TGFB1;HEYL;ACVR1;HEY1;DLL4
prerank,Golgi localization (GO:0051645),-0.3241574846284682,-0.7770024279206,0.7721280602636534,0.9297077534937557,1.0,6/11,26.60%,STK25;COPG1;YWHAZ;RIPOR1;PDCD10;CDC42
prerank,negative regulation of protein metabolic process (GO:0051248),-0.22720619732745215,-0.7764191925949235,0.8661417322834646,0.9300572645333406,1.0,14/48,21.98%,HSP90AB1;PFDN5;EDN1;APOE;INHBB;EGFR;CD84;FLOT2;AGAP2;CRYAB;PIN1;ITGB3;SNX3;PFDN6
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.23719719952347118,0.7760535551958556,0.8126272912423625,0.9576545984646034,1.0,14/45,20.46%,AURKAIP1;SMAD3;BRINP1;BRINP3;TOM1L2;TOM1L1;WEE2;PRCC;BRINP2;TRIM35;ZWINT;FOXC1;ZWILCH;ZFP36L2
prerank,glycolipid biosynthetic process (GO:0009247),0.24173260055630846,0.7754979285817668,0.7971887550200804,0.9577495728064701,1.0,12/38,20.27%,ST6GALNAC5;ST3GAL5;ST8SIA1;PIGU;PIGH;PIGP;ST8SIA5;PGAP3;PIGN;DPM1;MPPE1;B4GALT6
prerank,epithelial cell development (GO:0002064),-0.2777826699650683,-0.7753087915602528,0.7868852459016393,0.9311997336278912,1.0,11/20,40.40%,ACTA2;SIPA1L3;RILPL1;WNT7A;PKHD1;POF1B;GRHL2;RILPL2;WNT7B;RAB25;ROS1
prerank,chromatin disassembly (GO:0031498),-0.2996137070651025,-0.7750081584412906,0.7645951035781544,0.9307241804417613,1.0,7/14,37.31%,ARID1A;SMARCA4;SMARCC1;SMARCD2;SMARCD3;NFE2;HMGA1
prerank,nucleosome disassembly (GO:0006337),-0.2996137070651025,-0.7750081584412906,0.7645951035781544,0.9307241804417613,1.0,7/14,37.31%,ARID1A;SMARCA4;SMARCC1;SMARCD2;SMARCD3;NFE2;HMGA1
prerank,cellular response to misfolded protein (GO:0071218),-0.27318424409329445,-0.7748921989242654,0.7888675623800384,0.9304362456676365,1.0,4/20,12.45%,DNAJB12;RNF185;VCP;RNF5
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.24206184992895752,0.774768848901991,0.8080168776371308,0.9581280403043546,1.0,2/37,2.32%,CEMIP;PRKAG2
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.31241682354390754,-0.7739950484810981,0.7758007117437722,0.9312801971352095,1.0,7/13,36.59%,ALG9;ALG12;ALG1;ALG2;ALG3;MPDU1;ALG6
prerank,negative regulation of gluconeogenesis (GO:0045721),0.31565592487765415,0.7736002766913104,0.7462039045553145,0.959245482651154,1.0,2/11,14.06%,CRY1;EP300
prerank,phospholipid metabolic process (GO:0006644),0.21353445084912803,0.7732206526084866,0.8785425101214575,0.9590651957704294,1.0,11/71,14.72%,PLA2G5;PIP4K2A;PLA2G4A;PLPP3;PLPPR1;LGALS13;PLBD2;PIP4K2B;GNPAT;PLPPR5;FADS1
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.20925519682678753,-0.7727098481199632,0.8821292775665399,0.9326337325404703,1.0,22/70,28.48%,LPCAT3;MFSD2A;CHKA;DBI;CSNK2B;PLAAT3;MBOAT7;CEPT1;MBOAT1;NR1H2;CSNK2A1;CSNK2A2;LCAT;PCYT1A;LPCAT2;CHAT;PLA2G4F;ENPP2;PEMT;SLC27A1;LPIN2;PLA2G4B
prerank,cholesterol efflux (GO:0033344),-0.2779577259752351,-0.7727081936844743,0.781190019193858,0.932168295570087,1.0,5/20,14.00%,SCARB1;ABCG1;TSKU;APOE;NPC1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.29593118171543387,0.7722939650105927,0.7538126361655774,0.9597852857157733,1.0,16/16,70.44%,BLM;MCM2;RPA1;MCMDC2;MCM7;MCM6;MCM4;RECQL5;SSBP1;WRN;RECQL4;HMGA1;RAD51;PURA;TWNK;RECQL
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.24941457089732083,-0.772274936075406,0.8156424581005587,0.9323152303581008,1.0,14/31,34.24%,DCUN1D5;DCUN1D1;CDC14B;RAB1A;BMI1;FZR1;PIN1;TRIB3;DCUN1D3;MAGEC2;RPS2;PLK1;CDC20;UBE2C
prerank,alcohol catabolic process (GO:0046164),0.33028178383162893,0.7719981688016464,0.7231503579952268,0.959470219556603,1.0,2/10,10.00%,CYP27A1;CYP46A1
prerank,regulation of DNA replication (GO:0006275),0.2268106275588422,0.7715983586386876,0.8470588235294118,0.9593170921666321,1.0,9/49,15.52%,GLI2;STN1;USP37;BRPF3;ATAD5;BLM;EHMT2;PDS5A;FBXO5
prerank,lipid homeostasis (GO:0055088),0.22210009251934887,0.7710542079579367,0.8329896907216495,0.9594068367097516,1.0,11/57,19.97%,ZBTB20;ABCA1;IRS2;ABCB4;TLCD2;DGAT2;ABHD5;PPARG;MLXIPL;NR1D2;POLD1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.31733263197222805,0.7709140506280908,0.7404921700223713,0.9588564456382115,1.0,4/12,17.46%,SETMAR;STK33;ORC1;NAE1
prerank,regulation of exosomal secretion (GO:1903541),-0.2787025310147458,-0.7708883641248213,0.7855750487329435,0.9338694960844279,1.0,8/19,30.18%,RAB7A;TSG101;SDCBP;SNF8;CHMP2A;VPS4A;STAM;ATP13A2
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.3076377523582198,-0.7708764974547822,0.7617328519855595,0.933415076153428,1.0,6/13,41.77%,ENTPD7;OPA1;RAB23;EFL1;MFN1;RAN
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.3279217901998623,-0.770772197255907,0.7622504537205081,0.9330922837090716,1.0,6/10,30.28%,AKT1;TLR4;CD68;TREM2;TLR6;CD36
prerank,glycosphingolipid metabolic process (GO:0006687),-0.2273547273077127,-0.7705224499692107,0.8261682242990654,0.9330021251064291,1.0,9/42,15.26%,ST6GALNAC3;ESYT2;SUMF2;HEXA;PSAP;A4GALT;SUMF1;ABCA2;ESYT3
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.3152181412740105,0.7696067700123299,0.7404255319148936,0.9601039184102869,1.0,2/12,8.86%,STAP1;IL18
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.28361489669032225,0.7688325137537257,0.7700892857142857,0.9597509789877197,1.0,19/19,71.67%,POLR2G;DAXX;POLR2K;POLR2D;POLR2B;TINF2;POLR2H;ATRX;ACD;POLR2E;TERF2;POLR2J;TERF1;POLR2A;POLR2I;POLR2L;POLR2C;TERF2IP;POLR2F
prerank,regulation of DNA recombination at telomere (GO:0072695),0.28361489669032225,0.7688325137537257,0.7700892857142857,0.9597509789877197,1.0,19/19,71.67%,POLR2G;DAXX;POLR2K;POLR2D;POLR2B;TINF2;POLR2H;ATRX;ACD;POLR2E;TERF2;POLR2J;TERF1;POLR2A;POLR2I;POLR2L;POLR2C;TERF2IP;POLR2F
prerank,cholesterol metabolic process (GO:0008203),-0.21097527318252118,-0.7685540519374143,0.9178082191780822,0.9353230773970167,1.0,14/68,18.48%,SCARF1;PPARD;LBR;OSBPL1A;ACLY;ACAA2;PIP4P1;ABCG1;TSKU;DHCR24;APOE;TM7SF2;LCAT;CH25H
prerank,"wound healing, spreading of cells (GO:0044319)",-0.263915519381157,-0.768532556387166,0.811214953271028,0.9348860733430964,1.0,9/24,32.37%,CD44;CD151;MRTFA;PDCD10;ACVRL1;ITGA5;WNT7A;TMEFF2;RHOA
prerank,secondary alcohol metabolic process (GO:1902652),0.23724658070949745,0.7682875499730215,0.8187250996015937,0.9598440338771412,1.0,5/42,9.26%,ABCA1;CYP27A1;IL4;ABCA5;SCAP
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.24759384093334394,0.7681513983567619,0.8089430894308943,0.9592928176496571,1.0,10/31,18.45%,CACNA1I;SYT1;CACNA1G;SYT13;STXBP3;SCAMP5;SYT11;SYT12;SYT6;RAB3GAP1
prerank,retinol metabolic process (GO:0042572),0.29900841446495274,0.768108545805775,0.7571743929359823,0.9585854229247566,1.0,1/14,2.08%,DHRS3
prerank,positive regulation of protein deacetylation (GO:0090312),0.29726264225787846,0.7678957661826855,0.7538461538461538,0.9581516209162259,1.0,3/14,11.39%,AKAP8L;BRMS1;SAP30BP
prerank,sulfation (GO:0051923),0.32311991567055587,0.7674253713018744,0.7319148936170212,0.9581308838779294,1.0,3/11,14.74%,UST;SULT6B1;HS3ST5
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.23253446086199334,-0.7666604058147641,0.8679245283018868,0.9370338061162855,1.0,12/42,22.70%,SARS1;WARS2;CARS1;LARS2;WARS1;SARS2;TARS1;CARS2;FARS2;IARS1;AARS2;FARSB
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.22749500081357782,0.7665172286780328,0.8461538461538461,0.9587995877029374,1.0,8/47,14.82%,WNT4;ROCK2;PTGIS;CRY1;KHSRP;ERLIN1;EP300;GLA
prerank,inositol phosphate catabolic process (GO:0071545),-0.31255119580690305,-0.7664695120012553,0.7870722433460076,0.9368563480894928,1.0,4/12,24.43%,INPP5A;SYNJ1;IMPA2;INPP5B
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.2772654058817284,0.7664129925007731,0.8004246284501062,0.9582014317836818,1.0,9/22,25.93%,NR2F2;MEN1;PTEN;CDK5RAP1;IPO7;APC;LATS2;HEXIM1;LATS1
prerank,C4-dicarboxylate transport (GO:0015740),-0.30136582801690004,-0.7661716922512964,0.7749077490774908,0.9368517171953604,1.0,3/14,10.63%,LRRC8D;SLC1A1;SLC25A12
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.2760749089357221,-0.766071017881369,0.8061420345489443,0.9365191634061077,1.0,9/20,27.24%,TGFB1;ABI3;AP2M1;PPP2R5A;BCL2L1;TMEM59;CSK;NUMB;PPFIA1
prerank,apoptotic DNA fragmentation (GO:0006309),0.2901726419932313,0.7656905670538081,0.7850877192982456,0.9585747859029903,1.0,3/16,10.75%,CASP3;EXOG;CECR2
prerank,regulation of exocytosis (GO:0017157),-0.2233472606613669,-0.7647756365629808,0.8384615384615385,0.9378423776129665,1.0,6/46,10.09%,STXBP6;ANXA1;RAB8B;RAB27A;CPLANE2;RAB8A
prerank,cell cycle checkpoint signaling (GO:0000075),-0.31213865689330733,-0.764001341802835,0.7723132969034608,0.9384684064481451,1.0,2/12,8.20%,ZW10;PLK2
prerank,multivesicular body assembly (GO:0036258),-0.243290284568832,-0.7634067490263118,0.8256704980842912,0.9388362116481469,1.0,14/30,35.70%,RAB11A;CHMP2B;VPS36;TSG101;SNF8;IST1;CHMP2A;VPS4A;STAM2;STAM;CHMP7;VPS37C;CHMP4B;CHMP4A
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.23660181788663595,-0.7633961703524149,0.8467432950191571,0.9383814622380389,1.0,20/38,37.61%,PTPRJ;RACK1;AKT1;CIB1;EPHA2;PHLPP2;PHLDA3;TSC2;TRIB3;BANK1;PPP2R5B;PDCD6;MUL1;HYAL2;XDH;PKHD1;GPER1;PHLPP1;INPP5K;PLEKHA1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.2628542886195625,0.762714145015223,0.7888198757763976,0.9623730622776515,1.0,5/25,12.09%,OMA1;ATXN3;UFD1;UGGT2;POMT2
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.19520250534890307,-0.7622147037687446,0.9207317073170732,0.939558712110112,1.0,32/95,33.30%,MEF2C;LBP;VIM;CYRIB;DAB2IP;TNFRSF1B;PLAA;TIRAP;TLR4;NOD2;CX3CR1;RELA;XBP1;TNFAIP3;FZD5;CASP1;CD68;BCL10;TRAF6;CARD16;CCL2;SHPK;PDCD4;CD86;LILRB1;UPF1;HMGB2;IRGM;NLRP3;RHOA;CD14;TNIP2
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.303421343784378,-0.7612589420788402,0.7743682310469314,0.9403826918224691,1.0,4/13,16.72%,CASP8;PERP;BAK1;BAD
prerank,dendritic cell chemotaxis (GO:0002407),0.29783722627560283,0.7609814167327327,0.7345132743362832,0.964269142885296,1.0,2/14,13.05%,CCR6;CXCR4
prerank,response to leucine (GO:0043201),-0.32177200653733073,-0.7609606629254357,0.7783882783882784,0.9398463377562402,1.0,4/10,27.20%,RRAGD;SESN2;RPTOR;SESN1
prerank,cellular response to leucine (GO:0071233),-0.32177200653733073,-0.7609606629254357,0.7783882783882784,0.9398463377562402,1.0,4/10,27.20%,RRAGD;SESN2;RPTOR;SESN1
prerank,regulation of leukocyte activation (GO:0002694),-0.29328940050482494,-0.760938139832015,0.7703703703703704,0.9394144758577564,1.0,8/14,35.73%,MFHAS1;GPR137B;CD74;CD200;SHPK;PJA2;CD33;GPER1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.24773078810969354,-0.760879527117613,0.8116504854368932,0.9390372361976912,1.0,13/29,34.70%,HSP90AB1;PPIA;DKC1;HSP90AA1;PPP6R3;MRE11;TERF2IP;TNKS1BP1;PIF1;RAD50;TERT;WRAP53;NOP10
prerank,regulation of chromosome organization (GO:0033044),-0.2641514252654435,-0.7606041310746096,0.8190298507462687,0.9389568569776064,1.0,12/22,33.18%,RB1;SHCBP1L;WAPL;SMG1;LIG4;CENPV;UPF1;TERF2IP;MYC;PIF1;SMG6;BUB1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.20106253986792968,0.7605766501411279,0.8936605316973415,0.9641221204157531,1.0,5/87,3.70%,FLRT2;FGFR2;KL;FLRT1;SFRP1
prerank,regulation of lymphocyte activation (GO:0051249),0.3098556183301948,0.7604236395622092,0.7342047930283224,0.9635858177284639,1.0,12/12,69.04%,PAG1;LCK;IKZF3;SIT1;CD4;CD19;THEMIS2;CRTAM;DCAF15;CCL5;KAT2A;LAT
prerank,secretory granule organization (GO:0033363),-0.32566929006108364,-0.7598526683239422,0.8176991150442477,0.9395108347508202,1.0,2/10,5.28%,SRGN;LYST
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.30761680247387163,-0.7572529613964912,0.7870722433460076,0.9425357456199063,1.0,3/12,11.17%,PRPS2;PRPS1;PRPS1L1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.31945725499111666,-0.7564725429380121,0.7912885662431942,0.94310732227433,1.0,3/11,19.79%,NCL;SMARCA4;PWP1
prerank,muscle cell migration (GO:0014812),0.32086155612253936,0.7559980688169429,0.7454954954954955,0.9693983143947469,1.0,2/10,3.97%,MEGF10;DDR1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.2656080678509267,-0.7556624004076968,0.8223062381852552,0.9437158877275715,1.0,8/20,24.07%,DCUN1D5;HSP90AB1;DCUN1D1;ITCH;HSP90AA1;HSPA1A;HSPA1B;DCUN1D3
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.25265354531344825,-0.7552226620497959,0.8384201077199281,0.9438296058067536,1.0,10/30,25.24%,ABLIM3;SAE1;VPS11;CSNK2A2;UBL5;FZD5;NPEPPS;MICALL2;UBE2J2;ATG13
prerank,cyclooxygenase pathway (GO:0019371),-0.3194943169681641,-0.7549413983694033,0.770197486535009,0.9437237825193995,1.0,3/10,16.37%,PTGDS;PTGS1;CBR1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.2635289324973999,-0.754908207646868,0.7996108949416343,0.9432976070974947,1.0,9/22,21.89%,HSPA8;GPX1;PRUNE1;APOE;PIK3CA;MAP1B;ARL2;MAP1A;CAMSAP3
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.30279780748946783,-0.7545678038878102,0.7956204379562044,0.9432926712789348,1.0,6/12,27.06%,PFDN5;APOE;CRYAB;PFDN6;PFDN4;TREM2
prerank,regulation of calcium ion import (GO:0090279),0.27267004336360257,0.7545660122204341,0.7914893617021277,0.9707468526085767,1.0,7/21,23.12%,PDGFRB;TRIM27;PLPP4;CXCL12;WNK3;PRNP;EGF
prerank,positive regulation of DNA repair (GO:0045739),-0.21891790676095324,-0.753819256889943,0.8905950095969289,0.9437889520164208,1.0,11/46,20.91%,RPS3;BRCC3;UIMC1;BABAM1;DHX9;TRIM28;SLF1;XRCC1;EGFR;BABAM2;FGF10
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.28435392625341266,-0.7537220953942733,0.8026565464895635,0.9434416702714428,1.0,4/17,10.67%,CD44;TWIST1;PTTG1IP;CD74
prerank,nucleus organization (GO:0006997),-0.2217493991891805,-0.7534081867127931,0.8586278586278586,0.9434134209785447,1.0,6/47,9.44%,SYNE1;RPS19;CHMP2B;NUP93;NUP54;NDC1
prerank,regulation of humoral immune response (GO:0002920),-0.2228292985339398,-0.7531257167132525,0.892578125,0.9433126515332484,1.0,8/44,16.77%,CD55;CD81;GATA6;C1QC;C1QB;PHB2;CFP;C1QA
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.2968052077783084,-0.7529979395408306,0.7689463955637708,0.9429938784508408,1.0,6/13,34.22%,RPS15;NMD3;NPM1;XPO1;LTV1;NUP88
prerank,cellular senescence (GO:0090398),0.25031434370056166,0.7527956132673832,0.803030303030303,0.9725771727377773,1.0,2/27,4.82%,TBX3;MAPKAPK5
prerank,double-strand break repair via homologous recombination (GO:0000724),0.1971425168410857,0.7525725211093026,0.908,0.9721231958145502,1.0,25/95,20.39%,MCM3;RNF138;POLN;GEN1;GINS2;RAD51B;SWSAP1;BLM;RPA2;MCM2;MCM9;RAD51C;MCM8;FANCM;NBN;RPA1;SMC6;SEM1;PARP1;NSMCE2;SMC5;PALB2;UBE2N;CDC7;FBH1
prerank,Golgi inheritance (GO:0048313),-0.3170093325865207,-0.752492714593481,0.7827715355805244,0.9431974769771498,1.0,7/11,26.03%,STK25;VRK1;YWHAZ;PLK3;STX5;PDCD10;PLK5
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.3289631477317109,0.7517494280907777,0.7473233404710921,0.9725291652922528,1.0,1/10,1.29%,BMP5
prerank,protein heterooligomerization (GO:0051291),-0.2773216514239862,-0.7510739292845102,0.8096947935368043,0.9446742454051823,1.0,8/17,36.77%,MAT2A;PKD1;FARSB;PKD2;GRIN1;KRT10;TMEM120B;TMEM120A
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.22161678254361994,0.7510713220579166,0.8568421052631578,0.9727436314298582,1.0,3/52,2.66%,SAMD4A;TUT4;DCP1A
prerank,protein homooligomerization (GO:0051260),-0.18512818830863806,-0.750880975340319,0.9574036511156186,0.9444604857797351,1.0,30/114,24.89%,B2M;KCNJ2;EHD4;GBP5;AQP11;ATL3;FUS;PRMT8;ATL2;JMJD6;GLS;SAMHD1;ALDH1A3;CTH;NINJ1;MLKL;HSD17B10;POLQ;CHMP2A;ECT2;AQP4;EHD1;EHD3;TRMT61B;UPB1;ACOT13;PKD2;BCL10;ALAD;RNF112
prerank,reverse cholesterol transport (GO:0043691),-0.3029210048332079,-0.7507282943266871,0.7754318618042226,0.9442050985104978,1.0,4/13,17.95%,SCARB1;ABCG1;APOE;LCAT
prerank,histone H3-K4 trimethylation (GO:0080182),0.3085103652399787,0.7491436767983796,0.7782515991471215,0.97474147724041,1.0,2/11,6.63%,KMT2A;PRDM9
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.2772331833808146,0.7489618129452796,0.7921225382932167,0.9742166717882661,1.0,2/18,3.25%,GDNF;POR
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.24361796318332438,-0.748620858257934,0.8745098039215686,0.9465234549556311,1.0,8/29,21.97%,ELOVL7;ACLY;ELOVL5;PPT2;ACSL5;SLC25A1;ELOVL1;ACSF3
prerank,melanosome organization (GO:0032438),-0.24736005201565506,-0.7483503576273252,0.8448598130841122,0.9464006023387641,1.0,15/26,38.13%,AP3B1;LYST;HPS1;KIF13A;RAB32;DTNBP1;ABCB6;AP1G1;BLOC1S6;BLOC1S2;SHROOM2;BLOC1S1;AP3D1;GPR143;BLOC1S4
prerank,regulation of neuroblast proliferation (GO:1902692),-0.2866639415522733,-0.7482211785979832,0.8161764705882353,0.9461039894978256,1.0,6/15,17.76%,VEGFA;FZD3;DISC1;NF1;CX3CR1;KDM1A
prerank,mitochondrial membrane organization (GO:0007006),-0.2350482339568897,-0.7478688620263315,0.8613861386138614,0.9460841616465144,1.0,12/32,28.43%,CHCHD3;BCL2L1;BAK1;OPA1;BAD;HSPA9;CHCHD6;TIMM50;SLC25A4;APOO;MICOS13;PMAIP1
prerank,central nervous system neuron development (GO:0021954),-0.2848264588944015,-0.7477030004122237,0.8062730627306273,0.9458319877855051,1.0,4/15,19.77%,HSP90AB1;LHX6;HSP90AA1;RAPGEF2
prerank,neuron remodeling (GO:0016322),-0.32343136221425495,-0.7476856009422436,0.7888888888888889,0.9453872707761156,1.0,3/10,7.55%,SCARF1;APP;ANKS1A
prerank,rRNA methylation (GO:0031167),-0.25825407700727054,-0.7469904821700545,0.8521256931608133,0.9457994191430442,1.0,8/22,29.43%,NOP2;EMG1;MRM3;ZCCHC4;MRM2;NSUN5;FTSJ3;MRM1
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.30922681297038357,0.7466477142698237,0.7639198218262806,0.9767847407737857,1.0,2/11,10.97%,IL4I1;AHR
prerank,regulation of T cell migration (GO:2000404),-0.2804494564949227,-0.7463771621682128,0.811284046692607,0.9461216197419956,1.0,2/18,4.11%,LRCH1;APP
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.30913094466343083,-0.7459249266608153,0.8041044776119403,0.9462166607449993,1.0,3/11,12.45%,RNF185;VCP;RNF5
prerank,lymphocyte migration (GO:0072676),0.2464494728945321,0.745858221309614,0.836,0.9771610868023132,1.0,5/32,10.99%,TBX21;CCR6;GATA3;CCL25;MYO1G
prerank,positive regulation of histone deacetylation (GO:0031065),-0.3024630516067286,-0.7458575013896142,0.7894736842105263,0.9458311393038994,1.0,5/12,25.00%,CTBP1;VEGFA;NIPBL;PRKD2;APLNR
prerank,neuron projection organization (GO:0106027),-0.2863777428579811,-0.7457029012032137,0.8293135435992579,0.9455573382118241,1.0,3/15,10.04%,APP;INSR;DCTN1
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.28864756252173673,-0.7456575735437463,0.8104089219330854,0.9451539699932495,1.0,10/15,37.11%,PLCG2;DDRGK1;PHB2;GLI1;NPM1;FAM83D;CUL3;DYRK3;KLHL18;CDC73
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.2702658277400811,0.7455571452855633,0.7962577962577962,0.9768099412794821,1.0,5/18,16.60%,PPARA;IL4I1;PAG1;ASS1;MIA3
prerank,mesenchymal cell development (GO:0014031),-0.2700470967506863,-0.7452414937593155,0.8026070763500931,0.9452161536229068,1.0,7/18,29.78%,NOTCH1;HEYL;PEF1;SOX8;PDCD6;SNAI2;TBX20
prerank,nuclear membrane organization (GO:0071763),0.27215504358085835,0.7446455212971003,0.7891304347826087,0.9772875594628689,1.0,3/19,6.42%,AKAP8L;UBXN2B;UBXN2A
prerank,regulation of mitotic spindle organization (GO:0060236),0.24420253309580991,0.7442279651651772,0.841304347826087,0.9770971239425705,1.0,9/35,19.45%,GNAI1;MAP9;BORA;CHMP1A;FSD1;PARP3;NUMA1;DRG1;NUP62
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.2725143503664442,-0.7437921913001386,0.815028901734104,0.9466343186472754,1.0,5/18,21.97%,ELOVL7;ELOVL5;ACSL5;ELOVL1;ACSF3
prerank,negative regulation of translation (GO:0017148),0.19984725649240978,0.7437721239885094,0.9474708171206225,0.9769968975120737,1.0,16/87,17.02%,SAMD4A;ROCK2;IGF2BP2;DAPK1;NANOS3;FTO;CPEB3;DDX6;RIDA;FXR2;METTL16;CPEB1;PUS7;RBM24;METTL3;TOB1
prerank,positive regulation of mRNA processing (GO:0050685),0.2676325011142099,0.7437695983089269,0.8047210300429185,0.9762358163223961,1.0,3/21,7.83%,DAZAP1;TRA2A;CELF4
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.30946769176819056,0.7436750130437814,0.7927350427350427,0.9756043565484644,1.0,1/10,1.35%,LRP1
prerank,regulation of G0 to G1 transition (GO:0070316),0.23352979417626568,0.7436561800219272,0.865546218487395,0.9748710908744634,1.0,8/38,14.01%,UXT;TFDP1;L3MBTL2;RNF2;APAF1;PCGF6;EHMT2;EZH2
prerank,glycogen catabolic process (GO:0005980),0.2920731090698423,0.7434144798972689,0.7937219730941704,0.974426177729508,1.0,3/15,12.11%,PHKA1;STBD1;PYGM
prerank,regulation of secretion by cell (GO:1903530),0.21473726674509094,0.7433090575904934,0.8757637474541752,0.9738119934816962,1.0,15/54,20.42%,RIMS1;RAB3C;CHRNB4;SYT1;CPLX2;RAB10;MCTP2;LLGL1;HCRT;SCG5;VAMP3;HTR1A;RIMS2;STXBP5;RAB12
prerank,protein processing (GO:0016485),-0.18916180979816535,-0.7428299252245533,0.9603174603174603,0.9474079219322469,1.0,22/102,22.07%,SRGN;F3;ADAM10;BACE1;SPCS1;ADAM19;CPE;PSENEN;FAM111A;MMP14;SEC11A;SPRTN;FXN;APH1A;VSIR;PHEX;RCE1;TMEM208;PRSS12;GGT1;SEC11C;CASP1
prerank,pseudouridine synthesis (GO:0001522),0.30593918921832564,0.7421222128405833,0.778969957081545,0.9746168786838033,1.0,5/13,22.76%,RPUSD2;PUS7;NHP2;PUS1;PUS10
prerank,regulation of hippo signaling (GO:0035330),-0.2688808240525802,-0.7411528314733467,0.8089668615984406,0.9489997680820621,1.0,6/17,25.31%,MOB3B;WTIP;LIMD1;CIT;WWC2;MARK3
prerank,antibacterial humoral response (GO:0019731),0.2809563961058289,0.7409210831488524,0.7914893617021277,0.9755066641688331,1.0,5/16,22.82%,JCHAIN;ANG;PLA2G6;RNASE3;SLPI
prerank,tetrapyrrole metabolic process (GO:0033013),-0.27336952637066003,-0.740813764938927,0.8053435114503816,0.9489466912323296,1.0,4/18,17.42%,MTR;CUBN;MMADHC;CD320
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.30199393034343586,-0.7397602392291606,0.8060836501901141,0.949794806238767,1.0,6/11,36.80%,REST;STK26;PARK7;P4HB;FYN;MMP3
prerank,negative regulation of phagocytosis (GO:0050765),0.2785740497091566,0.7394818939806164,0.8053097345132744,0.9767152868712601,1.0,4/17,16.24%,PRTN3;CD300LF;CD47;SYT11
prerank,response to UV-B (GO:0010224),0.30101570514900466,0.7378869400399012,0.7797752808988764,0.9780608348153516,1.0,1/12,1.37%,HYAL3
prerank,regulation of mitochondrion organization (GO:0010821),0.22041946336945464,0.736653316044977,0.8747433264887063,0.9789113506994126,1.0,8/47,14.84%,PID1;OMA1;IAPP;PRKN;PARL;MAPT;EP300;STOX1
prerank,dendrite self-avoidance (GO:0070593),-0.2828420559202928,-0.7358096903693255,0.8273381294964028,0.9541793556059033,1.0,2/16,4.84%,BSG;ROBO4
prerank,base conversion or substitution editing (GO:0016553),0.30611807222371035,0.7348524202520276,0.7668161434977578,0.9805634662657499,1.0,1/11,3.49%,ADARB2
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.289377230935911,-0.7341928888320138,0.8446428571428571,0.9556253803915296,1.0,6/14,28.45%,CHKA;CEPT1;PCYT2;SELENOI;SLC27A1;LPIN2
prerank,protein acetylation (GO:0006473),-0.23313806912403573,-0.7341122663736617,0.8759398496240601,0.9552558032196675,1.0,11/30,36.16%,FOXO1;ING5;NAA60;CLOCK;DSCC1;NAA80;NAT9;NAA50;ESCO2;CREBBP;BLOC1S1
prerank,plasma membrane invagination (GO:0099024),-0.23908011757089975,-0.7339613209967015,0.8555133079847909,0.9549559419123255,1.0,3/29,5.58%,DOCK1;VAMP7;ARHGAP25
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.3156254285740875,-0.7339354177681576,0.8356164383561644,0.9545188481263159,1.0,5/10,30.33%,SMYD2;SETD2;KMT5A;METTL18;EEF1AKMT2
prerank,histone H3 deacetylation (GO:0070932),-0.27957981890299516,-0.7338450804942772,0.8274582560296846,0.9541592908665602,1.0,3/15,10.19%,HDAC9;HDAC4;SFPQ
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.2638717251319601,-0.7337086796115864,0.851145038167939,0.9538481148499958,1.0,9/18,35.50%,BCL2L1;BAK1;BAD;SLC25A4;ALKBH7;MUL1;PMAIP1;HEBP2;SLC25A31
prerank,rRNA transcription (GO:0009303),0.27706106373399747,0.7325779096520799,0.8064516129032258,0.9827558987874111,1.0,6/17,14.39%,POLR1G;GTF3C3;ANG;GTF3C2;GTF3C6;GTF3C4
prerank,protein homotetramerization (GO:0051289),-0.21259715557404787,-0.7325460297228528,0.9050505050505051,0.9547804149658204,1.0,17/49,31.33%,B2M;KCNJ2;GBP5;GLS;SAMHD1;ALDH1A3;CTH;HSD17B10;AQP4;UPB1;ACOT13;PKD2;CBY1;OSBPL2;GNMT;ALDOA;TRPM4
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.29878893833530384,0.7320579578049412,0.785024154589372,0.982689320898596,1.0,4/12,16.09%,PCGF5;SMCHD1;LRIF1;METTL3
prerank,regulation of lipid storage (GO:0010883),-0.25373330685381124,-0.7315564367308899,0.8490566037735849,0.9554646331908271,1.0,12/22,44.47%,NFKBIA;ITGB3;HILPDA;ALKBH7;C3;PTPN2;MEST;IKBKE;ITGAV;PLIN5;IL6;TNF
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.20364674190558268,-0.7315159631272993,0.9155722326454033,0.9550367202286362,1.0,16/61,23.96%,RPS3;BRCC3;USP7;RGCC;UIMC1;BABAM1;DHX9;TRIM28;USP9X;FGF2;EGFR;BABAM2;FGF10;TOX;STPG4;PRKD2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.19714943257251175,0.7308100793989762,0.931237721021611,0.9835556778926084,1.0,22/80,18.62%,RAB9B;VPS26B;UBE2O;GBF1;RAB29;TRIM27;RHOBTB3;BAIAP3;TBC1D10C;VPS50;PHETA1;DENND5A;TBC1D10A;SNX8;TMED9;ARL1;SNX6;VAMP3;GOSR2;SNX32;DENND2A;EVI5
prerank,regulation of defense response to virus (GO:0050688),-0.2852694140076312,-0.7306730723483605,0.8025830258302583,0.9555562690002359,1.0,4/14,26.71%,DHX9;ITCH;TNFAIP3;IFNLR1
prerank,protein import (GO:0017038),-0.18978285463376604,-0.7303942157154908,0.9411764705882353,0.9554295844396105,1.0,24/84,27.09%,RAB8B;NUP93;AKT1;PTTG1IP;E2F3;SYK;TOMM22;NUP188;HSPA4;PHB2;APOE;NUP155;TNPO3;RPAIN;HSP90AA1;TSC2;FIS1;NXT2;TNPO2;FAM53A;IPO13;SEC13;NUP107;PEX14
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.16312764039985525,0.730310316791586,0.9981785063752276,0.9834185291613265,1.0,68/341,18.69%,HECW2;TBL1XR1;SPSB1;TBX21;MDM2;ZNRF3;UBQLN4;TRIP12;RNF43;TTC3;RNF149;PRKN;HECW1;UBXN2B;COPS3;UBXN2A;SMURF2;KLHL42;ASB2;SIRT2;VPS37D;ANAPC1;KLHL25;KCTD21;PSMA3;CDC23;PSMF1;PSMA7;CDC16;AGAP3;ATXN3;UBAP1;TOPORS;SPOP;UBR3;MIB1;SIAH2;FBXO7;TOM1L1;UFD1;RNF217;GID4;BTRC;RNF146;PSME3;RNF122;ARIH2;VPS37A;BIRC2;UBA6;RNF34;KLHL22;DDIT3;KAT5;UBE3C;PSMD1;NEDD4;PSMB9;NFE2L2;SKP2;SPSB2;IFI27;FBXW11;FBXO21;ANAPC5;RNF13;PSMD13;SHARPIN
prerank,peptidyl-lysine acetylation (GO:0018394),0.3116369570675369,0.7302087820700656,0.8369565217391305,0.9827805756919402,1.0,10/10,68.86%,EP300;KAT5;KAT2B;SIRT1;ESCO1;KAT7;BAG6;BLOC1S1;CREBBP;KAT2A
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.24702862398628567,-0.7297937115954826,0.8443579766536965,0.9556945040495829,1.0,7/24,19.80%,PDE4D;PDE2A;PRKAR2B;PRKAR2A;CGAS;RAPGEF2;UBE2B
prerank,atrial septum development (GO:0003283),-0.2923085288772581,-0.7289022887315365,0.8104347826086956,0.9562614012422305,1.0,2/13,4.28%,BMPR2;TGFB2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.19631259975064266,0.7288004894395216,0.9596774193548387,0.9838300768004768,1.0,16/73,16.04%,KDM1B;POLR1A;GLMN;BAZ1B;POLR1G;TRIM27;PPM1D;IGF2;DNMT1;CTCF;POLR1B;EZH2;EP300;MYBBP1A;MYO1C;MTF2
prerank,carboxylic acid catabolic process (GO:0046395),-0.2963323461168026,-0.7287074550460859,0.8086303939962477,0.9560160602898247,1.0,6/12,29.47%,PON3;ACOT8;AMDHD2;RENBP;BCKDK;GNPDA1
prerank,protein lipidation (GO:0006497),0.212957363706096,0.7286312455328253,0.9302325581395349,0.9832633305080614,1.0,20/59,23.57%,WDR45B;WIPI1;ATG12;PIGU;GLUL;PIGH;PIGP;ATG10;ZDHHC2;PORCN;PGAP3;PIGN;DPM1;ZDHHC15;ZDHHC6;MPPE1;WDR45;ATG5;PIGB;UGCG
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.28475998789918744,-0.7285415961154992,0.8315217391304348,0.9557437102659257,1.0,1/14,2.55%,ME1
prerank,regulation of response to interferon-gamma (GO:0060330),-0.27943345311945267,-0.7282912898075606,0.8390596745027125,0.955571666908766,1.0,4/14,18.13%,HSP90AB1;JAK2;IFNGR1;STAT1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.3061278408220036,0.7280929757496414,0.7866379310344828,0.9831636903511565,1.0,4/11,18.59%,RPS6KA6;KAT5;SP100;TP53
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.2593550410763778,0.7276863290684886,0.8463203463203464,0.9829194677207788,1.0,1/22,0.56%,BMP2
prerank,mitochondrial genome maintenance (GO:0000002),0.2920405070179146,0.7272556446189669,0.7849462365591398,0.9827195258974644,1.0,4/11,17.35%,AKT3;TOP3A;SLC25A36;PARP1
prerank,positive regulation of cytokinesis (GO:0032467),-0.231355350916841,-0.7265580750977921,0.8712121212121212,0.9571869081710367,1.0,6/32,13.93%,PKP4;CDC14A;GIPC1;KIF23;PRKCE;CDC14B
prerank,positive regulation of double-strand break repair (GO:2000781),0.22284168443144875,0.7265153775682069,0.8673913043478261,0.982878594724901,1.0,9/39,17.35%,SHLD2;SETMAR;KMT5C;FMN2;SMCHD1;PARP3;RIF1;KMT5B;PARP1
prerank,dorsal/ventral pattern formation (GO:0009953),0.2613997290840836,0.7262631076782071,0.8243512974051896,0.9824804399427141,1.0,3/20,9.33%,GLI2;SFRP1;BMPR1A
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.31056952433673796,-0.7254710976828133,0.7965116279069767,0.9579776984409859,1.0,2/10,11.36%,ATF4;HSPA5
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.23177443463541447,-0.7252174090478357,0.870722433460076,0.9578064885500026,1.0,10/32,28.82%,RPL10;FOXO3;APP;RBM4B;PCIF1;PGAM1;PRKCD;EIF4E;METTL18;RBM3
prerank,covalent chromatin modification (GO:0016569),0.2882608138742264,0.7251380911807899,0.8115631691648822,0.9831174107666985,1.0,4/14,15.91%,MBD2;AURKC;SETD5;HDAC1
prerank,neurotransmitter biosynthetic process (GO:0042136),0.2900719113827259,0.7251185784778597,0.8008752735229759,0.9823779017459506,1.0,4/14,23.48%,MOXD1;ACHE;SLC22A2;DAGLA
prerank,fatty acid metabolic process (GO:0006631),0.18306816177157648,0.7250908255982442,0.9486652977412731,0.9816620403158696,1.0,18/115,14.26%,PPARA;ALOX12;ACSM5;ACADSB;ACSL1;BAAT;CPT1C;ABCD2;MSMO1;CPT2;ACOT11;LPIN3;HPGD;NDUFAB1;GNPAT;ACSL6;ACACA;MCAT
prerank,early endosome to Golgi transport (GO:0034498),-0.3102879324441915,-0.7250903281964884,0.8134328358208955,0.9574923273704488,1.0,6/11,37.29%,SURF4;EHD3;STX5;SNX2;RAB6A;SNX1
prerank,mitochondrial transport (GO:0006839),0.20879699851971337,0.7244673414769832,0.891170431211499,0.9816542161352402,1.0,10/53,15.29%,AIP;BCL2;SLC25A13;MTX2;FBXO7;TOMM70;COX18;TIMM22;SLC25A24;MAIP1
prerank,autophagy of peroxisome (GO:0030242),-0.29945970384078313,-0.7240264709827274,0.8092691622103387,0.9582169522826888,1.0,1/12,3.72%,MAP1LC3B
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.2224426912648668,0.7225980635330126,0.8952991452991453,0.9832762500432861,1.0,9/40,15.84%,PID1;BCL2;PPA2;NDUFS1;RNF122;MAPT;STOX1;SPART;SLC25A36
prerank,kinetochore organization (GO:0051383),-0.28966185984130566,-0.7221496003552312,0.8379888268156425,0.9598247948544563,1.0,6/13,33.85%,POGZ;NDC80;CENPF;CENPA;NUF2;CENPW
prerank,intracellular protein transmembrane transport (GO:0065002),-0.21396978034515685,-0.7220888224810487,0.8952569169960475,0.9594264731030651,1.0,14/42,31.19%,HSPD1;SEC63;HSPA5;TIMM17A;TIMM21;CHCHD4;SEC61B;ZFAND2B;TIMM50;PEX14;RTN2;SEC61A1;ROMO1;PEX6
prerank,neuron maturation (GO:0042551),-0.2620689728562343,-0.7212834732192599,0.8320610687022901,0.9598556823304365,1.0,3/18,7.55%,SCARF1;APP;ANKS1A
prerank,positive regulation of vacuole organization (GO:0044090),0.3096839626704385,0.721234061686837,0.8113207547169812,0.9842496195062989,1.0,4/10,18.45%,PIP4K2A;PIP4K2B;LRSAM1;RAB3GAP1
prerank,negative regulation of transferase activity (GO:0051348),-0.2381274234772639,-0.7207045233878481,0.872865275142315,0.960039884075128,1.0,14/28,37.29%,SMAD7;CDKN1B;BAG5;LIMK1;ERCC4;EIF4A2;CDKN1C;DTX3L;PARK7;SRC;PIF1;ABL1;CERS1;INPP5K
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.2471109842189635,-0.7203582933961913,0.8639705882352942,0.9599495648959512,1.0,9/22,27.04%,GLRX5;ISCA2;FXN;HSPA9;CIAO3;NFU1;ISCA1;CIAPIN1;IBA57
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.2950046726618676,-0.7202205745336256,0.8188976377952756,0.9596287966069542,1.0,2/12,7.70%,KLF2;TRIM16
prerank,cellular response to interleukin-7 (GO:0098761),0.27368459784343163,0.719730258032329,0.8365384615384616,0.9845491261645181,1.0,5/17,16.15%,STAT5B;IRS2;BRWD1;TSLP;CRLF2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.27368459784343163,0.719730258032329,0.8365384615384616,0.9845491261645181,1.0,5/17,16.15%,STAT5B;IRS2;BRWD1;TSLP;CRLF2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.2955889792622064,0.7194133001392023,0.8105515587529976,0.9841447523898077,1.0,3/12,11.25%,ROCK2;TMED10;CHRNA7
prerank,snRNA transcription (GO:0009301),-0.19791712680859205,-0.7192319745987724,0.9465346534653465,0.9602687183839681,1.0,24/70,32.12%,RPRD1B;GTF2E1;ZC3H8;INTS8;INTS1;POU2F1;POU2F2;CCNK;SP1;GTF2F1;USPL1;TAF9;NCBP2;ELL;RPRD1A;INTS12;INTS2;POLR2F;TAF5;GTF2F2;INTS3;POLR2C;POLR2L;POLR2I
prerank,mRNA methylation (GO:0080009),0.2837210402218867,0.7189602867171715,0.8343815513626834,0.9839137220066765,1.0,4/15,16.80%,VIRMA;METTL16;METTL3;METTL8
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.25712882942636606,-0.7186870533650739,0.8647058823529412,0.9604181229094911,1.0,5/20,11.39%,TGFB1;ABI3;AP2M1;PPP2R5A;BCL2L1
prerank,regulation of gluconeogenesis (GO:0006111),-0.2402153343532075,-0.7186353100081722,0.8764478764478765,0.9600136813350703,1.0,12/27,42.54%,PPARGC1A;USP7;ARPP19;NNMT;SIK1;PTPN2;GNMT;SIRT7;DDB1;C1QTNF3;CLK2;ERFE
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.3139034267238224,-0.7183736355880704,0.8315217391304348,0.9598397214619365,1.0,6/10,52.54%,USP7;GNMT;SIRT7;DGKQ;PDK2;FBP1
prerank,DNA biosynthetic process (GO:0071897),-0.2727166176701836,-0.7182721839620837,0.8327205882352942,0.9594861350395385,1.0,9/16,41.32%,PPIA;TYMS;RFC3;POLL;POLE;TERT;POLA1;POLH;WRN
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.2736313866701633,0.717663378900904,0.8147321428571429,0.9847754952077532,1.0,6/17,21.52%,CTNNA2;GMFB;BRK1;FCHSD2;WASF1;ABI2
prerank,response to X-ray (GO:0010165),-0.281701731754094,-0.7175051640415379,0.8097014925373134,0.9598379371950146,1.0,5/14,26.11%,ANXA1;BRCC3;IKBIP;NIPBL;LIG4
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.21525286729500692,-0.7173254254398799,0.9096267190569745,0.9595866236747089,1.0,7/41,13.81%,KCNJ2;KCNQ1;KCNJ10;ACE2;AKAP6;KCNJ15;GNB1
prerank,tRNA 5'-end processing (GO:0099116),-0.273654464431404,-0.7172864592496176,0.8315217391304348,0.9591648282654669,1.0,5/15,25.09%,RPP38;TRMT10C;HSD17B10;RPP21;RPP25L
prerank,negative regulation of ATPase activity (GO:0032780),0.272292812870083,0.7171874801506525,0.8004338394793926,0.9845979907114513,1.0,6/16,24.28%,TNNI3;VCPKMT;TP53;PAM16;PXK;SIRT1
prerank,stress granule assembly (GO:0034063),-0.2528811592707245,-0.7169029548454159,0.8661844484629295,0.9591111424184009,1.0,6/20,20.82%,RPS23;ATXN2L;CIRBP;YTHDF2;LSM14A;YTHDF1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.2680433014752463,-0.7168629605384826,0.8628884826325411,0.9586965822629835,1.0,5/17,20.15%,CAMLG;EMC10;SGTA;EMC6;EMC9
prerank,regulation of phosphatase activity (GO:0010921),0.25170878740157887,0.7167860055453696,0.8446389496717724,0.984289913987722,1.0,1/24,0.56%,BMP2
prerank,regulation of autophagosome assembly (GO:2000785),0.23229037941126796,0.7167356968650918,0.8609406952965235,0.9836028324601653,1.0,8/33,19.18%,PIP4K2A;PHF23;SCFD1;PIP4K2B;LRSAM1;IFT88;RAB3GAP1;NUPR1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.23728656577812682,0.7163773892306936,0.8741573033707866,0.9832787762016572,1.0,8/29,15.76%,SHISA9;GRIK2;CAMK2B;SYP;DLG4;ZDHHC2;DRD2;CLN3
prerank,regulation of microglial cell activation (GO:1903978),0.270735229484523,0.716120134492361,0.8201284796573876,0.9828367681148983,1.0,15/15,72.95%,STAP1;SYT11;TTBK1;SPHK1;MMP8;PTPRC;NR1D1;CCL3;CX3CL1;IL6;TAFA3;CST7;GRN;LDLR;TREM2
prerank,purine-containing compound biosynthetic process (GO:0072522),0.24681241765301593,0.7156676225167767,0.8675213675213675,0.9826321422683296,1.0,5/25,16.06%,AMPD3;PRPSAP2;GMPR;MTHFD1;ADSL
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.22921528772775285,-0.7156376940210091,0.8895582329317269,0.9595423046627933,1.0,12/30,30.32%,ELOVL7;ELOVL5;TECRL;ELOVL1;ACOT2;HACD4;SLC27A2;ACOX1;HACD2;ABCD3;SLC27A6;ACOT1
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.18196689693065124,-0.7154547717310286,0.9617834394904459,0.959290635917488,1.0,33/101,33.30%,MEF2C;LBP;VIM;DAB2IP;TGFB1;TNFRSF1B;PLAA;PRKCE;TLR4;NOD2;CX3CR1;HCK;RELA;XBP1;TNFAIP3;CASP1;PTPN22;CD68;BCL10;TRAF6;CARD16;CCL2;SHPK;PDCD4;CD86;LILRB1;UPF1;HMGB2;IRGM;NLRP3;RHOA;CD14;TNIP2
prerank,sensory perception of taste (GO:0050909),0.30284961084609585,0.7145980639591171,0.8048245614035088,0.9831297877408305,1.0,10/10,69.73%,ASIC2;TAS1R1;PKD1L3;PKD2L1;TAS1R3;GNAT3;ASIC1;TAS1R2;ASIC3;CD36
prerank,regulation of actin filament-based movement (GO:1903115),0.3099428357320504,0.714147777146829,0.7850678733031674,0.9829214380443404,1.0,2/10,11.12%,ANK2;PDE4B
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.2715217958742894,-0.7135208687850103,0.8620037807183365,0.9608791520649153,1.0,7/15,29.47%,OGA;AMDHD2;RENBP;LARGE1;CHST5;CHST3;GNPDA1
prerank,fatty acid biosynthetic process (GO:0006633),-0.19545159928047626,-0.7133371838320814,0.9630390143737166,0.9606034712033323,1.0,11/63,19.90%,ABHD2;ELOVL7;LTA4H;ACLY;ASAH2;ELOVL5;TECRL;GPX4;XBP1;ELOVL1;HACD4
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.24332828378245575,-0.713001454709444,0.8899253731343284,0.960492167883336,1.0,7/25,24.02%,LIMK2;SLIT2;ABI3;CDK10;RAP1GAP;PRKCD;TBC1D30
prerank,regulation of regulated secretory pathway (GO:1903305),0.22475998335545772,0.7118280052800761,0.9092783505154639,0.9848325965388928,1.0,11/34,23.33%,RIMS1;SYT1;SYT13;SNAPIN;SYT11;SYT12;SYT6;RIMS2;UNC13D;SYT3;RIMS3
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.29786115118297163,-0.7115027873479873,0.8547169811320755,0.9616499113615627,1.0,1/11,1.62%,PLCG2
prerank,central nervous system myelination (GO:0022010),0.296454892468042,0.7100616075820263,0.8072562358276644,0.9861178886507533,1.0,4/11,20.27%,HES5;PTEN;TENM4;B4GALT6
prerank,tRNA wobble uridine modification (GO:0002098),-0.2779907302971443,-0.7095890390689923,0.8390596745027125,0.963161878247447,1.0,3/14,14.02%,TRMT9B;DPH3;URM1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.2917381345724303,0.7094580572555643,0.8133333333333334,0.9860789036185175,1.0,6/11,28.50%,ZC3H3;PAPOLA;PAF1;ZFP36L1;LEO1;AHCYL1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.26123683144323956,0.7094489058435077,0.8473118279569892,0.9853457416161185,1.0,4/18,12.06%,CHRM2;CHRM3;CDK5R1;GNA15
prerank,negative regulation of TOR signaling (GO:0032007),0.22516898861123769,0.7078896533517912,0.8795918367346939,0.9863865757365186,1.0,5/36,12.29%,DEPTOR;FNIP1;MAPKAPK5;ITFG2;ATM
prerank,regulation of cell projection organization (GO:0031344),-0.28452262831441555,-0.7078784904024141,0.8702290076335878,0.9644772803906555,1.0,10/13,57.18%,MFSD2A;TREM2;ERMN;NTNG1;SEMA4D;MOV10;NTNG2;FAM110C;MACF1;CCL19
prerank,mRNA stabilization (GO:0048255),0.2190087642282941,0.7071405218160333,0.8934426229508197,0.9865106531319616,1.0,3/40,5.10%,TENT5A;GDNF;AXIN2
prerank,fatty acid transmembrane transport (GO:1902001),0.2584949734226576,0.7071351016541868,0.8354430379746836,0.9857712423770442,1.0,3/19,6.64%,PRKAG2;ABCD2;CPT2
prerank,regulation of nervous system process (GO:0031644),-0.2601344206587169,-0.7067946436672139,0.8861209964412812,0.9651433474654195,1.0,2/18,4.11%,NOS3;APP
prerank,autophagy of mitochondrion (GO:0000422),0.22478576700580064,0.7060725965034609,0.8857758620689655,0.9862378778932265,1.0,9/38,16.33%,WDR45B;WIPI1;PRKN;ATG12;FBXO7;FUNDC1;ULK2;FUNDC2;ATG9A
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.20611873322621715,-0.7054161644575393,0.9343629343629344,0.9660409456558308,1.0,8/49,11.36%,JAM3;PRKCZ;SMAD6;SVIP;AIDA;RPL13A;IMPACT;HSPA5
prerank,synaptic vesicle membrane organization (GO:0048499),-0.2639841452711995,-0.7053050421331781,0.875,0.9656898361581444,1.0,3/17,11.03%,STX3;STX1A;STX2
prerank,protein kinase A signaling (GO:0010737),-0.29366724399603816,-0.7052994815052518,0.8389513108614233,0.9652323885256491,1.0,2/12,6.15%,MYOM1;EZR
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.23710770991781177,-0.7052777992933195,0.8961038961038961,0.9647923273916017,1.0,15/28,48.42%,CYRIB;PRKDC;HSPD1;NOD2;FGF10;CCL2;TYROBP;TNIP2;IL12A;CCDC88B;IL23A;IL6;TNFSF11;IL12B;CCR2
prerank,nuclear envelope organization (GO:0006998),-0.24435530203935601,-0.7050537822472034,0.8616236162361623,0.9645603635044396,1.0,5/20,18.22%,NUP93;TOR1AIP1;TMEM43;NUP155;REEP4
prerank,RNA 3'-end processing (GO:0031123),-0.19164043000039052,-0.7033740839142401,0.9454191033138402,0.9658089852422039,1.0,19/69,25.64%,RPRD1B;SRSF5;SRSF2;SRSF6;U2AF1;ZC3H11A;RNPS1;SRSF4;MAGOH;CHTOP;ALYREF;DDX39B;CASC3;CPSF4;THOC6;DDX39A;NCBP2;CSTF2T;RPRD1A
prerank,histone H3-K9 demethylation (GO:0033169),-0.2922716440004541,-0.7029933498956512,0.85431654676259,0.9657023381219109,1.0,2/11,6.70%,JMJD1C;KDM3A
prerank,interstrand cross-link repair (GO:0036297),-0.19850898304119138,-0.7026314321141797,0.9258517034068137,0.9656028871419687,1.0,26/53,37.64%,UBB;USP1;UBC;RPS27A;ERCC1;VCP;SLX4;DCLRE1C;RPA3;WDR48;ERCC4;FAN1;RAD51AP1;FANCD2;ATRIP;FAAP24;RNF8;UBE2T;NEIL3;CENPX;FANCF;MSH6;UBA52;RAD51;FANCB;EME1
prerank,regulation of mast cell degranulation (GO:0043304),-0.2729007833655197,-0.7020013793709702,0.8482142857142857,0.965762633963683,1.0,6/14,23.70%,SYK;SPHK2;CD84;GAB2;LGALS9;STXBP2
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.2515155418063326,-0.7016105046788377,0.8660550458715597,0.9656910551629728,1.0,9/20,29.23%,AGRN;GNB1;GNA11;RGS10;CHRM1;LY6H;LY6G6D;PLCB1;CHRNB2
prerank,integrated stress response signaling (GO:0140467),-0.2689252772585919,-0.7016043556138444,0.8590225563909775,0.9652397059905468,1.0,3/14,11.36%,ATF4;IMPACT;HSPA5
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.2508469731783458,-0.70127948610329,0.8663101604278075,0.9651379402539989,1.0,3/20,8.39%,PAICS;ADSS2;IMPDH1
prerank,lymphocyte chemotaxis (GO:0048247),0.231103765049582,0.7011397587728538,0.8831967213114754,0.9909664747444185,1.0,3/34,10.09%,CYP7B1;CXCL16;CCL25
prerank,oligodendrocyte differentiation (GO:0048709),-0.2485120694756042,-0.7010873009142312,0.8695652173913043,0.9648816489737383,1.0,7/19,25.70%,SOX13;SOX6;EIF2B3;SOX9;SOX8;NSUN5;MYRF
prerank,regulation of lipid catabolic process (GO:0050994),0.2544118570621114,0.7009265666311466,0.8565488565488566,0.9904656222818524,1.0,19/19,74.59%,PDE3B;ALK;RARRES2;ANGPTL3;APOC3;SCT;LONP2;APOA2;IL1B;PRKAA1;HCAR2;ABCB11;TNF;ABCD1;CIDEA;ADRA2A;TYSND1;BSCL2;APOC1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.2748512058611356,0.7007256757743467,0.8318181818181818,0.9899497719113042,1.0,2/14,8.37%,GSTP1;NLRP2B
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.2703189051757997,-0.6996020960994419,0.8605072463768116,0.96589899603103,1.0,10/14,52.25%,PAEP;CD84;RASGRP1;ISL1;CARD9;IL23A;IL12B;IL23R;IL17F;IL1B
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.2982038221030916,-0.6986788737461784,0.8390151515151515,0.9663317433651061,1.0,5/11,36.84%,NR4A2;LMX1A;CTNNB1;WNT2;LRP6
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.24219815636527228,-0.6975083954712674,0.8660194174757282,0.9670386335985148,1.0,10/23,33.18%,ZW10;PLK2;PABIR1;CHEK1;CDK5RAP3;PLK3;PLK5;VPS4A;INTS3;BUB1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.1962511617972551,0.6969811228834213,0.9503239740820735,0.9932652697037968,1.0,12/68,14.42%,POLR1A;GTF2H2;MNAT1;FIP1L1;POLR1G;SYMPK;POLR1B;PABPN1;CCNH;SCAF8;TTF1;CPSF7
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.2752737930736218,0.6968373760682011,0.8311965811965812,0.9926876925473034,1.0,2/13,10.28%,CBLB;NUP35
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.21137140110231806,0.6965853058042896,0.9106029106029107,0.992212198818628,1.0,5/41,9.95%,SLC8A1;ITPR1;CACNA2D1;IBTK;SLC24A2
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.27946154848301386,-0.6965455686651814,0.8633093525179856,0.9675497688141054,1.0,5/12,37.82%,STMN2;CDH5;STMN1;MAP2;DYRK1A
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.22269440193764573,-0.6964019429207997,0.8984674329501916,0.967228849802138,1.0,6/30,14.72%,ST6GAL1;MGAT1;FUT8;DAD1;OST4;MCFD2
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.2532184815274042,-0.6962453402948353,0.8560460652591171,0.9669180068476363,1.0,8/18,30.82%,KDR;MIEF1;MIEF2;FIS1;MCU;MFF;MUL1;AURKA
prerank,GPI anchor metabolic process (GO:0006505),0.2358960877406365,0.6957761666241303,0.8895582329317269,0.9923090774024667,1.0,9/26,22.84%,PIGU;PIGH;PIGP;PGAP3;PIGN;DPM1;MPPE1;PGAP1;PIGB
prerank,water-soluble vitamin metabolic process (GO:0006767),0.19361646248678469,0.6957020063495079,0.9514563106796117,0.9916437528062885,1.0,9/68,12.43%,ENPP1;MMAB;PCCA;PDZD11;PDXK;ALDH1L1;FPGS;SLC46A1;MTHFD1
prerank,cytoplasmic microtubule organization (GO:0031122),-0.1982050377625921,-0.6956289944076237,0.9422310756972112,0.9670529661049299,1.0,16/54,24.08%,RAB11A;LIMK2;CHP1;EZR;SLAIN2;DCTN1;TRPV4;CIB1;PCM1;KATNAL2;CAMSAP3;PLK3;CCDC13;CLIP1;CCDC88A;CLIP2
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.25065795861055873,0.6945551280596871,0.8752642706131079,0.9920752387414273,1.0,2/19,8.31%,STN1;PINX1
prerank,regulation of nuclear division (GO:0051783),-0.2442826868210784,-0.6936439479103714,0.8809523809523809,0.9684759596418322,1.0,6/20,21.13%,CAV2;CDK13;L3MBTL1;PIN1;MKI67;RCC1
prerank,primary miRNA processing (GO:0031053),0.3000785032107859,0.6919199462703127,0.8064516129032258,0.9940160016858605,1.0,5/10,22.93%,SMAD3;METTL3;DROSHA;PUS10;MRPL44
prerank,microtubule bundle formation (GO:0001578),-0.20429191921904377,-0.6917306916831584,0.930635838150289,0.9698130356625561,1.0,10/42,26.08%,NAV1;RP1;CHP1;SPEF1;GAS8;GAS2L1;SPAG16;CLIP1;NCKAP5L;CAPN6
prerank,modulation by host of viral genome replication (GO:0044827),0.27619401956670675,0.6912270268404919,0.8852459016393442,0.993984098082413,1.0,4/13,17.86%,PRKN;YTHDC2;TBC1D20;IFI27
prerank,protein methylation (GO:0006479),-0.2076671439796129,-0.6910714360495488,0.9428571428571428,0.9699697358850148,1.0,13/40,30.36%,SNRPD3;PRMT8;EEF2KMT;FAM98A;ICMT;PRMT3;LCMT1;NTMT1;ATPSCKMT;SNRPB;EEF1AKMT3;EEF1AKMT2;RAB6A
prerank,NAD biosynthetic process (GO:0009435),-0.24200708724488285,-0.6906594712711803,0.8941398865784499,0.9698868940734143,1.0,9/20,30.33%,NAMPT;NAXE;QPRT;NNMT;NMNAT3;NAPRT;PARP10;NMNAT2;PARP9
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.2512884331523231,-0.6905069692565963,0.8911439114391144,0.9695875866277721,1.0,7/18,26.99%,CABYR;AQP4;ROPN1L;ADCY10;SPAG17;NEK10;SPA17
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.1892165667290972,-0.6903036921788044,0.9611111111111111,0.9693177813062084,1.0,18/62,32.12%,MLLT3;AFF4;GTF2H3;NELFE;CCNK;CDK13;GTF2H4;GTF2F1;TCEA1;ELOB;NCBP2;ELL;SETD2;POLR2F;GTF2F2;POLR2C;POLR2L;POLR2I
prerank,embryonic axis specification (GO:0000578),0.2716776170522058,0.6902500926037473,0.8624454148471615,0.9942269889146486,1.0,2/15,7.63%,TBX3;CXXC4
prerank,chromatin assembly (GO:0031497),-0.21181412408666894,-0.6901629581647869,0.9227799227799228,0.9689854920415555,1.0,13/38,29.34%,H3-3A;CDAN1;NAA60;LIN54;RBBP4;SOX9;EZH1;POLE3;NPM1;KAT6B;SMARCA5;ANP32B;HMGB2
prerank,negative regulation of endocytosis (GO:0045806),-0.23815116311653908,-0.6898590261429998,0.9016100178890877,0.9688108289453374,1.0,2/24,5.00%,CAV1;RAC1
prerank,iron-sulfur cluster assembly (GO:0016226),-0.23036090516476465,-0.6889427656137678,0.8797814207650273,0.9692047672883507,1.0,9/24,27.04%,GLRX5;ISCA2;FXN;HSPA9;CIAO3;NFU1;ISCA1;CIAPIN1;IBA57
prerank,glucan catabolic process (GO:0009251),0.27453819472727425,0.6885729537239013,0.8413793103448276,0.9951430498378214,1.0,3/15,12.11%,PHKA1;STBD1;PYGM
prerank,long-term synaptic potentiation (GO:0060291),-0.24462011214457174,-0.688567434361946,0.8816029143897997,0.969088494593926,1.0,3/21,8.20%,PTK2B;PRKCZ;PLK2
prerank,somite development (GO:0061053),0.28870622316609434,0.6881753704813717,0.8309859154929577,0.9947891712748371,1.0,4/11,17.21%,LOXL3;MTHFD1;PPP2R3A;SHH
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.3014032731429002,-0.6880469323159707,0.8583916083916084,0.9691234838924178,1.0,2/10,16.59%,TLR4;VSIR
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.2317010490085971,-0.6878789188743825,0.9176029962546817,0.96882282377082,1.0,11/27,27.37%,AKT1;DISC1;ULK4;HOMER1;NDEL1;MBOAT1;EFHC2;CCDC88A;BRSK2;TREM2;CAMK2G
prerank,regulation of embryonic development (GO:0045995),0.21449989112574913,0.6865986191914581,0.9254385964912281,0.9956203941424975,1.0,5/34,11.10%,PHLDB2;TRIP12;FOXA2;NPHP3;RPS6KA6
prerank,microtubule polymerization (GO:0046785),-0.22048695224581832,-0.686334811047875,0.9218181818181819,0.9697262144219615,1.0,9/28,29.96%,SLAIN2;TRPV4;NDE1;NDEL1;PIN1;TPX2;MAP7D3;TUBGCP6;TUBG2
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.2278882345091625,-0.6860383654286489,0.8960302457466919,0.9695349846422532,1.0,9/25,28.43%,TNFSF10;BAX;BBC3;BAD;BIK;PLAUR;HRK;MFF;PMAIP1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.27554445529058597,0.6850984401357195,0.8542141230068337,0.9963861073726898,1.0,2/13,10.84%,NFAT5;FUT9
prerank,nuclear pore complex assembly (GO:0051292),0.29884095507696784,0.6844481191086911,0.8380281690140845,0.9962777585141387,1.0,4/10,17.90%,RTN4;NUP205;AHCTF1;TMEM170A
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.26132862472894824,-0.684436403491668,0.8659217877094972,0.9705099316951347,1.0,8/15,37.09%,TSEN54;TRPT1;CPSF4;RTCB;ERN1;RTRAF;TSEN2;CPSF1
prerank,histone mRNA metabolic process (GO:0008334),-0.22386292174980602,-0.6840977658204188,0.883629191321499,0.9703648298252614,1.0,8/27,25.07%,ERI1;SNRPD3;LSM11;SNRPG;LSM1;LSM10;NCBP2;SNRPB
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.2865499065554367,-0.6840652358368595,0.8739054290718039,0.9699313301818663,1.0,4/10,26.83%,AIDA;DNAJA1;PTPN22;PDCD4
prerank,epithelial cell morphogenesis (GO:0003382),0.25677319713706376,0.6839053362654547,0.8405172413793104,0.9960954279776303,1.0,2/17,9.33%,COL22A1;CNMD
prerank,RNA catabolic process (GO:0006401),-0.2021032682580184,-0.6836138332463272,0.948,0.9698764915508723,1.0,19/46,34.73%,MTREX;PPP1R8;DIS3L2;YTHDF2;HSPA1A;RNH1;ZPR1;LSM2;RNASEH2C;HSPA1B;ERN1;DNA2;XRN2;ISG20;LSM6;SIDT2;ZC3H12D;RNASEH2A;DCP2
prerank,regulation of synapse maturation (GO:0090128),-0.2901984303922318,-0.6835055109718425,0.8537477148080439,0.9695151556519214,1.0,3/10,12.38%,ARHGEF15;DAB2IP;YWHAZ
prerank,regulation of DNA recombination (GO:0000018),0.22398057091530874,0.6826821858967258,0.8701030927835052,0.9965820273170181,1.0,6/32,15.10%,SHLD2;IL4;BLM;RPA2;THOC1;SIRT6
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.2720203364722448,-0.6823654111517675,0.8738229755178908,0.9700943380930299,1.0,6/13,27.56%,OGA;RENBP;PGM3;LARGE1;CHST5;CHST3
prerank,cellular lipid catabolic process (GO:0044242),-0.22489646199028152,-0.681601185520274,0.9120458891013384,0.9703269560550919,1.0,9/27,29.38%,PPARD;CYP1B1;ACADL;FAAH;ACOT8;ENPP2;ACOX1;LPIN2;MGST2
prerank,ether lipid metabolic process (GO:0046485),0.26844388850616224,0.6808307266142255,0.8445475638051044,0.9975705794542442,1.0,1/14,1.36%,AGMO
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.18790012614983986,-0.680720150762431,0.9664031620553359,0.9706538767424685,1.0,23/69,32.12%,RPRD1B;GTF2E1;ZC3H8;INTS8;INTS1;POU2F1;POU2F2;CCNK;SP1;GTF2F1;TAF9;NCBP2;ELL;RPRD1A;INTS12;INTS2;POLR2F;TAF5;GTF2F2;INTS3;POLR2C;POLR2L;POLR2I
prerank,protein import into peroxisome matrix (GO:0016558),0.2709353421217826,0.6800741124568178,0.856492027334852,0.9975748150755706,1.0,12/12,72.93%,PEX10;PEX5L;PEX2;PEX16;PEX5;PEX12;PEX1;PEX13;PEX26;PEX7;PEX6;PEX14
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.26680591027668754,-0.6798000530204925,0.8973451327433628,0.9710218247419733,1.0,3/14,15.68%,ACOX3;CROT;ACOT8
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.2721885236841973,0.6795134300776452,0.8674698795180723,0.9973889570559437,1.0,5/13,23.01%,FIP1L1;CPSF4L;CPSF7;CPSF6;NUDT21
prerank,regulation of T cell mediated immunity (GO:0002709),-0.29642921552142987,-0.678767824602707,0.8632162661737524,0.9714339617365784,1.0,6/10,52.25%,TNFRSF1B;TRPM4;ZBTB1;CCR2;RIPK3;IL1B
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.23302986910775242,0.678731211100353,0.8934426229508197,0.997390217429355,1.0,6/23,18.46%,ALOX12;GSTP1;HPGD;FADS1;ELOVL6;PTGS2
prerank,recombinational repair (GO:0000725),-0.17979438051923352,-0.6785967276454304,0.9817813765182186,0.9711265409542501,1.0,31/77,33.34%,ZFYVE26;YY1;SFPQ;PSMD14;SLX4;SAMHD1;REV3L;HUS1;XRCC1;RPA3;MMS22L;BRCA2;POLQ;AP5Z1;ERCC4;HELQ;SFR1;RHNO1;FAN1;POLL;NSMCE1;RAD51AP1;MRE11;RECQL;MEIOB;SWI5;EXD2;RMI1;RAD52;RAD50;AUNIP
prerank,negative regulation of catabolic process (GO:0009895),0.20536938518813225,0.6783410812364558,0.9368635437881874,0.9969851928502405,1.0,12/47,19.18%,PPARA;ACTN3;SIRT2;PDE3B;ALK;FMN2;PRKCG;SF3B3;CYP51A1;IRAK3;AZIN2;NUPR1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.24123670199819705,0.6782767533892955,0.8924731182795699,0.9963111465852983,1.0,6/22,15.81%,VPS25;VPS37D;UBAP1;TOM1L1;VPS37A;NEDD4
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.28501334426163794,-0.6779750868908361,0.8985239852398524,0.9712032156634326,1.0,3/11,29.18%,H3-3A;RBBP4;ASF1B
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.20629564216499122,0.6778259750119383,0.9326086956521739,0.9960270570426929,1.0,15/42,26.78%,SHLD2;UBQLN4;RADX;RPA2;SMCHD1;RIF1;SIRT6;PARP1;FBH1;RTEL1;TIMELESS;WAS;PPP4C;ARID2;MMS19
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.21119340496261724,0.6774263975655348,0.9397089397089398,0.9956517900835711,1.0,2/37,2.63%,PHLDB2;EPHA3
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.2884659909608951,0.6772845806852216,0.8483516483516483,0.9950562927181495,1.0,4/11,26.24%,PARN;EXOSC3;EXOSC2;TENT4B
prerank,chromatin assembly or disassembly (GO:0006333),-0.2813570830391491,-0.6767666548696428,0.8752260397830018,0.9717298859021853,1.0,3/11,17.01%,MTA2;CDAN1;RBBP4
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.2836367902726441,-0.6759956842554279,0.9025270758122743,0.9719465197135895,1.0,5/11,32.82%,FAS;LGALS9;PLAUR;PARK7;HTRA2
prerank,intracellular sterol transport (GO:0032366),0.2747914416173167,0.6754921737306543,0.8464730290456431,0.9959874897383637,1.0,3/13,13.35%,ABCA1;OSBP;RELCH
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.25138709763718664,0.6754720684217286,0.8828633405639913,0.9952697345414591,1.0,4/17,16.74%,SULF1;FSTL3;PCSK6;TWSG1
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.28327623426953086,-0.6752978228374966,0.889087656529517,0.972107280676852,1.0,3/11,18.39%,TGFB2;SOX4;ZFPM2
prerank,peptidyl-asparagine modification (GO:0018196),-0.2123167657498089,-0.6745072480069554,0.9239543726235742,0.9723101600991146,1.0,14/31,36.48%,ST6GAL1;MGAT1;FUT8;DAD1;OST4;MCFD2;HIF1AN;RPN2;STT3B;MGAT5;OSTC;NUDT14;RPN1;UGGT1
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.2108556501069801,0.6737198052013261,0.9425531914893617,0.9961617589827099,1.0,6/36,12.98%,VAMP5;RAB10;BBS2;OPTN;AFDN;SYS1
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.2575253249861605,-0.6730744064623464,0.8907103825136612,0.9730299967000157,1.0,6/14,28.43%,PPARGC1A;AKT1;ARPP19;NNMT;PTPN2;PMAIP1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.2818847861650964,0.6728517685111353,0.8818181818181818,0.9962551755100844,1.0,4/12,15.19%,GOLGA2;PTEN;BTRC;SKP1
prerank,glycogen metabolic process (GO:0005977),0.22843606644503736,0.6726223753163704,0.904862579281184,0.9957267402585931,1.0,4/27,12.11%,PRKAG2;PHKA1;STBD1;PYGM
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.24049190501756504,-0.6716444219585712,0.8974358974358975,0.9737395403085878,1.0,4/21,11.68%,RAB11A;BRD4;CDK4;RCC2
prerank,negative regulation of centrosome duplication (GO:0010826),-0.28876407667512716,-0.6714068279465883,0.8800738007380073,0.9734866894057097,1.0,7/11,37.54%,CCNF;TMEM67;RBM14;NPM1;KAT2A;CDK5RAP2;BRCA1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.1943310229679648,-0.6710156118687715,0.9613821138211383,0.97335797303557,1.0,16/48,32.03%,ACTB;SERTAD2;ARID1A;WBP2;ZMIZ2;SPHK2;CDCA4;CHEK1;POLR1F;TAF1B;SMARCA5;POLR2F;POLR1C;POLR1H;KAT2A;POLR2L
prerank,positive regulation of cell development (GO:0010720),0.2144413296859829,0.6708675667091415,0.9153674832962138,0.9966103021172604,1.0,3/31,9.19%,NKX6-1;SERPINF1;PDE3A
prerank,zymogen activation (GO:0031638),-0.20058118428775246,-0.670408537807332,0.9254901960784314,0.9733873809467,1.0,10/39,19.95%,CASP8;PERP;MMP14;BAK1;PGK1;VSIR;BAD;PLAU;PRSS12;GGT1
prerank,nuclear pore organization (GO:0006999),0.263395555417419,0.6701264445457906,0.8418708240534521,0.9965413687167893,1.0,5/14,17.90%,RTN4;NUP205;NUP35;AHCTF1;TMEM170A
prerank,7-methylguanosine RNA capping (GO:0009452),0.21953123779371309,0.6695103394099096,0.9349240780911063,0.9956131254493048,1.0,13/31,27.47%,GTF2H2;MNAT1;POLR2G;CCNH;POLR2K;POLR2D;POLR2B;ERCC2;RNMT;RAMAC;RNGTT;ERCC3;GTF2H1
prerank,7-methylguanosine mRNA capping (GO:0006370),0.21953123779371309,0.6695103394099096,0.9349240780911063,0.9956131254493048,1.0,13/31,27.47%,GTF2H2;MNAT1;POLR2G;CCNH;POLR2K;POLR2D;POLR2B;ERCC2;RNMT;RAMAC;RNGTT;ERCC3;GTF2H1
prerank,phosphate ion transmembrane transport (GO:0035435),0.27165117138675754,0.6693930472514033,0.8680089485458613,0.9949919439620244,1.0,2/12,7.18%,SLC20A2;SLC25A10
prerank,cellular polysaccharide catabolic process (GO:0044247),0.2568223762911236,0.6692175466303304,0.8612334801762115,0.9944097077102676,1.0,3/16,12.11%,PHKA1;STBD1;PYGM
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.2348669445655776,-0.6690187374565751,0.9104204753199269,0.9740548877292972,1.0,10/22,37.94%,FKBP1A;IKBKB;BOD1;STYXL1;PPP1R1B;MGAT5;CRY2;FKBP1B;PTPA;ROCK1
prerank,regulation of complement activation (GO:0030449),-0.2007128884415102,-0.6678003807917765,0.9546313799621928,0.9746097801122476,1.0,7/40,16.77%,CD55;CD81;C1QC;C1QB;PHB2;CFP;C1QA
prerank,regulation of microtubule nucleation (GO:0010968),-0.2866953659654636,-0.6675938891983952,0.8812615955473099,0.9743150010992567,1.0,3/10,21.17%,DCTN1;HSPA1A;HSPA1B
prerank,intracellular lipid transport (GO:0032365),0.24076458588394795,0.6661495274470779,0.8816067653276956,0.9963790543425484,1.0,3/21,6.64%,PRKAG2;ABCD2;CPT2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.23488068719694774,0.6647128362132926,0.8870636550308009,0.9968814990068706,1.0,5/23,17.70%,MTMR7;PTEN;MTMR10;OCRL;MTMR9
prerank,cellular defense response (GO:0006968),-0.2015550030007543,-0.664549595029832,0.958029197080292,0.9762689397750891,1.0,3/40,5.70%,LBP;PTK2B;NCF2
prerank,protein K63-linked ubiquitination (GO:0070534),-0.19387293745959622,-0.6627197988150725,0.9557692307692308,0.9771910940677155,1.0,11/41,21.06%,WWP2;RNF5;TRAF1;TRIM56;ITCH;TRIM5;UBE2G1;HECTD1;PELI1;UBE2B;BFAR
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.2547340806201515,-0.662572482777919,0.9107142857142857,0.976849748409103,1.0,3/16,8.39%,PAICS;ADSS2;IMPDH1
prerank,negative regulation of histone acetylation (GO:0035067),0.27433692862580056,0.6623244795821768,0.8701594533029613,0.998265874032717,1.0,6/11,26.01%,NOC2L;THAP7;TAF7;SET;SIRT1;SNCA
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.2813621688905616,-0.6622519380042098,0.8938223938223938,0.9766523770527968,1.0,5/10,23.92%,IMPACT;HSPA1A;NCK1;DNAJB1;HIF1AN
prerank,regulation of protein acetylation (GO:1901983),-0.26698775107422645,-0.6617685173675667,0.8823529411764706,0.976539747858634,1.0,4/12,29.84%,CAMK1;RAPGEF3;PARK7;TERF2IP
prerank,axoneme assembly (GO:0035082),0.21800427877843126,0.6606197046308102,0.9265658747300216,0.99889220776663,1.0,3/30,7.08%,CFAP74;DNAAF3;CCDC65
prerank,protein export from nucleus (GO:0006611),-0.2171986224995041,-0.6601809299002016,0.9289719626168225,0.9772974056533028,1.0,6/27,18.08%,TGFB1;PKD1;CHP1;STYX;SMURF1;CCHCR1
prerank,heterochromatin assembly (GO:0031507),0.237670058032055,0.6599017162743629,0.8940677966101694,0.9987633838010228,1.0,4/20,15.91%,SIRT2;MBD2;SMCHD1;HDAC1
prerank,monosaccharide transmembrane transport (GO:0015749),0.24823414355341822,0.6596318610729612,0.8928571428571429,0.9982597341474962,1.0,1/16,2.72%,SLC5A3
prerank,histone H2B ubiquitination (GO:0033523),-0.284530004651332,-0.6592627257103784,0.8811188811188811,0.9775453517390917,1.0,5/10,37.11%,RNF20;DTX3L;RNF40;RNF8;CDC73
prerank,dendritic cell migration (GO:0036336),-0.24893453817423544,-0.6575765118049499,0.8929219600725953,0.9783326444876866,1.0,1/16,1.81%,EPS8
prerank,regulation of DNA metabolic process (GO:0051052),0.19937159780435287,0.6565563530610646,0.9492600422832981,1.0,1.0,12/44,19.54%,KDM1B;RADX;HDAC8;HNRNPD;TOM1L1;THOC1;NBN;STOX1;CDK9;WRNIP1;UBE2N;SMG5
prerank,phagosome acidification (GO:0090383),0.22331144990027632,0.6560832788908973,0.9356223175965666,0.9997277058410357,1.0,5/26,15.87%,ATP6V0A4;ATP6V1H;RAB38;ATP6V1B2;RAB20
prerank,cell differentiation in hindbrain (GO:0021533),0.2740436856656956,0.6543439853940227,0.8815165876777251,1.0,1.0,1/11,1.67%,GRID2
prerank,protein heterotetramerization (GO:0051290),-0.2606842519665993,-0.6536087130350554,0.9053571428571429,0.980737187896472,1.0,5/13,31.40%,PKD1;FARSB;PKD2;GRIN1;KRT10
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.2840937257050597,-0.6529801349558257,0.8905380333951762,0.9807094148304719,1.0,2/10,11.76%,AKT1;PRKCE
prerank,negative regulation of translational initiation (GO:0045947),-0.2599863796469453,-0.6524660996517129,0.8984962406015038,0.9806434828212519,1.0,4/13,28.68%,FMR1;PAIP2B;EIF4EBP1;PAIP2
prerank,mRNA catabolic process (GO:0006402),0.2006001903997737,0.6520504397208582,0.9219409282700421,1.0,1.0,12/44,20.46%,TUT4;AGO4;DHX34;RIDA;PNPT1;METTL16;NBAS;NBDY;METTL3;AGO3;AGO1;ZFP36L2
prerank,retrograde axonal transport (GO:0008090),0.25291708380185035,0.6513803737963753,0.8849557522123894,1.0,1.0,5/16,20.40%,DLG2;KIF1A;ACTR10;FBXW11;TMEM108
prerank,dopaminergic neuron differentiation (GO:0071542),0.23821726826844808,0.6510220803089097,0.8927789934354485,1.0,1.0,3/19,8.68%,PHOX2A;FOXA2;RYK
prerank,"phototransduction, visible light (GO:0007603)",-0.24876082528217303,-0.6508498478742369,0.9055258467023173,0.9813075553001501,1.0,3/14,19.92%,RP1;GNB1;GNA11
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.26736124363858277,-0.6507359966063984,0.8973451327433628,0.9809250861735491,1.0,3/12,30.27%,NELFE;EAPP;RNF8
prerank,regulation of immune effector process (GO:0002697),-0.19302211479129228,-0.6504683666334706,0.9584120982986768,0.980671135326694,1.0,7/41,16.77%,CD55;CD81;C1QC;C1QB;PHB2;CFP;C1QA
prerank,positive regulation of actin nucleation (GO:0051127),-0.2783778172135085,-0.6497002294504205,0.9028776978417267,0.9807350366250274,1.0,1/11,1.59%,WASF2
prerank,magnesium ion transport (GO:0015693),0.26666825584078013,0.6492765952259011,0.9,1.0,1.0,4/12,21.13%,MAGT1;SLC41A1;TUSC3;NIPAL1
prerank,B cell activation involved in immune response (GO:0002312),0.2612216711657982,0.6487146378930311,0.8858921161825726,1.0,1.0,13/13,73.90%,CD180;EXOSC3;RNF168;GPR183;CD40LG;GAPT;CD19;MSH2;BATF;FCGR2B;MSH6;RNF8;LIG4
prerank,insulin secretion (GO:0030073),-0.2347524977473896,-0.6480683969276313,0.9332096474953617,0.9814036613667015,1.0,7/19,31.03%,ANXA1;RAB11B;PARK7;ADCYAP1;RAB11FIP5;CAMK2G;SNX19
prerank,tRNA methylation (GO:0030488),0.20716442601482365,0.6460936131776681,0.93058568329718,1.0,1.0,12/34,24.64%,DALRD3;FTSJ1;METTL6;NSUN6;BCDIN3D;TARBP1;TRMT12;TRMT1L;PRORP;THUMPD2;TRMT5;THUMPD3
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.17635875962525774,-0.6454337406418272,0.9887640449438202,0.982721655957354,1.0,18/64,32.12%,MLLT3;AFF4;GTF2H3;NELFE;CCNK;CDK13;GTF2H4;GTF2F1;TCEA1;ELOB;NCBP2;ELL;SETD2;POLR2F;GTF2F2;POLR2C;POLR2L;POLR2I
prerank,positive regulation of translational initiation (GO:0045948),0.24122447307255293,0.6445903710957357,0.9049676025917927,1.0,1.0,6/18,19.60%,KHDRBS1;POLR2G;EIF2B5;HABP4;CDC123;POLR2D
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.24564182869015153,0.6435499637070526,0.9074889867841409,1.0,1.0,1/17,1.74%,APOH
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.2511312209671934,-0.6434115741174006,0.9252336448598131,0.9836387905232895,1.0,1/14,3.16%,TPP1
prerank,L-serine metabolic process (GO:0006563),0.27385136831534007,0.6429903154399345,0.8761061946902655,1.0,1.0,10/10,72.63%,PSPH;PHGDH;CBS;SHMT1;SDS;PSAT1;SHMT2;SRR;SERINC5;SERINC3
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.22590646694049737,-0.6422779356204229,0.9236641221374046,0.9839236573657248,1.0,4/22,16.59%,CBFB;BCL6;SOX12;VSIR
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.24099292855299542,0.6418163870807204,0.9088983050847458,1.0,1.0,5/16,21.44%,CPEB3;KHSRP;RBM24;ZFP36L2;TARDBP
prerank,long-term memory (GO:0007616),0.23243281315677083,0.6411983741185123,0.9223946784922394,1.0,1.0,3/19,13.12%,CAMK4;CPEB3;RASGRF1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.2784333417022343,0.6404834703291711,0.8758029978586723,1.0,1.0,10/10,72.17%,RYK;WNT3;WNT5A;FZD1;WNT3A;WNT1;WNT9B;LRP6;WNT2;CTNNB1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.24280995995907906,-0.6401691880733676,0.9323308270676691,0.9848689694143749,1.0,4/16,18.05%,PIGL;PIGF;PIGC;PIGW
prerank,regulation of double-strand break repair (GO:2000779),0.19883488250873066,0.6398483789093928,0.9481327800829875,1.0,1.0,5/39,11.11%,SHLD2;TRIP12;OTUB2;RPA2;FMN2
prerank,regulation of centrosome cycle (GO:0046605),0.2260136145414972,0.6397463673281064,0.9064449064449065,1.0,1.0,3/21,9.61%,ATF5;GEN1;CHMP1A
prerank,negative regulation of B cell proliferation (GO:0030889),-0.26307467904132487,-0.6394271812289944,0.9177330895795247,0.9849180918749234,1.0,2/11,7.74%,RC3H1;TNFRSF21
prerank,RNA methylation (GO:0001510),0.1809031863915587,0.6393910150786826,0.9754601226993865,1.0,1.0,19/60,24.64%,VIRMA;FTSJ1;HENMT1;DIMT1;METTL16;MTERF4;METTL6;NSUN6;BCDIN3D;METTL3;METTL8;TFB1M;TARBP1;TRMT12;THUMPD2;RBM15;TRMT5;BUD23;THUMPD3
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.2624265246851559,-0.638227413871323,0.9169960474308301,0.9843355817800183,1.0,4/12,17.23%,ANAPC11;RB1;ANAPC7;CDC27
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.2624265246851559,-0.638227413871323,0.9169960474308301,0.9843355817800183,1.0,4/12,17.23%,ANAPC11;RB1;ANAPC7;CDC27
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.2624265246851559,-0.638227413871323,0.9169960474308301,0.9843355817800183,1.0,4/12,17.23%,ANAPC11;RB1;ANAPC7;CDC27
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.21014707563492221,0.6378122459981821,0.9197396963123644,1.0,1.0,3/29,7.15%,ACSM5;BAAT;ACOT11
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.21014707563492221,0.6378122459981821,0.9197396963123644,1.0,1.0,3/29,7.15%,ACSM5;BAAT;ACOT11
prerank,ncRNA transcription (GO:0098781),-0.25103461487666673,-0.6373260079684,0.9276437847866419,0.9844628447090897,1.0,4/13,20.74%,CAVIN1;SPIN1;GTF3C1;USPL1
prerank,eosinophil migration (GO:0072677),0.25288799598191836,0.6368497135621652,0.8973799126637555,0.9996992780143529,1.0,14/14,74.73%,SCG2;CCL13;CCL8;CCL26;CCL24;LGALS3;CCL11;CCL3;CCL1;CX3CL1;CCL7;CCL4;CCL5;CCL2
prerank,eosinophil chemotaxis (GO:0048245),0.25288799598191836,0.6368497135621652,0.8973799126637555,0.9996992780143529,1.0,14/14,74.73%,SCG2;CCL13;CCL8;CCL26;CCL24;LGALS3;CCL11;CCL3;CCL1;CX3CL1;CCL7;CCL4;CCL5;CCL2
prerank,coenzyme A metabolic process (GO:0015936),-0.2479525044207403,-0.6365515803254894,0.9140893470790378,0.9844983470130596,1.0,4/14,30.65%,ACLY;CROT;SLC25A16;PANK2
prerank,cell proliferation in forebrain (GO:0021846),-0.26765590369634007,-0.6360975709362331,0.9197207678883071,0.9843200795743394,1.0,5/10,38.75%,PCM1;NUMB;AKNA;WNT7A;HOOK3
prerank,regulation of telomere maintenance (GO:0032204),-0.2134837132535488,-0.6358167093379222,0.9461966604823747,0.9840446279147542,1.0,11/26,33.06%,USP7;ERCC1;ERCC4;SMG1;MRE11;UPF1;TERF2IP;MYC;PIF1;SMG6;RAD50
prerank,positive regulation of immunoglobulin production (GO:0002639),0.20908492450879207,0.63449667833188,0.93158953722334,1.0,1.0,8/31,19.60%,SHLD2;KMT5C;PAXIP1;TNFRSF4;RIF1;KMT5B;VAMP3;RBP4
prerank,spliceosomal complex assembly (GO:0000245),0.19044308809227445,0.633864631929443,0.9622641509433962,1.0,1.0,4/46,10.43%,CELF2;CELF4;RBM5;GCFC2
prerank,histone lysine demethylation (GO:0070076),0.2178436038838755,0.6331250001523049,0.9427312775330396,1.0,1.0,7/25,18.99%,KDM1B;KDM7A;KDM2A;PHF8;HR;KDM4C;KDM5B
prerank,calcium-ion regulated exocytosis (GO:0017156),0.20826960368346042,0.6329090146260552,0.9472573839662447,0.9995770476982542,1.0,8/27,19.52%,RIMS1;SYT1;SCIN;SYT13;SYT11;SYT12;SYT6;RIMS2
prerank,telomere maintenance via telomerase (GO:0007004),-0.20638463191645634,-0.6320010731847365,0.9449715370018975,0.9859232482019479,1.0,12/28,34.70%,HSP90AB1;DKC1;HSP90AA1;PPP6R3;MRE11;TERF2IP;TNKS1BP1;PIF1;RAD50;TERT;WRAP53;NOP10
prerank,regulation of catecholamine secretion (GO:0050433),0.2042920409508553,0.6318927832118107,0.9408163265306122,0.9995808903555192,1.0,8/29,18.26%,PRKN;SYT1;CHRNA4;SYT13;DRD2;SYT11;SYT12;SYT6
prerank,glial cell differentiation (GO:0010001),-0.2085168696560901,-0.6311064117290331,0.9515503875968992,0.9859811475604382,1.0,7/28,25.70%,ADGRG6;SOX4;SOX9;METRN;FGF10;SOX8;MYRF
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.25425324879151234,-0.6310670177975594,0.925,0.9855513473961734,1.0,13/13,74.60%,NELFE;EAPP;RNF8;NELFB;NELFCD;HNRNPU;NELFA;LARP7;RECQL5;TCERG1;RNF168;HEXIM1;SUPT4H1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.2759831240426588,-0.630226090287202,0.9172932330827067,0.9856182931576372,1.0,5/10,33.22%,EMC10;EMC6;EMC9;EMC1;EMC4
prerank,nuclear body organization (GO:0030575),-0.2581808181069188,-0.6299971947866085,0.9141856392294221,0.9853071776987414,1.0,4/12,20.74%,ETS1;ZPR1;SERBP1;USPL1
prerank,hexose metabolic process (GO:0019318),-0.1935266475349991,-0.6299533406023791,0.9660377358490566,0.9848877217750709,1.0,3/39,4.75%,PPARD;HK1;PGM1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.24601432614822616,0.6296377311810331,0.917960088691796,1.0,1.0,2/14,10.46%,EARS2;PNPT1
prerank,phagosome maturation (GO:0090382),-0.19939865807053753,-0.6290882375336315,0.9748062015503876,0.9849113441192465,1.0,12/35,31.52%,ATP6V0B;ATP6V0A2;MREG;ATP6V0C;RAB7A;ATP6V1G1;RAB32;RAB43;ATP6V0D1;CORO1A;ATP6V0E2;ATP6V1C1
prerank,RNA biosynthetic process (GO:0032774),0.20428113720686436,0.628180477188018,0.94375,1.0,1.0,30/31,72.21%,TTF1;GTF2B;TCEA2;TAF7;PRIM1;PRIM2;SETX;BRF1;TBPL1;BRF2;RSF1;TBPL2;ELL3;TAF13;PRMT5;TAF6;POLA2;TTF2;POLR2A;TAF12;NAT14;TBP;POLA1;TERT;HELB;NCOA6;TAF4;TAF5;SMARCA5;TAF10
prerank,negative regulation of B cell activation (GO:0050869),0.22098775768723303,0.6277450367943451,0.9356846473029046,1.0,1.0,4/21,13.34%,SFRP1;LYN;ATM;PARP3
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.24481340198121093,-0.6268580185657091,0.9148148148148149,0.9857381413875174,1.0,2/15,12.47%,CD55;SYK
prerank,intracellular cholesterol transport (GO:0032367),0.24211522156141513,0.626727201189544,0.8957055214723927,1.0,1.0,3/15,13.35%,ABCA1;OSBP;RELCH
prerank,central nervous system neuron differentiation (GO:0021953),-0.1978222108525565,-0.6266318175876308,0.9693140794223827,0.9854275399202147,1.0,18/33,39.76%,OPHN1;NR4A2;SOX4;AGTPBP1;FAIM2;TOX;CEND1;LMX1A;CTNNB1;WNT2;SPOCK1;DRAXIN;MAP2;LRP6;PROX1;NPY;ISL1;KNDC1
prerank,cellular response to UV-A (GO:0071492),-0.2637717686624877,-0.6263209847524739,0.9264705882352942,0.9851507454818653,1.0,8/11,49.67%,OPN3;PPID;MMP1;CERS1;MMP3;OPN5;MMP9;OPN1SW
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.19675266932537416,-0.6259804604948418,0.9597806215722121,0.9848951462848532,1.0,12/38,25.77%,ABLIM3;SAE1;VPS11;ATP5IF1;CSNK2A2;UBL5;FZD5;NPEPPS;MICALL2;UBE2J2;ATG13;SREBF1
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.18618639873639745,-0.6255293761997905,0.9803536345776032,0.984685309468438,1.0,3/42,5.56%,LBP;RPL30;RPS19
prerank,UV-damage excision repair (GO:0070914),0.25319034270088847,0.6253254583199727,0.9086651053864169,1.0,1.0,1/12,3.84%,DDB2
prerank,protein oxidation (GO:0018158),0.26593255844150543,0.6249392509464244,0.8924731182795699,0.999938414812379,1.0,2/11,7.26%,LOXL2;LOXL3
prerank,negative regulation of hippo signaling (GO:0035331),0.25376382805768294,0.624867487017133,0.9066390041493776,0.9992703105447832,1.0,2/12,8.84%,WWC1;AJUBA
prerank,protein N-linked glycosylation (GO:0006487),-0.16997629875967432,-0.6245217161819304,0.9822834645669292,0.984831361109013,1.0,19/66,27.12%,TMEM165;ST6GAL1;SLC39A8;MGAT1;FUT8;KRTCAP2;DAD1;GFPT1;OST4;MCFD2;TMEM258;ALG9;ALG12;ALG1;PGM3;RPN2;STT3B;ALG2;ALG3
prerank,peroxisome organization (GO:0007031),-0.21013100043166555,-0.6240183418897662,0.941398865784499,0.9846677551343873,1.0,11/25,35.11%,PLAAT3;ACOT8;PEX11G;FIS1;PEX11A;PEX14;MFF;ABCD3;PEX6;PEX7;SEC16B
prerank,nucleocytoplasmic transport (GO:0006913),-0.18682126879518604,-0.6239182892764894,0.9672447013487476,0.9842733060085722,1.0,23/40,41.58%,ANP32A;SNRPD3;HTATIP2;RITA1;HNRNPA1;DDX20;SMN1;SNRPG;NXT2;NCBP2;SNRPB;NUP98;NPM1;XPO1;SNUPN;RBM15B;RSRC1;SNRPE;SNRPF;GEMIN2;NCBP1;NXT1;GEMIN6
prerank,lipid phosphorylation (GO:0046834),-0.2712767876856948,-0.6237197657153272,0.9068100358422939,0.9839361545000939,1.0,1/10,1.75%,DGKH
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.2104492635761001,-0.6233289778358396,0.9608938547486033,0.9837188780570877,1.0,15/26,39.73%,APP;TAL1;DUSP3;HES1;USP22;ASNS;EIF4EBP1;EIF4E;TTL;RPS6KB1;CUL3;KLHL18;CCNB1;FOXA1;LGMN
prerank,telomere maintenance via recombination (GO:0000722),0.26131182011184384,0.6215273006459197,0.9023255813953488,1.0,1.0,4/11,18.05%,TEP1;SMC6;NSMCE2;SMC5
prerank,male meiosis I (GO:0007141),0.23468074921065613,0.6209809915578456,0.8883826879271071,1.0,1.0,3/16,15.20%,HSF2BP;ZSCAN21;BRDT
prerank,regulation of keratinocyte migration (GO:0051547),-0.254321066676353,-0.6201931940134009,0.914018691588785,0.9850664357412225,1.0,4/12,29.32%,IQSEC1;MAPRE2;FGF10;EPB41L4B
prerank,gas transport (GO:0015669),-0.2638556424123919,-0.6185835458753942,0.9346289752650176,0.9855019559987453,1.0,8/10,55.26%,CYGB;MYC;AQP1;MB;NGB;AQP6;CA2;IPCEF1
prerank,protein prenylation (GO:0018342),-0.26513829153500135,-0.6181781246498765,0.9216417910447762,0.9852566287333386,1.0,6/10,47.90%,RCE1;RABGGTB;CHM;RABGGTA;FNTB;AIPL1
prerank,lipid modification (GO:0030258),0.1934738003616711,0.6178966323112081,0.9675324675324676,1.0,1.0,4/37,7.13%,ALOX12;DGKD;PLPP3;PLPPR1
prerank,regulation of intracellular transport (GO:0032386),0.19286341292342396,0.6176951961852618,0.9569672131147541,1.0,1.0,5/38,12.67%,WWC1;SCFD1;ATP9A;DYNLT2B;RINT1
prerank,negative regulation by host of viral process (GO:0044793),0.26668499325519357,0.6169286392967365,0.8950749464668094,1.0,1.0,2/10,15.61%,PRKN;CRP
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.23214789100115735,-0.6168420028617015,0.9511278195488722,0.985501956472978,1.0,12/16,51.87%,CYRIB;LILRB1;IL12A;CEACAM1;IL12RB1;IL23A;KLRD1;IL12B;IL23R;RIPK3;KLRC1;XCL1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.21013432533449464,0.6165271253109178,0.9631147540983607,1.0,1.0,10/24,27.54%,STN1;PINX1;PARP1;GNL3L;TNKS;TINF2;XRN1;TNKS2;TENT4B;NAT10
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.24786175237293762,-0.615798647086163,0.9318600368324125,0.9855912987613997,1.0,10/12,53.68%,IL1R1;SLC11A1;IL12RB1;IL23A;IL12B;IL23R;CCR2;XCL1;IL1B;IL18R1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.26610978254854845,0.6156503931633117,0.8944099378881988,0.9999092788556007,1.0,4/10,23.52%,MTHFD1;MTHFD1L;MTHFR;MTHFD2L
prerank,negative regulation of signaling (GO:0023057),0.20814648289353976,0.615549239905375,0.9607843137254902,0.999265129057158,1.0,7/25,19.28%,NLRP12;ERBB3;OPTN;LIF;HHIP;TRAT1;SOCS5
prerank,superoxide anion generation (GO:0042554),0.2517085710920488,0.6152141646263958,0.9051918735891648,0.9987456576217889,1.0,1/13,2.60%,ALOX12
prerank,positive regulation of transporter activity (GO:0032411),0.24651955137695072,0.6117230973283921,0.912751677852349,1.0,1.0,6/13,26.09%,KMT2A;WNK3;PDZK1;RXRA;NR1H3;SGK1
prerank,protein import into peroxisome membrane (GO:0045046),0.2185667316912345,0.6115421562628813,0.9428571428571428,0.9995012924929751,1.0,9/22,26.46%,ABCD2;PXMP4;PEX11B;PXMP2;PEX19;PEX2;PEX16;ALDH3A2;PEX5
prerank,DNA-dependent DNA replication (GO:0006261),-0.1486668532519169,-0.6113793306962505,1.0,0.9873785897654574,1.0,49/128,37.58%,UBB;UBC;RPS27A;PSMA6;PSMB5;PSMC4;BAZ1A;PSMC5;PSMD14;PNKP;REV3L;DDX23;PSMD8;RPA3;PSMC1;RPAIN;PSMB4;PSMD11;PSMD12;GINS3;PSMA1;PSMC3;PSMB1;PSMA2;RFC3;PSMA4;RFC2;MCM5;POLE3;PSMB8;DNA2;POLB;RECQL;PSMC6;PSMD6;TWNK;CDC6;PSMA8;POLE;PSMB2;HELB;POLA1;GINS4;PSMD2;PURA;UBA52;RAD51;HMGA1;SIRT7
prerank,protein localization to cilium (GO:0061512),-0.19783111198419198,-0.6113599078644546,0.9704797047970479,0.9869387200451194,1.0,7/32,18.85%,IFT20;TULP2;ZNF423;ARL6;TUB;RABEP1;EHD1
prerank,lysosome organization (GO:0007040),-0.1881406686716245,-0.6106694415412158,0.9763636363636363,0.9868400039409329,1.0,11/36,30.15%,TPP1;TMEM165;HPS1;VPS33A;TFEB;TPCN2;GNPTAB;MYO7A;ATP10B;CORO1A;LAMTOR1
prerank,detection of visible light (GO:0009584),0.22641810338759352,0.6078906844099914,0.9246861924686193,1.0,1.0,1/16,3.74%,ABCA4
prerank,"base-excision repair, gap-filling (GO:0006287)",0.19199080329706816,0.6078766294647933,0.9627329192546584,1.0,1.0,11/35,22.53%,MPG;RPA2;RFC5;RPA1;PARP1;POLD4;POLD1;RFC1;PCNA;POLD3;POLD2
prerank,regulation of centrosome duplication (GO:0010824),-0.19263750842830213,-0.6077643711419445,0.9681050656660413,0.9878489771252703,1.0,6/29,17.86%,CHMP2B;PLK2;FBXW5;CCNF;TMEM67;CHMP2A
prerank,nucleic acid metabolic process (GO:0090304),0.16787923864175097,0.6077325364943515,0.9851694915254238,0.9994809447923307,1.0,1/69,0.19%,ENPP1
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.22458764210649176,-0.6077240249324587,0.956140350877193,0.9874152097707327,1.0,11/16,49.88%,TNFRSF1B;FGF10;PTPN22;LST1;TNFSF8;IL12A;CD22;TNFSF9;IL12B;LGALS3;TNFSF18
prerank,adrenergic receptor signaling pathway (GO:0071875),0.21728163235627843,0.6072253445000222,0.9323144104803494,0.9990560976506289,1.0,8/20,25.71%,ADRA1D;ADRA1B;DRD2;ADRB3;ADRA1A;LMBRD2;DRD3;ADCY9
prerank,regulation of histone methylation (GO:0031060),-0.24581408095162244,-0.6069310700675346,0.9332129963898917,0.9873590133028735,1.0,4/13,22.09%,CHTOP;TTLL12;AASS;NNMT
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.21485659370979182,-0.6058357197750258,0.9406474820143885,0.9874378840114978,1.0,6/21,28.45%,PPARD;FAAH;ACOT8;LDHD;ACOX1;LPIN2
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.2138666093448117,-0.6051675456725163,0.9567567567567568,0.9872986788338539,1.0,10/18,45.24%,SMAD4;JAK2;STAT1;IL6ST;SPI1;SRC;CBL;SOCS3;IL6;CEBPA
prerank,protein insertion into membrane (GO:0051205),-0.19271887687189412,-0.6041866927260482,0.9845857418111753,0.987300200778495,1.0,9/32,28.70%,APP;STX1A;SEC61B;SGTA;EGFR;STX5;UBE2J2;TRAM1;VAMP2
prerank,ncRNA 3'-end processing (GO:0043628),0.23435215825651107,0.6034896839506717,0.9192825112107623,1.0,1.0,7/14,25.94%,INTS6L;PTCD1;INTS7;TRNT1;SSB;INTS5;TOE1
prerank,axonemal dynein complex assembly (GO:0070286),0.2037205530235118,0.6027872256282325,0.9626556016597511,1.0,1.0,3/27,8.15%,DNAAF3;CCDC65;DNAL1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.20709011460637755,0.602449170206614,0.9509594882729211,0.9995092611326537,1.0,5/23,14.77%,KIF5C;DYNC1I1;CCDC186;KIF1A;MAP6
prerank,regulation of immunoglobulin production (GO:0002637),-0.20640184984937804,-0.6017753521810895,0.958,0.9879997418131008,1.0,4/23,18.10%,GPI;PHB2;CLCF1;XBP1
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.22172639989078147,-0.6008349824556661,0.9507299270072993,0.9879719176038622,1.0,9/16,41.02%,UQCC2;VCP;SLC25A33;COX7A2L;SHMT2;PDE12;COX7A2;PPIF;ABCD1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.25531534109594956,-0.598340988256056,0.921146953405018,0.9887083456616134,1.0,4/10,30.71%,GRB10;ITGB3;PRKD2;ITGA5
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.23261765543520607,-0.5967662891610479,0.9383177570093458,0.9890039053199845,1.0,7/14,37.09%,TSEN54;TRPT1;CPSF4;RTCB;RTRAF;TSEN2;CPSF1
prerank,negative regulation of organelle assembly (GO:1902116),0.18742710539498317,0.5958926205630241,0.9804772234273319,1.0,1.0,6/35,15.08%,PHF23;SCFD1;MDM1;YAP1;TCHP;NBDY
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.23194655567605527,0.5952719505025303,0.9328537170263789,1.0,1.0,5/14,23.01%,FIP1L1;CPSF4L;CPSF7;CPSF6;NUDT21
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.2008381451938957,-0.5951782390318517,0.9719626168224299,0.9892686566243808,1.0,16/25,44.30%,PRPF8;SRSF4;DDX23;SF3A3;SCAF11;LSM1;TRA2B;SMNDC1;SRSF10;GEMIN2;PRPF6;SRRM1;WDR83;SF3B1;PRPF4;SF3B4
prerank,t-circle formation (GO:0090656),-0.2529435935006232,-0.5938379980418169,0.9376181474480151,0.9885090710250352,1.0,4/10,27.98%,ERCC1;SLX4;EXO1;DNA2
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.2529435935006232,-0.5938379980418169,0.9376181474480151,0.9885090710250352,1.0,4/10,27.98%,ERCC1;SLX4;EXO1;DNA2
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.2529435935006232,-0.5938379980418169,0.9376181474480151,0.9885090710250352,1.0,4/10,27.98%,ERCC1;SLX4;EXO1;DNA2
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.21880580934627447,-0.5937460019766887,0.9591836734693877,0.9881039000961468,1.0,2/17,8.61%,MFSD2A;AKT1
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.20397771772789514,-0.5925553646339736,0.9511278195488722,0.988192338669424,1.0,2/22,7.70%,NCOR1;PPP2R5A
prerank,negative regulation of inclusion body assembly (GO:0090084),0.25194639360117144,0.5923549206598436,0.937365010799136,1.0,1.0,1/10,3.80%,DNAJB8
prerank,rRNA pseudouridine synthesis (GO:0031118),0.25422563006655186,0.5918460911757886,0.9334763948497854,1.0,1.0,2/10,8.62%,RPUSD2;RPUSD3
prerank,urogenital system development (GO:0001655),-0.2456624124567447,-0.5909353898940304,0.9328214971209213,0.9884180211211532,1.0,1/11,3.66%,ANXA1
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.20641746298875094,-0.5908379686863678,0.9668508287292817,0.9880118901398197,1.0,8/21,27.51%,DUSP3;JAK3;TNFAIP3;LAPTM5;PTPN22;BANK1;LST1;LAX1
prerank,lipoxygenase pathway (GO:0019372),0.2284993356093855,0.5893410528404627,0.9344978165938864,1.0,1.0,2/14,10.95%,ALOX12;HPGD
prerank,receptor catabolic process (GO:0032801),-0.20171293225738135,-0.5892475672316273,0.9723247232472325,0.9882379665111923,1.0,5/24,15.00%,TGFB1;AP2M1;KIF16B;SMURF1;AP2A1
prerank,ncRNA catabolic process (GO:0034661),0.20014592871784098,0.5873638813396668,0.9649122807017544,1.0,1.0,2/28,6.11%,TUT4;LIN28B
prerank,peroxisomal membrane transport (GO:0015919),0.19902028996530316,0.5865328593221986,0.9719827586206896,1.0,1.0,7/27,20.16%,ABCD2;PXMP4;PEX11B;PXMP2;PEX10;PEX19;PEX2
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.21669254447776543,-0.5850855543263422,0.9585687382297552,0.9894825810732496,1.0,3/16,16.07%,ACLY;PPT2;SLC25A1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.19941966749988696,0.5829180175427072,0.9523809523809523,1.0,1.0,5/27,15.64%,NAT8;TAF6L;KAT8;EP300;KAT5
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.20689413692495182,0.5822080316555195,0.9501084598698482,1.0,1.0,3/22,10.36%,STAP1;DYNLL1;ANKLE2
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.2099300073534472,-0.581295022776586,0.9700934579439252,0.990528191801695,1.0,7/19,35.69%,CHMP2B;HSPA1A;CHMP2A;HSPA1B;EML3;PLK1;CHMP4B
prerank,prostanoid metabolic process (GO:0006692),0.23146015658355776,0.5778961898501976,0.9457700650759219,1.0,1.0,3/13,12.33%,GSTP1;HPGD;PTGES
prerank,retinal metabolic process (GO:0042574),-0.23349596341218698,-0.5751963278476638,0.9523809523809523,0.9924191628866152,1.0,3/12,17.28%,CYP1B1;ALDH1A3;DHRS13
prerank,positive regulation of rRNA processing (GO:2000234),0.24943509917147866,0.5745804948365576,0.9247058823529412,1.0,1.0,10/10,75.07%,DIMT1;HEATR1;BUD23;WDR75;WDR43;TRMT112;SIRT7;RIOK1;RIOK2;UTP15
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.19311119699135168,-0.5736401720977142,0.9624505928853755,0.9925115641289955,1.0,5/25,17.86%,LYST;CHMP2B;VCP;LAPTM4B;CHMP2A
prerank,cilium-dependent cell motility (GO:0060285),0.20457100551118124,0.5733909983185487,0.972972972972973,1.0,1.0,2/22,7.08%,TEKT3;CCDC65
prerank,negative regulation of immune system process (GO:0002683),-0.21674577645926835,-0.5732940668842709,0.9517625231910947,0.9921798257890944,1.0,3/16,19.25%,COL3A1;CD200;SOX9
prerank,positive regulation of receptor internalization (GO:0002092),0.20405330297173868,0.570088921217209,0.9631236442516269,1.0,1.0,1/22,1.57%,MAGI2
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.22359926475668235,-0.568952213332278,0.9499105545617174,0.9932727613659106,1.0,5/13,30.71%,TGFB1;SYK;PRKCD;SOD1;TYROBP
prerank,microtubule anchoring (GO:0034453),0.23613167795735585,0.5685282757708924,0.9507042253521126,1.0,1.0,3/12,16.05%,SAXO2;BICD1;DAG1
prerank,protein destabilization (GO:0031648),0.1835980306935958,0.5682268601609982,0.9783037475345168,1.0,1.0,13/32,26.90%,MDM2;PRKN;SENP2;BTRC;EP300;CTSH;FBXW11;PEX2;PRNP;SIRT1;SNCA;RNF139;TRIM21
prerank,nucleosome organization (GO:0034728),0.16647541775600178,0.5674039528368435,0.9878296146044625,1.0,1.0,16/55,23.38%,PRDM9;CTCF;ANP32E;MCM3AP;DAXX;SPTY2D1;SMARCB1;BRDT;SART3;SRCAP;NAP1L2;SET;PAF1;SMARCD1;BPTF;NASP
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.19802864447014912,0.5673517959287926,0.975,1.0,1.0,4/21,18.17%,MITF;PAXIP1;MED12;MED4
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.23630473780449318,-0.5659150171002896,0.9686956521739131,0.9938176395454595,1.0,8/10,59.45%,E2F7;E2F8;STOML2;DBF4;SSBP1;CDT1;WIZ;ATRX
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.20836846575340462,0.5657990003205576,0.9669603524229075,1.0,1.0,8/16,26.05%,PINX1;ATM;PARP1;SMG5;RTEL1;TNKS;TINF2;TNKS2
prerank,positive regulation of acute inflammatory response (GO:0002675),0.2172903063787041,0.5656706989875409,0.9307359307359307,1.0,1.0,14/14,78.29%,OSMR;PTGS2;C2CD4A;C2CD4B;IL1B;FFAR2;OSM;CREB3L3;TNF;IL6;ADAM8;PTGER3;PARK7;IL6ST
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.18908829230282662,-0.565525131213848,0.9880952380952381,0.9935016940032204,1.0,5/27,22.11%,TLR4;PTPN6;CD200;TNFAIP3;PTPN22
prerank,microtubule nucleation (GO:0007020),-0.1994091993952004,-0.5643833055770073,0.9834254143646409,0.9934382629610111,1.0,6/19,29.96%,SLAIN2;NDE1;NDEL1;TPX2;TUBGCP6;TUBG2
prerank,serine family amino acid catabolic process (GO:0009071),-0.24482881941857498,-0.5616415741685714,0.9764065335753176,0.9938786121285235,1.0,5/10,35.52%,DLD;AMT;THNSL2;SHMT2;DAO
prerank,regulation of microtubule-based movement (GO:0060632),0.2344376846824386,0.5615216989400191,0.9381898454746137,1.0,1.0,2/11,11.71%,CCDC65;DYNLT2B
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.23790432348077023,-0.5600874423756794,0.9527272727272728,0.9939500538150174,1.0,5/10,38.03%,RC3H1;LGALS9;SCRIB;CRTAM;PDCD1LG2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.20581910488713964,0.5595751707906543,0.9521739130434783,1.0,1.0,3/18,13.00%,LYN;C3AR1;BCAR1
prerank,apoptotic nuclear changes (GO:0030262),-0.1892413870792067,-0.5591557680575371,0.9816176470588235,0.9937936506833845,1.0,8/24,30.87%,KPNA1;TOP2A;FOXL2;CDK5RAP3;DFFB;ACIN1;HMGB2;ENDOG
prerank,negative regulation of telomere maintenance (GO:0032205),0.21018501928071182,0.5582393514318649,0.9606986899563319,1.0,1.0,6/15,23.17%,PINX1;ATM;NBN;PARP1;RTEL1;TNKS
prerank,mitotic spindle assembly (GO:0090307),0.17018773757655448,0.5557533874367073,0.9878296146044625,1.0,1.0,6/42,12.63%,STAG1;MAP9;GOLGA2;MAP10;PIBF1;AURKC
prerank,snRNA 3'-end processing (GO:0034472),-0.20224995797488565,-0.5550270648987506,0.9634369287020109,0.9946070744377435,1.0,6/19,28.17%,INTS8;INTS1;EXOSC8;INTS12;INTS2;EXOSC9
prerank,mismatch repair (GO:0006298),0.1866944164951741,0.5534791195851654,0.9810526315789474,1.0,1.0,11/27,24.46%,RPA2;MCM9;PMS2;RPA1;POLD4;POLD1;PCNA;POLD3;POLD2;PMS1;MUTYH
prerank,isotype switching (GO:0045190),0.23260672639846225,0.5485186710296879,0.9585921325051759,1.0,1.0,1/10,4.57%,CCR6
prerank,lytic vacuole organization (GO:0080171),0.1742273854121568,0.5476634905020171,0.9866369710467706,1.0,1.0,4/32,15.76%,ABCA1;AKTIP;SNAPIN;CLN3
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.2295568481673897,-0.5460557609602104,0.9730700179533214,0.9967191139706935,1.0,7/10,55.88%,GNB1;PDE6B;RHO;GNAT1;PDE6A;CNGB1;SAG
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.22221132991286985,-0.5456934129832346,0.9662522202486679,0.9963751942364703,1.0,8/12,52.25%,PAEP;RASGRP1;ISL1;CARD9;IL23A;IL12B;IL23R;IL1B
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.20093286239770294,0.545637753280003,0.9691629955947136,1.0,1.0,6/18,20.16%,SFRP1;GSTP1;EMD;B4GALT7;TP53;PEX2
prerank,synaptic vesicle transport (GO:0048489),0.22847536464385632,0.5454235813981434,0.9636363636363636,1.0,1.0,3/11,15.98%,KIF5C;SNAPIN;TMEM230
prerank,glycerolipid metabolic process (GO:0046486),-0.2303684640010043,-0.5441172419913525,0.9728260869565217,0.9963495979854186,1.0,11/11,76.99%,DGKZ;PIP5K1A;DGKB;DGKG;PGP;DGKQ;GAL3ST1;PLA2G15;DGKA;PNPLA3;PDXP
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.23104783462723238,0.5427693504829753,0.954248366013072,1.0,1.0,4/11,24.68%,IL4;TAF7;SIRT1;CIITA
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.2323696026110632,-0.5426393943303667,0.9676840215439856,0.996328631462123,1.0,8/10,45.31%,TAF9;PIH1D2;ZNHIT6;RUVBL1;ZNHIT3;NAF1;NUFIP1;RUVBL2
prerank,coenzyme A biosynthetic process (GO:0015937),0.2271306126744669,0.5421347688351478,0.9523809523809523,1.0,1.0,3/11,19.84%,PANK3;PANK1;COASY
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.2271306126744669,0.5421347688351478,0.9523809523809523,1.0,1.0,3/11,19.84%,PANK3;PANK1;COASY
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.2271306126744669,0.5421347688351478,0.9523809523809523,1.0,1.0,3/11,19.84%,PANK3;PANK1;COASY
prerank,rRNA modification (GO:0000154),-0.1904250531216894,-0.541540592199112,0.9911504424778761,0.996177725446973,1.0,5/21,26.13%,THUMPD1;DKC1;ZCCHC4;MRM2;FTSJ3
prerank,piRNA metabolic process (GO:0034587),0.19737008351023017,0.5410292546406829,0.9821826280623608,1.0,1.0,3/19,14.33%,HENMT1;PIWIL2;TEX15
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.22760195974533892,-0.53976641845905,0.9616788321167883,0.9957541426177067,1.0,3/10,27.86%,CDC42EP3;CDC42;CDC42EP2
prerank,regulation of pseudopodium assembly (GO:0031272),-0.22760195974533892,-0.53976641845905,0.9616788321167883,0.9957541426177067,1.0,3/10,27.86%,CDC42EP3;CDC42;CDC42EP2
prerank,homocysteine metabolic process (GO:0050667),-0.22605769515776236,-0.5395039750308526,0.9763636363636363,0.995375294143789,1.0,6/11,43.02%,CTH;BLMH;MTRR;MPST;TST;DPEP1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.23299020838563905,0.5393896967842621,0.9472477064220184,1.0,1.0,10/10,76.72%,DLGAP1;DLGAP2;DLGAP3;CACNG5;NPTX2;NPTX1;AKAP9;NPTXR;DLGAP4;BEGAIN
prerank,organophosphate catabolic process (GO:0046434),0.2294269035214363,0.5326142855457744,0.9633867276887872,1.0,1.0,11/11,77.07%,PLBD2;PDXP;PLBD1;ANGPTL3;PNLIPRP2;ABHD12;APOA2;LIPG;PON1;NUDT15;ENPP2
prerank,N-terminal protein amino acid modification (GO:0031365),-0.20766822068335308,-0.5315235656050201,0.9764065335753176,0.9969268501773779,1.0,7/14,43.09%,NAA60;METAP1D;NTMT1;NAA50;METAP2;PDF;NAA11
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.1790988499968581,0.531262569037362,0.9840182648401826,1.0,1.0,29/29,82.12%,PRDM9;SYCE2;TEX11;P3H4;MEI4;SYCE1;KASH5;SYCE3;RNF212;SYCP1;BAG6;TRIP13;SYCP2;TERB2;HORMAD1;ANKRD31;RNF212B;TERB1;RAD21L1;IHO1;SIRT7;STAG3;TEX12;ZCWPW1;MEIOB;MAJIN;FANCD2;REC8;RAD21
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.17523734850506573,0.5311526276782859,0.9869281045751634,1.0,1.0,1/31,2.13%,MOCS2
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.20759907302851757,-0.5306744564207658,0.9670932358318098,0.9966769753116254,1.0,6/15,32.74%,SPCS1;RAB3GAP2;ZFAND2B;SEC61A1;SRPRA;EDEM1
prerank,regulation of cell aging (GO:0090342),0.2230141026708679,0.5297624299628446,0.9470046082949308,1.0,1.0,3/11,19.67%,PNPT1;MIF;NEK4
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.18745441153850997,-0.5286153895312105,0.9829867674858223,0.9957869522129474,1.0,8/20,34.01%,ZW10;MAD1L1;CENPF;BUB3;PLK1;CDC20;BUB1;MAD2L2
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.18745441153850997,-0.5286153895312105,0.9829867674858223,0.9957869522129474,1.0,8/20,34.01%,ZW10;MAD1L1;CENPF;BUB3;PLK1;CDC20;BUB1;MAD2L2
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.18745441153850997,-0.5286153895312105,0.9829867674858223,0.9957869522129474,1.0,8/20,34.01%,ZW10;MAD1L1;CENPF;BUB3;PLK1;CDC20;BUB1;MAD2L2
prerank,negative regulation of TORC1 signaling (GO:1904262),0.21790445100131844,0.5284545948752679,0.9659574468085106,1.0,1.0,13/13,78.23%,ITFG2;ATM;CASTOR1;DEPDC5;KPTN;SZT2;STK11;SPAAR;SESN3;RNF152;SESN1;CASTOR2;SESN2
prerank,rRNA catabolic process (GO:0016075),-0.19527592563227653,-0.5207127588124034,0.9817184643510055,0.997009752658451,1.0,9/16,50.43%,EXOSC8;DIS3;EXOSC9;PELO;ERN2;TRIR;DIS3L;SLFN14;EXOSC7
prerank,negative regulation of defense response to virus (GO:0050687),-0.22077944900070545,-0.5188894796136239,0.9762340036563071,0.9969320548627424,1.0,3/10,27.81%,ITCH;TSPAN6;MUL1
prerank,DNA modification (GO:0006304),0.18128836023079425,0.5175801145129474,0.9782135076252724,1.0,1.0,4/22,17.35%,MPG;PARP3;EXOSC3;PARP1
prerank,signal peptide processing (GO:0006465),0.21137690210279445,0.5175051156865095,0.9675174013921114,1.0,1.0,4/11,21.72%,HM13;PARL;SPCS3;SPPL3
prerank,negative regulation of cell communication (GO:0010648),-0.18205325144365941,-0.5153917790440335,0.9874326750448833,0.9971548229830921,1.0,6/21,28.24%,IGFBP3;KIF26A;ACVR1;UBASH3B;PTPN1;SRMS
prerank,negative regulation of cholesterol transport (GO:0032375),-0.2223702151130642,-0.515378265668081,0.9784560143626571,0.9967152867094413,1.0,2/10,25.42%,ABCA2;APOC1
prerank,regulation of receptor recycling (GO:0001919),-0.19465566093940803,-0.5146934839539705,0.9754253308128544,0.9964155230186059,1.0,7/16,33.98%,ANXA2;KIF16B;NSF;LAMTOR1;SCRIB;RAMP3;INPP5F
prerank,DNA catabolic process (GO:0006308),0.21448747724562173,0.5125760466527606,0.9760191846522782,1.0,1.0,11/11,78.57%,SETMAR;FBH1;MUS81;DNASE1L3;REXO4;DNASE1;DNASE1L1;ISG20;XRN2;DFFB;DNASE1L2
prerank,regulation of inclusion body assembly (GO:0090083),-0.2176850528554882,-0.5119799815306747,0.9866412213740458,0.9964638186406026,1.0,6/11,35.55%,BAG5;HSPA1A;HSPA1B;DNAJB1;DNAJB6;SNCAIP
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.20881684042720466,-0.5089929831318825,0.9850746268656716,0.9965771267518031,1.0,4/12,26.77%,ELOVL5;ACOT8;ELOVL1;ACOX1
prerank,base-excision repair (GO:0006284),-0.14727847287709014,-0.5079373067955866,0.9959919839679359,0.9963199883288272,1.0,15/48,32.91%,SMUG1;PNKP;XRCC1;RPA3;POLQ;NEIL1;APEX2;RFC3;RFC2;POLL;TDG;DNA2;POLB;NEIL3;POLE
prerank,"base-excision repair, AP site formation (GO:0006285)",0.18920170765486938,0.5077254846011423,0.9783080260303688,1.0,1.0,1/17,3.91%,MPG
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.17636861188112346,0.5052688065723896,0.9955654101995566,1.0,1.0,4/23,15.56%,GUCY2F;GUCA1B;METAP1;PDE6G
prerank,regulation of actin nucleation (GO:0051125),0.20741334638797318,0.5032540035453206,0.9758241758241758,1.0,1.0,2/12,14.53%,SCIN;ARPIN
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.19181024909584646,0.5030352653400006,0.9836065573770492,1.0,1.0,6/16,23.79%,EP300;NAA20;AANAT;NAA40;KAT2B;NAA15
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.21686268618060517,-0.5028204205863028,0.9758812615955473,0.9967531702447724,1.0,2/10,15.83%,ELOVL5;NR1H2
prerank,regulation of superoxide anion generation (GO:0032928),-0.19325213612540498,-0.4976082326592196,0.9836660617059891,0.9971661734295345,1.0,5/14,30.71%,TGFB1;SYK;PRKCD;SOD1;TYROBP
prerank,oligodendrocyte development (GO:0014003),0.1946743316732258,0.4971415681299641,0.9803063457330415,1.0,1.0,4/15,20.27%,HES5;EIF2B5;EIF2B2;B4GALT6
prerank,neuropeptide signaling pathway (GO:0007218),0.1428752866362688,0.4955236021614551,1.0,1.0,1.0,3/58,4.99%,SORCS1;GLRB;OPRK1
prerank,acyl-CoA metabolic process (GO:0006637),0.15430941947355165,0.4925793446222819,0.9957716701902748,1.0,1.0,8/35,21.38%,ACSM5;BAAT;ACOT11;ACSL6;ACACA;ACBD6;MCEE;HMGCS1
prerank,protein O-linked glycosylation via serine (GO:0018242),0.21311128156041642,0.4885461922728467,0.9652173913043478,1.0,1.0,2/10,14.58%,POGLUT2;MGAT5B
prerank,regulation of biosynthetic process (GO:0009889),0.20249348419926871,0.4882540989799415,0.9911111111111112,1.0,1.0,1/11,6.25%,GSTP1
prerank,protein targeting to peroxisome (GO:0006625),0.16355200345343346,0.4849764225877939,0.9977827050997783,1.0,1.0,7/29,20.16%,ABCD2;PXMP4;PEX11B;PXMP2;PEX10;PEX19;PEX2
prerank,regulation of T cell activation (GO:0050863),-0.14434745203874919,-0.48129195234903066,1.0,0.9988989228623122,1.0,16/42,37.51%,CYRIB;TNFRSF1B;HSPD1;DUSP3;JAK3;LAPTM5;PTPN22;CCL2;LAX1;TNFSF8;LAT;KAT2A;ABL1;CCL5;VTCN1;CRTAM
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.15057142371440543,-0.48028102784195403,1.0,0.9985722440557728,1.0,14/33,36.76%,HSP90AB1;DKC1;HSP90AA1;PPP6R3;ZBTB48;MRE11;TERF2IP;TNKS1BP1;PIF1;RAD50;TERT;WRAP53;NOP10;RAD51
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.15334457685276093,-0.4776500625554747,0.9961013645224172,0.9984354333574841,1.0,11/31,38.29%,HSPD1;TIMM17A;TIMM21;CHCHD4;TIMM50;PEX14;ROMO1;PEX6;PEX7;GRPEL1;DNLZ
prerank,snRNA processing (GO:0016180),-0.17534688724055986,-0.47215501707006563,0.9928952042628775,0.9985900802255447,1.0,7/16,36.58%,INTS8;INTS1;INTS12;INTS2;INTS3;INTS14;INTS4
prerank,positive regulation of chromosome organization (GO:2001252),0.17970732046796875,0.46666009024007793,0.9830148619957537,1.0,1.0,4/15,20.67%,PPP1R10;NBN;SIRT6;RTEL1
prerank,peptidyl-amino acid modification (GO:0018193),0.19702485563645494,0.4649218333477394,0.9871794871794872,1.0,1.0,10/10,80.31%,METAP1;TTLL4;FKBP7;ATP7A;APOA2;APOA1;FKBP10;PDF;METAP2;METAP1D
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.1645988278085902,0.46301612845058354,0.9936440677966102,1.0,1.0,8/21,25.69%,KNTC1;ATM;KLHL22;FBXO5;ZWINT;APC;TEX14;BUB1B
prerank,protein monoubiquitination (GO:0006513),0.14878925641334498,0.4620113046265016,0.9978632478632479,1.0,1.0,4/36,10.07%,PRKN;UBE2O;MGRN1;TOPORS
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.1467335144758567,-0.4610242845763495,0.9981718464351006,0.9992084974422373,1.0,15/33,39.64%,SNRPD3;LSM11;SNRPG;CPSF4;LSM10;NCBP2;CSTF2T;SNRPB;MAZ;PCF11;CSTF3;CPSF1;SNRPE;SNRPF;NCBP1
prerank,positive regulation of viral transcription (GO:0050434),-0.15348582705496538,-0.45843636144458044,0.9981785063752276,0.9990032466616666,1.0,8/25,32.12%,DHX9;NELFE;GTF2F1;POLR2F;GTF2F2;POLR2C;POLR2L;POLR2I
prerank,synaptonemal complex organization (GO:0070193),0.1789414202297984,0.45797258972773314,0.9977324263038548,1.0,1.0,15/15,82.12%,SYCE2;TEX11;P3H4;SYCE1;SYCE3;SYCP1;BAG6;TRIP13;SYCP2;HORMAD1;RAD21L1;STAG3;TEX12;REC8;RAD21
prerank,synaptonemal complex assembly (GO:0007130),0.1789414202297984,0.45797258972773314,0.9977324263038548,1.0,1.0,15/15,82.12%,SYCE2;TEX11;P3H4;SYCE1;SYCE3;SYCP1;BAG6;TRIP13;SYCP2;HORMAD1;RAD21L1;STAG3;TEX12;REC8;RAD21
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.1707802085735557,0.45760710115249037,0.9914529914529915,1.0,1.0,4/17,23.97%,SUMO1;KCNS1;KCNS2;KCNE4
prerank,transcription preinitiation complex assembly (GO:0070897),-0.18581293157564344,-0.4553573121205545,0.9866156787762906,0.9988249951255137,1.0,12/12,81.44%,BDP1;TAF1B;TBP;TAF7L;DR1;TAF12;GTF2A2;TAF11;POLR1E;TAF1;TAF7;GTF2B
prerank,DNA packaging (GO:0006323),-0.17108842024507875,-0.4509192106679012,1.0,0.998742998752096,1.0,4/16,30.79%,CDAN1;RBBP4;BANF2;BANF1
prerank,regulation of spindle assembly (GO:0090169),-0.1506361069288545,-0.45011931870976885,0.994475138121547,0.9983658303080536,1.0,7/25,35.69%,CHMP2B;HSPA1A;CHMP2A;HSPA1B;EML3;PLK1;CHMP4B
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.19207280337041138,0.44862619014145916,0.9955257270693513,1.0,1.0,3/10,22.67%,RIF1;RTEL1;DCLRE1B
prerank,response to hydroxyurea (GO:0072710),0.1847438231726061,0.4464147237240357,0.9911894273127754,1.0,1.0,1/11,9.24%,BLM
prerank,telomere capping (GO:0016233),0.1670101762950388,0.44600910621383405,0.9912280701754386,0.9994127194384503,1.0,2/16,12.89%,STN1;NBN
prerank,positive regulation of cilium assembly (GO:0045724),-0.1613939113654582,-0.4376833115213142,1.0,0.9987843878797482,1.0,1/18,5.06%,HTT
prerank,regulation of response to stress (GO:0080134),-0.18727180814830352,-0.43601983925191634,0.9902723735408561,0.9984423861008646,1.0,5/10,37.35%,MLC1;EIF4G1;DYRK3;SLC38A2;CRHBP
prerank,cellular response to hydroxyurea (GO:0072711),0.18483061962843983,0.43590236191006143,0.9892008639308856,0.9995533689254752,1.0,1/10,9.24%,BLM
prerank,regulation of transposition (GO:0010528),0.1685744751631242,0.4228406837218124,0.9956043956043956,0.9997782931509789,1.0,3/13,20.69%,PIWIL2;TEX15;UBR2
prerank,regulation of rRNA processing (GO:2000232),0.15511500618071455,0.40467318402196845,1.0,1.0,1.0,5/16,24.58%,SHQ1;DIMT1;HEATR1;KAT2B;BUD23
prerank,tRNA 5'-leader removal (GO:0001682),-0.14860090499839343,-0.3766110039739603,0.998211091234347,1.0,1.0,6/13,43.45%,RPP38;RPP21;RPP25L;RPP40;RPP30;RPP25
prerank,peptidyl-methionine modification (GO:0018206),-0.14415712202973344,-0.35800804862316,1.0,0.9998258904442116,1.0,2/12,19.70%,NAA60;METAP1D
prerank,natural killer cell activation (GO:0030101),0.12257798825268713,0.35213857873227355,1.0,1.0,1.0,3/23,17.16%,AXL;NFIL3;RABL3
prerank,protein import into mitochondrial matrix (GO:0030150),0.1318037957938682,0.3454051051321589,1.0,0.9998623200255804,1.0,5/18,20.55%,TOMM70;PAM16;TOMM40L;TOMM40;GRPEL2
